<SEC-DOCUMENT>0001035267-21-000067.txt : 20210421
<SEC-HEADER>0001035267-21-000067.hdr.sgml : 20210421
<ACCEPTANCE-DATETIME>20210421162533
ACCESSION NUMBER:		0001035267-21-000067
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		78
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210421
DATE AS OF CHANGE:		20210421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTUITIVE SURGICAL INC
		CENTRAL INDEX KEY:			0001035267
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				770416458
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30713
		FILM NUMBER:		21841822

	BUSINESS ADDRESS:	
		STREET 1:		1020 KIFER ROAD
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94086
		BUSINESS PHONE:		4085232100

	MAIL ADDRESS:	
		STREET 1:		1020 KIFER ROAD
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94086
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>isrg-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c61f603f-ef4a-4d04-b56b-7269297a821e,g:dd118a18-5d47-4c1c-822e-29e196fcfd78,d:a2d6c54d34c741ac83a377a4ad341cb9--><html xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:isrg="http://www.intuitivesurgical.com/20210331" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>isrg-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF8zLTEtMS0xLTA_b11d3c63-6892-467f-8f1f-1b570cd55732">0001035267</ix:nonNumeric><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF81LTEtMS0xLTA_7297e6fa-cc24-44da-a496-99332210b42f">2021</ix:nonNumeric><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF82LTEtMS0xLTA_9d43fbdc-078a-4a68-9974-f05d90eba642">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF83LTEtMS0xLTA_6ed2da94-caa6-4d6a-9e39-99f7e30e4267">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGV4dHJlZ2lvbjoxNTczNzhhMjZjZGE0Y2E4YjBiZGYzNWE5OTczNTU5MF84_b6794aa3-4c60-4f70-8d3b-fefcedbfa4dc">--12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="isrg-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i84a2d48a3f934a5e846fde7d9abe944f_I20210416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i19647b4382894b77b728740dfcec06ae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i810446be2da345f89c79c2feb9f44ba9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i237add5259254f3499eccc5ee17fb8f8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i868a03d2fcbe469b92b6fc91d48e532b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ea643af9acb406e83895b7a31182401_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i545d4914e37e4c5497107f4880ab0f98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44dcefa3072841ab9e340f65c68f2e09_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i072d37fe25bb4302a174a740eff0e4f2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35bf9937caf6400d88acb13a096891c5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a75be70358e4656aae6d18d193a651e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i368e30c496574fe38438f342b8cdc48b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895e7c92ed73488cbc1472585100ffd2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f73ee5f50b46c28090374917de184f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b0c8e7e84f143d7b433e4521292b760_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i222e4ab4f50046478fb8626cd2050931_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4f3b8761ea441979a441de6b8b02816_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66ed88632684468d94839263e693131e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8f11e0d90794805a51ee4875ef2bb22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba387424719640be97f87fe83a205421_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id41180fe238f4e5494e70d7abad1bfa9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i833afe2c87e8454a87024764d94c2822_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb7e13199f44d5493cb6aa8bb70dff9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i958d733265f7468c8bb333fd2012a22a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08ae6a1daaa4488ab4a2cbc44713a1ac_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95cda8b4c1784cb3a304cb36b3e28670_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35611a332ef451ebfedc87ebfa99560_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">isrg:CollarContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a170e992d9b457f9595e8e31c382067_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia441705586c64958893ba4b26e8f9831_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6653afda804c4e6c92c1ee18d4fb6513_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44e41d62be44428bbe7bec7558efa25e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54056e1ecde648908d7a97b1e1644204_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1482cb8fa3714e7dbbbc27ada59f5747_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf9140f4a144a61a11f812b3233bee0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i455a5987f0e4495ea102bd1bb887aac7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia049734db3fb46309a15c9c21f4d5265_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fbd0c73fe99402fb77a4384d2e76b14_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86716d46a32f4177960da8dbdf213b78_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bc25cae1624497fb0288262254a7cdd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i152085248b524a7aad79030a253fd4ad_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i157c8a2a14244227b32df8ba8e8c12cd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29851492d6bf481581aacf08b75f5339_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e08c5f1b214731b6b9dbc8c5f58cd8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42118bf09f1b4f93aa3651255ba5a1b2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0134fb267a9b433d82bc15fd159a7ef1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7055642a7210446390122584f500fda4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3e657c28bcd46ae88684e0e1d05b884_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81f67fc3a5914897bfb2af66c5111c5f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1bcf40fa8c74859aa7a3f6f5cd2a321_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac9c8091fc074a50b333fe645498f038_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4b1f60c62c3443bbb2842b9ac6ff27b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2d6bd374e56486b9e830cd18f662db8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a4f0809ae7c474bb8f654639db1dda5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i371d9d7cd5994bf2b5d51f8dee8c6f30_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c310e8fe3f4e1fa74d58cde4f02a61_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20d6d2cffa74ad38d0883a8f21b0bb6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20599bf2b00d4db08e12ef6ca86133f8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0077eedf3c254281b3ccb2d1eac594d1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i075a7596ace44e8a80d6c8d9082c1342_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ecd44c2474464dbc7542ef31537629_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i316ac96134214c19b317684c3c8230bf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac5907b4d5ac44a09eff901e7f3d5739_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61c5c9b528fc40b28e5777152e16f632_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16587b9e3fa145b7a10a7a0e68039b6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd60252340be492cb5cd60dbb4959028_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dd6688329e44797b0c7cb4a51d91169_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c76c59d0038424ab43ff393ceb37cad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1b9e18b6b6149f1915a82f93f47df83_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i271e251ff82d4aa7b389387881ee1fee_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:HighMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08d038617c24c269391ce3ad0e3231a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:ModerateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216f3f95bdf84de689a958b870cb7ff1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:LowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11f28dd5602b4bde94b164d567bb287f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia55e3aa5f4234c84951ca875ab824a3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e718a145634a8392de72f4b600c0c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c39a166bad441f2ac088d8f0528a593_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1892d132f6eb47d5b382a5ecafcffd20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i147cc30e329447d293e6ac6f2f569531_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i832e07083f234f9aaae70e7f780f75ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f25478b6fff402bad373bd68ce889d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dfde143ec884cdebe7ea1111dfe6d02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifff9ccbd873145ae8414978edefcf616_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49a8ca38f4be4272b8b9502372356738_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6609492761e040349e48efd7876d43c1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd61ce4b4e2448fb329c1b58561fb64_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i881c19778193492d86fa195d0bf3a940_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f94159c88ab4b1584580110f75e4c91_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i507a2382c629428daede99bd06d29782_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75cefa24a4ba4c7a815e48c26b538d47_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbff52cf66da42ddb55647513e2a8a81_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9090c608db4547b1ac6471900a3b840f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9031b8a49b4b4593a8779ea186c3cf54_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18b1114d0328455ba73b3e48af3193e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e99e82b25614f028c511ab87510f949_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99fdcc6b644e4e0586c5ffa4473d31b7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36bc009466044639ae7d55c36d1ffc8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f4ce614b87445998e895b069fde088_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba32cf8624a94ab7bc35931cbf181914_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79c415ee3f6d4597b0b02c0a172afe2c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90458d1fd5d54ab19b5ea2abf3dcaa97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:CumulativeEffectPeriodOfAdoptionAxis">isrg:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i176adc5116364bbf8f134ba16f508f2c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:CumulativeEffectPeriodOfAdoptionAxis">isrg:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74fb387009f84c1394a499016f35aa1c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="isrg:CumulativeEffectPeriodOfAdoptionAxis">isrg:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9d8f48f16b43ce9a99c9803cd1a5cd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46a4ba9a772c44c2bbbfed1bac1aa452_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2487fa8c7cfe45e6a641a9876f892024_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16767223fe4a41809418b76a6125e9b7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22d62ec7e4044391882881b01e0b6300_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1198994ab755477ab225bc58ca03d552_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353c4ffcf6cb428b973449a30ef061b1_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f43ed2b00934f689a166e4d0edb373d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a910f990374e8b85baf857795d2362_I20190131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10e5830a5be84ccbbde2a2eff58015cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78841269b3a04c14876727a1edd45ce7_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i895226f723b74a4e944e2ab935f3b6d5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ccbc7cfb7146c487ecb64b60bdc787_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic700f68e41144f91bd35e317ae4e9f00_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ided9f564a7fc43fb9785e126f3e0792d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d02f4e8f2a84d6fadf284cdaf0651f6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39ba5ce0cdf94b51beee72537008b906_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0b9d06046ac417db9b476df68156e12_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5af8b08c9064ce3af2ced0adcf153ad_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i176cc511d2d94ee3acf60b32b9c344a4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i002513af33834fe2a6163fa9af4c9055_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b706bb5ee44d3c9e5ab754d749034e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i223c3c0566cf457c938baba52b26ec0f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie628bd5d73914b17bff4771bcdd4ec83_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id57036158f3241fbb815a228531cfa32_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001035267</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM184Nw_05886f29-2467-469e-bd52-ce8749c0be2e">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6MjhjNDQxODIyM2M2NDM3NjlmYWU1Y2ZmZTJhOGU3N2IvdGFibGVyYW5nZToyOGM0NDE4MjIzYzY0Mzc2OWZhZTVjZmZlMmE4ZTc3Yl8wLTAtMS0xLTA_b97cf52b-d997-49ce-8e0c-343d777b4c6b">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xMzc_75499c38-32b5-4eb0-bb66-d2c2c77c9caf">March 31, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6NDE3Y2JkMzc2ZGU0NDJlNmI4N2YxMGMwMmNlNGE3MWUvdGFibGVyYW5nZTo0MTdjYmQzNzZkZTQ0MmU2Yjg3ZjEwYzAyY2U0YTcxZV8wLTAtMS0xLTA_c78fde82-0f75-4808-b2ae-24fc1867d933">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18yMjg_c7117581-e520-496c-8be8-fcfaa3819d8f">000-30713</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18yMzQ_fa9c64d5-49ca-48be-adff-865590678c71">Intuitive Surgical, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its Charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6NTY4MTBkZjRkMjc2NGUyNWJhYzEyZjFkMTlhODJjNDcvdGFibGVyYW5nZTo1NjgxMGRmNGQyNzY0ZTI1YmFjMTJmMWQxOWE4MmM0N18wLTAtMS0xLTA_3a86115c-dec2-4646-b622-c2b8e2095abd">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6NTY4MTBkZjRkMjc2NGUyNWJhYzEyZjFkMTlhODJjNDcvdGFibGVyYW5nZTo1NjgxMGRmNGQyNzY0ZTI1YmFjMTJmMWQxOWE4MmM0N18wLTItMS0xLTA_b4427ffe-5041-47ff-81c8-bb913f456770">77-0416458</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of<br/>Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18yOTc_b4d04c57-8908-4b4c-a0ba-608edd9e7080">1020 Kifer Road</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zMDE_ac6539cd-73c6-4f0a-8a95-37d6f183f139">Sunnyvale</ix:nonNumeric>, <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zMDU_a3f780e8-0228-470d-9f42-9058ca3e8cdb">California</ix:nonNumeric> <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zMDg_dee8b804-acb4-49de-af0c-9c9751884f88">94086</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zNjU_ef750cae-5990-4c35-98a9-dc9e13e6007e">408</ix:nonNumeric>) <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zNjk_89d14c69-2ba3-44b2-bdb0-df1a9f6b9ea3">523-2100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.637%"><tr><td style="width:1.0%"></td><td style="width:39.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6YWRkN2VlNzYyZmNiNGI3Y2E0NGRmYWQxYzNjM2ZlNjQvdGFibGVyYW5nZTphZGQ3ZWU3NjJmY2I0YjdjYTQ0ZGZhZDFjM2MzZmU2NF8xLTAtMS0xLTA_de5c8163-cb52-4d47-a49a-2a1e27a1d6b0">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6YWRkN2VlNzYyZmNiNGI3Y2E0NGRmYWQxYzNjM2ZlNjQvdGFibGVyYW5nZTphZGQ3ZWU3NjJmY2I0YjdjYTQ0ZGZhZDFjM2MzZmU2NF8xLTEtMS0xLTA_b7609244-acfb-4521-bae2-7bdb2c8ae8d3">ISRG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6YWRkN2VlNzYyZmNiNGI3Y2E0NGRmYWQxYzNjM2ZlNjQvdGFibGVyYW5nZTphZGQ3ZWU3NjJmY2I0YjdjYTQ0ZGZhZDFjM2MzZmU2NF8xLTItMS0xLTA_729d0f55-2ab2-488c-a411-5896936de78a">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM184NDE_b279861b-5c36-4f19-99f0-88a26e213c3f">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xMTY4_6e9fe7e5-22bd-49d9-99b1-8ad0d37d32b2">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.  </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6OGMzOWIxZTJmZjA3NGRhN2E5MWIzNGY0MDliZTEzYTkvdGFibGVyYW5nZTo4YzM5YjFlMmZmMDc0ZGE3YTkxYjM0ZjQwOWJlMTNhOV8wLTAtMS0xLTA_92939437-5a07-4877-907c-586647df8404">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#168;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6OGMzOWIxZTJmZjA3NGRhN2E5MWIzNGY0MDliZTEzYTkvdGFibGVyYW5nZTo4YzM5YjFlMmZmMDc0ZGE3YTkxYjM0ZjQwOWJlMTNhOV8xLTQtMS0xLTA_b3fdafbb-91a3-43f8-a843-fdba3c7fe5ee">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6OGMzOWIxZTJmZjA3NGRhN2E5MWIzNGY0MDliZTEzYTkvdGFibGVyYW5nZTo4YzM5YjFlMmZmMDc0ZGE3YTkxYjM0ZjQwOWJlMTNhOV8yLTQtMS0xLTA_d3a57837-22e1-474e-8fc9-9811d63b5e36">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.             &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xOTE5_eff6d096-37fa-4437-8247-e4783b42c906">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Registrant had <ix:nonFraction unitRef="shares" contextRef="i84a2d48a3f934a5e846fde7d9abe944f_I20210416" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xOTUw_e85cce17-1c93-441d-bde7-7e0a33dbf82e">118,412,888</ix:nonFraction> shares of Common Stock, $0.001 par value per share, outstanding as of April&#160;16, 2021.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_7"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.942%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_13">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_13">Financial Statements (unaudited):</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">Condensed consolidated balance sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16"> and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16"> 31, 20</a>20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">Condensed consolidated statements of comprehensive income for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22"> and 20</a>20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_22">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">Condensed consolidated statements of cash flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25"> months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">March 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25"> and 20</a>20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_25">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_28">Notes to condensed consolidated financial statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_28">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_70">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_70">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_70">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_163">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_163">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_163">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_166">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_166">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_166">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_172">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_172">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_172">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_175">Item&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_175">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_175">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_178">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_178">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_178">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_181">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_181">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_181">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_184">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_184">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_184">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_187">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_187">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_187">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_190">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_190">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_190">42</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_193">Signature</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_193">43</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_13"></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1.         FINANCIAL STATEMENTS</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_16"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">in millions (except par values)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMy0xLTEtMS0w_4e1d90e2-422d-4dde-a98d-200fc0e46cc6">1,401.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMy0zLTEtMS0w_0b6247fa-17a4-4996-ab4b-b53f6f851a52">1,622.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNC0xLTEtMS0w_059d85af-b3d9-4983-b4ba-1050c98db2b2">3,155.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNC0zLTEtMS0w_c36f43ac-1420-4a8b-b7a8-f69110305165">3,488.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNS0xLTEtMS0w_fac01494-1619-4376-af89-45735646eb14">654.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNS0zLTEtMS0w_ff021add-634d-44e7-a939-d50309bec5f4">645.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNi0xLTEtMS0w_24e170ea-1630-4b74-8544-f1142bae8737">576.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNi0zLTEtMS0w_180d50fa-5112-4b41-9952-f486e633d360">601.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNy0xLTEtMS0w_e85a2f06-9fe0-43e3-bf59-09db4e4228af">277.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNy0zLTEtMS0w_b866430c-e0e1-4fd8-aa9d-19fa3b26ed6c">267.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOC0xLTEtMS0w_3d48bbda-a84d-400a-bf1c-aa70af01e294">6,066.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOC0zLTEtMS0w_b28663c5-fc9b-42b7-99d6-dd3b5dcb547f">6,625.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOS0xLTEtMS0w_0d12eef3-fa71-4785-b9eb-e2bd5a5b723a">1,592.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOS0zLTEtMS0w_1405255e-e4f3-463b-a470-ff58576a5e41">1,577.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTAtMS0xLTEtMA_45cb8445-495a-430d-8554-d92223a0dd30">2,673.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTAtMy0xLTEtMA_df42819b-567f-4abd-b2db-6b73fcda7c51">1,757.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTEtMS0xLTEtMA_0e975406-82c4-4df8-bab1-43584e02e45a">336.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTEtMy0xLTEtMA_f4d87dab-3e93-42f5-971d-644ceb14c3a4">367.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:IntangibleAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTItMS0xLTEtMA_9673b074-919f-4006-a6f1-f6af4b8a5a3b">527.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="isrg:IntangibleAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTItMy0xLTEtMA_deea2281-25a9-4411-9b7b-b0cfe8028cd5">503.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTMtMS0xLTEtMA_3445fa61-d7bc-43db-8b40-697059225641">344.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTMtMy0xLTEtMA_154fc1f7-c976-4060-88ed-683fcb3855b8">336.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTQtMS0xLTEtMA_c51d02fe-f86d-45b7-a89c-01a4b7c52aef">11,540.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTQtMy0xLTEtMA_13b60722-87a2-40e8-a0b3-2da33c8e7874">11,168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTctMS0xLTEtMA_d9bb557e-a435-4be6-a21e-e856b7b121ef">103.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTctMy0xLTEtMA_dbb93335-57d3-4cc4-a473-f8e68c9562cb">81.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTgtMS0xLTEtMA_dd6f358a-24c2-4500-a1fa-220135d9673b">194.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTgtMy0xLTEtMA_735363f8-537f-423c-902a-1cccf5758da5">235.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTktMS0xLTEtMA_64c53883-bdf0-47ca-8f33-65e0d54fc755">358.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTktMy0xLTEtMA_e138f3ee-e25d-4264-a581-ff5792dae631">350.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjAtMS0xLTEtMA_af81faa7-bbc1-4886-9062-87da5079f531">248.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjAtMy0xLTEtMA_4b226eca-3023-461c-8a89-3f1598e812e2">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjEtMS0xLTEtMA_4949f9aa-7c9b-41d0-b6b8-ff01a099754c">904.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjEtMy0xLTEtMA_261c2cb7-616c-43d0-8824-33781bb1568c">965.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjItMS0xLTEtMA_c291e90c-ffd8-4c92-82b9-194d39b53c23">445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjItMy0xLTEtMA_d22cda6d-3fcd-4588-b8e5-580986c61600">444.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjMtMS0xLTEtMA_70175b11-93cf-487b-9882-a2cc0e718816">1,350.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjMtMy0xLTEtMA_2959eb16-59d0-46ef-929d-8829160483da">1,409.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingencies (Note 8)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjQtMS0xLTEtMA_bc32c4c4-fcbb-441e-8e7b-715f8a8ae111"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjQtMy0xLTEtMA_a7a26c90-6ecb-48b3-b3e4-68592f58207d"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, <ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzIx_2e54f3bb-9bb0-41b4-8598-b5c418602ddb"><ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzIx_905b9d1c-71ed-4973-8565-27f613bada4b">2.5</ix:nonFraction></ix:nonFraction> shares authorized, $<ix:nonFraction unitRef="usdPerShare" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzQz_a6c4026b-5890-472e-b668-6bc969c076e0"><ix:nonFraction unitRef="usdPerShare" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzQz_ec7875ba-1df2-4eea-83ef-e2107074b2a1">0.001</ix:nonFraction></ix:nonFraction> par value, issuable in series; <ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_85496b66-ebb6-4350-b27c-537713aaad10"><ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_85f62270-6f72-4def-956a-208d22c090d4"><ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_c4a2c753-6615-4b94-8075-8c5f4d223491"><ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_eeea65f4-a37c-44ce-946c-9418188e82e8">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2021, and December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMS0xLTEtMA_2ff93bfe-c5ed-4418-9867-b9ed4e3a3d11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMy0xLTEtMA_acc1b8b5-dc2f-4990-b31a-ba8fc6c9a1a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzE5_f4926cbc-9376-4f2e-b216-2f5700a19dbf"><ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzE5_f95904b3-5473-4efb-852e-424ea7b63302">300.0</ix:nonFraction></ix:nonFraction> shares authorized, $<ix:nonFraction unitRef="usdPerShare" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzQx_2e6e8811-0676-4d3e-96b1-a5f4ad7b67df"><ix:nonFraction unitRef="usdPerShare" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzQx_821d95c2-feda-44ad-a15d-799ce4dc93a7">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzU1_19450217-8c85-49ca-a10d-36bcd4c2451a"><ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzU1_93f1acfe-eb4e-42e9-973e-4800befd956d">118.4</ix:nonFraction></ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzY5_38c96413-a69b-40bb-9616-6ddc18c61fef"><ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzY5_bd2c4b60-b2bf-430e-888e-1dc9aed18429">117.7</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2021, and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMS0xLTEtMA_0bbef523-f9d5-4d66-8a25-3a1a290f7347">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMy0xLTEtMA_16bc15a1-0410-448e-9400-426d77d6f845">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjgtMS0xLTEtMA_ac28d75c-d19c-40cf-8d90-8027122b7fc2">6,627.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjgtMy0xLTEtMA_a73f2093-9291-4ba8-ad31-b64c841ca7de">6,445.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjktMS0xLTEtMA_bafe3243-aa92-4574-8aae-3ffda5bb0f31">3,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjktMy0xLTEtMA_68ff3f1b-9844-423c-acb8-7718cd3470b3">3,261.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzAtMS0xLTEtMA_b9e7821e-86d7-4c88-afef-d247e8609711">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzAtMy0xLTEtMA_c9035138-b5d0-4599-9055-9018223b71d1">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Intuitive Surgical, Inc. stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzEtMS0xLTEtMA_b4e9734d-be5d-472f-a1e7-c0f53b920d97">10,153.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzEtMy0xLTEtMA_a14b8da9-2806-499d-8009-74507aca8d1d">9,731.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest in joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzItMS0xLTEtMA_bb8d0ad4-52f7-4ced-9ad0-a2a1f154536e">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzItMy0xLTEtMA_25237f25-05fb-48bb-85e3-52d00a57e1dd">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzMtMS0xLTEtMA_75493539-8c0d-4967-bf92-5ded2e7ada48">10,190.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzMtMy0xLTEtMA_40b09471-144f-453e-b311-89650ca38f3b">9,759.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzQtMS0xLTEtMA_09aef8b1-b82c-4927-85ab-a9a75b07c983">11,540.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzQtMy0xLTEtMA_343ff772-1400-4984-8624-7d39a52d3842">11,168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_22"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="margin-top:6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">in millions (except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810446be2da345f89c79c2feb9f44ba9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMy0xLTEtMS0w_f4bf2e02-9500-4239-8125-d73d2668227f">1,074.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237add5259254f3499eccc5ee17fb8f8_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMy0zLTEtMS0w_432af79b-6a45-43ec-a5b3-f870bf659cb6">900.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i868a03d2fcbe469b92b6fc91d48e532b_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNC0xLTEtMS0w_37a80c8e-4cae-4a7e-9983-9d05e256cf34">217.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea643af9acb406e83895b7a31182401_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNC0zLTEtMS0w_fcce5fa4-b7ec-4a2f-9e6d-583978c7f2cd">198.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNS0xLTEtMS0w_40208a03-6563-4f51-8136-2f3f73c83978">1,292.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNS0zLTEtMS0w_236302ce-f4f2-4cee-8815-48e17f635f49">1,099.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i810446be2da345f89c79c2feb9f44ba9_D20210101-20210331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNy0xLTEtMS0w_71a2f112-744b-46df-a6df-0c36b572aafb">319.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237add5259254f3499eccc5ee17fb8f8_D20200101-20200331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNy0zLTEtMS0w_1a57734c-1113-42fd-b45d-e8e843bd845e">296.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i868a03d2fcbe469b92b6fc91d48e532b_D20210101-20210331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOC0xLTEtMS0w_8a87cbbe-757e-444e-93b0-80cbd1225bea">70.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ea643af9acb406e83895b7a31182401_D20200101-20200331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOC0zLTEtMS0w_0a6256de-87f7-41c2-9585-ae230d6e3720">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOS0xLTEtMS0w_17ebbdcb-d4a0-436a-a104-39bc5f486ba0">389.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOS0zLTEtMS0w_9b9b146c-9d42-40cd-98af-437ba70f5f28">361.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTAtMS0xLTEtMA_5784f4af-055b-433b-ab7e-6097953c3ad4">902.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTAtMy0xLTEtMA_3ecc2665-e641-44df-9db4-48daac6d1663">738.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTItMS0xLTEtMA_00555dee-65ef-4c53-85c8-b01cfb6f17ce">326.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTItMy0xLTEtMA_e64f7ef2-c4a4-4776-be63-2cf9e2dc80fd">308.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTMtMS0xLTEtMA_65a36ac2-4226-4b96-8649-878affa34dde">159.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTMtMy0xLTEtMA_9952bf9f-5b41-4217-8c26-7a2ec64c7a58">147.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTQtMS0xLTEtMA_2455e28f-7fcf-4e0e-9f9e-296431e75b6b">485.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTQtMy0xLTEtMA_1bfc6554-f726-4e1c-a3ae-94e6aa0fffca">455.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTUtMS0xLTEtMA_1c5eaf8a-134d-4605-8613-720cdf3484ca">416.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTUtMy0xLTEtMA_a44e1d5b-e2ab-4325-a8ba-4dbcf22305af">283.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTYtMS0xLTEtMA_c4dedb9f-964c-4393-9828-b7146da578a7">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTYtMy0xLTEtMA_d47ba7bc-7e25-464d-bdb1-4121ba3be24a">25.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTctMS0xLTEtMA_4efdc173-8b1c-4e1b-a5d4-dff3722ed71d">448.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTctMy0xLTEtMA_af231878-17c1-4585-9b83-3210f3f5e913">308.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTgtMS0xLTEtMA_f26ef1d4-bde1-4181-8284-4484bacfe9bd">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTgtMy0xLTEtMA_a48ebcc4-b92b-4169-9578-47e86d897ca7">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTktMS0xLTEtMA_4acb2f88-42e0-499a-8154-f4a7e2576f2e">435.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTktMy0xLTEtMA_7d04ff3c-629d-49a2-abd8-4aac846aa2e4">316.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income attributable to noncontrolling interest in joint venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjAtMS0xLTEtMA_7d78baa6-2e45-45ed-88cb-05259b2da58b">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjAtMy0xLTEtMA_92d5e597-c3ac-43aa-a77f-6f1604e1e200">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjEtMS0xLTEtMA_2db3a2ad-a36e-4c9e-a583-e3dcf164c2de">426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjEtMy0xLTEtMA_aa23d485-ae8d-4fc4-bcb2-09b22b5886e1">313.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjMtMS0xLTEtMA_8242cafb-4dc2-451a-b5e0-701d2fcf06e9">3.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjMtMy0xLTEtMA_35380cf4-15c7-45bc-8757-8bf1c964f1fa">2.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjQtMS0xLTEtMA_44cb67ce-4545-4ede-bb39-468b4de06543">3.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjQtMy0xLTEtMA_3e2d202d-aff7-4e37-8ee4-e127705300ac">2.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjYtMS0xLTEtMA_f846a162-9ee4-4b0c-b5fb-2cfa099c5d60">118.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjYtMy0xLTEtMA_8050e4c9-3410-4f82-8d87-47153224dd5d">116.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjctMS0xLTEtMA_bae52891-30e6-4ba5-a5b9-374540759604">121.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjctMy0xLTEtMA_fcc15e17-3fdd-4be3-8e42-8923860a8481">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjgtMS0xLTEtMA_0e7f55b5-ffee-4c3f-9577-811548a05c27">421.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjktMy0xLTEtNDAxNA_c78cdf79-47a1-40cd-92e6-4e787b226781">312.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: comprehensive income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjktMS0xLTEtMzY3MQ_b9c9b6ab-3445-4b31-9358-fd038c129dd9">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMzAtMy0xLTEtNDAxNA_7e7b02fb-9a82-4d71-9aee-2230398a5480">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMzAtMS0xLTEtMA_8dd3e509-f361-415d-9d74-2dbf3ac3b567">412.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMzAtMy0xLTEtMA_23332c27-607f-4be6-9305-bd342ed6e690">310.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_25"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">in millions&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMy0xLTEtMS0w_95b799e3-75b8-4a92-92d2-889c75297005">435.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMy0zLTEtMS0w_ba323ddb-b952-4f76-a2c5-c06aafb7c35f">316.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and loss on disposal of property, plant, and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNS0xLTEtMS0w_36ea83cb-7aac-4c30-8384-0738627fb7d8">64.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNS0zLTEtMS0w_fb7f3391-9f6c-45d3-bbc9-dd7f877eb827">51.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNi0xLTEtMS0w_d4c0b940-8419-4c7d-a914-6ac4c5b86d8c">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNi0zLTEtMS0w_14954265-9afe-4b42-9f90-dcc93af05135">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on investments, accretion, and amortization, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNy0xLTEtMS0w_1fd6b3d8-6710-44dd-a220-1fb17c6a2033">12.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNy0zLTEtMS0w_b21c7893-59ca-4666-a4c4-1200669394e9">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfOC0xLTEtMS0w_54f986e1-af4c-4693-9b1b-18dd50b42b0f">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfOC0zLTEtMS0w_fc270d49-d611-47fe-afd7-e9084b19480e">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTEtMS0xLTEtMA_e45857ab-d83c-4328-b5a8-1d41ae805faf">103.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTEtMy0xLTEtMA_93c6fa5d-0463-4aee-9614-e227f0548a15">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of contract acquisition assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTItMS0xLTEtMA_0dc14bd0-bcce-46dc-a236-1345e8709722">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTItMy0xLTEtMA_5c79ec51-39f3-40b9-841f-fa414d806824">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effects of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTQtMS0xLTEtMA_df3eb378-e579-48ae-94a3-34dcca973bed">14.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTQtMy0xLTEtMA_aa7ab3e5-a40c-4804-9cef-3301de5c5e6f">118.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTUtMS0xLTEtMA_e84338c0-1a1d-484f-a001-f1fcaeaf9f45">41.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTUtMy0xLTEtMA_fb48efec-4800-479f-a198-80a22100283c">65.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTYtMS0xLTEtMA_06b484fa-a26a-4b22-85db-872a52091f44">73.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTYtMy0xLTEtMA_5e0a056f-7fec-403e-9b72-f08c76a6baf3">131.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTgtMS0xLTEtMA_f0be20f5-99be-4a0e-a71b-8f1f5780b57c">23.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTgtMy0xLTEtMA_47445d39-717e-4d81-b0a8-134f8a62f242">21.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTktMS0xLTEtMA_7217f080-2ac0-4e89-aab3-05b99df7116b">40.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTktMy0xLTEtMA_15bf11aa-7cf7-40bd-9a43-9159fac229ba">95.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjAtMS0xLTEtMA_86c3aa8a-56a3-4f8d-bfb4-7efdf31a389b">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjAtMy0xLTEtMA_caabc856-d630-4aae-865d-fded104f505b">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjEtMS0xLTEtMA_3420260b-7864-44cf-8a2f-ded5b89457a2">31.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjEtMy0xLTEtMA_b9b76ed4-9d92-4069-b4b3-01eb2ca9c285">34.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjItMS0xLTEtMA_bf799b85-de3b-4e74-9f39-cd48ce5148cd">477.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjItMy0xLTEtMA_aa26b468-4010-40ac-8e3e-3614d3fb770d">352.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjQtMS0xLTEtMA_89f00b40-4308-476e-8845-bc48fddf540f">1,833.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjQtMy0xLTEtMA_02282689-0e72-4ddf-a748-0e29a166c89d">690.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjUtMS0xLTEtMA_962941a1-e6d2-4965-88b0-d98b3e72c32d">72.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjUtMy0xLTEtMA_87b1ea26-e47e-4b78-af66-7890eb7b021b">98.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjYtMS0xLTEtMA_a87f28b1-ac3b-4f69-bd30-33732cacf9bc">1,231.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjYtMy0xLTEtMA_378ea371-5324-4672-9ee3-54d96bfb3007">617.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant, and equipment and intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjctMS0xLTEtMA_1e1aa17b-f8b7-4bda-8cb9-3c944fff5059">58.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjctMy0xLTEtMA_c7a00c0e-4e9b-4575-9f80-41002aa3cf74">105.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjgtMS0xLTEtMA_5456aca8-2bf4-42fd-ba32-650ef93255f3">8.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjgtMy0xLTEtMA_89abcb08-6b76-42b6-90f8-1070694826f0">37.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzAtMS0xLTEtMA_2118ef99-f994-472b-920d-d9691cd0b718">597.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzAtMy0xLTEtMA_4b170ae9-81a9-4a61-88b9-348b3a91290f">117.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock relating to employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzItMS0xLTEtMA_80e94730-22bc-4dae-9d8e-b0b3d65f412f">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ProceedsFromStockPlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzItMy0xLTEtMA_9a929536-91d0-4e9d-8b38-55b93e529984">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzMtMS0xLTEtMA_2ed1f670-798e-47f1-8776-ad5d28c1f532">178.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzMtMy0xLTEtMA_e8f337d2-6701-4b9f-acff-df108890a035">148.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzQtMS0xLTEtMA_72b57507-008a-4c53-be87-c820d25ae954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzQtMy0xLTEtMA_e1ee69fd-81d3-4213-8a0a-21cd84435bd2">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of deferred purchase consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzYtMS0xLTEtMA_2dbf0612-addf-4fe0-8e20-2b746141c60d">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzYtMy0xLTEtMA_1796e5fc-7485-41a6-aaa5-2a76f00b0099">21.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzctMS0xLTEtMA_d627c5fd-045f-4096-92ae-38abda4be63f">102.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzctMy0xLTEtMA_f27311eb-4d45-4c83-b8b7-6a32cdca9e9c">178.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzgtMS0xLTEtMA_d7dd1ace-bb5a-4035-b097-3ec755a5da23">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzgtMy0xLTEtMA_4f663f64-5fd0-432d-9fd8-3602ce982aa5">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzktMS0xLTEtMA_86a9eb0c-8bae-41fa-86b8-4a271fd85f7b">220.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzktMy0xLTEtMA_31466a65-059c-4487-9ed9-e901c11a1e4e">56.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDAtMS0xLTEtMA_77738c8c-3198-41cf-a6e4-f03a73c24566">1,638.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDAtMy0xLTEtMA_d66398d9-a6e3-4313-84c8-0a9ccd2ab6ec">1,182.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDEtMS0xLTEtMA_2264e296-2a27-4b82-ade1-9b6d7031240d">1,417.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDEtMy0xLTEtMA_85b02015-24db-43c9-afa8-63caa924b674">1,238.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these Condensed Consolidated Financial Statements (Unaudited).</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, &#8220;Intuitive Surgical,&#8221; &#8220;Intuitive,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_31"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zMS9mcmFnOjU4MDMyNGU4N2U1MzQyMjBiMGE3YzRjNmVlY2U0NDk2L3RleHRyZWdpb246NTgwMzI0ZTg3ZTUzNDIyMGIwYTdjNGM2ZWVjZTQ0OTZfNjY1_d55e6bb3-b06b-4f00-9457-febb85d8018a" continuedAt="i5907a9f3a2f441d5a4fe20d2a2523161" escape="true">DESCRIPTION OF THE BUSINESS</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><ix:continuation id="i5907a9f3a2f441d5a4fe20d2a2523161"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive Surgical, Inc. (&#8220;Intuitive&#8221; or the &#8220;Company&#8221;) develops, manufactures, and markets the da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgical System and the Ion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> endoluminal system.&#160;The Company&#8217;s products and related services enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. The da Vinci Surgical System consists of a surgeon console or consoles, a patient-side cart, a high-performance vision system, and proprietary instruments and accessories. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for lung biopsies.</span></ix:continuation></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_34"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2NDc_a3763d87-acf2-471e-b64a-89b5517d5edc" continuedAt="i35def5020dc24e91999fbf1b13f438fe" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i35def5020dc24e91999fbf1b13f438fe" continuedAt="i941b2e356ff749738006cbf0f4dce8b0"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2Nzc_ad8c596b-a164-4e9f-b92e-3384f7f52d84" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#8220;Financial Statements&#8221;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first three months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2NDE_11788757-7009-4a26-a7ce-9858bfaed405" escape="true">The Financial Statements include the results and the balances of the Company&#8217;s majority-owned joint venture (referred to herein as the &#8220;Joint Venture&#8221;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#8220;Fosun Pharma&#8221;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#8217; equity. The noncontrolling interest&#8217;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to additional risks and uncertainties due to the COVID-19 pandemic. The extent of the impact on the Company's business is highly uncertain and difficult to predict. The Company's customers continue to divert certain resources to treat COVID-19 patients and defer certain elective surgical procedures, both of which may impact the Company's customers' ability to meet their obligations, including to the Company. Furthermore, capital markets and economies worldwide have been negatively impacted by the COVID-19 pandemic, and it is possible that the impact could cause an extended local and/or global economic recession. Such economic disruption could have a material adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. However, the magnitude and overall effectiveness of these actions remains uncertain.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be materially adversely affected by delays in payments of outstanding receivables, supply chain disruptions, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers. For example, we have experienced, and could continue to experience, increased difficulties in obtaining a sufficient amount of materials in the semiconductor and other markets. We are engaged in activities to seek to mitigate such supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. As of the date of issuance of these Financial Statements, the extent to which the COVID-19 pandemic may materially adversely affect the Company's financial condition, liquidity, or results of operations is uncertain.</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2NDI_e34475e4-e933-4f11-905d-efe27b42a72b" continuedAt="i4d604b424c8e4a8ca6c756ac1ede701c" escape="true"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to monitor new accounting pronouncements issued by the FASB and does not believe any accounting pronouncements issued through the date of this report will have a material impact on the Company's consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i941b2e356ff749738006cbf0f4dce8b0"><ix:continuation id="i4d604b424c8e4a8ca6c756ac1ede701c"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, that are of significance, or potential significance, to the Company.</span></div></ix:continuation></ix:continuation><div id="ia2d6c54d34c741ac83a377a4ad341cb9_37"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY3Mg_b6afbad9-b2f9-4d97-89a8-4cb515e8ea4c" continuedAt="i8d651fb8d17442daa729fac20e788e60" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i8d651fb8d17442daa729fac20e788e60" continuedAt="ia33eacdb40fc48f4b78559a1d6f3ae02"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Investments</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:AvailableForSaleSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY3Nw_1047bca4-1f8d-429b-a557-da6594992454" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s cash and available-for-sale marketable securities&#8217; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):  </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d37fe25bb4302a174a740eff0e4f2_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMy0xLTEtMS0w_4e9af3e1-1083-44e8-98bc-1f4612de024f">565.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d37fe25bb4302a174a740eff0e4f2_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMy05LTEtMS0w_6f23e34f-c521-415a-928a-0517c4141d59">565.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072d37fe25bb4302a174a740eff0e4f2_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMy0xMS0xLTEtMA_747a8d58-f800-4fa3-9278-9f854f5875a8">565.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xLTEtMS0w_d8c31fa2-cbe8-4817-a845-2e3b6974d5df">817.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS05LTEtMS0w_c8733397-3782-47ce-be82-47f18dd13f9d">817.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xMS0xLTEtMA_6cbcab04-c41e-4435-b064-57c1f3e56191">817.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xMy0xLTEtMA_6dfc9de5-f45b-4640-a286-1dbfa011f58d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xNS0xLTEtMA_146f5ef3-e232-41a5-968f-3dbebc28878e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xLTEtMS0w_ce5ea9df-9450-4964-93a1-348a8870a67e">2,678.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0zLTEtMS0w_52dd76c8-e2fb-4fd0-a342-baafe63215c6">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi01LTEtMS0w_06f3fff9-e88f-467d-87de-878c601cb1d1">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi03LTEtMS0w_3051dfbb-83a7-445e-873f-4e0a40bbc263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi05LTEtMS0w_09918744-0397-4138-b645-4e417b3fa56d">2,694.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xMS0xLTEtMA_db708f4e-e5ab-41b6-88a6-ed3e60698554">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xMy0xLTEtMA_6f85f1ad-1f29-4b4e-9227-86511dc48bf3">1,245.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xNS0xLTEtMA_ad6cbeec-88c0-487c-9ae5-b9752ada677a">1,444.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xLTEtMS0w_ddad1f7b-9650-4264-b03d-475047b62432">3,495.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0zLTEtMS0w_454a121d-0394-4f1f-8ba9-5008a9c4a908">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy01LTEtMS0w_8641455c-ad8c-4ec6-84ad-020e389cd01a">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy03LTEtMS0w_d50f2f6e-a07e-4ca7-a1aa-a8c59ca59f35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy05LTEtMS0w_fb9f1d79-86b4-4854-a4b6-db285a6f57a0">3,511.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xMS0xLTEtMA_d38c5e22-451e-4796-ab1d-28f12a2b892c">821.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xMy0xLTEtMA_2204f948-c804-4d0e-9262-09d8aedff69b">1,245.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xNS0xLTEtMA_5716ae15-ae17-4ff1-a9b0-86438b32a21a">1,444.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xLTEtMS0w_20abaf49-2299-44cb-9c8e-1ec773578332">643.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0zLTEtMS0w_cfddc9b9-9350-43f4-a8af-abd91672da55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS01LTEtMS0w_de752b1e-9c42-4f89-9401-8891addc1de2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS03LTEtMS0w_916386c0-9bfc-470f-9313-68563d26de1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS05LTEtMS0w_95a57782-7179-46af-ac9b-e3e363aa0339">643.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xMS0xLTEtMA_5ef68bfc-4912-42b8-95d2-6f00843021f3">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xMy0xLTEtMA_1707b20c-5c63-45dd-b8b8-e8faee02ba5b">627.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xNS0xLTEtMA_858c3d57-352e-4356-9217-8cc09f7929df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMS0xLTEtMA_2e5c5f9e-fbf9-4bcc-a27b-a6dd4f61ac22">1,640.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMy0xLTEtMA_d0b59d1d-16c0-46f8-92c4-e7e83bee69a6">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtNS0xLTEtMA_79f34c61-f8ae-4cf7-837b-06bb6b710742">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtNy0xLTEtMA_5b93528c-61d3-44d8-878a-a8e295e1308b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtOS0xLTEtMA_acb3e7ae-1685-4e2c-ab28-2a0a06db253b">1,647.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMTEtMS0xLTA_bd2b96c2-91a5-451c-a37d-1363e73afe6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMTMtMS0xLTA_685cd98b-9e41-4bbe-a1db-da4d529741b6">966.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMTUtMS0xLTA_ea0305c9-211f-4069-ae64-c3f596ac2a63">680.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMS0xLTEtMA_eaa3986e-5384-40a6-bcf9-e22259aaa7dd">676.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMy0xLTEtMA_61058909-4f1d-48b7-9ffa-1f4c23d03080">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtNS0xLTEtMA_66cb7e0f-409a-49f7-b219-d83cf0674b4e">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtNy0xLTEtMA_91e1529f-8f6e-48eb-a64a-2ea7684bd3cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtOS0xLTEtMA_6e6e121c-7078-461a-825a-dac3a92229b4">677.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMTEtMS0xLTA_610e466e-5894-4a8b-bcc9-0993566ccfa1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMTMtMS0xLTA_7ca69f53-fa43-4f9a-a3a1-cd46f7ffc15b">254.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04f73ee5f50b46c28090374917de184f_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMTUtMS0xLTA_727fe7aa-f95d-43b7-ad8c-ebe93f79accb">423.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMS0xLTEtMA_fbdba082-0924-4b25-ab40-4534cf7e6a01">184.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMy0xLTEtMA_01a7e0d1-489e-4612-ab2f-ba7d8ebedc0e">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtNS0xLTEtMA_c797d362-3cfd-483b-b3f1-27abad27b4cd">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtNy0xLTEtMA_9d30fc76-8629-4011-92cc-5333eadcecc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtOS0xLTEtMA_2d2fc881-3bee-44cd-8fac-84206a51fce4">186.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMTEtMS0xLTA_3bb1dd8a-2808-4486-ad1f-0f74ac1469ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMTMtMS0xLTA_a73648fc-5f15-4719-865d-1b4a4804e399">61.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMTUtMS0xLTA_3ead987c-2ad3-4f54-8377-d0afc9b98b37">124.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMS0xLTEtMA_094c6203-e765-44d5-9901-02b5aa04ae4a">3,144.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMy0xLTEtMA_15a6c88e-ba8b-4278-8551-860ab7ca891d">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtNS0xLTEtMA_57ac3d5c-6e00-45ee-99c0-6166364430b9">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtNy0xLTEtMA_830460e6-19a3-4ea0-9c4f-a8c6deb3ad36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtOS0xLTEtMA_ba58dc57-c46d-46b3-a649-76dd24a68569">3,154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMTEtMS0xLTA_fe5293c1-aea6-4613-b35e-91b96532633b">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMTMtMS0xLTA_bfd9b154-9791-4251-a6b1-1ceb141bee19">1,909.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMTUtMS0xLTA_6a67ba1b-d103-4d1f-9f1e-6b33787b032b">1,228.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMS0xLTEtMA_8bcfc64f-8902-4eca-bc46-9183dbb40df9">7,204.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMy0xLTEtMA_5b7f6a09-bdb8-4e19-b9b9-9992b638daf4">29.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtNS0xLTEtMA_b933c608-20e3-4898-a950-2e4793a5a243">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtNy0xLTEtMA_4976be97-4a5f-4696-a71a-19d828ff1bf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtOS0xLTEtMA_47147772-e65d-4310-92e9-04523adfd6df">7,230.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMTEtMS0xLTA_03d831a3-5645-4144-b49a-5ffe08ed9f3d">1,401.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMTMtMS0xLTA_67b1ee6d-fc9f-44b1-97d5-f3cfecfc86f1">3,155.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMTUtMS0xLTA_dd842dcf-8601-4673-bc9d-93589f3ab50a">2,673.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMy0xLTEtMS0w_92ef0975-d953-4ecd-a226-ac6a9b8f8b04">644.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMy05LTEtMS0w_76f99201-c08f-4e57-ba8d-53eeab013da1">644.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMy0xMS0xLTEtMA_5b739573-9a79-4586-907e-8325398a08e0">644.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xLTEtMS0w_ab857ac3-2707-4e89-bcd7-0e7951649ea4">625.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS05LTEtMS0w_4021ef89-61e2-40fb-8f7e-3a298beb6689">625.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xMS0xLTEtMA_8f4ba14c-6ae0-4136-811d-cc002ae304b8">625.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xMy0xLTEtMA_7ac1a089-565c-4d49-b8ce-29b7ee66c838">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xNS0xLTEtMA_025b1df6-fa3d-459f-a2e2-1adb58a31a1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xLTEtMS0w_07d29be1-7b3b-428f-a67f-cd4c6804fbb2">2,626.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0zLTEtMS0w_f778881a-ae98-4f36-8c3f-e2d0a454c84f">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi01LTEtMS0w_11b1d2d4-77b5-425a-b9ee-b0fe360788b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi03LTEtMS0w_7ca04422-20fa-46b4-a797-2cb59283877e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi05LTEtMS0w_448f5593-c94b-4a20-bda1-ef8ed79fd481">2,649.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xMS0xLTEtMA_2c36aaef-6533-42a6-8ef6-223aafdc6c16">212.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xMy0xLTEtMA_eaf76e20-e7a3-4d26-b51c-7f277d2ff92f">1,567.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xNS0xLTEtMA_027081c2-b0a1-42f1-90f2-8521d27fd4dc">869.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xLTEtMS0w_79d71fcb-0a54-4baa-b422-eac53d1aa5e0">3,252.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0zLTEtMS0w_3624e144-0c25-4680-80eb-3e7fdabf84bc">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy01LTEtMS0w_ed90edcd-316a-4819-9cc9-7a5628056ef7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy03LTEtMS01MjQ4_b9503cda-f530-470a-b7db-16ed59af71fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy05LTEtMS0w_200c74f1-bbb7-4810-bc74-8d4eb1d09711">3,275.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xMS0xLTEtMA_e7e89228-0cfd-44ce-bc46-d470469cf15c">838.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xMy0xLTEtMA_04e8d732-dc03-4413-b46c-abb5d6dcef05">1,567.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xNS0xLTEtMA_a969f0f1-e8d0-4857-82b1-934cc62b0bef">869.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xLTEtMS0w_0fc7ebe3-ffac-4efa-b0cd-69073484f1da">671.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0zLTEtMS0w_c748e070-f742-48db-8469-5efef7ed33f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS01LTEtMS0w_aa9a316a-d249-48d2-91c3-54d21a4c4a15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS03LTEtMS0w_cc95b22a-515c-436b-861e-b86bea13ed89">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS05LTEtMS0w_23cf5f47-aeba-4783-9e34-c658c787e651">671.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xMS0xLTEtMA_55911135-7e90-44f5-a2f0-760ec957b079">64.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xMy0xLTEtMA_dcccf69c-978a-4771-b3f5-f1c6a80e8048">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xNS0xLTEtMA_be462cb8-6534-4a16-898c-8b80ad4db21c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMS0xLTEtMA_ff03fedd-5de5-4b34-9fbb-166aa17be5b8">1,425.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMy0xLTEtMA_e104e1da-4ee4-4bd6-a03b-d0bb3729a08f">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtNS0xLTEtMA_502b7c35-4730-49b8-b9c3-d0df3d61943d">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtNy0xLTEtMA_891d28c8-1f0f-4a1d-b8a3-519cfdefdea3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtOS0xLTEtMA_73d62f25-6575-44cc-8f46-b134b7985f13">1,437.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMTEtMS0xLTA_e531609a-5204-42a7-ae05-1f112b0574e2">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMTMtMS0xLTA_04d8dcce-903f-4ac8-90cf-5a0261581e85">1,036.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66ed88632684468d94839263e693131e_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMTUtMS0xLTA_39d7cd17-34bb-4f99-a6e8-a2d03eab6d68">397.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMS0xLTEtMA_3ce92cd8-902f-44bc-bc4a-8f765d93975b">716.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMy0xLTEtMA_298bfb4b-4657-4f3e-b7e1-14d7b14705fd">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtNS0xLTEtMA_aeb9297c-972d-4516-9d6f-56451847ac02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtNy0xLTEtMA_cc15c13a-d4f1-48af-8e9c-6de653d64bc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtOS0xLTEtMA_024eff84-95f8-47e9-bc60-34bba686daba">719.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMTEtMS0xLTA_79bf9264-d4d7-4ae1-8381-67fb9196abcc">72.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMTMtMS0xLTA_3b0bd2b1-4458-4186-9351-35ec37e6143f">233.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMTUtMS0xLTA_e71c33cd-dfd4-4bfd-b84a-1fa46aed0307">412.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMS0xLTEtMA_ea9a84e9-8ef0-4b93-baa2-ac3e68a4f0a4">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMy0xLTEtMA_6187ff35-1898-49aa-84c0-974662abab2c">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtNS0xLTEtMA_69ff9c3c-757e-4f5a-bbb9-2ef89ba7529e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtNy0xLTEtMA_3aeadc4d-c3ba-4183-8297-739568198fcd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtOS0xLTEtMA_5a297f31-25b7-43d1-bd80-92baa21c0064">121.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMTEtMS0xLTA_4084e871-5a6f-444a-89e0-4bfe24889b96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMTMtMS0xLTA_f8789189-58b8-4f63-bb95-4d11644ae5ff">43.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMTUtMS0xLTA_4383f320-7b06-4aa7-9e65-772c0c327331">78.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMS0xLTEtMA_8c1e07df-391e-452e-b665-3ad631e59348">2,933.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMy0xLTEtMA_85da3e19-1010-41a8-8f59-6dba2281ea1b">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtNS0xLTEtMA_42ebbea2-adf8-4d57-bd3f-20d3709ccf2c">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtNy0xLTEtNTI0OA_267c779a-aff7-4a6e-8086-02437ce184c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtOS0xLTEtMA_2fadd11d-1f77-4140-93f2-0da86c6165f3">2,949.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMTEtMS0xLTA_b774a043-692a-48ae-8740-f5280f981c06">140.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMTMtMS0xLTA_4cdce0f8-ca64-43d8-a2a2-05b2eda01227">1,920.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMTUtMS0xLTA_8b5e5eb9-2a6e-4c91-85ff-4ea63a72f828">888.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMS0xLTEtMA_ab9de3f4-d74f-4142-ad19-662a41528e2d">6,829.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMy0xLTEtMA_f8944c7a-6d6f-47d2-a711-99ae96f1d3ee">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtNS0xLTEtMA_8f013e87-344c-4b47-8ed8-632b5f5b57c3">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:zerodash" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtNy0xLTEtNTI0OA_61d57149-de75-4d0e-854f-af4c609fb86c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtOS0xLTEtMA_39ade547-19be-40e3-8529-03006fcbbb73">6,869.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMTEtMS0xLTA_7a70258d-f304-4178-bb6b-b2b9373179ee">1,622.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMTMtMS0xLTA_cdbec4ce-80d5-4b4e-a554-d0a220bc866b">3,488.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMTUtMS0xLTA_8b924094-6d06-45fd-aeef-7ae136eaf1b9">1,757.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="ia33eacdb40fc48f4b78559a1d6f3ae02" continuedAt="i06eabb890981487887cdc7d955893165"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY2NQ_7d963c73-4374-4bbf-bb68-c474ffa34bb7" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of March&#160;31, 2021 (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMS0xLTEtMS0w_28cdd5a6-2374-4707-ad81-de13bb5d0033">3,166.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMS0zLTEtMS0w_4b20be27-e801-4b8b-932f-b2543bbda84a">3,175.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMi0xLTEtMS0w_3d08a5db-a5fe-4625-bbf3-35a8ee8946e6">2,655.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMi0zLTEtMS0w_2943d4a3-1f26-4ffc-8cb9-cca4b84dfa29">2,673.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfNC0xLTEtMS0w_7a832578-ccd9-4948-bb15-27ed6f3f1d0d">5,822.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="isrg:AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfNC0zLTEtMS0w_05fcc440-c373-4000-b5f1-e82fdc6acc6f">5,848.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities, because certain borrowers have the right to call or prepay certain obligations. Realized gains and losses recognized on the sale of investments were not material for any of the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment portfolio at any point in time contains available-for-sale debt securities including investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds. The Company segments its portfolio based on the underlying risk profiles of the securities and have a zero loss expectation for U.S. treasury and U.S. government agency securities. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. For the three months ended March&#160;31, 2021, the credit losses related to available-for-sales debt securities were not significant.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company generally recognizes equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY3NA_7ccc873a-f3ec-4185-b1a4-1a3da6fa28f9" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to equity investments (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:24.229%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020<br/>Carrying Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Changes in Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sales/Purchases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible and other assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments with readily determinable value (Level 1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi0xLTEtMS0w_75d93ff0-4f4c-4c39-8902-db7bf4fb0581">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba387424719640be97f87fe83a205421_D20210101-20210331" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi0zLTEtMS0w_45bcadfe-31e3-4682-87aa-6ab14f9131a0">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba387424719640be97f87fe83a205421_D20210101-20210331" decimals="-5" sign="-" name="isrg:EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi01LTEtMS0w_582eb5cf-64f5-4b06-bdbf-4eaefca9151f">71.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi03LTEtMS0w_7815efaa-1dc0-42be-bc2c-ad0593053ceb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id41180fe238f4e5494e70d7abad1bfa9_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi05LTEtMS0w_d337b426-d26d-4462-8971-1f3cfee1c1cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833afe2c87e8454a87024764d94c2822_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi0xMS0xLTEtMA_8ebef3f4-57ee-40cb-aa59-90d494d09658">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments without readily determinable value (Level 2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy0xLTEtMS0w_3297dc5f-c718-4b20-90ec-25e22e05503e">30.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331" decimals="-5" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy0zLTEtMS0w_2b2adcdb-e6ee-400e-a70a-07f829ee9075">14.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331" decimals="-5" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy01LTEtMS0w_0af10dfa-c925-459d-a2f9-9d19c5833b9b">0.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy03LTEtMS0w_3062b6fe-a568-4d28-a401-351487bb78aa">45.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdb7e13199f44d5493cb6aa8bb70dff9_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy05LTEtMS0w_19cb2b4c-f67c-4998-bf74-5f021f1520d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i958d733265f7468c8bb333fd2012a22a_I20210331" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy0xMS0xLTEtMA_79c4128c-06d6-414b-b9d6-bbeb739bd33b">45.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in Interest and other income, net.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a $<ix:nonFraction unitRef="usd" contextRef="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfMTU5OA_c702558d-2507-4d6c-87bf-78203d3f3e07">14.3</ix:nonFraction>&#160;million increase in fair value, which was reflected in Interest and other income, net, due to changes in observable prices for certain equity investments that had been held at cost, because they lacked readily determinable market values. Additionally, in January 2021, the Company sold all of its shares of Teladoc Health, Inc. ("Teladoc"), a publicly traded company, for $71.5&#160;million and recognized a gain of $11.4&#160;million, which was reflected in Interest and other income, net. This gain was offset by a $7.5&#160;million loss recognized upon the settlement of a corresponding derivative collar contract. There were no decreases in fair value reflected in net income due to impairments.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Derivatives</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of the Company&#8217;s hedging program is to mitigate the impact of changes in currency exchange rates on net cash flow from foreign currency-denominated sales, expenses, intercompany balances, and other monetary assets or liabilities denominated in currencies other than the U.S. dollar (&#8220;USD&#8221;). The terms of the Company&#8217;s derivative contracts are generally twelve months or shorter. The derivative assets and liabilities are measured using Level 2 fair value inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into currency forward contracts as cash flow hedges to hedge certain forecasted revenue transactions denominated in currencies other than the USD, primarily the Euro (&#8220;EUR&#8221;), the British Pound (&#8220;GBP&#8221;), the Japanese Yen (&#8220;JPY&#8221;),&#160;and the Korean Won (&#8220;KRW&#8221;). The Company also enters into currency forward contracts as cash flow hedges to hedge certain forecasted expense transactions denominated in EUR and the Swiss Franc (&#8220;CHF&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these derivatives, the Company reports the unrealized after-tax gain or loss from the hedge as a component of accumulated other comprehensive income/(loss) in stockholders&#8217; equity and reclassifies the amount into earnings in the same </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i06eabb890981487887cdc7d955893165"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period in which the hedged transaction affects earnings. The amounts reclassified to revenue and expenses related to the hedged transactions and the ineffective portions of cash flow hedges were not material for the periods presented.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives Not Designated as Hedging Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of forward contracts that the Company uses to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the USD, primarily the EUR, GBP, JPY, KRW, CHF, Indian Rupee ("INR"), Mexican Peso ("MXN"), Chinese Yuan ("CNY"), and New Taiwan Dollar ("TWD").</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY1OA_bccb512e-637d-4f1c-bfa2-a588b6972356" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.364%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized gains/(losses) in Interest and other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08ae6a1daaa4488ab4a2cbc44713a1ac_D20210101-20210331" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMi0xLTEtMS0w_50bf373f-9183-4fd3-adf9-abfea9f02f1c">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95cda8b4c1784cb3a304cb36b3e28670_D20200101-20200331" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMi0zLTEtMS0w_b3dc6c7e-ec77-4ccb-b216-d849aa882cf2">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains/(losses) related to balance sheet re-measurement</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMy0xLTEtMS0w_50cc882a-503f-4bd2-8782-2df3fc69beaf">7.1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMy0zLTEtMS0w_a02b285c-ec37-47d6-b831-6eda74fdc146">8.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January 2021, the Company settled a collar contract previously entered into to hedge its equity investment in Teladoc Health, Inc. For the three months ended March&#160;31, 2021, a loss of $<ix:nonFraction unitRef="usd" contextRef="ie35611a332ef451ebfedc87ebfa99560_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDk0NzgwMjMzNDIwOA_23e9739a-9c26-40dc-ae4f-7a908dc87619">7.5</ix:nonFraction>&#160;million was recognized in Interest and other income, net.</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY1MQ_431a0a1b-2104-4f4e-bfe5-6718dbaf1e6a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:47.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.257%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional amounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Forward contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a170e992d9b457f9595e8e31c382067_I20210331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy0xLTEtMS0w_1a7d312b-a761-4bfb-b95c-2893897bcc68">165.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia441705586c64958893ba4b26e8f9831_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy0zLTEtMS0w_d9f4dc1b-fa1e-4a72-b712-8d77153bf743">154.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6653afda804c4e6c92c1ee18d4fb6513_I20210331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy01LTEtMS0w_1b4ae8cd-ad04-4ae2-b93c-6ec259e417f8">384.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44e41d62be44428bbe7bec7558efa25e_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy03LTEtMS0w_37e001be-697e-4186-a310-6999cfe5cf68">309.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross fair value recorded in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54056e1ecde648908d7a97b1e1644204_I20210331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS0xLTEtMS0w_782a20be-efd9-4c51-a91c-f75f2e8cb005">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1482cb8fa3714e7dbbbc27ada59f5747_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS0zLTEtMS0w_b3df3db3-ff2e-4d06-9d36-c99631758472">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf9140f4a144a61a11f812b3233bee0_I20210331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS01LTEtMS0w_9cfef458-9a26-41ae-a00b-8e10c6eca3f4">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i455a5987f0e4495ea102bd1bb887aac7_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS03LTEtMS0w_5102700e-8aea-4c74-9931-0dddc7c7ddb2">0.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia049734db3fb46309a15c9c21f4d5265_I20210331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi0xLTEtMS0w_ffe88f28-406c-4dee-b427-5eba6c3e0f98">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fbd0c73fe99402fb77a4384d2e76b14_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi0zLTEtMS0w_dbcdda62-8b21-4c2c-9ef8-c5e6562f747a">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86716d46a32f4177960da8dbdf213b78_I20210331" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi01LTEtMS0w_27649360-6769-4ffa-b6e0-25164bc43d97">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bc25cae1624497fb0288262254a7cdd_I20201231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi03LTEtMS0w_b34a4ee0-84e2-420a-bc4a-c83c3b08d1f1">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_40"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzU0_e4158017-125c-4df5-b9bb-a92bf27a6b69" continuedAt="ic8b24cc3dee84f7d955ec45ffbe3c2a7" escape="true">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="ic8b24cc3dee84f7d955ec45ffbe3c2a7" continuedAt="i88ddd2edf7294ec18ce43bf57ed6b711"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Details</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzU1_239bf030-2671-4591-a595-6b6a63ae0d53" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide details of selected balance sheet line items (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Inventory</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMi0xLTEtMS0w_de271e9d-7ee7-4d64-adb9-667c42b85134">167.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMi0zLTEtMS0w_a36e9227-607a-47a2-98cc-d740037019e2">184.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMy0xLTEtMS0w_0a105006-300b-4dc4-8e75-7a3a5412c162">67.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMy0zLTEtMS0w_cebf51e1-824f-469b-9667-cfe521a23f88">75.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNC0xLTEtMS0w_9f59a224-614f-4d21-805d-897a86575883">341.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNC0zLTEtMS0w_f2b63086-bf9b-44e0-87be-ee693920a8ed">341.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNS0xLTEtMS0w_9fb065ec-72a3-41ca-bc2e-cc9ca68a202e">576.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNS0zLTEtMS0w_bcad0ba5-f6eb-4491-9714-516e47c2aaad">601.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzI3_1358293c-b543-407e-9bf6-47a5c8074d09" continuedAt="i785822ad8b124e6f81299105c6b58a6d" escape="true"></ix:nonNumeric><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzYw_7f65c956-7ae2-417b-b500-7662a168cbdb" continuedAt="i9dcf5a47201240ebbeaf8fd36f3d585b" escape="true"></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i88ddd2edf7294ec18ce43bf57ed6b711"><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i785822ad8b124e6f81299105c6b58a6d"><ix:continuation id="i9dcf5a47201240ebbeaf8fd36f3d585b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:69.968%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.994%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.997%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMi0xLTEtMS0w_274d2068-d544-4166-b43b-7fe131509a66">72.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMi0zLTEtMS0w_93f7acd4-952b-4840-9fed-f7b88677fd2f">28.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMy0xLTEtMS0w_e8b2ab0a-8abd-4e0d-8d87-ae06d673cf5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMy0zLTEtMS0w_dfd1aa82-9eff-4ed8-87f9-712bd52da2d9">60.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases &#8211; short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNC0xLTEtMS0w_e08a906b-8284-4964-9543-c9d351ee068c">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNC0zLTEtMS0w_4d09fe30-8461-4c0a-ae18-9aae1d607a05">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNS0xLTEtMS0w_778a66bc-1fbe-4e3e-8906-fad16c180637">126.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNS0zLTEtMS0w_8b5340c1-2718-492b-b871-7bc11c47882e">97.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaids and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNi0xLTEtMS0w_85b17752-05bc-4245-a764-d71246ef0190">277.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNi0zLTEtMS0w_16ebe76b-dd15-46c8-903f-9849c21f8daa">267.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzM5_ec28c56d-09ca-4382-9c3b-51f06e5e36d7" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other accrued liabilities&#8211;short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfMi0xLTEtMS0w_deb0ff10-1142-4a48-8556-17c025d233a3">50.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:TaxesPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfMi0zLTEtMS0w_734bdce8-c37a-4d02-9dde-ca3f688fd73d">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred purchase consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:DeferredPurchaseConsiderationPaymentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNC0xLTEtMS0w_bfd12804-2d2d-48b4-a4c4-954c4e828fa5">12.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="isrg:DeferredPurchaseConsiderationPaymentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNC0zLTEtMS0w_94828d99-8763-4757-b189-ce20e5675542">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNS0xLTEtMS0w_ea9bdb07-72b2-4b0f-99b5-f9e13ba4f97e">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNS0zLTEtMS0w_eb1a67d0-834c-4422-9100-ef0021e7ee13">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNi0xLTEtMS0w_488d8f60-bc15-4d3f-9d7b-a6491fb4f7cc">183.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNi0zLTEtMS0w_91a6a627-08a7-4987-9a42-3f3575200780">225.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities&#8211;short-term</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNy0xLTEtMS0w_66ef1bdb-0b11-4be2-b8fb-24fec061a1d3">248.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNy0zLTEtMS0w_70784cee-60ac-4bef-9451-f8e07e17bd94">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzU2_5979090c-3149-4d50-9911-8a7a78099e8d" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other long-term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes&#8211;long-term</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMi0xLTEtMS0w_97c3468d-fffc-45c3-88d6-c11dac2223cd">319.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMi0zLTEtMS0w_94b01b7e-8601-466f-84a5-6c1e5c9ee113">305.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue&#8211;long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMy0xLTEtMS0w_363e7180-34aa-4e47-975e-9cf97930d0cc">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMy0zLTEtMS0w_3c8793ea-3823-4b93-8847-7db1d4295156">32.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNC0xLTEtMS0w_dc22aeaa-cefb-42f3-9843-d0a62411771b">95.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNC0zLTEtMS0w_d56e8561-2d30-4ac3-a93e-a566fb2d9bb7">106.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNS0xLTEtMS0w_19b66141-0c99-45af-b60d-3bd9493746ea">445.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNS0zLTEtMS0w_0b36cd3b-7990-4ddb-9a08-e158f6f0e037">444.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzQx_556202ee-e9ca-46fc-9b66-00b27f578e6c" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental non-cash investing and financing activities (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMi0xLTEtMS0w_39c6d707-a1a8-4228-90ee-0dcd9156114e">73.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentTransfersAndChanges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMi0zLTEtMS0w_e76d7208-4f04-4266-b99d-42fde7309bb4">45.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0xLTEtMS00NDgw_be7de2d8-451c-43ce-a81b-4a9db17cdafe">27.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0zLTEtMS00NDg2_dd9a51bc-643d-44b3-b8a6-6830c5a67d0f">50.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payments and contingent consideration related to business combinations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0xLTEtMS0w_5eec1387-6963-4c82-835d-7fab379ea601">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0zLTEtMS0w_3994a57a-c05d-4cad-aeca-ec6e9de92bc4">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU1OQ_3d0cc6bc-cd5c-49c0-a6ca-7d3a6a4878eb" continuedAt="id7d35b2838634ab69efc9fcd9bdac90d" escape="true">REVENUE AND CONTRACT ACQUISITION COSTS</ix:nonNumeric></span></div><ix:continuation id="id7d35b2838634ab69efc9fcd9bdac90d" continuedAt="idc899909567245edb54bd8aa90980771"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU2MA_9afd06f8-dc1c-4a31-8497-a1ab1d69250e" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by types and geography (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i152085248b524a7aad79030a253fd4ad_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMi0xLTEtMS0w_5add32e2-fe46-4fe7-a88b-2dbad47a1b37">500.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i157c8a2a14244227b32df8ba8e8c12cd_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMi0zLTEtMS0w_41f011bd-3b79-45fa-95cb-8d022c53933f">444.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29851492d6bf481581aacf08b75f5339_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMy0xLTEtMS0w_ad041073-ee15-44eb-a1f4-6f885b745f45">202.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e08c5f1b214731b6b9dbc8c5f58cd8_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMy0zLTEtMS0w_f90407c8-dc50-49a5-a4fe-70db5a883b99">198.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42118bf09f1b4f93aa3651255ba5a1b2_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNC0xLTEtMS0w_90a7c274-b2b7-4bd2-8d03-3b1dac881f22">144.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0134fb267a9b433d82bc15fd159a7ef1_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNC0zLTEtMS0w_bc0a1ad0-b64a-47fc-a493-732f029863a4">138.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7055642a7210446390122584f500fda4_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNS0xLTEtMS0w_99c804a8-a65a-4a3c-acf5-f1abbf2cd754">847.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e657c28bcd46ae88684e0e1d05b884_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNS0zLTEtMS0w_6a021c1d-12fe-4282-b8bd-82d3d8eaf54c">781.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Outside of U.S. (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f67fc3a5914897bfb2af66c5111c5f_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOC0xLTEtMS0w_e1d15c22-0c0f-45ed-88ea-96787a3bfe07">205.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1bcf40fa8c74859aa7a3f6f5cd2a321_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOC0zLTEtMS0w_5bf08099-9f8e-4043-963b-5a7014eb51d0">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9c8091fc074a50b333fe645498f038_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOS0xLTEtMS0w_9eb61052-4a4c-4c80-bc41-598be937f724">166.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4b1f60c62c3443bbb2842b9ac6ff27b_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOS0zLTEtMS0w_22053c82-182b-4c22-9688-945003bd3905">84.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2d6bd374e56486b9e830cd18f662db8_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTAtMS0xLTEtMA_4e503880-caad-48b7-96cf-e63d882151c2">73.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a4f0809ae7c474bb8f654639db1dda5_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTAtMy0xLTEtMA_81401d8d-820c-4168-a35d-1d6e270b38c4">60.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total OUS revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i371d9d7cd5994bf2b5d51f8dee8c6f30_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTEtMS0xLTEtMA_09d4f102-8f17-4382-a195-f92869bafb61">444.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35c310e8fe3f4e1fa74d58cde4f02a61_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTEtMy0xLTEtMA_d024f365-45e6-4928-8a40-a4a151eb4f53">317.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic20d6d2cffa74ad38d0883a8f21b0bb6_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTQtMS0xLTEtMA_a56257e9-7d61-4420-8995-f31c05506f7b">705.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20599bf2b00d4db08e12ef6ca86133f8_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTQtMy0xLTEtMA_6b0620ca-2bfe-4198-b248-ffe52f5655e6">617.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0077eedf3c254281b3ccb2d1eac594d1_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTUtMS0xLTEtMA_57941f1b-38e2-4417-9db0-219edf09d5d3">368.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i075a7596ace44e8a80d6c8d9082c1342_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTUtMy0xLTEtMA_5c13badd-ea11-4671-b968-809557a22d63">283.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ecd44c2474464dbc7542ef31537629_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTYtMS0xLTEtMA_945d4548-ed77-4c53-be6b-ce751bbc5906">217.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316ac96134214c19b317684c3c8230bf_D20200101-20200331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTYtMy0xLTEtMA_05ed1bef-f1bb-4b4c-aa72-8669c52e828c">198.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTctMS0xLTEtMA_018a6f6f-bca3-4382-bea8-f1172be40dc3">1,292.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTctMy0xLTEtMA_42a9bc1f-1519-4acf-8909-98c61f682ea2">1,099.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which revenue has not yet been recognized. A significant portion of this amount relates to performance obligations in the Company&#8217;s service contracts that will be satisfied and recognized as revenue in future periods. In addition, non-lease elements associated with the Company's lease arrangements are primarily comprised of service contracts that will be satisfied and recognized as revenue in future periods. The transaction price allocated to the remaining performance obligations and the non-lease elements associated with lease arrangements was $<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfODU1_b4b6c466-a8a1-4ad5-a7db-b539d16a3684">1,673</ix:nonFraction> million as of March&#160;31, 2021. The remaining performance obligations are expected to be satisfied over the term of the individual sales arrangements, which generally are <ix:nonNumeric contextRef="iac5907b4d5ac44a09eff901e7f3d5739_I20210331" format="ixt-sec:duryear" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMTAwNw_19a8723f-918d-49f9-bbf0-c906d6baa4ba">5</ix:nonNumeric> years. Service revenue associated with the lease arrangements will generally be recognized over the service period, which generally coincides with the lease term.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU2Ng_37bd0102-fb3e-4d08-b09e-f6fb4b4a263f" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s contract assets and liabilities (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfMy0xLTEtMS0w_4689419c-fd2c-48a5-a791-9b925ebc8f3a">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfMy0zLTEtMS0w_8e34a6a2-a74a-4242-a090-12cea62a36ca">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfNC0xLTEtMS0w_1829419a-d19b-4e22-984f-a5e575dbe6b0">389.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfNC0zLTEtMS0w_c70db16a-6551-4e1e-99a9-58fa6d076dc3">382.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invoices its customers based on the billing schedules in its sales arrangements. Payments are generally due 30 days from date of invoice. Contract assets for the periods presented primarily represent the difference between the revenue that was recognized based on the relative standalone selling price of the related performance obligations satisfied and the contractual billing terms in the arrangements. Deferred revenue for the periods presented primarily relates to service contracts where the service fees are billed up-front, generally quarterly or annually, prior to those services having been performed. The associated deferred revenue is generally recognized over the term of the service period. The Company did not have any significant impairment losses on its contract assets for the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMjE4Ng_260d00b6-6754-419a-a3d7-40373bd144ba">153.9</ix:nonFraction>&#160;million of revenue that was included in the deferred revenue balance as of December&#160;31, 2020. During the three months ended March&#160;31, 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMjM4Nw_9fa65115-69e3-4ecc-8834-b69d88770a9a">137.0</ix:nonFraction>&#160;million, of revenue that was included in the deferred revenue balance as of December&#160;31, 2019.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="idc899909567245edb54bd8aa90980771"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intuitive System Leasing</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU1Nw_bee96965-fc76-4268-b07f-eb39f28762bf" escape="true"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU2Nw_ea2238d9-24c5-4bc9-8e5f-719e3401a53a" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMi0xLTEtMS0w_727c161a-62fc-4fc6-8b44-939149058dc2">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMi0zLTEtMS0w_35094c97-3acd-413b-8431-36d4c27bef4f">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMy0xLTEtMS0w_514aca0b-3052-490c-b2ba-480bbfafb041">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMy0zLTEtMS0w_f60e8660-ba41-4d5d-ba60-636052ea11f1">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, and 2020, variable lease revenue relating to usage-based arrangements was not material.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts is based on the Company&#8217;s assessment of the collectibility of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. For the three months ended March&#160;31, 2021, and 2020, bad debt expense was not significant.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of lease and trade receivables as hospital cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.</span></div></ix:continuation><div id="ia2d6c54d34c741ac83a377a4ad341cb9_46"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:LessorSalesTypeLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzE5_158e5f20-3368-4382-9a2f-70cef172db0e" continuedAt="i8eb4f819baa940b1bb59159642ce66ec" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i8eb4f819baa940b1bb59159642ce66ec"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzA1_56be0b9b-8e04-4732-9aee-fe6dc2024bf5" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-type Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzA3_10189b62-c999-4327-8a0b-918cac29fde0" continuedAt="ibdbcc35dbfcf4652b5e76bffd4e03ed6" escape="true">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:center"><ix:continuation id="ibdbcc35dbfcf4652b5e76bffd4e03ed6"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:SalesTypeLeaseGrossInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMi0xLTEtMS0w_e36b6507-c4bb-4b3a-9d98-1588ae2bf306">281.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="isrg:SalesTypeLeaseGrossInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMi0zLTEtMS0w_37299846-d15b-442a-b3d9-c43ffb34a3a2">286.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:SalestypeLeaseDeferredSellingProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMy0xLTEtMS0w_c8bb1c4a-abdd-46ce-8b78-9bff1d91ec47">10.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="isrg:SalestypeLeaseDeferredSellingProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMy0zLTEtMS0w_59913d96-fe8d-4c08-b6d4-559ed55246d3">11.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNC0xLTEtMS0w_84b11348-43cb-4b55-831f-4d4374b79691">270.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNC0zLTEtMS0w_2df5795d-5e41-405e-9571-fa77676f48c9">275.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNS0xLTEtMS0w_2089c5ba-1cf9-4550-83b6-afdd6c0e6ed2">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNS0zLTEtMS0w_bd8127c0-050f-46f0-97b7-d8370b65be6c">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNi0xLTEtMS0w_74c95514-5bc5-42c3-b1bd-5caf7689e297">266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNi0zLTEtMS0w_9b0a6b2d-7963-418f-b297-13160c8068dd">270.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61c5c9b528fc40b28e5777152e16f632_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOC0xLTEtMS0w_3061399a-cb17-44e3-8f41-2a2486a8505a">79.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16587b9e3fa145b7a10a7a0e68039b6b_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOC0zLTEtMS0w_95bceacd-ff90-43b9-b822-a841be8ca319">81.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd60252340be492cb5cd60dbb4959028_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOS0xLTEtMS0w_bda182b4-a899-4e5f-945f-96df01550926">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd6688329e44797b0c7cb4a51d91169_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOS0zLTEtMS0w_e583c6ac-30da-495b-a7ca-967678ae598a">189.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMTAtMS0xLTEtMA_cf7eeefc-5e3e-4328-8c78-87e1d3e7fcaa">266.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:SalesTypeLeaseLeaseReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMTAtMy0xLTEtMA_4cceb7a7-0bd4-48ab-8c5b-7547fb3e18b5">270.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzE3_5db5d371-1c70-4c22-9d2b-98a08309810f" escape="true"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of gross lease receivables at March&#160;31, 2021, are as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfMS0xLTEtMS0w_50618462-9ba9-447c-9aec-9c9d2b84f4af">66.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfMi0xLTEtMS0w_22f31ef8-a95b-4bcd-a375-d968495d83f3">74.5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfMy0xLTEtMS0w_d14243db-a2f8-4f5b-908e-c0c0392f052e">59.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNC0xLTEtMS0w_b94b80ba-2d12-4167-99f8-4ded04ca0189">49.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNS0xLTEtMS0w_83ccf2c9-47e9-45cc-92be-d21e1508d955">27.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNi0xLTEtMS0w_50dce811-081a-43bb-857d-84659f723e86">5.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNy0xLTEtMS0w_e00230d5-e330-4ee9-8cdc-d4aae6714ed6">281.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into sales-type leases with certain qualified customers to purchase its systems. Sales-type leases have terms that generally range from <ix:nonNumeric contextRef="i3c76c59d0038424ab43ff393ceb37cad_I20210331" format="ixt-sec:durmonth" name="us-gaap:LessorSalesTypeLeaseTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMTA5OTUxMTYyODMwMQ_f0d2a382-3c36-4a04-8ed1-bc18374f314c">24</ix:nonNumeric> to <ix:nonNumeric contextRef="if1b9e18b6b6149f1915a82f93f47df83_I20210331" format="ixt-sec:durmonth" name="us-gaap:LessorSalesTypeLeaseTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMTA5OTUxMTYyODMwOA_437dc51e-1954-4952-bff3-c73b7919515b">84</ix:nonNumeric> months and are usually collateralized by a security interest in the underlying assets. The allowance for loan loss is based on the Company's assessment of current expected lifetime loss on lease receivables. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the lease receivable balances, and current economic conditions that may affect a customer's ability to pay. Lease receivables are considered past due 90 days after invoice.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages the credit risk in net investment in sales-type leases using a number of factors, including, but not limited to the following: size of operations; profitability, liquidity, and debt ratios; payment history; and past due amounts. The Company also uses credit scores obtained from external providers as a key credit quality indicator for the purposes of determining credit quality. The following table presents credit quality by class of net investment in sales-type lease as of March&#160;31, 2021. <ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMTE1NDQ4NzIwOTQ4OTU_c9272e5c-05c9-44ca-a2fd-6b9d2fb2eca7" continuedAt="icf64fe054729492da005571179fbebfd" escape="true">The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of March&#160;31, 2021 (in millions):</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify"><ix:continuation id="icf64fe054729492da005571179fbebfd"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.311%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Rating:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0xLTEtMS01MTk2_56773257-0ac9-40b6-8cc6-9cd9d9350808">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0zLTEtMS01MTk2_6170c0c8-26be-4bf6-858d-1547fccbf223">70.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi01LTEtMS01MTk2_81607ce5-5625-4817-8afc-d761983daa2b">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi03LTEtMS01MTk2_c7815509-224c-4fd3-9202-f8f301a2374b">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi05LTEtMS01MTk2_336910ff-b0e3-4fea-b372-a461b56af323">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0xMS0xLTEtNTE5Ng_1ecaf384-0ed6-4cf7-b122-fdaa4360a1be">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0xMy0xLTEtNTE5Ng_ecf54204-113b-4d02-bb47-7bafdd825c3e">129.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0xLTEtMS01MTk2_ad1e6b9e-cee8-4902-9299-99a64ab577c6">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0zLTEtMS01MTk2_dd12dace-5112-4adc-b180-7dde6a3c54a8">77.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy01LTEtMS01MTk2_f0918574-27a3-4d9f-a1a6-dcfa8ebb4a9c">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy03LTEtMS01MTk2_9b8cd359-12d9-4c2f-8750-7815089aa83c">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy05LTEtMS01MTk2_2160ea71-1a19-4f75-861e-e403749caaa3">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0xMS0xLTEtNTE5Ng_ce2288f4-d100-49d9-9e2d-1dd81fb77e69">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0xMy0xLTEtNTE5Ng_d8030347-b9da-4f39-b4db-d91d9152a658">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0xLTEtMS01MTk2_6d14bf53-b72d-4a7b-9cca-c3b34df7e2f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0zLTEtMS01MTk2_94f9b14b-d23a-4d4a-9c69-a9f25e9b6074">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC01LTEtMS01MTk2_7b9c8c47-d6b2-4616-82ec-5f00365b7fab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC03LTEtMS01MTk2_b18fe953-94c8-4924-9d9a-973be934f506">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC05LTEtMS01MTk2_78e30dad-b888-4fd7-80dc-d65c3b4760d6">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0xMS0xLTEtNTE5Ng_76fef06c-090b-4021-add4-754bfd87a087">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0xMy0xLTEtNTE5Ng_40090f76-b56f-48b4-a6f5-d184603ec64f">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0xLTEtMS01MTk2_451b93e1-7573-4a79-9a9a-52ff9f0c6685">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0zLTEtMS01MTk2_0a3ea637-1132-49e5-a17f-522a9773f696">149.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS01LTEtMS01MTk2_8c6c856d-0034-4fea-92fe-6b3f5acc8f8e">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS03LTEtMS01MTk2_d36e7bca-3472-4f14-b717-8bf45a775586">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS05LTEtMS01MTk2_aeee7888-e80f-4a4d-8bb9-bc4670864bda">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0xMS0xLTEtNTE5Ng_aa9055c4-20aa-4956-8160-c498053d46c2">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:SalesTypeLeaseNetInvestmentInLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0xMy0xLTEtNTE5Ng_f9941579-5c17-4ed3-bce3-c39242cfb855">270.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, and 2020, credit losses related to net investment in sales-type leases were not significant.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_49"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg3Nw_9adf504e-1a88-45e2-9e81-35d1b7c1a173" continuedAt="i03ba9c6016424141b217dddbfdf6818f" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i03ba9c6016424141b217dddbfdf6818f" continuedAt="i1bbcdcd2c28b4ab89bb9862bd838cf6a"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material acquisitions for the three months ended March&#160;31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orpheus Medical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company acquired Orpheus Medical Ltd. and its wholly-owned subsidiaries (&#8220;Orpheus Medical&#8221;) to deepen and expand our integrated informatics platform (the &#8220;Orpheus Medical Acquisition&#8221;). Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in capturing, processing, and archiving clinical videos across the hospital. The Orpheus Medical Acquisition did not have a material impact on the financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg3OA_a8edac6c-3255-4d4d-8265-d7cf1bc7d13b" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfMS0xLTEtMS0w_337a17ad-4fc3-4781-a3cd-528d8d0ae598">336.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition activity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfMi0xLTEtMS0w_5d4ad550-6ca7-463e-a2ea-9bf3b1ecb628">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfMy0xLTEtMS0w_5643ff9e-d93d-4b7b-868b-a9a2e2d37f35">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfNC0xLTEtMS0w_f68c78b5-a977-45ed-8385-7256ebe4af93">344.5</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg3OQ_6a65432e-fe0a-4b91-8c88-9d1241abd2be" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11f28dd5602b4bde94b164d567bb287f_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi0yLTEtMS0w_88fad381-ccbc-4000-aa2f-50e7f44d056f">215.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11f28dd5602b4bde94b164d567bb287f_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi00LTEtMS0w_8771a2cb-ed23-430c-a73d-44c196bf9ed3">161.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11f28dd5602b4bde94b164d567bb287f_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi02LTEtMS0w_9dab3ef3-8cac-4dad-ade8-0952d4a9904b">53.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55e3aa5f4234c84951ca875ab824a3e_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi04LTEtMS0w_5e6b77b5-f5dc-41e7-a503-bbe668fe89dd">198.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia55e3aa5f4234c84951ca875ab824a3e_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi0xMC0xLTEtMA_4b52051f-c76d-4ae3-9e1b-0ddd06693c73">158.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia55e3aa5f4234c84951ca875ab824a3e_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi0xMi0xLTEtMA_ee727335-b8d2-4f65-9cbf-f99767237e2b">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution rights and others</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy0yLTEtMS0w_5a032325-4ea9-4c99-9fc9-21a6780e9c36">44.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy00LTEtMS0w_03ff07f6-c426-4c74-93de-4b450c5b49a9">31.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy02LTEtMS0w_baf6e485-9803-40c0-a7e5-4b0c4af754d3">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e718a145634a8392de72f4b600c0c0_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy04LTEtMS0w_c825275e-e8c3-4a4d-a257-cd1c5cc32705">91.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e718a145634a8392de72f4b600c0c0_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy0xMC0xLTEtMA_89c2d645-071c-413d-88e5-da748698b979">77.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e718a145634a8392de72f4b600c0c0_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy0xMi0xLTEtMA_14696fc1-6140-4055-b5c8-f01db820a7e0">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC0yLTEtMS0w_d0f42eb1-2dfd-41b1-af1d-13fdd98a1ca1">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC00LTEtMS0w_d0d040e1-cc67-42b5-9915-dcae258eb674">38.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC02LTEtMS0w_8cb94d56-f6a1-44ea-be93-a02d271a5c87">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c39a166bad441f2ac088d8f0528a593_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC04LTEtMS0w_aedec318-979c-4189-b178-153142d9ab5c">59.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c39a166bad441f2ac088d8f0528a593_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC0xMC0xLTEtMA_58c45d6a-4407-42e5-a623-ab96bf52eb0b">35.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c39a166bad441f2ac088d8f0528a593_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC0xMi0xLTEtMA_b19a106c-fb23-4de8-b96e-6443c57270ef">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS0yLTEtMS0w_c01497a7-f5f9-4011-b1f3-a737b456a2ec">319.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS00LTEtMS0w_001c6840-14e7-4b6e-805b-441e2e686f96">232.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS02LTEtMS0w_68db9ef4-c3eb-4e5f-91a1-7883882f0ddb">87.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS04LTEtMS0w_028d5fbb-5c62-43bc-a0a1-16dad4ca1ab9">349.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS0xMC0xLTEtMA_09158885-1afe-4422-97a4-ac3a4504eca9">271.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS0xMi0xLTEtMA_c5033d09-3bfc-4a26-93b0-524203f7a190">77.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i1bbcdcd2c28b4ab89bb9862bd838cf6a"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTMyOQ_d4c0b940-8419-4c7d-a914-6ac4c5b86d8c">6.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTMzNg_14954265-9afe-4b42-9f90-dcc93af05135">12.3</ix:nonFraction> million for the three months ended March&#160;31, 2021, and 2020, respectively.</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg4MA_11a9d9ff-ef96-4e71-89c8-e879c1e60ed5" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to intangible assets as of March&#160;31, 2021, is as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfMS0xLTEtMS0w_a2150466-c0b1-42c8-9496-c61264266f0b">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfMi0xLTEtMS0w_7301f803-af6a-4dd8-834f-8d7ea6ebe116">23.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfMy0xLTEtMS0w_c55be7b6-f124-4b9a-852d-3d915669d0df">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNC0xLTEtMS0w_3831efbe-6851-4e4e-a455-5b64e6c8aba7">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNS0xLTEtMS0w_a7c8c318-afd4-4083-9c73-461060819ec5">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="isrg:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNi0xLTEtMS0w_db285831-938a-434f-9a17-1b98ab006e4b">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNy0xLTEtMS0w_f8f3375b-62aa-442f-8b79-d196b7c82fe8">87.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, measurement-period adjustments to intangible assets, changes in foreign currency exchange rates, impairments of intangible assets, accelerated amortization of intangible assets, and other events.</span></div></ix:continuation><div id="ia2d6c54d34c741ac83a377a4ad341cb9_52"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81Mi9mcmFnOjc2N2E0MmZkZjM5YTQ0MDk4MTY2NDhkM2VjOWNlOGU4L3RleHRyZWdpb246NzY3YTQyZmRmMzlhNDQwOTgxNjY0OGQzZWM5Y2U4ZThfODE4OQ_4f877fdd-2ad4-4050-a8f1-cc0695983356" continuedAt="i092f5bacc52f4459b87606feb8ddd32f" escape="true">CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i092f5bacc52f4459b87606feb8ddd32f" continuedAt="i97240fee34fe4d80b0328e3403ab53b5"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in a variety of claims, lawsuits, investigations, and proceedings relating to securities laws, product liability, intellectual property, insurance, contract disputes, employment, and other matters. Certain of these lawsuits and claims are described in further detail below. It is not possible to predict what the outcome of these matters will be, and the Company cannot guarantee that any resolution will be reached on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A liability and related charge to earnings are recorded in the Financial Statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. Nevertheless, it is possible that additional future legal costs (including settlements, judgments, legal fees, and other related defense costs) could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently named as a defendant in a number of individual product liability lawsuits filed in various state and federal courts. The plaintiffs generally allege that they or a family member underwent surgical procedures that utilized the da Vinci Surgical System and sustained a variety of personal injuries and, in some cases, death as a result of such surgery. Several of the filed cases have trial dates in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cases raise a variety of allegations including, to varying degrees, that plaintiffs&#8217; injuries resulted from purported defects in the da Vinci Surgical System and/or failure on the Company&#8217;s part to provide adequate training resources to the healthcare professionals who performed plaintiffs&#8217; surgeries. The cases further allege that the Company failed to adequately disclose and/or misrepresented the potential risks and/or benefits of the da Vinci Surgical System. Plaintiffs also assert a variety of causes of action, including, for example, strict liability based on purported design defects, negligence, fraud, breach of express and implied warranties, unjust enrichment, and loss of consortium. Plaintiffs seek recovery for alleged personal injuries and, in many cases, punitive damages. The Company disputes these allegations and is defending against these claims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of the anticipated cost of resolving the pending cases is based on negotiations with attorneys for the claimants. The final outcome of the pending lawsuits and claims, and others that might arise, is dependent on many variables that are difficult to predict, and the ultimate cost associated with these product liability lawsuits and claims may be materially different than the amount of the current estimate and accruals and could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations. Although there is a reasonable possibility that a loss in excess of the amount recognized exists, the Company is unable to estimate the possible loss or range of loss in excess of the amount recognized at this time.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i97240fee34fe4d80b0328e3403ab53b5"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2017, Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US LLC (collectively, &#8220;Ethicon&#8221;) filed a complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint, which was served on the Company on July 12, 2017, alleges that the Company&#8217;s EndoWrist</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stapler instruments infringe several of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,585,658, 8,479,969, 9,113,874, 8,998,058, 8,991,677, 9,084,601, and 8,616,431. A claim construction hearing occurred on October 1, 2018, and the court issued a scheduling order on December 28, 2018. On March 20, 2019, the court granted the Company&#8217;s Motion to Stay pending an Inter Partes Review to be held at the Patent Trademark and Appeals Board to review patentability of six of the seven patents noted above and vacated the trial date. On August 1, 2019, the court granted the parties' joint stipulation to modify the stay in light of Ethicon's U.S. International Trade Commission (&#8220;USITC&#8221;) complaint against Intuitive involving U.S. Patent Nos. 8,479,969 and 9,113,874, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2018, Ethicon filed a second complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that the Company&#8217;s SureForm 60 Staplers infringe five of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 8,602,288, 8,602,287, and 9,326,770. The Company filed an answer denying all claims. On March 19, 2019, Ethicon filed a Motion for Leave to File a First Amended Complaint, removing allegations related to U.S. Patent No. 9,326,770 and adding allegations related to U.S. Patent Nos. 9,844,379 and 8,479,969. On July 17, 2019, the court entered an order denying the amendment, without prejudice, and granting the parties&#8217; joint stipulation to stay the case in its entirety in light of the USITC investigation involving U.S. Patent Nos. 9,844,369 and 7,490,749, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2019, Ethicon filed a complaint with the USITC, asserting infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 9,844,379, 9,113,874, and 8,479,969. On June 28, 2019, the USITC voted to institute an investigation (No. 337-TA-1167) with respect to the claims in this complaint. The accused products include the Company's EndoWrist 30, EndoWrist 45, SureForm 45, and SureForm 60 Staplers, as well as the stapler reload cartridges. The evidentiary hearing took place in February 2021. A Final Initial Determination by the USITC was scheduled for October 2021. An unfavorable ruling by the USITC could have an adverse effect on our results of operations, including a prohibition on importing the accused products into the U.S. or necessitating workarounds that may limit certain features of our products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, Restore Robotics LLC and Restore Repair LLC (&#8220;Restore&#8221;) filed a complaint alleging anti-trust claims against the Company. On May 13, 2019, Restore filed an amended complaint alleging anti-trust claims relating to the da Vinci Surgical System and EndoWrist service, maintenance, and repair processes. On September 16, 2019, the Court partially granted and partially denied the Company's Motion to Dismiss the amended complaint.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company filed an answer denying the anti-trust allegations and filed a counterclaim against Restore. The Company filed amended counterclaims after the Court partially granted and partially denied Restore's Motion to Dismiss the counterclaim. The amended counterclaims allege that Restore violated the Federal Lanham Act, the Federal Computer Fraud and Abuse Act, and Florida's Deceptive and Unfair Trade Practices Act and that Restore is also liable to the Company for Unfair Competition and Tortious Interference with Contract. On January 7, 2020, the Court denied Restore's Motion to Dismiss the amended counterclaims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or before February 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, Rebotix Repair Inc. (&#8220;Rebotix&#8221;) filed a complaint alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The complaint was formally served on the Company on October 6, 2020. On March 8, 2021, the Court partially granted and partially denied the Company's Motion to Dismiss the complaint. The Company filed an answer denying the anti-trust allegations and filed counterclaims against Rebotix. The counterclaims allege that Rebotix violated the Federal Lanham Act and Florida's Deceptive and Unfair Trade Practices Act and that Rebotix is also liable to the Company for Tortious Interference with Contract.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or around March 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTU4_402e0ba9-f9d9-4a15-8ce8-d025eec45099" continuedAt="if545dd5793fc4010909c13d212dbdc78" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="if545dd5793fc4010909c13d212dbdc78" continuedAt="idc6e14cb2e7647198c0464fdd3922b38"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholders&#8217; Equity</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTQ0_14d0210c-238f-41cd-ae9a-3b8afb170633" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in stockholders&#8217; equity (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1892d132f6eb47d5b382a5ecafcffd20_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xLTEtMS0w_00b9be88-f7b9-4992-ac12-97bffd8fa985">117.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1892d132f6eb47d5b382a5ecafcffd20_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0zLTEtMS0w_64601b73-23ff-4ce6-8f79-2df5b0aaaee9">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147cc30e329447d293e6ac6f2f569531_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy01LTEtMS0w_80e9f9c6-5202-4f0e-9466-afc610d8269d">6,445.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i832e07083f234f9aaae70e7f780f75ea_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy03LTEtMS0w_a6f29b08-9b08-4c62-a15a-da17e51d65e2">3,261.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f25478b6fff402bad373bd68ce889d7_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy05LTEtMS0w_97e4c6dd-bb70-4359-a518-c5d21d662022">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dfde143ec884cdebe7ea1111dfe6d02_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xMS0xLTEtMA_2e2bda48-cd9d-4121-9a04-d6f092d640f3">9,731.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff9ccbd873145ae8414978edefcf616_I20201231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xMy0xLTEtMA_a7d1fc93-6fbb-43d4-8cd8-28936b2aee68">27.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xNS0xLTEtMA_9a286d72-f145-4bd8-a3d4-6e67d2871165">9,759.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i49a8ca38f4be4272b8b9502372356738_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS0xLTEtMS0w_caf4f61b-87d0-4a4d-96df-6409d82a8929">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS01LTEtMS0w_d6a2e43d-f085-4c4c-a37c-f88e68363a19">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS0xMS0xLTEtMA_1484c14e-5959-4d8e-8329-eb564c435680">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS0xNS0xLTEtMA_aed3754f-7ae0-4840-9688-836196d5d6a4">84.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i49a8ca38f4be4272b8b9502372356738_D20210101-20210331" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi0xLTEtMS0w_9780cc33-3b8b-458e-8a35-45a45f090605">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi01LTEtMS0w_37e3c26a-30b1-477d-8361-24660a175f7e">5.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fd61ce4b4e2448fb329c1b58561fb64_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi03LTEtMS0w_55cf9b6c-f0a2-4884-b047-b0c13accdcb4">172.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi0xMS0xLTEtMA_ac9eb48c-b835-49cb-85cc-4a0c6aa10eb8">178.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi0xNS0xLTEtMA_d59456d9-f2f3-46ef-89de-67e7736d9e36">178.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNy01LTEtMS0w_5e184c91-c252-47d1-983e-c437dff5d661">103.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNy0xMS0xLTEtMA_49f7de8e-6d5f-4648-baa9-fa85d7999663">103.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNy0xNS0xLTEtMA_c09e286d-2958-43ae-bde3-1044e006d960">103.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fd61ce4b4e2448fb329c1b58561fb64_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfOS03LTEtMS0w_09a9a217-ffcc-4ca5-836c-307960e7c0ff">426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfOS0xMS0xLTEtMA_0c68ad5f-d219-4835-9af5-142559bf4868">426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfOS0xNS0xLTEtMA_7bdaf1c1-8a98-4913-95c6-8320fcd2662b">426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i881c19778193492d86fa195d0bf3a940_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtOS0xLTEtMA_a88e00a2-4c6b-46a1-b67a-f1a5d5c14d85">13.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtMTEtMS0xLTA_99aed765-b5c1-4d2f-b2b6-98a926f7fef0">13.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f94159c88ab4b1584580110f75e4c91_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtMTMtMS0xLTA_37e44266-42c2-4bc0-9b74-8a9b8a29b91d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtMTUtMS0xLTA_d7ae5cbe-dfed-4932-82d9-fde2402bcf1b">13.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f94159c88ab4b1584580110f75e4c91_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTItMTMtMS0xLTA_fc8fea90-52fe-4872-a9db-bd6a0c614aed">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTItMTUtMS0xLTA_834b16ad-5029-415f-a5f9-1ce011852542">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i507a2382c629428daede99bd06d29782_I20210331" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMS0xLTEtMA_350640be-6d26-4057-b45e-1270b50b7588">118.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507a2382c629428daede99bd06d29782_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMy0xLTEtMA_f6aeb58d-d6f3-4e37-9b0f-8645b9bfe2cb">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75cefa24a4ba4c7a815e48c26b538d47_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtNS0xLTEtMA_c08ae561-4ae4-462a-bd31-a63b627d475c">6,627.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbff52cf66da42ddb55647513e2a8a81_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtNy0xLTEtMA_6790f99e-e2b9-42db-ad29-fcf418ebecdb">3,514.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9090c608db4547b1ac6471900a3b840f_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtOS0xLTEtMA_76d39776-5353-44b5-940f-de4205f5804a">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9031b8a49b4b4593a8779ea186c3cf54_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMTEtMS0xLTA_887b8a34-ad26-48dd-b470-141841ad941e">10,153.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b1114d0328455ba73b3e48af3193e1_I20210331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMTMtMS0xLTA_7d16b925-73d5-495e-aeb9-b8fc1ddd83dd">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMTUtMS0xLTA_f4c46f0a-7236-457e-99ed-60b0de9b9d12">10,190.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:25.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.135%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.164%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2e99e82b25614f028c511ab87510f949_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMS0xLTEtMA_9b28da4a-4a68-49b6-895b-f6a32f9e3eb0">116.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e99e82b25614f028c511ab87510f949_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMy0xLTEtMA_5fd84565-fa0f-4949-892c-c3e7234e8467">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fdcc6b644e4e0586c5ffa4473d31b7_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtNS0xLTEtMA_592cc440-e615-40ac-a6bd-87aa471bbe72">5,756.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib36bc009466044639ae7d55c36d1ffc8_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtNy0xLTEtMA_2437aff3-aede-4dba-bb1e-5b26516d96d9">2,494.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f4ce614b87445998e895b069fde088_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtOS0xLTEtMA_5570bfa6-38a1-4532-95fd-d470b6bbb244">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba32cf8624a94ab7bc35931cbf181914_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMTEtMS0xLTA_5df45ae0-cc8f-4aa5-a0bb-1889ab0b1ba6">8,263.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c415ee3f6d4597b0b02c0a172afe2c_I20191231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMTMtMS0xLTA_b6a6c8f6-b379-4ea6-8d08-31d97a6b9fa0">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMTUtMS0xLTA_c1822d84-c4d8-4326-a1fc-83eff713a49c">8,284.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90458d1fd5d54ab19b5ea2abf3dcaa97_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTktNy0xLTEtNDU2NQ_70a5c324-d8e3-4b96-8498-e35668322285">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i176adc5116364bbf8f134ba16f508f2c_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTktMTEtMS0xLTUyMjQ_0774a810-e02c-4987-a5e3-65862f6606a2">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74fb387009f84c1394a499016f35aa1c_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTktMTUtMS0xLTUyMjc_82c54683-40a7-4062-82b6-2b9950ed63bd">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtMS0xLTEtMA_523de7a9-850a-411f-9343-7ae11b271014">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtNS0xLTEtMA_e0ab9325-7ef3-468a-a9d7-3e68d3935a7e">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtMTEtMS0xLTA_9d035e97-8c67-4d9b-9faf-e1a95961fb94">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtMTUtMS0xLTA_84b5398d-53db-4130-8236-82a4a8fd8b2d">91.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331" decimals="-5" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtMS0xLTEtMA_c082e6d6-8acb-46ae-a68b-e216f37b48eb">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtNS0xLTEtMA_797cc402-3737-437d-92b3-b758464c7fd5">6.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtNy0xLTEtMA_1c7bc63a-9499-406f-a792-076a8c0df84e">142.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtMTEtMS0xLTA_2d8cad61-4820-492b-b4e8-c5add1499f28">148.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtMTUtMS0xLTA_e33fd8dd-b1dc-41c6-ae36-940f6df614b7">148.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjItNS0xLTEtMA_67eadb43-7abd-4b70-9222-35504835d116">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjItMTEtMS0xLTA_ac03d7d5-7813-497d-a475-ea6c9af0be07">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjItMTUtMS0xLTA_2d78ca11-ba4e-4e6d-95c4-f8b28632e5a5">90.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtMS0xLTEtMA_b2b4200d-09b0-45aa-a87e-3a9e60a7da36">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtNS0xLTEtMA_939d385a-5071-443d-b7ee-f40df3965f54">5.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtNy0xLTEtMA_edc62ccb-4ed6-4b99-a474-7f28bf74fcb4">94.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtMTEtMS0xLTA_cea74c04-e40d-4fec-92cb-d652d7949b13">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtMTUtMS0xLTA_7b00eab6-1ce6-4fee-a2be-01c1453de8bd">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjQtNy0xLTEtMA_dcb281aa-a563-491c-8654-a0b3a81edda3">313.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjQtMTEtMS0xLTA_83649b19-644d-4c31-af17-025f3f51cb28">313.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjQtMTUtMS0xLTA_d32e7592-877b-4ff2-97e0-1c4f9948edf6">313.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff9d8f48f16b43ce9a99c9803cd1a5cd_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtOS0xLTEtMA_a1a0008f-82da-48fc-af45-129d1cf32fc9">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtMTEtMS0xLTA_26fb41e5-43a9-41c6-9ebf-1f5d24494c5c">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a4ba9a772c44c2bbbfed1bac1aa452_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtMTMtMS0xLTA_e7aff574-6293-4da5-94ce-f74180b7e04d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtMTUtMS0xLTA_d0fdde14-3a2d-4704-b9f5-3fa410e80e12">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46a4ba9a772c44c2bbbfed1bac1aa452_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjYtMTMtMS0xLTA_fd703fa4-ffce-4d55-9502-364c83d31825">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjYtMTUtMS0xLTA_b5afee90-61e8-45e8-abaa-c8f5144fa0d9">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2487fa8c7cfe45e6a641a9876f892024_I20200331" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMS0xLTEtMA_c34ce9cf-ad01-4f90-b3d2-20ba16ea5728">116.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2487fa8c7cfe45e6a641a9876f892024_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMy0xLTEtMA_43ad273a-2574-4778-b8f9-94ab112f1ef4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16767223fe4a41809418b76a6125e9b7_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctNS0xLTEtMA_26bbfd35-87ba-4925-96f1-a5ab02b137c3">5,926.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d62ec7e4044391882881b01e0b6300_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctNy0xLTEtMA_5e14d811-ccfa-4f5d-bdb2-681a9764df5c">2,570.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1198994ab755477ab225bc58ca03d552_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctOS0xLTEtMA_804e1972-6400-48c8-a8dc-e5a683828bfa">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353c4ffcf6cb428b973449a30ef061b1_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMTEtMS0xLTA_eab8af90-7325-474d-a68d-447be257fa8e">8,506.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f43ed2b00934f689a166e4d0edb373d_I20200331" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMTMtMS0xLTA_0a78ceee-a05f-452a-8319-b6538665c452">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMTUtMS0xLTA_ea291f57-bc34-4813-81dc-243404cf2eb9">8,530.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors (the &#8220;Board&#8221;) has authorized an aggregate of&#160;$<ix:nonFraction unitRef="usd" contextRef="i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfMjQ5_bc21e42a-f0b8-4359-b7b2-8b6a7a395e1e">7.5</ix:nonFraction> billion of funding for the Company&#8217;s common stock repurchase program (the &#8220;Repurchase Program&#8221;) since its establishment in March 2009. The most recent authorization occurred in January 2019 when the Board increased the authorized amount available under the Repurchase Program to&#160;$<ix:nonFraction unitRef="usd" contextRef="i09a910f990374e8b85baf857795d2362_I20190131" decimals="INF" format="ixt:numdotdecimal" name="isrg:StockRepurchaseProgramincreasedtoauthorizedamount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfNTIz_717338a5-b290-4bf6-b05d-e25886646f98">2.0</ix:nonFraction> billion. As of March&#160;31, 2021, the remaining amount of share repurchases authorized by the Board was $<ix:nonFraction unitRef="usd" contextRef="i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfNjA3_ae2fd2c4-fe4f-43a7-92b6-4e7ca95366f2">1.6</ix:nonFraction> billion.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="idc6e14cb2e7647198c0464fdd3922b38"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTQ3_4f927e28-e31a-4b81-a061-f88ea8b69ae9" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides share repurchase activities (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMi0xLTEtMS0zNzM3_747ba855-1415-4120-947d-ce8af1cefa5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMi0zLTEtMS0xNjQ4_902580be-df09-4367-9c2e-e04891360364">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMy0xLTEtMS0zNzM3_d88d932d-4231-46bc-b0d1-c5f88328768e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMy0zLTEtMS0xNjQ4_a522c85a-dad9-44d5-8bee-e441a0dad85f">521.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfNC0xLTEtMS0zNzM3_befb96aa-4020-434e-976e-c2bfe36b8bc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfNC0zLTEtMS0xNjQ4_2777324f-4975-49c9-868f-169b428a4ca7">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss), Net of Tax, Attributable to Intuitive</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTM1_939dcb3d-8f5b-4b3a-bee7-65101ce1b529" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi0xLTEtMS0w_c1379b77-6cd6-4904-9ce4-beb14a651b9f">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi0zLTEtMS0w_557a8643-c72b-4b57-93f0-71c05f16e9de">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi01LTEtMS0w_3f04a6db-60c7-46cf-8543-ffbdb3af23d5">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi03LTEtMS0w_05960815-79c6-4b4a-a11b-e06587b66f72">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi05LTEtMS0w_196053e3-be1a-4bac-9aa4-a84f65366087">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy0xLTEtMS0w_7e5fffdf-ce68-4e03-938f-92839558ab52">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy0zLTEtMS0w_1253bb3d-e9a5-4817-931c-c7fb3b870474">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy01LTEtMS0w_2b8194ad-cb04-4920-b761-b403ac6ca06a">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy03LTEtMS0w_0c7dcfc2-d90d-44fe-bb07-2798c1d3e9cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy05LTEtMS0w_55c698f5-9d6c-49f4-ab83-289bf3b03436">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC0xLTEtMS0w_9a1a9b13-9cd1-44c1-a8f6-d6901dd8493c">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC0zLTEtMS0w_81410ab5-f134-4c22-b445-45bdf81e352d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC01LTEtMS0w_ea424461-18fd-405c-a0c0-4e13c9070534">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC03LTEtMS0w_4ec81cfa-03c2-4594-999c-eb4f343fecc4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC05LTEtMS0w_dc0a173a-f689-43e1-b4a2-e801c7612d33">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS0xLTEtMS0w_63d63cd3-2cc5-4e9b-84f2-618fbfeab343">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS0zLTEtMS0w_be8ee90e-69ca-432e-8517-f7fa553193b7">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS01LTEtMS0w_d36a6df8-3fe5-4486-884a-7438247f2e9d">9.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS03LTEtMS0w_cbc5a958-421b-470e-8053-2546f2526c60">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS05LTEtMS0w_557040ad-dc3b-420d-a5ee-7254d9366630">13.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi0xLTEtMS0w_b788c26d-a5af-4944-b193-3faba73befb6">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi0zLTEtMS0w_31e23319-610a-46d5-ade5-5ea131ae4e27">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi01LTEtMS0w_7335a0c4-50c9-4a30-a874-9d9a41ff0a48">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi03LTEtMS0w_698f0d76-b363-4cac-84cb-9832ad8c231f">6.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi05LTEtMS0w_95429251-6dff-4342-b5fe-7fbe8901a56e">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtMS0xLTEtMA_b5ca554a-82f9-4abd-94f4-0faf51df5ef5">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtMy0xLTEtMA_c75247e7-f726-4b98-be82-10ef5989e731">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" format="ixt:zerodash" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtNS0xLTEtMA_4327bd15-2fc9-439f-a8f8-771b477ce04b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtNy0xLTEtMA_0c7025f1-3885-4120-9b65-4c5e24d9d9c3">8.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtOS0xLTEtMA_570c2980-50d8-4153-aa9e-4ecd55780512">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtMS0xLTEtMA_78be56a4-d0eb-478a-8967-c89c64a44ffa">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtMy0xLTEtMA_0012cec7-c00c-4700-bea0-54c2f450d6a7">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtNS0xLTEtMA_4a9f68ee-0391-482a-a68d-6481f2719f07">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtNy0xLTEtMA_c1ba34a3-924e-4e5b-9c48-6dcaf9dff40a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtOS0xLTEtMA_c41e6ea9-d8cf-4a3f-beef-56484b4b3a0e">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItMS0xLTEtMA_2098bf4d-e10a-4423-9745-3982277f3a7f">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItMy0xLTEtMA_e7b17444-1565-40ce-82dc-ea9c55bc222e">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItNS0xLTEtMA_dc208f3a-8bd7-4b65-9c1c-a7b9e71bd0ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItNy0xLTEtMA_53755b5a-f84c-4a43-a0f3-f669ee94464d">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItOS0xLTEtMA_2f843e58-a15f-470f-b513-3ae807693d04">2.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtMS0xLTEtMA_56b9e38c-8831-4eb4-ae23-a8e6affadbcc">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtMy0xLTEtMA_5f44d829-8350-42c1-9320-3c93a65ae4b4">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtNS0xLTEtMA_973cd1cf-6460-4254-9ef3-bd9039b76505">20.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtNy0xLTEtMA_fb555f6b-0873-4720-9e8f-5f485bd9a1c8">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtOS0xLTEtMA_355593e7-7789-4e3e-8d40-1da94c64b9c6">3.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtMS0xLTEtMA_1740e803-93be-43bd-b9bb-4a7127eb85b8">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtMy0xLTEtMA_8badb1a5-d544-4eea-806f-107a16fe2e3d">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtNS0xLTEtMA_346f66c0-0448-409f-b33d-39223ff8024f">20.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtNy0xLTEtMA_7a88ee70-1512-4082-9f34-465335c4f884">8.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtOS0xLTEtMA_88c64148-3921-4135-82c1-7680ff9333e8">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_58"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg1NQ_673dfbe6-d1aa-4120-8023-f91332bc3a76" continuedAt="i6c0b80f56cd64d1dbc33a2ceb2e59dda" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6c0b80f56cd64d1dbc33a2ceb2e59dda" continuedAt="i52c3c1151ccb41a5887823bcfaee9d2e">In April 2020, the Company's shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from <ix:nonFraction unitRef="shares" contextRef="i10e5830a5be84ccbbde2a2eff58015cb_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMjQ1_e2586ea5-82e5-4549-8fe6-bfdd4ba1b766">28,450,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i78841269b3a04c14876727a1edd45ce7_I20200430" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMjUx_88b32c20-a3a5-45e2-aa14-48a08c8a6c57">32,450,000</ix:nonFraction>. As of&#160;March&#160;31, 2021, approximately&#160;<ix:nonFraction unitRef="shares" contextRef="i895226f723b74a4e944e2ab935f3b6d5_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMjc5_c533ff08-07e5-430d-9fc2-dd3bdaad73e4">6.6</ix:nonFraction> million&#160;shares were reserved for future issuance under the Company's stock plans. A maximum of approximately&#160;<ix:nonFraction unitRef="shares" contextRef="i33ccbc7cfb7146c487ecb64b60bdc787_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMzgz_ef31aac4-dfe3-4045-8ef0-7f1a0945e0a9">2.9</ix:nonFraction> million&#160;of these shares can be awarded as restricted stock units (&#8220;RSUs&#8221;).</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i52c3c1151ccb41a5887823bcfaee9d2e" continuedAt="i19f11052a8fd439b96b5711789739b52"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Information</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg1Nw_dd74ad91-72ad-439c-b04f-398f2c028674" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:70.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise&#160;Price Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfMi0yLTEtMS0w_59704b14-340e-447f-a8de-afa2dc3d05b2">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfMi00LTEtMS0w_c1e08e16-574b-45e7-a8ea-6b17a13a687f">305.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNC0yLTEtMS0w_72f678c7-6456-4d9c-b3f7-4564584d4a6b">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNC00LTEtMS0w_c7fc3253-2194-4416-8492-7806827a883f">740.73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNS0yLTEtMS0w_6bcd46df-ccdc-4635-88d1-a05727fcfef9">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNS00LTEtMS0w_563ed16b-1695-42f3-a9a6-54b4b7a58d94">194.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNi0yLTEtMS0w_a1a6cbb4-3232-4f68-8b38-18a82e8269d6">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNi00LTEtMS0w_44efca46-371a-405b-b12c-6ae02afd4c8c">572.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNy0yLTEtMS0w_11f4311a-2950-4071-8f76-e7e63db50018">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNy00LTEtMS0w_26062f13-8ff5-41e1-8d68-28d6359d5ed8">328.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, options to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfNjc2_783ca983-4610-4e5d-b189-5380f8163808">3.5</ix:nonFraction> million shares of common stock were exercisable at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i19647b4382894b77b728740dfcec06ae_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfNzUw_2b49fd57-cbb0-44ff-85c6-e3c9db69f1d5">252.72</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units Information</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg0Mw_65cf54de-0c69-42ed-a328-3f45a65ef1f0" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSUs activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic700f68e41144f91bd35e317ae4e9f00_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMS0xLTEtMS0w_30de5bfa-549c-4825-bc32-772dde4e3a8f">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic700f68e41144f91bd35e317ae4e9f00_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMS0zLTEtMS0w_ba9d67d6-2782-472c-8c2a-346fd354a50b">489.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMi0xLTEtMS0w_0c4dc3cb-09dd-4c7f-b497-a3c6b7ff98b3">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMi0zLTEtMS0w_8699a147-5f88-43d7-9a7f-e96e777819d3">738.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMy0xLTEtMS0w_5947b791-fb2d-4549-b4dd-c0a2a031f45f">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMy0zLTEtMS0w_4af6c5cf-2549-47b1-b2fe-fa37e43c4e43">427.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNC0xLTEtMS0w_f4290e55-d443-404b-941a-a3334b62c968">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNC0zLTEtMS0w_5c270455-f8bc-4576-94d2-9d5616ada593">555.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at March&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ided9f564a7fc43fb9785e126f3e0792d_I20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNS0xLTEtMS0w_95727b7b-a813-447d-bb04-bcf831a9b504">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ided9f564a7fc43fb9785e126f3e0792d_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNS0zLTEtMS0w_f97d7d71-ac82-42f7-a998-29f8721f3e52">593.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), employees purchased approximately <ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTA1NQ_2130753f-0c60-4594-af3b-324ef4548a8f">0.1</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTA2OQ_d616cbaf-7268-4e16-abf9-0face877e6a4">41.4</ix:nonFraction> million and approximately <ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTA5MA_83b55b3b-a03d-4947-8b00-dcb9f9caf146">0.1</ix:nonFraction> million shares for $<ix:nonFraction unitRef="usd" contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTEwNA_4cf91a68-601f-4c45-aeea-a394fbf06a16">36.6</ix:nonFraction> million during the three months ended March&#160;31, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg0OA_80d6135a-41ae-44d5-ba9c-2b82c96ab7b2" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense for the three months ended March&#160;31, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d02f4e8f2a84d6fadf284cdaf0651f6_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMi0xLTEtMS0w_9eadb06a-828f-4d26-b20c-e91bfaa2d58e">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39ba5ce0cdf94b51beee72537008b906_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMi0zLTEtMS0w_9d3da9f4-e671-4450-97f6-a0a2eb7d16d3">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0b9d06046ac417db9b476df68156e12_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMy0xLTEtMS0w_e39193f4-ac9e-42c3-a14e-73d94167f1ee">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5af8b08c9064ce3af2ced0adcf153ad_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMy0zLTEtMS0w_dceecf8a-3f95-4983-aa2d-cb772cb607d7">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i176cc511d2d94ee3acf60b32b9c344a4_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNC0xLTEtMS0w_335cd9bf-11eb-4025-80ff-0664c6fba803">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002513af33834fe2a6163fa9af4c9055_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNC0zLTEtMS0w_10fa36b6-b0aa-440d-b168-e926c0ec3c2d">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0b706bb5ee44d3c9e5ab754d749034e_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNS0xLTEtMS0w_5f156044-fd4a-45c3-9dfc-cfbd55aaecf6">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223c3c0566cf457c938baba52b26ec0f_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNS0zLTEtMS0w_286356d4-8ba7-4f96-ab74-0b9ccc6ac628">45.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie628bd5d73914b17bff4771bcdd4ec83_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNi0xLTEtMS0w_719951c2-3821-4773-b0ec-d58540a649b3">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57036158f3241fbb815a228531cfa32_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNi0zLTEtMS0w_01a01257-3f4f-4b45-a01b-11fca4e66690">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNy0xLTEtMS0w_3ff8e7ad-a93a-41c9-90af-dd9a579961b8">104.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNy0zLTEtMS0w_ae0cc683-71e5-4974-8ece-f45ab1a54938">91.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOC0xLTEtMS0w_f47ea28c-aa03-4097-8f02-3e0897504bbe">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOC0zLTEtMS0w_e515f91c-68cd-4472-a3d2-fa6531cafd39">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense after income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOS0xLTEtMS0w_78928c78-4004-45f2-bad6-63bea2814b68">83.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOS0zLTEtMS0w_7b225b4f-4d80-4e49-b402-90dcd65aab18">72.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><ix:continuation id="i19f11052a8fd439b96b5711789739b52"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg0NA_c161c948-eee1-42fc-a4bb-f840b902fc43" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#8217;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three months ended March&#160;31, 2021, and 2020, were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMy0xLTEtMS0w_e3f03640-e971-43ab-b57a-cfc1c5c060ab">0.7</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMy0zLTEtMS0w_cc018001-a43d-442a-9bb4-cdb68e4b64f6">0.9</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNC0xLTEtMS0w_4a8b2903-5c7f-4105-b1a7-88ddb854ead2">4.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNC0zLTEtMS0w_72adcec3-8e66-45e4-a5df-6ce901310228">4.3</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNS0xLTEtMS0w_6f7f1998-e1c0-4acf-bf2a-9a86935e8273">34</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNS0zLTEtMS0w_eb6f9835-4374-45f9-8c4e-b7a223ee5278">28</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNi0xLTEtMS0w_fb149a3c-387b-4289-8139-0ed1cf120b20">211.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNi0zLTEtMS0w_cbf1cde6-16f6-420e-8db3-dfe2c799a5ef">133.25</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOC0xLTEtMS0w_f4364b3f-ec2b-4454-bfe2-8370d43a7cf9">0.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOC0zLTEtMS0w_63972bd6-094d-49a7-8762-380bfd8c8074">1.5</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOS0xLTEtMS0w_03444556-7978-45fb-93c1-d190675c977f">1.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOS0zLTEtMS0w_9659e619-8e30-4a59-b3f1-486f6b9f99bd">1.1</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTAtMS0xLTEtMA_cff53355-05be-450c-b4ee-f1591b242bed">35</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTAtMy0xLTEtMA_7007caf0-ccdf-4daa-966e-87f9d620644a">27</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTEtMS0xLTEtMA_afbbc87d-b6ab-4ac1-a7fc-60a06b3c0c99">223.17</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTEtMy0xLTEtMA_bb171172-2912-4c4a-93d3-1d70772c33c8">149.85</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_61"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfMzk1Nw_18571426-48f5-42b9-b227-248ffab2b204" continuedAt="i61229ea57a1b4ac0944dde24a092d17b" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i61229ea57a1b4ac0944dde24a092d17b"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) for the three months ended March&#160;31, 2021, was $<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNzg_86dc735f-690a-467c-a855-e6d57921ff9a">13.6</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfODU_34a31302-6c66-4e17-a190-dfbaaf0bb129">3.0</ix:nonFraction>% of income before taxes, compared to $(<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfMTA5OTUxMTYzMTc5OA_264fc47b-fa28-462b-a596-7711f611ae77">8.1</ix:nonFraction>)&#160;million, or (<ix:nonFraction unitRef="number" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfMTA5OTUxMTYzMTgwNg_94d9871b-f60f-4ceb-aa51-2a63fde7f720">2.6</ix:nonFraction>)% of income before taxes, for the three months ended March&#160;31, 2020. The higher income tax expense for the three months ended March&#160;31, 2021, was primarily due to higher pre-tax income.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the three months ended March&#160;31, 2021, and 2020, differed from the U.S. federal statutory rate of 21% mainly due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and the federal research and development (&#8220;R&amp;D&#8221;) credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit). </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the three months ended March&#160;31, 2021, and 2020, included excess tax benefits associated with employee equity plans of $<ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODQ5NQ_2e2584d4-6fde-480c-add5-82d6f3c5a72d">73.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODUwMw_1e425e1e-2530-4da8-9261-32e01df49306">65.4</ix:nonFraction>&#160;million, which reduced our effective tax rate by <ix:nonFraction unitRef="number" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODU0OA_7c9e5672-7a6b-47a0-9bc8-c059f8289507">16.4</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODU1Ng_16d77c57-1448-419d-aed9-8657275a3fce">21.2</ix:nonFraction> percentage points, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of the Company&#8217;s unrecognized tax benefits could change due to activities of various tax authorities, including potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect the Company&#8217;s effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, the Company cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The outcome of these audits cannot be predicted with certainty. The Company&#8217;s management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes. If any issues addressed in the Company&#8217;s tax audits are resolved in a manner not consistent with management&#8217;s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfNjYy_d07a8b57-80f2-4d01-be18-4ab9e7ec9a86" continuedAt="i4b5dac94665f4d84b4d34267201887bb" escape="true">NET INCOME PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i4b5dac94665f4d84b4d34267201887bb"><ix:nonNumeric contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfNjY2_8c1a2d42-6f14-44d0-919d-7221c754683e" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMy0xLTEtMS0w_6f95209d-a19f-4220-850f-7d02a84843fd">426.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMy0zLTEtMS0w_7a378e0b-9b07-4515-a0d5-7f203c914c05">313.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in basic calculation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfNy0xLTEtMS0w_7da1fc1f-1355-40d8-967a-1e323b998045">118.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfNy0zLTEtMS0w_2b2f74e8-2193-4383-9eee-af75b5311fd9">116.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOC0xLTEtMS0w_ac7e7a93-d153-4c84-9395-9365ffcb934f">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOC0zLTEtMS0w_b2f4111f-1fac-490b-baa7-fa438f012c20">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in diluted calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOS0xLTEtMS0w_16785f74-cb44-4d02-b1d0-96d8979fc5c1">121.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOS0zLTEtMS0w_c0f87020-799a-49ee-83d3-d75627cdaa66">119.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTEtMS0xLTEtMA_f9717467-7aec-428d-ac43-478872d0f293">3.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTEtMy0xLTEtMA_db4ef791-0e9f-48a5-bf95-56f47ab68f67">2.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTItMS0xLTEtMA_3c230895-6a71-42f0-88cf-f694eddfc566">3.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTItMy0xLTEtMA_08690a6b-d3f3-40c1-a75c-cdca3e5a1134">2.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation awards of approximately <ix:nonFraction unitRef="shares" contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfMjU1_41d64d8e-577b-4d53-94f1-e1dcf544b74c">0.3</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfMjYy_ed565bc4-48a3-4395-bd56-0246906ac32f">1.0</ix:nonFraction>&#160;million shares for the three months ended March&#160;31, 2021, and 2020, respectively, were outstanding but were not included in the computation of diluted net income per share attributable to Intuitive Surgical, Inc. common stockholders because the effect of including such shares would have been anti-dilutive in the periods presented.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, &#8220;Intuitive Surgical,&#8221; &#8220;Intuitive,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This management&#8217;s discussion and analysis of financial condition as of March&#160;31, 2021, and results of operations for the three months ended March&#160;31, 2021, and 2020, should be read in conjunction with management&#8217;s discussion and analysis of financial condition and results of operations included in our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). Forward-looking statements relate to expectations concerning matters that are not historical facts. Words such as &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;targeted,&#8221; and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements related to the expected impacts of the COVID-19 pandemic on our business, financial condition, and results of operations, the potential impact on our procedure volume, our acquisitions, our expected business, our expected new product introductions, the impacts of Extended Use Instruments, procedures and procedure adoption, future results of operations, future financial position, our ability to increase our revenues, the anticipated mix of our revenues between product and service revenues, our financing plans and future capital requirements, anticipated costs of revenue, anticipated expenses, our potential tax assets or liabilities, the effect of recent accounting pronouncements, our investments, anticipated cash flows, our ability to finance operations from cash flows and similar matters, and statements based on current expectations, estimates, forecasts, and projections about the economies and markets in which we operate and our beliefs and assumptions regarding these economies and markets. These forward-looking statements should be considered in light of various important factors, including, but not limited to, the following: our ability to obtain accurate procedure volume and mix in the midst of the COVID-19 pandemic; the risk that the COVID-19 pandemic could lead to further material delays and cancellations of, or reduced demand for, procedures; curtailed or delayed capital spending by hospitals; disruption to our supply chain, including increased difficulties in obtaining a sufficient amount of materials in the semiconductor and other markets; closures of our facilities; delays in surgeon training; delays in gathering clinical evidence; delays in obtaining new product approvals or clearances from the U.S. Food and Drug Administration due to the effects of the COVID-19 pandemic; the evaluation of the risks of robotic-assisted surgery in the presence of infectious diseases; diversion of management and other resources to respond to COVID-19 outbreaks; the impact of global and regional economic and credit market conditions on healthcare spending; the risk that the COVID-19 virus disrupts local economies and causes economies in our key markets to enter prolonged recessions; healthcare reform legislation in the U.S. and its impact on hospital spending, reimbursement, and fees levied on certain medical device revenues; changes in hospital admissions and actions by payers to limit or manage surgical procedures; the timing and success of product development and market acceptance of developed products; the results of any collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships, including the joint venture with Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; our completion of and ability to successfully integrate acquisitions, including Sch&#246;lly Fiberoptic's robotic endoscope business and Orpheus Medical; procedure counts; regulatory approvals, clearances, and restrictions or any dispute that may occur with any regulatory body; guidelines and recommendations in the healthcare and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which we operate; risks associated with our operations outside of the United States; unanticipated manufacturing disruptions or the inability to meet demand for products; our reliance on sole and single source suppliers; the results of legal proceedings to which we are or may become a party; product liability and other litigation claims; adverse publicity regarding us and the safety of our products and adequacy of training; our ability to expand into foreign markets; the impact of changes to tax legislation, guidance, and interpretations; changes in tariffs, trade barriers, and regulatory requirements; and other risk factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors described throughout this filing and in the Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, and other periodic filings with the Securities and Exchange Commission. Our actual results may differ materially and adversely from those expressed in any forward-looking statement. We undertake no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Intuitive Surgical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci S HD Surgical System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Si</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Si HD Surgical System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Xi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci SP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, EndoWrist</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Firefly</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, InSite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Intuitive Surgical EcoSystem</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, da Vinci X</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, SureForm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Iris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and SynchroSeal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are trademarks or registered trademarks of the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive is committed to advancing patient care in surgery and other acute medical interventions. We are focused on innovating to enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. Our mission reflects that we believe that minimally invasive care is life-enhancing care. Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings. While surgery and acute interventions have improved significantly in the past decades, there remains a significant need for better outcomes and decreased variability of these outcomes across care teams. The current healthcare environment continues to stress critical resources, including the professionals who staff care teams: surgeons, anesthesiologists, nurses, and other staff. At the same time, governments strain to cover the healthcare needs of their populations and demand lower total cost per patient to treat disease. In the face of these challenges, we believe scientific, process, and technological advances in biology, computing, imaging, algorithms, and robotics offer new methods to solve continued and difficult problems.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We address these needs by focusing on the quadruple aim. First, we focus on products and services that can improve outcomes and decrease variability in the hands of care teams. Second, we seek to improve the patient experience by minimizing disruption to lives and creating greater predictability for the treatment experience. Third, we seek to improve care team satisfaction by creating products and services that are dependable, smart, and optimized for the care environment in which they are used. Finally, we seek to lower the total cost to treat per patient episode when compared with existing treatment alternatives, providing a return on investment for hospitals and healthcare systems and value for payers.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open surgery remains the predominant form of surgery and is used in almost every area of the body. However, the large incisions required for open surgery create trauma to patients, typically resulting in longer hospitalization and recovery times, increased hospitalization costs, and additional pain and suffering relative to minimally invasive surgery (&#8220;MIS&#8221;), where MIS is available. For over three decades, MIS has reduced trauma to patients by allowing selected surgeries to be performed through small ports rather than large incisions. MIS has been widely adopted for certain surgical procedures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Da Vinci Surgical Systems enable surgeons to extend the benefits of MIS to many patients who would otherwise undergo a more invasive surgery by using computational, robotic, and imaging technologies to overcome many of the limitations of traditional open surgery or conventional MIS. Surgeons using a da Vinci Surgical System operate while seated comfortably at a console viewing a 3D, high-definition image of the surgical field. This immersive console connects surgeons to the surgical field and their instruments. While seated at the console, the surgeon manipulates instrument controls in a natural manner, similar to open surgical technique. Our technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon&#8217;s hand. In designing our products, we focus on making our technology easy and safe to use.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our da Vinci products fall into five broad categories: da Vinci Surgical Systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems (&#8220;Firefly&#8221;) and da Vinci Endoscopes. We also provide a comprehensive suite of services, training, and education programs. Within our integrated ecosystem, our hardware, software, and digital solutions are designed to decrease variability in surgery by offering dependable, consistent functionality and user experiences for surgeons seeking better outcomes. We take a holistic approach, offering intelligent technology and systems designed to work together to make MIS intervention more available and applicable.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have commercialized the following da Vinci Surgical Systems: the da Vinci standard Surgical System in 1999, the da Vinci S Surgical System in 2006, the da Vinci Si Surgical System in 2009, and the fourth generation da Vinci Xi Surgical System in 2014. We have extended our fourth generation platform by adding the da Vinci X Surgical System, commercialized in the second quarter of 2017, and the da Vinci SP Surgical System, commercialized in the third quarter of 2018. The da Vinci SP Surgical System accesses the body through a single incision while the other da Vinci Surgical Systems access the body through multiple incisions. We are early in the launch of our da Vinci SP Surgical System, and we have an installed base of 75 da Vinci SP Surgical Systems as of March&#160;31, 2021. Our plans for the rollout of the da Vinci SP Surgical System include putting systems in the hands of experienced da Vinci users first while we optimize training pathways and our supply chain. We received U.S. Food and Drug Administration (&#8220;FDA&#8221;) clearances for the da Vinci SP Surgical System for urological and certain transoral procedures. We also received clearance in South Korea where the da Vinci SP Surgical System may be used for a broad set of procedures. We plan to seek FDA clearances for additional indications for da Vinci SP over time. The success of the da Vinci SP Surgical System is dependent on positive experiences and improved clinical outcomes for the procedures for which it has been cleared as well as securing additional clinical clearances. All da Vinci systems include a surgeon&#8217;s console (or consoles), imaging electronics, a patient-side cart, and computational hardware and software.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer approximately 70 different multi-port da Vinci instruments to provide surgeons with flexibility in choosing the types of tools needed to perform a particular surgery. These multi-port instruments are generally robotically controlled and provide end effectors (tips) that are similar to those used in either open or laparoscopic surgery. We offer advanced instrumentation for the da Vinci Xi and da Vinci X platforms, including da Vinci Energy and da Vinci Stapler products, to provide surgeons with sophisticated, computer-aided tools to precisely and efficiently interact with tissue. Da Vinci X and da </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vinci Xi Surgical Systems share the same instruments whereas the da Vinci Si Surgical System uses instruments that are not compatible with da Vinci X or da Vinci Xi systems. We currently offer nine core instruments on our da Vinci SP Surgical System. We plan to expand the SP instrument offering over time.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Training technologies include our Intuitive Simulation products, our Intuitive Telepresence remote case observation and telementoring tools, and our dual console for use in surgeon proctoring and collaborative surgery.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, the FDA cleared our Ion endoluminal system to enable minimally invasive biopsies in the lung. Our Ion system extends our commercial offering beyond surgery into diagnostic procedures with this first application. We are introducing the Ion system in the U.S. in a measured fashion while we optimize training pathways and our supply chain and collect additional clinical data. We are early in the launch and have placed 50 Ion systems for commercial use as of March&#160;31, 2021. Ion systems are not included in our da Vinci Surgical System installed base. We currently have 2 Ion systems placed with hospitals for gathering clinical data in addition to the systems placed for commercial use.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of new product introductions depends on a number of factors including, but not limited to, pricing, competition, market and consumer acceptance, the effective forecasting and management of product demand, inventory levels, the management of manufacturing and supply costs, and the risk that new products may have quality or other defects in the early stages of introduction.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, prior to the spread of COVID-19, we experienced procedure growth trends consistent with those experienced in the fourth quarter of 2019, including strength in general surgery, growth in mature procedures in the U.S., and growth in OUS urology. Beginning in January 2020, we saw a substantial reduction in da Vinci procedures in China and, by early February 2020, procedures per week in China had declined by approximately 90% compared to the weekly procedure rates experienced in early January 2020. As the COVID-19 pandemic subsided in China in March 2020, da Vinci procedure volume began to recover and, by the end of the first quarter of 2020, China procedures per week were approximately 70% of the early January 2020 weekly procedure rate. As the COVID-19 pandemic spread to Western Europe and the U.S., we experienced a significant decline in da Vinci procedures in the last half of March 2020 to approximately 65% of the weekly procedure rate experienced earlier in the first quarter of 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, in the U.S., the COVID-19 resurgence that affected procedures later in the fourth quarter of 2020 continued well into January 2021. Then, as COVID-19 cases subsided beginning in February 2021, da Vinci procedures experienced a steady improvement throughout February and March. In Europe, the spread of COVID-19 varied regionally, and procedure growth rates were mixed with strength in France and a year-over-year decline in the U.K. While there have been COVID-19 hot spots within some of our Asia Pacific markets, they tended to be isolated and, in general, procedures performed well. China growth was significantly higher than other regions, reflecting the severity of the COVID-19 impact on China during the first quarter of the prior year and the additional system installations during 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depth and extent to which the COVID-19 pandemic will impact individual markets will vary based on the availability of testing capabilities, personal protective equipment, intensive care units and operating rooms, and medical staff, as well as government interventions. The impact of COVID-19 on our procedure volumes varies widely by country, region, and type. When COVID-19 infection rates spike in a particular region, procedure volumes have been negatively impacted and the diagnoses of new conditions and their related treatments have been deferred. While there is a backlog of patients, it is unpredictable when those patients will ultimately seek diagnosis and treatment and whether they will be treated through surgery. Based on our experience during 2020, we do not expect all markets, regions, and procedure types to recover at the same time or at the same pace.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">System Demand</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, customers in regions impacted by COVID-19 deferred decisions to purchase or lease systems into future quarters and, in some cases, indefinitely. However, in the first quarter of 2021, we experienced strong system demand. In general, we believe that the COVID-19 pandemic had less of an impact on hospital spending capacity and that customers recognize that da Vinci surgery meets their quadruple aim objectives better than other surgical approaches. More specifically, during the first quarter of 2021, system demand reflected procedure growth, hospitals purchasing systems in preparation for a post-COVID-19 pandemic environment, and hospitals upgrading their system portfolio to access and/or standardize on fourth generation capabilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Increase in Risks</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital markets and worldwide economies have been significantly impacted by the COVID-19 pandemic, and it is possible that factors related to the COVID-19 pandemic could cause a prolonged recession in local and/or global economies. Such an economic recession could have a material adverse effect on our long-term business as hospitals curtail and reduce capital and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">overall spending. The COVID-19 pandemic and local actions, such as &#8220;shelter-in-place&#8221; orders and restrictions on our ability to travel and access our customers or temporary closures of our facilities, including our training and manufacturing operations, or the facilities of our suppliers and their contract manufacturers, could further significantly impact our sales and our ability to produce and ship our products and supply our customers. Any of these events could negatively impact the number of da Vinci procedures performed or the number of system placements and have a material adverse effect on our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our priorities and actions during the COVID-19 pandemic have been and remain as follows. First, we are focused on the health and safety of all those we serve &#8211; patients, customers, our communities, and our employees &#8211; implementing continuous updates to our health and safety policies and processes. Second, we are supporting our customers according to their priorities &#8211; clinical, operational, and economic &#8211; and ensuring continuity of supply by working with our suppliers and our distributors. Third, we are securing our workforce economically. We have built a valuable team over the years, and we believe they will be important in a recovery that follows the pandemic. Finally, we will continue to invest in our priority development programs while eliminating avoidable spend.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_76"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Model</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from the placements of da Vinci Surgical Systems, in sales or sales-type lease arrangements where revenue is recognized up-front or in operating lease transactions and usage-based models where revenue is recognized over time. We earn recurring revenue from the sales of instruments, accessories, and services, as well as the revenue from operating leases. The da Vinci Surgical System generally sells for between $0.5 million and $2.5 million, depending upon the model, configuration, and geography, and represents a significant capital equipment investment for our customers when purchased. Our instruments and accessories have limited lives and will either expire or wear out as they are used in surgery, at which point they need to be replaced. We generally earn between $600 and $3,500 of instruments and accessories revenue per surgical procedure performed, depending on the type and complexity of the specific procedures performed and the number and type of instruments used. Further, in late 2020, we launched our Extended Use Program (refer to further discussion immediately below) in the U.S. and Europe, with the intention to reduce the cost for customers to treat patients, which in turn will reduce the overall instruments and accessories revenue per procedure. We typically enter into service contracts at the time systems are sold or leased at an annual fee between $80,000 and $190,000, depending upon the configuration of the underlying system and composition of the services offered under the contract. These service contracts have generally been renewed at the end of the initial contractual service periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the da Vinci Surgical System model described above, we generate revenue from the placements of the Ion endoluminal system at the time of sale in or sales-type lease arrangements or over time in operating lease transactions and usage-based models. We generate revenue from the placements of the Ion system, and we earn recurring revenue from the sales of instruments and accessories used in biopsies and ongoing system service. Ion systems are presented separately from our da Vinci Surgical Systems installed base. We are introducing the Ion system in the U.S. in a measured fashion. For the three months ended March&#160;31, 2021, Ion's contribution to revenue and gross margin was not significant.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Extended Use Program</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced our "Extended Use Program," which consists of select da Vinci Xi and da Vinci X instruments possessing 12 to 18 uses ("Extended Use Instruments") compared to the current 10 use instruments. These Extended Use Instruments represent some of our higher volume instruments but exclude stapling, monopolar, and advanced energy instruments. Instruments included in the program are used across a number of da Vinci surgeries. Their increased uses are the result of continuous, significant investments in the design and production capabilities of our instruments, resulting in improved quality and durability. Extended Use Instruments have been introduced in the U.S. and Europe in the fourth quarter of 2020. They are being introduced at various times throughout 2021 and 2022 in other geographies, depending on regulatory processes. In addition, simultaneous with the regional launches of Extended Use Instruments, we will lower the price of certain instruments that are most commonly used in lower acuity procedures and/or lower reimbursed procedures within the region. These actions will reduce the cost for customers to treat patients, which in turn will reduce our revenue per procedure. Based on 2019 volume and mix of procedures, our Extended Use Program and the reduced pricing on certain other instruments would have reduced 2019 annual instruments and accessories revenue by approximately $150 to $170&#160;million. During the first quarter of 2021, we saw customers begin to adjust their instrument buying patterns to reduce their inventory levels to reflect the additional uses per instrument. In addition, we saw increased usage of Extended Use Instruments; however, we anticipate that full adoption will occur over the next few quarters as customers utilize their remaining 10 use instruments. We expect increased usage of Extended Use Instruments and customer buying patterns to continue to reduce instruments and accessories revenue per </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">procedure over the next few quarters. The precise impact of these actions on future revenue will be dependent on the future volume and mix of procedures and whether cost elasticity will enable greater penetration into available markets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recurring Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recurring revenue consists of instruments and accessories revenue, service revenue, and operating lease revenue. Recurring revenue increased to $3.4 billion, or 77% of total revenue in 2020, compared to $3.2&#160;billion, or 72% of total revenue in 2019, and $2.6&#160;billion, or 71% of total revenue in 2018.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments and accessories revenue has grown at a faster rate than systems revenue over time. Instruments and accessories revenue increased to $2.46&#160;billion in 2020, compared to $2.41&#160;billion in 2019 and $1.96&#160;billion in 2018. The growth of instruments and accessories revenue largely reflects continued procedure adoption.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue was $724&#160;million in 2020, compared to $724&#160;million in 2019 and $635&#160;million in 2018. Service revenue remained unchanged, driven by the growth of the installed base of da Vinci Surgical Systems, offset by the effects of the Customer Relief Program that was implemented as a result of the COVID-19 pandemic in the second quarter of 2020. The installed base of da Vinci Surgical Systems grew 7% to approximately 5,989 at December&#160;31, 2020; 12% to approximately 5,582 at December&#160;31, 2019; and 13% to approximately 4,986 at December&#160;31, 2018.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the installed base, number of shipments, and utilization of da Vinci Surgical Systems as metrics for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Management believes that the installed base, number of shipments, and utilization of da Vinci Surgical Systems provide meaningful supplemental information regarding our performance, as management believes that the installed base, number of shipments, and utilization of da Vinci Surgical Systems are an indicator of the rate of adoption of robotic-assisted surgery as well as an indicator of future recurring revenue (particularly service revenue). Management believes that both it and investors benefit from referring to the installed base, number of shipments, and utilization of da Vinci Surgical Systems in assessing our performance and when planning, forecasting, and analyzing future periods. The installed base, number of shipments, and utilization of da Vinci Surgical Systems also facilitate management&#8217;s internal comparisons of our historical performance. We believe that the installed base, number of shipments, and utilization of da Vinci Surgical Systems are useful to investors as metrics, because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making, and (2) they are used by institutional investors and the analyst community to help them analyze the performance of our business. The vast majority of da Vinci Surgical Systems installed are connected via the internet. System logs can also be accessed by field engineers for systems that are not connected to the internet. We utilize this information as well as other information from agreements and discussions with our customers that involve estimates and judgments, which are, by their nature, subject to substantial uncertainties and assumptions. Estimates and judgments for determining the installed base, number of shipments, and utilization of da Vinci Surgical Systems may be impacted over time by various factors, including system internet connectivity, hospital and distributor reporting behavior, and inherent complexities in new agreements. Such estimates and judgments are also susceptible to technical errors. In addition, the relationship between the installed base, number of shipments, and utilization of da Vinci Surgical Systems and our revenues may fluctuate from period to period, and growth in the installed base, number of shipments, and utilization of da Vinci Surgical Systems may not correspond to an increase in revenue. The installed base, number of shipments, and utilization of da Vinci Surgical Systems are not intended to be considered in isolation or as a substitute for, or superior to, revenue or other financial information prepared and presented in accordance with GAAP.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intuitive System Leasing</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2013, we have entered into sales-type and operating lease arrangements directly with certain qualified customers as a way to offer customers flexibility in how they acquire systems and expand their robotic-assisted surgery programs while leveraging our balance sheet. These leases generally have commercially competitive terms as compared to other third-party entities that offer equipment leasing. We have also entered into usage-based arrangements with qualified customers that have committed da Vinci programs where we charge for the system and service as the systems are utilized. We include operating and sales-type leases, and systems placed under usage-based arrangements, in our system shipment and installed base disclosures. We exclude operating lease-related revenue, usage-based revenue, and Ion system revenue from our da Vinci Surgical System average selling price (&#8220;ASP&#8221;) computations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the years ended December 31, 2020, 2019, and 2018, we shipped 432, 425, and 272 da Vinci Surgical Systems, respectively, under lease and usage-based arrangements, of which 317, 384, and 229 systems, respectively, were operating lease and usage-based arrangements. Revenue from operating lease arrangements is generally recognized on a straight-line basis over the lease term. More recently, we have entered into usage-based arrangements with certain qualified customers whereby systems revenue and service revenue are recognized as the systems are used. We generally set operating lease and usage-based pricing at a modest premium relative to purchased systems reflecting the time value of money and, in the case of usage-based arrangements, the risk that system utilization may fall short of anticipated levels. The proportion of revenue recognized from usage-based arrangements has not been significant and has been included in our operating lease metrics herein. Operating lease revenue has grown at a faster rate than overall systems revenue and was $177&#160;million, $107&#160;million, and $51&#160;million for the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2020, 2019, and 2018, respectively. Generally, lease transactions generate similar gross margins as our sale transactions. As of December&#160;31, 2020, a total of 901 da Vinci Surgical Systems were installed at customers under operating lease or usage-based arrangements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our system leasing and usage-based models provide customers with flexibility regarding how they acquire or obtain access to our systems. We believe that these alternative financing structures have been effective and well-received, and we are willing to expand the proportion of these structures based on customer demand. As revenue for operating leases and usage-based arrangements is recognized over time, total systems revenue growth is reduced in a period when the number of operating lease and usage-based placements increases as a proportion of total system placements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to the credit risks relating to our lease financing arrangements may increase if our customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty or other customer-specific factors. In addition, as customers continue to divert significant resources to the treatment of or the preparation to treat patients with COVID-19, we may be exposed to defaults under our lease financing arrangements. Moreover, usage-based arrangements generally contain no minimum payments; therefore, customers may exit such arrangements without paying a financial penalty to us. As a result of the COVID-19 pandemic, we anticipate that some customers will exit such arrangements or seek to amend the terms of our operating lease and usage-based arrangements with them.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some operating lease arrangements, our customers are provided with the right to purchase the leased system at certain points during and/or at the end of the lease term. Revenue generated from customer purchases of systems under operating lease arrangements (&#8220;Lease Buyouts&#8221;) was $52.2 million, $92.8&#160;million, and $48.8&#160;million for the years ended December 31, 2020, 2019, and 2018, respectively. We expect that revenue recognized from customer exercises of the buyout options will fluctuate based on the timing of when, and if, customers choose to exercise their buyout options.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Systems Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System placements are driven by procedure growth in most markets. In some markets, systems placements are constrained by regulation. In geographies where da Vinci procedure adoption is in an early stage, system sales will precede procedure growth. System placements also vary due to seasonality largely aligned with hospital budgeting cycles. We typically place a higher proportion of annual system placements in the fourth quarter and a lower proportion in the first quarter as customer budgets are reset. Systems revenue is also affected by the proportion of system placements under operating lease and usage-based arrangements, recurring operating lease and usage-based revenue, operating lease buyouts, product mix, ASPs, trade-in activities, and customer mix. Systems revenue declined 12% to $1.18&#160;billion in 2020. Systems revenue grew 19% to $1.35&#160;billion in 2019 and 21% to $1.13&#160;billion in 2018. Based on the factors outlined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, we believe that historical system shipment trends may not be a good indicator of future system shipments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedure Mix / Products</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our da Vinci Surgical Systems are generally used for soft tissue surgery for areas of the body between the pelvis and the neck, primarily in general surgery, gynecologic surgery, urologic surgery, cardiothoracic surgery, and head and neck surgery. Within these categories, procedures range in complexity from cancer and other highly complex procedures to less complex procedures for benign conditions. Cancer and other highly complex procedures tend to be reimbursed at higher rates than less complex procedures for benign conditions. Thus, hospitals are more sensitive to the costs associated with treating less complex, benign conditions. Our strategy is to provide hospitals with attractive clinical and economic solutions across the spectrum of procedure complexity. Our fully featured&#160;da Vinci Xi&#160;Surgical System with advanced instruments (including da Vinci Energy and EndoWrist and&#160;SureForm&#160;Stapler products) and our Integrated Table Motion product targets the more complex procedure segment. Our da Vinci X Surgical System is targeted towards price sensitive markets and procedures. Our da Vinci SP Surgical System complements the da Vinci Xi and X Surgical Systems by enabling surgeons to access narrow workspaces.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedure Seasonality</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More than half of da Vinci procedures performed are for benign conditions, most notably hernia repairs, hysterectomies, and cholecystectomies. These benign procedures and other short-term elective procedures tend to be more seasonal than cancer operations and surgeries for other life threatening conditions. Seasonality in the U.S. for procedures for benign conditions typically results in higher fourth quarter procedure volume when more patients have met annual deductibles and lower first quarter procedure volume when deductibles are reset. Seasonality outside the U.S. varies and is more pronounced around local holidays and vacation periods. As a result of the factors outlined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, including past and potentially future recommendations of authorities to defer elective procedures, historical procedure patterns may be disrupted.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distribution Channels</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide our products through direct sales organizations in the U.S., Europe (excluding Spain, Portugal, Italy, Greece, and most Eastern European countries), China, Japan, South Korea, India, and Taiwan. In 2018, we began direct operations in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">India and Taiwan. In January 2019, our Intuitive-Fosun joint venture began direct sales for da Vinci products and services in China. In the remainder of our OUS markets, we provide our products through distributors.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_79"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulatory Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products must meet the requirements of a large and growing body of international standards that govern the product safety, efficacy, advertising, labeling, safety reporting design, manufacture, materials content and sourcing, testing, certification, packaging, installation, use, and disposal of our products. Examples of such standards include electrical safety standards, such as those of the International Electrotechnical Commission, and composition standards, such as the Reduction of Hazardous Substances and the Waste Electrical and Electronic Equipment Directives. Failure to meet these standards could limit our ability to market our products in those regions that require compliance to such standards.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and operations are also subject to increasingly stringent medical device, privacy, and other regulations by regional, federal, state, and local authorities. We anticipate that timelines for the introduction of new products and/or indications may be extended relative to past experience as a result of these regulations. For example, we have seen elongated regulatory approval timelines in the U.S. and the EU.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clearances and Approvals</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have generally obtained the clearances required to market our products associated with our da Vinci Surgical Multiport Systems (Standard, S, Si, Xi, and X systems) for our targeted surgical specialties within the U.S., South Korea, Japan, and the European markets in which we operate. Since 2019, we obtained regulatory clearances for the following products:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In November 2019, we obtained FDA clearance for our SynchroSeal instrument and E-100 generator. Following the FDA clearance, in February 2020, we received CE mark clearance for both products. In March 2020, we received regulatory clearance in Japan to market both our SynchroSeal instrument and E-100 generator. In August 2020, we received regulatory clearance in South Korea to market our E-100 generator.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In July 2019, we obtained FDA clearance for our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload, which round out our SureForm 45 portfolio. We have also received CE mark clearance for our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In June 2019, we received CE mark clearance for our da Vinci Endoscope Plus for the da Vinci Xi and da Vinci X Surgical Systems in Europe. Following the CE mark, in July 2019, we obtained FDA clearance for our da Vinci Endoscope Plus. We have also received regulatory clearances in South Korea and Japan to market our da Vinci Endoscope Plus in December 2019 and May 2020, respectively.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In June 2019, we obtained FDA clearance for our da Vinci Handheld Camera and, in February 2020, we received CE mark clearance.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2019, we obtained FDA clearance for our Ion endoluminal system, our new flexible, robotic-assisted, catheter-based platform, designed to navigate through very small lung airways to reach peripheral nodules for biopsies. We are introducing the Ion endoluminal system in a measured fashion while we optimize training pathways and our supply chain and collect additional clinical data. We have placed 50 Ion systems for commercial use as of March&#160;31, 2021.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In February 2019, we obtained FDA clearance for our Iris augmented reality product. Iris is a service that delivers a 3D image of the patient anatomy (initially targeting kidneys) to aid surgeons in both pre- and intra-operative settings. We are currently conducting a pilot study of our Iris product and service in the field at a small group of U.S. hospitals to gain initial product experience and insights.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In December 2018, we received product registration for our da Vinci Xi Surgical System in China. The registration approval does not include advanced energy or stapling products that attach to the da Vinci Xi system. Separate product registrations are required for each of these products with the China National Medical Products Administration (&#8220;NMPA&#8221;).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In October 2018, the China National Health Commission published on its official website the quota for major medical equipment to be imported and sold in China through 2020. After an adjustment notice was published in the third quarter of 2020, the government will now allow for the total sale of 225 new surgical robots into China, which could include da Vinci Surgical Systems as well as surgical systems introduced by others. As of March&#160;31, 2021, we have sold 129 da Vinci Surgical Systems under this quota. Future sales of da Vinci Surgical Systems under the quota are uncertain, as they are dependent on hospitals completing a tender process and receiving associated approvals.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to the descriptions of our products that received regulatory clearances in 2021, 2020, and 2019 in the New Product Introductions section below.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Japanese Ministry of Health, Labor, and Welfare (&#8220;MHLW&#8221;) considers reimbursement for procedures in April of even-numbered years. The process for obtaining reimbursement requires Japanese university hospitals and surgical societies, with our support, to seek reimbursement. There are multiple pathways to obtain reimbursement for procedures, including those that require in-country clinical data/economic data. In April 2012 and April 2016, the MHLW granted reimbursement status for robotic-assisted prostatectomy and partial nephrectomy, respectively. Most prostatectomies and partial nephrectomies were open procedures prior to da Vinci reimbursement. Da Vinci procedure reimbursement for robotic-assisted prostatectomy and partial nephrectomy procedures are higher than open and conventional laparoscopic procedure reimbursements. An additional 12 da Vinci procedures were granted reimbursement effective April 1, 2018, including gastrectomy, low anterior resection, lobectomy, and hysterectomy, for both malignant and benign conditions. An additional 7 da Vinci procedures were granted reimbursement effective April 1, 2020. These additional 19 reimbursed procedures have varying levels of conventional laparoscopic penetration and will be reimbursed at rates equal to the conventional laparoscopic procedures. Given the reimbursement level and laparoscopic penetration for these 19 procedures, there can be no assurance that the adoption pace for these procedures will be similar to robotic-assisted prostatectomy or partial nephrectomy, given their higher reimbursement, or any other da Vinci procedure.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recalls and Corrections</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical device companies have regulatory obligations to correct or remove medical devices in the field that could pose a risk to health. The definition of &#8220;recalls and corrections&#8221; is expansive and includes repair, replacement, inspections, relabeling, and issuance of new or additional instructions for use or reinforcement of existing instructions for use and training when such actions are taken for specific reasons of safety or compliance. These field actions require stringent documentation, reporting, and monitoring worldwide. There are other actions that a medical device manufacturer may take in the field without reporting including, but not limited to, routine servicing and stock rotations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we determine whether a field action is reportable in any regulatory jurisdiction, we prepare and submit notifications to the appropriate regulatory agency for the particular jurisdiction. Regulators can require the expansion, reclassification, or change in scope and language of the field action. In general, upon submitting required notifications to regulators regarding a field action that is a recall or correction, we will notify customers regarding the field action, provide any additional documentation required in their national language, and arrange, as required, return or replacement of the affected product or a field service visit to perform the correction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Field actions as well as certain outcomes from regulatory activities can result in adverse effects on our business, including damage to our reputation, delays by customers of purchase decisions, reduction or stoppage of the use of installed systems, and reduced revenue as well as increased expenses.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_82"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We model patient value as equal to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">procedure efficacy / invasiveness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In this equation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">procedure efficacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as a measure of the success of the surgery in resolving the underlying disease, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">invasiveness</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is defined as a measure of patient pain and disruption of regular activities. When the patient value of a da Vinci procedure is greater than that of alternative treatment options, patients may benefit from seeking out surgeons and hospitals that offer da Vinci Surgery, which could potentially result in a local market share shift. Adoption of da Vinci procedures occurs procedure by procedure and market by market and is driven by the relative patient value and total treatment costs of da Vinci procedures as compared to alternative treatment options for the same disease state or condition.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the number and type of da Vinci procedures as metrics for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Management believes that the number and type of da Vinci procedures provide meaningful supplemental information regarding our performance, as management believes procedure volume is an indicator of the rate of adoption of robotic-assisted surgery as well as an indicator of future revenue (including revenue from usage-based arrangements). Management believes that both it and investors benefit from referring to the number and type of da Vinci procedures in assessing our performance and when planning, forecasting, and analyzing future periods. The number and type of da Vinci procedures also facilitate management&#8217;s internal comparisons of our historical performance. We believe that the number and type of da Vinci procedures are useful to investors as metrics, because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making, and (2) they are used by institutional investors and the analyst community to help them analyze the performance of our business. The vast majority of da Vinci Surgical Systems installed are connected via the internet. System logs can also be accessed by field engineers for systems that are not connected to the internet. We utilize certain methods that rely on information collected from the systems installed for determining the number and type of da Vinci procedures performed that involve estimates and judgments, which are, by their nature, subject to substantial uncertainties and assumptions. Estimates and judgments for determining the number and type of da Vinci procedures may be impacted over time by various factors, including changes in treatment modalities, hospital and distributor reporting behavior, and system internet connectivity. Such estimates and judgments are also susceptible to algorithmic or other technical errors. In addition, the relationship between the number and type of da Vinci procedures and our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenues may fluctuate from period to period, and da Vinci procedure volume growth may not correspond to an increase in revenue. The number and type of da Vinci procedures are not intended to be considered in isolation or as a substitute for, or superior to, revenue or other financial information prepared and presented in accordance with GAAP.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Worldwide Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our da Vinci systems and instruments are regulated independently in various countries and regions of the world. The discussion of indications for use and representative or target procedures is intended solely to provide an understanding of the market for da Vinci products and is not intended to promote for sale or use of any Intuitive product outside of its licensed or cleared labeling and indications for use.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of robotic-assisted surgery using the da Vinci Surgical System has the potential to grow for those procedures that offer greater patient value than to non-da Vinci alternatives and competitive total economics for healthcare providers. Our da Vinci Surgical Systems are used primarily in general surgery, gynecologic surgery, urologic surgery, cardiothoracic surgery, and head and neck surgery. We focus our organization and investments on developing, marketing, and training products and services for procedures in which da Vinci can bring patient value relative to alternative treatment options and/or economic benefit to healthcare providers. Target procedures in general surgery include hernia repair (both ventral and inguinal), colorectal procedures, bariatrics, and cholecystostomies. Target procedures in gynecology include hysterectomy for both cancer and benign conditions. Target procedures in urology include prostatectomy and partial nephrectomy. In cardiothoracic surgery, target procedures include lobectomy. In head and neck surgery, target procedures include certain procedures resecting benign and malignant tumors classified as T1 and T2. Not all of the indications, procedures, or products described may be available in a given country or region or on all generations of da Vinci surgical systems. Surgeons and their patients need to consult the product labeling in their specific country and for each product in order to determine the cleared uses, as well as important limitations, restrictions, or contraindications.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, approximately 1,243,000 surgical procedures were performed with da Vinci Surgical Systems, compared to approximately 1,229,000 and 1,038,000 surgical procedures performed with da Vinci Surgical Systems in 2019 and 2018, respectively. The reduced growth in our overall procedure volume in 2020 reflects significant disruption caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, and was driven by growth in U.S. general surgery procedures and worldwide urology procedures.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall U.S. procedure volume with da Vinci Surgical Systems declined to approximately 876,000 in 2020, compared to approximately 883,000 in 2019 and approximately 753,000 in 2018. General surgery was our largest and fastest growing U.S. specialty in 2020 with procedure volume that grew to approximately 434,000 in 2020, compared to approximately 421,000 in 2019 and approximately 325,000 in 2018. Gynecology was our second largest U.S. surgical specialty in 2020 with procedure volume that declined to approximately 267,000 in 2020, compared to approximately 282,000 in 2019 and approximately 265,000 in 2018. Urology was our third largest U.S. surgical specialty in 2020 with procedure volume that declined to approximately 134,000 in 2020, compared to approximately 138,000 in 2019 and approximately 128,000 in 2018.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedures Outside of the U.S.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall OUS procedure volume with da Vinci Surgical Systems grew to approximately 367,000 in 2020, compared to approximately 346,000 in 2019 and approximately 285,000 in 2018. Procedure growth in most OUS markets was driven largely by urology procedure volume, which grew to approximately 214,000 in 2020, compared to approximately 206,000 in 2019 and approximately 175,000 in 2018. General surgery and thoracic procedures also contributed to OUS procedure growth with higher growth rates than urology procedures.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Business Events and Trends</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_88"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Overall. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total da Vinci procedures performed by our customers grew approximately 16% for the three months ended March&#160;31, 2021, compared to approximately 10% for the three months ended March&#160;31, 2020. The first quarter procedure results for both periods reflect significant disruption caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. We saw continued recovery and growth in most of the major procedure categories in the latter part of the first quarter of 2021, most notably in general surgery procedures (particularly bariatrics and cholecystectomies) and, to a lesser extent, gynecology and urology procedures. The rates of recovery in urology procedures continue to be impacted by the COVID-19 pandemic due to delays in both the diagnosis of and procedures in patient populations that are considered to be at higher risk from COVID-19 infections as well as for conditions that may progress more slowly.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;U.S. da Vinci procedures grew approximately 14% for the three months ended March&#160;31, 2021, compared to approximately 9% for the three months ended March&#160;31, 2020. The first quarter procedure results for both periods reflect significant disruption caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. The U.S. procedure growth was largely attributable to general surgery procedures, most notably bariatric, cholecystectomy, and hernia procedures. Growth in the more mature gynecologic and urologic procedure categories was more moderate. During the COVID-19 pandemic, we believe patients have delayed non-urgent procedures to a greater extent than urgent procedures, particularly when patients are at higher risk of COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">OUS Procedures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> OUS da Vinci procedures grew approximately 23% for the three months ended March&#160;31, 2021, compared to approximately 12% for the three months ended March&#160;31, 2020. The first quarter procedure results for both periods reflect significant procedure disruption caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. The OUS procedure growth was driven by continued growth in urology procedures, most notably partial nephrectomy and prostatectomy procedures, and earlier stage growth in general surgery (particularly colorectal), gynecology, and thoracic procedures. The OUS procedure growth rate reflects continued da Vinci adoption in European and Asian markets. The COVID-19 outbreak in China during the first quarter of 2020, coupled with low COVID-19 rates in 2021, resulted in China's procedure volume significantly increasing in the first quarter of 2021 compared to the first quarter of 2020. We also saw strong procedure growth in France and South Korea, while the UK, India, and other regions saw significant disruption from the COVID-19 pandemic.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_91"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System Demand</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We placed 298 da Vinci Surgical Systems in the first quarter of 2021, compared to 237 systems in the first quarter of 2020. The increase in systems placed reflects procedure growth, more customers trading in da Vinci Si Surgical Systems for fourth generation da Vinci systems in order to access fourth generation instruments and capabilities as well as to standardize their system portfolio, and further customer validation that da Vinci surgery addresses their quadruple aim objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While first quarter 2021 placements grew more than 25% compared with 2020, future demand for da Vinci Surgical Systems will be impacted by a number of factors: economic and geopolitical factors; the impact of the current COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above; hospital response to the evolving healthcare environment; procedure growth rates; hospital consolidation trends; evolving system utilization and point of care dynamics; capital replacement trends; additional reimbursements in various global markets, including Japan: the timing around governmental tenders and authorizations, including China; the timing of when we receive regulatory clearance in our other OUS markets for our da Vinci Xi Surgical System, da Vinci X Surgical System, and da Vinci SP Surgical System, and related instruments; and market response. Market acceptance of our recently launched da Vinci SP Surgical System and the nature and timing of additional da Vinci SP regulatory indications may also impact future system placements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand may also be impacted by robotic-assisted surgery competition, including from companies that have introduced products in the field of robotic-assisted surgery or have made explicit statements about their efforts to enter the field including, but not limited to, the following companies: Asensus Surgical, Inc.; avateramedical GmbH; CMR Surgical Ltd.; Johnson &amp; Johnson (including their wholly owned subsidiaries Auris Health, Inc. and Verb Surgical Inc.); Medicaroid, Inc.; Medrobotics Corporation; Medtronic plc; meerecompany Inc.; MicroPort Scientific Corporation; Olympus Corporation; Samsung Group; Shandong Weigao Group Medical Polymer Company Ltd.; Smart Robot Technology Group Co. Ltd.; and Titan Medical Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the above factors will also impact future demand for our Ion system, as we extend our commercial offering into diagnostics, along with additional factors associated with a new product introduction, including, but not limited to, our ability to optimize manufacturing and our supply chain, competition, clinical data to demonstrate value, and market acceptance.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Product Introductions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SynchroSeal and E-100 Generator.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we obtained FDA clearance for our SynchroSeal instrument and E-100 generator. Following the FDA clearance, in February 2020, we received CE mark clearance for both products. In March 2020, we received regulatory clearance in Japan to market both our SynchroSeal instrument and E-100 generator. In August 2020, we received regulatory clearance in South Korea to market our E-100 generator. SynchroSeal is a single-use, bipolar, electrosurgical instrument intended for grasping, dissection, sealing, and transection of tissue. With its wristed articulation, rapid sealing cycle, and refined curved jaw, SynchroSeal offers enhanced versatility to the da Vinci Energy portfolio. The E-100 generator is an electrosurgical generator developed to power two key instruments &#8211; Vessel Sealer Extend and SynchroSeal &#8211; on the da Vinci X and da Vinci Xi Surgical Systems. The generator delivers high frequency energy for cutting, coagulation, and vessel sealing of tissues.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SureForm 45 Curved-Tip and Gray Reload.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In July 2019, we obtained FDA clearance for the SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. We have also received CE mark clearance for our SureForm 45 Curved-Tip stapler and SureForm 45 Gray reload. SureForm 45 Curved-Tip is a single-use, fully wristed stapling instrument with a curved tip intended for resection, transection, and/or creation of anastomoses. SureForm 45 Gray reload is a new, single-use cartridge that contains multiple staggered rows of implantable staples and a stainless steel knife. The SureForm 45 Curved-Tip stapler and Gray reload have particular utility in thoracic procedures and round out our SureForm 45 portfolio. Not all reloads or staplers are available for use on all systems or in all countries.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Da Vinci Endoscope Plus.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, we received CE mark clearance for our da Vinci Endoscope Plus, an enhanced 3D endoscope for use with our da Vinci X and Xi Surgical Systems. Following the CE mark, in July 2019, we obtained FDA clearance for our da Vinci Endoscope Plus. We have also received regulatory clearances in South Korea and Japan to market our da Vinci Endoscope Plus in December 2019 and May 2020, respectively. The da Vinci Endoscope Plus leverages new sensor technology to allow for increased sharpness and color accuracy.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Da Vinci Handheld Camera.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In June 2019, we obtained FDA clearance for our da Vinci Handheld Camera, a lightweight, 2D camera head, which can be connected to third-party laparoscopes. This allows the laparoscopic image to be displayed on the da Vinci X/Xi vision cart to address aspects of da Vinci procedures that may require use of a laparoscope, thus eliminating the need for redundant equipment in the operating room and increasing procedure efficiency. In February 2020, we received CE mark clearance for our da Vinci Handheld Camera. We broadly launched the da Vinci Handheld Camera in our European direct markets as well as in the U.S. in May 2020 and June 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ion endoluminal system. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, we obtained FDA clearance for the Ion endoluminal system, our new flexible, robotic-assisted, catheter-based platform designed to navigate through very small lung airways to reach peripheral nodules for biopsies. The Ion system uses an ultra-thin articulating robotic catheter that can articulate 180 degrees in all directions. The outer diameter of the catheter is 3.5mm, which allows physicians to navigate through small and tortuous airways to reach nodules in most airway segments within the lung. The Ion system&#8217;s flexible biopsy needle can also pass through very tight bends via Ion&#8217;s catheter to collect tissue in the peripheral lung. The catheter&#8217;s 2mm working channel can also accommodate other biopsy tools, such as biopsy forceps or cytology brushes, if necessary. We are introducing Ion in a measured fashion while we optimize training pathways and our supply chain and collect additional clinical data. We have placed 50 Ion systems for commercial use as of March&#160;31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Iris.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In February 2019, we obtained FDA clearance for our Iris augmented reality product. Iris is a service that delivers a 3D image of the patient anatomy (initially targeting kidneys) to aid surgeons in both the pre- and intra-operative settings. We are now in the early stages of an Iris pilot study in the field at a small group of U.S. hospitals to gain initial product experience and insights.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter 2021 Operational and Financial Highlights</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenue increased by 18% to $1.29 billion for the three months ended March&#160;31, 2021, compared to $1.10&#160;billion for the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approximately 360,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">da Vinci procedures were performed during the three months ended March&#160;31, 2021, an increase of 16% compared to approximately 310,000 for the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Instruments and accessories revenue increased by 14% to $706 million for the three months ended March&#160;31, 2021, compared to $618&#160;million for the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Systems revenue increased by 30% to $369 million for the three months ended March&#160;31, 2021, compared to $283&#160;million during the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A total of 298 da Vinci Surgical Systems were shipped during the three months ended March&#160;31, 2021, an increase of 26% compared to 237 systems during the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of March&#160;31, 2021, we had a da Vinci Surgical System installed base of approximately 6,142 systems, an increase of approximately 8% compared to the installed base of approximately 5,669 systems as of March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Utilization of da Vinci systems, measured in terms of procedures per system per year, increased 8% relative to the first quarter of 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the three months ended March&#160;31, 2021, we placed 14 Ion systems for commercial use, an increase of 75% compared to 8 systems during the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit as a percentage of revenue was 69.9% for the three months ended March&#160;31, 2021, compared to 67.1% for the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income increased by 47% to $417 million for the three months ended March&#160;31, 2021, compared to $283&#160;million during the three months ended March&#160;31, 2020. Operating income included $104 million and $91 million of share-based compensation expense related to employee stock plans and $6.9 million and $13.3 million of intangible asset-related charges for the three months ended March&#160;31, 2021, and 2020, respectively.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of March&#160;31, 2021, we had $7.23&#160;billion in cash, cash equivalents, and investments. Cash, cash equivalents, and investments increased by $361&#160;million, compared to December&#160;31, 2020, primarily as a result of cash provided by our operations and proceeds from stock option exercises and employee stock purchases, partially offset by capital expenditures and taxes paid related to net share settlements of equity awards.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, certain unaudited Condensed Consolidated Statements of Income information (in millions, except percentages):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.279%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of&#160;Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">361.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">435.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income attributable to noncontrolling interest in joint venture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_112"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Total Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue increased by 18% to $1.3&#160;billion for the three months ended March&#160;31, 2021, compared to $1.1&#160;billion for the three months ended March&#160;31, 2020, resulting from 30% higher systems revenue, driven by 26% higher system placements, 14% higher instruments and accessories revenue, driven by approximately 16% higher procedure volume partially offset by the impact of extended use instruments, and 9% higher service revenue.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue denominated in foreign currencies as a percentage of total revenue was approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 23% and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21% for the three months ended March&#160;31, 2021, and 2020, respectively. We generally sell our products and services in local currencies where we have direct distribution channels. Foreign currency rate fluctuations did not have a material impact on total revenue for the three months ended March&#160;31, 2021, nor for the three months ended and March&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated in the U.S. accounted for</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 66% and 71% of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> total revenue for the three months ended March&#160;31, 2021, and the three months ended March&#160;31, 2020, respectively. We believe that U.S. revenue has accounted for the large majority of total revenue due to U.S. patients&#8217; ability to choose their provider and method of treatment, reimbursement structures supportive of innovation and MIS, and our initial investments focused on U.S. infrastructure. We have been investing in our business in the OUS markets, and our OUS procedures have grown faster in proportion to U.S. procedures. We expect that our OUS procedures and revenue will make up a greater portion of our business in the long term.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic is expected to continue to cause a strain on hospital resources, as outlined in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, we cannot reliably estimate the extent total revenue will be impacted in the second quarter of 2021 and beyond.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our revenue and system unit shipments for the three months ended March&#160;31, 2021, and 2020, respectively (in millions, except percentages and unit shipments):  </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847.5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781.6&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue &#8211; U.S.</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Revenue &#8211; OUS</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total recurring revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">855.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of Total revenue </span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Da Vinci Surgical Systems Shipments by Region:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. unit shipments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OUS unit shipments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unit shipments*</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*Systems shipped under operating leases (included in total unit shipments)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Da Vinci Surgical Systems Shipments involving System Trade-ins:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unit shipments involving trade-ins</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unit shipments not involving trade-ins</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ion Systems Shipments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_115"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenue increased by 19% to $1.07 billion for the three months ended March&#160;31, 2021, compared to $0.90 billion for the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Instruments and accessories revenue increased by 14% to $706&#160;million for the three months ended March&#160;31, 2021, compared to $618 million for the three months ended March&#160;31, 2020. The increase in instruments and accessories revenue was driven primarily by procedure growth of approximately 16%, partially offset by customer buying patterns. The first quarter 2021 U.S. procedure growth was approximately 14%, driven by growth in general surgery procedures, most notably bariatric, cholecystectomy, and hernia repair procedures, as well as moderate growth in the more mature gynecologic and urologic procedures categories. The first quarter 2021 OUS procedure growth was approximately 23%, driven by continued growth in urology procedures, most notably partial nephrectomy and prostatectomy procedures, and earlier stage growth in general surgery (particularly colorectal), gynecology, and thoracic procedures. Both growth rates were impacted by the disruption </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">caused by the COVID-19 pandemic, as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 Pandemic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above. Geographically, the first quarter 2021 OUS procedure growth was driven by procedure expansion in China, France, South Korea, Japan, and Germany, while procedures declined in the UK.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems revenue increased by 30% to $369 million for the three months ended March&#160;31, 2021, compared to $283 million for the three months ended March&#160;31, 2020. The higher first quarter 2021 systems revenue was primarily driven by higher system shipments, higher operating lease revenue, higher first quarter 2021 ASPs, and higher lease buyouts, partially offset by a higher proportion of system shipments under operating leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, a total o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f 298 da Vinci Surgical Systems were shipped compared to 237 systems during the first quarter of 2020. By geography, 190 systems were shipped into the U.S., 59 into Europe, 44 into Asia, and 5 into other markets during the first quarter of 2021, compared to 182 systems shipped into the U.S., 25 into Europe, 27 into Asia, and 3 into other markets during the first quarter of 2020. The increase in systems shipments was primarily driven by procedure growth, more customers trading in da Vinci Si Surgical Systems for fourth generation da Vinci Xi and da Vinci X systems in order to access fourth generation instruments and capabilities as well as to standardize their system portfolio, and further customer validation that da Vinci surgery addresses their quadruple aim objectives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We shipped 137 and 121 da Vinci Surgical Systems under lease arrangements, of which 127 and 77 systems were classified as operating leases for the three months ended March&#160;31, 2021, and 2020, respectively. Operating lease revenue was $59.0 million for the three months ended March&#160;31, 2021, compared to $39.1 million for the three months ended March&#160;31, 2020. Systems placed as operating leases represented 43% of total shipments during the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">first quarter of 2021, compared to 32% during the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> first quarter of 2020. A total of 1,006 da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical Systems were installed at customers under operating lease or usage-based arrangements as of March&#160;31, 2021, compared to 721 as of March&#160;31, 2020. Revenue from Lease Buyouts was $19.1 million for the three months ended March&#160;31, 2021, compared to $12.2 million for the three months ended March&#160;31, 2020. We expect revenue from Lease Buyouts to fluctuate period to period depending on the timing of when, and if, customers choose to exercise the buyout options embedded in their leases.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The da Vinci Surgical System ASP, excluding the impact of systems shipped under operating lease or usage-based arrangements and Ion systems, was approximately $1.65 million for the three months ended March&#160;31, 2021, compared to approximately $1.44 million for the three months ended March&#160;31, 2020. ASP fluctuates from period to period based on geographic and product mix, product pricing, systems shipped involving trade-ins, and changes in foreign exchange rates.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_118"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue increased by 9% to $218&#160;million for the three months ended March&#160;31, 2021, compared to $199 million for the three months ended March&#160;31, 2020. The increase in service revenue was primarily driven by a larger installed base of da Vinci Surgical Systems producing service revenue.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_121"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross profit for the three months ended March&#160;31, 2021, increased 25% to $755 million, representing 70.3% of product revenue, compared to $604 million, representing 67.1% of product revenue, for the three months ended March&#160;31, 2020. The higher product gross profit for the three months ended March&#160;31, 2021, was primarily driven by higher product revenue and higher product gross profit margin. The higher product gross profit margin for the three months ended March&#160;31, 2021, was primarily driven by higher system first quarter 2021 ASPs, lower year-over-year costs associated with da Vinci Si product transitions, lower freight costs, and lower intangible assets amortization expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product gross profit for the three months ended March&#160;31, 2021, and 2020, included share-based compensation expense of $15.3 million and $12.8 million, respectively, and intangible assets amortization expense of $4.2 million and $8.8 million, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service gross profit for the three months ended March&#160;31, 2021, increased 10% to $147 million, representing 67.7% of service revenue, compared to $134 million, representing 67.5% of service revenue, for the three months ended March&#160;31, 2020. The higher service gross profit for the three months ended March&#160;31, 2021, was primarily driven by higher service revenue, reflecting a larger installed base of da Vinci Surgical Systems, and higher service gross profit margin. The higher service gross profit margin for the three months ended March&#160;31, 2021, was primarily driven by lower intangible assets amortization expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service gross profit for the three months ended March&#160;31, 2021, and 2020, included share-based compensation expense of $5.7 million and $5.5 million, respectively, and intangible assets amortization expense of $0.3 million and $0.9 million, respectively.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses include costs for sales, marketing, and administrative personnel, sales and marketing activities, tradeshow expenses, legal expenses, regulatory fees, and general corporate expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended March&#160;31, 2021, increased by 6% to $326 million, compared to $308 million for the three months ended March&#160;31, 2020. The increase in selling, general and administrative expenses for the three months ended March&#160;31, 2021, was primarily driven by higher headcount, resulting in increased fixed and share-based compensation expense, higher variable compensation, and increased infrastructure to support our growth, partially offset by lower marketing, travel, and training expenses.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the three months ended March&#160;31, 2021, and 2020, included share-based compensation expense of $53.1 million and $45.7 million, respectively, and intangible assets amortization expense of $1.7 million and $1.7 million, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our spending in the first quarter of 2021 reflected a continued curtailment of certain costs as a result of the COVID-19 pandemic, including travel, marketing events, surgeon training, clinical trials, and other related expenses. We expect that these costs will increase to the extent that the impact of COVID-19 decreases and decline to the extent that the impact of COVID-19 increases. However, we will continue to support our customers, invest in innovation focused on the quadruple aim, and invest in manufacturing and our supply chain to ensure supply for our customers. We will manage the hiring of volume-related roles, such as sales representatives and manufacturing employees, to meet the needs of the business.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_127"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs are expensed as incurred. Research and development expenses include costs associated with the design, development, testing, and significant enhancement of our products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended March&#160;31, 2021, increased by 9% to $160 million, compared to $147 million for the three months ended March&#160;31, 2020. The increases in research and development expenses for the three months ended March&#160;31, 2021, were primarily driven by higher personnel-related expenses and other project costs incurred to support a broader set of product development initiatives, including Ion and SP platform investments, informatics, advanced instrumentation, advanced imaging, and future generations of robotics, partially offset by lower intangible asset-related charges.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses for the three months ended March&#160;31, 2021, and 2020, included share-based compensation expense of $30.1&#160;million and $27.2&#160;million, respectively, and intangible asset charges of $0.7 million and $1.9 million, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses fluctuate with project timing. Based upon our broader set of product development initiatives and the stage of the underlying projects, we expect to continue to make substantial investments in research and development and anticipate that research and development expenses will continue to increase in the future.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_130"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest and Other Income, Net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, for the three months ended March&#160;31, 2021, and 2020, was $32.0 million, and $25.1 million, respectively. The increase in interest and other income, net, for the three months ended March&#160;31, 2021, was primarily driven by unrealized gains on investments resulting from strategic arrangements, partially offset by lower interest income earned, despite higher cash and investment balances, due to the decline in average interest rates. During the first quarter of 2021, the Company recorded unrealized gains on strategic investments of approximately $14&#160;million.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_133"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Tax Expense (Benefit)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) for the three months ended March&#160;31, 2021, was $13.6 million, or 3.0% of income before taxes, compared to $(8.1) million, or (2.6)% of income before taxes, for the three months ended March&#160;31, 2020. The higher income tax expense for the three months ended March&#160;31, 2021, was primarily due to higher pre-tax income.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended March&#160;31, 2021, and 2020, differs from the U.S. federal statutory rate of 21% primarily due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and federal R&amp;D credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes for the three months ended March&#160;31, 2021, and 2020, included excess tax benefits associated with employee equity plans of $73.4&#160;million and $65.4&#160;million, which reduced our effective tax rate by 16.4 and 21.2 percentage points, respectively. The amount of excess tax benefits or deficiencies will fluctuate from period to period based on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the price of our stock, the volume of share-based instruments settled or vested, and the value assigned to employee equity awards under U.S. GAAP, which results in increased income tax expense volatility.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of our unrecognized tax benefits could change due to activities of various tax authorities, including evolving interpretations of existing tax laws in the jurisdictions we operate, potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect our effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, we cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the examination of our income tax returns by the IRS and other tax authorities. The outcome of these audits cannot be predicted with certainty. Management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. If any issues addressed in our tax audits are resolved in a manner not consistent with management&#8217;s expectations, we could be required to adjust our provision for income taxes in the period such resolution occurs.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_136"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interest in Joint Venture</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interest in Joint Venture for the three months ended March&#160;31, 2021, and 2020, was $8.9 million and $2.7 million, respectively. The increase in net income attributable to noncontrolling interest in Joint Venture was primarily due to increased sales in China during the three months ended March&#160;31, 2021.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_139"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_142"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal source of liquidity is cash provided by operations and by the issuance of common stock through the exercise of stock options and our employee stock purchase program. Cash and cash equivalents plus short- and long-term investments increased by $0.36&#160;billion to $7.23&#160;billion as of March&#160;31, 2021, from $6.87&#160;billion as of December&#160;31, 2020, primarily from cash provided by our operations and proceeds from stock option exercises and employee stock purchases, partially offset by capital expenditures and taxes paid related to net share settlements of equity awards.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash requirements depend on numerous factors, including market acceptance of our products, the resources we devote to developing and supporting our products, and other factors. We expect to continue to devote substantial resources to expand procedure adoption and acceptance of our products. We have made substantial investments in our commercial operations, product development activities, facilities, and intellectual property. Based upon our business model, we anticipate that we will continue to be able to fund future growth through cash provided by our operations. We believe that our current cash, cash equivalents, and investment balances, together with income to be derived from the sale of our products, will be sufficient to meet our liquidity requirements for the foreseeable future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item&#160;7A. Quantitative and Qualitative Disclosures About Market Risk&#8221; in our Form 10-K for the fiscal year ended December&#160;31, 2020, for discussion on the impact of interest rate risk and market risk on our investment portfolio.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_145"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Condensed Consolidated Cash Flow Data</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the three months ended March&#160;31, 2021, and 2020 (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended&#160;<br/>&#160;March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(597.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, net cash provided by operating activities of $478 million exceeded our net income of $435 million, primarily due to the following reasons:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Our net income included non-cash charges of $212 million, consisting primarily of the following significant items: share-based compensation of $103 million; depreciation expense and losses on the disposal of property, plant, and equipment of $65 million; deferred income taxes of $45 million; gain on investments, accretion, and amortization, net, of $13 million; and amortization of intangible assets of $7 million.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The non-cash charges outlined above were partially offset by changes in operating assets and liabilities that resulted in $169 million of cash used by operating activities during the three months ended March&#160;31, 2021. Prepaid expenses and other assets increased by $73 million, primarily due to an increase in prepaid taxes, driven by the timing of tax payments, and an increase in leasing. Inventory, including the effect of systems inventory built and transferred to property, plant, and equipment as a result of systems placed under operating lease and usage-based arrangements, increased by $41 million, primarily due to build-up to address the growth in the business as well as to mitigate risks of disruption that could arise from trade, supply, or other matters. Refer to further details in the supplemental cash flow information in Note 4 to the Condensed Consolidated Financial Statements (Unaudited) included in Item&#160;1, Part I. Accrued compensation and employee benefits decreased by $40 million, primarily due to the payments of 2020 incentive compensation. Other liabilities decreased by $31 million, primarily due to the timing of payments. Accounts receivable increased by $14 million, primarily due to the timing of collections. The unfavorable impact of these items on cash provided by operating activities was partially offset by a $24 million increase in accounts payable, primarily due to the timing of billings.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_151"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the three months ended March&#160;31, 2021, consisted primarily of purchases of investments (net of proceeds from sales and maturities of investments) of $530 million, the acquisition of property and equipment of $59 million, and the acquisition of a business, net of cash acquired, of $9 million. We invest predominantly in high quality, fixed income securities. Our investment portfolio may, at any time, contain investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_154"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in financing activities during the three months ended March&#160;31, 2021, consisted primarily of taxes paid on behalf of employees related to net share settlements of vested employee stock purchases of&#160;$178 million and the payment of deferred purchase consideration from prior acquisitions of $8 million, partially offset by proceeds from stock option exercises and employee stock purchases of $84 million.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_157"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Expenditures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is not capital equipment intensive. However, with the growth of our business and our investments in property and facilities and in manufacturing automation, capital investments in these areas have increased. We expect these capital investments to exceed $300&#160;million in both 2021 and 2022. We intend to fund these needs with cash generated from operations.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_160"></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our Financial Statements, which have been prepared in accordance with U.S. GAAP. The preparation of these Financial Statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, we evaluate our critical accounting estimates. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. There have been no new or material changes to the critical accounting estimates discussed in our Annual Report on Form 10-K for the fiscal year ended&#160;December&#160;31, 2020, that are of significance, or potential significance, to the Company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_163"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our market risk during the three months ended March&#160;31, 2021, compared to the disclosures in Part II, Item&#160;7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2020.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_166"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based on the foregoing, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_172"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information included in Note 8 to the Condensed Consolidated Financial Statements (Unaudited) included in Part I, Item 1 of this quarterly report is incorporated herein by reference.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_175"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the factors discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which could materially affect our business, financial position, or future results of operations. The risks described in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations. The risk factor set forth below updates, and should be read together with, the risk factors described in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISKS RELATING TO OUR BUSINESS</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR RELIANCE ON SOLE AND SINGLE SOURCE SUPPLIERS AND OUR ABILITY TO PURCHASE AT ACCEPTABLE PRICES A SUFFICIENT AMOUNT OF MATERIALS, PARTS, AND COMPONENTS COULD HARM OUR ABILITY TO MEET DEMAND FOR OUR PRODUCTS IN A TIMELY MANNER OR WITHIN BUDGET.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the components necessary for the assembly of our products are currently provided to us by sole-sourced suppliers or single-sourced suppliers. We generally purchase components through purchase orders rather than long-term supply agreements and generally do not maintain large volumes of inventory. While alternative suppliers exist and could be identified for sole-sourced components, the disruption or termination of the supply of components could cause a significant increase in the costs of these components, which could affect our operating results. A disruption or termination in the supply of components could also result in our inability to meet demand for our products, which could harm our ability to generate revenues, lead to customer dissatisfaction, and damage our reputation. Furthermore, if we are required to change the manufacturer of a key component of our products, we may be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could delay our ability to manufacture our products in a timely manner or within budget, which may have a material adverse impact on our business, financial condition, results of operations, or cash flows.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to meet customers' demands depends, in part, on our ability to timely obtain an adequate delivery of quality materials, parts, and components from our suppliers. For example, we have experienced, and could continue to experience, increased difficulties in obtaining a sufficient amount of materials in the semiconductor market, as prices of such materials increased and global supply has become more limited due to the increased demand for chips to support expansion of server and cloud networks as a greater proportion of the global population worked remotely, the introduction of 5G, and the continued electrification of vehicles. We engage in activities to seek to mitigate such supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. If our timely access to adequate quantities of these important supply-chain materials in the semiconductor or other markets is adversely impacted, our ability to meet customer demand could be affected, which could negatively impact our results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_178"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unregistered sales of equity securities during the period covered by this report.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c) Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes our stock repurchase activity for the quarter ended March&#160;31, 2021.</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.887%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares<br/>Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares&#160;Purchased&#160;As<br/>Part of a Publicly<br/>Announced Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar<br/>Amount&#160;of&#160;Shares&#160;That<br/>May Yet be Purchased<br/>Under the Program (1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 to January 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;billion</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 to February 28, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;billion</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 to March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;billion</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total during quarter ended March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Since March 2009, we have had an active stock repurchase program. As of&#160;March&#160;31, 2021, our Board of Directors (the &#8220;Board&#8221;) had authorized an aggregate amount of up to&#160;$7.5&#160;billion&#160;for stock repurchases, of which the most recent authorization occurred in January 2019, when the Board increased the authorized amount available under our share repurchase program to&#160;$2.0&#160;billion. The remaining $1.6&#160;billion&#160;represents the amount available to repurchase shares under the authorized repurchase program as of&#160;March&#160;31, 2021. The authorized stock repurchase program does not have an expiration date.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_181"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_184"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_187"></div><div style="margin-bottom:6pt;margin-top:9pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:6pt;padding-left:63pt;text-align:justify;text-indent:-63pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-31xamendedandrestatedce.htm">Amended and Restated Certificate of Incorporation of Intuitive Surgical, Inc., as amended (incorporated by reference to Exhibit 3.1 of the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on July 23, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">Amended and Restated Bylaws of Intuitive Surgical, Inc. (incorporated by reference to Exhibit 3.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm"> of the Current Report on Form 8-K filed with the Securities and Exchange Commission on&#160;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">February</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">&#160;</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1035267/000103526721000021/exhibit31-amendedandrestat.htm">).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-311q121.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-312q121.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-321q121.htm">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex-322q121.htm">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from Intuitive Surgical, Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2021, formatted in Inline XBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed Consolidated Statements of Comprehensive Income, (iii) the unaudited Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements (unaudited), tagged at Level I through IV.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, formatted in Inline XBRL and contained in Exhibit 101.</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ia2d6c54d34c741ac83a377a4ad341cb9_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ia2d6c54d34c741ac83a377a4ad341cb9_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:55.263%"><tr><td style="width:1.0%"></td><td style="width:7.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INTUITIVE SURGICAL, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARSHALL L. MOHR</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marshall L. Mohr</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and duly authorized signatory)</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: April&#160;21, 2021</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex-31xamendedandrestatedce.htm
<DESCRIPTION>EX-3.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia6c0703dc9c54a06adacc0023baefb57_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 3.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORRECTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">INTUITIVE SURGICAL, INC., a corporation organized and existing under the laws of the state of Delaware (the &#8220;Corporation&#8221;) hereby certifies that&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;The name of the Corporation is Intuitive Surgical, Inc.  The name under which this corporation was originally incorporated is Intuitive Surgical Devices, Inc.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">2.&#160;&#160;&#160;&#160;The date of filing of the Corporation&#8217;s original Certificate of Incorporation was November 9, 1995.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;The Corporation filed an Amended and Restated Certificate of Incorporation on June 30, 2003.  Said Amended and Restated Certificate requires correction as permitted by Section 103 of the General Corporation law of the State of Delaware.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">4.&#160;&#160;&#160;&#160;The inaccuracy or defect of said Amended and Restated Certificate of Incorporation is as follows&#58;  Due to a clerical error, the Corporation&#8217;s former Certificate of Incorporation was mistakenly filed in lieu of a Certificate of Amendment.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">5.&#160;&#160;&#160;&#160;The Amended and Restated Certificate of Incorporation is corrected to read as shown in the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">IN WITNESS WHEREOF, the undersigned has signed this certificate this 12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:138%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%"> day of September, 2003, and hereby affirms and acknowledges under penalty of perjury that the filing of this Amended and Restated Certificate of Incorporation is the act and deed of Intuitive Surgical, Inc.</font></div><div style="margin-bottom:12pt;padding-left:108pt;padding-right:108pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;    </font></div><div style="margin-bottom:17pt;margin-top:5pt;padding-left:216pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.551%"><tr><td style="width:1.0%"></td><td style="width:12.209%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.591%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">INTUITIVE SURGICAL, INC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;   </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Lonnie M. Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lonnie M. Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:138%">President and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="ia6c0703dc9c54a06adacc0023baefb57_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF INTUITIVE SURGICAL, INC. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A DELAWARE CORPORATION</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE I.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">The name of the corporation is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">Intuitive Surgical, Inc.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">The address of the corporation&#8217;s registered office in the State of Delaware is 1013 Centre Road, City of Wilmington, County of New Castle.  The name of its registered agent at such address is The Prentice-Hall Corporation System, Inc.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">The purpose of this corporation is to engage in any lawful act or activity for which a corporation may be organized under the General Corporation Law of Delaware (&#8220;DGCL&#8221;).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Classes of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  This corporation is authorized to issue two classes of stock to be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221;  The total number of shares which the corporation is authorized to issue is two hundred five million (205,000,000) shares, of which two hundred million (200,000,000) shares shall be Common Stock, par value $0.001 per share, and five million (5,000,000) shares shall be Preferred Stock, par value $0.001 per share.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Rights.  Preferences and Restrictions of Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  The Preferred Stock may be issued from time to time in one or more series.  The Board of Directors is hereby authorized, by filing a certificate (a &#8220;Preferred Stock Designation&#8221;) pursuant to DGCL, to fix or alter from time to time the designation, powers, preferences and rights (voting or otherwise) granted upon, and the qualifications, limitations or restrictions of, any wholly unissued series of Preferred Stock, and to establish from time to time the number of shares constituting any such series or any of them&#59; and to increase or decrease the number of shares of any series subsequent to the issuance of shares of that series, but not below the number of shares of such series then outstanding. In case the number of shares of any series shall be decreased in accordance with the foregoing sentence, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">For the management of the business and for the conduct of the affairs of the corporation, and in further definition, limitation and regulation of the powers of the corporation, of its directors and of its stockholders or any class thereof, as the case may be, it is further provided that&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Management of Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  The management of the business and the conduct of the affairs of the corporation shall be vested in its Board of Directors.  The number of directors which shall constitute the whole Board of Directors shall be fixed exclusively by one or more resolutions adopted by the Board of Directors.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, the directors shall be divided into three classes designated as Class I, Class II and Class III, respectively.  Directors shall be assigned to each class in accordance with a resolution or resolutions adopted by the Board of Directors.  At the first annual meeting of stockholders following the closing of the initial public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale of Common Stock to the public (the &#8220;Initial Public Offering&#8221;), the term of office of the Class I directors shall expire and Class I directors shall be elected for a full term of three years.  At the second annual meeting of stockholders following the Initial Public Offering, the term of office of the Class II directors shall expire and Class II directors shall be elected for a full term of three years.  At the third annual meeting of stockholders following the Initial Public Offering, the term of office of the Class III directors shall expire and Class III directors shall be elected for a full term of three years.  At each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting.  During such time or times that the corporation is subject to Section 2115(b) of the California General Corporation Law (&#8220;CGCL&#8221;), this Section B.1. of this Article V shall become effective and be applicable only when the corporation is a &#8220;listed&#8221; corporation within the meaning of Section 301.5 of the CGCL.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">2.&#160;&#160;&#160;&#160;In the event that the corporation is subject to Section 2115(b) of the CGCL AND is not a &#8220;listed&#8221; corporation or ceases to be a &#8220;listed&#8221; corporation under Section 301.5 of the CGCL, Section B.1. of this Article V shall not apply and all directors shall be shall be elected at each annual meeting of stockholders to hold office until the next annual meeting.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;No person entitled to vote at an election for directors may cumulate votes to which such person is entitled, unless, at the time of such election, the corporation is subject to Section 2115(b) of the CGCL AND is not a &#8220;listed&#8221; corporation or ceases to be a &#8220;listed&#8221; corporation under Section 301.5 of the CGCL.  During this time, every stockholder entitled to vote at an election for directors may cumulate such stockholder&#8217;s votes and give one candidate a number of votes equal to the number of directors to be elected multiplied by the number of votes to which such stockholder&#8217;s shares are otherwise entitled, or distribute the stockholder&#8217;s votes on the same principle among as many candidates as such stockholder thinks fit.  No stockholder, however, shall be entitled to so cumulate such stockholder&#8217;s votes unless (i) the names of such candidate or candidates have been placed in nomination prior to the voting and (ii) the stockholder has given notice at the meeting, prior to the voting, of such stockholder&#8217;s intention to cumulate such stockholder&#8217;s votes.  If any stockholder has given proper notice to cumulate votes, all stockholders may cumulate their votes for any candidates who have been properly placed in nomination.  Under cumulative voting, the candidates receiving the highest number of votes, up to the number of directors to be elected, are elected.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">Notwithstanding the foregoing provisions of this section, each director shall serve until his successor is duly elected and qualified or until his death, resignation or removal.  No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">C.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Removal of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;During such time or times that the corporation is subject to Section 2115(b) of the CGCL, the Board of Directors or any individual director may be removed from office at any time without cause by the affirmative vote of the holders of at least a majority of the outstanding shares entitled to vote on such removal&#59; provided, however, that unless the entire Board is removed, no individual director may be removed when the votes cast against such director&#8217;s removal, or not consenting in writing to such removal, would be sufficient to elect that director if voted cumulatively at an election which the same total number of votes were cast (or, if such action is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">taken by written consent, all shares entitled to vote were voted) and the entire number of directors authorized at the time of such director&#8217;s most recent election were then being elected.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">2.&#160;&#160;&#160;&#160;At any time or times that the corporation is not subject to Section 2115(b) of the CGCL and subject to any limitations imposed by law, Section C.1. above shall no longer apply and removal shall be as provided in Section 141 (k) of the DGCL.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">D.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Vacancies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;Subject to the rights of the holders of any series of Preferred Stock, any vacancies on the Board of Directors resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in the number of directors, shall, unless the Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders, except as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors, and not by the stockholders. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director&#8217;s successor shall have been elected and qualified.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">2.&#160;&#160;&#160;&#160;If at the time of filling any vacancy or any newly created directorship, the directors then in office shall constitute less than a majority of the whole board (as constituted immediately prior to any such increase), the Delaware Court of Chancery may, upon application of any stockholder or stockholders holding at least ten percent (10%) of the total number of the shares at the time outstanding having the right to vote for such directors, summarily order an election to be held to fill any such vacancies or newly created directorships, or to replace the directors chosen by the directors then in offices as aforesaid, which election shall be governed by Section 211 of the DGCL.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">3.&#160;&#160;&#160;&#160;At any time or times that the corporation is subject to Section 2115(b) of the CGCL, if, after the filling of any vacancy by the directors then in office who have been elected by stockholders shall constitute less than a majority of the directors then in office, then&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">(a)&#160;&#160;&#160;&#160;Any holder or holders of an aggregate of five percent (5%) or more of the total number of shares at the time outstanding having the right to vote for those directors may call a special meeting of stockholders&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">(b)&#160;&#160;&#160;&#160;The Superior Court of the proper county shall, upon application of such stockholder or stockholders, summarily order a special meeting of stockholders, to be held to elect the entire board, all in accordance with Section 305(c) of the CGCL.  The term of office of any director shall terminate upon that election of a successor.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">E.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Bylaw Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  Subject to paragraph (h) of Section 43 of the Bylaws, the Bylaws may be altered or amended or new Bylaws adopted by the affirmative vote of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all of the then-outstanding shares of the voting stock of the corporation entitled to vote.  The Board of Directors shall also have the power to adopt, amend, or repeal Bylaws.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">F.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Ballots</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  The directors of the corporation need not be elected by written ballot unless the Bylaws so provide.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">G.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Action by Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  No action shall be taken by the stockholders of the corporation except at an annual or special meeting of stockholders called in accordance with the Bylaws&#59; no action shall be taken by the stockholders by written consent.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">H.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Advance Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  Advance notice of stockholder nominations for the election of directors and of business to be brought by stockholders before any meeting of the stockholders of the corporation shall be given in the manner provided in the Bylaws of the corporation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">I.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Special Meetings of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  Special meetings of the stockholders may be called only by the Chairman of the Board, the Chief Executive Officer, or a majority of the members of the Board of Directors.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">A.&#160;&#160;&#160;&#160;The liability of the directors for monetary damages shall be eliminated to the fullest extent under applicable law.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">B.&#160;&#160;&#160;&#160;This corporation is authorized to provide indemnification of agents (as defined in Section 317 of the CGCL) for breach of duty to the corporation and its shareholders through bylaw provisions or through agreements with the agents, or through shareholder resolutions, or otherwise, in excess of the indemnification otherwise permitted by Section 317 of the CGCL, subject, at any time or times the corporation is subject to Section 2115(b) to the limits on such excess indemnification set forth in Section 204 of the CGCL.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">C.&#160;&#160;&#160;&#160;Any repeal or modification of this Article VI shall be prospective and shall not affect the rights under this Article VI in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">&#160;&#160;&#160;&#160;ARTICLE VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">A.&#160;&#160;&#160;&#160;The corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, except as provided in paragraph B of this Article VII, and all rights conferred upon the stockholders herein are granted subject to this reservation.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">B.&#160;&#160;&#160;&#160;Notwithstanding any other provisions of this Certificate of Incorporation or any provision of law which might otherwise permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the voting stock required by law, this Certificate of Incorporation or any Preferred Stock Designation, the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2&#47;3%) of the voting power of all of the then-outstanding shares of the voting stock, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI and VII.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><div id="ia6c0703dc9c54a06adacc0023baefb57_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">a Delaware Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">Pursuant to &#167;&#160;242 of the General Corporation Law</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">of the State of Delaware</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">It is hereby certified that&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;The following amendment to the Amended and Restated Certificate of Incorporation of the corporation has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;Paragraph (a) of Article Four of Exhibit A of the Amended and Restated Certificate of Incorporation is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#8220;A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Classes of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  This corporation is authorized to issue two classes of stock to be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221;  The total number of shares which the corporation is authorized to issue is one hundred two million five hundred thousand (102,500,000) shares, of which one hundred million (100,000,000) shares shall be Common Stock, par value $0.001 per share, and two million five hundred thousand (2,500,000) shares shall be Preferred stock, par value $0.001 per share.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">When the foregoing amendment becomes effective, (i) each share of Common Stock issued and outstanding or held in the treasury of the corporation immediately prior to the time this amendment becomes effective shall be reclassified and changed into and shall constitute one-half (1&#47;2) of one fully paid and nonassessable share of Common Stock and (ii) each share of Preferred Stock issued and outstanding or held in the treasury of the corporation immediately prior to the time this amendment becomes effective shall be reclassified and changed into and shall constitute one-half (1&#47;2) of one fully paid and nonassessable share of Preferred Stock, in each case without the necessity of further action of any kind (the &#8220;Reverse Split&#8221;). Any fractional shares remaining after applying the Reverse Split to each certificate representing shares of Common Stock or Preferred Stock then held by any holder shall be redeemed at a purchase price equal to the closing bid price of the Common Stock on the Nasdaq National Market on the effective date of the Reverse Split.  Shares of capital stock that were outstanding prior to the Reverse Split, and that are not outstanding after and as a result of the Reverse Split, shall resume the status of authorized but unissued shares of Common Stock or Preferred Stock, as the case may be.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">2.&#160;&#160;&#160;&#160;The capital of the corporation will not be reduced under or by reason of the foregoing amendment.</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">IN WITNESS WHEREOF, this Certificate is hereby executed by the undersigned on June 30, 2003.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:108pt;padding-right:108pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">              </font></div><div style="margin-bottom:17pt;margin-top:5pt;padding-left:216pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:43.750%"><tr><td style="width:1.0%"></td><td style="width:12.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">INTUITIVE SURGICAL, INC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">By&#58;   </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:138%">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%"> Lonnie M. Smith   </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lonnie M. Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font><br></font></div></div></div><div id="ia6c0703dc9c54a06adacc0023baefb57_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">a Delaware Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">Pursuant to &#167; 242 of the General Corporation Law</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">of the State of Delaware</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">It is hereby certified that the following amendment to the Amended and Restated Certificate of Incorporation of the corporation has been duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">Section B of Article V of Exhibit A of the Amended and Restated Certificate of Incorporation is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#8220;B. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Board of Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">1.&#160;&#160;&#160;&#160;Subject to the rights of the holders of any series of Preferred Stock to elect additional directors under specified circumstances, commencing with the 2013 annual meeting of stockholders, directors shall be elected at each annual meeting of stockholders to hold office until the next annual meeting.  Directors elected at the 2010 annual meeting of stockholders shall hold office until the 2013 annual meeting of stockholders, directors elected at the 2011 annual meeting of stockholders shall hold office until the 2014 annual meeting of stockholders, and directors elected at the 2012 annual meeting of stockholders shall hold office until the 2015 annual meeting of stockholders.  Notwithstanding the foregoing provisions of this section, each director shall serve until his successor is duly elected and qualified or until his death, resignation or removal.  No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director.&#8221;</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">IN WITNESS WHEREOF, this Certificate is hereby executed by the undersigned on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">4&#47;21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">, 2012.</font></div><div style="margin-bottom:17pt;margin-top:5pt;padding-left:216pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:44.391%"><tr><td style="width:1.0%"></td><td style="width:12.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.543%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">INTUITIVE SURGICAL, INC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">By&#58;   </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:138%">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%"> Gary S. Guthart, Ph.D.   </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary S. Guthart, Ph.D.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="ia6c0703dc9c54a06adacc0023baefb57_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STATE OF DELAWARE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">Intuitive Surgical, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">FIRST</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#58;  That Paragraph (A) of Article Four of Exhibit A of the Amended and Restated Certificate of Incorporation is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#8220;A. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Classes of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">.  This corporation is authorized to issue two classes of stock to be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221;  The total number of shares which the corporation is authorized to issue is three hundred two million five hundred thousand (302,500,000) shares, of which three hundred million (300,000,000) shares shall be Common Stock, par value $0.001 per share, and two million five hundred thousand (2,500,000) shares shall be Preferred Stock, par value $0.001 per share.  At the effective time of this Certificate of Amendment (the &#8220;Effective Time&#8221;), each issued and outstanding share of the corporation&#8217;s Common Stock shall be divided into three (3) validly issued, fully paid and non-assessable shares of Common Stock reflecting a three (3) for one (1) stock split (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%;text-decoration:underline">Stock Split</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#8221;).  The Stock Split shall occur without any further action on the part of the corporation or the holders of shares of Common Stock and whether or not certificates representing such holders&#8217; shares prior to the Stock Split are surrendered for cancellation.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">SECOND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#58;  That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:138%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">, the Corporation has caused this certificate to be signed this 29th day of September, 2017.</font></div><div style="margin-bottom:17pt;margin-top:5pt;padding-left:216pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:46.153%"><tr><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.234%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gary S. Guthart</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gary S. Guthart</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt"><font><br></font></div></div></div><div id="ia6c0703dc9c54a06adacc0023baefb57_16"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF AMENDMENT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATE OF INCORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTUITIVE SURGICAL, INC.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pursuant to &#167; 242 of the General Corporation Law</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">of the State of Delaware</font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive Surgical, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware does hereby certify&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIRST</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; That Paragraph (E) of Article V of the Amended and Restated Certificate of Incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;), is hereby amended to read in its entirety as follows&#58; </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;E. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bylaw Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to paragraph (h) of Section 43 of the Bylaws, the Bylaws may be altered or amended or new Bylaws adopted by the affirmative vote of the majority of shares present in person or represented by proxy at a meeting of stockholders and entitled to vote thereon. The Board of Directors shall also have the power to adopt, amend, or repeal Bylaws.&#8221; </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECOND</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; That Paragraph (I) of Article V of the Certificate of Incorporation is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;I. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Special Meetings of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise required by law, special meetings of the stockholders may be called, for any purpose or purposes, (i) by the Chairman of the Board of Directors, (ii) by the Chief Executive Officer, (iii) by the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution is presented to the Board of Directors for adoption), or (iv) upon written request to the Secretary, by one or more holders of record of the corporation&#8217;s common stock owning not less than 20% of the total number of shares of common stock of the corporation entitled to vote on the matter or matters to be brought before the proposed special meeting, who otherwise comply with such other requirements and procedures set forth in the Bylaws as now or hereinafter in effect.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIRD</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; That Paragraph (A) of Article VII of the Certificate of Incorporation is hereby amended to read in its entirety as follows&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;A. The corporation reserves the right to amend, alter, change, or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all rights conferred upon the stockholders herein are granted subject to this reservation.&#8221;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOURTH</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; That Paragraph (B) of Article VII of the Certificate of Incorporation shall be deleted in its entirety. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FIFTH&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Corporation has caused this certificate to be signed this 24th day of April, 2020. </font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:15.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INTUITIVE SURGICAL, INC.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;s&#47; Siang Chin</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Siang Chin</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Assistant Secretary</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>ex-311q121.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i1f088383086a44b28d90684db7e792b3_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 31.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Executive Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Gary S. Guthart, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Intuitive Surgical, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  April&#160;21, 2021 </font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> S. G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">UTHART</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Gary S. Guthart, Ph.D.</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">President and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>ex-312q121.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i296ad5286fb742429575e6f48cc4e8df_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 31.2</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Financial Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Marshall L. Mohr, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Intuitive Surgical, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  April&#160;21, 2021 </font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARSHALL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> L. M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">OHR</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Marshall L. Mohr</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>ex-321q121.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iec26b540f64947fdab23130256bfdcb7_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 32.1</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Executive Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Intuitive Surgical, Inc. (the &#8220;Company&#8221;) hereby certifies, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:8.57pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended March&#160;31, 2021 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:5.8pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  April&#160;21, 2021 </font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> S. G</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">UTHART</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Gary S. Guthart, Ph.D.</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">President and Chief Executive Officer</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>ex-322q121.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id826cb02435d4fa6995f8c40feaa6cec_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">EXHIBIT 32.2</font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Certification of Chief Financial Officer</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Intuitive Surgical, Inc. (the &#8220;Company&#8221;) hereby certifies, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:8.57pt">the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended March&#160;31, 2021 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%;padding-left:5.8pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;  April&#160;21, 2021 </font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:52.243%"><tr><td style="width:1.0%"></td><td style="width:17.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">&#47; M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">ARSHALL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%"> L. M</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:144%">OHR</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Marshall L. Mohr</font></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:144%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>isrg-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c61f603f-ef4a-4d04-b56b-7269297a821e,g:dd118a18-5d47-4c1c-822e-29e196fcfd78-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:isrg="http://www.intuitivesurgical.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.intuitivesurgical.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="isrg-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.intuitivesurgical.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsUnaudited" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFTHEBUSINESS" roleURI="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF THE BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2104103 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2305301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails">
        <link:definition>2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1">
        <link:definition>2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails">
        <link:definition>2407402 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails">
        <link:definition>2408403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails">
        <link:definition>2409404 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails">
        <link:definition>2410405 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION">
        <link:definition>2111104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables">
        <link:definition>2312302 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails">
        <link:definition>2413406 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails">
        <link:definition>2414407 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails">
        <link:definition>2415408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails">
        <link:definition>2416409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails">
        <link:definition>2417410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTS" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS">
        <link:definition>2118105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSTables" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables">
        <link:definition>2319303 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails">
        <link:definition>2420411 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails">
        <link:definition>2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1">
        <link:definition>2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails">
        <link:definition>2422413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails">
        <link:definition>2423414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.intuitivesurgical.com/role/LEASES">
        <link:definition>2124106 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.intuitivesurgical.com/role/LEASESTables">
        <link:definition>2325304 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseReceivablesDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails">
        <link:definition>2426415 - Disclosure - LEASES - Lease Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLeaseReceivablesDetails_1" roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1">
        <link:definition>2426415 - Disclosure - LEASES - Lease Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails">
        <link:definition>2427416 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESCreditQualityIndicatorDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails">
        <link:definition>2428417 - Disclosure - LEASES - Credit Quality Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails">
        <link:definition>2429418 - Disclosure - LEASES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2130107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2331305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsGoodwillandOtherDetails" roleURI="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails">
        <link:definition>2432419 - Disclosure - Intangible Assets, Goodwill and Other (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails">
        <link:definition>2433420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails">
        <link:definition>2434421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails">
        <link:definition>2435422 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONTINGENCIES" roleURI="http://www.intuitivesurgical.com/role/CONTINGENCIES">
        <link:definition>2136108 - Disclosure - CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2137109 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>2338306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails">
        <link:definition>2439423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails">
        <link:definition>2440424 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
        <link:definition>2441425 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails">
        <link:definition>2442426 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>2143110 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>2344307 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails">
        <link:definition>2445427 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails">
        <link:definition>2446428 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails">
        <link:definition>2447429 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails">
        <link:definition>2448430 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails">
        <link:definition>2449431 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.intuitivesurgical.com/role/INCOMETAXES">
        <link:definition>2150111 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails">
        <link:definition>2451432 - Disclosure - INCOME TAXES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARE" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE">
        <link:definition>2152112 - Disclosure - NET INCOME PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHARETables" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables">
        <link:definition>2353308 - Disclosure - NET INCOME PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails">
        <link:definition>2454433 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMEPERSHAREAdditionalInformationDetails" roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails">
        <link:definition>2455434 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="isrg_SalestypeLeaseDeferredSellingProfit" abstract="false" name="SalestypeLeaseDeferredSellingProfit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" abstract="false" name="SalesTypeLeaseNetInvestmentInLeaseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_AccelerateShareRepurchaseProgramMember" abstract="true" name="AccelerateShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_CumulativeEffectPeriodOfAdoptionDomain" abstract="true" name="CumulativeEffectPeriodOfAdoptionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ModerateMember" abstract="true" name="ModerateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_IntangibleAndOtherAssets" abstract="false" name="IntangibleAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" abstract="false" name="SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_GoldmanSachsCo.Member" abstract="true" name="GoldmanSachsCo.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" abstract="false" name="CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_DeferredPurchaseConsiderationPaymentsCurrent" abstract="false" name="DeferredPurchaseConsiderationPaymentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_IntangibleAndOtherAssetsNetMember" abstract="true" name="IntangibleAndOtherAssetsNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" abstract="false" name="EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_AccumulatedOtherComprehensiveIncomeRollForward" abstract="true" name="AccumulatedOtherComprehensiveIncomeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_CollarContractMember" abstract="true" name="CollarContractMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_CostOfSalesServiceMember" abstract="true" name="CostOfSalesServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_SellingGeneralAndAdministrativeMember" abstract="true" name="SellingGeneralAndAdministrativeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_SalesTypeLeaseGrossInvestmentInLease" abstract="false" name="SalesTypeLeaseGrossInvestmentInLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_InstrumentsandAccessoriesMember" abstract="true" name="InstrumentsandAccessoriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_LowMember" abstract="true" name="LowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_HighMember" abstract="true" name="HighMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_SystemsMember" abstract="true" name="SystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_ManufacturingProcessTechnologyMember" abstract="true" name="ManufacturingProcessTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" abstract="false" name="LessorSalesTypeLeaseLeaseIncomeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_CumulativeEffectPeriodOfAdoptionAxis" abstract="true" name="CumulativeEffectPeriodOfAdoptionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" abstract="false" name="CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ChindexMember" abstract="true" name="ChindexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_SchllyFiberopticGmbHMember" abstract="true" name="SchllyFiberopticGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_StockRepurchaseProgramincreasedtoauthorizedamount" abstract="false" name="StockRepurchaseProgramincreasedtoauthorizedamount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_DeferredPurchaseConsiderationPayments" abstract="false" name="DeferredPurchaseConsiderationPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ResearchAndDevelopmentMember" abstract="true" name="ResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_ServicesMember" abstract="true" name="ServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" abstract="false" name="AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" abstract="true" name="CumulativeEffectPeriodOfAdoptionAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" abstract="false" name="BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_ConsolidatingReportingAxis" abstract="true" name="ConsolidatingReportingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" abstract="false" name="BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_CostOfSalesProductMember" abstract="true" name="CostOfSalesProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="isrg_ConsolidatingReportingDomain" abstract="true" name="ConsolidatingReportingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_A2010IncentiveAwardPlanMember" abstract="true" name="A2010IncentiveAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="isrg_CommonStockRepurchaseProgramMember" abstract="true" name="CommonStockRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>isrg-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c61f603f-ef4a-4d04-b56b-7269297a821e,g:dd118a18-5d47-4c1c-822e-29e196fcfd78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="simple" xlink:href="isrg-20210331.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a4853dc4-50d1-4f21-a83e-5497598a73a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e9375244-c270-4c64-9c9d-f3d646f8349d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a4853dc4-50d1-4f21-a83e-5497598a73a5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e9375244-c270-4c64-9c9d-f3d646f8349d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_bb55863b-a7a3-4dcc-90d9-f6395c0c105e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a4853dc4-50d1-4f21-a83e-5497598a73a5" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_bb55863b-a7a3-4dcc-90d9-f6395c0c105e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_eb45a484-f5a9-492e-b610-a94d3bff4df1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a4853dc4-50d1-4f21-a83e-5497598a73a5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_eb45a484-f5a9-492e-b610-a94d3bff4df1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ac0d4400-82cc-45d1-b88f-371bf10e7769" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a4853dc4-50d1-4f21-a83e-5497598a73a5" xlink:to="loc_us-gaap_InventoryNet_ac0d4400-82cc-45d1-b88f-371bf10e7769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6e1a8a83-a872-4d99-9fa0-be086ffbfaac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a4853dc4-50d1-4f21-a83e-5497598a73a5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6e1a8a83-a872-4d99-9fa0-be086ffbfaac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_790f2040-12ae-4953-b1c8-660de3f87f2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a041819e-8eb6-4ae6-9b4d-a9bb10720474" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_790f2040-12ae-4953-b1c8-660de3f87f2d" xlink:to="loc_us-gaap_PreferredStockValue_a041819e-8eb6-4ae6-9b4d-a9bb10720474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c355e62e-a52c-4d0a-842c-f2ce0cf9ab75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_790f2040-12ae-4953-b1c8-660de3f87f2d" xlink:to="loc_us-gaap_CommonStockValue_c355e62e-a52c-4d0a-842c-f2ce0cf9ab75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1f761d02-45ab-483b-9ef0-8a362d8d8a4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_790f2040-12ae-4953-b1c8-660de3f87f2d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1f761d02-45ab-483b-9ef0-8a362d8d8a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_80da9a3e-8f42-4646-95d2-40838b7504b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_790f2040-12ae-4953-b1c8-660de3f87f2d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_80da9a3e-8f42-4646-95d2-40838b7504b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e1c0152-6de6-4fd1-9a20-1b8c332744a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_790f2040-12ae-4953-b1c8-660de3f87f2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7e1c0152-6de6-4fd1-9a20-1b8c332744a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_00343ba7-3490-49ed-ad40-e0870e296b2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b185f022-40ef-45a5-b2c4-94c7c80e9d74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_00343ba7-3490-49ed-ad40-e0870e296b2e" xlink:to="loc_us-gaap_Liabilities_b185f022-40ef-45a5-b2c4-94c7c80e9d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_11f2d288-8f90-43b1-ac0a-bd4f30903413" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_00343ba7-3490-49ed-ad40-e0870e296b2e" xlink:to="loc_us-gaap_CommitmentsAndContingencies_11f2d288-8f90-43b1-ac0a-bd4f30903413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f47a63f1-1443-4de2-ab5c-8a47f1245615" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_00343ba7-3490-49ed-ad40-e0870e296b2e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f47a63f1-1443-4de2-ab5c-8a47f1245615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_384a83de-f5a9-4172-a6bc-3d0e0c550a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_12876b05-c34a-4fb8-8f45-efd2a06f167f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_384a83de-f5a9-4172-a6bc-3d0e0c550a5d" xlink:to="loc_us-gaap_AccountsPayableCurrent_12876b05-c34a-4fb8-8f45-efd2a06f167f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_59e7541d-b980-4a9d-999d-668c9483d1d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_384a83de-f5a9-4172-a6bc-3d0e0c550a5d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_59e7541d-b980-4a9d-999d-668c9483d1d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_6e024f80-f751-4406-a510-11ce71673aff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_384a83de-f5a9-4172-a6bc-3d0e0c550a5d" xlink:to="loc_us-gaap_DeferredRevenueCurrent_6e024f80-f751-4406-a510-11ce71673aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_fa842c8e-c97c-4c5d-a7d4-ed22c5b78b08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_384a83de-f5a9-4172-a6bc-3d0e0c550a5d" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_fa842c8e-c97c-4c5d-a7d4-ed22c5b78b08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c913bcdd-2df6-4092-a85a-ac7fa706028e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_07d556f7-bd02-475b-ac13-3f1f3d99a398" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c913bcdd-2df6-4092-a85a-ac7fa706028e" xlink:to="loc_us-gaap_LiabilitiesCurrent_07d556f7-bd02-475b-ac13-3f1f3d99a398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_802e2d6a-6c71-438b-aa02-88b007d7ea3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_c913bcdd-2df6-4092-a85a-ac7fa706028e" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_802e2d6a-6c71-438b-aa02-88b007d7ea3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f88d617-55db-43ad-bf4e-237876d74081" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2b10c9ec-a70d-4f83-ab88-9e5cfa0762a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f88d617-55db-43ad-bf4e-237876d74081" xlink:to="loc_us-gaap_StockholdersEquity_2b10c9ec-a70d-4f83-ab88-9e5cfa0762a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_405821a7-6154-4dc2-b326-d315a0b6f699" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3f88d617-55db-43ad-bf4e-237876d74081" xlink:to="loc_us-gaap_MinorityInterest_405821a7-6154-4dc2-b326-d315a0b6f699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d03e1b5b-ccf0-48ad-9f93-699de501de44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:to="loc_us-gaap_AssetsCurrent_d03e1b5b-ccf0-48ad-9f93-699de501de44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_54f4a636-9187-4507-82fe-1067499eaef1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_54f4a636-9187-4507-82fe-1067499eaef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_d50f8644-2492-49a2-9426-ba1dfd0607ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_d50f8644-2492-49a2-9426-ba1dfd0607ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_d3aeef39-37b9-4c44-9c24-423faa725850" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_d3aeef39-37b9-4c44-9c24-423faa725850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssets_9050472a-f769-45b4-b59c-124cf9b16d6b" xlink:href="isrg-20210331.xsd#isrg_IntangibleAndOtherAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:to="loc_isrg_IntangibleAndOtherAssets_9050472a-f769-45b4-b59c-124cf9b16d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_858011b6-b072-4d7b-9537-e5fac18434ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_57d2d9ca-5b47-4688-a28b-0d6fb5a07f41" xlink:to="loc_us-gaap_Goodwill_858011b6-b072-4d7b-9537-e5fac18434ca" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4021f8dd-c6ac-41e6-9b19-6fc9e10f980f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_e9f910bc-f1ef-4fa4-81d3-16730f391a61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4021f8dd-c6ac-41e6-9b19-6fc9e10f980f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_e9f910bc-f1ef-4fa4-81d3-16730f391a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0ddc423d-048e-4999-a586-37601be209f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4021f8dd-c6ac-41e6-9b19-6fc9e10f980f" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0ddc423d-048e-4999-a586-37601be209f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1d3d6e8-7272-4a73-9c1c-95b246199fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0addf20-b4d6-482f-a740-47fd9b0e725f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1d3d6e8-7272-4a73-9c1c-95b246199fbf" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0addf20-b4d6-482f-a740-47fd9b0e725f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0e7976ac-49df-4d3a-ac51-a9659c71489b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c1d3d6e8-7272-4a73-9c1c-95b246199fbf" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0e7976ac-49df-4d3a-ac51-a9659c71489b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6e684e56-662a-4564-8588-d7a1c01c26f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_68baa70b-0460-483d-a69a-e30e880f0c19" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6e684e56-662a-4564-8588-d7a1c01c26f8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_68baa70b-0460-483d-a69a-e30e880f0c19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a75a3ae6-da30-4d46-91e4-32a4b6c1c586" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6e684e56-662a-4564-8588-d7a1c01c26f8" xlink:to="loc_us-gaap_ProfitLoss_a75a3ae6-da30-4d46-91e4-32a4b6c1c586" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_79a05f94-bc5a-4a8c-8406-de743764b924" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_786ff549-036f-45c0-bbcc-6cacf50c2683" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_79a05f94-bc5a-4a8c-8406-de743764b924" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_786ff549-036f-45c0-bbcc-6cacf50c2683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9f09b6ef-eb9f-4a40-8d2e-21b87b0a7064" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_79a05f94-bc5a-4a8c-8406-de743764b924" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9f09b6ef-eb9f-4a40-8d2e-21b87b0a7064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d2f65494-a233-4d54-a5d4-4ab28ddeca1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_00d6d286-c350-48b3-95f6-98b2d7a65519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d2f65494-a233-4d54-a5d4-4ab28ddeca1b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_00d6d286-c350-48b3-95f6-98b2d7a65519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6fd13c1a-6ce5-4cad-be1d-8f8e7e80b878" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_d2f65494-a233-4d54-a5d4-4ab28ddeca1b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6fd13c1a-6ce5-4cad-be1d-8f8e7e80b878" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_3b149b32-f234-4ed8-ba65-1648780da5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_77eb981f-7a29-451b-af65-936b9d6d6a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3b149b32-f234-4ed8-ba65-1648780da5bf" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_77eb981f-7a29-451b-af65-936b9d6d6a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c1dea6e4-f36a-4d80-a6c3-b5f20afeee23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_3b149b32-f234-4ed8-ba65-1648780da5bf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c1dea6e4-f36a-4d80-a6c3-b5f20afeee23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_98061cfc-cc33-4f2c-99da-3fa5506481ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_816a8f20-deaf-4d3b-a98d-b92f78290791" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_98061cfc-cc33-4f2c-99da-3fa5506481ff" xlink:to="loc_us-gaap_GrossProfit_816a8f20-deaf-4d3b-a98d-b92f78290791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f2440c37-0282-42ca-aba3-3c71e265c36d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_98061cfc-cc33-4f2c-99da-3fa5506481ff" xlink:to="loc_us-gaap_OperatingExpenses_f2440c37-0282-42ca-aba3-3c71e265c36d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd91679a-8bff-43a1-a362-4701724a2621" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4a8512c6-f455-40c8-92f3-5443234e09c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd91679a-8bff-43a1-a362-4701724a2621" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4a8512c6-f455-40c8-92f3-5443234e09c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7a84ee27-8552-4a50-90af-3a98599c2043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd91679a-8bff-43a1-a362-4701724a2621" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7a84ee27-8552-4a50-90af-3a98599c2043" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_4a4d616f-b5dd-4de0-9b71-e5376ae10683" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd91679a-8bff-43a1-a362-4701724a2621" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_4a4d616f-b5dd-4de0-9b71-e5376ae10683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bf0b1a1a-fde1-487e-bf9a-c7b5ff49ca50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd91679a-8bff-43a1-a362-4701724a2621" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bf0b1a1a-fde1-487e-bf9a-c7b5ff49ca50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_3fb2515d-617b-4de8-9498-6495c9edd5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd91679a-8bff-43a1-a362-4701724a2621" xlink:to="loc_us-gaap_ProceedsFromStockPlans_3fb2515d-617b-4de8-9498-6495c9edd5f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a20e120-6a84-4cd0-acba-3fdfb6e2339e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_13b6720a-6cc9-4996-a96d-2b233c3ce022" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a20e120-6a84-4cd0-acba-3fdfb6e2339e" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_13b6720a-6cc9-4996-a96d-2b233c3ce022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_52ea8714-d372-4b4f-8ea3-cd6ca9b1da96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a20e120-6a84-4cd0-acba-3fdfb6e2339e" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_52ea8714-d372-4b4f-8ea3-cd6ca9b1da96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_5df3c8a1-8c71-46a4-8889-819600f3e539" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a20e120-6a84-4cd0-acba-3fdfb6e2339e" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_5df3c8a1-8c71-46a4-8889-819600f3e539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_ed61b60f-21b8-4de2-b84f-8cb538b7abbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a20e120-6a84-4cd0-acba-3fdfb6e2339e" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_ed61b60f-21b8-4de2-b84f-8cb538b7abbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3e681fcc-7466-4817-b6e2-78f43b543057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7a20e120-6a84-4cd0-acba-3fdfb6e2339e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3e681fcc-7466-4817-b6e2-78f43b543057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ec1d64a-49fd-4d1e-bfc2-bb2358687581" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2eb8211b-a346-4126-b104-c56f5617d16f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ec1d64a-49fd-4d1e-bfc2-bb2358687581" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2eb8211b-a346-4126-b104-c56f5617d16f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a2a37d18-f93a-4640-9ee7-a62b0bbe5ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ec1d64a-49fd-4d1e-bfc2-bb2358687581" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a2a37d18-f93a-4640-9ee7-a62b0bbe5ca6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a70a487-1436-40e2-93b5-9af7e7fea2c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ec1d64a-49fd-4d1e-bfc2-bb2358687581" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4a70a487-1436-40e2-93b5-9af7e7fea2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_585cf1e9-0f5c-49e8-9ae4-dea7fd6280da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5ec1d64a-49fd-4d1e-bfc2-bb2358687581" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_585cf1e9-0f5c-49e8-9ae4-dea7fd6280da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89c56981-1ca9-4e7a-9a04-9564b9ae40be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_ProfitLoss_89c56981-1ca9-4e7a-9a04-9564b9ae40be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3b7444c4-3153-4967-b339-ca9c8f6e2d75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_Depreciation_3b7444c4-3153-4967-b339-ca9c8f6e2d75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9f78b7ca-306c-4ee9-954e-9dafdd320e42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9f78b7ca-306c-4ee9-954e-9dafdd320e42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_42692876-e3ed-43a4-98dd-214959812a26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_42692876-e3ed-43a4-98dd-214959812a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ea55576e-df19-4d2d-9488-bfbe03e19696" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ea55576e-df19-4d2d-9488-bfbe03e19696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ed204c9a-61d5-4293-85b4-d7f4fccf7052" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_ShareBasedCompensation_ed204c9a-61d5-4293-85b4-d7f4fccf7052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_2c96ab16-62f2-4d1e-b809-7ff0c1a9bcb9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_2c96ab16-62f2-4d1e-b809-7ff0c1a9bcb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbfce14c-44fb-40a3-a200-d8698a1911df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbfce14c-44fb-40a3-a200-d8698a1911df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_83c1e4e1-ea32-4718-b146-a291fd4d7abe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_83c1e4e1-ea32-4718-b146-a291fd4d7abe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4098a934-8fea-4ae0-806d-1b776064c99c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4098a934-8fea-4ae0-806d-1b776064c99c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2d18618c-b93b-4d81-8b47-b55ebc7b4ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2d18618c-b93b-4d81-8b47-b55ebc7b4ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_3bfb1f7c-2d0d-4b68-9cb7-92881db5ae56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_3bfb1f7c-2d0d-4b68-9cb7-92881db5ae56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_eccc175b-bd1b-4610-b530-987ae6c1d9da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_eccc175b-bd1b-4610-b530-987ae6c1d9da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_3965cb79-b46d-42b0-b70b-a4d9adba0148" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f51a714d-29e8-47de-ab08-efb37a21256f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_3965cb79-b46d-42b0-b70b-a4d9adba0148" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="simple" xlink:href="isrg-20210331.xsd#DESCRIPTIONOFTHEBUSINESS"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="isrg-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="isrg-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31289e51-8aad-450e-9b43-12d2e0795d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4bda0396-eae6-4cea-a79f-2b64b1580fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31289e51-8aad-450e-9b43-12d2e0795d8f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4bda0396-eae6-4cea-a79f-2b64b1580fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3393ad0c-f6dc-4003-8f4b-998daead0ab3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31289e51-8aad-450e-9b43-12d2e0795d8f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3393ad0c-f6dc-4003-8f4b-998daead0ab3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5a88bc74-4673-4009-a1dc-674064d68b65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_31289e51-8aad-450e-9b43-12d2e0795d8f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5a88bc74-4673-4009-a1dc-674064d68b65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_43a91d2f-a682-4e60-99cf-b440c103ed4e" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6bc06f34-12c4-4054-8da6-78a300f05e39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_43a91d2f-a682-4e60-99cf-b440c103ed4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6bc06f34-12c4-4054-8da6-78a300f05e39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_fcbd68c4-9fbd-4a16-b8bf-aee457ea209a" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9ef6428f-4619-4826-bbe4-b0b7af36bf04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_fcbd68c4-9fbd-4a16-b8bf-aee457ea209a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_9ef6428f-4619-4826-bbe4-b0b7af36bf04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f7e33a3-045b-412d-a530-4966efb4fc91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_fcbd68c4-9fbd-4a16-b8bf-aee457ea209a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f7e33a3-045b-412d-a530-4966efb4fc91" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_090749ba-4097-46dc-9af5-1b49b6651306" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b74364bd-fc88-4d7b-a431-8b43f44360f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_090749ba-4097-46dc-9af5-1b49b6651306" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b74364bd-fc88-4d7b-a431-8b43f44360f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_832e071e-e13c-4931-a162-26c1bb5fbb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_090749ba-4097-46dc-9af5-1b49b6651306" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_832e071e-e13c-4931-a162-26c1bb5fbb3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_1503866a-93ad-4562-8b4f-fb53e2241a28" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_090749ba-4097-46dc-9af5-1b49b6651306" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_1503866a-93ad-4562-8b4f-fb53e2241a28" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_fbd7a35b-b875-43d7-bc61-867301e0d5fa" xlink:href="isrg-20210331.xsd#isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ed9c0cb0-1ab4-4c70-bb80-5fdc8137d44d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_fbd7a35b-b875-43d7-bc61-867301e0d5fa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_ed9c0cb0-1ab4-4c70-bb80-5fdc8137d44d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8ad67ba9-1b30-4572-86c8-3ea682b61398" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_fbd7a35b-b875-43d7-bc61-867301e0d5fa" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_8ad67ba9-1b30-4572-86c8-3ea682b61398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e39382a3-cd31-4330-a4d1-3aa74e88ba67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6e4cc076-9cbe-422d-a2d1-07da35c0ca54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e39382a3-cd31-4330-a4d1-3aa74e88ba67" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_6e4cc076-9cbe-422d-a2d1-07da35c0ca54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_f1cc9a5d-2753-44f6-8ee5-7ada246dfd83" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e39382a3-cd31-4330-a4d1-3aa74e88ba67" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_f1cc9a5d-2753-44f6-8ee5-7ada246dfd83" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b3960450-3228-451c-a038-076fa71cf626" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9ce7f7db-e01c-4de6-b05c-e5ba5373124f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b3960450-3228-451c-a038-076fa71cf626" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9ce7f7db-e01c-4de6-b05c-e5ba5373124f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_477d5484-8dc6-46f4-953d-056bdecdae85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b3960450-3228-451c-a038-076fa71cf626" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_477d5484-8dc6-46f4-953d-056bdecdae85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_262c4bdc-33e9-4c36-81c2-14f5073d3eff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b3960450-3228-451c-a038-076fa71cf626" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_262c4bdc-33e9-4c36-81c2-14f5073d3eff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cbb833a3-1878-4885-b4fc-30c9fe03107d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_fb5dd064-3e63-4e44-86a7-eb5767d577d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cbb833a3-1878-4885-b4fc-30c9fe03107d" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_fb5dd064-3e63-4e44-86a7-eb5767d577d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_682877e9-0370-4e70-9528-5c39f0893cda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cbb833a3-1878-4885-b4fc-30c9fe03107d" xlink:to="loc_us-gaap_PrepaidTaxes_682877e9-0370-4e70-9528-5c39f0893cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_d84d4852-3301-4648-be3a-1d05cb9e59a7" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cbb833a3-1878-4885-b4fc-30c9fe03107d" xlink:to="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_d84d4852-3301-4648-be3a-1d05cb9e59a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_b242f2ed-f608-4347-a5a6-2e7fa93dd088" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_cbb833a3-1878-4885-b4fc-30c9fe03107d" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_b242f2ed-f608-4347-a5a6-2e7fa93dd088" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a07071da-2d0b-4ba4-9ff1-0acf59bd8c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_e98d5f49-2511-4295-9a4e-f6de1314c441" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a07071da-2d0b-4ba4-9ff1-0acf59bd8c0d" xlink:to="loc_us-gaap_TaxesPayableCurrent_e98d5f49-2511-4295-9a4e-f6de1314c441" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_73af4e80-7f6e-4d51-81df-847853982161" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a07071da-2d0b-4ba4-9ff1-0acf59bd8c0d" xlink:to="loc_us-gaap_LitigationReserveCurrent_73af4e80-7f6e-4d51-81df-847853982161" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6032ec3c-d6e4-4a5d-9e23-7743ce89ff3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a07071da-2d0b-4ba4-9ff1-0acf59bd8c0d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_6032ec3c-d6e4-4a5d-9e23-7743ce89ff3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_8e2fb3c6-04ca-4529-8a31-a61214a941d1" xlink:href="isrg-20210331.xsd#isrg_DeferredPurchaseConsiderationPaymentsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_a07071da-2d0b-4ba4-9ff1-0acf59bd8c0d" xlink:to="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_8e2fb3c6-04ca-4529-8a31-a61214a941d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_7db147b3-84c2-4c92-aeab-24791ad46bb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_131ef3f2-3dbe-48d0-8275-1f78d76ccdfc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_7db147b3-84c2-4c92-aeab-24791ad46bb1" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_131ef3f2-3dbe-48d0-8275-1f78d76ccdfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_9a87199e-139e-46cd-8807-1b1067824a12" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_7db147b3-84c2-4c92-aeab-24791ad46bb1" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_9a87199e-139e-46cd-8807-1b1067824a12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4195fff3-1600-477f-b8c4-d5db357510ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_7db147b3-84c2-4c92-aeab-24791ad46bb1" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_4195fff3-1600-477f-b8c4-d5db357510ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTS"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASES" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASES"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESLeaseReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_81d4383c-d6f6-4930-9040-e4740b4477b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_8e17f04d-6795-42ec-8ae1-4f5777418202" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_81d4383c-d6f6-4930-9040-e4740b4477b1" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_8e17f04d-6795-42ec-8ae1-4f5777418202" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_137b467d-3e6e-4227-89f9-cc26e2498eb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_81d4383c-d6f6-4930-9040-e4740b4477b1" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_137b467d-3e6e-4227-89f9-cc26e2498eb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESLeaseReceivablesDetails_1"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_cc3fff27-337d-4778-af2a-42915e6e5914" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit_7fef72e9-e828-44ff-89ff-fdbc70a5cbb6" xlink:href="isrg-20210331.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_cc3fff27-337d-4778-af2a-42915e6e5914" xlink:to="loc_isrg_SalestypeLeaseDeferredSellingProfit_7fef72e9-e828-44ff-89ff-fdbc70a5cbb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_05a3ddf1-a84a-439b-bea8-cff5efbede90" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_cc3fff27-337d-4778-af2a-42915e6e5914" xlink:to="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_05a3ddf1-a84a-439b-bea8-cff5efbede90" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_7d3e5ed2-52bb-4ba2-a349-d6a2c92d228f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_7d3e5ed2-52bb-4ba2-a349-d6a2c92d228f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_3efe097d-a925-4ed3-95be-06c31e7ae03a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_3efe097d-a925-4ed3-95be-06c31e7ae03a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_68edb5cc-30f4-4686-a22f-56fdc6f37057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_68edb5cc-30f4-4686-a22f-56fdc6f37057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_be2a37a4-2fb7-4220-b0bd-f543431c1b37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_be2a37a4-2fb7-4220-b0bd-f543431c1b37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_541430be-af80-4093-b539-fdab7f45b353" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_541430be-af80-4093-b539-fdab7f45b353" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_36980159-bd83-447b-aaa5-5e706a840617" xlink:href="isrg-20210331.xsd#isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_a403597d-fee4-4114-a318-dd568c51bf21" xlink:to="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_36980159-bd83-447b-aaa5-5e706a840617" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESCreditQualityIndicatorDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_8154326d-cd2a-4f24-a219-4c97a8255805" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_8154326d-cd2a-4f24-a219-4c97a8255805" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_a99b5b96-2c11-4c99-af8f-4d70165679f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_a99b5b96-2c11-4c99-af8f-4d70165679f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_11b459b7-2bbc-4e03-a194-b39db1f88a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_11b459b7-2bbc-4e03-a194-b39db1f88a7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_e4486bba-246a-430e-b64e-5052ec753abb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_e4486bba-246a-430e-b64e-5052ec753abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_1c1d9b60-87a8-405c-8c56-bf5dd2fd6558" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_1c1d9b60-87a8-405c-8c56-bf5dd2fd6558" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_aa9bb19f-c277-4b47-9f77-99d480742ded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_d49e0a02-128b-4b36-901a-417bc9084d27" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_aa9bb19f-c277-4b47-9f77-99d480742ded" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#IntangibleAssetsGoodwillandOtherDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2faba2be-404d-4920-a79d-380cd3beaf13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a2a26285-6a77-4379-b5f7-5eec2129a8da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2faba2be-404d-4920-a79d-380cd3beaf13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a2a26285-6a77-4379-b5f7-5eec2129a8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5886112b-7e4a-4989-88c5-11dc95028b30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2faba2be-404d-4920-a79d-380cd3beaf13" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_5886112b-7e4a-4989-88c5-11dc95028b30" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5039b0df-4075-4d76-ba01-0ae666977adb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_5039b0df-4075-4d76-ba01-0ae666977adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_229d4c15-273f-475d-a1b1-f96c2d57193c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_229d4c15-273f-475d-a1b1-f96c2d57193c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f3978780-1e77-4cc0-a57a-bdda524b86fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_f3978780-1e77-4cc0-a57a-bdda524b86fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dccc308f-b6c1-41e3-9b43-1d6da2aa555e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dccc308f-b6c1-41e3-9b43-1d6da2aa555e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3d445e31-0d1d-408f-a385-b6c98f47c966" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3d445e31-0d1d-408f-a385-b6c98f47c966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_1f110be3-9190-41c8-b174-c603b0d67530" xlink:href="isrg-20210331.xsd#isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_98f111c2-e2c5-4cfb-a297-194b3e26145f" xlink:to="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_1f110be3-9190-41c8-b174-c603b0d67530" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="simple" xlink:href="isrg-20210331.xsd#CONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5a933fb3-2e2e-412d-91f5-2520a04067b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bce416d9-14ba-4505-b4e8-5b1c10c634d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5a933fb3-2e2e-412d-91f5-2520a04067b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_bce416d9-14ba-4505-b4e8-5b1c10c634d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_024db586-b22c-4631-85d1-5329cd7aec95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5a933fb3-2e2e-412d-91f5-2520a04067b3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_024db586-b22c-4631-85d1-5329cd7aec95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d3611ed8-07d5-4601-b01e-0e296bf3ea1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_cbd4d3af-b663-449b-86f2-b5e2d6cb1bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d3611ed8-07d5-4601-b01e-0e296bf3ea1b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_cbd4d3af-b663-449b-86f2-b5e2d6cb1bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_40f7b9a4-8683-47e7-a7ab-165abfd93d01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_d3611ed8-07d5-4601-b01e-0e296bf3ea1b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_40f7b9a4-8683-47e7-a7ab-165abfd93d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d5b50c09-203f-462f-8f0c-eb3ae5839a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2c00261f-b34a-44b1-9e85-488233a33620" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d5b50c09-203f-462f-8f0c-eb3ae5839a1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_2c00261f-b34a-44b1-9e85-488233a33620" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_57b34939-38ef-4823-ad66-76f53e14d786" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d5b50c09-203f-462f-8f0c-eb3ae5839a1d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_57b34939-38ef-4823-ad66-76f53e14d786" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_c7925380-6bb7-48e9-b3c0-1d04e6250ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_146be110-705d-4d6d-9396-167652091644" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_c7925380-6bb7-48e9-b3c0-1d04e6250ca0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_146be110-705d-4d6d-9396-167652091644" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_ddd61f78-5550-4434-aae5-6f8d08c22cf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_c7925380-6bb7-48e9-b3c0-1d04e6250ca0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_ddd61f78-5550-4434-aae5-6f8d08c22cf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bef57e02-7818-4cb4-9bcb-5f140799e4d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_5e0fffb2-8fee-4a23-8a7c-385abdfe5eea" xlink:href="isrg-20210331.xsd#isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bef57e02-7818-4cb4-9bcb-5f140799e4d8" xlink:to="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_5e0fffb2-8fee-4a23-8a7c-385abdfe5eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7d055982-fdbe-4344-9fc1-4a9e60521a58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bef57e02-7818-4cb4-9bcb-5f140799e4d8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_7d055982-fdbe-4344-9fc1-4a9e60521a58" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_388347fc-7858-4e4b-b41f-5d5047cc2f56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_558a70f1-9ba3-46ef-b52a-91e9f08c4ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_388347fc-7858-4e4b-b41f-5d5047cc2f56" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_558a70f1-9ba3-46ef-b52a-91e9f08c4ffa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9b988fd8-2960-45ad-a920-7469e4e61a63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_388347fc-7858-4e4b-b41f-5d5047cc2f56" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9b988fd8-2960-45ad-a920-7469e4e61a63" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="simple" xlink:href="isrg-20210331.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHARE"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHARETables"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1735fa31-877c-4069-8e7b-6818a948ed76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_13762512-7311-4874-b20c-63202959158d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1735fa31-877c-4069-8e7b-6818a948ed76" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_13762512-7311-4874-b20c-63202959158d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_45de8e4d-40b8-47fa-82d2-a0c18871d655" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1735fa31-877c-4069-8e7b-6818a948ed76" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_45de8e4d-40b8-47fa-82d2-a0c18871d655" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHAREAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>isrg-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c61f603f-ef4a-4d04-b56b-7269297a821e,g:dd118a18-5d47-4c1c-822e-29e196fcfd78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="simple" xlink:href="isrg-20210331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="extended" id="i0fbba4f941a14678984a221df78d9b38_CoverPage"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended" id="i61245107491c4e12a10ebf27288ddcfd_CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i64fd388077014c82a57211cc42dee84a_CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended" id="ib33e7550b5ba4a8689d83b7f0072e0d9_CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_fde75091-9a3b-4d91-b324-90f2e6285c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_RevenuesAbstract_fde75091-9a3b-4d91-b324-90f2e6285c8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96d312cc-f32d-4a11-9450-d92ddef80d93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_fde75091-9a3b-4d91-b324-90f2e6285c8c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96d312cc-f32d-4a11-9450-d92ddef80d93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_da8ef30a-6b7d-4615-9f06-a5cf095f1df2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_CostOfRevenueAbstract_da8ef30a-6b7d-4615-9f06-a5cf095f1df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_45e943b1-28cb-4552-9f60-d435d74276cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_da8ef30a-6b7d-4615-9f06-a5cf095f1df2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_45e943b1-28cb-4552-9f60-d435d74276cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c0fd4bae-0393-41af-bae8-ee2ff9474e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_GrossProfit_c0fd4bae-0393-41af-bae8-ee2ff9474e91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89ac7091-66d2-42ae-95bd-2a4e04c45d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89ac7091-66d2-42ae-95bd-2a4e04c45d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6cbf14cb-25be-4e6c-a874-15466e7db897" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6cbf14cb-25be-4e6c-a874-15466e7db897" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_693545d8-1f72-4e00-970a-e90a05768339" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:to="loc_us-gaap_OperatingExpenses_693545d8-1f72-4e00-970a-e90a05768339" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_141dffa1-861e-4edc-9f3f-e24ba2fde659" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_OperatingIncomeLoss_141dffa1-861e-4edc-9f3f-e24ba2fde659" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d0d78d67-ba64-4df0-85a6-acf8ee77fbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d0d78d67-ba64-4df0-85a6-acf8ee77fbf4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_614372ff-6c72-4256-8355-bf24055a5235" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_614372ff-6c72-4256-8355-bf24055a5235" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d59e7347-8d43-4b59-9c61-7c5e30673b04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d59e7347-8d43-4b59-9c61-7c5e30673b04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1c8fcb10-36d4-4361-b5c1-42f16308adb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_ProfitLoss_1c8fcb10-36d4-4361-b5c1-42f16308adb1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_88a69629-1f70-4fb8-bbe9-bf23082dd484" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_88a69629-1f70-4fb8-bbe9-bf23082dd484" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_384f2ed1-941e-48a6-8ad1-595fcaa6ce7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_NetIncomeLoss_384f2ed1-941e-48a6-8ad1-595fcaa6ce7f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c19b4778-5213-4a44-accf-ef7bf4f588b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:to="loc_us-gaap_EarningsPerShareBasic_c19b4778-5213-4a44-accf-ef7bf4f588b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3cd9bc8f-6a95-4750-ae99-a483ed7ba6cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3cd9bc8f-6a95-4750-ae99-a483ed7ba6cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16b9a703-51c8-4884-9ed8-3a301aedf4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16b9a703-51c8-4884-9ed8-3a301aedf4bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cebda746-8f4f-4069-ad6d-a6cfdab5deac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cebda746-8f4f-4069-ad6d-a6cfdab5deac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_508563ff-b3db-4111-ac7c-a93aa8e80623" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_508563ff-b3db-4111-ac7c-a93aa8e80623" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c8e54ae-e0b9-4d29-9cbf-1b951b8da892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c8e54ae-e0b9-4d29-9cbf-1b951b8da892" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b852ada1-f481-4727-bc01-d0c4a9ea98dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b852ada1-f481-4727-bc01-d0c4a9ea98dd" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:to="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_26897614-b561-41af-84fc-cf34a6f86262_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:to="loc_srt_ProductsAndServicesDomain_26897614-b561-41af-84fc-cf34a6f86262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:to="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_4f4a8171-b70b-4f7b-afbc-2f6837d44cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:to="loc_us-gaap_ProductMember_4f4a8171-b70b-4f7b-afbc-2f6837d44cbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_79a88001-60ad-4f1f-abd9-eca13cd266f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:to="loc_us-gaap_ServiceMember_79a88001-60ad-4f1f-abd9-eca13cd266f4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i8aebabc2ba3448468410ae12c6dc097d_CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="simple" xlink:href="isrg-20210331.xsd#DESCRIPTIONOFTHEBUSINESS"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="extended" id="i3e8bc3809df64d22a81d35e0d8259fdc_DESCRIPTIONOFTHEBUSINESS"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="isrg-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="ic13eb8f2d96b4e608781408255b060ca_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="isrg-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i2ea8deda2e2e4a3f829b227ce5b0b2f9_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTS"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="extended" id="i6730fe93251a4f7e9995a81a2190d2f8_FINANCIALINSTRUMENTS"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended" id="idfdbf184cf7647cd9a07b21faf238892_FINANCIALINSTRUMENTSTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="extended" id="i332e4552a7b34d8fa7c53415ef964ce8_FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b1168d1-4a7a-48c0-9276-d983bee8381a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b1168d1-4a7a-48c0-9276-d983bee8381a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_672e8fd9-f0f3-42f3-900a-9c1639033f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_672e8fd9-f0f3-42f3-900a-9c1639033f2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b32320a8-a63d-4702-ae08-5c8e24c2ec73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b32320a8-a63d-4702-ae08-5c8e24c2ec73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_b80cde4b-9e6c-4d06-a796-c24b5ddc9bfe" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_b80cde4b-9e6c-4d06-a796-c24b5ddc9bfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e68170f0-845f-4e52-a019-583aefcf7536" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e68170f0-845f-4e52-a019-583aefcf7536" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fce3906c-6de1-4d7b-baa2-8442becb9c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fce3906c-6de1-4d7b-baa2-8442becb9c87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a9f3ad72-5035-482e-91ee-141d623608f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a9f3ad72-5035-482e-91ee-141d623608f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65cd9943-d18d-48d9-8400-91c7d44a9130" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65cd9943-d18d-48d9-8400-91c7d44a9130" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_3d2a3d94-c9cd-49b7-84af-53f068b34fc9" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_3d2a3d94-c9cd-49b7-84af-53f068b34fc9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_9fca2554-7cbc-466c-833d-4a78ca23f6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_9fca2554-7cbc-466c-833d-4a78ca23f6bc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_67f93c50-12c0-4296-831b-ffb17c4e4b05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_67f93c50-12c0-4296-831b-ffb17c4e4b05" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1ae8dd99-98da-4ddb-81af-bad16e99e664" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1ae8dd99-98da-4ddb-81af-bad16e99e664" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e203c240-57d2-4748-a642-df76c289ba72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e203c240-57d2-4748-a642-df76c289ba72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f24a5d28-e586-41ee-aaad-c1bd8da10350_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f24a5d28-e586-41ee-aaad-c1bd8da10350_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_37327b14-17ae-4e5d-af91-01be29c97f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_CashMember_37327b14-17ae-4e5d-af91-01be29c97f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ed19e6c9-4800-46d0-a5d9-ccc411a06e35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ed19e6c9-4800-46d0-a5d9-ccc411a06e35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_71338dd1-2cbb-4ebd-b7d4-185a563d25d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_71338dd1-2cbb-4ebd-b7d4-185a563d25d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_18369f15-89a1-4cba-a667-43f2e6b7c7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_CommercialPaperMember_18369f15-89a1-4cba-a667-43f2e6b7c7d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8a1f7356-b66b-4964-91fb-b53ade5b2628" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8a1f7356-b66b-4964-91fb-b53ade5b2628" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_842fd1fa-a6aa-4eba-8ef1-2e8926c62ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_842fd1fa-a6aa-4eba-8ef1-2e8926c62ad3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_eab6237f-1641-4494-bbc2-cd8bd40cc008" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_eab6237f-1641-4494-bbc2-cd8bd40cc008" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_a27f973b-818f-4ae9-ae37-aa7cb1e320bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_MunicipalNotesMember_a27f973b-818f-4ae9-ae37-aa7cb1e320bd" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="extended" id="ib7a9499288e847688cda8aea7a8cc930_FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="extended" id="ifb73f8f2ba5b4f069f67ce6932b0b22c_FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c54c8796-b4f7-41fc-b73a-43f150fb7cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c54c8796-b4f7-41fc-b73a-43f150fb7cd4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_af6d4798-f8fb-4fe4-8590-40e7ba83fe66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_af6d4798-f8fb-4fe4-8590-40e7ba83fe66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_4c3b9985-04a6-4f7b-a6f9-adcef8f23a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_4c3b9985-04a6-4f7b-a6f9-adcef8f23a9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_1ec3d212-a022-4680-bc76-316822402f85" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_1ec3d212-a022-4680-bc76-316822402f85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_306df352-8192-45b2-9e66-cffa11c9fd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_306df352-8192-45b2-9e66-cffa11c9fd0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_00f507c2-0ac7-4325-9843-0765e753e743" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_00f507c2-0ac7-4325-9843-0765e753e743" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_8903a452-82ea-4655-bf5e-e734435b82f0" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_8903a452-82ea-4655-bf5e-e734435b82f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_259afa46-19ff-4bc5-8070-dc4df64f86a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e636f820-b814-4c7e-91ff-4056c0d07082" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c54c8796-b4f7-41fc-b73a-43f150fb7cd4" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_07effada-cadc-4c9b-b1a5-c121a12963a4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_07effada-cadc-4c9b-b1a5-c121a12963a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1486c0ea-ed30-4fa1-b079-7f3cc2bb8e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1486c0ea-ed30-4fa1-b079-7f3cc2bb8e1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssetsNetMember_bf93dabb-65f1-469b-9b46-285d2b2b16d9" xlink:href="isrg-20210331.xsd#isrg_IntangibleAndOtherAssetsNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:to="loc_isrg_IntangibleAndOtherAssetsNetMember_bf93dabb-65f1-469b-9b46-285d2b2b16d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9304590d-638f-49d2-838e-0a435b9938dc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9304590d-638f-49d2-838e-0a435b9938dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1ee0cb74-b503-4eed-8adc-d9585a9c0161" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1ee0cb74-b503-4eed-8adc-d9585a9c0161" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2c362742-a5e3-45bf-ae5a-f3bde0380c63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2c362742-a5e3-45bf-ae5a-f3bde0380c63" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="extended" id="i88f1eb39b0b54e1b84bd3d8129f28609_FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d092b292-ca4a-4357-a29c-5061d231c16f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d092b292-ca4a-4357-a29c-5061d231c16f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e97e33e1-4591-4a2c-a73c-a0790b9a658a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e97e33e1-4591-4a2c-a73c-a0790b9a658a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ede498b4-dd0d-45cb-864d-979c36ea1cc6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ede498b4-dd0d-45cb-864d-979c36ea1cc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6e17e09e-c5a3-41cc-99a5-addedb7a3a74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6e17e09e-c5a3-41cc-99a5-addedb7a3a74" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CollarContractMember_37965949-6f52-4203-8c14-1f93672e2207" xlink:href="isrg-20210331.xsd#isrg_CollarContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:to="loc_isrg_CollarContractMember_37965949-6f52-4203-8c14-1f93672e2207" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_209048c7-01a0-4428-843a-36c594c5e46d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_209048c7-01a0-4428-843a-36c594c5e46d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_71186b95-7b43-4cca-ba71-957da0c4f182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_209048c7-01a0-4428-843a-36c594c5e46d" xlink:to="loc_us-gaap_OtherIncomeMember_71186b95-7b43-4cca-ba71-957da0c4f182" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b974a53c-d05d-4dc9-bee4-a3f669c22dd1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:to="loc_us-gaap_HedgingDesignationDomain_b974a53c-d05d-4dc9-bee4-a3f669c22dd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_43cd6c68-10bc-4e23-a9e2-38eead8e384c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:to="loc_us-gaap_HedgingDesignationDomain_43cd6c68-10bc-4e23-a9e2-38eead8e384c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_af6bccde-1de6-4a0c-a6d9-5403d5dee702" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_43cd6c68-10bc-4e23-a9e2-38eead8e384c" xlink:to="loc_us-gaap_NondesignatedMember_af6bccde-1de6-4a0c-a6d9-5403d5dee702" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="extended" id="i2b1ff5a2ffdc47f4babcd5f262785cb5_FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77580029-6c42-456a-bbaa-a47ddfb308ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e7ce74a3-93c0-47a0-b1f0-b8685087fcc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77580029-6c42-456a-bbaa-a47ddfb308ac" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e7ce74a3-93c0-47a0-b1f0-b8685087fcc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77580029-6c42-456a-bbaa-a47ddfb308ac" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_27be6b42-686a-4401-a20e-04e973a8e12f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_27be6b42-686a-4401-a20e-04e973a8e12f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d55188c-141f-4758-ae54-8b9a410d304a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d55188c-141f-4758-ae54-8b9a410d304a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_a13c03cc-6526-4a47-a699-5ba054610c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d55188c-141f-4758-ae54-8b9a410d304a" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_a13c03cc-6526-4a47-a699-5ba054610c0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a91638b3-30be-4059-b9aa-bb57ff228e11_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:to="loc_us-gaap_HedgingDesignationDomain_a91638b3-30be-4059-b9aa-bb57ff228e11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:to="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36bec257-06c2-4160-bd92-635711ab4949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36bec257-06c2-4160-bd92-635711ab4949" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d258a26c-d7e9-41a1-8da8-f05e21c032b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:to="loc_us-gaap_NondesignatedMember_d258a26c-d7e9-41a1-8da8-f05e21c032b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9373ba74-d0a2-4692-8e61-9b9fa9f8be84_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9373ba74-d0a2-4692-8e61-9b9fa9f8be84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_296024f4-b62e-4765-81cd-8ae2ac9742ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_296024f4-b62e-4765-81cd-8ae2ac9742ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_b235d828-da5d-4bca-8bb7-8c0d783c9992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:to="loc_us-gaap_OtherLiabilitiesMember_b235d828-da5d-4bca-8bb7-8c0d783c9992" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="extended" id="ic6edb4f8b09546f6b4baa9c6ff76c02c_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="extended" id="i83ada6730087424eb145941b4057e3ee_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="extended" id="i6875c34f14414af8b9062c2679fe806d_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="extended" id="ia0262ca30dca4127a8978aa0a4af9bd0_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="extended" id="idf058ec182d44e7089544f398cbc55b7_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="extended" id="iddeef13132ca49c38fdb54d1cf1ac565_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="extended" id="i7f2dd61672854034a2cfdded95568de5_BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTS"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="extended" id="ifa34a9798cf34b2f8a3bedfd3c1d1515_REVENUEANDCONTRACTACQUISITIONCOSTS"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="extended" id="i902bc80a392e43d4acc0b84857c1d96b_REVENUEANDCONTRACTACQUISITIONCOSTSTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="extended" id="i631dc871a7f5455797049dc609121d12_REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e2218a9f-27a4-457b-91b3-ad0186c8299e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33dfe2fd-d4fe-4f3a-8895-7aaf2a605759" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2218a9f-27a4-457b-91b3-ad0186c8299e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33dfe2fd-d4fe-4f3a-8895-7aaf2a605759" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2218a9f-27a4-457b-91b3-ad0186c8299e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:to="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_f51d7868-480a-4f4b-afdf-91b32ee1401e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:to="loc_us-gaap_GeographicDistributionDomain_f51d7868-480a-4f4b-afdf-91b32ee1401e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:to="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_1f065410-e7c7-4fe8-9164-e35d14b836d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_1f065410-e7c7-4fe8-9164-e35d14b836d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_79c8de35-3ab7-46bc-bc87-5c3cdbd752bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_79c8de35-3ab7-46bc-bc87-5c3cdbd752bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:to="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_855e4e21-7452-4981-9753-e6ccc6945e2d_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:to="loc_srt_ProductsAndServicesDomain_855e4e21-7452-4981-9753-e6ccc6945e2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:to="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_InstrumentsandAccessoriesMember_c4c224f6-4b69-483d-9d65-3000bee554f4" xlink:href="isrg-20210331.xsd#isrg_InstrumentsandAccessoriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:to="loc_isrg_InstrumentsandAccessoriesMember_c4c224f6-4b69-483d-9d65-3000bee554f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SystemsMember_4c172d8c-1541-4409-a53e-c283230d691a" xlink:href="isrg-20210331.xsd#isrg_SystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:to="loc_isrg_SystemsMember_4c172d8c-1541-4409-a53e-c283230d691a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ServicesMember_e450c737-0a4d-4367-8f21-77e29a7f62b2" xlink:href="isrg-20210331.xsd#isrg_ServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:to="loc_isrg_ServicesMember_e450c737-0a4d-4367-8f21-77e29a7f62b2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="extended" id="i06f39d603cc94ecd8bc571b73f75e19b_REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_223cc1fd-cf67-427a-8f46-4b4208c04e57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_223cc1fd-cf67-427a-8f46-4b4208c04e57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_be2940af-2f41-4432-a3d3-5cf1a26e15bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_be2940af-2f41-4432-a3d3-5cf1a26e15bb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="extended" id="i10dfbec47fc443708d59c05995d6b7b9_REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_223cc1fd-cf67-427a-8f46-4b4208c04e57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_223cc1fd-cf67-427a-8f46-4b4208c04e57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended" id="i06960183f1f94cbabefa4b0cacd1786d_REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="extended" id="ifff047fea85e47ecbadda2d1c740b504_REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASES" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASES"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASES" xlink:type="extended" id="ia43762a979fc4886bbec0adc91d5a23c_LEASES"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="extended" id="i5967741c21c44f7e9c286dbea05ccfc2_LEASESTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESLeaseReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="extended" id="i1b5aaf741dfc42c98ae58421a1a38b47_LEASESLeaseReceivablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_5310feb8-91df-4ea5-9179-59b1bb931efd" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_5310feb8-91df-4ea5-9179-59b1bb931efd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit_ac171272-dcd2-4aed-a953-cc4d6e1914a1" xlink:href="isrg-20210331.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_isrg_SalestypeLeaseDeferredSellingProfit_ac171272-dcd2-4aed-a953-cc4d6e1914a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_05fba6a0-b579-43a7-8c23-eba179fe98bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_05fba6a0-b579-43a7-8c23-eba179fe98bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_c2636e7c-4b65-4126-ad2d-34b53ad8bc08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_c2636e7c-4b65-4126-ad2d-34b53ad8bc08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_22c9b4e8-4db3-43b0-8049-c2e59811ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_22c9b4e8-4db3-43b0-8049-c2e59811ff09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCapitalLeasedAsssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_45e4e8fc-af51-4008-aa28-3024d35cc13f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_45e4e8fc-af51-4008-aa28-3024d35cc13f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_32e36477-296b-4fc2-9494-d242fdba4b82" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_32e36477-296b-4fc2-9494-d242fdba4b82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e5f1baf9-e710-4596-bc33-1de3365a052b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e5f1baf9-e710-4596-bc33-1de3365a052b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="extended" id="i5d57270519bf41a1b87972fb227492e2_LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESCreditQualityIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="extended" id="i77867c0d83db4e929f07ace67adfd68e_LEASESCreditQualityIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_86d7088d-9461-43d6-a82a-29c58384c587" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_86d7088d-9461-43d6-a82a-29c58384c587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_c9ed3e05-ff3d-4b87-8fbe-6dab463fbb59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_c9ed3e05-ff3d-4b87-8fbe-6dab463fbb59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_5bb69f4f-c123-445f-8e02-672e59be6cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_5bb69f4f-c123-445f-8e02-672e59be6cbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_43dba50c-c991-4b58-b6ba-3a46503e444d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_43dba50c-c991-4b58-b6ba-3a46503e444d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_94272768-6f9f-4b92-8243-fad0b7776f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_94272768-6f9f-4b92-8243-fad0b7776f74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_82339599-1b2f-4245-945b-2f67e1b8040c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_82339599-1b2f-4245-945b-2f67e1b8040c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_305531b2-707e-4b3e-805c-399cf03613a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_305531b2-707e-4b3e-805c-399cf03613a6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_496f0905-bfd9-463a-bee0-2ffb52d8b345_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_496f0905-bfd9-463a-bee0-2ffb52d8b345_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_HighMember_21dca812-90ef-458a-aad8-1a2d236309e4" xlink:href="isrg-20210331.xsd#isrg_HighMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:to="loc_isrg_HighMember_21dca812-90ef-458a-aad8-1a2d236309e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ModerateMember_66f9421c-aa55-4dbe-a664-38824221d456" xlink:href="isrg-20210331.xsd#isrg_ModerateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:to="loc_isrg_ModerateMember_66f9421c-aa55-4dbe-a664-38824221d456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LowMember_0c9a0ee5-fd6a-47e8-b473-8decb076a86f" xlink:href="isrg-20210331.xsd#isrg_LowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:to="loc_isrg_LowMember_0c9a0ee5-fd6a-47e8-b473-8decb076a86f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="extended" id="i42335fc0b8cc41c58ac82c3154f7f608_LEASESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_46859c72-0b8c-4097-8d61-a5419954da15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_69dc0618-5f44-42e5-af5d-bfe63f110443" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_46859c72-0b8c-4097-8d61-a5419954da15" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_69dc0618-5f44-42e5-af5d-bfe63f110443" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_46859c72-0b8c-4097-8d61-a5419954da15" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:to="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d80bf139-04b1-4fe9-a203-763d56b24980_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:to="loc_srt_RangeMember_d80bf139-04b1-4fe9-a203-763d56b24980_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:to="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5255fe19-3291-4dc7-a0ed-31945a2b13c1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:to="loc_srt_MinimumMember_5255fe19-3291-4dc7-a0ed-31945a2b13c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c12af629-44d8-44cc-bbc6-96beadf8ded2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:to="loc_srt_MaximumMember_c12af629-44d8-44cc-bbc6-96beadf8ded2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended" id="ie40c0e0f0dee4c1e8d1548e603ce45f2_GOODWILLANDINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended" id="i228eed9ab66d4072b8bcc1ec9cedff86_GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#IntangibleAssetsGoodwillandOtherDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails" xlink:type="extended" id="i7e33ff560c8849adbac443938e5fc4ae_IntangibleAssetsGoodwillandOtherDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_db21ebba-35b7-4235-95e3-bfe2d7156c5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_db21ebba-35b7-4235-95e3-bfe2d7156c5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_f3e65d3a-91ac-40d8-b543-c3428a15a817" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_f3e65d3a-91ac-40d8-b543-c3428a15a817" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_10068f08-0bb4-4ade-9494-e378706542ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_10068f08-0bb4-4ade-9494-e378706542ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_c4841906-73e2-4efd-8fa2-b712e0c78038" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_c4841906-73e2-4efd-8fa2-b712e0c78038" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_a2ea3b53-b220-4b12-be12-530740449998" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_a2ea3b53-b220-4b12-be12-530740449998" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9b5f7f32-5fe8-44c6-84b6-6f3100931991" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9b5f7f32-5fe8-44c6-84b6-6f3100931991" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_a989fcee-e971-4472-b063-9b335ee25013" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_a989fcee-e971-4472-b063-9b335ee25013" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPayments_8efb004b-7a83-4448-bbe2-f44b53c7427e" xlink:href="isrg-20210331.xsd#isrg_DeferredPurchaseConsiderationPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_DeferredPurchaseConsiderationPayments_8efb004b-7a83-4448-bbe2-f44b53c7427e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_e8d4c88f-5977-4dab-bbe3-daa2a6e136da" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_e8d4c88f-5977-4dab-bbe3-daa2a6e136da" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc5a95de-3371-43bd-983f-7adf6c4f7fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc5a95de-3371-43bd-983f-7adf6c4f7fed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334b34a5-b115-4998-8c4a-1ee636c027e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334b34a5-b115-4998-8c4a-1ee636c027e1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a43a1de6-e4f0-474f-9e50-67df790154ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a43a1de6-e4f0-474f-9e50-67df790154ea" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1fc0a080-cde4-41f7-9bd9-4114715ecdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_Goodwill_1fc0a080-cde4-41f7-9bd9-4114715ecdbd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4055f96-d695-4af1-96db-89407c7841b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4055f96-d695-4af1-96db-89407c7841b4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_13aed1c0-6b58-474c-a0d0-7f6d6b495269" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_13aed1c0-6b58-474c-a0d0-7f6d6b495269" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_54c28874-e1dd-4dec-b4dd-a129c0bf18c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_54c28874-e1dd-4dec-b4dd-a129c0bf18c2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_19b9a7a6-07be-4f48-ba7d-5d92dea135c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_19b9a7a6-07be-4f48-ba7d-5d92dea135c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ChindexMember_9ae876b4-136a-47e6-aa4b-eb5b24074bb7" xlink:href="isrg-20210331.xsd#isrg_ChindexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:to="loc_isrg_ChindexMember_9ae876b4-136a-47e6-aa4b-eb5b24074bb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SchllyFiberopticGmbHMember_7f18c2ba-30a5-45d2-bcdc-6c00934b56b5" xlink:href="isrg-20210331.xsd#isrg_SchllyFiberopticGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:to="loc_isrg_SchllyFiberopticGmbHMember_7f18c2ba-30a5-45d2-bcdc-6c00934b56b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd046b6b-7ab3-4648-85a5-030a74b1be63_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dd046b6b-7ab3-4648-85a5-030a74b1be63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ManufacturingProcessTechnologyMember_6c5fa7c9-6c28-4067-a135-1e23e135f13f" xlink:href="isrg-20210331.xsd#isrg_ManufacturingProcessTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:to="loc_isrg_ManufacturingProcessTechnologyMember_6c5fa7c9-6c28-4067-a135-1e23e135f13f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_f6479ba1-90aa-4304-b500-d380b335199b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_f6479ba1-90aa-4304-b500-d380b335199b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="extended" id="if762908d5ee2454cb2a0d9d0e3bd6e6c_GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="extended" id="i4eeeed4a1662459ead759b9d1a6a735b_GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dbf15fde-dc2b-439e-9d88-803a3afd086b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dbf15fde-dc2b-439e-9d88-803a3afd086b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_292482e7-ec32-4f99-977c-67145cecc10f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_292482e7-ec32-4f99-977c-67145cecc10f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8db67e2e-d6f3-443d-b080-b48030d7d451" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8db67e2e-d6f3-443d-b080-b48030d7d451" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4fcbded9-06f5-4f2e-899a-ee4640ff9e65_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4fcbded9-06f5-4f2e-899a-ee4640ff9e65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_19186d36-6d93-4c3a-9eb7-a07d3b76f73c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_19186d36-6d93-4c3a-9eb7-a07d3b76f73c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_de8be163-ee6e-438c-a9b7-e71cacea259c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:to="loc_us-gaap_DistributionRightsMember_de8be163-ee6e-438c-a9b7-e71cacea259c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_103baa8b-0f64-431d-b05c-2dba9bc98de4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_103baa8b-0f64-431d-b05c-2dba9bc98de4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="extended" id="id25dfea4f2d54c1786ba06695b40df13_GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="simple" xlink:href="isrg-20210331.xsd#CONTINGENCIES"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="extended" id="i6164d153474f41ad985ca7a13af42408_CONTINGENCIES"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="extended" id="ic574e18753e6426fa11ca8297d867f6c_STOCKHOLDERSEQUITY"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended" id="i2ab6408c04a64828a9d0657beeaf460c_STOCKHOLDERSEQUITYTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="extended" id="ic1eefe05043449a89fd17ce6e52c955d_STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_b6024669-2e26-4cab-95d3-5eb389809b55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6024669-2e26-4cab-95d3-5eb389809b55" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d6db9dbd-85aa-4ac6-b830-634d790cc0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d6db9dbd-85aa-4ac6-b830-634d790cc0d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2db937cf-4342-4ef9-948d-58ea25ad23e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2db937cf-4342-4ef9-948d-58ea25ad23e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ef789c97-d15f-422e-b2df-6dc6f2270309" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ef789c97-d15f-422e-b2df-6dc6f2270309" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b15f8d39-ac73-4a0a-a527-cbd979ab4fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b15f8d39-ac73-4a0a-a527-cbd979ab4fdf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_47cba255-6f0c-4b34-a5c9-78e6a8ee2fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_47cba255-6f0c-4b34-a5c9-78e6a8ee2fb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dbc2d3bc-c16b-48de-b876-fb4936af7881" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dbc2d3bc-c16b-48de-b876-fb4936af7881" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f857b31-344b-4517-94f2-55ff03faa2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f857b31-344b-4517-94f2-55ff03faa2b1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_89d7acc9-d6c3-4b07-98d7-4ffe5452505d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_89d7acc9-d6c3-4b07-98d7-4ffe5452505d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_31bf2246-66ba-4bcc-bfce-9871c500ee24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_31bf2246-66ba-4bcc-bfce-9871c500ee24" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_039dc1d6-89e3-455e-bb5e-f8787cc05bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_NetIncomeLoss_039dc1d6-89e3-455e-bb5e-f8787cc05bfe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cdecf637-76c3-4830-a0e2-f628d0533893" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cdecf637-76c3-4830-a0e2-f628d0533893" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_58cf7dc7-f281-42ec-8da6-0d61448c85e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_58cf7dc7-f281-42ec-8da6-0d61448c85e5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_451eb4e4-de13-4a90-b63e-260e2a2c67fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_451eb4e4-de13-4a90-b63e-260e2a2c67fa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e2ad2360-5f00-43d2-b727-7a5d3a381329" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_410a8d16-e384-4f6e-aa31-4949139d8346" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6024669-2e26-4cab-95d3-5eb389809b55" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b999d467-c28b-48dd-88cc-ba70aaca8956_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:to="loc_us-gaap_EquityComponentDomain_b999d467-c28b-48dd-88cc-ba70aaca8956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:to="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4ac3b520-6bd1-43b4-8f90-338ca4e25222" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_CommonStockMember_4ac3b520-6bd1-43b4-8f90-338ca4e25222" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_89f02ad2-64d7-4d50-a3ec-05ff8e1cbf99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_89f02ad2-64d7-4d50-a3ec-05ff8e1cbf99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c7eda51a-a227-4d6a-9d62-eec914c6c564" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_RetainedEarningsMember_c7eda51a-a227-4d6a-9d62-eec914c6c564" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df90fae4-4b6d-4d98-8785-eedf3567937b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df90fae4-4b6d-4d98-8785-eedf3567937b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_ed1f7354-0dc1-4e4c-8df0-7407a1700fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_ParentMember_ed1f7354-0dc1-4e4c-8df0-7407a1700fe9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_eee664e4-f765-4e3b-8e21-9a0177f80fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_eee664e4-f765-4e3b-8e21-9a0177f80fe3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_b99a5db4-f218-470d-872d-447105e06d2d_default" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_b99a5db4-f218-470d-872d-447105e06d2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_4421ce60-1496-4fb1-a563-2284bdd25c3e" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_4421ce60-1496-4fb1-a563-2284bdd25c3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3de1293e-2b07-4b7f-97a5-9477bc9732c0" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_4421ce60-1496-4fb1-a563-2284bdd25c3e" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3de1293e-2b07-4b7f-97a5-9477bc9732c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="extended" id="ib819922c3fd3477dae5d9339b2deba8c_STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d7ac8fbe-b53a-422c-9de0-b18d8b7adf2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d7ac8fbe-b53a-422c-9de0-b18d8b7adf2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0f480ee5-8508-4f67-844c-172dfb46b36a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0f480ee5-8508-4f67-844c-172dfb46b36a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_43f55e7c-17c4-4346-bc60-fe6259b119c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_43f55e7c-17c4-4346-bc60-fe6259b119c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6c7cf998-d513-4245-9f6c-16b2bf80190c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:to="loc_us-gaap_EquityComponentDomain_6c7cf998-d513-4245-9f6c-16b2bf80190c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_96636b58-b1c1-4ff2-9dfc-a660f66ee31d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:to="loc_us-gaap_EquityComponentDomain_96636b58-b1c1-4ff2-9dfc-a660f66ee31d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0654333f-6f1d-419d-a6c9-0274ec5adb97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_96636b58-b1c1-4ff2-9dfc-a660f66ee31d" xlink:to="loc_us-gaap_CommonStockMember_0654333f-6f1d-419d-a6c9-0274ec5adb97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cf00b6c2-1863-49a4-873b-b6d14cabf9b7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cf00b6c2-1863-49a4-873b-b6d14cabf9b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_13701077-5f86-42a7-bf64-7300b4de0391" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_13701077-5f86-42a7-bf64-7300b4de0391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_1f504cd6-e2fb-4b50-9b75-690e88072ca9" xlink:href="isrg-20210331.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_13701077-5f86-42a7-bf64-7300b4de0391" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_1f504cd6-e2fb-4b50-9b75-690e88072ca9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended" id="i8367099178ef4c64bc6a4611855c28e5_STOCKHOLDERSEQUITYStockRepurchaseProgramDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1500d928-1f93-4a4c-ac6d-31bbc6c78d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1500d928-1f93-4a4c-ac6d-31bbc6c78d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_a1aaaa82-9bcf-4b8f-9b8f-ab6a90a613ff" xlink:href="isrg-20210331.xsd#isrg_StockRepurchaseProgramincreasedtoauthorizedamount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_a1aaaa82-9bcf-4b8f-9b8f-ab6a90a613ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7c9a6f0a-ca68-4bd9-95b5-8ff169b41d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7c9a6f0a-ca68-4bd9-95b5-8ff169b41d4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_ce49441e-a8fd-4c00-91c9-453979b5d746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_ce49441e-a8fd-4c00-91c9-453979b5d746" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_623b2767-d9e1-4f90-a106-185d2bff677b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_623b2767-d9e1-4f90-a106-185d2bff677b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_0ae87ad1-0633-49d5-83f2-e36512942e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_0ae87ad1-0633-49d5-83f2-e36512942e3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_d86471da-805e-496e-bd2b-d0af8b33c766_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_d86471da-805e-496e-bd2b-d0af8b33c766_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_ac870c15-0192-4f5e-a6e6-2decc06f041e" xlink:href="isrg-20210331.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_ac870c15-0192-4f5e-a6e6-2decc06f041e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccelerateShareRepurchaseProgramMember_44162600-0919-44f4-9937-b9768ea870c5" xlink:href="isrg-20210331.xsd#isrg_AccelerateShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:to="loc_isrg_AccelerateShareRepurchaseProgramMember_44162600-0919-44f4-9937-b9768ea870c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_52168d82-fce4-4e66-a85d-f1620e8c6799_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:to="loc_us-gaap_EquityComponentDomain_52168d82-fce4-4e66-a85d-f1620e8c6799_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ea8ceeaf-9bff-4ed2-a176-55c7fc4c568d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:to="loc_us-gaap_EquityComponentDomain_ea8ceeaf-9bff-4ed2-a176-55c7fc4c568d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8fb70edf-dc0d-4d90-b4cc-a33f5b20a40a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ea8ceeaf-9bff-4ed2-a176-55c7fc4c568d" xlink:to="loc_us-gaap_CommonStockMember_8fb70edf-dc0d-4d90-b4cc-a33f5b20a40a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c0ede49-833f-44f2-bb74-e83c10196164_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9c0ede49-833f-44f2-bb74-e83c10196164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_724c2b76-06f4-49c7-a892-79ce5304d36a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_724c2b76-06f4-49c7-a892-79ce5304d36a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_GoldmanSachsCo.Member_3110860e-a0b2-4404-81ce-55c55e4512c0" xlink:href="isrg-20210331.xsd#isrg_GoldmanSachsCo.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_724c2b76-06f4-49c7-a892-79ce5304d36a" xlink:to="loc_isrg_GoldmanSachsCo.Member_3110860e-a0b2-4404-81ce-55c55e4512c0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="extended" id="i77f9fdba572d4256b6a929a334f78c86_STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATION"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended" id="i106c670efff5421a9873e7cf0f9d9d6b_SHAREBASEDCOMPENSATION"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended" id="i18e3a1c4bc504f02b22bcbacfc706a70_SHAREBASEDCOMPENSATIONTables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended" id="ifcca552ec58341c7aa00e42b32268bbe_SHAREBASEDCOMPENSATIONAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7685ee1d-01bc-42c7-b2ae-9ddd57e29f81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7685ee1d-01bc-42c7-b2ae-9ddd57e29f81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_814b2891-aa0f-43d1-8d9c-33d3d2aa847a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_814b2891-aa0f-43d1-8d9c-33d3d2aa847a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9d8a92c5-42f3-4487-92ea-4cdd5ec77208" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9d8a92c5-42f3-4487-92ea-4cdd5ec77208" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e3eb2bec-1b5f-4cff-b0a5-25998374e18a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e3eb2bec-1b5f-4cff-b0a5-25998374e18a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4558fb7e-b9e9-478f-97f9-ca2c148f4635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4558fb7e-b9e9-478f-97f9-ca2c148f4635" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_37a3f869-7d1f-4548-9db3-12f11d4d10fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_37a3f869-7d1f-4548-9db3-12f11d4d10fa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_53a0eba1-55f3-418c-97e5-300c7ba68c81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_53a0eba1-55f3-418c-97e5-300c7ba68c81" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:to="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ce2ec1bc-f1af-418e-81cd-3977c80c9895_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ce2ec1bc-f1af-418e-81cd-3977c80c9895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_60507e90-1d3a-400f-9a97-f53b575bd297" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_60507e90-1d3a-400f-9a97-f53b575bd297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_50c83497-425b-4c3d-9774-02e33b555a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:to="loc_us-gaap_EmployeeStockMember_50c83497-425b-4c3d-9774-02e33b555a3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:to="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b742d669-b089-492b-ac2a-98fb6b98dc94_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:to="loc_us-gaap_PlanNameDomain_b742d669-b089-492b-ac2a-98fb6b98dc94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a33433e5-d9b6-42a4-a416-f4b3b6af1b48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:to="loc_us-gaap_PlanNameDomain_a33433e5-d9b6-42a4-a416-f4b3b6af1b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_A2010IncentiveAwardPlanMember_ebe200c0-27e3-43af-88a8-93a11148327f" xlink:href="isrg-20210331.xsd#isrg_A2010IncentiveAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a33433e5-d9b6-42a4-a416-f4b3b6af1b48" xlink:to="loc_isrg_A2010IncentiveAwardPlanMember_ebe200c0-27e3-43af-88a8-93a11148327f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="extended" id="ia72b17053e984eb3998262bd8e93e3f1_SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="extended" id="ie4f954faec96428282c0f84dcd12f331_SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_93bc774d-8650-4c63-a363-e991125b3f81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_93bc774d-8650-4c63-a363-e991125b3f81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876b0967-00b6-4f5d-905e-1850ec482507" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876b0967-00b6-4f5d-905e-1850ec482507" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_863469bb-7625-438e-b69e-499cee2bbecd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_863469bb-7625-438e-b69e-499cee2bbecd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_46896fb5-397a-4cbc-8ff5-0437386f0c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_46896fb5-397a-4cbc-8ff5-0437386f0c0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_137188c5-910a-4ba3-9416-0dab7a6e20c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_44ec2eee-0521-4771-b612-977dbb40a718" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_44ec2eee-0521-4771-b612-977dbb40a718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_173d0043-7088-4929-8a22-9ab7105dedf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_173d0043-7088-4929-8a22-9ab7105dedf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4c86b388-b195-4051-ba91-11883680a9a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4c86b388-b195-4051-ba91-11883680a9a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85bc65f1-828e-4d88-b069-ab31cf6cfe8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85bc65f1-828e-4d88-b069-ab31cf6cfe8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dba8d5c2-262b-493e-a557-d3cfc1dacca2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:to="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_616d80ce-5bcc-45d1-b13d-a3790b455eae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_616d80ce-5bcc-45d1-b13d-a3790b455eae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ac87b8f-fdfe-4b26-999e-69ffa9d604a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ac87b8f-fdfe-4b26-999e-69ffa9d604a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2d97a7e3-062f-4f25-bed2-000e9154201b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ac87b8f-fdfe-4b26-999e-69ffa9d604a1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2d97a7e3-062f-4f25-bed2-000e9154201b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended" id="id5f6f73d84e14f37a8761b95f6d9bbd7_SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_db06c504-bea1-48e5-8870-485da72f4301" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_db06c504-bea1-48e5-8870-485da72f4301" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a6f1ade0-8e23-4c3e-bde3-37e2de6b7b07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a6f1ade0-8e23-4c3e-bde3-37e2de6b7b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2d9142f6-9cd2-4734-ab3b-601b03824f85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2d9142f6-9cd2-4734-ab3b-601b03824f85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b0c75e28-bd67-4705-8361-507955498b79_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b0c75e28-bd67-4705-8361-507955498b79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1a7e798f-3d41-4be1-a85a-b9a25f51f7d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:to="loc_us-gaap_CostOfSalesMember_1a7e798f-3d41-4be1-a85a-b9a25f51f7d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SellingGeneralAndAdministrativeMember_9d410a87-89eb-4df4-b104-1bcd7340d680" xlink:href="isrg-20210331.xsd#isrg_SellingGeneralAndAdministrativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:to="loc_isrg_SellingGeneralAndAdministrativeMember_9d410a87-89eb-4df4-b104-1bcd7340d680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ResearchAndDevelopmentMember_61afd2b1-3cd6-48db-b94e-8395b88c9130" xlink:href="isrg-20210331.xsd#isrg_ResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:to="loc_isrg_ResearchAndDevelopmentMember_61afd2b1-3cd6-48db-b94e-8395b88c9130" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:to="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain_3f4092f4-6545-4536-a3ce-20b94cf06673_default" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:to="loc_isrg_ConsolidatingReportingDomain_3f4092f4-6545-4536-a3ce-20b94cf06673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:to="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesProductMember_f4857b0a-7a99-4e60-b34c-55c04b803fb4" xlink:href="isrg-20210331.xsd#isrg_CostOfSalesProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:to="loc_isrg_CostOfSalesProductMember_f4857b0a-7a99-4e60-b34c-55c04b803fb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesServiceMember_df9e1a61-fa60-4984-a694-cfe199e87250" xlink:href="isrg-20210331.xsd#isrg_CostOfSalesServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:to="loc_isrg_CostOfSalesServiceMember_df9e1a61-fa60-4984-a694-cfe199e87250" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="extended" id="ia2b959f6aa63485a9537b7b83549b9dc_SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4f039790-0988-4a83-9b67-d5c7615cde0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4f039790-0988-4a83-9b67-d5c7615cde0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e0dc9dc0-d0ef-4d98-8e20-4cc748068269" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e0dc9dc0-d0ef-4d98-8e20-4cc748068269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_84f21a07-b9c7-4d8c-bca6-fb127702908a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_84f21a07-b9c7-4d8c-bca6-fb127702908a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40bfdf2a-00ed-4994-84ac-74e0771e4daa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40bfdf2a-00ed-4994-84ac-74e0771e4daa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:to="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0df151d-4928-4852-984d-ad88e3557648_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0df151d-4928-4852-984d-ad88e3557648_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_27d5179d-7d19-44be-8393-fa8cc086cf4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:to="loc_us-gaap_StockOptionMember_27d5179d-7d19-44be-8393-fa8cc086cf4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_183fcf64-5449-42ae-a9c1-49fec139fde3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:to="loc_us-gaap_EmployeeStockMember_183fcf64-5449-42ae-a9c1-49fec139fde3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="simple" xlink:href="isrg-20210331.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="extended" id="i7085aab3f4f845d6b2c313dfc7d65899_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended" id="ia737f552edcd412ebbfa5f23945a5986_INCOMETAXESAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3c85c02a-ba80-4991-9ba8-547c14b8a265" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3c85c02a-ba80-4991-9ba8-547c14b8a265" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_84f4e311-58f5-43ec-8d19-7d23e8aac5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_84f4e311-58f5-43ec-8d19-7d23e8aac5cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_4d66b1c2-861a-4f18-9a56-c5919e7a92c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_4d66b1c2-861a-4f18-9a56-c5919e7a92c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_0f6104e4-7d11-4818-af1f-7d06f8fe8dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_0f6104e4-7d11-4818-af1f-7d06f8fe8dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_a116eed3-3ef1-4daf-b36b-8fff3eafb6da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_a116eed3-3ef1-4daf-b36b-8fff3eafb6da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ad7eefa6-e1b9-4698-9375-3fe8b5f1fcbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ad7eefa6-e1b9-4698-9375-3fe8b5f1fcbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_e5efd44a-a2ba-4184-b3d7-673937cbe4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad7eefa6-e1b9-4698-9375-3fe8b5f1fcbb" xlink:to="loc_us-gaap_ForeignCountryMember_e5efd44a-a2ba-4184-b3d7-673937cbe4e6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHARE"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="extended" id="i9e6eab5974fd43d6aab9771ff4c3a483_NETINCOMEPERSHARE"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHARETables"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="extended" id="i2e2acb5331bb4ccba350e3fc45e29d8d_NETINCOMEPERSHARETables"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="extended" id="i91a972ac487345feac085f71fc1a595b_NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHAREAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="extended" id="i8165b5944189467a812b3b7b7da2f1ef_NETINCOMEPERSHAREAdditionalInformationDetails"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>isrg-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c61f603f-ef4a-4d04-b56b-7269297a821e,g:dd118a18-5d47-4c1c-822e-29e196fcfd78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ffdc2142-d9c1-44eb-b839-83457489afaf_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6022c344-bf8a-4348-bd94-625dbc99eae3_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_96b82f0b-ac08-40ae-b19c-c37715a09d7c_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_08537dc1-54ff-469e-8eee-0d09574a89cc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense related to employee stock plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e14b71de-7ff5-4fdb-ae7a-9cec9fd6622d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3ff03212-8c9f-43c3-8bbb-43d643cda594_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_d87bdbb4-c67c-44b8-bcb6-baa2cb62d5d4_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_be2340b4-3450-40a8-82f1-a8bc5c4f7547_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8fe67682-51fe-4808-9562-68b84292a7a6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_b1b4b975-5ecb-4f1a-81f6-57f3e772611d_terseLabel_en-US" xlink:label="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_label_en-US" xlink:label="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Four</link:label>
    <link:label id="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_documentation_en-US" xlink:label="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:href="isrg-20210331.xsd#isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="lab_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_489126e6-2933-4a58-9dc7-ed40496dbd23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_9a6ab896-1fea-4034-9a67-62e1f8ef2e3e_terseLabel_en-US" xlink:label="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred payments and contingent consideration related to business combinations</link:label>
    <link:label id="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_label_en-US" xlink:label="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Present Value of Future Cash Payments</link:label>
    <link:label id="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_documentation_en-US" xlink:label="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Present Value of Future Cash Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:to="lab_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_7b31814c-09c2-4355-a8f3-6c73855be05f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition activity</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fa053ec2-7faf-4ef9-bd40-535a37cfca00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fb0a978c-b515-46fc-a475-fb507c23b23b_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_4d7fd588-deff-4219-8d3c-5d81e91f5c60_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2b1ed433-9027-41d7-8fcd-b077c8293003_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_eacf6a04-cb00-4d15-ab70-0de68573dc48_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_5a81eef2-27eb-42f3-8087-cc2d6a846717_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_bf04fc25-69e2-464a-987f-fb22e8cdd149_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost Basis by Year of Origination and Credit Quality Indicator</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable Credit Quality Indicators [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:to="lab_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_GoldmanSachsCo.Member_6e0b6050-4f16-4541-b75b-8546db8436e8_terseLabel_en-US" xlink:label="lab_isrg_GoldmanSachsCo.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goldman</link:label>
    <link:label id="lab_isrg_GoldmanSachsCo.Member_label_en-US" xlink:label="lab_isrg_GoldmanSachsCo.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goldman, Sachs &amp; Co. [Member]</link:label>
    <link:label id="lab_isrg_GoldmanSachsCo.Member_documentation_en-US" xlink:label="lab_isrg_GoldmanSachsCo.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goldman, Sachs &amp; Co. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_GoldmanSachsCo.Member" xlink:href="isrg-20210331.xsd#isrg_GoldmanSachsCo.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_GoldmanSachsCo.Member" xlink:to="lab_isrg_GoldmanSachsCo.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_0a480b2f-568a-47d1-9305-c800e12645db_terseLabel_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated total undiscounted contingent consideration</link:label>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_label_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Undiscounted Expected Outcome</link:label>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_documentation_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Undiscounted Expected Outcome</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" xlink:to="lab_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_ef826130-e586-44f5-ac44-b7aac41ecfd3_totalLabel_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value, Fair Value</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_label_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_documentation_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:to="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_3132a917-1d0e-4aa5-9d93-79db37832c6c_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_d657c30c-7b38-42ec-b923-6bc1f0bb0767_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short- term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6313d563-208a-46c7-8348-e2f2d7770984_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_301a99f5-eda9-4db8-98ee-8d80daa5d926_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding used in diluted calculation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_85d0afd2-c177-47e3-b207-0c8ab63fb756_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_b4d7f044-9073-4574-a3d8-24bb358fc887_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">excess tax benefits associated with employee equity plans (in percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_4b5d34f3-6081-480e-a6ed-a3d04588eddd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_20aed6b2-1b86-4bd8-8e5e-ee174fe952bf_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2131b9ac-7cd5-4668-b842-7e8e4d5f963f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7e4f3b28-7733-4ffb-9ec9-9685b16dd6cf_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_88099211-4af5-4d76-8df3-17385f1e317c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_7191c753-1727-4c0a-87d1-6d49f89e976e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contribution from noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_5e112b66-e3ac-4870-908b-e17bdaa7195b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_63b16ad3-c7e1-4c14-a28c-f030c36509c1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_97078089-2672-48c4-b658-cc5640d76f63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_dcd988a6-8dd1-4a01-a270-4d2c8002127b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4cd6c605-ecca-4fa7-82ee-3f7fc313292f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_db96c8ce-7b21-4e22-8303-493180d2e428_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_4a0f2ba5-b559-4785-bb55-b0fb4391d6f9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_be9c0c25-e17e-4a15-84c9-6c066aadcaf8_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_85e60de9-081f-40dd-883c-fca1f19e92e4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ea81fb6b-5106-443a-aa26-06cfdba2911e_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd1f2359-07e1-483e-9298-118ba54b87de_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_d365dcf5-81f4-485b-b0e4-154066510393_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_341af8e5-9a09-4499-bcc3-b48b8f0d8014_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes&#8212;long-term</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_20fad1f3-93e9-40da-83f0-9cbf4af2b597_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_b7b0fd72-6900-43e1-bd1f-acb2ebc7a613_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. government securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_763afd2b-18d3-4210-b8ec-1e228b800580_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_40a148ec-100c-4a75-9f70-fd5a4ad7ca18_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price allocated to remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_64469d32-0434-4017-b3f2-7326346b7c70_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_5920b56d-223a-4174-a0bf-d097a3fe3f10_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_db4450ca-92af-43cf-b184-1d583378565d_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_bd288145-168a-4548-9026-193dbfde63ae_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_43326f1f-31f0-4aae-9944-1f5dc8182895_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_477aad29-597b-4a79-88b9-4ad6c8674117_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_163682a9-9508-4218-ba6a-356edb4fae77_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 8)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_25049d4c-4686-403b-848b-4f640882dad8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_fc671dfc-2d0b-4739-832b-69344c027ab8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation and other</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d52de196-1613-49f4-b378-3f62d5768f73_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e72bd02b-8a0b-4069-93d4-50dfb97413db_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cc2f03d0-7ce7-491a-838a-e200792313d2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining amount of share repurchases authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ConsolidatingReportingDomain_a9144e9d-4ccb-476b-a3e2-34082b46a519_terseLabel_en-US" xlink:label="lab_isrg_ConsolidatingReportingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Domain]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingDomain_label_en-US" xlink:label="lab_isrg_ConsolidatingReportingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Domain]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingDomain_documentation_en-US" xlink:label="lab_isrg_ConsolidatingReportingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ConsolidatingReportingDomain" xlink:to="lab_isrg_ConsolidatingReportingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_facc21fd-c60a-497e-8da0-6270fa26b360_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b80df6e-558d-468b-a95d-1105ee2e5315_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, number of shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_fdde700f-a604-4906-bc1f-a76f32ba577c_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_19bda65c-4d6b-4b44-ab5f-11d7f8f3bfff_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of contract acquisition assets</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7afab94a-3439-4a01-a6d3-1b11a8fcab8d_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cb7cc29e-9a54-430d-9612-7326fbe41922_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Intuitive Surgical, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_dca42396-40ac-45b2-b1a6-9a995367e1b0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_IntangibleAndOtherAssets_c5a24bdc-ccc5-4434-a062-4b56cf875e4b_terseLabel_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets, net</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssets_label_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible And Other Assets</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssets_documentation_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssets" xlink:href="isrg-20210331.xsd#isrg_IntangibleAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_IntangibleAndOtherAssets" xlink:to="lab_isrg_IntangibleAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_45faa823-9baf-4287-96b4-c8a71c2779e3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligations</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_8be1e35d-1480-45cd-87df-6a6e7ea086c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred purchase consideration</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bb68bd1f-582a-4043-84c8-124f539bfb33_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_b9800e2d-b6d6-4f16-a377-bfb6cdb70b51_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_74ede314-323d-413e-8215-55c93f57b1cc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5be650a7-dcef-4ecb-8d42-cd23bc1820e2_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_e600d63f-bb61-4c91-a3a9-e7f7fe83a9dc_terseLabel_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Gains&#160;(Losses)</link:label>
    <link:label id="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_label_en-US" xlink:label="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Translation Adjustment Summary [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:to="lab_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_e67de30a-1afa-4aeb-a8b5-9d04dd775781_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_0a2cfe67-2ae1-4ed0-a3d0-599f853720aa_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Swiss</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_a197a4a1-442b-4665-8cc2-a4874a8d564d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_e42c8d54-f08c-4ef9-b634-5ad456064c49_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesMember" xlink:to="lab_us-gaap_OtherLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_7f5fa881-0a0a-480c-a4e0-2c74795effae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_d02e3f26-9d97-4a00-b348-a8d94bf36e81_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6d6f69b8-85cd-4334-916d-2883d9c8bfff_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_0f04f37b-b04b-4713-917a-9946a339dcf8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess tax benefits associated with employee equity plans</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_605f90b7-fe11-44e8-8b7a-c8dffea48b03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9f05333-ba14-443f-8869-e08f9c666fb6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3681502e-d0f8-41b3-8e44-220816537975_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_7b64d221-cb96-4306-9202-74b6403cbcbb_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales/Purchases/Others</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_label_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:to="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d3b01a31-6443-4b54-8767-7adac1b4229e_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b4c55bda-6276-4732-a17d-6fcf0c84a2c5_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c388ad51-7d77-450c-879b-01124782835c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_e90b2fd1-3e38-4e51-bdbb-b97e7148fcb6_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4402e8a1-8be4-4ffe-a9ae-37310a452bdb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_7e4c00ba-537e-4dfd-a9ef-6d3d9b7aa8da_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_50638e3a-2eca-4fd1-af78-a74ab3d7697e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_93e5bc5c-4dac-4aa1-ba2d-5cee6205514f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_255f1a6d-cd85-49cb-9dfa-981a16878607_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Disaggregated by Types and Geography</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent_853139ad-0c7b-44bb-98f3-f7cd97683dd9_terseLabel_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of deferred purchase consideration payments</link:label>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent_label_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase Consideration Payments, Current</link:label>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent_documentation_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase Consideration Payments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:href="isrg-20210331.xsd#isrg_DeferredPurchaseConsiderationPaymentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:to="lab_isrg_DeferredPurchaseConsiderationPaymentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_282df0e8-9a69-4788-af00-45227c82c124_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_75971799-34ae-458b-be11-20358795d5d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_303a545a-54d6-46d0-96a5-f4be6af4cd74_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Available-For-Sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a1c6ccaf-19e2-4d1a-a487-cd6e10b98e72_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_09f89482-887b-41f4-8239-a5945278f3cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b756e29d-0f1a-4507-bb78-8533b4a70ec3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4178b116-0c14-4c4a-91f1-4b724c5de6f4_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income attributable to Intuitive Surgical, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e4dd7ce5-8dbe-4dc7-9aec-703d9b005a53_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f7abd872-f139-4873-8444-bc1bb17791c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_60b06b0b-9b02-4160-8750-42ed6fbdda39_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_1660ee9b-3419-40b7-a07b-e239a8e78854_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue&#8212;long-term</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5fcd1015-f49f-4a38-84d6-4818d1c2d38c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_6bbc3375-dff9-4ae6-8284-a7a9011aa956_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_0469dbe9-bbdb-4935-8e67-006e3d0db82b_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated Two Years before Latest Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4bdf57f8-3fd5-4571-aa76-df1647f5549c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d8eae9f3-9b15-4cde-9a76-8c66f288b42d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effects of acquisition:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_43b0ef18-cecf-4b27-b36c-04276302312d_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_86f7fbbf-fe83-416f-a1c0-7265ebf1e63b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_818f2528-b00e-4466-8186-525678d4d51d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9172442e-2fdc-4c2b-b16b-dff8d3042a22_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2146da8b-06bb-4a63-9173-76128d86d6d8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_bb6475e3-397c-40f0-9625-16d04452f2ed_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9487b4c1-e0e2-491b-8d00-b1964ab26191_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccelerateShareRepurchaseProgramMember_569244d7-1d8f-4fd9-97b6-b2e0dbfffc45_terseLabel_en-US" xlink:label="lab_isrg_AccelerateShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR Program</link:label>
    <link:label id="lab_isrg_AccelerateShareRepurchaseProgramMember_label_en-US" xlink:label="lab_isrg_AccelerateShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerate Share Repurchase Program [Member]</link:label>
    <link:label id="lab_isrg_AccelerateShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_isrg_AccelerateShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerate Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccelerateShareRepurchaseProgramMember" xlink:href="isrg-20210331.xsd#isrg_AccelerateShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccelerateShareRepurchaseProgramMember" xlink:to="lab_isrg_AccelerateShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock_4bf5ce14-16cf-40b4-9e5b-5c510f64af9d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Receivables</link:label>
    <link:label id="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leases in Financial Statements of Lessor Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_92185716-80be-48dd-ba2c-1f3da36b0c02_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d637556a-178b-48b8-b6f1-8ace3669b830_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_1dae4858-7773-405a-8a3f-4ba7b0094285_terseLabel_en-US" xlink:label="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net tangible assets acquired</link:label>
    <link:label id="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_label_en-US" xlink:label="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets</link:label>
    <link:label id="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_documentation_en-US" xlink:label="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" xlink:to="lab_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1b12b871-9581-4365-a961-6752b8fceff7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_9cc1f2ba-d3e7-4726-8a78-cb9cc4898cc9_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_7c6d0db0-b95a-41cc-ba30-3536cbc07928_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2aa109bf-bc6a-46e5-963e-edec583aee46_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_64554e0c-11ee-44da-8e11-521c7239dc2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_e0499a28-34dd-4b50-acdd-c8cff4f15150_terseLabel_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in undiscounted expected contingent liability</link:label>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_label_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Undiscounted Expected Outcome</link:label>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_documentation_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Undiscounted Expected Outcome</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" xlink:to="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7eba5708-07c4-46cc-a9fa-adaf90e43744_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_27d01aec-5c8a-40b8-8a97-0e50d05807c1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_6a7f5c14-4140-479c-8495-73c7a1c7540c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a831dafa-83f6-4e2c-9e77-c2b1accecd01_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fd0f848e-e896-4a91-8b41-67ade2e5e027_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_d1e1622d-aaac-4ab3-895f-359413233daf_terseLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in income tax expense</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_271851e1-4040-4acd-b2b1-62082f1a9849_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_d5baab30-7108-4f03-a209-d8952dccb5b6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_1cba640d-8999-4818-bfb9-94a6bb46d8fb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock relating to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7bc7f81a-936d-4fb0-9249-3643c266194f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_7ce4182d-7887-4e9f-93ae-2020f274286e_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_c9fba74a-8f0d-4ba3-ab6e-4c3524a02d87_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bd899d79-9b11-4828-a355-72466100e692_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_46fd7d84-305f-4b3b-9ffc-4d63bcd563a9_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated Three Years before Latest Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_879554ea-b3d4-4dc5-9a50-0d644329b670_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Intuitive Surgical, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_8c7a1035-f3b2-4cef-8cc5-2123ea76fe95_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Intuitive Surgical, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_5a2fe162-787c-4140-b93b-8c201ed7c9b0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_517b39bc-d093-487a-a185-8af73cfe91b3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_f51fb610-0f6e-452d-ac02-6fb91f64c06f_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeasedAssetsLineItems_d8a18395-cf01-4617-9d81-48e8b509871b_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_CapitalLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_CapitalLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems" xlink:to="lab_us-gaap_CapitalLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_ca2daf52-fed3-4542-8ceb-b6a3804bf370_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_e6033f70-9fcc-4683-89a9-db6c0d76e763_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e02de3f5-6d0e-4510-837c-886129acf529_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_01aaa75c-8ffc-40e3-bb4d-7d39a998b042_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_fcf56520-98aa-4093-b1a9-28b4a0acab5c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_4f656e1f-60e5-4fac-b4d4-272597cc0a42_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable value beginning balance, Carrying Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_fe9e54b7-57e9-4bbd-a5d4-dcab49eb34a9_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments with readily determinable value beginning balance, Carrying Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_7c164807-910f-4b4e-8064-4cd2496add50_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_f9318acc-83c4-49a9-9aa9-f030b69a96f4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized gains/(losses) in Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_ff3ff2e7-5710-4961-8202-0e6a59e90d2e_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated Four Years before Latest Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_2fcfcbf6-f6b6-459c-a31c-e5918c56d137_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_e0dcfba4-1370-4ffe-9328-139db6cfb61f_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8958a320-51f9-42f6-8921-dfddcb8e0b35_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_40486df6-e3a0-42c8-92d1-194893a4e902_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d88da261-023e-4349-a18f-76557fff6625_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_946fcac1-8444-434a-b796-fa356ab6e06a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_6a66ead7-4c1c-4e7e-bdbd-3b6fb9b04470_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_fd0c109b-dc4f-47e4-95c5-d476de3287ac_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ConsolidatingReportingAxis_ff099f4f-55b2-4907-97a5-b277db416b16_terseLabel_en-US" xlink:label="lab_isrg_ConsolidatingReportingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Axis]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingAxis_label_en-US" xlink:label="lab_isrg_ConsolidatingReportingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Axis]</link:label>
    <link:label id="lab_isrg_ConsolidatingReportingAxis_documentation_en-US" xlink:label="lab_isrg_ConsolidatingReportingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidating Reporting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingAxis" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ConsolidatingReportingAxis" xlink:to="lab_isrg_ConsolidatingReportingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_8d499527-57e2-4fe9-8028-cb74df27d494_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_80dbc04d-ee8b-4a88-80a0-f51cc0f8d918_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_7e5f52c8-d3ca-4785-baf1-d2ca40e7c894_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_5113c634-566b-4348-bf6e-47d2bb38dfcb_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense before income taxes</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_997f4f99-8459-4c39-bfa6-18a8465c3ad7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_708f3d74-a3fe-4a37-b948-62b416480d0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_b6d90ace-97eb-4610-a384-c76749894ae2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_fc961d7c-a377-42c4-af05-712a21391206_verboseLabel_en-US" xlink:label="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment in sales-type leases &#8211; short-term</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_label_en-US" xlink:label="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Current</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_documentation_en-US" xlink:label="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:to="lab_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a19b7b38-647f-4c19-bc39-731e1c759ac8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_8c1743da-f4ea-4600-835c-eec891b50afe_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4f0d1f4f-2f47-491b-ba73-9d020229eec1_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPayments_98553d47-3114-4651-bea1-57ebe16baf0e_terseLabel_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred cash payments</link:label>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPayments_label_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase Consideration Payments</link:label>
    <link:label id="lab_isrg_DeferredPurchaseConsiderationPayments_documentation_en-US" xlink:label="lab_isrg_DeferredPurchaseConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Purchase Consideration Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPayments" xlink:href="isrg-20210331.xsd#isrg_DeferredPurchaseConsiderationPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_DeferredPurchaseConsiderationPayments" xlink:to="lab_isrg_DeferredPurchaseConsiderationPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ManufacturingProcessTechnologyMember_a480d7ef-08bc-403b-b85f-0e29f7d55bfa_terseLabel_en-US" xlink:label="lab_isrg_ManufacturingProcessTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing process technology</link:label>
    <link:label id="lab_isrg_ManufacturingProcessTechnologyMember_label_en-US" xlink:label="lab_isrg_ManufacturingProcessTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Process Technology [Member]</link:label>
    <link:label id="lab_isrg_ManufacturingProcessTechnologyMember_documentation_en-US" xlink:label="lab_isrg_ManufacturingProcessTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Process Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ManufacturingProcessTechnologyMember" xlink:href="isrg-20210331.xsd#isrg_ManufacturingProcessTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ManufacturingProcessTechnologyMember" xlink:to="lab_isrg_ManufacturingProcessTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_6916710f-52a3-4a30-b49b-06d649e0a153_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_21dc054f-6389-418f-bd29-220726c1ef9b_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final average price per share paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Final Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_16f4c5f4-4f01-4c96-90b5-6fcc37ccad0a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b3f24ee2-ae0d-4118-8a10-79acd2944d60_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_26450f56-4eca-4d1e-ba09-89e8f7fc2e16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b7f5f7f8-aa26-4e22-bf96-a0688653094e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value at grant date (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3d404903-2603-47be-b43e-7ed0b6656b64_terseLabel_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting standard</link:label>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_documentation_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_ad52affb-b000-4801-812a-107448167d1e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_8d93f1a2-b4a5-4e66-bb72-ed2080e5fd27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_b6cec4b5-a67a-4208-a40b-dd55d7e06bc9_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_0bc16aa4-7997-49f7-8c67-1ca6637f169c_verboseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_c0d2aa87-06d4-48df-bd9b-98dac9f09504_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_258232ee-7f52-4d45-9c06-7b046c23776e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_02601f68-4a45-435e-b313-bc4c353feb69_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis_071b3c3a-d561-4dcb-a079-a76eb103faaa_terseLabel_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis_documentation_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_isrg_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_05ce7201-2ec3-42a9-ada8-72095811d5d2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_d23ffb3e-4f44-4a4e-ad0c-4b072f9a0209_terseLabel_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains&#160;(Losses) on&#160;Hedge Instruments</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_label_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax [Abstract]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_documentation_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:href="isrg-20210331.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:to="lab_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1d88f7c2-2788-466d-aa2a-dd7577a47488_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net loss attributable to noncontrolling interest in joint venture</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_df991e85-5d2f-4f1b-b653-0ea768f188b1_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interest in joint venture</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5b13ca27-c0d6-44ac-8802-5e9103a971ea_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7a58d46b-368e-4cab-8622-c8a277f08e21_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dbcbf7cd-e76d-407c-ab52-b1cc72018621_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_08026108-1956-49a7-a9da-8416e2fd5b8a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_078a2865-9dc1-44d1-987d-d95c6d55d5fd_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation related accruals</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_ea06c6e0-80b0-43e4-ae4a-7af2fbcfdb7f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_cf89f59c-c3e5-4cf8-b514-180763bde14b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Other than Long-term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:to="lab_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_97a8611e-f153-499d-a03f-388ceb4dbfa6_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5a6efb91-3c02-4d71-af66-cea968d3b487_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_cedcde4d-8241-46cd-b0ca-3f64ecf44a22_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2f8cd5d1-675c-4bbb-a530-27aea9208c33_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_624c1a7f-7a1a-4352-8f11-7a800af57405_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_0957f82a-3168-4324-b606-8e37916fc99a_totalLabel_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value, Amortized Cost</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_label_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_documentation_en-US" xlink:label="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:to="lab_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_623b3ca1-b756-4f1e-9e06-934370e94b3b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of contingent liability</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6e6a33c3-dbb9-490a-8637-9da8de75da89_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_da5f6967-5aa7-4d4e-9a7f-44dc000ca8c5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalesTypeLeaseGrossInvestmentInLease_4edd5254-9fcd-493b-b283-ef54a65d1f9e_terseLabel_en-US" xlink:label="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross lease receivables</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseGrossInvestmentInLease_label_en-US" xlink:label="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Gross Investment in Lease</link:label>
    <link:label id="lab_isrg_SalesTypeLeaseGrossInvestmentInLease_documentation_en-US" xlink:label="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Gross Investment in Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:to="lab_isrg_SalesTypeLeaseGrossInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b06d36a4-c583-41b5-bd96-4e0ee958e15b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ed2e26db-93c2-4466-a536-8324253a7cb8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b7523ce-2c4a-4628-bdaa-ce8f2809db64_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_be34a5d2-20cc-4788-8478-e29b1396695c_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_34ba0084-6450-4a19-a6c9-82c75169cc4d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f3881c75-ca5f-41e4-ac56-5b3e78fcd2fb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f0c70a71-0eae-48bc-91f3-707ff3177a2b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1c01388b-75d8-4cb8-8a56-184d51ba94ee_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_f163160a-7fcf-4619-8ccd-62ba3a80e700_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental non-cash investing activities:</link:label>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_048ec6cc-2a60-4914-9c45-7829c09867d3_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_c043f1ef-13d3-43f0-b962-a40ce00fff4a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_9f9bad32-f539-426a-bdfd-2a30c6cf6d1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_d44a2372-30c7-4d3a-8c74-525796d63349_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside of U.S. (&#8220;OUS&#8221;)</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionForeignMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Foreign [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionForeignMember" xlink:to="lab_us-gaap_GeographicDistributionForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_59f9e59e-5291-4e50-b78f-f0a6d5615d3a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">I.R.S. Employer Identification No.</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_5d492598-d90f-407d-aec8-5ac5d81ae451_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8703b39e-62d7-40fe-9ed9-efd5f9790ab9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_ce5074b7-62a6-4a3c-970b-fdebfc167617_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5adc42aa-4c05-459a-8164-8b56e9244a54_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol(s)</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_52f15198-2653-4aae-81ff-fbb961d14498_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_53cf48ff-e855-44a4-b713-99eb0decf664_terseLabel_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net additional expense</link:label>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_label_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Expense</link:label>
    <link:label id="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_documentation_en-US" xlink:label="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" xlink:to="lab_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncome_fc5e94a1-2de2-4e92-a752-df4873b95fb2_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type lease revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseIncome" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_a769fd41-f0bc-41d8-bcdf-2f4eae05342c_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest in joint venture</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_7988ad07-89d3-4fe4-8d86-fefd0d48df9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_700c038e-2c6a-47cb-a286-8d4a5dabf54d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_38bea25c-4432-48c3-ab0b-da1d445605e4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_6c28395c-cb43-4af1-a349-39ad755f3025_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_b77f54b4-02ae-4461-b4a4-5f294a2e7fbf_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_74dd7fcd-48be-4646-9bd3-f7f99adcbcbe_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_3d71ab45-023c-4705-8ef4-28c8a937d435_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_45980e05-425b-498f-a6c9-eacc445d68b9_terseLabel_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Exercise&#160;Price Per Share</link:label>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_label_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_documentation_en-US" xlink:label="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:href="isrg-20210331.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="lab_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9886c79d-dc24-4c93-b81b-a3074e71e72a_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c15424c4-d7cd-40cf-b394-cc4e966e1546_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_8cfcf702-8579-4a21-8871-ca0e1faa003d_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_37d7b1af-72d2-452a-b5e9-0489024e9c93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity Under All Stock Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_d9e93479-f97a-405c-8030-5325ba9c2608_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant, and equipment and intellectual property</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_014da621-0c53-48e7-ba2a-c37a5962137f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_b36f773e-c65f-4352-824f-a5d92aec6d44_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_268b0b9a-023d-48de-a4e5-616006d2d739_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_3a5ef7fd-28cb-48e5-b218-70188377026a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6be4dd8c-1599-4023-bb6e-596a4ea4ec91_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_977cbdef-b602-4b48-b7f7-c3f9e9438fb4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_44cee537-03b2-4ff8-9d07-c36a11855c45_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward_846c50c9-7d8a-452c-80c9-61672bb06fec_terseLabel_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward_label_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward_documentation_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:href="isrg-20210331.xsd#isrg_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:to="lab_isrg_AccumulatedOtherComprehensiveIncomeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_68423149-de62-4dfb-9b55-4e01a63030c4_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_b28def50-aa7b-45ec-8c18-bef1cb5917db_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f56c1ae6-8fb3-4dc1-a807-f2760d7d356a_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_22f24ff5-574b-4ad8-b2c6-9c7a50736700_totalLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_d069d32a-6d0b-48aa-9877-2ad1709243eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d2677c37-9086-4c76-bee5-65e06f1ab08a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_94106c94-fe62-4212-b559-e206f44949d4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_98ee02b6-6858-4c33-a485-e4faa3bb05c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, weighted-average exercise price (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_9c026837-d540-47fe-8a37-d5e56c1da6ac_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, number of shares purchased by employees</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_be111313-2729-4584-abc8-f0b3a685826b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gains/(losses) related to balance sheet re-measurement</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_54e4691e-ca5f-4a1a-92f5-57b06a996e72_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_be93b827-d98a-4609-b377-0b9708dc197a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_IntangibleAndOtherAssetsNetMember_0c8bca74-7258-4a29-80d6-f5e773d69624_terseLabel_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and other assets, net</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssetsNetMember_label_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and Other Assets, Net [Member]</link:label>
    <link:label id="lab_isrg_IntangibleAndOtherAssetsNetMember_documentation_en-US" xlink:label="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible and Other Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssetsNetMember" xlink:href="isrg-20210331.xsd#isrg_IntangibleAndOtherAssetsNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_IntangibleAndOtherAssetsNetMember" xlink:to="lab_isrg_IntangibleAndOtherAssetsNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_12d1980c-85d8-4b11-afd2-f34ed8a5c1e1_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_9fbd0ea2-0284-46d9-9270-2c9b6639337a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Intuitive Surgical, Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_fab12842-aed8-4757-b3ad-8e28e056fb7e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_0dcff4e6-ac9c-4ca3-a47a-e0fb9c234f0a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f89cabd6-3087-43cb-afb8-5bf8e1ab8119_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_49465f78-9711-4236-9aff-0b4e748b8fd1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_830fbb0c-5b79-4296-8295-9bf757a6aefe_terseLabel_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses)&#160;on Available-for-Sale Securities</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_label_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax [Abstract]</link:label>
    <link:label id="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_documentation_en-US" xlink:label="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:href="isrg-20210331.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:to="lab_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_44fd2ad1-5f97-480f-a36a-0abfefbc19ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchase Activities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_b62b95b9-0cac-4046-9e1f-09736780a45d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_03fdcb7d-e45b-461b-98a1-eacbc6d41880_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_1bcf0c02-54c6-4be9-b04f-1436fe17b13d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_e1c044dc-87c4-4774-9c1e-366c733cb81a_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense after income taxes</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_ba466b80-bacd-4af8-84d6-7f2d1ca2e046_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated Five or More Years before Latest Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_5b2d2af3-ecad-4806-ad0b-36398be17c61_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation and Joint Ventures</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_a96b58a3-ace5-437c-8299-8011e3dd099a_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomesticMember_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomesticMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution, Domestic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomesticMember" xlink:to="lab_us-gaap_GeographicDistributionDomesticMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_c8755385-d64c-4587-aebe-266c081b2f3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ec305b07-0c7d-4ccd-845b-07a48b1436c6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income, Net of Tax</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a6bd8278-a8c2-4fbf-8257-97d5de57cc3c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7488493e-7f32-421f-94c4-423cf3a31995_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Estimated Future Amortization Expense Of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7ad532e1-5b40-4f8a-babd-cf989da7ceef_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_4cd61098-33fa-4d5d-b7e6-5b8bacd953c3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_d5c266d4-cc94-40c1-a423-85b6b09e86a7_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF THE BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_8d34907e-5904-4dde-b73b-ae56d5453a1a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_40e86e34-2350-40eb-9ecb-ed18e07043d1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2196c6b6-2dc1-4a8b-bf19-d8741a78b664_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: dilutive effect of potential common shares</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_62cf27b2-13d2-4184-b696-3bad1f9da22c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in one to five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_cad288d2-c59a-423e-b381-506e4e5f9e82_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_4d7ef20f-d201-4441-a8be-575d38c1b121_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_72081197-73ca-4c27-80af-cf62901a097b_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs capitalized as contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_2d973288-a68a-4931-9d58-8cbfa0e8a343_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Transfers and Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CostOfSalesProductMember_446ddb1c-c364-4c16-b548-7b2b210519d2_terseLabel_en-US" xlink:label="lab_isrg_CostOfSalesProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales - products</link:label>
    <link:label id="lab_isrg_CostOfSalesProductMember_label_en-US" xlink:label="lab_isrg_CostOfSalesProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Product [Member]</link:label>
    <link:label id="lab_isrg_CostOfSalesProductMember_documentation_en-US" xlink:label="lab_isrg_CostOfSalesProductMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesProductMember" xlink:href="isrg-20210331.xsd#isrg_CostOfSalesProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CostOfSalesProductMember" xlink:to="lab_isrg_CostOfSalesProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_4946623b-721b-495b-a3b4-b9f7ce9697ba_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_ff5e16f3-5b9c-4423-897f-34ddcfe3b8f5_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated in Current Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_8479ea4a-7930-402a-84a3-98b4e0625c52_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Details</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_acc37c03-ae86-4a18-ac6e-f0c380df45a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:to="lab_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_05c46270-64d7-41bc-b9bb-5cac68145ec0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_6dd96693-f32f-4320-baf4-bc90896d4273_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_2e1b06a7-7cac-42b5-9778-3ad06a39725e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3e5b521c-c77c-45f6-8dc4-bfa909e56dae_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CommonStockRepurchaseProgramMember_1422d61a-e6c4-4635-8738-4fc85a20fd24_terseLabel_en-US" xlink:label="lab_isrg_CommonStockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Program</link:label>
    <link:label id="lab_isrg_CommonStockRepurchaseProgramMember_label_en-US" xlink:label="lab_isrg_CommonStockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Repurchase Program [Member]</link:label>
    <link:label id="lab_isrg_CommonStockRepurchaseProgramMember_documentation_en-US" xlink:label="lab_isrg_CommonStockRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember" xlink:href="isrg-20210331.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CommonStockRepurchaseProgramMember" xlink:to="lab_isrg_CommonStockRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_c1d76e21-5844-42a7-9131-4bd760715d66_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_573cf525-69d3-4b17-9dbf-972a164549e6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d61da3dc-93a7-4a8a-85e7-76e8b1404c6e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7347c67c-f5a9-4108-b16c-90aea8e27d87_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_bc829130-9e5a-4bed-96c6-dfd194a00414_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_8674c7d1-9029-40cd-bcbc-cf1dd9737162_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e4c7aa69-1c32-42ef-bce6-94c33a6eda9a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_87137422-53fc-413a-8cd5-27c40d631598_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of outstanding currency forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_8fb368ed-af29-41de-904c-96221c4c1cdc_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_1db1c8a7-e9e2-4759-94df-d94477bec633_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8c604ae0-8e46-4f85-908e-a87ee2e5d5d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2c2e44b1-e69d-44e4-9b34-ebab9705ca21_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b692e413-c31a-4ead-83d1-9fe348a74bb3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_886dcb60-613e-4b72-abec-908c718e1017_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_ae8591b9-a7a6-4dda-99a1-3faee225d497_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ResearchAndDevelopmentMember_2d30d829-3e5d-453b-ab53-3d534ee7daf3_terseLabel_en-US" xlink:label="lab_isrg_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_isrg_ResearchAndDevelopmentMember_label_en-US" xlink:label="lab_isrg_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:label id="lab_isrg_ResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_isrg_ResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ResearchAndDevelopmentMember" xlink:href="isrg-20210331.xsd#isrg_ResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ResearchAndDevelopmentMember" xlink:to="lab_isrg_ResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_401bc832-e4cc-42d6-9303-a33140aaf0f8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_96d944c7-1bc1-456e-bd9c-753583e2df28_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseReceivable_a138a110-e40b-4a60-8315-4b6c5af1c9a2_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross lease receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_16ce388a-b61e-490a-b4e1-ce59a44fed6d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_3eb76f25-da10-4d46-a7bd-4f4d1ecf2890_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Joint Venture</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_a982d0df-33b8-44fb-86db-fc8386f6226d_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_16976582-d944-486f-abf2-c07db51fddec_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Equity Investment Activity</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_0f044f9a-55e0-485a-89a4-eb6896b29339_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_49bfd01f-4b37-4f43-8942-307c37cbf825_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_80af8399-1f5a-49f4-a08e-1df619c1a92b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_7ec2663e-b316-4096-89ed-21655d8801d9_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited/expired, Number Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_24254163-d8cd-4063-ba92-da3f614155f3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_8e2ee4e5-311a-4a9f-b6f1-031d047eaca1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_bf215a4b-93b0-4a63-90a1-6a00cb7dc5db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b459194d-cb30-45e9-872a-5f7c2c24a5fa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_50fbb377-b449-475f-a5ec-6ff39955ecc3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_f5356cb1-5baa-405a-be56-7015e1b46f08_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_4c0e3638-4166-4cea-b9d8-c23e2c1e36c6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_6ad745f5-6016-44bc-8411-9d98cf7c469d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_89751da6-bef5-4bdb-bbc4-1e5adfeaa1e0_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionDomain_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionDomain" xlink:to="lab_us-gaap_GeographicDistributionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_46ad5e1f-e91c-4765-a013-68edb592df29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_5daf9881-e3ad-48cf-b91d-1c5656182085_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1_d3a8341a-b3e1-4542-97d6-8be00f89b0d7_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type leases terms</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:to="lab_us-gaap_LessorSalesTypeLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_383449f2-fca3-440f-a71b-ed3c0779c8bb_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease Revenue</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain_ec3de557-5ec4-4fc1-b909-b1f9df0bc33a_terseLabel_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain_documentation_en-US" xlink:label="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_isrg_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_19f7a68c-8479-40b1-9e39-5c2e28237daf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_5612d370-0473-4508-9ac4-6b65bcd2c962_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited/expired, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3385ef0e-a874-451a-ad74-301afedaadf0_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_aa6fda6b-5e3e-453e-9a75-a8556f6ad4fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_57134bb1-964c-4984-b284-5ba9a3fae618_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_549a1eeb-e066-4002-a4e2-8f811e7b9e83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_57d08a76-d694-4220-8624-93da9083709d_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_98563043-16ec-400a-9ba8-eda1c0018d82_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_2efec1f5-df53-47b5-a5bf-180e2b975755_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b4fcbbb6-8c0f-4c20-af5c-f94349c27096_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock through employee stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6bce9101-926b-4e77-93dc-2c73365cbe7a_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bfa7b840-ba5e-4a5c-9ae4-e1eeeceb22e8_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d570fb7d-c697-4214-b363-dcca354aef1a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9effe5ea-2697-45d8-8c27-e9703ebbfa66_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_A2010IncentiveAwardPlanMember_af9152a8-ebf7-4936-9370-913b844eb3a0_terseLabel_en-US" xlink:label="lab_isrg_A2010IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Incentive Award Plan</link:label>
    <link:label id="lab_isrg_A2010IncentiveAwardPlanMember_label_en-US" xlink:label="lab_isrg_A2010IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Incentive Award Plan [Member]</link:label>
    <link:label id="lab_isrg_A2010IncentiveAwardPlanMember_documentation_en-US" xlink:label="lab_isrg_A2010IncentiveAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Incentive Award Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_A2010IncentiveAwardPlanMember" xlink:href="isrg-20210331.xsd#isrg_A2010IncentiveAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_A2010IncentiveAwardPlanMember" xlink:to="lab_isrg_A2010IncentiveAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ac88f563-2658-4667-a54e-af0bfab0ae82_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_26374e11-b4fb-49c1-9f33-6882d19c9df3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_ffc39861-e0d9-43d0-bcab-1a7e68bb0352_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales/Purchases/Others</link:label>
    <link:label id="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_label_en-US" xlink:label="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Sales, Purchases and Other Adjustments</link:label>
    <link:label id="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Sales, Purchases and Other Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:to="lab_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_dd28d46b-0117-4cb0-9df4-f6f428fc39e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_db825bc9-c6e3-4439-a92f-e0c0e5322e34_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3ef8206d-76a2-48ae-a3c3-f54aed7401d0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_592b06b6-904b-4a6e-b1d1-e949f9fb187d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5623235-72ac-4526-9077-2c7e58eac8c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_HighMember_1cf466c3-f666-40cd-8f63-daf07dcc9d21_terseLabel_en-US" xlink:label="lab_isrg_HighMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High</link:label>
    <link:label id="lab_isrg_HighMember_label_en-US" xlink:label="lab_isrg_HighMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High [Member]</link:label>
    <link:label id="lab_isrg_HighMember_documentation_en-US" xlink:label="lab_isrg_HighMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_HighMember" xlink:href="isrg-20210331.xsd#isrg_HighMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_HighMember" xlink:to="lab_isrg_HighMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c9e2ebf1-8e53-4853-a04d-3de2643379e3_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable value, Carrying Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b97bb3f4-9521-4ed0-ade2-e3a681955a56_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments without readily determinable value, Carrying Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SellingGeneralAndAdministrativeMember_b6f9c0ee-4309-418b-9ab3-12656e780ec7_terseLabel_en-US" xlink:label="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_isrg_SellingGeneralAndAdministrativeMember_label_en-US" xlink:label="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative [Member]</link:label>
    <link:label id="lab_isrg_SellingGeneralAndAdministrativeMember_documentation_en-US" xlink:label="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs related to selling, general and administrative activities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SellingGeneralAndAdministrativeMember" xlink:href="isrg-20210331.xsd#isrg_SellingGeneralAndAdministrativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SellingGeneralAndAdministrativeMember" xlink:to="lab_isrg_SellingGeneralAndAdministrativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_78580264-fba6-42f3-a273-96ab963a3ddd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_986068aa-991c-4ac3-ab98-e9f4eb927ad6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contract Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset and Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_34df2549-30a0-4ce1-b8dc-6eb614859c3a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_5dcd13c1-d55f-4fbd-9f0a-d393fbf33a67_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_6aa5b6a7-bbe3-4aa3-841a-96f6748552ca_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_5673bbf5-118e-4439-9fde-44a8f4ed1b28_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other accrued liabilities&#8212;short-term</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_749e006c-35ce-4160-8ebc-228085026514_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_LowMember_1c633392-41c6-43aa-8829-298736b5452d_terseLabel_en-US" xlink:label="lab_isrg_LowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low</link:label>
    <link:label id="lab_isrg_LowMember_label_en-US" xlink:label="lab_isrg_LowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low [Member]</link:label>
    <link:label id="lab_isrg_LowMember_documentation_en-US" xlink:label="lab_isrg_LowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Low</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LowMember" xlink:href="isrg-20210331.xsd#isrg_LowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_LowMember" xlink:to="lab_isrg_LowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_5e008a97-4c55-47f9-8696-a9ed20eb3b70_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5d8ecaf6-7e13-4e13-b25f-f5d3b6397592_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_2bd484b8-c6b5-4bce-b0df-53d71cdeee46_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE AND CONTRACT ACQUISITION COSTS</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_ae6d4d58-8b98-4db5-bd6c-cc475aa0c174_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5a8b8292-4875-4add-962a-42971e7a05fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_4f8cfe31-0b98-4271-8974-ae38ba26cc8d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_be07bfd7-424d-414e-84fe-67f6721dea21_totalLabel_en-US" xlink:label="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_label_en-US" xlink:label="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities Fair Value Total</link:label>
    <link:label id="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_documentation_en-US" xlink:label="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available For Sale Securities Debt Maturities Fair Value Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:href="isrg-20210331.xsd#isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:to="lab_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_4294f8e5-086a-46f0-995d-b697554bea2d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_97b6b7fc-834c-436d-a631-3850199ac88b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_3f86ca2b-0620-45f3-a602-250a6e41e124_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_7b67e7e1-5f4d-4089-be3a-4e332b972664_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3eddd1b9-ad65-479a-8b18-7049061442d3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_10dfcea7-5a23-4b86-965c-e6e16d4b68cc_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_598fa124-e012-455c-97e9-46077c9206e2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_38ca51f2-ba94-4bae-ad23-9d7f2aeeb2e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_dbad1ecf-68dd-4760-b12d-1184a398fb70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f7274c95-a37d-432c-a386-d9a238f21841_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_1ea17494-10cb-4700-83d1-0de9a6cc9d5b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_a8164ff2-b465-4957-b420-23fc45bcaf42_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_26ef6f99-2cc6-4d98-b418-4a826b59cd7d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3cc42e41-5204-48cc-ab06-33e530d2cecd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_bacd14ca-baa9-406e-8519-adbbf26488e4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_cdf570b6-b189-45b1-be98-db36434c16ff_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_886ba721-f5fe-4955-bd9a-eced043c77b7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_fcabb165-bd31-4fcb-9353-3a42b3845481_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_b6794211-bddb-4964-8b55-b281eb3da314_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_437ac24e-49fa-48cf-8c73-8a83b845abdc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_07035198-e489-45bf-99cb-5099d2015064_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_baea83fd-5ac4-44ab-b4fa-2701efb6c141_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CostOfSalesServiceMember_2fa50e71-9c05-4382-9dad-9fa7bb25e351_terseLabel_en-US" xlink:label="lab_isrg_CostOfSalesServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales - services</link:label>
    <link:label id="lab_isrg_CostOfSalesServiceMember_label_en-US" xlink:label="lab_isrg_CostOfSalesServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Service [Member]</link:label>
    <link:label id="lab_isrg_CostOfSalesServiceMember_documentation_en-US" xlink:label="lab_isrg_CostOfSalesServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesServiceMember" xlink:href="isrg-20210331.xsd#isrg_CostOfSalesServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CostOfSalesServiceMember" xlink:to="lab_isrg_CostOfSalesServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_271c8a69-79fc-46cc-93b9-4b2a1d764da4_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f638063f-34d8-4f14-87cd-05f9588705c2_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_afa528dd-32b5-4971-b320-d609ae3fde6f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2f011493-2301-4a2c-8e7a-74d45b8e3d29_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_771980a9-50bb-484e-b4b8-a0838a57c4c5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c9a38931-b772-47bf-b39d-e4072e162ead_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested beginning balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_154da256-4fca-42b9-8036-b26f030aab9f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested ending balance (usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_52d7e0bc-b15e-4746-8bfc-e4191dd029c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b2f07d6a-9bcb-4880-84f3-021e7b290d22_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_b3d2e5f0-796b-460a-88f0-ccfef88ce0d3_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_5515de8a-e44f-4375-a10a-75bb68216590_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalestypeLeaseDeferredSellingProfit_0c531550-5450-41da-9b02-cbad31f34818_negatedLabel_en-US" xlink:label="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned income</link:label>
    <link:label id="lab_isrg_SalestypeLeaseDeferredSellingProfit_label_en-US" xlink:label="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Deferred Selling Profit</link:label>
    <link:label id="lab_isrg_SalestypeLeaseDeferredSellingProfit_documentation_en-US" xlink:label="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Deferred Selling Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit" xlink:href="isrg-20210331.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalestypeLeaseDeferredSellingProfit" xlink:to="lab_isrg_SalestypeLeaseDeferredSellingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cf99bc05-a27e-4369-b27f-c367dd03cbb9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State or Other Jurisdiction of Incorporation or Organization</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_f982e1b9-493d-44ab-b043-f696be0c18c7_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturities of Gross Lease Receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:to="lab_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalNotesMember_3ac62eb9-1086-43cc-8ca3-96058a4f3cab_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal securities</link:label>
    <link:label id="lab_us-gaap_MunicipalNotesMember_label_en-US" xlink:label="lab_us-gaap_MunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MunicipalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalNotesMember" xlink:to="lab_us-gaap_MunicipalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_1453aaf8-a3d1-468c-a965-d05e291ef9e5_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:label id="lab_us-gaap_GeographicDistributionAxis_label_en-US" xlink:label="lab_us-gaap_GeographicDistributionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Distribution [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicDistributionAxis" xlink:to="lab_us-gaap_GeographicDistributionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ModerateMember_2f46e2af-2793-442b-b864-b963b1e346d7_terseLabel_en-US" xlink:label="lab_isrg_ModerateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Moderate</link:label>
    <link:label id="lab_isrg_ModerateMember_label_en-US" xlink:label="lab_isrg_ModerateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Moderate [Member]</link:label>
    <link:label id="lab_isrg_ModerateMember_documentation_en-US" xlink:label="lab_isrg_ModerateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Moderate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ModerateMember" xlink:href="isrg-20210331.xsd#isrg_ModerateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ModerateMember" xlink:to="lab_isrg_ModerateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_bd012e2a-6e1e-4869-88a8-d533f1ca977e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_4524dc0e-d348-4f5b-b788-efd6a59be9a2_terseLabel_en-US" xlink:label="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax</link:label>
    <link:label id="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_documentation_en-US" xlink:label="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:href="isrg-20210331.xsd#isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_90828114-aa23-4d03-9b81-6fe61d22a618_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_e29e719e-7ef6-4f4b-8579-6cdb6b768e07_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock reserved for issuance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_c802d273-5a1f-4bf5-936b-56e1653758c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777c6c64-fd8a-4606-a73a-ec9eb41b4696_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_63ad4c6f-4c61-4948-850d-5c0c4ff486cc_totalLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_610cbad5-8b8e-4eab-b22d-1b8beb394c70_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_73a66aff-9cf7-497a-b8c7-88dee884c1c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted, Weighted Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_3e98e2ff-024a-4719-b4bf-007eb7958213_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_6d972798-2072-4677-8d9a-e51f8be3ab2e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, value of shares purchased by employees</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_65bf26c7-7db4-444b-af60-837eda445966_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SchllyFiberopticGmbHMember_d9c51fa7-34cd-4ac0-85fc-faa72a76e4ad_terseLabel_en-US" xlink:label="lab_isrg_SchllyFiberopticGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sch&#246;lly</link:label>
    <link:label id="lab_isrg_SchllyFiberopticGmbHMember_label_en-US" xlink:label="lab_isrg_SchllyFiberopticGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sch&#246;lly Fiberoptic GmbH [Member]</link:label>
    <link:label id="lab_isrg_SchllyFiberopticGmbHMember_documentation_en-US" xlink:label="lab_isrg_SchllyFiberopticGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sch&#246;lly Fiberoptic GmbH [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SchllyFiberopticGmbHMember" xlink:href="isrg-20210331.xsd#isrg_SchllyFiberopticGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SchllyFiberopticGmbHMember" xlink:to="lab_isrg_SchllyFiberopticGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_30d25616-908e-4891-9ce1-8c922fb3192e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_89c9e518-a26b-4499-90f8-92a260d3229a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_4a0f29d3-624a-4bd6-a5da-ef76d82437f4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_2931016d-c281-45c3-a549-1c8fba6e4a9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Re-measurement of deferred tax assets</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b2dad315-c23b-455b-9abe-e5254d5fe1f9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense, percentage of pre-tax income</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_a0aed97a-3710-43e0-9ec1-952e202cfbd2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_1900146b-8c11-4f8c-84fa-5d56aeb1cd82_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities - Short-term</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_cfdcf723-7ae1-4a9c-8cdd-3c3aa8d5027e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e54dad4e-1e82-4986-99e8-9de810490fa3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_44a1cfd7-69b1-44ac-b67e-36d6a0814a4f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_CollarContractMember_9397613e-f23b-49e1-b92b-29765d1e392b_terseLabel_en-US" xlink:label="lab_isrg_CollarContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar Contract</link:label>
    <link:label id="lab_isrg_CollarContractMember_label_en-US" xlink:label="lab_isrg_CollarContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar Contract [Member]</link:label>
    <link:label id="lab_isrg_CollarContractMember_documentation_en-US" xlink:label="lab_isrg_CollarContractMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collar Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CollarContractMember" xlink:href="isrg-20210331.xsd#isrg_CollarContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_CollarContractMember" xlink:to="lab_isrg_CollarContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_7ccc73ff-6a10-4960-8387-6eb126b8ee2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_8152779d-2637-43c3-b29f-eaced6305a0a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of March 31, 2021, and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_9f425d00-199b-4a2a-8ba7-e1c64e95fdec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_68f2c5ac-951d-47f7-8e2d-23eb55f3d9ca_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_e86c0875-e70e-4187-a88f-7dc5e5fbee66_terseLabel_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LessorSalesTypeLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:to="lab_us-gaap_LessorSalesTypeLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_0f005588-c993-498c-8838-547a83a1aefd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of performance obligation</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Explanation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_6285d724-6881-4342-b6fc-f512d336d028_terseLabel_en-US" xlink:label="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, increased to authorized amount</link:label>
    <link:label id="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_label_en-US" xlink:label="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, increased to authorized amount</link:label>
    <link:label id="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_documentation_en-US" xlink:label="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased to authorized shares repurchase amount for Stock Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:href="isrg-20210331.xsd#isrg_StockRepurchaseProgramincreasedtoauthorizedamount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:to="lab_isrg_StockRepurchaseProgramincreasedtoauthorizedamount" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_InstrumentsandAccessoriesMember_c6851b28-9993-4cc8-9d5c-30a5dce56691_terseLabel_en-US" xlink:label="lab_isrg_InstrumentsandAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and accessories</link:label>
    <link:label id="lab_isrg_InstrumentsandAccessoriesMember_label_en-US" xlink:label="lab_isrg_InstrumentsandAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and Accessories [Member]</link:label>
    <link:label id="lab_isrg_InstrumentsandAccessoriesMember_documentation_en-US" xlink:label="lab_isrg_InstrumentsandAccessoriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments and Accessories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_InstrumentsandAccessoriesMember" xlink:href="isrg-20210331.xsd#isrg_InstrumentsandAccessoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_InstrumentsandAccessoriesMember" xlink:to="lab_isrg_InstrumentsandAccessoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d62c35d9-7a5e-4b40-becc-fe48aeb7db11_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_879f973b-5d61-43ed-8524-b01f0123d43d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete provisions</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_e5241f2e-9ad7-4d29-b9b8-c121944bc82a_terseLabel_en-US" xlink:label="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_label_en-US" xlink:label="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter</link:label>
    <link:label id="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_documentation_en-US" xlink:label="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:href="isrg-20210331.xsd#isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:to="lab_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_d4c79e6b-d53d-4f93-98b4-86cf54a9b59b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_e42410af-7bce-466b-9f45-9621f9f7f7c4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_9c442594-d06a-44d3-b7c3-86153f2da270_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54a1e8fa-1488-4364-9aa4-a9b14039df58_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a84d89f8-aa11-4f71-93fc-c9db3a223682_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_96da65a4-fdba-4490-b6f6-45d199572b45_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Summary of Changes in Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7cce6126-504c-40ab-9872-f1222a46a374_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_11ea19af-a1ba-413e-a814-576fc25d4fc9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding used in basic calculation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_fdaee0ad-5943-4535-84a9-43a6596faec3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Originated in Fiscal Year before Latest Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_cc3747ae-1f3a-47e2-9211-69bf4209cdf2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ServicesMember_1e15bf09-3611-463d-8d57-9d1f806229d7_terseLabel_en-US" xlink:label="lab_isrg_ServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_isrg_ServicesMember_label_en-US" xlink:label="lab_isrg_ServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services [Member]</link:label>
    <link:label id="lab_isrg_ServicesMember_documentation_en-US" xlink:label="lab_isrg_ServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ServicesMember" xlink:href="isrg-20210331.xsd#isrg_ServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ServicesMember" xlink:to="lab_isrg_ServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_31974389-12ab-40f8-879a-b36972f4505b_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_979e6086-32dc-4fcb-9f9e-7adf8d636f2e_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long- term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e5fdcd74-5856-47e0-9d14-8434863851cb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_8c4b6b1c-5193-4cd7-9fc2-5523fc116037_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:to="lab_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d48af8c6-ac52-4494-b9b9-d39ae7a8793e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_0950ab8d-164b-4990-86ef-bff7104a4223_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Intuitive Surgical, Inc. stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_916b5f0b-c7f5-4500-a11b-44bb15749d06_terseLabel_en-US" xlink:label="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Receivables</link:label>
    <link:label id="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Lease Income [Table Text Block]</link:label>
    <link:label id="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_documentation_en-US" xlink:label="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Sales-type Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:href="isrg-20210331.xsd#isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:to="lab_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_826b2da1-1e32-423e-910d-70b008c4e802_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ab632896-2705-46c5-8cb4-dcd7f199820c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and developed technology</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1da0d42c-8e4b-4ca9-85d3-7e5a9f23ff6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionRightsMember_64334bf7-2729-4f2c-9baf-1c08629b6f80_terseLabel_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution rights and others</link:label>
    <link:label id="lab_us-gaap_DistributionRightsMember_label_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionRightsMember" xlink:to="lab_us-gaap_DistributionRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_564cd069-864b-4f80-9040-7e80acc0e6c8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e15f235e-1993-43fa-bffe-10fe363e5bb4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_204558fe-1452-4977-8dbc-c91b7ba4a20e_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on investments, accretion, and amortization, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ae1bec55-faaf-4dd9-b35f-a785dd777a2f_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_d5da132f-b17d-4e35-9a53-845762b3629d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_aaeec06c-f39b-4057-98be-a93b64a0c8fe_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capital Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capital Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCapitalLeasedAsssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:to="lab_us-gaap_ScheduleOfCapitalLeasedAsssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_2ffa5e38-3ec7-4792-a345-6bf71b21fc97_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_4a4e19a4-910e-457c-a5f0-312f9253c5a9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_0a08ef0f-3a3a-479b-91bd-db3ece44f42e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of March 31, 2021, and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_98f0afda-d519-4f96-9663-4520616ecd22_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_d768d746-688d-470d-882f-ca277608226a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_ChindexMember_5c6ff363-f9b1-4800-b738-127693d79e05_terseLabel_en-US" xlink:label="lab_isrg_ChindexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chindex</link:label>
    <link:label id="lab_isrg_ChindexMember_label_en-US" xlink:label="lab_isrg_ChindexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chindex [Member]</link:label>
    <link:label id="lab_isrg_ChindexMember_documentation_en-US" xlink:label="lab_isrg_ChindexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chindex [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ChindexMember" xlink:href="isrg-20210331.xsd#isrg_ChindexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_ChindexMember" xlink:to="lab_isrg_ChindexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e1fb58cc-b236-42d6-b617-753cd77df688_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options excluded from computation of diluted net income per share</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_dfdfffba-80be-46d0-a599-5e2e0a802e7d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current-period other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_a7ab6141-ae17-4992-af85-2aaccc411d8b_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and loss on disposal of property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_e26773e4-9cd7-4186-82e8-9623d4c19362_terseLabel_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Fair Value</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_label_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_documentation_en-US" xlink:label="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:to="lab_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_5dac4279-6bcd-4497-857c-c4e4eac2b951_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_abbd10bc-afc8-49d3-864e-e2e1697f36c5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_21c9611b-68f1-41ae-bd24-f5e539ff7331_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e2cbc048-1607-492e-87ca-d9908bfe9718_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9a0169a0-7d56-480c-aa54-08f91e9d1097_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_0cabb314-7db8-4a9f-b08b-be6138cba19c_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain" xlink:to="lab_us-gaap_InternalCreditAssessmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_39cbf998-47cc-475e-a492-7ebf9232c92a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d0f81339-4e54-4494-96ee-f1fcbd2580e4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_362b8379-ff3e-4094-9ded-edb80645a5cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_220f5eeb-3cef-478e-bcaf-72e4a9bd6004_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_f9f207e6-7446-415c-ac17-7e0ebfe43e38_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_215bece4-3546-48c7-a80b-73d9f2e7d366_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis" xlink:to="lab_us-gaap_InternalCreditAssessmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_isrg_SystemsMember_5a3096ad-fa8f-4902-bd60-cf24c95b4922_terseLabel_en-US" xlink:label="lab_isrg_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems</link:label>
    <link:label id="lab_isrg_SystemsMember_label_en-US" xlink:label="lab_isrg_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems [Member]</link:label>
    <link:label id="lab_isrg_SystemsMember_documentation_en-US" xlink:label="lab_isrg_SystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SystemsMember" xlink:href="isrg-20210331.xsd#isrg_SystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_isrg_SystemsMember" xlink:to="lab_isrg_SystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_30f1fb8b-fb1a-4310-ae7f-d51ea1aa563e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of share repurchases authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_9dba98bc-4afe-4057-93f5-3e86217702b4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature in one to five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_b8ef14c1-4f38-40bf-ace5-dc9db6a8c6b7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_39d55c3b-c78f-4a1d-905a-30d8b22d3d78_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_9c2020d8-2832-43cd-86b1-da7f95bb8804_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_564550ae-3e64-40e7-8c6c-44ced80d0acc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_de2c2537-ed6b-4fff-9f36-1cd41cc0e2ba_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_476fd19e-f3f3-4a8a-9374-f6ca1179e2eb_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>isrg-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c61f603f-ef4a-4d04-b56b-7269297a821e,g:dd118a18-5d47-4c1c-822e-29e196fcfd78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="simple" xlink:href="isrg-20210331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_7fbcec44-7e7f-43ff-8f21-3339ca6896bb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_DocumentType_7fbcec44-7e7f-43ff-8f21-3339ca6896bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_681b86e8-02c9-4a7a-bd6d-342a6ec0b873" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_DocumentQuarterlyReport_681b86e8-02c9-4a7a-bd6d-342a6ec0b873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ec9ab466-2b78-4d9f-94f7-8484b1d3acc8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_DocumentPeriodEndDate_ec9ab466-2b78-4d9f-94f7-8484b1d3acc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ce59ba77-6f27-4230-9200-0076a7755b10" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_DocumentTransitionReport_ce59ba77-6f27-4230-9200-0076a7755b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_75452451-2987-4059-a77c-cfd6f342869c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityFileNumber_75452451-2987-4059-a77c-cfd6f342869c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_57167794-6270-4de0-ab61-109b9f98d62b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityRegistrantName_57167794-6270-4de0-ab61-109b9f98d62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ac0fdc80-9e34-4d34-aa2a-8a72013a3c3f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ac0fdc80-9e34-4d34-aa2a-8a72013a3c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_731ad747-62e2-4253-8b98-5d7fc5bd8d09" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityTaxIdentificationNumber_731ad747-62e2-4253-8b98-5d7fc5bd8d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_12f1dbd1-a88f-4fc6-90b2-7c041b31fd8a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityAddressAddressLine1_12f1dbd1-a88f-4fc6-90b2-7c041b31fd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_80362a17-e070-4da5-8ad1-a15ad36f4364" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityAddressCityOrTown_80362a17-e070-4da5-8ad1-a15ad36f4364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4cf19c2a-a919-4027-8f26-5eb66c7c1f08" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityAddressStateOrProvince_4cf19c2a-a919-4027-8f26-5eb66c7c1f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_785ece6e-a42a-48ca-905d-736edbd2f72c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityAddressPostalZipCode_785ece6e-a42a-48ca-905d-736edbd2f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_58e49771-8588-4a50-acf7-a97f501c1c14" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_CityAreaCode_58e49771-8588-4a50-acf7-a97f501c1c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0efc09ad-ff24-4d46-ae21-86b64c43304a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_LocalPhoneNumber_0efc09ad-ff24-4d46-ae21-86b64c43304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_20995f9d-ac88-4263-86fa-5d06eef1a0ec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_Security12bTitle_20995f9d-ac88-4263-86fa-5d06eef1a0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_00e5167e-e7db-4b20-b226-3dcdb5e63f37" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_TradingSymbol_00e5167e-e7db-4b20-b226-3dcdb5e63f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_06a5ee00-84eb-4b48-a51e-1a029bcc3982" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_SecurityExchangeName_06a5ee00-84eb-4b48-a51e-1a029bcc3982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e61df6ab-ba17-452f-b3d0-803c4ffbf230" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityCurrentReportingStatus_e61df6ab-ba17-452f-b3d0-803c4ffbf230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ed6cf931-ac76-4352-9d65-f5f90a1bf8d3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityInteractiveDataCurrent_ed6cf931-ac76-4352-9d65-f5f90a1bf8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_c46869d8-36da-4cfc-99c6-4989dc77c45f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityFilerCategory_c46869d8-36da-4cfc-99c6-4989dc77c45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c8a9b514-3f7e-449b-ba46-754c2a65a977" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntitySmallBusiness_c8a9b514-3f7e-449b-ba46-754c2a65a977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4206ed85-eda4-4afd-b857-dbcef3536e51" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityEmergingGrowthCompany_4206ed85-eda4-4afd-b857-dbcef3536e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e65260ef-a1b5-4fbc-9fcf-d7fe3e6326fb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityShellCompany_e65260ef-a1b5-4fbc-9fcf-d7fe3e6326fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_73a5496d-da3f-4609-af67-f694b62f92d4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_73a5496d-da3f-4609-af67-f694b62f92d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a324a48e-bf88-4b47-8615-68bcd0fb6ab3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_EntityCentralIndexKey_a324a48e-bf88-4b47-8615-68bcd0fb6ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8555ae00-f09d-46bc-9017-1fc13e8171a8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_CurrentFiscalYearEndDate_8555ae00-f09d-46bc-9017-1fc13e8171a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3c5a9fcb-aa59-460b-a8ae-59a8f83cc14b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_DocumentFiscalYearFocus_3c5a9fcb-aa59-460b-a8ae-59a8f83cc14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_34f87b55-518d-438e-bda9-375516b5e22b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_34f87b55-518d-438e-bda9-375516b5e22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7525b8d4-b787-46a0-bd5d-0374e917ce12" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35193d3b-12f8-446f-9dab-b51f48162b0e" xlink:to="loc_dei_AmendmentFlag_7525b8d4-b787-46a0-bd5d-0374e917ce12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8b5b32c9-bcf7-4135-941b-d4a15da247cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8b5b32c9-bcf7-4135-941b-d4a15da247cc" xlink:to="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a79e6dc8-4f26-4cbb-9782-28ea211593ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a79e6dc8-4f26-4cbb-9782-28ea211593ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_79916c13-3e90-409c-93e0-25cd8df0faee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_79916c13-3e90-409c-93e0-25cd8df0faee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_10a1c7ab-0c90-4603-ba5f-277cf6133943" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_10a1c7ab-0c90-4603-ba5f-277cf6133943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a4d6db93-8b71-4f50-aea1-cb97d58c58d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:to="loc_us-gaap_InventoryNet_a4d6db93-8b71-4f50-aea1-cb97d58c58d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_327e0505-9cc6-424c-8aa4-ea6cd8243052" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_327e0505-9cc6-424c-8aa4-ea6cd8243052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f917688a-7433-4c31-9b4b-6f4d05e8ea46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_28d7efc7-f8cb-4749-afd6-ca7340a397d8" xlink:to="loc_us-gaap_AssetsCurrent_f917688a-7433-4c31-9b4b-6f4d05e8ea46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7e4f2c18-a9b7-4062-9673-d59bd1426c52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7e4f2c18-a9b7-4062-9673-d59bd1426c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_e0005c64-b6d1-4d30-a19d-3163f74a33bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_e0005c64-b6d1-4d30-a19d-3163f74a33bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_52d32547-ce49-40d7-98f0-8563f6205a20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_52d32547-ce49-40d7-98f0-8563f6205a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssets_93059240-50f7-4696-a2c9-66b131362475" xlink:href="isrg-20210331.xsd#isrg_IntangibleAndOtherAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_isrg_IntangibleAndOtherAssets_93059240-50f7-4696-a2c9-66b131362475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c36ca53-bf21-46dd-abfc-66b9f3bf2f14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_us-gaap_Goodwill_9c36ca53-bf21-46dd-abfc-66b9f3bf2f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fc2878f4-2ab2-43d3-bec8-5a0d640c74e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1ceac9c1-5817-400b-8795-87eabad49884" xlink:to="loc_us-gaap_Assets_fc2878f4-2ab2-43d3-bec8-5a0d640c74e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8b5b32c9-bcf7-4135-941b-d4a15da247cc" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2398c6bb-68f0-4c3d-a3f4-6be4d68c557a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:to="loc_us-gaap_AccountsPayableCurrent_2398c6bb-68f0-4c3d-a3f4-6be4d68c557a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9fea446e-f509-491e-b3d5-36f6ab7e2102" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9fea446e-f509-491e-b3d5-36f6ab7e2102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_5f5a3354-988c-4169-88d0-56a6c52c1171" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:to="loc_us-gaap_DeferredRevenueCurrent_5f5a3354-988c-4169-88d0-56a6c52c1171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f69f5f4b-e4cb-4713-ae53-26612954d22d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f69f5f4b-e4cb-4713-ae53-26612954d22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bb52a453-ca55-4eb9-acd3-c856acb8e742" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1b203047-6c59-408a-8da5-ed1fe6b3ca0e" xlink:to="loc_us-gaap_LiabilitiesCurrent_bb52a453-ca55-4eb9-acd3-c856acb8e742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_be836607-352c-4c87-aa6d-bac004f7cccc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_be836607-352c-4c87-aa6d-bac004f7cccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c5cbdbb4-8a6a-4445-a7c1-beb111590258" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_Liabilities_c5cbdbb4-8a6a-4445-a7c1-beb111590258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_153f0dd9-4de4-428a-bc07-24076c52e4ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_153f0dd9-4de4-428a-bc07-24076c52e4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cc7e6066-9a28-4a9b-a102-cd982b719fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:to="loc_us-gaap_PreferredStockValue_cc7e6066-9a28-4a9b-a102-cd982b719fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b399b2c0-c68a-4eef-85d7-72488c825c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:to="loc_us-gaap_CommonStockValue_b399b2c0-c68a-4eef-85d7-72488c825c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_406352f3-308a-4d3b-baa4-705d1d7b950e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_406352f3-308a-4d3b-baa4-705d1d7b950e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cddbbe39-6fa8-43e5-8384-40ec462f4651" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cddbbe39-6fa8-43e5-8384-40ec462f4651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9366b29a-0b1c-4596-9797-98e14ddb3058" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9366b29a-0b1c-4596-9797-98e14ddb3058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c3322192-7012-41a1-9d18-c98a6d982f48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8f194132-1cc1-44c5-9b5b-9bd64fdba2e1" xlink:to="loc_us-gaap_StockholdersEquity_c3322192-7012-41a1-9d18-c98a6d982f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_89302889-b741-46e3-a0ab-14e3a6e620c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_MinorityInterest_89302889-b741-46e3-a0ab-14e3a6e620c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_334a3815-6090-4646-adee-37f21d451f82" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_334a3815-6090-4646-adee-37f21d451f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_4cc77292-7407-467d-b81d-e87d9c2fed73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a733b183-ec63-484b-b314-c4ac2f68c72c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_4cc77292-7407-467d-b81d-e87d9c2fed73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5f06bbd0-cd22-4143-95e7-f3b21719dd10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5f06bbd0-cd22-4143-95e7-f3b21719dd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9d208a41-8853-4c3f-a637-562971827613" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9d208a41-8853-4c3f-a637-562971827613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_dc487959-35b2-4dfd-8f06-90b0a691f380" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_PreferredStockSharesIssued_dc487959-35b2-4dfd-8f06-90b0a691f380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_4d9ed982-cce2-4902-940d-a0d3691db7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_4d9ed982-cce2-4902-940d-a0d3691db7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2d75d544-72d1-4e7e-af0b-8948ffd75460" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2d75d544-72d1-4e7e-af0b-8948ffd75460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3ee6bbd9-e98b-43f3-87b0-dfaf5cf12aca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3ee6bbd9-e98b-43f3-87b0-dfaf5cf12aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5833dafd-538a-4e9b-bd51-df9bf3711747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_CommonStockSharesIssued_5833dafd-538a-4e9b-bd51-df9bf3711747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_917cc12e-4dea-41cf-b9eb-1ab7d8c5fa77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9dcbae9-1491-4247-85c8-6ea6c96a6b67" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_917cc12e-4dea-41cf-b9eb-1ab7d8c5fa77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ed35f16f-d34a-4b6d-b1af-9a3617db20ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ed35f16f-d34a-4b6d-b1af-9a3617db20ad" xlink:to="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:to="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_26897614-b561-41af-84fc-cf34a6f86262" xlink:to="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_4f4a8171-b70b-4f7b-afbc-2f6837d44cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:to="loc_us-gaap_ProductMember_4f4a8171-b70b-4f7b-afbc-2f6837d44cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_79a88001-60ad-4f1f-abd9-eca13cd266f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_edab312f-da16-467e-aa8b-014113db7848" xlink:to="loc_us-gaap_ServiceMember_79a88001-60ad-4f1f-abd9-eca13cd266f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b70d043e-d73f-47f9-aad1-89a8bd187f85" xlink:to="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_fde75091-9a3b-4d91-b324-90f2e6285c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_RevenuesAbstract_fde75091-9a3b-4d91-b324-90f2e6285c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96d312cc-f32d-4a11-9450-d92ddef80d93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_fde75091-9a3b-4d91-b324-90f2e6285c8c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96d312cc-f32d-4a11-9450-d92ddef80d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_da8ef30a-6b7d-4615-9f06-a5cf095f1df2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_CostOfRevenueAbstract_da8ef30a-6b7d-4615-9f06-a5cf095f1df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_45e943b1-28cb-4552-9f60-d435d74276cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_da8ef30a-6b7d-4615-9f06-a5cf095f1df2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_45e943b1-28cb-4552-9f60-d435d74276cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c0fd4bae-0393-41af-bae8-ee2ff9474e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_GrossProfit_c0fd4bae-0393-41af-bae8-ee2ff9474e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89ac7091-66d2-42ae-95bd-2a4e04c45d2a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_89ac7091-66d2-42ae-95bd-2a4e04c45d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_6cbf14cb-25be-4e6c-a874-15466e7db897" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_6cbf14cb-25be-4e6c-a874-15466e7db897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_693545d8-1f72-4e00-970a-e90a05768339" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_e88f49f9-574f-424b-823a-5e82683a8894" xlink:to="loc_us-gaap_OperatingExpenses_693545d8-1f72-4e00-970a-e90a05768339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_141dffa1-861e-4edc-9f3f-e24ba2fde659" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_OperatingIncomeLoss_141dffa1-861e-4edc-9f3f-e24ba2fde659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d0d78d67-ba64-4df0-85a6-acf8ee77fbf4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d0d78d67-ba64-4df0-85a6-acf8ee77fbf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_614372ff-6c72-4256-8355-bf24055a5235" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_614372ff-6c72-4256-8355-bf24055a5235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d59e7347-8d43-4b59-9c61-7c5e30673b04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d59e7347-8d43-4b59-9c61-7c5e30673b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1c8fcb10-36d4-4361-b5c1-42f16308adb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_ProfitLoss_1c8fcb10-36d4-4361-b5c1-42f16308adb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_88a69629-1f70-4fb8-bbe9-bf23082dd484" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_88a69629-1f70-4fb8-bbe9-bf23082dd484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_384f2ed1-941e-48a6-8ad1-595fcaa6ce7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_NetIncomeLoss_384f2ed1-941e-48a6-8ad1-595fcaa6ce7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c19b4778-5213-4a44-accf-ef7bf4f588b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:to="loc_us-gaap_EarningsPerShareBasic_c19b4778-5213-4a44-accf-ef7bf4f588b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3cd9bc8f-6a95-4750-ae99-a483ed7ba6cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1993e218-596e-4397-827d-9397948d965d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3cd9bc8f-6a95-4750-ae99-a483ed7ba6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16b9a703-51c8-4884-9ed8-3a301aedf4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_16b9a703-51c8-4884-9ed8-3a301aedf4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cebda746-8f4f-4069-ad6d-a6cfdab5deac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_93e4d6c6-be6a-4a14-818c-b89a9acb0bc4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_cebda746-8f4f-4069-ad6d-a6cfdab5deac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_508563ff-b3db-4111-ac7c-a93aa8e80623" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_508563ff-b3db-4111-ac7c-a93aa8e80623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c8e54ae-e0b9-4d29-9cbf-1b951b8da892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3c8e54ae-e0b9-4d29-9cbf-1b951b8da892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b852ada1-f481-4727-bc01-d0c4a9ea98dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d11124eb-31e5-4947-ade2-7309c807df36" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b852ada1-f481-4727-bc01-d0c4a9ea98dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="isrg-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_64d24d0e-e9ba-4933-8f54-627a36bafe13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_ProfitLoss_64d24d0e-e9ba-4933-8f54-627a36bafe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cf10e1b1-73f9-47d2-907d-af5aba422cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cf10e1b1-73f9-47d2-907d-af5aba422cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cf10e1b1-73f9-47d2-907d-af5aba422cdc" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3087ce41-04e8-4151-bf25-c71f0b827186" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_Depreciation_3087ce41-04e8-4151-bf25-c71f0b827186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ada65485-fab4-4947-b83a-85e5838e5496" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ada65485-fab4-4947-b83a-85e5838e5496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_6a5675db-eee7-464c-9f96-b3699fe46c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_6a5675db-eee7-464c-9f96-b3699fe46c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e748b2b7-82fe-49dd-a3ab-5f789060796f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e748b2b7-82fe-49dd-a3ab-5f789060796f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ec9c094b-1770-4624-82cf-9a81e4a316d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_ShareBasedCompensation_ec9c094b-1770-4624-82cf-9a81e4a316d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_e65da2de-d212-47b4-a900-166a57dc2b46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_e65da2de-d212-47b4-a900-166a57dc2b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf1c31a-4c5e-42a5-b5f2-792651d1fcce" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbebcbc7-1ce4-4780-a6a6-9147b290b2ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dbebcbc7-1ce4-4780-a6a6-9147b290b2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_0fdae208-7038-4c08-b00b-f3b5e0fc5656" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_0fdae208-7038-4c08-b00b-f3b5e0fc5656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_58738029-5045-4270-8fb6-abd2f1619228" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_58738029-5045-4270-8fb6-abd2f1619228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d4930e2b-dc8b-42ee-a6fd-45dfb5105ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d4930e2b-dc8b-42ee-a6fd-45dfb5105ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_abca467f-0c2c-45b7-8e89-248a6151ad78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_abca467f-0c2c-45b7-8e89-248a6151ad78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_64936756-02b6-4123-91f4-6c964a6549f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_64936756-02b6-4123-91f4-6c964a6549f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_743c1aa5-038a-43c7-8d62-fbae6236ec0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_743c1aa5-038a-43c7-8d62-fbae6236ec0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_728a3497-adae-4e97-9e76-ff1a13ee826b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_038f8c29-e0c1-4200-8eaf-1a62e4bc665f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_728a3497-adae-4e97-9e76-ff1a13ee826b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_38c2d5b4-ccb4-4ef3-b394-e2fbe8a29304" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_38c2d5b4-ccb4-4ef3-b394-e2fbe8a29304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_6b7a5ba1-9eb7-4de9-bb6a-f47d4930590f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_6b7a5ba1-9eb7-4de9-bb6a-f47d4930590f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_efd32e08-510a-48e3-a934-58e485bfd4c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_efd32e08-510a-48e3-a934-58e485bfd4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_02b5aba0-edbf-483f-9d13-1e4298a06257" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_02b5aba0-edbf-483f-9d13-1e4298a06257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e10ebabb-52e8-4513-8359-0509ec150c05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e10ebabb-52e8-4513-8359-0509ec150c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d090db7-e969-4387-8256-1db34a26a0c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_710a880a-397f-46ee-bd3b-1f14af21cb20" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3d090db7-e969-4387-8256-1db34a26a0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_3a37f9cb-882a-4014-a347-69fe9ca0bf04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:to="loc_us-gaap_ProceedsFromStockPlans_3a37f9cb-882a-4014-a347-69fe9ca0bf04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_65f1ef70-baab-41a2-9664-756b606e57d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_65f1ef70-baab-41a2-9664-756b606e57d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4bcb1159-6ce7-4ded-9a71-c193cf4d8655" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4bcb1159-6ce7-4ded-9a71-c193cf4d8655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_7140f271-34a5-4c9e-bcd9-b1ed13211116" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_7140f271-34a5-4c9e-bcd9-b1ed13211116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_313e21af-4253-4adc-a008-bb7ed434497d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_313e21af-4253-4adc-a008-bb7ed434497d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ae28aba4-acb1-45ca-9f1c-da0820e2c938" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a8d2f49d-0969-4df0-b1b6-1ef57e1635c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ae28aba4-acb1-45ca-9f1c-da0820e2c938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_28c4e610-912b-4ab7-b8d6-eb7f103d4777" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_28c4e610-912b-4ab7-b8d6-eb7f103d4777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_757caf1c-7dc7-42d9-8cac-995cce776e50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_757caf1c-7dc7-42d9-8cac-995cce776e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2745f56f-023f-45ab-9a66-e6a0c6b58640" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2745f56f-023f-45ab-9a66-e6a0c6b58640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_726a1429-2239-4d18-ae28-bab832a6c3dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_10f55689-3a3b-4795-8bdd-d22e7ce97f53" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_726a1429-2239-4d18-ae28-bab832a6c3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="simple" xlink:href="isrg-20210331.xsd#DESCRIPTIONOFTHEBUSINESS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fd826d57-eaf6-466e-b0f3-2a2bfd6bad79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_d1efa108-c547-412f-9c46-9acb6c0d209c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fd826d57-eaf6-466e-b0f3-2a2bfd6bad79" xlink:to="loc_us-gaap_NatureOfOperations_d1efa108-c547-412f-9c46-9acb6c0d209c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="isrg-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c76e1dea-84f1-4b9f-a6fe-41dacad68b88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c91ba3f5-9408-44b5-907d-e8f7fd89805e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c76e1dea-84f1-4b9f-a6fe-41dacad68b88" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_c91ba3f5-9408-44b5-907d-e8f7fd89805e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="isrg-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d6ca73b4-caf7-4137-9098-530baae7d856" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c7f8fdae-00b3-4ead-8fa0-e59a7dc34310" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d6ca73b4-caf7-4137-9098-530baae7d856" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c7f8fdae-00b3-4ead-8fa0-e59a7dc34310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f0c627bc-0a22-45da-9e54-7417dabdcb57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d6ca73b4-caf7-4137-9098-530baae7d856" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_f0c627bc-0a22-45da-9e54-7417dabdcb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_99fbb383-2d23-43b4-b81b-93de7f3ddb51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d6ca73b4-caf7-4137-9098-530baae7d856" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_99fbb383-2d23-43b4-b81b-93de7f3ddb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_9c1a2d71-a5ef-4ec3-a3d4-89000b03ff29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_09373f36-d9af-4456-8ee2-ec8e92327747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_9c1a2d71-a5ef-4ec3-a3d4-89000b03ff29" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_09373f36-d9af-4456-8ee2-ec8e92327747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0395e439-b2c2-4c4f-a7e5-739424b82f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_fa5161a5-64b4-4c07-984e-4a1e11234541" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0395e439-b2c2-4c4f-a7e5-739424b82f5b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_fa5161a5-64b4-4c07-984e-4a1e11234541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b62291e9-c74b-43c8-b231-c48d725a8d23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0395e439-b2c2-4c4f-a7e5-739424b82f5b" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b62291e9-c74b-43c8-b231-c48d725a8d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_6b6291ef-8315-4cb4-9d3c-fd3715b55671" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0395e439-b2c2-4c4f-a7e5-739424b82f5b" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_6b6291ef-8315-4cb4-9d3c-fd3715b55671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_51f5241d-cf04-4dfe-9aff-c3d31ae24293" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0395e439-b2c2-4c4f-a7e5-739424b82f5b" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_51f5241d-cf04-4dfe-9aff-c3d31ae24293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7fabb06f-3187-45e2-bf7e-31f6f6b023b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_0395e439-b2c2-4c4f-a7e5-739424b82f5b" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_7fabb06f-3187-45e2-bf7e-31f6f6b023b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_ed5d6412-fc4e-4059-a0cd-13d115f61dbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_ed5d6412-fc4e-4059-a0cd-13d115f61dbe" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_446bf2b5-6fe8-4206-b2d5-7443bb4f29c9" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1ae8dd99-98da-4ddb-81af-bad16e99e664" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1ae8dd99-98da-4ddb-81af-bad16e99e664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e203c240-57d2-4748-a642-df76c289ba72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7a92b4f2-b883-4029-a72a-ec4ef6a03cd4" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e203c240-57d2-4748-a642-df76c289ba72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f24a5d28-e586-41ee-aaad-c1bd8da10350" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_37327b14-17ae-4e5d-af91-01be29c97f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_CashMember_37327b14-17ae-4e5d-af91-01be29c97f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ed19e6c9-4800-46d0-a5d9-ccc411a06e35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ed19e6c9-4800-46d0-a5d9-ccc411a06e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_71338dd1-2cbb-4ebd-b7d4-185a563d25d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_71338dd1-2cbb-4ebd-b7d4-185a563d25d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_18369f15-89a1-4cba-a667-43f2e6b7c7d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_CommercialPaperMember_18369f15-89a1-4cba-a667-43f2e6b7c7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8a1f7356-b66b-4964-91fb-b53ade5b2628" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8a1f7356-b66b-4964-91fb-b53ade5b2628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_842fd1fa-a6aa-4eba-8ef1-2e8926c62ad3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_842fd1fa-a6aa-4eba-8ef1-2e8926c62ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_eab6237f-1641-4494-bbc2-cd8bd40cc008" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_eab6237f-1641-4494-bbc2-cd8bd40cc008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalNotesMember_a27f973b-818f-4ae9-ae37-aa7cb1e320bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MunicipalNotesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_04746448-9ef6-4bda-b9f8-ff454d7f14f4" xlink:to="loc_us-gaap_MunicipalNotesMember_a27f973b-818f-4ae9-ae37-aa7cb1e320bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_587be257-02e8-43d0-905e-80d5f5a74d23" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b1168d1-4a7a-48c0-9276-d983bee8381a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b1168d1-4a7a-48c0-9276-d983bee8381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_672e8fd9-f0f3-42f3-900a-9c1639033f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_672e8fd9-f0f3-42f3-900a-9c1639033f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b32320a8-a63d-4702-ae08-5c8e24c2ec73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b32320a8-a63d-4702-ae08-5c8e24c2ec73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_b80cde4b-9e6c-4d06-a796-c24b5ddc9bfe" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost_b80cde4b-9e6c-4d06-a796-c24b5ddc9bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e68170f0-845f-4e52-a019-583aefcf7536" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e68170f0-845f-4e52-a019-583aefcf7536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fce3906c-6de1-4d7b-baa2-8442becb9c87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fce3906c-6de1-4d7b-baa2-8442becb9c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a9f3ad72-5035-482e-91ee-141d623608f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a9f3ad72-5035-482e-91ee-141d623608f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65cd9943-d18d-48d9-8400-91c7d44a9130" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_65cd9943-d18d-48d9-8400-91c7d44a9130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_3d2a3d94-c9cd-49b7-84af-53f068b34fc9" xlink:href="isrg-20210331.xsd#isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue_3d2a3d94-c9cd-49b7-84af-53f068b34fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_9fca2554-7cbc-466c-833d-4a78ca23f6bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_9fca2554-7cbc-466c-833d-4a78ca23f6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_67f93c50-12c0-4296-831b-ffb17c4e4b05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_7dd467c5-a48b-4750-9fec-2d7fc549a477" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_67f93c50-12c0-4296-831b-ffb17c4e4b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_fa143dd9-006c-4a28-a318-597833dcdcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_fb3991ae-638e-405c-9f5b-bf2c81fa9809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_fa143dd9-006c-4a28-a318-597833dcdcfc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_fb3991ae-638e-405c-9f5b-bf2c81fa9809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_9c7d8788-ea80-4891-9930-58ffeaf1e7de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_fb3991ae-638e-405c-9f5b-bf2c81fa9809" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_9c7d8788-ea80-4891-9930-58ffeaf1e7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_69e74885-c803-4b9f-a148-d225a6d616ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_fb3991ae-638e-405c-9f5b-bf2c81fa9809" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_69e74885-c803-4b9f-a148-d225a6d616ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_af540623-5792-4f62-9dbe-070304ce9304" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_fb3991ae-638e-405c-9f5b-bf2c81fa9809" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_af540623-5792-4f62-9dbe-070304ce9304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2771a4bb-cc67-4fb4-ac1b-8f0db9030f8a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_fa143dd9-006c-4a28-a318-597833dcdcfc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2771a4bb-cc67-4fb4-ac1b-8f0db9030f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_35e289e6-cc37-4740-bd73-b215f0888214" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2771a4bb-cc67-4fb4-ac1b-8f0db9030f8a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_35e289e6-cc37-4740-bd73-b215f0888214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_76e06046-987d-415c-97c9-5c15e6f12093" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2771a4bb-cc67-4fb4-ac1b-8f0db9030f8a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_76e06046-987d-415c-97c9-5c15e6f12093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_962eff55-1681-4d46-b88d-9e46cf029738" xlink:href="isrg-20210331.xsd#isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_2771a4bb-cc67-4fb4-ac1b-8f0db9030f8a" xlink:to="loc_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal_962eff55-1681-4d46-b88d-9e46cf029738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_2712b44a-31eb-4add-a221-48fc723c2d78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_fa143dd9-006c-4a28-a318-597833dcdcfc" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_2712b44a-31eb-4add-a221-48fc723c2d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_80e5130a-aeaa-4f65-b67f-2401d30b96de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_80e5130a-aeaa-4f65-b67f-2401d30b96de" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07effada-cadc-4c9b-b1a5-c121a12963a4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1486c0ea-ed30-4fa1-b079-7f3cc2bb8e1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_1486c0ea-ed30-4fa1-b079-7f3cc2bb8e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_IntangibleAndOtherAssetsNetMember_bf93dabb-65f1-469b-9b46-285d2b2b16d9" xlink:href="isrg-20210331.xsd#isrg_IntangibleAndOtherAssetsNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1000097e-78a4-41b3-a48a-33c77d6f35f7" xlink:to="loc_isrg_IntangibleAndOtherAssetsNetMember_bf93dabb-65f1-469b-9b46-285d2b2b16d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_9304590d-638f-49d2-838e-0a435b9938dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1ee0cb74-b503-4eed-8adc-d9585a9c0161" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1ee0cb74-b503-4eed-8adc-d9585a9c0161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2c362742-a5e3-45bf-ae5a-f3bde0380c63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_73181772-80bf-47d3-bbed-c52696e56f37" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2c362742-a5e3-45bf-ae5a-f3bde0380c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c54c8796-b4f7-41fc-b73a-43f150fb7cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable_d6f21e38-1faf-44f3-b14a-4ac084884748" xlink:to="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c54c8796-b4f7-41fc-b73a-43f150fb7cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_c54c8796-b4f7-41fc-b73a-43f150fb7cd4" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_af6d4798-f8fb-4fe4-8590-40e7ba83fe66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_af6d4798-f8fb-4fe4-8590-40e7ba83fe66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_4c3b9985-04a6-4f7b-a6f9-adcef8f23a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_4c3b9985-04a6-4f7b-a6f9-adcef8f23a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_1ec3d212-a022-4680-bc76-316822402f85" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments_1ec3d212-a022-4680-bc76-316822402f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_306df352-8192-45b2-9e66-cffa11c9fd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_306df352-8192-45b2-9e66-cffa11c9fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_00f507c2-0ac7-4325-9843-0765e753e743" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss_00f507c2-0ac7-4325-9843-0765e753e743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_8903a452-82ea-4655-bf5e-e734435b82f0" xlink:href="isrg-20210331.xsd#isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments_8903a452-82ea-4655-bf5e-e734435b82f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_259afa46-19ff-4bc5-8070-dc4df64f86a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_259afa46-19ff-4bc5-8070-dc4df64f86a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e636f820-b814-4c7e-91ff-4056c0d07082" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_8250da8c-c08e-46d0-80f3-1433876ecb84" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_e636f820-b814-4c7e-91ff-4056c0d07082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6a5050c3-5cb9-4e72-b1a2-49200107df9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6a5050c3-5cb9-4e72-b1a2-49200107df9f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ede498b4-dd0d-45cb-864d-979c36ea1cc6" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_6e17e09e-c5a3-41cc-99a5-addedb7a3a74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_6e17e09e-c5a3-41cc-99a5-addedb7a3a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CollarContractMember_37965949-6f52-4203-8c14-1f93672e2207" xlink:href="isrg-20210331.xsd#isrg_CollarContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b8db188c-d276-4254-b7d6-3e6286d96f88" xlink:to="loc_isrg_CollarContractMember_37965949-6f52-4203-8c14-1f93672e2207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_209048c7-01a0-4428-843a-36c594c5e46d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5c2b5a78-61f2-4a33-8bad-e6aa93047cf5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_209048c7-01a0-4428-843a-36c594c5e46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_71186b95-7b43-4cca-ba71-957da0c4f182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_209048c7-01a0-4428-843a-36c594c5e46d" xlink:to="loc_us-gaap_OtherIncomeMember_71186b95-7b43-4cca-ba71-957da0c4f182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_43cd6c68-10bc-4e23-a9e2-38eead8e384c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b974a53c-d05d-4dc9-bee4-a3f669c22dd1" xlink:to="loc_us-gaap_HedgingDesignationDomain_43cd6c68-10bc-4e23-a9e2-38eead8e384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_af6bccde-1de6-4a0c-a6d9-5403d5dee702" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_43cd6c68-10bc-4e23-a9e2-38eead8e384c" xlink:to="loc_us-gaap_NondesignatedMember_af6bccde-1de6-4a0c-a6d9-5403d5dee702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2407f1fd-76a7-414b-8748-e7491923ab68" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d092b292-ca4a-4357-a29c-5061d231c16f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_d092b292-ca4a-4357-a29c-5061d231c16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e97e33e1-4591-4a2c-a73c-a0790b9a658a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_f7bbc53e-921c-4fcc-a815-b7d27fe8fc75" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_e97e33e1-4591-4a2c-a73c-a0790b9a658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d0e7a9c2-ec0b-4e0a-a99a-99ae912aeff9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_d0e7a9c2-ec0b-4e0a-a99a-99ae912aeff9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3d55188c-141f-4758-ae54-8b9a410d304a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_27be6b42-686a-4401-a20e-04e973a8e12f" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3d55188c-141f-4758-ae54-8b9a410d304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_a13c03cc-6526-4a47-a699-5ba054610c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3d55188c-141f-4758-ae54-8b9a410d304a" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_a13c03cc-6526-4a47-a699-5ba054610c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a91638b3-30be-4059-b9aa-bb57ff228e11" xlink:to="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36bec257-06c2-4160-bd92-635711ab4949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_36bec257-06c2-4160-bd92-635711ab4949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_d258a26c-d7e9-41a1-8da8-f05e21c032b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_715802f6-2249-4f4a-8936-764363b0d4ef" xlink:to="loc_us-gaap_NondesignatedMember_d258a26c-d7e9-41a1-8da8-f05e21c032b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_9373ba74-d0a2-4692-8e61-9b9fa9f8be84" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_296024f4-b62e-4765-81cd-8ae2ac9742ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_296024f4-b62e-4765-81cd-8ae2ac9742ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesMember_b235d828-da5d-4bca-8bb7-8c0d783c9992" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_6e224c10-512d-4608-8338-07d5ebbfe197" xlink:to="loc_us-gaap_OtherLiabilitiesMember_b235d828-da5d-4bca-8bb7-8c0d783c9992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77580029-6c42-456a-bbaa-a47ddfb308ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e6e1490d-3bc1-425c-8bef-35dc26c6edc6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77580029-6c42-456a-bbaa-a47ddfb308ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_e7ce74a3-93c0-47a0-b1f0-b8685087fcc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_77580029-6c42-456a-bbaa-a47ddfb308ac" xlink:to="loc_us-gaap_DerivativeNotionalAmount_e7ce74a3-93c0-47a0-b1f0-b8685087fcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87930613-7fb9-4c81-8509-d8be1c45b53b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_18e5f070-6b8d-48ce-84f7-0ab23cb20457" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_87930613-7fb9-4c81-8509-d8be1c45b53b" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_18e5f070-6b8d-48ce-84f7-0ab23cb20457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2502893c-b7fd-40fa-ba8b-2e731ea5e58b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e9091180-2616-414c-b9e0-f828a1c8ac98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2502893c-b7fd-40fa-ba8b-2e731ea5e58b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e9091180-2616-414c-b9e0-f828a1c8ac98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_08737a61-6a80-4b57-bdf8-2e431fb5a7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2502893c-b7fd-40fa-ba8b-2e731ea5e58b" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_08737a61-6a80-4b57-bdf8-2e431fb5a7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7d196dd1-5b69-4e6c-bb5d-cc083b5e6d25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2502893c-b7fd-40fa-ba8b-2e731ea5e58b" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7d196dd1-5b69-4e6c-bb5d-cc083b5e6d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_4e97e7a8-5a39-437c-8675-0e3a255d2ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2502893c-b7fd-40fa-ba8b-2e731ea5e58b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_4e97e7a8-5a39-437c-8675-0e3a255d2ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_36cbd5db-4393-4ff3-b7e7-a7e02375433c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2502893c-b7fd-40fa-ba8b-2e731ea5e58b" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_36cbd5db-4393-4ff3-b7e7-a7e02375433c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21373e68-11db-49e7-9d3a-468683d4029c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_36b65173-aef3-400f-868c-7e91c91e6bad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21373e68-11db-49e7-9d3a-468683d4029c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_36b65173-aef3-400f-868c-7e91c91e6bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4ba953b2-0b14-4682-b0d5-4fbf49ff265e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21373e68-11db-49e7-9d3a-468683d4029c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4ba953b2-0b14-4682-b0d5-4fbf49ff265e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f68c1101-9545-49e1-8364-1280ac185742" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21373e68-11db-49e7-9d3a-468683d4029c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f68c1101-9545-49e1-8364-1280ac185742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_df775093-54e2-475e-8a37-4fa2d91df0c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_21373e68-11db-49e7-9d3a-468683d4029c" xlink:to="loc_us-gaap_InventoryNet_df775093-54e2-475e-8a37-4fa2d91df0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c1d2f2-fc9f-46de-bf81-f61b3e8e8f77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_070fd6a0-6d20-45c8-9789-d1d8659ca417" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c1d2f2-fc9f-46de-bf81-f61b3e8e8f77" xlink:to="loc_us-gaap_PrepaidTaxes_070fd6a0-6d20-45c8-9789-d1d8659ca417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_15bd5a3b-fb1b-4981-8112-d10a78473b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c1d2f2-fc9f-46de-bf81-f61b3e8e8f77" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_15bd5a3b-fb1b-4981-8112-d10a78473b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_1d4e27a6-bf65-4996-88cf-ca88d7d2b58a" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c1d2f2-fc9f-46de-bf81-f61b3e8e8f77" xlink:to="loc_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent_1d4e27a6-bf65-4996-88cf-ca88d7d2b58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_2f94e21a-207e-4310-b188-03dbf91b5932" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c1d2f2-fc9f-46de-bf81-f61b3e8e8f77" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_2f94e21a-207e-4310-b188-03dbf91b5932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f87db4b5-8c99-4357-9001-87c4c4b008cb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22c1d2f2-fc9f-46de-bf81-f61b3e8e8f77" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f87db4b5-8c99-4357-9001-87c4c4b008cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_280b3932-25a9-4277-b4e0-9c380b43d0bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:to="loc_us-gaap_TaxesPayableCurrent_280b3932-25a9-4277-b4e0-9c380b43d0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_019ea6f2-de54-4abb-ae50-31bce7bfee17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:to="loc_us-gaap_LitigationReserveCurrent_019ea6f2-de54-4abb-ae50-31bce7bfee17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_75487cf8-328d-4df6-8fa0-4e216673cb08" xlink:href="isrg-20210331.xsd#isrg_DeferredPurchaseConsiderationPaymentsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:to="loc_isrg_DeferredPurchaseConsiderationPaymentsCurrent_75487cf8-328d-4df6-8fa0-4e216673cb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b1f09c09-49f5-499c-aeed-6fd2d1be0217" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent_b1f09c09-49f5-499c-aeed-6fd2d1be0217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_db0e53c2-389b-4d3c-8c5a-05bc01c06517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_db0e53c2-389b-4d3c-8c5a-05bc01c06517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_74c43527-cb11-4777-b701-de8c1947e329" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52730d67-3928-4ca9-b0e8-5824c537da17" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_74c43527-cb11-4777-b701-de8c1947e329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c9f1b48-e5e3-4361-b7e0-eb81de184008" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_6454a478-dadd-4b1e-a82f-653305ce5683" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c9f1b48-e5e3-4361-b7e0-eb81de184008" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_6454a478-dadd-4b1e-a82f-653305ce5683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_7921803f-1e8d-4acf-938a-77ab45e67d1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c9f1b48-e5e3-4361-b7e0-eb81de184008" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_7921803f-1e8d-4acf-938a-77ab45e67d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_3b72eafe-080b-4910-8288-26e7d184eaa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c9f1b48-e5e3-4361-b7e0-eb81de184008" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_3b72eafe-080b-4910-8288-26e7d184eaa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_3c059a57-84d7-416a-be04-8b893170129a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3c9f1b48-e5e3-4361-b7e0-eb81de184008" xlink:to="loc_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent_3c059a57-84d7-416a-be04-8b893170129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5a38382-da7a-4c67-96ef-4347b9bf1db8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_2fac233a-6fab-414d-80cb-0ee6290464d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f5a38382-da7a-4c67-96ef-4347b9bf1db8" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_2fac233a-6fab-414d-80cb-0ee6290464d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_1709aa8d-516d-4f06-a873-0d477fb7555a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTransfersAndChanges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_2fac233a-6fab-414d-80cb-0ee6290464d9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges_1709aa8d-516d-4f06-a873-0d477fb7555a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1e6a6b78-0520-4387-a7ef-b5308f0b79c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_2fac233a-6fab-414d-80cb-0ee6290464d9" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_1e6a6b78-0520-4387-a7ef-b5308f0b79c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_29d1177a-1b96-48da-9ac9-d8adc7a08b1c" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_2fac233a-6fab-414d-80cb-0ee6290464d9" xlink:to="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_29d1177a-1b96-48da-9ac9-d8adc7a08b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_829d9050-51b1-4f4a-9c66-ee56e632ca27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_be443d44-0287-414c-af22-059e741be89c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_829d9050-51b1-4f4a-9c66-ee56e632ca27" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_be443d44-0287-414c-af22-059e741be89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_101cf3c1-8168-4d7e-99a1-fab93edb6f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_93d29b85-6be0-411f-9946-cd5007c49582" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_101cf3c1-8168-4d7e-99a1-fab93edb6f7a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_93d29b85-6be0-411f-9946-cd5007c49582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5d13eed3-6ecd-483b-b0a3-3ecd632d45a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_101cf3c1-8168-4d7e-99a1-fab93edb6f7a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_5d13eed3-6ecd-483b-b0a3-3ecd632d45a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_e8d33e1b-6ebf-4882-ae63-2ebea5d593a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_101cf3c1-8168-4d7e-99a1-fab93edb6f7a" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock_e8d33e1b-6ebf-4882-ae63-2ebea5d593a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_2a9a26e1-290b-47b9-b726-3d2ab10f9c02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_101cf3c1-8168-4d7e-99a1-fab93edb6f7a" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_2a9a26e1-290b-47b9-b726-3d2ab10f9c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_357a3f26-01bb-4154-b558-f03bc11f3cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_357a3f26-01bb-4154-b558-f03bc11f3cf8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:to="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionAxis_f51d7868-480a-4f4b-afdf-91b32ee1401e" xlink:to="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionDomesticMember_1f065410-e7c7-4fe8-9164-e35d14b836d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionDomesticMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:to="loc_us-gaap_GeographicDistributionDomesticMember_1f065410-e7c7-4fe8-9164-e35d14b836d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicDistributionForeignMember_79c8de35-3ab7-46bc-bc87-5c3cdbd752bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeographicDistributionForeignMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicDistributionDomain_1246daae-e608-4551-b1d0-b11f9f0abc81" xlink:to="loc_us-gaap_GeographicDistributionForeignMember_79c8de35-3ab7-46bc-bc87-5c3cdbd752bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:to="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_855e4e21-7452-4981-9753-e6ccc6945e2d" xlink:to="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_InstrumentsandAccessoriesMember_c4c224f6-4b69-483d-9d65-3000bee554f4" xlink:href="isrg-20210331.xsd#isrg_InstrumentsandAccessoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:to="loc_isrg_InstrumentsandAccessoriesMember_c4c224f6-4b69-483d-9d65-3000bee554f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SystemsMember_4c172d8c-1541-4409-a53e-c283230d691a" xlink:href="isrg-20210331.xsd#isrg_SystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:to="loc_isrg_SystemsMember_4c172d8c-1541-4409-a53e-c283230d691a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ServicesMember_e450c737-0a4d-4367-8f21-77e29a7f62b2" xlink:href="isrg-20210331.xsd#isrg_ServicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0d051a71-6cd6-4db3-9495-3daec68d70a0" xlink:to="loc_isrg_ServicesMember_e450c737-0a4d-4367-8f21-77e29a7f62b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e2218a9f-27a4-457b-91b3-ad0186c8299e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_35ecc24b-b1e2-4245-b6cb-d181f9449cd3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e2218a9f-27a4-457b-91b3-ad0186c8299e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33dfe2fd-d4fe-4f3a-8895-7aaf2a605759" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e2218a9f-27a4-457b-91b3-ad0186c8299e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33dfe2fd-d4fe-4f3a-8895-7aaf2a605759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7c96b16-ff9e-4f24-8e87-90d4b4cb46d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_8593a1e8-0c91-4c79-9f93-6667726b485f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7c96b16-ff9e-4f24-8e87-90d4b4cb46d5" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_8593a1e8-0c91-4c79-9f93-6667726b485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7c96b16-ff9e-4f24-8e87-90d4b4cb46d5" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_be2940af-2f41-4432-a3d3-5cf1a26e15bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_be2940af-2f41-4432-a3d3-5cf1a26e15bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_54f52554-c9d8-41df-82d5-e6f688e145f9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_223cc1fd-cf67-427a-8f46-4b4208c04e57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_1d3e7e7e-6ac7-425b-9d0f-69cf27552edc" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_223cc1fd-cf67-427a-8f46-4b4208c04e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ce8519c8-711b-4663-a61d-ca6f5c78cfd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7c96b16-ff9e-4f24-8e87-90d4b4cb46d5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ce8519c8-711b-4663-a61d-ca6f5c78cfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_3631362f-54eb-4c41-a674-75d0f9238759" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7c96b16-ff9e-4f24-8e87-90d4b4cb46d5" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation_3631362f-54eb-4c41-a674-75d0f9238759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_37f5bcb2-e480-4384-9730-9ea4581fe3e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7c96b16-ff9e-4f24-8e87-90d4b4cb46d5" xlink:to="loc_us-gaap_CapitalizedContractCostNet_37f5bcb2-e480-4384-9730-9ea4581fe3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95569c36-7624-43e0-8428-60cea24b6e29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_af3d4d54-df0d-4df0-bad7-decb4808cdf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95569c36-7624-43e0-8428-60cea24b6e29" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_af3d4d54-df0d-4df0-bad7-decb4808cdf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_95ea6c05-67a8-4257-9035-a335a53b9b66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_95569c36-7624-43e0-8428-60cea24b6e29" xlink:to="loc_us-gaap_ContractWithCustomerLiability_95ea6c05-67a8-4257-9035-a335a53b9b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54a0bc7b-73e8-4196-8bbd-808f888bba3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseIncome_896e5f40-3faf-4cbc-beca-cd525d3841c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54a0bc7b-73e8-4196-8bbd-808f888bba3c" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseIncome_896e5f40-3faf-4cbc-beca-cd525d3841c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_53b49c42-933c-4a6f-abb3-b60e5fc53ce9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54a0bc7b-73e8-4196-8bbd-808f888bba3c" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_53b49c42-933c-4a6f-abb3-b60e5fc53ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASES" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d6e61794-567d-46b5-8aee-01e14de198b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeasesTextBlock_3f89174b-660e-4f5a-b0fd-ac9bbbcf7ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d6e61794-567d-46b5-8aee-01e14de198b5" xlink:to="loc_us-gaap_LessorSalesTypeLeasesTextBlock_3f89174b-660e-4f5a-b0fd-ac9bbbcf7ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_21b5a69e-1d58-450e-80c9-8fedf2f1d726" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock_59dac50b-85d9-4d18-a4af-52e7f9b07ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21b5a69e-1d58-450e-80c9-8fedf2f1d726" xlink:to="loc_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock_59dac50b-85d9-4d18-a4af-52e7f9b07ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_dd6ba3d7-efdf-4f72-9468-aa4640bc8ada" xlink:href="isrg-20210331.xsd#isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21b5a69e-1d58-450e-80c9-8fedf2f1d726" xlink:to="loc_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock_dd6ba3d7-efdf-4f72-9468-aa4640bc8ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_850663d0-3602-47d4-9c79-f2eda736d43d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21b5a69e-1d58-450e-80c9-8fedf2f1d726" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock_850663d0-3602-47d4-9c79-f2eda736d43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_547b0178-473d-4d3f-8330-823655101f93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21b5a69e-1d58-450e-80c9-8fedf2f1d726" xlink:to="loc_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock_547b0178-473d-4d3f-8330-823655101f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESLeaseReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_05ef45e3-2ccb-463c-b7df-43c1723e4f36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCapitalLeasedAsssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_05ef45e3-2ccb-463c-b7df-43c1723e4f36" xlink:to="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_45e4e8fc-af51-4008-aa28-3024d35cc13f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_32e36477-296b-4fc2-9494-d242fdba4b82" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_32e36477-296b-4fc2-9494-d242fdba4b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_e5f1baf9-e710-4596-bc33-1de3365a052b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ce1bbd2b-1231-4fbd-be51-f8670d6235c8" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_e5f1baf9-e710-4596-bc33-1de3365a052b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CapitalLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalLeasedAsssetsTable_75152327-5d74-4c2b-8ae4-18c8ba48dbfe" xlink:to="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_5310feb8-91df-4ea5-9179-59b1bb931efd" xlink:href="isrg-20210331.xsd#isrg_SalesTypeLeaseGrossInvestmentInLease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_isrg_SalesTypeLeaseGrossInvestmentInLease_5310feb8-91df-4ea5-9179-59b1bb931efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalestypeLeaseDeferredSellingProfit_ac171272-dcd2-4aed-a953-cc4d6e1914a1" xlink:href="isrg-20210331.xsd#isrg_SalestypeLeaseDeferredSellingProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_isrg_SalestypeLeaseDeferredSellingProfit_ac171272-dcd2-4aed-a953-cc4d6e1914a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_05fba6a0-b579-43a7-8c23-eba179fe98bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_05fba6a0-b579-43a7-8c23-eba179fe98bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_c2636e7c-4b65-4126-ad2d-34b53ad8bc08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss_c2636e7c-4b65-4126-ad2d-34b53ad8bc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseLeaseReceivable_22c9b4e8-4db3-43b0-8049-c2e59811ff09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseLeaseReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalLeasedAssetsLineItems_d5e733a4-8659-47d9-b73f-9459a04b8c59" xlink:to="loc_us-gaap_SalesTypeLeaseLeaseReceivable_22c9b4e8-4db3-43b0-8049-c2e59811ff09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESLeaseReceivablesDetails_1"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_2f003daf-2347-4311-9312-557f66b0530a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear_2f003daf-2347-4311-9312-557f66b0530a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_a115271d-1a2d-4f80-b75a-a2e503e2f200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths_a115271d-1a2d-4f80-b75a-a2e503e2f200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_4f966f1e-cd97-4b13-bb1a-a900b598d927" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears_4f966f1e-cd97-4b13-bb1a-a900b598d927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_02a0f1cb-9a31-40d9-bd7d-b72c2ab2ffa6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears_02a0f1cb-9a31-40d9-bd7d-b72c2ab2ffa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_05b9f8f0-581f-44b8-857a-ea36f8e222fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears_05b9f8f0-581f-44b8-857a-ea36f8e222fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_24e09cd0-c283-4a8a-ba61-febe05daa8ae" xlink:href="isrg-20210331.xsd#isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter_24e09cd0-c283-4a8a-ba61-febe05daa8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_2d030022-04aa-4e67-a5fe-26d61506f461" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7b0258d3-b8bc-4bc2-b309-340bd53dcbea" xlink:to="loc_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived_2d030022-04aa-4e67-a5fe-26d61506f461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESCreditQualityIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7662be93-5001-47fc-aca6-f1193a199149" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7662be93-5001-47fc-aca6-f1193a199149" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_496f0905-bfd9-463a-bee0-2ffb52d8b345" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_HighMember_21dca812-90ef-458a-aad8-1a2d236309e4" xlink:href="isrg-20210331.xsd#isrg_HighMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:to="loc_isrg_HighMember_21dca812-90ef-458a-aad8-1a2d236309e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ModerateMember_66f9421c-aa55-4dbe-a664-38824221d456" xlink:href="isrg-20210331.xsd#isrg_ModerateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:to="loc_isrg_ModerateMember_66f9421c-aa55-4dbe-a664-38824221d456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_LowMember_0c9a0ee5-fd6a-47e8-b473-8decb076a86f" xlink:href="isrg-20210331.xsd#isrg_LowMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_834b1907-1412-4d25-8266-65fe05ae3f11" xlink:to="loc_isrg_LowMember_0c9a0ee5-fd6a-47e8-b473-8decb076a86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable_bf1ae8f8-c3c7-47d4-a223-077c87edd15e" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_86d7088d-9461-43d6-a82a-29c58384c587" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear_86d7088d-9461-43d6-a82a-29c58384c587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_c9ed3e05-ff3d-4b87-8fbe-6dab463fbb59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear_c9ed3e05-ff3d-4b87-8fbe-6dab463fbb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_5bb69f4f-c123-445f-8e02-672e59be6cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear_5bb69f4f-c123-445f-8e02-672e59be6cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_43dba50c-c991-4b58-b6ba-3a46503e444d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear_43dba50c-c991-4b58-b6ba-3a46503e444d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_94272768-6f9f-4b92-8243-fad0b7776f74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear_94272768-6f9f-4b92-8243-fad0b7776f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_82339599-1b2f-4245-945b-2f67e1b8040c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear_82339599-1b2f-4245-945b-2f67e1b8040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_305531b2-707e-4b3e-805c-399cf03613a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesTypeLeaseNetInvestmentInLease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems_d8c330dd-f639-4ba8-b011-0e009471a9f9" xlink:to="loc_us-gaap_SalesTypeLeaseNetInvestmentInLease_305531b2-707e-4b3e-805c-399cf03613a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#LEASESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ea608b53-1b38-4a55-9928-6a5ecb0b0544" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea608b53-1b38-4a55-9928-6a5ecb0b0544" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:to="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d80bf139-04b1-4fe9-a203-763d56b24980" xlink:to="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5255fe19-3291-4dc7-a0ed-31945a2b13c1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:to="loc_srt_MinimumMember_5255fe19-3291-4dc7-a0ed-31945a2b13c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c12af629-44d8-44cc-bbc6-96beadf8ded2" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0a1eae2-e286-4425-923a-e4ebe64938d9" xlink:to="loc_srt_MaximumMember_c12af629-44d8-44cc-bbc6-96beadf8ded2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_46859c72-0b8c-4097-8d61-a5419954da15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d763031c-5d84-4aca-96a2-a80cf55c12e6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_46859c72-0b8c-4097-8d61-a5419954da15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_69dc0618-5f44-42e5-af5d-bfe63f110443" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LessorSalesTypeLeaseTermOfContract1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_46859c72-0b8c-4097-8d61-a5419954da15" xlink:to="loc_us-gaap_LessorSalesTypeLeaseTermOfContract1_69dc0618-5f44-42e5-af5d-bfe63f110443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d01b4d8b-15b4-4208-92eb-056117a69a40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e81f0a32-e432-4b30-8617-3ea754dedd9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d01b4d8b-15b4-4208-92eb-056117a69a40" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_e81f0a32-e432-4b30-8617-3ea754dedd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de27ea07-380f-4368-a6ac-c21c296523bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_db0e4c7e-8c7f-4d75-b2b0-2a270489e88a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de27ea07-380f-4368-a6ac-c21c296523bf" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_db0e4c7e-8c7f-4d75-b2b0-2a270489e88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_38cc0af3-25f6-4b84-9512-6579c856a3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de27ea07-380f-4368-a6ac-c21c296523bf" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_38cc0af3-25f6-4b84-9512-6579c856a3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5a0ad8b5-9eb8-48c3-94d9-684a11ad8182" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_de27ea07-380f-4368-a6ac-c21c296523bf" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5a0ad8b5-9eb8-48c3-94d9-684a11ad8182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#IntangibleAssetsGoodwillandOtherDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_970b5918-1b66-4067-bff8-43d74a52bd76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_970b5918-1b66-4067-bff8-43d74a52bd76" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_19b9a7a6-07be-4f48-ba7d-5d92dea135c5" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ChindexMember_9ae876b4-136a-47e6-aa4b-eb5b24074bb7" xlink:href="isrg-20210331.xsd#isrg_ChindexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:to="loc_isrg_ChindexMember_9ae876b4-136a-47e6-aa4b-eb5b24074bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SchllyFiberopticGmbHMember_7f18c2ba-30a5-45d2-bcdc-6c00934b56b5" xlink:href="isrg-20210331.xsd#isrg_SchllyFiberopticGmbHMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_442e01f1-d8ad-4791-9066-fd0a4ed0b9ae" xlink:to="loc_isrg_SchllyFiberopticGmbHMember_7f18c2ba-30a5-45d2-bcdc-6c00934b56b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_dd046b6b-7ab3-4648-85a5-030a74b1be63" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ManufacturingProcessTechnologyMember_6c5fa7c9-6c28-4067-a135-1e23e135f13f" xlink:href="isrg-20210331.xsd#isrg_ManufacturingProcessTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:to="loc_isrg_ManufacturingProcessTechnologyMember_6c5fa7c9-6c28-4067-a135-1e23e135f13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_f6479ba1-90aa-4304-b500-d380b335199b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_698f212a-1e9c-4872-980a-8598a5dfb983" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_f6479ba1-90aa-4304-b500-d380b335199b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c39ab849-3494-45c9-b0fa-366e72371b45" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_db21ebba-35b7-4235-95e3-bfe2d7156c5d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_db21ebba-35b7-4235-95e3-bfe2d7156c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_f3e65d3a-91ac-40d8-b543-c3428a15a817" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments_f3e65d3a-91ac-40d8-b543-c3428a15a817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_10068f08-0bb4-4ade-9494-e378706542ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_10068f08-0bb4-4ade-9494-e378706542ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_c4841906-73e2-4efd-8fa2-b712e0c78038" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome_c4841906-73e2-4efd-8fa2-b712e0c78038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_a2ea3b53-b220-4b12-be12-530740449998" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome_a2ea3b53-b220-4b12-be12-530740449998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9b5f7f32-5fe8-44c6-84b6-6f3100931991" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9b5f7f32-5fe8-44c6-84b6-6f3100931991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_a989fcee-e971-4472-b063-9b335ee25013" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense_a989fcee-e971-4472-b063-9b335ee25013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_DeferredPurchaseConsiderationPayments_8efb004b-7a83-4448-bbe2-f44b53c7427e" xlink:href="isrg-20210331.xsd#isrg_DeferredPurchaseConsiderationPayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_DeferredPurchaseConsiderationPayments_8efb004b-7a83-4448-bbe2-f44b53c7427e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_e8d4c88f-5977-4dab-bbe3-daa2a6e136da" xlink:href="isrg-20210331.xsd#isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets_e8d4c88f-5977-4dab-bbe3-daa2a6e136da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc5a95de-3371-43bd-983f-7adf6c4f7fed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fc5a95de-3371-43bd-983f-7adf6c4f7fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334b34a5-b115-4998-8c4a-1ee636c027e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_334b34a5-b115-4998-8c4a-1ee636c027e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a43a1de6-e4f0-474f-9e50-67df790154ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_a43a1de6-e4f0-474f-9e50-67df790154ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1fc0a080-cde4-41f7-9bd9-4114715ecdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_Goodwill_1fc0a080-cde4-41f7-9bd9-4114715ecdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4055f96-d695-4af1-96db-89407c7841b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_e4055f96-d695-4af1-96db-89407c7841b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_13aed1c0-6b58-474c-a0d0-7f6d6b495269" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_13aed1c0-6b58-474c-a0d0-7f6d6b495269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_54c28874-e1dd-4dec-b4dd-a129c0bf18c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e13592e0-0811-4b8d-9af4-75ec8792abae" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_54c28874-e1dd-4dec-b4dd-a129c0bf18c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8ad62879-0c60-401a-b87e-ec45e9a9364d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_01495077-bfe5-4433-9843-47ef6b00de96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8ad62879-0c60-401a-b87e-ec45e9a9364d" xlink:to="loc_us-gaap_GoodwillRollForward_01495077-bfe5-4433-9843-47ef6b00de96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cde3a012-9fcf-4538-befa-09c67b5fcc60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_01495077-bfe5-4433-9843-47ef6b00de96" xlink:to="loc_us-gaap_Goodwill_cde3a012-9fcf-4538-befa-09c67b5fcc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_03e752f6-45ff-4ab3-9783-57f7d46507f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_01495077-bfe5-4433-9843-47ef6b00de96" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_03e752f6-45ff-4ab3-9783-57f7d46507f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_39824cad-9fa3-4e16-9f5f-c6909a51cb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_01495077-bfe5-4433-9843-47ef6b00de96" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_39824cad-9fa3-4e16-9f5f-c6909a51cb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_932f2f08-07d9-4bbe-ae31-825230e1a285" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_01495077-bfe5-4433-9843-47ef6b00de96" xlink:to="loc_us-gaap_Goodwill_932f2f08-07d9-4bbe-ae31-825230e1a285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbb690ea-5315-465b-a890-e761f248865a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbb690ea-5315-465b-a890-e761f248865a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4fcbded9-06f5-4f2e-899a-ee4640ff9e65" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_19186d36-6d93-4c3a-9eb7-a07d3b76f73c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_19186d36-6d93-4c3a-9eb7-a07d3b76f73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_de8be163-ee6e-438c-a9b7-e71cacea259c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:to="loc_us-gaap_DistributionRightsMember_de8be163-ee6e-438c-a9b7-e71cacea259c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_103baa8b-0f64-431d-b05c-2dba9bc98de4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ba47dd94-0f75-4012-b5bf-47a6a1c8c5a7" xlink:to="loc_us-gaap_CustomerRelationshipsMember_103baa8b-0f64-431d-b05c-2dba9bc98de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_25bfb0c9-e225-4c20-abe0-c8f3e9709d45" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dbf15fde-dc2b-439e-9d88-803a3afd086b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_dbf15fde-dc2b-439e-9d88-803a3afd086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_292482e7-ec32-4f99-977c-67145cecc10f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_292482e7-ec32-4f99-977c-67145cecc10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8db67e2e-d6f3-443d-b080-b48030d7d451" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0373bd38-571b-48b6-b216-414e6a0fffd0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8db67e2e-d6f3-443d-b080-b48030d7d451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ed17bdd3-b9cd-4843-a822-b351d962929f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ed17bdd3-b9cd-4843-a822-b351d962929f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_544c743c-3c12-4b60-a1b0-e05afb2c6797" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_544c743c-3c12-4b60-a1b0-e05afb2c6797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c691fd26-62ff-4436-ada8-f94caa16a6f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c691fd26-62ff-4436-ada8-f94caa16a6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_08b945fb-923f-43da-b27b-633e22f8da94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_08b945fb-923f-43da-b27b-633e22f8da94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_75d1c824-658b-4652-a8a1-201224849bb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_75d1c824-658b-4652-a8a1-201224849bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_1e243b01-98d6-48a8-bec1-2f4a9c29d685" xlink:href="isrg-20210331.xsd#isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_1e243b01-98d6-48a8-bec1-2f4a9c29d685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c042fdbc-68e0-43f6-b41e-9fbee9b6193c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0307c6fc-1415-4fef-9074-6b9f472f9b60" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c042fdbc-68e0-43f6-b41e-9fbee9b6193c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="simple" xlink:href="isrg-20210331.xsd#CONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/CONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_675e1852-1885-4227-ac77-bb50e57cfe65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4b600257-cd33-4cf1-b1df-ca5d0665e608" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_675e1852-1885-4227-ac77-bb50e57cfe65" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4b600257-cd33-4cf1-b1df-ca5d0665e608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_be5f71cc-303e-45ab-a4b8-34b2b6891e6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_81372471-5120-4f8d-ab39-e744f47c8aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_be5f71cc-303e-45ab-a4b8-34b2b6891e6f" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_81372471-5120-4f8d-ab39-e744f47c8aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b3a6cdd6-a1c7-4067-9bf1-4261c33fbf89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_6b075c65-63b4-4868-9246-da1ab57e0018" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b3a6cdd6-a1c7-4067-9bf1-4261c33fbf89" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_6b075c65-63b4-4868-9246-da1ab57e0018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fb3ea3b4-92f3-41c6-8d5c-10844d6f8280" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b3a6cdd6-a1c7-4067-9bf1-4261c33fbf89" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fb3ea3b4-92f3-41c6-8d5c-10844d6f8280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0a8d30f9-5ebf-4bcc-93d2-73b55263f345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b3a6cdd6-a1c7-4067-9bf1-4261c33fbf89" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_0a8d30f9-5ebf-4bcc-93d2-73b55263f345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8b9d6edb-bda1-4569-9c0b-a4e28d11772f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8b9d6edb-bda1-4569-9c0b-a4e28d11772f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b999d467-c28b-48dd-88cc-ba70aaca8956" xlink:to="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4ac3b520-6bd1-43b4-8f90-338ca4e25222" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_CommonStockMember_4ac3b520-6bd1-43b4-8f90-338ca4e25222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_89f02ad2-64d7-4d50-a3ec-05ff8e1cbf99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_89f02ad2-64d7-4d50-a3ec-05ff8e1cbf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c7eda51a-a227-4d6a-9d62-eec914c6c564" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_RetainedEarningsMember_c7eda51a-a227-4d6a-9d62-eec914c6c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df90fae4-4b6d-4d98-8785-eedf3567937b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df90fae4-4b6d-4d98-8785-eedf3567937b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_ed1f7354-0dc1-4e4c-8df0-7407a1700fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_ParentMember_ed1f7354-0dc1-4e4c-8df0-7407a1700fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_eee664e4-f765-4e3b-8e21-9a0177f80fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46c27115-7d16-4f7d-9bad-1e1e4c92a81a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_eee664e4-f765-4e3b-8e21-9a0177f80fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_4421ce60-1496-4fb1-a563-2284bdd25c3e" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionAxis_b99a5db4-f218-470d-872d-447105e06d2d" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_4421ce60-1496-4fb1-a563-2284bdd25c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3de1293e-2b07-4b7f-97a5-9477bc9732c0" xlink:href="isrg-20210331.xsd#isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_CumulativeEffectPeriodOfAdoptionDomain_4421ce60-1496-4fb1-a563-2284bdd25c3e" xlink:to="loc_isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3de1293e-2b07-4b7f-97a5-9477bc9732c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_b6024669-2e26-4cab-95d3-5eb389809b55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6e4fee69-6819-4d91-a015-888400735953" xlink:to="loc_us-gaap_ClassOfStockLineItems_b6024669-2e26-4cab-95d3-5eb389809b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_b6024669-2e26-4cab-95d3-5eb389809b55" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d6db9dbd-85aa-4ac6-b830-634d790cc0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d6db9dbd-85aa-4ac6-b830-634d790cc0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2db937cf-4342-4ef9-948d-58ea25ad23e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2db937cf-4342-4ef9-948d-58ea25ad23e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ef789c97-d15f-422e-b2df-6dc6f2270309" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ef789c97-d15f-422e-b2df-6dc6f2270309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b15f8d39-ac73-4a0a-a527-cbd979ab4fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_b15f8d39-ac73-4a0a-a527-cbd979ab4fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_47cba255-6f0c-4b34-a5c9-78e6a8ee2fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_47cba255-6f0c-4b34-a5c9-78e6a8ee2fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dbc2d3bc-c16b-48de-b876-fb4936af7881" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_dbc2d3bc-c16b-48de-b876-fb4936af7881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f857b31-344b-4517-94f2-55ff03faa2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7f857b31-344b-4517-94f2-55ff03faa2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_89d7acc9-d6c3-4b07-98d7-4ffe5452505d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_89d7acc9-d6c3-4b07-98d7-4ffe5452505d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_31bf2246-66ba-4bcc-bfce-9871c500ee24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_31bf2246-66ba-4bcc-bfce-9871c500ee24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_039dc1d6-89e3-455e-bb5e-f8787cc05bfe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_NetIncomeLoss_039dc1d6-89e3-455e-bb5e-f8787cc05bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cdecf637-76c3-4830-a0e2-f628d0533893" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cdecf637-76c3-4830-a0e2-f628d0533893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_58cf7dc7-f281-42ec-8da6-0d61448c85e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_58cf7dc7-f281-42ec-8da6-0d61448c85e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_451eb4e4-de13-4a90-b63e-260e2a2c67fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_451eb4e4-de13-4a90-b63e-260e2a2c67fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e2ad2360-5f00-43d2-b727-7a5d3a381329" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e2ad2360-5f00-43d2-b727-7a5d3a381329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_410a8d16-e384-4f6e-aa31-4949139d8346" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9f56b86d-8c05-4c16-99a5-26d6b40fe411" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_410a8d16-e384-4f6e-aa31-4949139d8346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_25a44fb8-6793-4c07-a025-04ff1b4dec3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_25a44fb8-6793-4c07-a025-04ff1b4dec3d" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_96636b58-b1c1-4ff2-9dfc-a660f66ee31d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6c7cf998-d513-4245-9f6c-16b2bf80190c" xlink:to="loc_us-gaap_EquityComponentDomain_96636b58-b1c1-4ff2-9dfc-a660f66ee31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0654333f-6f1d-419d-a6c9-0274ec5adb97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_96636b58-b1c1-4ff2-9dfc-a660f66ee31d" xlink:to="loc_us-gaap_CommonStockMember_0654333f-6f1d-419d-a6c9-0274ec5adb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_13701077-5f86-42a7-bf64-7300b4de0391" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cf00b6c2-1863-49a4-873b-b6d14cabf9b7" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_13701077-5f86-42a7-bf64-7300b4de0391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_1f504cd6-e2fb-4b50-9b75-690e88072ca9" xlink:href="isrg-20210331.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_13701077-5f86-42a7-bf64-7300b4de0391" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_1f504cd6-e2fb-4b50-9b75-690e88072ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_ad44323d-dfa8-4ca8-bafe-a2c841d9808e" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d7ac8fbe-b53a-422c-9de0-b18d8b7adf2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_d7ac8fbe-b53a-422c-9de0-b18d8b7adf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0f480ee5-8508-4f67-844c-172dfb46b36a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_0f480ee5-8508-4f67-844c-172dfb46b36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_43f55e7c-17c4-4346-bc60-fe6259b119c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_796fb5c9-ed85-4e57-8134-e8dd311e45f5" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_43f55e7c-17c4-4346-bc60-fe6259b119c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fc74fb4c-e2ac-41aa-b09e-8fe99be23d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fc74fb4c-e2ac-41aa-b09e-8fe99be23d9e" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_d86471da-805e-496e-bd2b-d0af8b33c766" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CommonStockRepurchaseProgramMember_ac870c15-0192-4f5e-a6e6-2decc06f041e" xlink:href="isrg-20210331.xsd#isrg_CommonStockRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:to="loc_isrg_CommonStockRepurchaseProgramMember_ac870c15-0192-4f5e-a6e6-2decc06f041e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccelerateShareRepurchaseProgramMember_44162600-0919-44f4-9937-b9768ea870c5" xlink:href="isrg-20210331.xsd#isrg_AccelerateShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_a514b4ba-47fa-42f2-be17-598b1edf7542" xlink:to="loc_isrg_AccelerateShareRepurchaseProgramMember_44162600-0919-44f4-9937-b9768ea870c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ea8ceeaf-9bff-4ed2-a176-55c7fc4c568d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_52168d82-fce4-4e66-a85d-f1620e8c6799" xlink:to="loc_us-gaap_EquityComponentDomain_ea8ceeaf-9bff-4ed2-a176-55c7fc4c568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8fb70edf-dc0d-4d90-b4cc-a33f5b20a40a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ea8ceeaf-9bff-4ed2-a176-55c7fc4c568d" xlink:to="loc_us-gaap_CommonStockMember_8fb70edf-dc0d-4d90-b4cc-a33f5b20a40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_724c2b76-06f4-49c7-a892-79ce5304d36a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9c0ede49-833f-44f2-bb74-e83c10196164" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_724c2b76-06f4-49c7-a892-79ce5304d36a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_GoldmanSachsCo.Member_3110860e-a0b2-4404-81ce-55c55e4512c0" xlink:href="isrg-20210331.xsd#isrg_GoldmanSachsCo.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_724c2b76-06f4-49c7-a892-79ce5304d36a" xlink:to="loc_isrg_GoldmanSachsCo.Member_3110860e-a0b2-4404-81ce-55c55e4512c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_f0460715-905b-4bf5-bc19-5956b81a656b" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1500d928-1f93-4a4c-ac6d-31bbc6c78d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1500d928-1f93-4a4c-ac6d-31bbc6c78d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_a1aaaa82-9bcf-4b8f-9b8f-ab6a90a613ff" xlink:href="isrg-20210331.xsd#isrg_StockRepurchaseProgramincreasedtoauthorizedamount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_isrg_StockRepurchaseProgramincreasedtoauthorizedamount_a1aaaa82-9bcf-4b8f-9b8f-ab6a90a613ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7c9a6f0a-ca68-4bd9-95b5-8ff169b41d4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_7c9a6f0a-ca68-4bd9-95b5-8ff169b41d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_ce49441e-a8fd-4c00-91c9-453979b5d746" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_ce49441e-a8fd-4c00-91c9-453979b5d746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_623b2767-d9e1-4f90-a106-185d2bff677b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_623b2767-d9e1-4f90-a106-185d2bff677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_0ae87ad1-0633-49d5-83f2-e36512942e3c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_7d676143-e1c6-4c6e-8c20-7c50ca9d91c8" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_0ae87ad1-0633-49d5-83f2-e36512942e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bcb422b2-30d8-4f84-8ac4-00c69b5875d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:href="isrg-20210331.xsd#isrg_AccumulatedOtherComprehensiveIncomeRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bcb422b2-30d8-4f84-8ac4-00c69b5875d9" xlink:to="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:href="isrg-20210331.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:to="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_b23a46f1-9cbb-48a7-958c-fcc79a0bdb96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_b23a46f1-9cbb-48a7-958c-fcc79a0bdb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_9c2fd827-87ae-4645-aaef-af5b8b1e8ac1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_9c2fd827-87ae-4645-aaef-af5b8b1e8ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_86e855fd-6ad3-422e-bfed-58d7e8e84df6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_86e855fd-6ad3-422e-bfed-58d7e8e84df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_909da767-1641-4863-a120-e8c74d73c5af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax_909da767-1641-4863-a120-e8c74d73c5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_bcd11626-cb68-49ce-ba05-c24fa934c370" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract_4ade0034-581b-4119-a914-1ae0d395b268" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_bcd11626-cb68-49ce-ba05-c24fa934c370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:href="isrg-20210331.xsd#isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:to="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_09b15fce-9c7f-4bfd-a177-3ef817b61c23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_09b15fce-9c7f-4bfd-a177-3ef817b61c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_bf6d9ce5-c7c3-47b0-b90c-eba926ebd0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_bf6d9ce5-c7c3-47b0-b90c-eba926ebd0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_f1fe6e27-63b7-4a8d-b4b6-8487640cabce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_f1fe6e27-63b7-4a8d-b4b6-8487640cabce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_78c00104-d2b1-42d5-bdbf-5768aec6b347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_78c00104-d2b1-42d5-bdbf-5768aec6b347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_159b652a-f730-41b8-ae15-110b9c892a07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract_6faca740-45be-4f1e-bdfb-42a62679e82e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_159b652a-f730-41b8-ae15-110b9c892a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CumulativeTranslationAdjustmentSummaryRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:to="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d5455c0e-83c8-4985-8212-e6716ca2ed15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d5455c0e-83c8-4985-8212-e6716ca2ed15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_7bce9c5d-244a-413a-98d3-402fd1380de7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_7bce9c5d-244a-413a-98d3-402fd1380de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_99d2a0a8-2f64-4fad-ab4e-1b3549258af2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax_99d2a0a8-2f64-4fad-ab4e-1b3549258af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cd16ed2e-bbf2-4973-a481-d84f77733bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_cd16ed2e-bbf2-4973-a481-d84f77733bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d1763a14-6bfa-4d39-b48b-5578c2bfb1ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward_007537d0-25f6-4b1e-874d-0c0b9f05ed0e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_d1763a14-6bfa-4d39-b48b-5578c2bfb1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_51f4cb7c-c229-47e6-9d50-79616054bd01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_51f4cb7c-c229-47e6-9d50-79616054bd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_bcb4577c-8e5f-4c68-88cf-f04695f9ec5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_bcb4577c-8e5f-4c68-88cf-f04695f9ec5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_29eba8a8-064c-45e6-88dc-81bd139183ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_29eba8a8-064c-45e6-88dc-81bd139183ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_5b09e96b-1175-4dc9-8f48-42fbdbf0336a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_5b09e96b-1175-4dc9-8f48-42fbdbf0336a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e5f7c26d-ac5e-4512-b266-1c49fbfe162b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_3698e901-d15c-409a-8180-d47b3146a4b7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e5f7c26d-ac5e-4512-b266-1c49fbfe162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_AccumulatedOtherComprehensiveIncomeRollForward_fbebf70d-727e-4280-b924-b8d55ea14bdd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_825fad82-aaa7-4993-87fe-c91269d4497e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_825fad82-aaa7-4993-87fe-c91269d4497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_98a84558-55b5-4ccb-8dd0-e4e5d5a1b5f9" xlink:href="isrg-20210331.xsd#isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:to="loc_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax_98a84558-55b5-4ccb-8dd0-e4e5d5a1b5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9d0424b9-9f13-4ae9-b85d-74a44d77a3bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_9d0424b9-9f13-4ae9-b85d-74a44d77a3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f69cb5c-c5e1-443e-a9d6-fdf8f5dc5bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f69cb5c-c5e1-443e-a9d6-fdf8f5dc5bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ea0011d8-ed80-4185-b64c-ff724dae7d76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_2b7ee655-e4ca-4ea1-ae36-9d9b3c47cc23" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ea0011d8-ed80-4185-b64c-ff724dae7d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bc8152e9-ceec-4a0b-a610-567602e6c175" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bcb422b2-30d8-4f84-8ac4-00c69b5875d9" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bc8152e9-ceec-4a0b-a610-567602e6c175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11ce25e0-94f5-4bed-8f6d-a280cac0bc3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_13e979ff-54dc-4c33-8444-c6dfa3940fe3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11ce25e0-94f5-4bed-8f6d-a280cac0bc3a" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_13e979ff-54dc-4c33-8444-c6dfa3940fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef695e0b-258d-4d0f-8513-a4aca1eed964" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9586186a-5d72-4c85-a579-eece2580e0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef695e0b-258d-4d0f-8513-a4aca1eed964" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_9586186a-5d72-4c85-a579-eece2580e0cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6200b350-dab7-47d7-a3f5-50e8015a23b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef695e0b-258d-4d0f-8513-a4aca1eed964" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_6200b350-dab7-47d7-a3f5-50e8015a23b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_5e3dda9a-0faf-4250-b40b-b1303e5aec6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef695e0b-258d-4d0f-8513-a4aca1eed964" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_5e3dda9a-0faf-4250-b40b-b1303e5aec6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_272e6a1b-5e72-4a79-b86b-b602526eed0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ef695e0b-258d-4d0f-8513-a4aca1eed964" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_272e6a1b-5e72-4a79-b86b-b602526eed0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b460ac10-ee41-4a8e-98fb-ce83ba48b6e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b460ac10-ee41-4a8e-98fb-ce83ba48b6e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:to="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ce2ec1bc-f1af-418e-81cd-3977c80c9895" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_60507e90-1d3a-400f-9a97-f53b575bd297" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_60507e90-1d3a-400f-9a97-f53b575bd297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_50c83497-425b-4c3d-9774-02e33b555a3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b85edf1-89f4-438f-b1df-80c28dc2c5b5" xlink:to="loc_us-gaap_EmployeeStockMember_50c83497-425b-4c3d-9774-02e33b555a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:to="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a33433e5-d9b6-42a4-a416-f4b3b6af1b48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b742d669-b089-492b-ac2a-98fb6b98dc94" xlink:to="loc_us-gaap_PlanNameDomain_a33433e5-d9b6-42a4-a416-f4b3b6af1b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_A2010IncentiveAwardPlanMember_ebe200c0-27e3-43af-88a8-93a11148327f" xlink:href="isrg-20210331.xsd#isrg_A2010IncentiveAwardPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a33433e5-d9b6-42a4-a416-f4b3b6af1b48" xlink:to="loc_isrg_A2010IncentiveAwardPlanMember_ebe200c0-27e3-43af-88a8-93a11148327f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_be64fed2-3117-4c25-a246-1a853adec375" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7685ee1d-01bc-42c7-b2ae-9ddd57e29f81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7685ee1d-01bc-42c7-b2ae-9ddd57e29f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_814b2891-aa0f-43d1-8d9c-33d3d2aa847a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_814b2891-aa0f-43d1-8d9c-33d3d2aa847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9d8a92c5-42f3-4487-92ea-4cdd5ec77208" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9d8a92c5-42f3-4487-92ea-4cdd5ec77208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e3eb2bec-1b5f-4cff-b0a5-25998374e18a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e3eb2bec-1b5f-4cff-b0a5-25998374e18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4558fb7e-b9e9-478f-97f9-ca2c148f4635" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_4558fb7e-b9e9-478f-97f9-ca2c148f4635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_37a3f869-7d1f-4548-9db3-12f11d4d10fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_37a3f869-7d1f-4548-9db3-12f11d4d10fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_53a0eba1-55f3-418c-97e5-300c7ba68c81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a599b8c9-7cf5-4554-9b9a-ca895a66e0cf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_53a0eba1-55f3-418c-97e5-300c7ba68c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_255c3882-d67b-4074-b43c-229a73822877" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_255c3882-d67b-4074-b43c-229a73822877" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6cdefcf-ff95-4e60-b0ea-63d49a3192dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6cdefcf-ff95-4e60-b0ea-63d49a3192dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ab04749b-2d0a-4b2c-9dd8-207244b1457f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ab04749b-2d0a-4b2c-9dd8-207244b1457f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ced9f916-b3b7-48f9-9807-f53f42a0b176" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ced9f916-b3b7-48f9-9807-f53f42a0b176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e8d54214-c4ec-4305-bca7-25802e585f24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e8d54214-c4ec-4305-bca7-25802e585f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c223435c-7b10-48d8-b1d4-f4a97e52cc07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_25dc9cf3-2fc1-41c4-b32c-5848955776b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c223435c-7b10-48d8-b1d4-f4a97e52cc07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:href="isrg-20210331.xsd#isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_255c3882-d67b-4074-b43c-229a73822877" xlink:to="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_97297ff2-e8bb-4afa-8be4-71d8d3d5de88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_97297ff2-e8bb-4afa-8be4-71d8d3d5de88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd641cd1-af70-431c-a310-c48995ff3dac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cd641cd1-af70-431c-a310-c48995ff3dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ddccf70c-ea49-4200-83c9-0ef468c2bdc3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ddccf70c-ea49-4200-83c9-0ef468c2bdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ec5afa7c-7241-4cd6-bdc7-80e755eeb1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_ec5afa7c-7241-4cd6-bdc7-80e755eeb1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_24de0bdb-7d8c-4d0d-b47c-d6ed2e00dbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_fd8ebf73-9ad8-4a66-af72-8e54b9bb138f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_24de0bdb-7d8c-4d0d-b47c-d6ed2e00dbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1b0546df-52b6-40c9-93ae-308c37165ac5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1b0546df-52b6-40c9-93ae-308c37165ac5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:to="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ac87b8f-fdfe-4b26-999e-69ffa9d604a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_616d80ce-5bcc-45d1-b13d-a3790b455eae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ac87b8f-fdfe-4b26-999e-69ffa9d604a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2d97a7e3-062f-4f25-bed2-000e9154201b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6ac87b8f-fdfe-4b26-999e-69ffa9d604a1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2d97a7e3-062f-4f25-bed2-000e9154201b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8939917a-d4aa-4708-8655-d5a834aa1adb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_93bc774d-8650-4c63-a363-e991125b3f81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_93bc774d-8650-4c63-a363-e991125b3f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876b0967-00b6-4f5d-905e-1850ec482507" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_876b0967-00b6-4f5d-905e-1850ec482507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_863469bb-7625-438e-b69e-499cee2bbecd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_863469bb-7625-438e-b69e-499cee2bbecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_46896fb5-397a-4cbc-8ff5-0437386f0c0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_46896fb5-397a-4cbc-8ff5-0437386f0c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_137188c5-910a-4ba3-9416-0dab7a6e20c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_01f9d564-4760-4b7d-b60b-fe74f73286a1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_137188c5-910a-4ba3-9416-0dab7a6e20c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_50ed99b1-58c5-469d-b5f5-77034f105670" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_44ec2eee-0521-4771-b612-977dbb40a718" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_44ec2eee-0521-4771-b612-977dbb40a718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_173d0043-7088-4929-8a22-9ab7105dedf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_173d0043-7088-4929-8a22-9ab7105dedf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4c86b388-b195-4051-ba91-11883680a9a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_4c86b388-b195-4051-ba91-11883680a9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85bc65f1-828e-4d88-b069-ab31cf6cfe8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_85bc65f1-828e-4d88-b069-ab31cf6cfe8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dba8d5c2-262b-493e-a557-d3cfc1dacca2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_29e00c16-a656-452f-9af3-b71177876688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_dba8d5c2-262b-493e-a557-d3cfc1dacca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_16cfb43c-8bc6-4e20-9ee5-8ba8a52b53ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_16cfb43c-8bc6-4e20-9ee5-8ba8a52b53ea" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b0c75e28-bd67-4705-8361-507955498b79" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1a7e798f-3d41-4be1-a85a-b9a25f51f7d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:to="loc_us-gaap_CostOfSalesMember_1a7e798f-3d41-4be1-a85a-b9a25f51f7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_SellingGeneralAndAdministrativeMember_9d410a87-89eb-4df4-b104-1bcd7340d680" xlink:href="isrg-20210331.xsd#isrg_SellingGeneralAndAdministrativeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:to="loc_isrg_SellingGeneralAndAdministrativeMember_9d410a87-89eb-4df4-b104-1bcd7340d680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ResearchAndDevelopmentMember_61afd2b1-3cd6-48db-b94e-8395b88c9130" xlink:href="isrg-20210331.xsd#isrg_ResearchAndDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8107f0c8-0c8c-48f5-8e4d-cc7c82d0add5" xlink:to="loc_isrg_ResearchAndDevelopmentMember_61afd2b1-3cd6-48db-b94e-8395b88c9130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:to="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:href="isrg-20210331.xsd#isrg_ConsolidatingReportingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ConsolidatingReportingAxis_3f4092f4-6545-4536-a3ce-20b94cf06673" xlink:to="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesProductMember_f4857b0a-7a99-4e60-b34c-55c04b803fb4" xlink:href="isrg-20210331.xsd#isrg_CostOfSalesProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:to="loc_isrg_CostOfSalesProductMember_f4857b0a-7a99-4e60-b34c-55c04b803fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_isrg_CostOfSalesServiceMember_df9e1a61-fa60-4984-a694-cfe199e87250" xlink:href="isrg-20210331.xsd#isrg_CostOfSalesServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_isrg_ConsolidatingReportingDomain_ca355664-2e88-4ba4-9237-2e490d4c4f8e" xlink:to="loc_isrg_CostOfSalesServiceMember_df9e1a61-fa60-4984-a694-cfe199e87250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8ef626e7-bb22-4f91-bee1-9e39023a9cd0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_db06c504-bea1-48e5-8870-485da72f4301" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_db06c504-bea1-48e5-8870-485da72f4301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a6f1ade0-8e23-4c3e-bde3-37e2de6b7b07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_a6f1ade0-8e23-4c3e-bde3-37e2de6b7b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2d9142f6-9cd2-4734-ab3b-601b03824f85" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_4db59f84-6d7a-4379-b67b-c67cf9712a76" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_2d9142f6-9cd2-4734-ab3b-601b03824f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be0cd773-4789-4025-a642-239434c1f072" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_be0cd773-4789-4025-a642-239434c1f072" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:to="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d0df151d-4928-4852-984d-ad88e3557648" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_27d5179d-7d19-44be-8393-fa8cc086cf4b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:to="loc_us-gaap_StockOptionMember_27d5179d-7d19-44be-8393-fa8cc086cf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_183fcf64-5449-42ae-a9c1-49fec139fde3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d39cce9f-2c9c-4bd4-b80a-a39e61b83b47" xlink:to="loc_us-gaap_EmployeeStockMember_183fcf64-5449-42ae-a9c1-49fec139fde3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a7610e6-1498-413d-837c-73c5a823587f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4f039790-0988-4a83-9b67-d5c7615cde0b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_4f039790-0988-4a83-9b67-d5c7615cde0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e0dc9dc0-d0ef-4d98-8e20-4cc748068269" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e0dc9dc0-d0ef-4d98-8e20-4cc748068269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_84f21a07-b9c7-4d8c-bca6-fb127702908a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_84f21a07-b9c7-4d8c-bca6-fb127702908a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40bfdf2a-00ed-4994-84ac-74e0771e4daa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2608c867-ef73-44ec-a041-f389153a441a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_40bfdf2a-00ed-4994-84ac-74e0771e4daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="simple" xlink:href="isrg-20210331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_97eb88c8-4cf1-4615-9658-3f968e7ace9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8396b3c9-3e82-424c-aaac-fc05322f80f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_97eb88c8-4cf1-4615-9658-3f968e7ace9f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8396b3c9-3e82-424c-aaac-fc05322f80f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#INCOMETAXESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f02b4bb4-3206-4bfa-bca4-d4991dfee9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9421f21d-11fa-4b58-b796-f0b26e318d86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f02b4bb4-3206-4bfa-bca4-d4991dfee9bb" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9421f21d-11fa-4b58-b796-f0b26e318d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b6b14285-d55c-4919-b30b-14c48a52c699" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f02b4bb4-3206-4bfa-bca4-d4991dfee9bb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b6b14285-d55c-4919-b30b-14c48a52c699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f02b4bb4-3206-4bfa-bca4-d4991dfee9bb" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ad7eefa6-e1b9-4698-9375-3fe8b5f1fcbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_a116eed3-3ef1-4daf-b36b-8fff3eafb6da" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ad7eefa6-e1b9-4698-9375-3fe8b5f1fcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_e5efd44a-a2ba-4184-b3d7-673937cbe4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ad7eefa6-e1b9-4698-9375-3fe8b5f1fcbb" xlink:to="loc_us-gaap_ForeignCountryMember_e5efd44a-a2ba-4184-b3d7-673937cbe4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8332b2d3-f91e-4aa9-8ca5-c9e548313519" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3c85c02a-ba80-4991-9ba8-547c14b8a265" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_3c85c02a-ba80-4991-9ba8-547c14b8a265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_84f4e311-58f5-43ec-8d19-7d23e8aac5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_84f4e311-58f5-43ec-8d19-7d23e8aac5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_4d66b1c2-861a-4f18-9a56-c5919e7a92c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_4d66b1c2-861a-4f18-9a56-c5919e7a92c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_0f6104e4-7d11-4818-af1f-7d06f8fe8dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_ae4c2da4-7c50-49d1-a3e3-62e82c0f9c97" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_0f6104e4-7d11-4818-af1f-7d06f8fe8dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_db49a8dc-6ee7-4a13-bfd3-fe78ed4a7459" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f02b4bb4-3206-4bfa-bca4-d4991dfee9bb" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities_db49a8dc-6ee7-4a13-bfd3-fe78ed4a7459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b0f25df7-230b-4cab-b921-33935c1e75e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f02b4bb4-3206-4bfa-bca4-d4991dfee9bb" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_b0f25df7-230b-4cab-b921-33935c1e75e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHARE"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2ac401c1-f6d2-4841-bda3-d1056d01db6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e5ee3d59-54f7-4add-b334-47ca538b9cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2ac401c1-f6d2-4841-bda3-d1056d01db6d" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e5ee3d59-54f7-4add-b334-47ca538b9cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43f95dde-3013-42bf-a0f6-fd930c74672f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_18d6cf9a-bad1-46b9-83dc-9871fc170b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43f95dde-3013-42bf-a0f6-fd930c74672f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_18d6cf9a-bad1-46b9-83dc-9871fc170b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_42b0ee23-f173-43b1-adc1-dca212295747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_2d42acba-47ae-48f6-9d41-33cf105d27f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_42b0ee23-f173-43b1-adc1-dca212295747" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_2d42acba-47ae-48f6-9d41-33cf105d27f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d313cc96-c7ea-4b3f-ac74-d224b043481c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_2d42acba-47ae-48f6-9d41-33cf105d27f4" xlink:to="loc_us-gaap_NetIncomeLoss_d313cc96-c7ea-4b3f-ac74-d224b043481c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3a5d192a-ecd5-4f77-a61d-7dbb3227d42d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_42b0ee23-f173-43b1-adc1-dca212295747" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3a5d192a-ecd5-4f77-a61d-7dbb3227d42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ac88d095-2055-43b7-84d6-7319d56d0541" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3a5d192a-ecd5-4f77-a61d-7dbb3227d42d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ac88d095-2055-43b7-84d6-7319d56d0541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f4fe66ec-1d4e-4eb6-a880-51576bbae098" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3a5d192a-ecd5-4f77-a61d-7dbb3227d42d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_f4fe66ec-1d4e-4eb6-a880-51576bbae098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8198bd1a-a24b-43f1-97fe-be048dc7ec04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3a5d192a-ecd5-4f77-a61d-7dbb3227d42d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8198bd1a-a24b-43f1-97fe-be048dc7ec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6aee9954-482f-4311-b914-d7eb498f6856" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_42b0ee23-f173-43b1-adc1-dca212295747" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6aee9954-482f-4311-b914-d7eb498f6856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ec9af80d-1433-4603-8580-bc5e7425b8eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6aee9954-482f-4311-b914-d7eb498f6856" xlink:to="loc_us-gaap_EarningsPerShareBasic_ec9af80d-1433-4603-8580-bc5e7425b8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_97a6bcfc-d987-4b55-ac17-9dfb80fc5ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6aee9954-482f-4311-b914-d7eb498f6856" xlink:to="loc_us-gaap_EarningsPerShareDiluted_97a6bcfc-d987-4b55-ac17-9dfb80fc5ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="simple" xlink:href="isrg-20210331.xsd#NETINCOMEPERSHAREAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_acde804b-4106-4ab7-acb6-47794d184e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_649887d5-3091-454f-a79c-335d00276783" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_acde804b-4106-4ab7-acb6-47794d184e0e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_649887d5-3091-454f-a79c-335d00276783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>isrg-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:isrg="http://www.intuitivesurgical.com/20210331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="isrg-20210331.xsd" xlink:type="simple"/>
    <context id="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i84a2d48a3f934a5e846fde7d9abe944f_I20210416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="i19647b4382894b77b728740dfcec06ae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i810446be2da345f89c79c2feb9f44ba9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i237add5259254f3499eccc5ee17fb8f8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i868a03d2fcbe469b92b6fc91d48e532b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3ea643af9acb406e83895b7a31182401_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i545d4914e37e4c5497107f4880ab0f98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i44dcefa3072841ab9e340f65c68f2e09_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i072d37fe25bb4302a174a740eff0e4f2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i35bf9937caf6400d88acb13a096891c5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a75be70358e4656aae6d18d193a651e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i368e30c496574fe38438f342b8cdc48b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i895e7c92ed73488cbc1472585100ffd2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i231cdf83bcbe4b678c5570b5502a3b15_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i04f73ee5f50b46c28090374917de184f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifa4632879d684ddaa9023f7e0b54ac98_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i54ca0c6dceff44bdb8e26225c230f09c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9b0c8e7e84f143d7b433e4521292b760_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i222e4ab4f50046478fb8626cd2050931_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4f3b8761ea441979a441de6b8b02816_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66ed88632684468d94839263e693131e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie679b530e22f47f0b9f133ad1641a2e0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if8f11e0d90794805a51ee4875ef2bb22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i014ce2f5b0f444f4b1647a8837939eb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba387424719640be97f87fe83a205421_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id41180fe238f4e5494e70d7abad1bfa9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i833afe2c87e8454a87024764d94c2822_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifdb7e13199f44d5493cb6aa8bb70dff9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i958d733265f7468c8bb333fd2012a22a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">isrg:IntangibleAndOtherAssetsNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i08ae6a1daaa4488ab4a2cbc44713a1ac_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i95cda8b4c1784cb3a304cb36b3e28670_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie35611a332ef451ebfedc87ebfa99560_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">isrg:CollarContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a170e992d9b457f9595e8e31c382067_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia441705586c64958893ba4b26e8f9831_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6653afda804c4e6c92c1ee18d4fb6513_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i44e41d62be44428bbe7bec7558efa25e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i54056e1ecde648908d7a97b1e1644204_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1482cb8fa3714e7dbbbc27ada59f5747_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bf9140f4a144a61a11f812b3233bee0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i455a5987f0e4495ea102bd1bb887aac7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia049734db3fb46309a15c9c21f4d5265_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6fbd0c73fe99402fb77a4384d2e76b14_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86716d46a32f4177960da8dbdf213b78_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7bc25cae1624497fb0288262254a7cdd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i152085248b524a7aad79030a253fd4ad_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i157c8a2a14244227b32df8ba8e8c12cd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i29851492d6bf481581aacf08b75f5339_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i33e08c5f1b214731b6b9dbc8c5f58cd8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i42118bf09f1b4f93aa3651255ba5a1b2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0134fb267a9b433d82bc15fd159a7ef1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7055642a7210446390122584f500fda4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie3e657c28bcd46ae88684e0e1d05b884_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionDomesticMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i81f67fc3a5914897bfb2af66c5111c5f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic1bcf40fa8c74859aa7a3f6f5cd2a321_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iac9c8091fc074a50b333fe645498f038_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie4b1f60c62c3443bbb2842b9ac6ff27b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="id2d6bd374e56486b9e830cd18f662db8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4a4f0809ae7c474bb8f654639db1dda5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i371d9d7cd5994bf2b5d51f8dee8c6f30_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i35c310e8fe3f4e1fa74d58cde4f02a61_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GeographicDistributionAxis">us-gaap:GeographicDistributionForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic20d6d2cffa74ad38d0883a8f21b0bb6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i20599bf2b00d4db08e12ef6ca86133f8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:InstrumentsandAccessoriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0077eedf3c254281b3ccb2d1eac594d1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i075a7596ace44e8a80d6c8d9082c1342_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:SystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic5ecd44c2474464dbc7542ef31537629_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i316ac96134214c19b317684c3c8230bf_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">isrg:ServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iac5907b4d5ac44a09eff901e7f3d5739_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i61c5c9b528fc40b28e5777152e16f632_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i16587b9e3fa145b7a10a7a0e68039b6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd60252340be492cb5cd60dbb4959028_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8dd6688329e44797b0c7cb4a51d91169_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c76c59d0038424ab43ff393ceb37cad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if1b9e18b6b6149f1915a82f93f47df83_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i271e251ff82d4aa7b389387881ee1fee_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:HighMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic08d038617c24c269391ce3ad0e3231a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:ModerateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i216f3f95bdf84de689a958b870cb7ff1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">isrg:LowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i11f28dd5602b4bde94b164d567bb287f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia55e3aa5f4234c84951ca875ab824a3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94e718a145634a8392de72f4b600c0c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2c39a166bad441f2ac088d8f0528a593_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1892d132f6eb47d5b382a5ecafcffd20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i147cc30e329447d293e6ac6f2f569531_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i832e07083f234f9aaae70e7f780f75ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f25478b6fff402bad373bd68ce889d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8dfde143ec884cdebe7ea1111dfe6d02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifff9ccbd873145ae8414978edefcf616_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49a8ca38f4be4272b8b9502372356738_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6609492761e040349e48efd7876d43c1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8fd61ce4b4e2448fb329c1b58561fb64_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i881c19778193492d86fa195d0bf3a940_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9f94159c88ab4b1584580110f75e4c91_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i507a2382c629428daede99bd06d29782_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i75cefa24a4ba4c7a815e48c26b538d47_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icbff52cf66da42ddb55647513e2a8a81_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9090c608db4547b1ac6471900a3b840f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9031b8a49b4b4593a8779ea186c3cf54_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i18b1114d0328455ba73b3e48af3193e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2e99e82b25614f028c511ab87510f949_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99fdcc6b644e4e0586c5ffa4473d31b7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib36bc009466044639ae7d55c36d1ffc8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i25f4ce614b87445998e895b069fde088_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iba32cf8624a94ab7bc35931cbf181914_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i79c415ee3f6d4597b0b02c0a172afe2c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i90458d1fd5d54ab19b5ea2abf3dcaa97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:CumulativeEffectPeriodOfAdoptionAxis">isrg:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i176adc5116364bbf8f134ba16f508f2c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:CumulativeEffectPeriodOfAdoptionAxis">isrg:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i74fb387009f84c1394a499016f35aa1c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="isrg:CumulativeEffectPeriodOfAdoptionAxis">isrg:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iff9d8f48f16b43ce9a99c9803cd1a5cd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i46a4ba9a772c44c2bbbfed1bac1aa452_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2487fa8c7cfe45e6a641a9876f892024_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i16767223fe4a41809418b76a6125e9b7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i22d62ec7e4044391882881b01e0b6300_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1198994ab755477ab225bc58ca03d552_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i353c4ffcf6cb428b973449a30ef061b1_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5f43ed2b00934f689a166e4d0edb373d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i09a910f990374e8b85baf857795d2362_I20190131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-31</instant>
        </period>
    </context>
    <context id="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">isrg:CommonStockRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i10e5830a5be84ccbbde2a2eff58015cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78841269b3a04c14876727a1edd45ce7_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i895226f723b74a4e944e2ab935f3b6d5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i33ccbc7cfb7146c487ecb64b60bdc787_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">isrg:A2010IncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic700f68e41144f91bd35e317ae4e9f00_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ided9f564a7fc43fb9785e126f3e0792d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8d02f4e8f2a84d6fadf284cdaf0651f6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i39ba5ce0cdf94b51beee72537008b906_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic0b9d06046ac417db9b476df68156e12_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie5af8b08c9064ce3af2ced0adcf153ad_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="isrg:ConsolidatingReportingAxis">isrg:CostOfSalesServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i176cc511d2d94ee3acf60b32b9c344a4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i002513af33834fe2a6163fa9af4c9055_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if0b706bb5ee44d3c9e5ab754d749034e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i223c3c0566cf457c938baba52b26ec0f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:SellingGeneralAndAdministrativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie628bd5d73914b17bff4771bcdd4ec83_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id57036158f3241fbb815a228531cfa32_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">isrg:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001035267</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF8zLTEtMS0xLTA_b11d3c63-6892-467f-8f1f-1b570cd55732">0001035267</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF81LTEtMS0xLTA_7297e6fa-cc24-44da-a496-99332210b42f">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF82LTEtMS0xLTA_9d43fbdc-078a-4a68-9974-f05d90eba642">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGFibGU6MWM4MjRlNWM5ZmFmNGU0ZDhkYmFkNDEzNTJjZDA1OTQvdGFibGVyYW5nZToxYzgyNGU1YzlmYWY0ZTRkOGRiYWQ0MTM1MmNkMDU5NF83LTEtMS0xLTA_6ed2da94-caa6-4d6a-9e39-99f7e30e4267">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80L2ZyYWc6MTU3Mzc4YTI2Y2RhNGNhOGIwYmRmMzVhOTk3MzU1OTAvdGV4dHJlZ2lvbjoxNTczNzhhMjZjZGE0Y2E4YjBiZGYzNWE5OTczNTU5MF84_b6794aa3-4c60-4f70-8d3b-fefcedbfa4dc">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM184Nw_05886f29-2467-469e-bd52-ce8749c0be2e">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6MjhjNDQxODIyM2M2NDM3NjlmYWU1Y2ZmZTJhOGU3N2IvdGFibGVyYW5nZToyOGM0NDE4MjIzYzY0Mzc2OWZhZTVjZmZlMmE4ZTc3Yl8wLTAtMS0xLTA_b97cf52b-d997-49ce-8e0c-343d777b4c6b">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xMzc_75499c38-32b5-4eb0-bb66-d2c2c77c9caf">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6NDE3Y2JkMzc2ZGU0NDJlNmI4N2YxMGMwMmNlNGE3MWUvdGFibGVyYW5nZTo0MTdjYmQzNzZkZTQ0MmU2Yjg3ZjEwYzAyY2U0YTcxZV8wLTAtMS0xLTA_c78fde82-0f75-4808-b2ae-24fc1867d933">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18yMjg_c7117581-e520-496c-8be8-fcfaa3819d8f">000-30713</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18yMzQ_fa9c64d5-49ca-48be-adff-865590678c71">Intuitive Surgical, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6NTY4MTBkZjRkMjc2NGUyNWJhYzEyZjFkMTlhODJjNDcvdGFibGVyYW5nZTo1NjgxMGRmNGQyNzY0ZTI1YmFjMTJmMWQxOWE4MmM0N18wLTAtMS0xLTA_3a86115c-dec2-4646-b622-c2b8e2095abd">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6NTY4MTBkZjRkMjc2NGUyNWJhYzEyZjFkMTlhODJjNDcvdGFibGVyYW5nZTo1NjgxMGRmNGQyNzY0ZTI1YmFjMTJmMWQxOWE4MmM0N18wLTItMS0xLTA_b4427ffe-5041-47ff-81c8-bb913f456770">77-0416458</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18yOTc_b4d04c57-8908-4b4c-a0ba-608edd9e7080">1020 Kifer Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zMDE_ac6539cd-73c6-4f0a-8a95-37d6f183f139">Sunnyvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zMDU_a3f780e8-0228-470d-9f42-9058ca3e8cdb">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zMDg_dee8b804-acb4-49de-af0c-9c9751884f88">94086</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zNjU_ef750cae-5990-4c35-98a9-dc9e13e6007e">408</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18zNjk_89d14c69-2ba3-44b2-bdb0-df1a9f6b9ea3">523-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6YWRkN2VlNzYyZmNiNGI3Y2E0NGRmYWQxYzNjM2ZlNjQvdGFibGVyYW5nZTphZGQ3ZWU3NjJmY2I0YjdjYTQ0ZGZhZDFjM2MzZmU2NF8xLTAtMS0xLTA_de5c8163-cb52-4d47-a49a-2a1e27a1d6b0">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6YWRkN2VlNzYyZmNiNGI3Y2E0NGRmYWQxYzNjM2ZlNjQvdGFibGVyYW5nZTphZGQ3ZWU3NjJmY2I0YjdjYTQ0ZGZhZDFjM2MzZmU2NF8xLTEtMS0xLTA_b7609244-acfb-4521-bae2-7bdb2c8ae8d3">ISRG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6YWRkN2VlNzYyZmNiNGI3Y2E0NGRmYWQxYzNjM2ZlNjQvdGFibGVyYW5nZTphZGQ3ZWU3NjJmY2I0YjdjYTQ0ZGZhZDFjM2MzZmU2NF8xLTItMS0xLTA_729d0f55-2ab2-488c-a411-5896936de78a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM184NDE_b279861b-5c36-4f19-99f0-88a26e213c3f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xMTY4_6e9fe7e5-22bd-49d9-99b1-8ad0d37d32b2">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6OGMzOWIxZTJmZjA3NGRhN2E5MWIzNGY0MDliZTEzYTkvdGFibGVyYW5nZTo4YzM5YjFlMmZmMDc0ZGE3YTkxYjM0ZjQwOWJlMTNhOV8wLTAtMS0xLTA_92939437-5a07-4877-907c-586647df8404">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6OGMzOWIxZTJmZjA3NGRhN2E5MWIzNGY0MDliZTEzYTkvdGFibGVyYW5nZTo4YzM5YjFlMmZmMDc0ZGE3YTkxYjM0ZjQwOWJlMTNhOV8xLTQtMS0xLTA_b3fdafbb-91a3-43f8-a843-fdba3c7fe5ee">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGFibGU6OGMzOWIxZTJmZjA3NGRhN2E5MWIzNGY0MDliZTEzYTkvdGFibGVyYW5nZTo4YzM5YjFlMmZmMDc0ZGE3YTkxYjM0ZjQwOWJlMTNhOV8yLTQtMS0xLTA_d3a57837-22e1-474e-8fc9-9811d63b5e36">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xOTE5_eff6d096-37fa-4437-8247-e4783b42c906">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i84a2d48a3f934a5e846fde7d9abe944f_I20210416"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xL2ZyYWc6MDkwYWNhY2ExZjMxNDk3OWFiZjlmOGE4NTlkNWE1YzMvdGV4dHJlZ2lvbjowOTBhY2FjYTFmMzE0OTc5YWJmOWY4YTg1OWQ1YTVjM18xOTUw_e85cce17-1c93-441d-bde7-7e0a33dbf82e"
      unitRef="shares">118412888</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMy0xLTEtMS0w_4e1d90e2-422d-4dde-a98d-200fc0e46cc6"
      unitRef="usd">1401800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMy0zLTEtMS0w_0b6247fa-17a4-4996-ab4b-b53f6f851a52"
      unitRef="usd">1622600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNC0xLTEtMS0w_059d85af-b3d9-4983-b4ba-1050c98db2b2"
      unitRef="usd">3155700000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNC0zLTEtMS0w_c36f43ac-1420-4a8b-b7a8-f69110305165"
      unitRef="usd">3488800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNS0xLTEtMS0w_fac01494-1619-4376-af89-45735646eb14"
      unitRef="usd">654300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNS0zLTEtMS0w_ff021add-634d-44e7-a939-d50309bec5f4"
      unitRef="usd">645500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNi0xLTEtMS0w_24e170ea-1630-4b74-8544-f1142bae8737"
      unitRef="usd">576800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNi0zLTEtMS0w_180d50fa-5112-4b41-9952-f486e633d360"
      unitRef="usd">601500000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNy0xLTEtMS0w_e85a2f06-9fe0-43e3-bf59-09db4e4228af"
      unitRef="usd">277800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfNy0zLTEtMS0w_b866430c-e0e1-4fd8-aa9d-19fa3b26ed6c"
      unitRef="usd">267500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOC0xLTEtMS0w_3d48bbda-a84d-400a-bf1c-aa70af01e294"
      unitRef="usd">6066400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOC0zLTEtMS0w_b28663c5-fc9b-42b7-99d6-dd3b5dcb547f"
      unitRef="usd">6625900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOS0xLTEtMS0w_0d12eef3-fa71-4785-b9eb-e2bd5a5b723a"
      unitRef="usd">1592900000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfOS0zLTEtMS0w_1405255e-e4f3-463b-a470-ff58576a5e41"
      unitRef="usd">1577300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTAtMS0xLTEtMA_45cb8445-495a-430d-8554-d92223a0dd30"
      unitRef="usd">2673000000.0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTAtMy0xLTEtMA_df42819b-567f-4abd-b2db-6b73fcda7c51"
      unitRef="usd">1757700000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTEtMS0xLTEtMA_0e975406-82c4-4df8-bab1-43584e02e45a"
      unitRef="usd">336600000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTEtMy0xLTEtMA_f4d87dab-3e93-42f5-971d-644ceb14c3a4"
      unitRef="usd">367700000</us-gaap:DeferredIncomeTaxAssetsNet>
    <isrg:IntangibleAndOtherAssets
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTItMS0xLTEtMA_9673b074-919f-4006-a6f1-f6af4b8a5a3b"
      unitRef="usd">527000000.0</isrg:IntangibleAndOtherAssets>
    <isrg:IntangibleAndOtherAssets
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTItMy0xLTEtMA_deea2281-25a9-4411-9b7b-b0cfe8028cd5"
      unitRef="usd">503600000</isrg:IntangibleAndOtherAssets>
    <us-gaap:Goodwill
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTMtMS0xLTEtMA_3445fa61-d7bc-43db-8b40-697059225641"
      unitRef="usd">344500000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTMtMy0xLTEtMA_154fc1f7-c976-4060-88ed-683fcb3855b8"
      unitRef="usd">336700000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTQtMS0xLTEtMA_c51d02fe-f86d-45b7-a89c-01a4b7c52aef"
      unitRef="usd">11540400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTQtMy0xLTEtMA_13b60722-87a2-40e8-a0b3-2da33c8e7874"
      unitRef="usd">11168900000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTctMS0xLTEtMA_d9bb557e-a435-4be6-a21e-e856b7b121ef"
      unitRef="usd">103100000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTctMy0xLTEtMA_dbb93335-57d3-4cc4-a473-f8e68c9562cb"
      unitRef="usd">81600000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTgtMS0xLTEtMA_dd6f358a-24c2-4500-a1fa-220135d9673b"
      unitRef="usd">194800000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTgtMy0xLTEtMA_735363f8-537f-423c-902a-1cccf5758da5"
      unitRef="usd">235000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTktMS0xLTEtMA_64c53883-bdf0-47ca-8f33-65e0d54fc755"
      unitRef="usd">358100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMTktMy0xLTEtMA_e138f3ee-e25d-4264-a581-ff5792dae631"
      unitRef="usd">350300000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjAtMS0xLTEtMA_af81faa7-bbc1-4886-9062-87da5079f531"
      unitRef="usd">248600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjAtMy0xLTEtMA_4b226eca-3023-461c-8a89-3f1598e812e2"
      unitRef="usd">298300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjEtMS0xLTEtMA_4949f9aa-7c9b-41d0-b6b8-ff01a099754c"
      unitRef="usd">904600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjEtMy0xLTEtMA_261c2cb7-616c-43d0-8824-33781bb1568c"
      unitRef="usd">965200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjItMS0xLTEtMA_c291e90c-ffd8-4c92-82b9-194d39b53c23"
      unitRef="usd">445600000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjItMy0xLTEtMA_d22cda6d-3fcd-4588-b8e5-580986c61600"
      unitRef="usd">444600000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:Liabilities
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjMtMS0xLTEtMA_70175b11-93cf-487b-9882-a2cc0e718816"
      unitRef="usd">1350200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjMtMy0xLTEtMA_2959eb16-59d0-46ef-929d-8829160483da"
      unitRef="usd">1409800000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjQtMS0xLTEtMA_bc32c4c4-fcbb-441e-8e7b-715f8a8ae111"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjQtMy0xLTEtMA_a7a26c90-6ecb-48b3-b3e4-68592f58207d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzIx_2e54f3bb-9bb0-41b4-8598-b5c418602ddb"
      unitRef="shares">2500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzIx_905b9d1c-71ed-4973-8565-27f613bada4b"
      unitRef="shares">2500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzQz_a6c4026b-5890-472e-b668-6bc969c076e0"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzQz_ec7875ba-1df2-4eea-83ef-e2107074b2a1"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_85496b66-ebb6-4350-b27c-537713aaad10"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_85f62270-6f72-4def-956a-208d22c090d4"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_c4a2c753-6615-4b94-8075-8c5f4d223491"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjc4MGIyZjkzMzRkYjQ5N2I5NjNhZDQyNDRkY2U3NjNiXzc3_eeea65f4-a37c-44ce-946c-9418188e82e8"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMS0xLTEtMA_2ff93bfe-c5ed-4418-9867-b9ed4e3a3d11"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjYtMy0xLTEtMA_acc1b8b5-dc2f-4990-b31a-ba8fc6c9a1a2"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzE5_f4926cbc-9376-4f2e-b216-2f5700a19dbf"
      unitRef="shares">300000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzE5_f95904b3-5473-4efb-852e-424ea7b63302"
      unitRef="shares">300000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzQx_2e6e8811-0676-4d3e-96b1-a5f4ad7b67df"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzQx_821d95c2-feda-44ad-a15d-799ce4dc93a7"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzU1_19450217-8c85-49ca-a10d-36bcd4c2451a"
      unitRef="shares">118400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzU1_93f1acfe-eb4e-42e9-973e-4800befd956d"
      unitRef="shares">118400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzY5_38c96413-a69b-40bb-9616-6ddc18c61fef"
      unitRef="shares">117700000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMC0xLTEtMC90ZXh0cmVnaW9uOjM1Y2I4YzVhOTk4ODQ3ODNhNjQ4NzI5N2I4YjljMDJiXzY5_bd2c4b60-b2bf-430e-888e-1dc9aed18429"
      unitRef="shares">117700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMS0xLTEtMA_0bbef523-f9d5-4d66-8a25-3a1a290f7347"
      unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjctMy0xLTEtMA_16bc15a1-0410-448e-9400-426d77d6f845"
      unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjgtMS0xLTEtMA_ac28d75c-d19c-40cf-8d90-8027122b7fc2"
      unitRef="usd">6627300000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjgtMy0xLTEtMA_a73f2093-9291-4ba8-ad31-b64c841ca7de"
      unitRef="usd">6445200000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjktMS0xLTEtMA_bafe3243-aa92-4574-8aae-3ffda5bb0f31"
      unitRef="usd">3514700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMjktMy0xLTEtMA_68ff3f1b-9844-423c-acb8-7718cd3470b3"
      unitRef="usd">3261300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzAtMS0xLTEtMA_b9e7821e-86d7-4c88-afef-d247e8609711"
      unitRef="usd">11400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzAtMy0xLTEtMA_c9035138-b5d0-4599-9055-9018223b71d1"
      unitRef="usd">24900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzEtMS0xLTEtMA_b4e9734d-be5d-472f-a1e7-c0f53b920d97"
      unitRef="usd">10153500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzEtMy0xLTEtMA_a14b8da9-2806-499d-8009-74507aca8d1d"
      unitRef="usd">9731500000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzItMS0xLTEtMA_bb8d0ad4-52f7-4ced-9ad0-a2a1f154536e"
      unitRef="usd">36700000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzItMy0xLTEtMA_25237f25-05fb-48bb-85e3-52d00a57e1dd"
      unitRef="usd">27600000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzMtMS0xLTEtMA_75493539-8c0d-4967-bf92-5ded2e7ada48"
      unitRef="usd">10190200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzMtMy0xLTEtMA_40b09471-144f-453e-b311-89650ca38f3b"
      unitRef="usd">9759100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzQtMS0xLTEtMA_09aef8b1-b82c-4927-85ab-a9a75b07c983"
      unitRef="usd">11540400000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8xNi9mcmFnOmU1M2E2Mjg5MjM5ZTQ0MjZiOWRiZDljN2ZmZjNhZTk1L3RhYmxlOmQyMjg0OGU5N2UxNDRiY2VhNjAwNTAyNzdlNTUyYzcwL3RhYmxlcmFuZ2U6ZDIyODQ4ZTk3ZTE0NGJjZWE2MDA1MDI3N2U1NTJjNzBfMzQtMy0xLTEtMA_343ff772-1400-4984-8624-7d39a52d3842"
      unitRef="usd">11168900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i810446be2da345f89c79c2feb9f44ba9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMy0xLTEtMS0w_f4bf2e02-9500-4239-8125-d73d2668227f"
      unitRef="usd">1074600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i237add5259254f3499eccc5ee17fb8f8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMy0zLTEtMS0w_432af79b-6a45-43ec-a5b3-f870bf659cb6"
      unitRef="usd">900800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i868a03d2fcbe469b92b6fc91d48e532b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNC0xLTEtMS0w_37a80c8e-4cae-4a7e-9983-9d05e256cf34"
      unitRef="usd">217500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ea643af9acb406e83895b7a31182401_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNC0zLTEtMS0w_fcce5fa4-b7ec-4a2f-9e6d-583978c7f2cd"
      unitRef="usd">198700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNS0xLTEtMS0w_40208a03-6563-4f51-8136-2f3f73c83978"
      unitRef="usd">1292100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNS0zLTEtMS0w_236302ce-f4f2-4cee-8815-48e17f635f49"
      unitRef="usd">1099500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i810446be2da345f89c79c2feb9f44ba9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNy0xLTEtMS0w_71a2f112-744b-46df-a6df-0c36b572aafb"
      unitRef="usd">319300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i237add5259254f3499eccc5ee17fb8f8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfNy0zLTEtMS0w_1a57734c-1113-42fd-b45d-e8e843bd845e"
      unitRef="usd">296700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i868a03d2fcbe469b92b6fc91d48e532b_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOC0xLTEtMS0w_8a87cbbe-757e-444e-93b0-80cbd1225bea"
      unitRef="usd">70200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i3ea643af9acb406e83895b7a31182401_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOC0zLTEtMS0w_0a6256de-87f7-41c2-9585-ae230d6e3720"
      unitRef="usd">64600000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOS0xLTEtMS0w_17ebbdcb-d4a0-436a-a104-39bc5f486ba0"
      unitRef="usd">389500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfOS0zLTEtMS0w_9b9b146c-9d42-40cd-98af-437ba70f5f28"
      unitRef="usd">361300000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTAtMS0xLTEtMA_5784f4af-055b-433b-ab7e-6097953c3ad4"
      unitRef="usd">902600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTAtMy0xLTEtMA_3ecc2665-e641-44df-9db4-48daac6d1663"
      unitRef="usd">738200000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTItMS0xLTEtMA_00555dee-65ef-4c53-85c8-b01cfb6f17ce"
      unitRef="usd">326000000.0</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTItMy0xLTEtMA_e64f7ef2-c4a4-4776-be63-2cf9e2dc80fd"
      unitRef="usd">308100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTMtMS0xLTEtMA_65a36ac2-4226-4b96-8649-878affa34dde"
      unitRef="usd">159800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTMtMy0xLTEtMA_9952bf9f-5b41-4217-8c26-7a2ec64c7a58"
      unitRef="usd">147100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTQtMS0xLTEtMA_2455e28f-7fcf-4e0e-9f9e-296431e75b6b"
      unitRef="usd">485800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTQtMy0xLTEtMA_1bfc6554-f726-4e1c-a3ae-94e6aa0fffca"
      unitRef="usd">455200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTUtMS0xLTEtMA_1c5eaf8a-134d-4605-8613-720cdf3484ca"
      unitRef="usd">416800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTUtMy0xLTEtMA_a44e1d5b-e2ab-4325-a8ba-4dbcf22305af"
      unitRef="usd">283000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTYtMS0xLTEtMA_c4dedb9f-964c-4393-9828-b7146da578a7"
      unitRef="usd">32000000.0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTYtMy0xLTEtMA_d47ba7bc-7e25-464d-bdb1-4121ba3be24a"
      unitRef="usd">25100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTctMS0xLTEtMA_4efdc173-8b1c-4e1b-a5d4-dff3722ed71d"
      unitRef="usd">448800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTctMy0xLTEtMA_af231878-17c1-4585-9b83-3210f3f5e913"
      unitRef="usd">308100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTgtMS0xLTEtMA_f26ef1d4-bde1-4181-8284-4484bacfe9bd"
      unitRef="usd">13600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTgtMy0xLTEtMA_a48ebcc4-b92b-4169-9578-47e86d897ca7"
      unitRef="usd">-8100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTktMS0xLTEtMA_4acb2f88-42e0-499a-8154-f4a7e2576f2e"
      unitRef="usd">435200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMTktMy0xLTEtMA_7d04ff3c-629d-49a2-abd8-4aac846aa2e4"
      unitRef="usd">316200000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjAtMS0xLTEtMA_7d78baa6-2e45-45ed-88cb-05259b2da58b"
      unitRef="usd">8900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjAtMy0xLTEtMA_92d5e597-c3ac-43aa-a77f-6f1604e1e200"
      unitRef="usd">2700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjEtMS0xLTEtMA_2db3a2ad-a36e-4c9e-a583-e3dcf164c2de"
      unitRef="usd">426300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjEtMy0xLTEtMA_aa23d485-ae8d-4fc4-bcb2-09b22b5886e1"
      unitRef="usd">313500000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjMtMS0xLTEtMA_8242cafb-4dc2-451a-b5e0-701d2fcf06e9"
      unitRef="usdPerShare">3.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjMtMy0xLTEtMA_35380cf4-15c7-45bc-8757-8bf1c964f1fa"
      unitRef="usdPerShare">2.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjQtMS0xLTEtMA_44cb67ce-4545-4ede-bb39-468b4de06543"
      unitRef="usdPerShare">3.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjQtMy0xLTEtMA_3e2d202d-aff7-4e37-8ee4-e127705300ac"
      unitRef="usdPerShare">2.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjYtMS0xLTEtMA_f846a162-9ee4-4b0c-b5fb-2cfa099c5d60"
      unitRef="shares">118100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjYtMy0xLTEtMA_8050e4c9-3410-4f82-8d87-47153224dd5d"
      unitRef="shares">116400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjctMS0xLTEtMA_bae52891-30e6-4ba5-a5b9-374540759604"
      unitRef="shares">121300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjctMy0xLTEtMA_fcc15e17-3fdd-4be3-8e42-8923860a8481"
      unitRef="shares">119800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjgtMS0xLTEtMA_0e7f55b5-ffee-4c3f-9577-811548a05c27"
      unitRef="usd">421900000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjktMy0xLTEtNDAxNA_c78cdf79-47a1-40cd-92e6-4e787b226781"
      unitRef="usd">312900000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMjktMS0xLTEtMzY3MQ_b9c9b6ab-3445-4b31-9358-fd038c129dd9"
      unitRef="usd">9100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMzAtMy0xLTEtNDAxNA_7e7b02fb-9a82-4d71-9aee-2230398a5480"
      unitRef="usd">2900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMzAtMS0xLTEtMA_8dd3e509-f361-415d-9d74-2dbf3ac3b567"
      unitRef="usd">412800000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yMi9mcmFnOjJhN2MxNmEwYjU4YjQwMzhhY2M4MjQwOGY4N2I0NjA5L3RhYmxlOmUyOTE3Yzk0YTk5NDRkOWJiZTc2ODhhOWRkMjEyODVjL3RhYmxlcmFuZ2U6ZTI5MTdjOTRhOTk0NGQ5YmJlNzY4OGE5ZGQyMTI4NWNfMzAtMy0xLTEtMA_23332c27-607f-4be6-9305-bd342ed6e690"
      unitRef="usd">310000000.0</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMy0xLTEtMS0w_95b799e3-75b8-4a92-92d2-889c75297005"
      unitRef="usd">435200000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMy0zLTEtMS0w_ba323ddb-b952-4f76-a2c5-c06aafb7c35f"
      unitRef="usd">316200000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNS0xLTEtMS0w_36ea83cb-7aac-4c30-8384-0738627fb7d8"
      unitRef="usd">64800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNS0zLTEtMS0w_fb7f3391-9f6c-45d3-bbc9-dd7f877eb827"
      unitRef="usd">51100000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNi0xLTEtMS0w_d4c0b940-8419-4c7d-a914-6ac4c5b86d8c"
      unitRef="usd">6900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNi0zLTEtMS0w_14954265-9afe-4b42-9f90-dcc93af05135"
      unitRef="usd">12300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNy0xLTEtMS0w_1fd6b3d8-6710-44dd-a220-1fb17c6a2033"
      unitRef="usd">12600000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNy0zLTEtMS0w_b21c7893-59ca-4666-a4c4-1200669394e9"
      unitRef="usd">-200000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfOC0xLTEtMS0w_54f986e1-af4c-4693-9b1b-18dd50b42b0f"
      unitRef="usd">44700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfOC0zLTEtMS0w_fc270d49-d611-47fe-afd7-e9084b19480e"
      unitRef="usd">64500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTEtMS0xLTEtMA_e45857ab-d83c-4328-b5a8-1d41ae805faf"
      unitRef="usd">103200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTEtMy0xLTEtMA_93c6fa5d-0463-4aee-9614-e227f0548a15"
      unitRef="usd">90600000</us-gaap:ShareBasedCompensation>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTItMS0xLTEtMA_0dc14bd0-bcce-46dc-a236-1345e8709722"
      unitRef="usd">4900000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTItMy0xLTEtMA_5c79ec51-39f3-40b9-841f-fa414d806824"
      unitRef="usd">4100000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTQtMS0xLTEtMA_df3eb378-e579-48ae-94a3-34dcca973bed"
      unitRef="usd">14300000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTQtMy0xLTEtMA_aa7ab3e5-a40c-4804-9cef-3301de5c5e6f"
      unitRef="usd">-118200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTUtMS0xLTEtMA_e84338c0-1a1d-484f-a001-f1fcaeaf9f45"
      unitRef="usd">41200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTUtMy0xLTEtMA_fb48efec-4800-479f-a198-80a22100283c"
      unitRef="usd">65200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTYtMS0xLTEtMA_06b484fa-a26a-4b22-85db-872a52091f44"
      unitRef="usd">73200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTYtMy0xLTEtMA_5e0a056f-7fec-403e-9b72-f08c76a6baf3"
      unitRef="usd">131900000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTgtMS0xLTEtMA_f0be20f5-99be-4a0e-a71b-8f1f5780b57c"
      unitRef="usd">23700000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTgtMy0xLTEtMA_47445d39-717e-4d81-b0a8-134f8a62f242"
      unitRef="usd">21900000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTktMS0xLTEtMA_7217f080-2ac0-4e89-aab3-05b99df7116b"
      unitRef="usd">-40200000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMTktMy0xLTEtMA_15bf11aa-7cf7-40bd-9a43-9159fac229ba"
      unitRef="usd">-95200000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjAtMS0xLTEtMA_86c3aa8a-56a3-4f8d-bfb4-7efdf31a389b"
      unitRef="usd">6800000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjAtMy0xLTEtMA_caabc856-d630-4aae-865d-fded104f505b"
      unitRef="usd">800000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjEtMS0xLTEtMA_3420260b-7864-44cf-8a2f-ded5b89457a2"
      unitRef="usd">-31100000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjEtMy0xLTEtMA_b9b76ed4-9d92-4069-b4b3-01eb2ca9c285"
      unitRef="usd">-34800000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjItMS0xLTEtMA_bf799b85-de3b-4e74-9f39-cd48ce5148cd"
      unitRef="usd">477600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjItMy0xLTEtMA_aa26b468-4010-40ac-8e3e-3614d3fb770d"
      unitRef="usd">352800000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjQtMS0xLTEtMA_89f00b40-4308-476e-8845-bc48fddf540f"
      unitRef="usd">1833100000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjQtMy0xLTEtMA_02282689-0e72-4ddf-a748-0e29a166c89d"
      unitRef="usd">690000000.0</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjUtMS0xLTEtMA_962941a1-e6d2-4965-88b0-d98b3e72c32d"
      unitRef="usd">72000000.0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjUtMy0xLTEtMA_87b1ea26-e47e-4b78-af66-7890eb7b021b"
      unitRef="usd">98200000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjYtMS0xLTEtMA_a87f28b1-ac3b-4f69-bd30-33732cacf9bc"
      unitRef="usd">1231400000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjYtMy0xLTEtMA_378ea371-5324-4672-9ee3-54d96bfb3007"
      unitRef="usd">617600000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjctMS0xLTEtMA_1e1aa17b-f8b7-4bda-8cb9-3c944fff5059"
      unitRef="usd">58600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjctMy0xLTEtMA_c7a00c0e-4e9b-4575-9f80-41002aa3cf74"
      unitRef="usd">105200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjgtMS0xLTEtMA_5456aca8-2bf4-42fd-ba32-650ef93255f3"
      unitRef="usd">8700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMjgtMy0xLTEtMA_89abcb08-6b76-42b6-90f8-1070694826f0"
      unitRef="usd">37700000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzAtMS0xLTEtMA_2118ef99-f994-472b-920d-d9691cd0b718"
      unitRef="usd">-597000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzAtMy0xLTEtMA_4b170ae9-81a9-4a61-88b9-348b3a91290f"
      unitRef="usd">-117100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockPlans
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzItMS0xLTEtMA_80e94730-22bc-4dae-9d8e-b0b3d65f412f"
      unitRef="usd">84000000.0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzItMy0xLTEtMA_9a929536-91d0-4e9d-8b38-55b93e529984"
      unitRef="usd">91300000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzMtMS0xLTEtMA_2ed1f670-798e-47f1-8776-ad5d28c1f532"
      unitRef="usd">178300000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzMtMy0xLTEtMA_e8f337d2-6701-4b9f-acff-df108890a035"
      unitRef="usd">148900000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzQtMS0xLTEtMA_72b57507-008a-4c53-be87-c820d25ae954"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzQtMy0xLTEtMA_e1ee69fd-81d3-4213-8a0a-21cd84435bd2"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzYtMS0xLTEtMA_2dbf0612-addf-4fe0-8e20-2b746141c60d"
      unitRef="usd">-7900000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzYtMy0xLTEtMA_1796e5fc-7485-41a6-aaa5-2a76f00b0099"
      unitRef="usd">-21100000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzctMS0xLTEtMA_d627c5fd-045f-4096-92ae-38abda4be63f"
      unitRef="usd">-102200000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzctMy0xLTEtMA_f27311eb-4d45-4c83-b8b7-6a32cdca9e9c"
      unitRef="usd">-178700000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzgtMS0xLTEtMA_d7dd1ace-bb5a-4035-b097-3ec755a5da23"
      unitRef="usd">800000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzgtMy0xLTEtMA_4f663f64-5fd0-432d-9fd8-3602ce982aa5"
      unitRef="usd">-800000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzktMS0xLTEtMA_86a9eb0c-8bae-41fa-86b8-4a271fd85f7b"
      unitRef="usd">-220800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfMzktMy0xLTEtMA_31466a65-059c-4487-9ed9-e901c11a1e4e"
      unitRef="usd">56200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDAtMS0xLTEtMA_77738c8c-3198-41cf-a6e4-f03a73c24566"
      unitRef="usd">1638500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDAtMy0xLTEtMA_d66398d9-a6e3-4313-84c8-0a9ccd2ab6ec"
      unitRef="usd">1182600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDEtMS0xLTEtMA_2264e296-2a27-4b82-ade1-9b6d7031240d"
      unitRef="usd">1417700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8yNS9mcmFnOjIwZjc4NDM0OTIyMTQ4ZjJhY2M2MmY4NmJiYjk0NTA0L3RhYmxlOjUxMmE1OThhNTcwYTRiMGFhODBlNjE1NjU4ODRmZDNhL3RhYmxlcmFuZ2U6NTEyYTU5OGE1NzBhNGIwYWE4MGU2MTU2NTg4NGZkM2FfNDEtMy0xLTEtMA_85b02015-24db-43c9-afa8-63caa924b674"
      unitRef="usd">1238800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zMS9mcmFnOjU4MDMyNGU4N2U1MzQyMjBiMGE3YzRjNmVlY2U0NDk2L3RleHRyZWdpb246NTgwMzI0ZTg3ZTUzNDIyMGIwYTdjNGM2ZWVjZTQ0OTZfNjY1_d55e6bb3-b06b-4f00-9457-febb85d8018a">DESCRIPTION OF THE BUSINESS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intuitive Surgical, Inc. (&#x201c;Intuitive&#x201d; or the &#x201c;Company&#x201d;) develops, manufactures, and markets the da Vinci&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Surgical System and the Ion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; endoluminal system.&#160;The Company&#x2019;s products and related services enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. The da Vinci Surgical System consists of a surgeon console or consoles, a patient-side cart, a high-performance vision system, and proprietary instruments and accessories. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for lung biopsies.&lt;/span&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2NDc_a3763d87-acf2-471e-b64a-89b5517d5edc">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#x201c;Financial Statements&#x201d;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first three months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Financial Statements include the results and the balances of the Company&#x2019;s majority-owned joint venture (referred to herein as the &#x201c;Joint Venture&#x201d;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#x201c;Fosun Pharma&#x201d;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#x2019; equity. The noncontrolling interest&#x2019;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to additional risks and uncertainties due to the COVID-19 pandemic. The extent of the impact on the Company's business is highly uncertain and difficult to predict. The Company's customers continue to divert certain resources to treat COVID-19 patients and defer certain elective surgical procedures, both of which may impact the Company's customers' ability to meet their obligations, including to the Company. Furthermore, capital markets and economies worldwide have been negatively impacted by the COVID-19 pandemic, and it is possible that the impact could cause an extended local and/or global economic recession. Such economic disruption could have a material adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. However, the magnitude and overall effectiveness of these actions remains uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be materially adversely affected by delays in payments of outstanding receivables, supply chain disruptions, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers. For example, we have experienced, and could continue to experience, increased difficulties in obtaining a sufficient amount of materials in the semiconductor and other markets. We are engaged in activities to seek to mitigate such supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. As of the date of issuance of these Financial Statements, the extent to which the COVID-19 pandemic may materially adversely affect the Company's financial condition, liquidity, or results of operations is uncertain.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to monitor new accounting pronouncements issued by the FASB and does not believe any accounting pronouncements issued through the date of this report will have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no new or material changes to the significant accounting policies discussed in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, that are of significance, or potential significance, to the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2Nzc_ad8c596b-a164-4e9f-b92e-3384f7f52d84">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#x201c;Financial Statements&#x201d;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#x201c;U.S.&#x201d;) generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first three months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2NDE_11788757-7009-4a26-a7ce-9858bfaed405">The Financial Statements include the results and the balances of the Company&#x2019;s majority-owned joint venture (referred to herein as the &#x201c;Joint Venture&#x201d;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#x201c;Fosun Pharma&#x201d;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#x2019; equity. The noncontrolling interest&#x2019;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNC9mcmFnOmY2OWRhMGJlNGM3NzQ3MmY4OTJmZjIyYjFiM2Q1YWVmL3RleHRyZWdpb246ZjY5ZGEwYmU0Yzc3NDcyZjg5MmZmMjJiMWIzZDVhZWZfMTE2NDI_e34475e4-e933-4f11-905d-efe27b42a72b">&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company continues to monitor new accounting pronouncements issued by the FASB and does not believe any accounting pronouncements issued through the date of this report will have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no new or material changes to the significant accounting policies discussed in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, that are of significance, or potential significance, to the Company.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY3Mg_b6afbad9-b2f9-4d97-89a8-4cb515e8ea4c">FINANCIAL INSTRUMENTS&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s cash and available-for-sale marketable securities&#x2019; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,678.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,694.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,495.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,511.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,647.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,204.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,649.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,869.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,488.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the contractual maturities of the Company&#x2019;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of March&#160;31, 2021 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in one to five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,822.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,848.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actual maturities may differ from contractual maturities, because certain borrowers have the right to call or prepay certain obligations. Realized gains and losses recognized on the sale of investments were not material for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investment portfolio at any point in time contains available-for-sale debt securities including investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds. The Company segments its portfolio based on the underlying risk profiles of the securities and have a zero loss expectation for U.S. treasury and U.S. government agency securities. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. For the three months ended March&#160;31, 2021, the credit losses related to available-for-sales debt securities were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company generally recognizes equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the activity related to equity investments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;br/&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Changes in Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sales/Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable value (Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable value (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Recorded in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized a $14.3&#160;million increase in fair value, which was reflected in Interest and other income, net, due to changes in observable prices for certain equity investments that had been held at cost, because they lacked readily determinable market values. Additionally, in January 2021, the Company sold all of its shares of Teladoc Health, Inc. ("Teladoc"), a publicly traded company, for $71.5&#160;million and recognized a gain of $11.4&#160;million, which was reflected in Interest and other income, net. This gain was offset by a $7.5&#160;million loss recognized upon the settlement of a corresponding derivative collar contract. There were no decreases in fair value reflected in net income due to impairments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The objective of the Company&#x2019;s hedging program is to mitigate the impact of changes in currency exchange rates on net cash flow from foreign currency-denominated sales, expenses, intercompany balances, and other monetary assets or liabilities denominated in currencies other than the U.S. dollar (&#x201c;USD&#x201d;). The terms of the Company&#x2019;s derivative contracts are generally twelve months or shorter. The derivative assets and liabilities are measured using Level 2 fair value inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into currency forward contracts as cash flow hedges to hedge certain forecasted revenue transactions denominated in currencies other than the USD, primarily the Euro (&#x201c;EUR&#x201d;), the British Pound (&#x201c;GBP&#x201d;), the Japanese Yen (&#x201c;JPY&#x201d;),&#160;and the Korean Won (&#x201c;KRW&#x201d;). The Company also enters into currency forward contracts as cash flow hedges to hedge certain forecasted expense transactions denominated in EUR and the Swiss Franc (&#x201c;CHF&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For these derivatives, the Company reports the unrealized after-tax gain or loss from the hedge as a component of accumulated other comprehensive income/(loss) in stockholders&#x2019; equity and reclassifies the amount into earnings in the same &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period in which the hedged transaction affects earnings. The amounts reclassified to revenue and expenses related to the hedged transactions and the ineffective portions of cash flow hedges were not material for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other derivatives not designated as hedging instruments consist primarily of forward contracts that the Company uses to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the USD, primarily the EUR, GBP, JPY, KRW, CHF, Indian Rupee ("INR"), Mexican Peso ("MXN"), Chinese Yuan ("CNY"), and New Taiwan Dollar ("TWD").&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized gains/(losses) in Interest and other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gains/(losses) related to balance sheet re-measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, in January 2021, the Company settled a collar contract previously entered into to hedge its equity investment in Teladoc Health, Inc. For the three months ended March&#160;31, 2021, a loss of $7.5&#160;million was recognized in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notional amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross fair value recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:AvailableForSaleSecuritiesTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY3Nw_1047bca4-1f8d-429b-a557-da6594992454">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company&#x2019;s cash and available-for-sale marketable securities&#x2019; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,678.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,694.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,495.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,511.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,444.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,640.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,647.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,144.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,228.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,204.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,155.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and&lt;br/&gt;Cash&lt;br/&gt;Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-&lt;br/&gt;term&lt;br/&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,626.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,649.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,252.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;671.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,437.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,036.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government agencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,949.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,920.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,829.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,869.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,488.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i072d37fe25bb4302a174a740eff0e4f2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMy0xLTEtMS0w_4e9af3e1-1083-44e8-98bc-1f4612de024f"
      unitRef="usd">565100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i072d37fe25bb4302a174a740eff0e4f2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMy05LTEtMS0w_6f23e34f-c521-415a-928a-0517c4141d59"
      unitRef="usd">565100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i072d37fe25bb4302a174a740eff0e4f2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMy0xMS0xLTEtMA_747a8d58-f800-4fa3-9278-9f854f5875a8"
      unitRef="usd">565100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xLTEtMS0w_d8c31fa2-cbe8-4817-a845-2e3b6974d5df"
      unitRef="usd">817200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS05LTEtMS0w_c8733397-3782-47ce-be82-47f18dd13f9d"
      unitRef="usd">817200000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xMS0xLTEtMA_6cbcab04-c41e-4435-b064-57c1f3e56191"
      unitRef="usd">817200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xMy0xLTEtMA_6dfc9de5-f45b-4640-a286-1dbfa011f58d"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i35bf9937caf6400d88acb13a096891c5_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNS0xNS0xLTEtMA_146f5ef3-e232-41a5-968f-3dbebc28878e"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xLTEtMS0w_ce5ea9df-9450-4964-93a1-348a8870a67e"
      unitRef="usd">2678200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0zLTEtMS0w_52dd76c8-e2fb-4fd0-a342-baafe63215c6"
      unitRef="usd">17700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi01LTEtMS0w_06f3fff9-e88f-467d-87de-878c601cb1d1"
      unitRef="usd">1800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi03LTEtMS0w_3051dfbb-83a7-445e-873f-4e0a40bbc263"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi05LTEtMS0w_09918744-0397-4138-b645-4e417b3fa56d"
      unitRef="usd">2694100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xMS0xLTEtMA_db708f4e-e5ab-41b6-88a6-ed3e60698554"
      unitRef="usd">4000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xMy0xLTEtMA_6f85f1ad-1f29-4b4e-9227-86511dc48bf3"
      unitRef="usd">1245800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i3a75be70358e4656aae6d18d193a651e_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNi0xNS0xLTEtMA_ad6cbeec-88c0-487c-9ae5-b9752ada677a"
      unitRef="usd">1444300000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xLTEtMS0w_ddad1f7b-9650-4264-b03d-475047b62432"
      unitRef="usd">3495400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0zLTEtMS0w_454a121d-0394-4f1f-8ba9-5008a9c4a908"
      unitRef="usd">17700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy01LTEtMS0w_8641455c-ad8c-4ec6-84ad-020e389cd01a"
      unitRef="usd">1800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy03LTEtMS0w_d50f2f6e-a07e-4ca7-a1aa-a8c59ca59f35"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy05LTEtMS0w_fb9f1d79-86b4-4854-a4b6-db285a6f57a0"
      unitRef="usd">3511300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xMS0xLTEtMA_d38c5e22-451e-4796-ab1d-28f12a2b892c"
      unitRef="usd">821200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xMy0xLTEtMA_2204f948-c804-4d0e-9262-09d8aedff69b"
      unitRef="usd">1245800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfNy0xNS0xLTEtMA_5716ae15-ae17-4ff1-a9b0-86438b32a21a"
      unitRef="usd">1444300000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xLTEtMS0w_20abaf49-2299-44cb-9c8e-1ec773578332"
      unitRef="usd">643000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0zLTEtMS0w_cfddc9b9-9350-43f4-a8af-abd91672da55"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS01LTEtMS0w_de752b1e-9c42-4f89-9401-8891addc1de2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS03LTEtMS0w_916386c0-9bfc-470f-9313-68563d26de1f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS05LTEtMS0w_95a57782-7179-46af-ac9b-e3e363aa0339"
      unitRef="usd">643000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xMS0xLTEtMA_5ef68bfc-4912-42b8-95d2-6f00843021f3"
      unitRef="usd">15500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xMy0xLTEtMA_1707b20c-5c63-45dd-b8b8-e8faee02ba5b"
      unitRef="usd">627500000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i895e7c92ed73488cbc1472585100ffd2_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfOS0xNS0xLTEtMA_858c3d57-352e-4356-9217-8cc09f7929df"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMS0xLTEtMA_2e5c5f9e-fbf9-4bcc-a27b-a6dd4f61ac22"
      unitRef="usd">1640200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMy0xLTEtMA_d0b59d1d-16c0-46f8-92c4-e7e83bee69a6"
      unitRef="usd">8900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtNS0xLTEtMA_79f34c61-f8ae-4cf7-837b-06bb6b710742"
      unitRef="usd">1800000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtNy0xLTEtMA_5b93528c-61d3-44d8-878a-a8e295e1308b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtOS0xLTEtMA_acb3e7ae-1685-4e2c-ab28-2a0a06db253b"
      unitRef="usd">1647300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMTEtMS0xLTA_bd2b96c2-91a5-451c-a37d-1363e73afe6d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMTMtMS0xLTA_685cd98b-9e41-4bbe-a1db-da4d529741b6"
      unitRef="usd">966700000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i231cdf83bcbe4b678c5570b5502a3b15_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTAtMTUtMS0xLTA_ea0305c9-211f-4069-ae64-c3f596ac2a63"
      unitRef="usd">680600000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMS0xLTEtMA_eaa3986e-5384-40a6-bcf9-e22259aaa7dd"
      unitRef="usd">676500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMy0xLTEtMA_61058909-4f1d-48b7-9ffa-1f4c23d03080"
      unitRef="usd">1600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtNS0xLTEtMA_66cb7e0f-409a-49f7-b219-d83cf0674b4e"
      unitRef="usd">300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtNy0xLTEtMA_91e1529f-8f6e-48eb-a64a-2ea7684bd3cd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtOS0xLTEtMA_6e6e121c-7078-461a-825a-dac3a92229b4"
      unitRef="usd">677800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMTEtMS0xLTA_610e466e-5894-4a8b-bcc9-0993566ccfa1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMTMtMS0xLTA_7ca69f53-fa43-4f9a-a3a1-cd46f7ffc15b"
      unitRef="usd">254600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i04f73ee5f50b46c28090374917de184f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTEtMTUtMS0xLTA_727fe7aa-f95d-43b7-ad8c-ebe93f79accb"
      unitRef="usd">423200000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMS0xLTEtMA_fbdba082-0924-4b25-ab40-4534cf7e6a01"
      unitRef="usd">184500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMy0xLTEtMA_01a7e0d1-489e-4612-ab2f-ba7d8ebedc0e"
      unitRef="usd">1700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtNS0xLTEtMA_c797d362-3cfd-483b-b3f1-27abad27b4cd"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtNy0xLTEtMA_9d30fc76-8629-4011-92cc-5333eadcecc2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtOS0xLTEtMA_2d2fc881-3bee-44cd-8fac-84206a51fce4"
      unitRef="usd">186000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMTEtMS0xLTA_3bb1dd8a-2808-4486-ad1f-0f74ac1469ec"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMTMtMS0xLTA_a73648fc-5f15-4719-865d-1b4a4804e399"
      unitRef="usd">61100000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ifa4632879d684ddaa9023f7e0b54ac98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTMtMTUtMS0xLTA_3ead987c-2ad3-4f54-8377-d0afc9b98b37"
      unitRef="usd">124900000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMS0xLTEtMA_094c6203-e765-44d5-9901-02b5aa04ae4a"
      unitRef="usd">3144200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMy0xLTEtMA_15a6c88e-ba8b-4278-8551-860ab7ca891d"
      unitRef="usd">12200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtNS0xLTEtMA_57ac3d5c-6e00-45ee-99c0-6166364430b9"
      unitRef="usd">2300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtNy0xLTEtMA_830460e6-19a3-4ea0-9c4f-a8c6deb3ad36"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtOS0xLTEtMA_ba58dc57-c46d-46b3-a649-76dd24a68569"
      unitRef="usd">3154100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMTEtMS0xLTA_fe5293c1-aea6-4613-b35e-91b96532633b"
      unitRef="usd">15500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMTMtMS0xLTA_bfd9b154-9791-4251-a6b1-1ceb141bee19"
      unitRef="usd">1909900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTQtMTUtMS0xLTA_6a67ba1b-d103-4d1f-9f1e-6b33787b032b"
      unitRef="usd">1228700000</us-gaap:MarketableSecuritiesNoncurrent>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMS0xLTEtMA_8bcfc64f-8902-4eca-bc46-9183dbb40df9"
      unitRef="usd">7204700000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMy0xLTEtMA_5b7f6a09-bdb8-4e19-b9b9-9992b638daf4"
      unitRef="usd">29900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtNS0xLTEtMA_b933c608-20e3-4898-a950-2e4793a5a243"
      unitRef="usd">4100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtNy0xLTEtMA_4976be97-4a5f-4696-a71a-19d828ff1bf7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtOS0xLTEtMA_47147772-e65d-4310-92e9-04523adfd6df"
      unitRef="usd">7230500000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMTEtMS0xLTA_03d831a3-5645-4144-b49a-5ffe08ed9f3d"
      unitRef="usd">1401800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMTMtMS0xLTA_67b1ee6d-fc9f-44b1-97d5-f3cfecfc86f1"
      unitRef="usd">3155700000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjUxNTZkNzU1ZGMxOTRmM2Y5YWM4NzYzYzBjMDhhODY3L3RhYmxlcmFuZ2U6NTE1NmQ3NTVkYzE5NGYzZjlhYzg3NjNjMGMwOGE4NjdfMTgtMTUtMS0xLTA_dd842dcf-8601-4673-bc9d-93589f3ab50a"
      unitRef="usd">2673000000.0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMy0xLTEtMS0w_92ef0975-d953-4ecd-a226-ac6a9b8f8b04"
      unitRef="usd">644300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMy05LTEtMS0w_76f99201-c08f-4e57-ba8d-53eeab013da1"
      unitRef="usd">644300000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia66dcc52e3ba4558bd0c5d1f6008fce9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMy0xMS0xLTEtMA_5b739573-9a79-4586-907e-8325398a08e0"
      unitRef="usd">644300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xLTEtMS0w_ab857ac3-2707-4e89-bcd7-0e7951649ea4"
      unitRef="usd">625800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS05LTEtMS0w_4021ef89-61e2-40fb-8f7e-3a298beb6689"
      unitRef="usd">625800000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xMS0xLTEtMA_8f4ba14c-6ae0-4136-811d-cc002ae304b8"
      unitRef="usd">625800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xMy0xLTEtMA_7ac1a089-565c-4d49-b8ce-29b7ee66c838"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9b0c8e7e84f143d7b433e4521292b760_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNS0xNS0xLTEtMA_025b1df6-fa3d-459f-a2e2-1adb58a31a1b"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xLTEtMS0w_07d29be1-7b3b-428f-a67f-cd4c6804fbb2"
      unitRef="usd">2626800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0zLTEtMS0w_f778881a-ae98-4f36-8c3f-e2d0a454c84f"
      unitRef="usd">23000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi01LTEtMS0w_11b1d2d4-77b5-425a-b9ee-b0fe360788b8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi03LTEtMS0w_7ca04422-20fa-46b4-a797-2cb59283877e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi05LTEtMS0w_448f5593-c94b-4a20-bda1-ef8ed79fd481"
      unitRef="usd">2649800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xMS0xLTEtMA_2c36aaef-6533-42a6-8ef6-223aafdc6c16"
      unitRef="usd">212500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xMy0xLTEtMA_eaf76e20-e7a3-4d26-b51c-7f277d2ff92f"
      unitRef="usd">1567900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ib33c48a9a35d4e3988e697d97e54a4d8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNi0xNS0xLTEtMA_027081c2-b0a1-42f1-90f2-8521d27fd4dc"
      unitRef="usd">869400000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xLTEtMS0w_79d71fcb-0a54-4baa-b422-eac53d1aa5e0"
      unitRef="usd">3252600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0zLTEtMS0w_3624e144-0c25-4680-80eb-3e7fdabf84bc"
      unitRef="usd">23000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy01LTEtMS0w_ed90edcd-316a-4819-9cc9-7a5628056ef7"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy03LTEtMS01MjQ4_b9503cda-f530-470a-b7db-16ed59af71fd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy05LTEtMS0w_200c74f1-bbb7-4810-bc74-8d4eb1d09711"
      unitRef="usd">3275600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xMS0xLTEtMA_e7e89228-0cfd-44ce-bc46-d470469cf15c"
      unitRef="usd">838300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xMy0xLTEtMA_04e8d732-dc03-4413-b46c-abb5d6dcef05"
      unitRef="usd">1567900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfNy0xNS0xLTEtMA_a969f0f1-e8d0-4857-82b1-934cc62b0bef"
      unitRef="usd">869400000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xLTEtMS0w_0fc7ebe3-ffac-4efa-b0cd-69073484f1da"
      unitRef="usd">671300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0zLTEtMS0w_c748e070-f742-48db-8469-5efef7ed33f0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS01LTEtMS0w_aa9a316a-d249-48d2-91c3-54d21a4c4a15"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS03LTEtMS0w_cc95b22a-515c-436b-861e-b86bea13ed89"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS05LTEtMS0w_23cf5f47-aeba-4783-9e34-c658c787e651"
      unitRef="usd">671300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xMS0xLTEtMA_55911135-7e90-44f5-a2f0-760ec957b079"
      unitRef="usd">64100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xMy0xLTEtMA_dcccf69c-978a-4771-b3f5-f1c6a80e8048"
      unitRef="usd">607200000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="id4f3b8761ea441979a441de6b8b02816_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfOS0xNS0xLTEtMA_be462cb8-6534-4a16-898c-8b80ad4db21c"
      unitRef="usd">0</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMS0xLTEtMA_ff03fedd-5de5-4b34-9fbb-166aa17be5b8"
      unitRef="usd">1425400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMy0xLTEtMA_e104e1da-4ee4-4bd6-a03b-d0bb3729a08f"
      unitRef="usd">11900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtNS0xLTEtMA_502b7c35-4730-49b8-b9c3-d0df3d61943d"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtNy0xLTEtMA_891d28c8-1f0f-4a1d-b8a3-519cfdefdea3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtOS0xLTEtMA_73d62f25-6575-44cc-8f46-b134b7985f13"
      unitRef="usd">1437100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMTEtMS0xLTA_e531609a-5204-42a7-ae05-1f112b0574e2"
      unitRef="usd">3400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMTMtMS0xLTA_04d8dcce-903f-4ac8-90cf-5a0261581e85"
      unitRef="usd">1036500000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i66ed88632684468d94839263e693131e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTAtMTUtMS0xLTA_39d7cd17-34bb-4f99-a6e8-a2d03eab6d68"
      unitRef="usd">397200000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMS0xLTEtMA_3ce92cd8-902f-44bc-bc4a-8f765d93975b"
      unitRef="usd">716500000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMy0xLTEtMA_298bfb4b-4657-4f3e-b7e1-14d7b14705fd"
      unitRef="usd">2500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtNS0xLTEtMA_aeb9297c-972d-4516-9d6f-56451847ac02"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtNy0xLTEtMA_cc15c13a-d4f1-48af-8e9c-6de653d64bc8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtOS0xLTEtMA_024eff84-95f8-47e9-bc60-34bba686daba"
      unitRef="usd">719000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMTEtMS0xLTA_79bf9264-d4d7-4ae1-8381-67fb9196abcc"
      unitRef="usd">72500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMTMtMS0xLTA_3b0bd2b1-4458-4186-9351-35ec37e6143f"
      unitRef="usd">233600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="ie679b530e22f47f0b9f133ad1641a2e0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTEtMTUtMS0xLTA_e71c33cd-dfd4-4bfd-b84a-1fa46aed0307"
      unitRef="usd">412900000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMS0xLTEtMA_ea9a84e9-8ef0-4b93-baa2-ac3e68a4f0a4"
      unitRef="usd">119800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMy0xLTEtMA_6187ff35-1898-49aa-84c0-974662abab2c"
      unitRef="usd">2000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtNS0xLTEtMA_69ff9c3c-757e-4f5a-bbb9-2ef89ba7529e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtNy0xLTEtMA_3aeadc4d-c3ba-4183-8297-739568198fcd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtOS0xLTEtMA_5a297f31-25b7-43d1-bd80-92baa21c0064"
      unitRef="usd">121800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMTEtMS0xLTA_4084e871-5a6f-444a-89e0-4bfe24889b96"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMTMtMS0xLTA_f8789189-58b8-4f63-bb95-4d11644ae5ff"
      unitRef="usd">43600000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="if8f11e0d90794805a51ee4875ef2bb22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTMtMTUtMS0xLTA_4383f320-7b06-4aa7-9e65-772c0c327331"
      unitRef="usd">78200000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMS0xLTEtMA_8c1e07df-391e-452e-b665-3ad631e59348"
      unitRef="usd">2933000000.0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMy0xLTEtMA_85da3e19-1010-41a8-8f59-6dba2281ea1b"
      unitRef="usd">16400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtNS0xLTEtMA_42ebbea2-adf8-4d57-bd3f-20d3709ccf2c"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtNy0xLTEtNTI0OA_267c779a-aff7-4a6e-8086-02437ce184c3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtOS0xLTEtMA_2fadd11d-1f77-4140-93f2-0da86c6165f3"
      unitRef="usd">2949200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMTEtMS0xLTA_b774a043-692a-48ae-8740-f5280f981c06"
      unitRef="usd">140000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMTMtMS0xLTA_4cdce0f8-ca64-43d8-a2a2-05b2eda01227"
      unitRef="usd">1920900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTQtMTUtMS0xLTA_8b5e5eb9-2a6e-4c91-85ff-4ea63a72f828"
      unitRef="usd">888300000</us-gaap:MarketableSecuritiesNoncurrent>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMS0xLTEtMA_ab9de3f4-d74f-4142-ad19-662a41528e2d"
      unitRef="usd">6829900000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMy0xLTEtMA_f8944c7a-6d6f-47d2-a711-99ae96f1d3ee"
      unitRef="usd">39400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtNS0xLTEtMA_8f013e87-344c-4b47-8ed8-632b5f5b57c3"
      unitRef="usd">200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtNy0xLTEtNTI0OA_61d57149-de75-4d0e-854f-af4c609fb86c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtOS0xLTEtMA_39ade547-19be-40e3-8529-03006fcbbb73"
      unitRef="usd">6869100000</isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMTEtMS0xLTA_7a70258d-f304-4178-bb6b-b2b9373179ee"
      unitRef="usd">1622600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMTMtMS0xLTA_cdbec4ce-80d5-4b4e-a554-d0a220bc866b"
      unitRef="usd">3488800000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjdjN2U1Y2U1ODNmMDQ3ZDhhZjBhY2VmNzliNzVmMTcyL3RhYmxlcmFuZ2U6N2M3ZTVjZTU4M2YwNDdkOGFmMGFjZWY3OWI3NWYxNzJfMTgtMTUtMS0xLTA_8b924094-6d06-45fd-aeef-7ae136eaf1b9"
      unitRef="usd">1757700000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY2NQ_7d963c73-4374-4bbf-bb68-c474ffa34bb7">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the contractual maturities of the Company&#x2019;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of March&#160;31, 2021 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature in one to five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,673.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,822.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,848.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMS0xLTEtMS0w_28cdd5a6-2374-4707-ad81-de13bb5d0033"
      unitRef="usd">3166600000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMS0zLTEtMS0w_4b20be27-e801-4b8b-932f-b2543bbda84a"
      unitRef="usd">3175200000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMi0xLTEtMS0w_3d08a5db-a5fe-4625-bbf3-35a8ee8946e6"
      unitRef="usd">2655800000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfMi0zLTEtMS0w_2943d4a3-1f26-4ffc-8cb9-cca4b84dfa29"
      unitRef="usd">2673000000.0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfNC0xLTEtMS0w_7a832578-ccd9-4948-bb15-27ed6f3f1d0d"
      unitRef="usd">5822400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <isrg:AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjM0MWE1N2QzOWM5YTQ4NThhMWNlZDU2MmQyNjdkOTY5L3RhYmxlcmFuZ2U6MzQxYTU3ZDM5YzlhNDg1OGExY2VkNTYyZDI2N2Q5NjlfNC0zLTEtMS0w_05fcc440-c373-4000-b5f1-e82fdc6acc6f"
      unitRef="usd">5848200000</isrg:AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY3NA_7ccc873a-f3ec-4185-b1a4-1a3da6fa28f9">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the activity related to equity investments (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;br/&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Changes in Fair Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Sales/Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable value (Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(71.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable value (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Recorded in Interest and other income, net.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i222e4ab4f50046478fb8626cd2050931_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi0xLTEtMS0w_75d93ff0-4f4c-4c39-8902-db7bf4fb0581"
      unitRef="usd">60100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="iba387424719640be97f87fe83a205421_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi0zLTEtMS0w_45bcadfe-31e3-4682-87aa-6ab14f9131a0"
      unitRef="usd">11400000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <isrg:EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments
      contextRef="iba387424719640be97f87fe83a205421_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi01LTEtMS0w_582eb5cf-64f5-4b06-bdbf-4eaefca9151f"
      unitRef="usd">-71500000</isrg:EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i368e30c496574fe38438f342b8cdc48b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi03LTEtMS0w_7815efaa-1dc0-42be-bc2c-ad0593053ceb"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id41180fe238f4e5494e70d7abad1bfa9_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi05LTEtMS0w_d337b426-d26d-4462-8971-1f3cfee1c1cb"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i833afe2c87e8454a87024764d94c2822_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMi0xMS0xLTEtMA_8ebef3f4-57ee-40cb-aa59-90d494d09658"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i014ce2f5b0f444f4b1647a8837939eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy0xLTEtMS0w_3297dc5f-c718-4b20-90ec-25e22e05503e"
      unitRef="usd">30200000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss
      contextRef="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy0zLTEtMS0w_2b2adcdb-e6ee-400e-a70a-07f829ee9075"
      unitRef="usd">14300000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments
      contextRef="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy01LTEtMS0w_0af10dfa-c925-459d-a2f9-9d19c5833b9b"
      unitRef="usd">900000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i54ca0c6dceff44bdb8e26225c230f09c_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy03LTEtMS0w_3062b6fe-a568-4d28-a401-351487bb78aa"
      unitRef="usd">45400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ifdb7e13199f44d5493cb6aa8bb70dff9_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy05LTEtMS0w_19cb2b4c-f67c-4998-bf74-5f021f1520d5"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i958d733265f7468c8bb333fd2012a22a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmIxMTdhOGQwZmY3YjQ5NGI5ZDA5MmMwOTAzYTY5OTVjL3RhYmxlcmFuZ2U6YjExN2E4ZDBmZjdiNDk0YjlkMDkyYzA5MDNhNjk5NWNfMy0xMS0xLTEtMA_79c4128c-06d6-414b-b9d6-bbeb739bd33b"
      unitRef="usd">45400000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss
      contextRef="if2210e2c76a4479f9008688ae2d13a13_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfMTU5OA_c702558d-2507-4d6c-87bf-78203d3f3e07"
      unitRef="usd">14300000</isrg:EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY1OA_bccb512e-637d-4f1c-bfa2-a588b6972356">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized gains/(losses) in Interest and other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gains/(losses) related to balance sheet re-measurement&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i08ae6a1daaa4488ab4a2cbc44713a1ac_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMi0xLTEtMS0w_50bf373f-9183-4fd3-adf9-abfea9f02f1c"
      unitRef="usd">7400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i95cda8b4c1784cb3a304cb36b3e28670_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMi0zLTEtMS0w_b3dc6c7e-ec77-4ccb-b216-d849aa882cf2"
      unitRef="usd">3600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMy0xLTEtMS0w_50cc882a-503f-4bd2-8782-2df3fc69beaf"
      unitRef="usd">-7100000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOmVkNDkzOTk5OGI1NjQ1YWY4NDk1MGQyOWEzNmE0MTg3L3RhYmxlcmFuZ2U6ZWQ0OTM5OTk4YjU2NDVhZjg0OTUwZDI5YTM2YTQxODdfMy0zLTEtMS0w_a02b285c-ec37-47d6-b831-6eda74fdc146"
      unitRef="usd">-8600000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie35611a332ef451ebfedc87ebfa99560_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDk0NzgwMjMzNDIwOA_23e9739a-9c26-40dc-ae4f-7a908dc87619"
      unitRef="usd">7500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RleHRyZWdpb246ZTlkYmRjODUxZDAzNDdmOTk3YWMxYTBjM2YxNjY5OGRfNDY1MQ_431a0a1b-2104-4f4e-bfe5-6718dbaf1e6a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notional amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross fair value recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3a170e992d9b457f9595e8e31c382067_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy0xLTEtMS0w_1a7d312b-a761-4bfb-b95c-2893897bcc68"
      unitRef="usd">165000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia441705586c64958893ba4b26e8f9831_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy0zLTEtMS0w_d9f4dc1b-fa1e-4a72-b712-8d77153bf743"
      unitRef="usd">154300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6653afda804c4e6c92c1ee18d4fb6513_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy01LTEtMS0w_1b4ae8cd-ad04-4ae2-b93c-6ec259e417f8"
      unitRef="usd">384400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i44e41d62be44428bbe7bec7558efa25e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfMy03LTEtMS0w_37e001be-697e-4186-a310-6999cfe5cf68"
      unitRef="usd">309800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i54056e1ecde648908d7a97b1e1644204_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS0xLTEtMS0w_782a20be-efd9-4c51-a91c-f75f2e8cb005"
      unitRef="usd">4800000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1482cb8fa3714e7dbbbc27ada59f5747_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS0zLTEtMS0w_b3df3db3-ff2e-4d06-9d36-c99631758472"
      unitRef="usd">900000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i3bf9140f4a144a61a11f812b3233bee0_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS01LTEtMS0w_9cfef458-9a26-41ae-a00b-8e10c6eca3f4"
      unitRef="usd">3200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i455a5987f0e4495ea102bd1bb887aac7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNS03LTEtMS0w_5102700e-8aea-4c74-9931-0dddc7c7ddb2"
      unitRef="usd">700000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia049734db3fb46309a15c9c21f4d5265_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi0xLTEtMS0w_ffe88f28-406c-4dee-b427-5eba6c3e0f98"
      unitRef="usd">1200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6fbd0c73fe99402fb77a4384d2e76b14_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi0zLTEtMS0w_dbcdda62-8b21-4c2c-9ef8-c5e6562f747a"
      unitRef="usd">4300000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i86716d46a32f4177960da8dbdf213b78_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi01LTEtMS0w_27649360-6769-4ffa-b6e0-25164bc43d97"
      unitRef="usd">2100000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i7bc25cae1624497fb0288262254a7cdd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV8zNy9mcmFnOmU5ZGJkYzg1MWQwMzQ3Zjk5N2FjMWEwYzNmMTY2OThkL3RhYmxlOjE2NzlhNTdhMzcwZDQ0YTRhZjYzZDkzY2ZhN2MwNmU4L3RhYmxlcmFuZ2U6MTY3OWE1N2EzNzBkNDRhNGFmNjNkOTNjZmE3YzA2ZThfNi03LTEtMS0w_b34a4ee0-84e2-420a-bc4a-c83c3b08d1f1"
      unitRef="usd">5400000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzU0_e4158017-125c-4df5-b9bb-a92bf27a6b69">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Balance Sheet Details&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide details of selected balance sheet line items (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases &#x2013; short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of deferred purchase consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental non-cash investing and financing activities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition of property, plant, and equipment in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred payments and contingent consideration related to business combinations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzU1_239bf030-2671-4591-a595-6b6a63ae0d53">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide details of selected balance sheet line items (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;341.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMi0xLTEtMS0w_de271e9d-7ee7-4d64-adb9-667c42b85134"
      unitRef="usd">167900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMi0zLTEtMS0w_a36e9227-607a-47a2-98cc-d740037019e2"
      unitRef="usd">184100000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMy0xLTEtMS0w_0a105006-300b-4dc4-8e75-7a3a5412c162"
      unitRef="usd">67900000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfMy0zLTEtMS0w_cebf51e1-824f-469b-9667-cfe521a23f88"
      unitRef="usd">75600000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNC0xLTEtMS0w_9f59a224-614f-4d21-805d-897a86575883"
      unitRef="usd">341000000.0</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNC0zLTEtMS0w_f2b63086-bf9b-44e0-87be-ee693920a8ed"
      unitRef="usd">341800000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNS0xLTEtMS0w_9fb065ec-72a3-41ca-bc2e-cc9ca68a202e"
      unitRef="usd">576800000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOjU5ZDI3Yjc5ZjNiMDQyZGJiZjNlMmZhMTQ2OTA2NjhlL3RhYmxlcmFuZ2U6NTlkMjdiNzlmM2IwNDJkYmJmM2UyZmExNDY5MDY2OGVfNS0zLTEtMS0w_bcad0ba5-f6eb-4491-9714-516e47c2aaad"
      unitRef="usd">601500000</us-gaap:InventoryNet>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzI3_1358293c-b543-407e-9bf6-47a5c8074d09">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases &#x2013; short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzYw_7f65c956-7ae2-417b-b500-7662a168cbdb">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.968%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.994%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.541%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases &#x2013; short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMi0xLTEtMS0w_274d2068-d544-4166-b43b-7fe131509a66"
      unitRef="usd">72400000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMi0zLTEtMS0w_93f7acd4-952b-4840-9fed-f7b88677fd2f"
      unitRef="usd">28900000</us-gaap:PrepaidTaxes>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMy0xLTEtMS0w_e8b2ab0a-8abd-4e0d-8d87-ae06d673cf5c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfMy0zLTEtMS0w_dfd1aa82-9eff-4ed8-87f9-712bd52da2d9"
      unitRef="usd">60100000</us-gaap:EquitySecuritiesFvNi>
    <isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNC0xLTEtMS0w_e08a906b-8284-4964-9543-c9d351ee068c"
      unitRef="usd">79000000.0</isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent>
    <isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNC0zLTEtMS0w_4d09fe30-8461-4c0a-ae18-9aae1d607a05"
      unitRef="usd">81100000</isrg:SalesTypeLeaseNetInvestmentInLeaseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNS0xLTEtMS0w_778a66bc-1fbe-4e3e-8906-fad16c180637"
      unitRef="usd">126400000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNS0zLTEtMS0w_8b5340c1-2718-492b-b871-7bc11c47882e"
      unitRef="usd">97400000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNi0xLTEtMS0w_85b17752-05bc-4245-a764-d71246ef0190"
      unitRef="usd">277800000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmYzMzJlMTE1MTUzOTRlMTM5YjBkYmQ3YWRmMjc4MzAwL3RhYmxlcmFuZ2U6ZjMzMmUxMTUxNTM5NGUxMzliMGRiZDdhZGYyNzgzMDBfNi0zLTEtMS0w_16ebe76b-dd15-46c8-903f-9849c21f8daa"
      unitRef="usd">267500000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzM5_ec28c56d-09ca-4382-9c3b-51f06e5e36d7">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of deferred purchase consideration payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other accrued liabilities&#x2013;short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:TaxesPayableCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfMi0xLTEtMS0w_deb0ff10-1142-4a48-8556-17c025d233a3"
      unitRef="usd">50700000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfMi0zLTEtMS0w_734bdce8-c37a-4d02-9dde-ca3f688fd73d"
      unitRef="usd">47200000</us-gaap:TaxesPayableCurrent>
    <isrg:DeferredPurchaseConsiderationPaymentsCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNC0xLTEtMS0w_bfd12804-2d2d-48b4-a4c4-954c4e828fa5"
      unitRef="usd">12700000</isrg:DeferredPurchaseConsiderationPaymentsCurrent>
    <isrg:DeferredPurchaseConsiderationPaymentsCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNC0zLTEtMS0w_94828d99-8763-4757-b189-ce20e5675542"
      unitRef="usd">10400000</isrg:DeferredPurchaseConsiderationPaymentsCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNS0xLTEtMS0w_ea9bdb07-72b2-4b0f-99b5-f9e13ba4f97e"
      unitRef="usd">1800000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNS0zLTEtMS0w_eb1a67d0-834c-4422-9100-ef0021e7ee13"
      unitRef="usd">15100000</us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNi0xLTEtMS0w_488d8f60-bc15-4d3f-9d7b-a6491fb4f7cc"
      unitRef="usd">183400000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNi0zLTEtMS0w_91a6a627-08a7-4987-9a42-3f3575200780"
      unitRef="usd">225600000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNy0xLTEtMS0w_66ef1bdb-0b11-4be2-b8fb-24fec061a1d3"
      unitRef="usd">248600000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY5MGQyMDE0ZmNkNDRiZDRhYmJmNWVmOTkxMjAxMTQ5L3RhYmxlcmFuZ2U6ZjkwZDIwMTRmY2Q0NGJkNGFiYmY1ZWY5OTEyMDExNDlfNy0zLTEtMS0w_70784cee-60ac-4bef-9451-f8e07e17bd94"
      unitRef="usd">298300000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzU2_5979090c-3149-4d50-9911-8a7a78099e8d">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&#x2013;long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMi0xLTEtMS0w_97c3468d-fffc-45c3-88d6-c11dac2223cd"
      unitRef="usd">319500000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMi0zLTEtMS0w_94b01b7e-8601-466f-84a5-6c1e5c9ee113"
      unitRef="usd">305600000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMy0xLTEtMS0w_363e7180-34aa-4e47-975e-9cf97930d0cc"
      unitRef="usd">31100000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfMy0zLTEtMS0w_3c8793ea-3823-4b93-8847-7db1d4295156"
      unitRef="usd">32100000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNC0xLTEtMS0w_dc22aeaa-cefb-42f3-9843-d0a62411771b"
      unitRef="usd">95000000.0</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNC0zLTEtMS0w_d56e8561-2d30-4ac3-a93e-a566fb2d9bb7"
      unitRef="usd">106900000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNS0xLTEtMS0w_19b66141-0c99-45af-b60d-3bd9493746ea"
      unitRef="usd">445600000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmQxZWExYjEyZjA2ZDRjZWM5OGE4MThkZWExNmExMTBhL3RhYmxlcmFuZ2U6ZDFlYTFiMTJmMDZkNGNlYzk4YTgxOGRlYTE2YTExMGFfNS0zLTEtMS0w_0b36cd3b-7990-4ddb-9a08-e158f6f0e037"
      unitRef="usd">444600000</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RleHRyZWdpb246ZWI4OWY1MWQzZTQ0NGJhNmI3NzU3OWIzNzY1Nzg3NDhfMzQx_556202ee-e9ca-46fc-9b66-00b27f578e6c">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides supplemental non-cash investing and financing activities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition of property, plant, and equipment in accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred payments and contingent consideration related to business combinations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMi0xLTEtMS0w_39c6d707-a1a8-4228-90ee-0dcd9156114e"
      unitRef="usd">73500000</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:PropertyPlantAndEquipmentTransfersAndChanges
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMi0zLTEtMS0w_e76d7208-4f04-4266-b99d-42fde7309bb4"
      unitRef="usd">45400000</us-gaap:PropertyPlantAndEquipmentTransfersAndChanges>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0xLTEtMS00NDgw_be7de2d8-451c-43ce-a81b-4a9db17cdafe"
      unitRef="usd">27600000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0zLTEtMS00NDg2_dd9a51bc-643d-44b3-b8a6-6830c5a67d0f"
      unitRef="usd">50000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0xLTEtMS0w_5eec1387-6963-4c82-835d-7fab379ea601"
      unitRef="usd">3800000</isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments>
    <isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80MC9mcmFnOmViODlmNTFkM2U0NDRiYTZiNzc1NzliMzc2NTc4NzQ4L3RhYmxlOmY1NzkyNTg0NzNkYjQ3ZDk4NzllOGMzOTk1MzllOGFhL3RhYmxlcmFuZ2U6ZjU3OTI1ODQ3M2RiNDdkOTg3OWU4YzM5OTUzOWU4YWFfMy0zLTEtMS0w_3994a57a-c05d-4cad-aeca-ec6e9de92bc4"
      unitRef="usd">4100000</isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU1OQ_3d0cc6bc-cd5c-49c0-a6ca-7d3a6a4878eb">REVENUE AND CONTRACT ACQUISITION COSTS&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by types and geography (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Outside of U.S. (&#x201c;OUS&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total OUS revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which revenue has not yet been recognized. A significant portion of this amount relates to performance obligations in the Company&#x2019;s service contracts that will be satisfied and recognized as revenue in future periods. In addition, non-lease elements associated with the Company's lease arrangements are primarily comprised of service contracts that will be satisfied and recognized as revenue in future periods. The transaction price allocated to the remaining performance obligations and the non-lease elements associated with lease arrangements was $1,673 million as of March&#160;31, 2021. The remaining performance obligations are expected to be satisfied over the term of the individual sales arrangements, which generally are 5 years. Service revenue associated with the lease arrangements will generally be recognized over the service period, which generally coincides with the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information summarizes the Company&#x2019;s contract assets and liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company invoices its customers based on the billing schedules in its sales arrangements. Payments are generally due 30 days from date of invoice. Contract assets for the periods presented primarily represent the difference between the revenue that was recognized based on the relative standalone selling price of the related performance obligations satisfied and the contractual billing terms in the arrangements. Deferred revenue for the periods presented primarily relates to service contracts where the service fees are billed up-front, generally quarterly or annually, prior to those services having been performed. The associated deferred revenue is generally recognized over the term of the service period. The Company did not have any significant impairment losses on its contract assets for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, the Company recognized $153.9&#160;million of revenue that was included in the deferred revenue balance as of December&#160;31, 2020. During the three months ended March&#160;31, 2020, the Company recognized $137.0&#160;million, of revenue that was included in the deferred revenue balance as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intuitive System Leasing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue from Intuitive System Leasing arrangements (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2021, and 2020, variable lease revenue relating to usage-based arrangements was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Trade Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allowance for doubtful accounts is based on the Company&#x2019;s assessment of the collectibility of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#x2019;s ability to pay. For the three months ended March&#160;31, 2021, and 2020, bad debt expense was not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of lease and trade receivables as hospital cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU2MA_9afd06f8-dc1c-4a31-8497-a1ab1d69250e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue disaggregated by types and geography (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Outside of U.S. (&#x201c;OUS&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total OUS revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments and accessories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Systems&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,292.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,099.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i152085248b524a7aad79030a253fd4ad_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMi0xLTEtMS0w_5add32e2-fe46-4fe7-a88b-2dbad47a1b37"
      unitRef="usd">500800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i157c8a2a14244227b32df8ba8e8c12cd_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMi0zLTEtMS0w_41f011bd-3b79-45fa-95cb-8d022c53933f"
      unitRef="usd">444400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29851492d6bf481581aacf08b75f5339_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMy0xLTEtMS0w_ad041073-ee15-44eb-a1f4-6f885b745f45"
      unitRef="usd">202700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33e08c5f1b214731b6b9dbc8c5f58cd8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMy0zLTEtMS0w_f90407c8-dc50-49a5-a4fe-70db5a883b99"
      unitRef="usd">198800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42118bf09f1b4f93aa3651255ba5a1b2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNC0xLTEtMS0w_90a7c274-b2b7-4bd2-8d03-3b1dac881f22"
      unitRef="usd">144000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0134fb267a9b433d82bc15fd159a7ef1_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNC0zLTEtMS0w_bc0a1ad0-b64a-47fc-a493-732f029863a4"
      unitRef="usd">138400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7055642a7210446390122584f500fda4_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNS0xLTEtMS0w_99c804a8-a65a-4a3c-acf5-f1abbf2cd754"
      unitRef="usd">847500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3e657c28bcd46ae88684e0e1d05b884_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfNS0zLTEtMS0w_6a021c1d-12fe-4282-b8bd-82d3d8eaf54c"
      unitRef="usd">781600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81f67fc3a5914897bfb2af66c5111c5f_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOC0xLTEtMS0w_e1d15c22-0c0f-45ed-88ea-96787a3bfe07"
      unitRef="usd">205100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1bcf40fa8c74859aa7a3f6f5cd2a321_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOC0zLTEtMS0w_5bf08099-9f8e-4043-963b-5a7014eb51d0"
      unitRef="usd">173100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac9c8091fc074a50b333fe645498f038_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOS0xLTEtMS0w_9eb61052-4a4c-4c80-bc41-598be937f724"
      unitRef="usd">166000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4b1f60c62c3443bbb2842b9ac6ff27b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfOS0zLTEtMS0w_22053c82-182b-4c22-9688-945003bd3905"
      unitRef="usd">84500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2d6bd374e56486b9e830cd18f662db8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTAtMS0xLTEtMA_4e503880-caad-48b7-96cf-e63d882151c2"
      unitRef="usd">73500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a4f0809ae7c474bb8f654639db1dda5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTAtMy0xLTEtMA_81401d8d-820c-4168-a35d-1d6e270b38c4"
      unitRef="usd">60300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i371d9d7cd5994bf2b5d51f8dee8c6f30_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTEtMS0xLTEtMA_09d4f102-8f17-4382-a195-f92869bafb61"
      unitRef="usd">444600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35c310e8fe3f4e1fa74d58cde4f02a61_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTEtMy0xLTEtMA_d024f365-45e6-4928-8a40-a4a151eb4f53"
      unitRef="usd">317900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic20d6d2cffa74ad38d0883a8f21b0bb6_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTQtMS0xLTEtMA_a56257e9-7d61-4420-8995-f31c05506f7b"
      unitRef="usd">705900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20599bf2b00d4db08e12ef6ca86133f8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTQtMy0xLTEtMA_6b0620ca-2bfe-4198-b248-ffe52f5655e6"
      unitRef="usd">617500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0077eedf3c254281b3ccb2d1eac594d1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTUtMS0xLTEtMA_57941f1b-38e2-4417-9db0-219edf09d5d3"
      unitRef="usd">368700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i075a7596ace44e8a80d6c8d9082c1342_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTUtMy0xLTEtMA_5c13badd-ea11-4671-b968-809557a22d63"
      unitRef="usd">283300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5ecd44c2474464dbc7542ef31537629_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTYtMS0xLTEtMA_945d4548-ed77-4c53-be6b-ce751bbc5906"
      unitRef="usd">217500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i316ac96134214c19b317684c3c8230bf_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTYtMy0xLTEtMA_05ed1bef-f1bb-4b4c-aa72-8669c52e828c"
      unitRef="usd">198700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTctMS0xLTEtMA_018a6f6f-bca3-4382-bea8-f1172be40dc3"
      unitRef="usd">1292100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmFkNzU4NmY2YWZhNTRjNGQ5OGZiOTQyZWI1YTVkMjJhL3RhYmxlcmFuZ2U6YWQ3NTg2ZjZhZmE1NGM0ZDk4ZmI5NDJlYjVhNWQyMmFfMTctMy0xLTEtMA_42a9bc1f-1519-4acf-8909-98c61f682ea2"
      unitRef="usd">1099500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfODU1_b4b6c466-a8a1-4ad5-a7db-b539d16a3684"
      unitRef="usd">1673000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="iac5907b4d5ac44a09eff901e7f3d5739_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMTAwNw_19a8723f-918d-49f9-bbf0-c906d6baa4ba">P5Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU2Ng_37bd0102-fb3e-4d08-b09e-f6fb4b4a263f">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following information summarizes the Company&#x2019;s contract assets and liabilities (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;389.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfMy0xLTEtMS0w_4689419c-fd2c-48a5-a791-9b925ebc8f3a"
      unitRef="usd">39100000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfMy0zLTEtMS0w_8e34a6a2-a74a-4242-a090-12cea62a36ca"
      unitRef="usd">34600000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfNC0xLTEtMS0w_1829419a-d19b-4e22-984f-a5e575dbe6b0"
      unitRef="usd">389200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOmI5MWQyZTA1YTAwODQ3YmFhY2JhZmQzNzNlOWE1MWZiL3RhYmxlcmFuZ2U6YjkxZDJlMDVhMDA4NDdiYWFjYmFmZDM3M2U5YTUxZmJfNC0zLTEtMS0w_c70db16a-6551-4e1e-99a9-58fa6d076dc3"
      unitRef="usd">382300000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMjE4Ng_260d00b6-6754-419a-a3d7-40373bd144ba"
      unitRef="usd">153900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMjM4Nw_9fa65115-69e3-4ecc-8834-b69d88770a9a"
      unitRef="usd">137000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU1Nw_bee96965-fc76-4268-b07f-eb39f28762bf">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue from Intuitive System Leasing arrangements (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RleHRyZWdpb246ZmRjOWJhODVkYzEyNDg1M2E2MDIzODdkY2ViZWU2NWFfMzU2Nw_ea2238d9-24c5-4bc9-8e5f-719e3401a53a">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents revenue from Intuitive System Leasing arrangements (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales-type lease revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease revenue &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock>
    <us-gaap:SalesTypeLeaseLeaseIncome
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMi0xLTEtMS0w_727c161a-62fc-4fc6-8b44-939149058dc2"
      unitRef="usd">17300000</us-gaap:SalesTypeLeaseLeaseIncome>
    <us-gaap:SalesTypeLeaseLeaseIncome
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMi0zLTEtMS0w_35094c97-3acd-413b-8431-36d4c27bef4f"
      unitRef="usd">55000000.0</us-gaap:SalesTypeLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMy0xLTEtMS0w_514aca0b-3052-490c-b2ba-480bbfafb041"
      unitRef="usd">59000000.0</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80My9mcmFnOmZkYzliYTg1ZGMxMjQ4NTNhNjAyMzg3ZGNlYmVlNjVhL3RhYmxlOjAxZjNmMzZlMjQ5MTQ3YTFiMDM2MWMyMWFiZDM1Y2RmL3RhYmxlcmFuZ2U6MDFmM2YzNmUyNDkxNDdhMWIwMzYxYzIxYWJkMzVjZGZfMy0zLTEtMS0w_f60e8660-ba41-4d5d-ba60-636052ea11f1"
      unitRef="usd">39100000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:LessorSalesTypeLeasesTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzE5_158e5f20-3368-4382-9a2f-70cef172db0e">LEASES&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales-type Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of gross lease receivables at March&#160;31, 2021, are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorSalesTypeLeasesTextBlock>
    <isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzA1_56be0b9b-8e04-4732-9aee-fe6dc2024bf5">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales-type Leases. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock>
    <us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzA3_10189b62-c999-4327-8a0b-918cac29fde0">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment in sales-type leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Prepaids and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Intangible and other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock>
    <isrg:SalesTypeLeaseGrossInvestmentInLease
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMi0xLTEtMS0w_e36b6507-c4bb-4b3a-9d98-1588ae2bf306"
      unitRef="usd">281000000.0</isrg:SalesTypeLeaseGrossInvestmentInLease>
    <isrg:SalesTypeLeaseGrossInvestmentInLease
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMi0zLTEtMS0w_37299846-d15b-442a-b3d9-c43ffb34a3a2"
      unitRef="usd">286100000</isrg:SalesTypeLeaseGrossInvestmentInLease>
    <isrg:SalestypeLeaseDeferredSellingProfit
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMy0xLTEtMS0w_c8bb1c4a-abdd-46ce-8b78-9bff1d91ec47"
      unitRef="usd">10600000</isrg:SalestypeLeaseDeferredSellingProfit>
    <isrg:SalestypeLeaseDeferredSellingProfit
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMy0zLTEtMS0w_59913d96-fe8d-4c08-b6d4-559ed55246d3"
      unitRef="usd">11100000</isrg:SalestypeLeaseDeferredSellingProfit>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNC0xLTEtMS0w_84b11348-43cb-4b55-831f-4d4374b79691"
      unitRef="usd">270400000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNC0zLTEtMS0w_2df5795d-5e41-405e-9571-fa77676f48c9"
      unitRef="usd">275000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNS0xLTEtMS0w_2089c5ba-1cf9-4550-83b6-afdd6c0e6ed2"
      unitRef="usd">4000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNS0zLTEtMS0w_bd8127c0-050f-46f0-97b7-d8370b65be6c"
      unitRef="usd">4400000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNi0xLTEtMS0w_74c95514-5bc5-42c3-b1bd-5caf7689e297"
      unitRef="usd">266400000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfNi0zLTEtMS0w_9b0a6b2d-7963-418f-b297-13160c8068dd"
      unitRef="usd">270600000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i61c5c9b528fc40b28e5777152e16f632_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOC0xLTEtMS0w_3061399a-cb17-44e3-8f41-2a2486a8505a"
      unitRef="usd">79000000.0</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i16587b9e3fa145b7a10a7a0e68039b6b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOC0zLTEtMS0w_95bceacd-ff90-43b9-b822-a841be8ca319"
      unitRef="usd">81100000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="ibd60252340be492cb5cd60dbb4959028_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOS0xLTEtMS0w_bda182b4-a899-4e5f-945f-96df01550926"
      unitRef="usd">187400000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i8dd6688329e44797b0c7cb4a51d91169_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfOS0zLTEtMS0w_e583c6ac-30da-495b-a7ca-967678ae598a"
      unitRef="usd">189500000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMTAtMS0xLTEtMA_cf7eeefc-5e3e-4328-8c78-87e1d3e7fcaa"
      unitRef="usd">266400000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeLeaseLeaseReceivable
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmNlOTY1OTVlNDE0ZTQ4NjE4YjE3ZGEzM2JkNGNkNjcwL3RhYmxlcmFuZ2U6Y2U5NjU5NWU0MTRlNDg2MThiMTdkYTMzYmQ0Y2Q2NzBfMTAtMy0xLTEtMA_4cceb7a7-0bd4-48ab-8c5b-7547fb3e18b5"
      unitRef="usd">270600000</us-gaap:SalesTypeLeaseLeaseReceivable>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMzE3_5db5d371-1c70-4c22-9d2b-98a08309810f">&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of gross lease receivables at March&#160;31, 2021, are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfMS0xLTEtMS0w_50618462-9ba9-447c-9aec-9c9d2b84f4af"
      unitRef="usd">66000000.0</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfMi0xLTEtMS0w_22f31ef8-a95b-4bcd-a375-d968495d83f3"
      unitRef="usd">74500000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfMy0xLTEtMS0w_d14243db-a2f8-4f5b-908e-c0c0392f052e"
      unitRef="usd">59000000.0</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNC0xLTEtMS0w_b94b80ba-2d12-4167-99f8-4ded04ca0189"
      unitRef="usd">49100000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNS0xLTEtMS0w_83ccf2c9-47e9-45cc-92be-d21e1508d955"
      unitRef="usd">27300000</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears>
    <isrg:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNi0xLTEtMS0w_50dce811-081a-43bb-857d-84659f723e86"
      unitRef="usd">5100000</isrg:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter>
    <us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOjRjYWRhOWZkMDk1NzRiMTk4YjIwMzZhZGYyZTk0MGJkL3RhYmxlcmFuZ2U6NGNhZGE5ZmQwOTU3NGIxOThiMjAzNmFkZjJlOTQwYmRfNy0xLTEtMS0w_e00230d5-e330-4ee9-8cdc-d4aae6714ed6"
      unitRef="usd">281000000.0</us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived>
    <us-gaap:LessorSalesTypeLeaseTermOfContract1
      contextRef="i3c76c59d0038424ab43ff393ceb37cad_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMTA5OTUxMTYyODMwMQ_f0d2a382-3c36-4a04-8ed1-bc18374f314c">P24M</us-gaap:LessorSalesTypeLeaseTermOfContract1>
    <us-gaap:LessorSalesTypeLeaseTermOfContract1
      contextRef="if1b9e18b6b6149f1915a82f93f47df83_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMTA5OTUxMTYyODMwOA_437dc51e-1954-4952-bff3-c73b7919515b">P84M</us-gaap:LessorSalesTypeLeaseTermOfContract1>
    <us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RleHRyZWdpb246MjViNTE5ZDYxYmIxNDM0ODliNjE5YmI0MzcyMzhmNTFfMTE1NDQ4NzIwOTQ4OTU_c9272e5c-05c9-44ca-a2fd-6b9d2fb2eca7">The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of March&#160;31, 2021 (in millions):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Credit Rating:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;High&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Moderate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Low&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FinancingReceivableCreditQualityIndicatorsTableTextBlock>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0xLTEtMS01MTk2_56773257-0ac9-40b6-8cc6-9cd9d9350808"
      unitRef="usd">14700000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0zLTEtMS01MTk2_6170c0c8-26be-4bf6-858d-1547fccbf223"
      unitRef="usd">70900000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi01LTEtMS01MTk2_81607ce5-5625-4817-8afc-d761983daa2b"
      unitRef="usd">28600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi03LTEtMS01MTk2_c7815509-224c-4fd3-9202-f8f301a2374b"
      unitRef="usd">8500000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi05LTEtMS01MTk2_336910ff-b0e3-4fea-b372-a461b56af323"
      unitRef="usd">5700000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0xMS0xLTEtNTE5Ng_1ecaf384-0ed6-4cf7-b122-fdaa4360a1be"
      unitRef="usd">1200000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i271e251ff82d4aa7b389387881ee1fee_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMi0xMy0xLTEtNTE5Ng_ecf54204-113b-4d02-bb47-7bafdd825c3e"
      unitRef="usd">129600000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0xLTEtMS01MTk2_ad1e6b9e-cee8-4902-9299-99a64ab577c6"
      unitRef="usd">6300000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0zLTEtMS01MTk2_dd12dace-5112-4adc-b180-7dde6a3c54a8"
      unitRef="usd">77200000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy01LTEtMS01MTk2_f0918574-27a3-4d9f-a1a6-dcfa8ebb4a9c"
      unitRef="usd">30100000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy03LTEtMS01MTk2_9b8cd359-12d9-4c2f-8750-7815089aa83c"
      unitRef="usd">17300000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy05LTEtMS01MTk2_2160ea71-1a19-4f75-861e-e403749caaa3"
      unitRef="usd">3900000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0xMS0xLTEtNTE5Ng_ce2288f4-d100-49d9-9e2d-1dd81fb77e69"
      unitRef="usd">1600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="ic08d038617c24c269391ce3ad0e3231a_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfMy0xMy0xLTEtNTE5Ng_d8030347-b9da-4f39-b4db-d91d9152a658"
      unitRef="usd">136400000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0xLTEtMS01MTk2_6d14bf53-b72d-4a7b-9cca-c3b34df7e2f6"
      unitRef="usd">0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0zLTEtMS01MTk2_94f9b14b-d23a-4d4a-9c69-a9f25e9b6074"
      unitRef="usd">1200000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC01LTEtMS01MTk2_7b9c8c47-d6b2-4616-82ec-5f00365b7fab"
      unitRef="usd">0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC03LTEtMS01MTk2_b18fe953-94c8-4924-9d9a-973be934f506"
      unitRef="usd">1000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC05LTEtMS01MTk2_78e30dad-b888-4fd7-80dc-d65c3b4760d6"
      unitRef="usd">600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0xMS0xLTEtNTE5Ng_76fef06c-090b-4021-add4-754bfd87a087"
      unitRef="usd">1600000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i216f3f95bdf84de689a958b870cb7ff1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNC0xMy0xLTEtNTE5Ng_40090f76-b56f-48b4-a6f5-d184603ec64f"
      unitRef="usd">4400000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0xLTEtMS01MTk2_451b93e1-7573-4a79-9a9a-52ff9f0c6685"
      unitRef="usd">21000000.0</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0zLTEtMS01MTk2_0a3ea637-1132-49e5-a17f-522a9773f696"
      unitRef="usd">149300000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS01LTEtMS01MTk2_8c6c856d-0034-4fea-92fe-6b3f5acc8f8e"
      unitRef="usd">58700000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS03LTEtMS01MTk2_d36e7bca-3472-4f14-b717-8bf45a775586"
      unitRef="usd">26800000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS05LTEtMS01MTk2_aeee7888-e80f-4a4d-8bb9-bc4670864bda"
      unitRef="usd">10200000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0xMS0xLTEtNTE5Ng_aa9055c4-20aa-4956-8160-c498053d46c2"
      unitRef="usd">4400000</us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear>
    <us-gaap:SalesTypeLeaseNetInvestmentInLease
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80Ni9mcmFnOjI1YjUxOWQ2MWJiMTQzNDg5YjYxOWJiNDM3MjM4ZjUxL3RhYmxlOmM3Y2FkN2I1NTdmNjQwMzFiYmEzMDhlZmJlYWJhNDZjL3RhYmxlcmFuZ2U6YzdjYWQ3YjU1N2Y2NDAzMWJiYTMwOGVmYmVhYmE0NmNfNS0xMy0xLTEtNTE5Ng_f9941579-5c17-4ed3-bce3-c39242cfb855"
      unitRef="usd">270400000</us-gaap:SalesTypeLeaseNetInvestmentInLease>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg3Nw_9adf504e-1a88-45e2-9e81-35d1b7c1a173">GOODWILL AND INTANGIBLE ASSETS&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions in 2021&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material acquisitions for the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions in 2020&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Orpheus Medical&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company acquired Orpheus Medical Ltd. and its wholly-owned subsidiaries (&#x201c;Orpheus Medical&#x201d;) to deepen and expand our integrated informatics platform (the &#x201c;Orpheus Medical Acquisition&#x201d;). Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in capturing, processing, and archiving clinical videos across the hospital. The Orpheus Medical Acquisition did not have a material impact on the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution rights and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense related to intangible assets was $6.9 million and $12.3 million for the three months ended March&#160;31, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future amortization expense related to intangible assets as of March&#160;31, 2021, is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, measurement-period adjustments to intangible assets, changes in foreign currency exchange rates, impairments of intangible assets, accelerated amortization of intangible assets, and other events.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg3OA_a8edac6c-3255-4d4d-8265-d7cf1bc7d13b">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the changes in the carrying amount of goodwill (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition activity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfMS0xLTEtMS0w_337a17ad-4fc3-4781-a3cd-528d8d0ae598"
      unitRef="usd">336700000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfMi0xLTEtMS0w_5d4ad550-6ca7-463e-a2ea-9bf3b1ecb628"
      unitRef="usd">8000000.0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfMy0xLTEtMS0w_5643ff9e-d93d-4b7b-868b-a9a2e2d37f35"
      unitRef="usd">-200000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOmRlMDFjMTY4MzY2NDQ3ZDU5MWNiMWZmZWQxOGFmNTkwL3RhYmxlcmFuZ2U6ZGUwMWMxNjgzNjY0NDdkNTkxY2IxZmZlZDE4YWY1OTBfNC0xLTEtMS0w_f68c78b5-a977-45ed-8385-7256ebe4af93"
      unitRef="usd">344500000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg3OQ_6a65432e-fe0a-4b91-8c88-9d1241abd2be">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.703%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution rights and others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(232.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(271.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i11f28dd5602b4bde94b164d567bb287f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi0yLTEtMS0w_88fad381-ccbc-4000-aa2f-50e7f44d056f"
      unitRef="usd">215300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i11f28dd5602b4bde94b164d567bb287f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi00LTEtMS0w_8771a2cb-ed23-430c-a73d-44c196bf9ed3"
      unitRef="usd">161700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i11f28dd5602b4bde94b164d567bb287f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi02LTEtMS0w_9dab3ef3-8cac-4dad-ade8-0952d4a9904b"
      unitRef="usd">53600000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia55e3aa5f4234c84951ca875ab824a3e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi04LTEtMS0w_5e6b77b5-f5dc-41e7-a503-bbe668fe89dd"
      unitRef="usd">198400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia55e3aa5f4234c84951ca875ab824a3e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi0xMC0xLTEtMA_4b52051f-c76d-4ae3-9e1b-0ddd06693c73"
      unitRef="usd">158700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia55e3aa5f4234c84951ca875ab824a3e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMi0xMi0xLTEtMA_ee727335-b8d2-4f65-9cbf-f99767237e2b"
      unitRef="usd">39700000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy0yLTEtMS0w_5a032325-4ea9-4c99-9fc9-21a6780e9c36"
      unitRef="usd">44100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy00LTEtMS0w_03ff07f6-c426-4c74-93de-4b450c5b49a9"
      unitRef="usd">31800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1b1b0ddfcc524bdfb1eea3cbcdfb68d3_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy02LTEtMS0w_baf6e485-9803-40c0-a7e5-4b0c4af754d3"
      unitRef="usd">12300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i94e718a145634a8392de72f4b600c0c0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy04LTEtMS0w_c825275e-e8c3-4a4d-a257-cd1c5cc32705"
      unitRef="usd">91900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i94e718a145634a8392de72f4b600c0c0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy0xMC0xLTEtMA_89c2d645-071c-413d-88e5-da748698b979"
      unitRef="usd">77400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i94e718a145634a8392de72f4b600c0c0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfMy0xMi0xLTEtMA_14696fc1-6140-4055-b5c8-f01db820a7e0"
      unitRef="usd">14500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC0yLTEtMS0w_d0f42eb1-2dfd-41b1-af1d-13fdd98a1ca1"
      unitRef="usd">59900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC00LTEtMS0w_d0d040e1-cc67-42b5-9915-dcae258eb674"
      unitRef="usd">38600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i530ff65fad824e5fbe0164b84b4bb9ab_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC02LTEtMS0w_8cb94d56-f6a1-44ea-be93-a02d271a5c87"
      unitRef="usd">21300000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2c39a166bad441f2ac088d8f0528a593_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC04LTEtMS0w_aedec318-979c-4189-b178-153142d9ab5c"
      unitRef="usd">59000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2c39a166bad441f2ac088d8f0528a593_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC0xMC0xLTEtMA_58c45d6a-4407-42e5-a623-ab96bf52eb0b"
      unitRef="usd">35800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2c39a166bad441f2ac088d8f0528a593_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNC0xMi0xLTEtMA_b19a106c-fb23-4de8-b96e-6443c57270ef"
      unitRef="usd">23200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS0yLTEtMS0w_c01497a7-f5f9-4011-b1f3-a737b456a2ec"
      unitRef="usd">319300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS00LTEtMS0w_001c6840-14e7-4b6e-805b-441e2e686f96"
      unitRef="usd">232100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS02LTEtMS0w_68db9ef4-c3eb-4e5f-91a1-7883882f0ddb"
      unitRef="usd">87200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS04LTEtMS0w_028d5fbb-5c62-43bc-a0a1-16dad4ca1ab9"
      unitRef="usd">349300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS0xMC0xLTEtMA_09158885-1afe-4422-97a4-ac3a4504eca9"
      unitRef="usd">271900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjI4MzA5ZTY3ZjhiZTQxMDNiZWY4ZGM4YWUyNjdjMWNjL3RhYmxlcmFuZ2U6MjgzMDllNjdmOGJlNDEwM2JlZjhkYzhhZTI2N2MxY2NfNS0xMi0xLTEtMA_c5033d09-3bfc-4a26-93b0-524203f7a190"
      unitRef="usd">77400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTMyOQ_d4c0b940-8419-4c7d-a914-6ac4c5b86d8c"
      unitRef="usd">6900000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTMzNg_14954265-9afe-4b42-9f90-dcc93af05135"
      unitRef="usd">12300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RleHRyZWdpb246Y2U3YTU3OGVjMzQ2NDM4NmI1MzZjZmM3YTE0YTNlOWZfNTg4MA_11a9d9ff-ef96-4e71-89c8-e879c1e60ed5">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated future amortization expense related to intangible assets as of March&#160;31, 2021, is as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfMS0xLTEtMS0w_a2150466-c0b1-42c8-9496-c61264266f0b"
      unitRef="usd">18900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfMi0xLTEtMS0w_7301f803-af6a-4dd8-834f-8d7ea6ebe116"
      unitRef="usd">23100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfMy0xLTEtMS0w_c55be7b6-f124-4b9a-852d-3d915669d0df"
      unitRef="usd">18500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNC0xLTEtMS0w_3831efbe-6851-4e4e-a455-5b64e6c8aba7"
      unitRef="usd">14300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNS0xLTEtMS0w_a7c8c318-afd4-4083-9c73-461060819ec5"
      unitRef="usd">9500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <isrg:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNi0xLTEtMS0w_db285831-938a-434f-9a17-1b98ab006e4b"
      unitRef="usd">2900000</isrg:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV80OS9mcmFnOmNlN2E1NzhlYzM0NjQzODZiNTM2Y2ZjN2ExNGEzZTlmL3RhYmxlOjNmZDE4MmFiMmE0MTQ0NjZiNGM4MTM2OTRlZTQzNzM3L3RhYmxlcmFuZ2U6M2ZkMTgyYWIyYTQxNDQ2NmI0YzgxMzY5NGVlNDM3MzdfNy0xLTEtMS0w_f8f3375b-62aa-442f-8b79-d196b7c82fe8"
      unitRef="usd">87200000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81Mi9mcmFnOjc2N2E0MmZkZjM5YTQ0MDk4MTY2NDhkM2VjOWNlOGU4L3RleHRyZWdpb246NzY3YTQyZmRmMzlhNDQwOTgxNjY0OGQzZWM5Y2U4ZThfODE4OQ_4f877fdd-2ad4-4050-a8f1-cc0695983356">CONTINGENCIES&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is involved in a variety of claims, lawsuits, investigations, and proceedings relating to securities laws, product liability, intellectual property, insurance, contract disputes, employment, and other matters. Certain of these lawsuits and claims are described in further detail below. It is not possible to predict what the outcome of these matters will be, and the Company cannot guarantee that any resolution will be reached on commercially reasonable terms, if at all.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A liability and related charge to earnings are recorded in the Financial Statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. Nevertheless, it is possible that additional future legal costs (including settlements, judgments, legal fees, and other related defense costs) could have a material adverse effect on the Company&#x2019;s business, financial position, and future results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is currently named as a defendant in a number of individual product liability lawsuits filed in various state and federal courts. The plaintiffs generally allege that they or a family member underwent surgical procedures that utilized the da Vinci Surgical System and sustained a variety of personal injuries and, in some cases, death as a result of such surgery. Several of the filed cases have trial dates in the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cases raise a variety of allegations including, to varying degrees, that plaintiffs&#x2019; injuries resulted from purported defects in the da Vinci Surgical System and/or failure on the Company&#x2019;s part to provide adequate training resources to the healthcare professionals who performed plaintiffs&#x2019; surgeries. The cases further allege that the Company failed to adequately disclose and/or misrepresented the potential risks and/or benefits of the da Vinci Surgical System. Plaintiffs also assert a variety of causes of action, including, for example, strict liability based on purported design defects, negligence, fraud, breach of express and implied warranties, unjust enrichment, and loss of consortium. Plaintiffs seek recovery for alleged personal injuries and, in many cases, punitive damages. The Company disputes these allegations and is defending against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimate of the anticipated cost of resolving the pending cases is based on negotiations with attorneys for the claimants. The final outcome of the pending lawsuits and claims, and others that might arise, is dependent on many variables that are difficult to predict, and the ultimate cost associated with these product liability lawsuits and claims may be materially different than the amount of the current estimate and accruals and could have a material adverse effect on the Company&#x2019;s business, financial position, and future results of operations. Although there is a reasonable possibility that a loss in excess of the amount recognized exists, the Company is unable to estimate the possible loss or range of loss in excess of the amount recognized at this time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Patent Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 30, 2017, Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US LLC (collectively, &#x201c;Ethicon&#x201d;) filed a complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint, which was served on the Company on July 12, 2017, alleges that the Company&#x2019;s EndoWrist&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stapler instruments infringe several of Ethicon&#x2019;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,585,658, 8,479,969, 9,113,874, 8,998,058, 8,991,677, 9,084,601, and 8,616,431. A claim construction hearing occurred on October 1, 2018, and the court issued a scheduling order on December 28, 2018. On March 20, 2019, the court granted the Company&#x2019;s Motion to Stay pending an Inter Partes Review to be held at the Patent Trademark and Appeals Board to review patentability of six of the seven patents noted above and vacated the trial date. On August 1, 2019, the court granted the parties' joint stipulation to modify the stay in light of Ethicon's U.S. International Trade Commission (&#x201c;USITC&#x201d;) complaint against Intuitive involving U.S. Patent Nos. 8,479,969 and 9,113,874, discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 27, 2018, Ethicon filed a second complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that the Company&#x2019;s SureForm 60 Staplers infringe five of Ethicon&#x2019;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 8,602,288, 8,602,287, and 9,326,770. The Company filed an answer denying all claims. On March 19, 2019, Ethicon filed a Motion for Leave to File a First Amended Complaint, removing allegations related to U.S. Patent No. 9,326,770 and adding allegations related to U.S. Patent Nos. 9,844,379 and 8,479,969. On July 17, 2019, the court entered an order denying the amendment, without prejudice, and granting the parties&#x2019; joint stipulation to stay the case in its entirety in light of the USITC investigation involving U.S. Patent Nos. 9,844,369 and 7,490,749, discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 30, 2019, Ethicon filed a complaint with the USITC, asserting infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 9,844,379, 9,113,874, and 8,479,969. On June 28, 2019, the USITC voted to institute an investigation (No. 337-TA-1167) with respect to the claims in this complaint. The accused products include the Company's EndoWrist 30, EndoWrist 45, SureForm 45, and SureForm 60 Staplers, as well as the stapler reload cartridges. The evidentiary hearing took place in February 2021. A Final Initial Determination by the USITC was scheduled for October 2021. An unfavorable ruling by the USITC could have an adverse effect on our results of operations, including a prohibition on importing the accused products into the U.S. or necessitating workarounds that may limit certain features of our products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commercial Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 27, 2019, Restore Robotics LLC and Restore Repair LLC (&#x201c;Restore&#x201d;) filed a complaint alleging anti-trust claims against the Company. On May 13, 2019, Restore filed an amended complaint alleging anti-trust claims relating to the da Vinci Surgical System and EndoWrist service, maintenance, and repair processes. On September 16, 2019, the Court partially granted and partially denied the Company's Motion to Dismiss the amended complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company filed an answer denying the anti-trust allegations and filed a counterclaim against Restore. The Company filed amended counterclaims after the Court partially granted and partially denied Restore's Motion to Dismiss the counterclaim. The amended counterclaims allege that Restore violated the Federal Lanham Act, the Federal Computer Fraud and Abuse Act, and Florida's Deceptive and Unfair Trade Practices Act and that Restore is also liable to the Company for Unfair Competition and Tortious Interference with Contract. On January 7, 2020, the Court denied Restore's Motion to Dismiss the amended counterclaims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or before February 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, Rebotix Repair Inc. (&#x201c;Rebotix&#x201d;) filed a complaint alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The complaint was formally served on the Company on October 6, 2020. On March 8, 2021, the Court partially granted and partially denied the Company's Motion to Dismiss the complaint. The Company filed an answer denying the anti-trust allegations and filed counterclaims against Rebotix. The counterclaims allege that Rebotix violated the Federal Lanham Act and Florida's Deceptive and Unfair Trade Practices Act and that Rebotix is also liable to the Company for Tortious Interference with Contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or around March 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTU4_402e0ba9-f9d9-4a15-8ce8-d025eec45099">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the changes in stockholders&#x2019; equity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,445.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,731.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,759.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,627.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,153.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,190.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,756.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,263.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,284.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase and retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,926.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,570.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,506.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,530.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;) has authorized an aggregate of&#160;$7.5 billion of funding for the Company&#x2019;s common stock repurchase program (the &#x201c;Repurchase Program&#x201d;) since its establishment in March 2009. The most recent authorization occurred in January 2019 when the Board increased the authorized amount available under the Repurchase Program to&#160;$2.0 billion. As of March&#160;31, 2021, the remaining amount of share repurchases authorized by the Board was $1.6 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides share repurchase activities (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss), Net of Tax, Attributable to Intuitive&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTQ0_14d0210c-238f-41cd-ae9a-3b8afb170633">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the changes in stockholders&#x2019; equity (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.478%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.379%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional Paid-In Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,445.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,261.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,731.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,759.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,627.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,153.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,190.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.135%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.164%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.388%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.170%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Additional&lt;br/&gt;Paid-In&lt;br/&gt;Capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Retained&lt;br/&gt;Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Intuitive Surgical, Inc. Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest in Joint Venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,756.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,494.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,263.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,284.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Adoption of new accounting standard&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock through employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares withheld related to net share settlement of equity awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to employee stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase and retirement of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interest in joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,926.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,570.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,506.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,530.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1892d132f6eb47d5b382a5ecafcffd20_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xLTEtMS0w_00b9be88-f7b9-4992-ac12-97bffd8fa985"
      unitRef="shares">117700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1892d132f6eb47d5b382a5ecafcffd20_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0zLTEtMS0w_64601b73-23ff-4ce6-8f79-2df5b0aaaee9"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i147cc30e329447d293e6ac6f2f569531_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy01LTEtMS0w_80e9f9c6-5202-4f0e-9466-afc610d8269d"
      unitRef="usd">6445200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i832e07083f234f9aaae70e7f780f75ea_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy03LTEtMS0w_a6f29b08-9b08-4c62-a15a-da17e51d65e2"
      unitRef="usd">3261300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f25478b6fff402bad373bd68ce889d7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy05LTEtMS0w_97e4c6dd-bb70-4359-a518-c5d21d662022"
      unitRef="usd">24900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8dfde143ec884cdebe7ea1111dfe6d02_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xMS0xLTEtMA_2e2bda48-cd9d-4121-9a04-d6f092d640f3"
      unitRef="usd">9731500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifff9ccbd873145ae8414978edefcf616_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xMy0xLTEtMA_a7d1fc93-6fbb-43d4-8cd8-28936b2aee68"
      unitRef="usd">27600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMy0xNS0xLTEtMA_9a286d72-f145-4bd8-a3d4-6e67d2871165"
      unitRef="usd">9759100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i49a8ca38f4be4272b8b9502372356738_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS0xLTEtMS0w_caf4f61b-87d0-4a4d-96df-6409d82a8929"
      unitRef="shares">900000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS01LTEtMS0w_d6a2e43d-f085-4c4c-a37c-f88e68363a19"
      unitRef="usd">84000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS0xMS0xLTEtMA_1484c14e-5959-4d8e-8329-eb564c435680"
      unitRef="usd">84000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNS0xNS0xLTEtMA_aed3754f-7ae0-4840-9688-836196d5d6a4"
      unitRef="usd">84000000.0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i49a8ca38f4be4272b8b9502372356738_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi0xLTEtMS0w_9780cc33-3b8b-458e-8a35-45a45f090605"
      unitRef="shares">200000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi01LTEtMS0w_37e3c26a-30b1-477d-8361-24660a175f7e"
      unitRef="usd">5100000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8fd61ce4b4e2448fb329c1b58561fb64_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi03LTEtMS0w_55cf9b6c-f0a2-4884-b047-b0c13accdcb4"
      unitRef="usd">172900000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi0xMS0xLTEtMA_ac9eb48c-b835-49cb-85cc-4a0c6aa10eb8"
      unitRef="usd">178000000.0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNi0xNS0xLTEtMA_d59456d9-f2f3-46ef-89de-67e7736d9e36"
      unitRef="usd">178000000.0</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9bf66c38011f422e87c4322ec309dc7c_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNy01LTEtMS0w_5e184c91-c252-47d1-983e-c437dff5d661"
      unitRef="usd">103200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNy0xMS0xLTEtMA_49f7de8e-6d5f-4648-baa9-fa85d7999663"
      unitRef="usd">103200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfNy0xNS0xLTEtMA_c09e286d-2958-43ae-bde3-1044e006d960"
      unitRef="usd">103200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i8fd61ce4b4e2448fb329c1b58561fb64_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfOS03LTEtMS0w_09a9a217-ffcc-4ca5-836c-307960e7c0ff"
      unitRef="usd">426300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfOS0xMS0xLTEtMA_0c68ad5f-d219-4835-9af5-142559bf4868"
      unitRef="usd">426300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfOS0xNS0xLTEtMA_7bdaf1c1-8a98-4913-95c6-8320fcd2662b"
      unitRef="usd">426300000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i881c19778193492d86fa195d0bf3a940_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtOS0xLTEtMA_a88e00a2-4c6b-46a1-b67a-f1a5d5c14d85"
      unitRef="usd">-13500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6609492761e040349e48efd7876d43c1_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtMTEtMS0xLTA_99aed765-b5c1-4d2f-b2b6-98a926f7fef0"
      unitRef="usd">-13500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9f94159c88ab4b1584580110f75e4c91_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtMTMtMS0xLTA_37e44266-42c2-4bc0-9b74-8a9b8a29b91d"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTAtMTUtMS0xLTA_d7ae5cbe-dfed-4932-82d9-fde2402bcf1b"
      unitRef="usd">-13300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9f94159c88ab4b1584580110f75e4c91_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTItMTMtMS0xLTA_fc8fea90-52fe-4872-a9db-bd6a0c614aed"
      unitRef="usd">8900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTItMTUtMS0xLTA_834b16ad-5029-415f-a5f9-1ce011852542"
      unitRef="usd">8900000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i507a2382c629428daede99bd06d29782_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMS0xLTEtMA_350640be-6d26-4057-b45e-1270b50b7588"
      unitRef="shares">118400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i507a2382c629428daede99bd06d29782_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMy0xLTEtMA_f6aeb58d-d6f3-4e37-9b0f-8645b9bfe2cb"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75cefa24a4ba4c7a815e48c26b538d47_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtNS0xLTEtMA_c08ae561-4ae4-462a-bd31-a63b627d475c"
      unitRef="usd">6627300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icbff52cf66da42ddb55647513e2a8a81_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtNy0xLTEtMA_6790f99e-e2b9-42db-ad29-fcf418ebecdb"
      unitRef="usd">3514700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9090c608db4547b1ac6471900a3b840f_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtOS0xLTEtMA_76d39776-5353-44b5-940f-de4205f5804a"
      unitRef="usd">11400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9031b8a49b4b4593a8779ea186c3cf54_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMTEtMS0xLTA_887b8a34-ad26-48dd-b470-141841ad941e"
      unitRef="usd">10153500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i18b1114d0328455ba73b3e48af3193e1_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMTMtMS0xLTA_7d16b925-73d5-495e-aeb9-b8fc1ddd83dd"
      unitRef="usd">36700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmU3Yjc3ZDIzZDQyMjRjMWJiN2FkZDNiNzQ4NzYzYzdmL3RhYmxlcmFuZ2U6ZTdiNzdkMjNkNDIyNGMxYmI3YWRkM2I3NDg3NjNjN2ZfMTMtMTUtMS0xLTA_f4c46f0a-7236-457e-99ed-60b0de9b9d12"
      unitRef="usd">10190200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2e99e82b25614f028c511ab87510f949_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMS0xLTEtMA_9b28da4a-4a68-49b6-895b-f6a32f9e3eb0"
      unitRef="shares">116000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e99e82b25614f028c511ab87510f949_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMy0xLTEtMA_5fd84565-fa0f-4949-892c-c3e7234e8467"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99fdcc6b644e4e0586c5ffa4473d31b7_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtNS0xLTEtMA_592cc440-e615-40ac-a6bd-87aa471bbe72"
      unitRef="usd">5756800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib36bc009466044639ae7d55c36d1ffc8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtNy0xLTEtMA_2437aff3-aede-4dba-bb1e-5b26516d96d9"
      unitRef="usd">2494500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i25f4ce614b87445998e895b069fde088_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtOS0xLTEtMA_5570bfa6-38a1-4532-95fd-d470b6bbb244"
      unitRef="usd">12400000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba32cf8624a94ab7bc35931cbf181914_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMTEtMS0xLTA_5df45ae0-cc8f-4aa5-a0bb-1889ab0b1ba6"
      unitRef="usd">8263800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79c415ee3f6d4597b0b02c0a172afe2c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMTMtMS0xLTA_b6a6c8f6-b379-4ea6-8d08-31d97a6b9fa0"
      unitRef="usd">20900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTgtMTUtMS0xLTA_c1822d84-c4d8-4326-a1fc-83eff713a49c"
      unitRef="usd">8284700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90458d1fd5d54ab19b5ea2abf3dcaa97_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTktNy0xLTEtNDU2NQ_70a5c324-d8e3-4b96-8498-e35668322285"
      unitRef="usd">-100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i176adc5116364bbf8f134ba16f508f2c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTktMTEtMS0xLTUyMjQ_0774a810-e02c-4987-a5e3-65862f6606a2"
      unitRef="usd">-100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i74fb387009f84c1394a499016f35aa1c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMTktMTUtMS0xLTUyMjc_82c54683-40a7-4062-82b6-2b9950ed63bd"
      unitRef="usd">-100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtMS0xLTEtMA_523de7a9-850a-411f-9343-7ae11b271014"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtNS0xLTEtMA_e0ab9325-7ef3-468a-a9d7-3e68d3935a7e"
      unitRef="usd">91300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtMTEtMS0xLTA_9d035e97-8c67-4d9b-9faf-e1a95961fb94"
      unitRef="usd">91300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjAtMTUtMS0xLTA_84b5398d-53db-4130-8236-82a4a8fd8b2d"
      unitRef="usd">91300000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtMS0xLTEtMA_c082e6d6-8acb-46ae-a68b-e216f37b48eb"
      unitRef="shares">300000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtNS0xLTEtMA_797cc402-3737-437d-92b3-b758464c7fd5"
      unitRef="usd">6700000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtNy0xLTEtMA_1c7bc63a-9499-406f-a792-076a8c0df84e"
      unitRef="usd">142200000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtMTEtMS0xLTA_2d8cad61-4820-492b-b4e8-c5add1499f28"
      unitRef="usd">148900000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjEtMTUtMS0xLTA_e33fd8dd-b1dc-41c6-ae36-940f6df614b7"
      unitRef="usd">148900000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjItNS0xLTEtMA_67eadb43-7abd-4b70-9222-35504835d116"
      unitRef="usd">90600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjItMTEtMS0xLTA_ac03d7d5-7813-497d-a475-ea6c9af0be07"
      unitRef="usd">90600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjItMTUtMS0xLTA_2d78ca11-ba4e-4e6d-95c4-f8b28632e5a5"
      unitRef="usd">90600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ibc16bfd66d8b4b23b62e6cd1e2799be8_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtMS0xLTEtMA_b2b4200d-09b0-45aa-a87e-3a9e60a7da36"
      unitRef="shares">200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iee7a66f310764fa7948b3de4c3f1174e_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtNS0xLTEtMA_939d385a-5071-443d-b7ee-f40df3965f54"
      unitRef="usd">5200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtNy0xLTEtMA_edc62ccb-4ed6-4b99-a474-7f28bf74fcb4"
      unitRef="usd">94800000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtMTEtMS0xLTA_cea74c04-e40d-4fec-92cb-d652d7949b13"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjMtMTUtMS0xLTA_7b00eab6-1ce6-4fee-a2be-01c1453de8bd"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:NetIncomeLoss
      contextRef="i1135abc8f2524640af87fe6ad1f593b7_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjQtNy0xLTEtMA_dcb281aa-a563-491c-8654-a0b3a81edda3"
      unitRef="usd">313500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjQtMTEtMS0xLTA_83649b19-644d-4c31-af17-025f3f51cb28"
      unitRef="usd">313500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjQtMTUtMS0xLTA_d32e7592-877b-4ff2-97e0-1c4f9948edf6"
      unitRef="usd">313500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff9d8f48f16b43ce9a99c9803cd1a5cd_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtOS0xLTEtMA_a1a0008f-82da-48fc-af45-129d1cf32fc9"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i12780346691a4e4a83f9ceb1676d66c5_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtMTEtMS0xLTA_26fb41e5-43a9-41c6-9ebf-1f5d24494c5c"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46a4ba9a772c44c2bbbfed1bac1aa452_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtMTMtMS0xLTA_e7aff574-6293-4da5-94ce-f74180b7e04d"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjUtMTUtMS0xLTA_d0fdde14-3a2d-4704-b9f5-3fa410e80e12"
      unitRef="usd">-3300000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i46a4ba9a772c44c2bbbfed1bac1aa452_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjYtMTMtMS0xLTA_fd703fa4-ffce-4d55-9502-364c83d31825"
      unitRef="usd">2700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjYtMTUtMS0xLTA_b5afee90-61e8-45e8-abaa-c8f5144fa0d9"
      unitRef="usd">2700000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2487fa8c7cfe45e6a641a9876f892024_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMS0xLTEtMA_c34ce9cf-ad01-4f90-b3d2-20ba16ea5728"
      unitRef="shares">116600000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2487fa8c7cfe45e6a641a9876f892024_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMy0xLTEtMA_43ad273a-2574-4778-b8f9-94ab112f1ef4"
      unitRef="usd">100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i16767223fe4a41809418b76a6125e9b7_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctNS0xLTEtMA_26bbfd35-87ba-4925-96f1-a5ab02b137c3"
      unitRef="usd">5926800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22d62ec7e4044391882881b01e0b6300_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctNy0xLTEtMA_5e14d811-ccfa-4f5d-bdb2-681a9764df5c"
      unitRef="usd">2570900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1198994ab755477ab225bc58ca03d552_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctOS0xLTEtMA_804e1972-6400-48c8-a8dc-e5a683828bfa"
      unitRef="usd">8900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i353c4ffcf6cb428b973449a30ef061b1_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMTEtMS0xLTA_eab8af90-7325-474d-a68d-447be257fa8e"
      unitRef="usd">8506700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5f43ed2b00934f689a166e4d0edb373d_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMTMtMS0xLTA_0a78ceee-a05f-452a-8319-b6538665c452"
      unitRef="usd">23800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmVjOTFiMTNlYTczOTQ0N2ViNzZkNjlhZWQ2ZmY2ZmU4L3RhYmxlcmFuZ2U6ZWM5MWIxM2VhNzM5NDQ3ZWI3NmQ2OWFlZDZmZjZmZThfMjctMTUtMS0xLTA_ea291f57-bc34-4813-81dc-243404cf2eb9"
      unitRef="usd">8530500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfMjQ5_bc21e42a-f0b8-4359-b7b2-8b6a7a395e1e"
      unitRef="usd">7500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <isrg:StockRepurchaseProgramincreasedtoauthorizedamount
      contextRef="i09a910f990374e8b85baf857795d2362_I20190131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfNTIz_717338a5-b290-4bf6-b05d-e25886646f98"
      unitRef="usd">2000000000.0</isrg:StockRepurchaseProgramincreasedtoauthorizedamount>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfNjA3_ae2fd2c4-fe4f-43a7-92b6-4e7ca95366f2"
      unitRef="usd">1600000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTQ3_4f927e28-e31a-4b81-a061-f88ea8b69ae9">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides share repurchase activities (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;521.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMi0xLTEtMS0zNzM3_747ba855-1415-4120-947d-ce8af1cefa5f"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMi0zLTEtMS0xNjQ4_902580be-df09-4367-9c2e-e04891360364"
      unitRef="shares">200000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMy0xLTEtMS0zNzM3_d88d932d-4231-46bc-b0d1-c5f88328768e"
      unitRef="usdPerShare">0</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfMy0zLTEtMS0xNjQ4_a522c85a-dad9-44d5-8bee-e441a0dad85f"
      unitRef="usdPerShare">521.8</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfNC0xLTEtMS0zNzM3_befb96aa-4020-434e-976e-c2bfe36b8bc6"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i5f65a667a1e7429a903ea521425fd631_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmNhZWQ3ZjZhNDk3MjQ4ZmU4ZmFlNTRjODc4ODFkODUyL3RhYmxlcmFuZ2U6Y2FlZDdmNmE0OTcyNDhmZThmYWU1NGM4Nzg4MWQ4NTJfNC0zLTEtMS0xNjQ4_2777324f-4975-49c9-868f-169b428a4ca7"
      unitRef="usd">100000000.0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RleHRyZWdpb246ZWU3OWQxMzhmYzNiNDJlYjg1NWY4MGU3OWZlMmYyNmNfOTM1_939dcb3d-8f5b-4b3a-bee7-65101ce1b529">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.886%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&#160;(Losses)&lt;br/&gt;on&#160;Hedge&lt;br/&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;br/&gt;(Losses)&#160;on Available-for-Sale Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Gains&#160;(Losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Employee Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current-period other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi0xLTEtMS0w_c1379b77-6cd6-4904-9ce4-beb14a651b9f"
      unitRef="usd">-2900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi0zLTEtMS0w_557a8643-c72b-4b57-93f0-71c05f16e9de"
      unitRef="usd">29500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi01LTEtMS0w_3f04a6db-60c7-46cf-8543-ffbdb3af23d5"
      unitRef="usd">4700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi03LTEtMS0w_05960815-79c6-4b4a-a11b-e06587b66f72"
      unitRef="usd">-6400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMi05LTEtMS0w_196053e3-be1a-4bac-9aa4-a84f65366087"
      unitRef="usd">24900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy0xLTEtMS0w_7e5fffdf-ce68-4e03-938f-92839558ab52"
      unitRef="usd">4600000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy0zLTEtMS0w_1253bb3d-e9a5-4817-931c-c7fb3b870474"
      unitRef="usd">-10000000.0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy01LTEtMS0w_2b8194ad-cb04-4920-b761-b403ac6ca06a"
      unitRef="usd">-9700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy03LTEtMS0w_0c7dcfc2-d90d-44fe-bb07-2798c1d3e9cc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMy05LTEtMS0w_55c698f5-9d6c-49f4-ab83-289bf3b03436"
      unitRef="usd">-15100000</isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC0xLTEtMS0w_9a1a9b13-9cd1-44c1-a8f6-d6901dd8493c"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC0zLTEtMS0w_81410ab5-f134-4c22-b445-45bdf81e352d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC01LTEtMS0w_ea424461-18fd-405c-a0c0-4e13c9070534"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC03LTEtMS0w_4ec81cfa-03c2-4594-999c-eb4f343fecc4"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNC05LTEtMS0w_dc0a173a-f689-43e1-b4a2-e801c7612d33"
      unitRef="usd">-1600000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS0xLTEtMS0w_63d63cd3-2cc5-4e9b-84f2-618fbfeab343"
      unitRef="usd">6100000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS0zLTEtMS0w_be8ee90e-69ca-432e-8517-f7fa553193b7"
      unitRef="usd">-10000000.0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS01LTEtMS0w_d36a6df8-3fe5-4486-884a-7438247f2e9d"
      unitRef="usd">-9700000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS03LTEtMS0w_cbc5a958-421b-470e-8053-2546f2526c60"
      unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNS05LTEtMS0w_557040ad-dc3b-420d-a5ee-7254d9366630"
      unitRef="usd">-13500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi0xLTEtMS0w_b788c26d-a5af-4944-b193-3faba73befb6"
      unitRef="usd">3200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi0zLTEtMS0w_31e23319-610a-46d5-ade5-5ea131ae4e27"
      unitRef="usd">19500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi01LTEtMS0w_7335a0c4-50c9-4a30-a874-9d9a41ff0a48"
      unitRef="usd">-5000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi03LTEtMS0w_698f0d76-b363-4cac-84cb-9832ad8c231f"
      unitRef="usd">-6300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfNi05LTEtMS0w_95429251-6dff-4342-b5fe-7fbe8901a56e"
      unitRef="usd">11400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtMS0xLTEtMA_b5ca554a-82f9-4abd-94f4-0faf51df5ef5"
      unitRef="usd">700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtMy0xLTEtMA_c75247e7-f726-4b98-be82-10ef5989e731"
      unitRef="usd">20400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtNS0xLTEtMA_4327bd15-2fc9-439f-a8f8-771b477ce04b"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtNy0xLTEtMA_0c7025f1-3885-4120-9b65-4c5e24d9d9c3"
      unitRef="usd">-8700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i545d4914e37e4c5497107f4880ab0f98_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTAtOS0xLTEtMA_570c2980-50d8-4153-aa9e-4ecd55780512"
      unitRef="usd">12400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtMS0xLTEtMA_78be56a4-d0eb-478a-8967-c89c64a44ffa"
      unitRef="usd">2800000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtMy0xLTEtMA_0012cec7-c00c-4700-bea0-54c2f450d6a7"
      unitRef="usd">16800000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtNS0xLTEtMA_4a9f68ee-0391-482a-a68d-6481f2719f07"
      unitRef="usd">-20600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtNy0xLTEtMA_c1ba34a3-924e-4e5b-9c48-6dcaf9dff40a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTEtOS0xLTEtMA_c41e6ea9-d8cf-4a3f-beef-56484b4b3a0e"
      unitRef="usd">-1000000.0</isrg:OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItMS0xLTEtMA_2098bf4d-e10a-4423-9745-3982277f3a7f"
      unitRef="usd">1700000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItMy0xLTEtMA_e7b17444-1565-40ce-82dc-ea9c55bc222e"
      unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItNS0xLTEtMA_dc208f3a-8bd7-4b65-9c1c-a7b9e71bd0ba"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItNy0xLTEtMA_53755b5a-f84c-4a43-a0f3-f669ee94464d"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTItOS0xLTEtMA_2f843e58-a15f-470f-b513-3ae807693d04"
      unitRef="usd">2500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtMS0xLTEtMA_56b9e38c-8831-4eb4-ae23-a8e6affadbcc"
      unitRef="usd">1100000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtMy0xLTEtMA_5f44d829-8350-42c1-9320-3c93a65ae4b4"
      unitRef="usd">15800000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtNS0xLTEtMA_973cd1cf-6460-4254-9ef3-bd9039b76505"
      unitRef="usd">-20600000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtNy0xLTEtMA_fb555f6b-0873-4720-9e8f-5f485bd9a1c8"
      unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTMtOS0xLTEtMA_355593e7-7789-4e3e-8d40-1da94c64b9c6"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtMS0xLTEtMA_1740e803-93be-43bd-b9bb-4a7127eb85b8"
      unitRef="usd">1800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtMy0xLTEtMA_8badb1a5-d544-4eea-806f-107a16fe2e3d"
      unitRef="usd">36200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtNS0xLTEtMA_346f66c0-0448-409f-b33d-39223ff8024f"
      unitRef="usd">-20600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtNy0xLTEtMA_7a88ee70-1512-4082-9f34-465335c4f884"
      unitRef="usd">-8500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i44dcefa3072841ab9e340f65c68f2e09_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81NS9mcmFnOmVlNzlkMTM4ZmMzYjQyZWI4NTVmODBlNzlmZTJmMjZjL3RhYmxlOmQzYmE1ZDU4ODBiMzQ1MzE4NDkzZmY4ZTBkZDg3NGJiL3RhYmxlcmFuZ2U6ZDNiYTVkNTg4MGIzNDUzMTg0OTNmZjhlMGRkODc0YmJfMTQtOS0xLTEtMA_88c64148-3921-4135-82c1-7680ff9333e8"
      unitRef="usd">8900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg1NQ_673dfbe6-d1aa-4120-8023-f91332bc3a76">SHARE-BASED COMPENSATIONIn April 2020, the Company's shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from 28,450,000 to 32,450,000. As of&#160;March&#160;31, 2021, approximately&#160;6.6 million&#160;shares were reserved for future issuance under the Company's stock plans. A maximum of approximately&#160;2.9 million&#160;of these shares can be awarded as restricted stock units (&#x201c;RSUs&#x201d;).&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Option Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&#160;Price Per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, options to purchase an aggregate of 3.5 million shares of common stock were exercisable at a weighted average price of $252.72 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSUs activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at March&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), employees purchased approximately 0.1 million shares for $41.4 million and approximately 0.1 million shares for $36.6 million during the three months ended March&#160;31, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense for the three months ended March&#160;31, 2021, and 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense after income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#x2019;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three months ended March&#160;31, 2021, and 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$211.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$133.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$223.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$149.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i10e5830a5be84ccbbde2a2eff58015cb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMjQ1_e2586ea5-82e5-4549-8fe6-bfdd4ba1b766"
      unitRef="shares">28450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i78841269b3a04c14876727a1edd45ce7_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMjUx_88b32c20-a3a5-45e2-aa14-48a08c8a6c57"
      unitRef="shares">32450000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i895226f723b74a4e944e2ab935f3b6d5_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMjc5_c533ff08-07e5-430d-9fc2-dd3bdaad73e4"
      unitRef="shares">6600000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i33ccbc7cfb7146c487ecb64b60bdc787_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMzgz_ef31aac4-dfe3-4045-8ef0-7f1a0945e0a9"
      unitRef="shares">2900000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg1Nw_dd74ad91-72ad-439c-b04f-398f2c028674">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of stock option activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.118%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&#160;Price Per&lt;br/&gt;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited/expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfMi0yLTEtMS0w_59704b14-340e-447f-a8de-afa2dc3d05b2"
      unitRef="shares">4500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if1e8abbc9f904cd8a70381d22f05a4c7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfMi00LTEtMS0w_c1e08e16-574b-45e7-a8ea-6b17a13a687f"
      unitRef="usdPerShare">305.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNC0yLTEtMS0w_72f678c7-6456-4d9c-b3f7-4564584d4a6b"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNC00LTEtMS0w_c7fc3253-2194-4416-8492-7806827a883f"
      unitRef="usdPerShare">740.73</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNS0yLTEtMS0w_6bcd46df-ccdc-4635-88d1-a05727fcfef9"
      unitRef="shares">200000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNS00LTEtMS0w_563ed16b-1695-42f3-a9a6-54b4b7a58d94"
      unitRef="usdPerShare">194.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNi0yLTEtMS0w_a1a6cbb4-3232-4f68-8b38-18a82e8269d6"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNi00LTEtMS0w_44efca46-371a-405b-b12c-6ae02afd4c8c"
      unitRef="usdPerShare">572.55</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNy0yLTEtMS0w_11f4311a-2950-4071-8f76-e7e63db50018"
      unitRef="shares">4400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOmUyNDNjNmQ4NGIyYzQxY2E4OWIxYmQ0NGI1Zjg3MDEzL3RhYmxlcmFuZ2U6ZTI0M2M2ZDg0YjJjNDFjYTg5YjFiZDQ0YjVmODcwMTNfNy00LTEtMS0w_26062f13-8ff5-41e1-8d68-28d6359d5ed8"
      unitRef="usdPerShare">328.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfNjc2_783ca983-4610-4e5d-b189-5380f8163808"
      unitRef="shares">3500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i19647b4382894b77b728740dfcec06ae_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfNzUw_2b49fd57-cbb0-44ff-85c6-e3c9db69f1d5"
      unitRef="usdPerShare">252.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg0Mw_65cf54de-0c69-42ed-a328-3f45a65ef1f0">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSUs activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.894%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at December&#160;31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;555.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested balance at March&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic700f68e41144f91bd35e317ae4e9f00_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMS0xLTEtMS0w_30de5bfa-549c-4825-bc32-772dde4e3a8f"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic700f68e41144f91bd35e317ae4e9f00_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMS0zLTEtMS0w_ba9d67d6-2782-472c-8c2a-346fd354a50b"
      unitRef="usdPerShare">489.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMi0xLTEtMS0w_0c4dc3cb-09dd-4c7f-b497-a3c6b7ff98b3"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMi0zLTEtMS0w_8699a147-5f88-43d7-9a7f-e96e777819d3"
      unitRef="usdPerShare">738.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMy0xLTEtMS0w_5947b791-fb2d-4549-b4dd-c0a2a031f45f"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfMy0zLTEtMS0w_4af6c5cf-2549-47b1-b2fe-fa37e43c4e43"
      unitRef="usdPerShare">427.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNC0xLTEtMS0w_f4290e55-d443-404b-941a-a3334b62c968"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i2aacfcd9659445e38d3794bb1eb7050a_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNC0zLTEtMS0w_5c270455-f8bc-4576-94d2-9d5616ada593"
      unitRef="usdPerShare">555.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ided9f564a7fc43fb9785e126f3e0792d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNS0xLTEtMS0w_95727b7b-a813-447d-bb04-bcf831a9b504"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ided9f564a7fc43fb9785e126f3e0792d_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjBhMGZiODUyMDVmNzRhMTk5MWE4MzA0ODQ3MTY4YjMxL3RhYmxlcmFuZ2U6MGEwZmI4NTIwNWY3NGExOTkxYTgzMDQ4NDcxNjhiMzFfNS0zLTEtMS0w_f97d7d71-ac82-42f7-a998-29f8721f3e52"
      unitRef="usdPerShare">593.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTA1NQ_2130753f-0c60-4594-af3b-324ef4548a8f"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTA2OQ_d616cbaf-7268-4e16-abf9-0face877e6a4"
      unitRef="usd">41400000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTA5MA_83b55b3b-a03d-4947-8b00-dcb9f9caf146"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTEwNA_4cf91a68-601f-4c45-aeea-a394fbf06a16"
      unitRef="usd">36600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg0OA_80d6135a-41ae-44d5-ba9c-2b82c96ab7b2">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes share-based compensation expense for the three months ended March&#160;31, 2021, and 2020 (in millions):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of sales &#x2013; services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense after income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8d02f4e8f2a84d6fadf284cdaf0651f6_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMi0xLTEtMS0w_9eadb06a-828f-4d26-b20c-e91bfaa2d58e"
      unitRef="usd">15300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39ba5ce0cdf94b51beee72537008b906_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMi0zLTEtMS0w_9d3da9f4-e671-4450-97f6-a0a2eb7d16d3"
      unitRef="usd">12800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic0b9d06046ac417db9b476df68156e12_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMy0xLTEtMS0w_e39193f4-ac9e-42c3-a14e-73d94167f1ee"
      unitRef="usd">5700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5af8b08c9064ce3af2ced0adcf153ad_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfMy0zLTEtMS0w_dceecf8a-3f95-4983-aa2d-cb772cb607d7"
      unitRef="usd">5500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i176cc511d2d94ee3acf60b32b9c344a4_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNC0xLTEtMS0w_335cd9bf-11eb-4025-80ff-0664c6fba803"
      unitRef="usd">21000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i002513af33834fe2a6163fa9af4c9055_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNC0zLTEtMS0w_10fa36b6-b0aa-440d-b168-e926c0ec3c2d"
      unitRef="usd">18300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if0b706bb5ee44d3c9e5ab754d749034e_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNS0xLTEtMS0w_5f156044-fd4a-45c3-9dfc-cfbd55aaecf6"
      unitRef="usd">53100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i223c3c0566cf457c938baba52b26ec0f_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNS0zLTEtMS0w_286356d4-8ba7-4f96-ab74-0b9ccc6ac628"
      unitRef="usd">45700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie628bd5d73914b17bff4771bcdd4ec83_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNi0xLTEtMS0w_719951c2-3821-4773-b0ec-d58540a649b3"
      unitRef="usd">30100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id57036158f3241fbb815a228531cfa32_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNi0zLTEtMS0w_01a01257-3f4f-4b45-a01b-11fca4e66690"
      unitRef="usd">27200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNy0xLTEtMS0w_3ff8e7ad-a93a-41c9-90af-dd9a579961b8"
      unitRef="usd">104200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfNy0zLTEtMS0w_ae0cc683-71e5-4974-8ece-f45ab1a54938"
      unitRef="usd">91200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOC0xLTEtMS0w_f47ea28c-aa03-4097-8f02-3e0897504bbe"
      unitRef="usd">20600000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOC0zLTEtMS0w_e515f91c-68cd-4472-a3d2-fa6531cafd39"
      unitRef="usd">18900000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOS0xLTEtMS0w_78928c78-4004-45f2-bad6-63bea2814b68"
      unitRef="usd">83600000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjhjOGI4NmNjM2YwYjRjNWRhNmFiMmJiMjFjMmYzNWU0L3RhYmxlcmFuZ2U6OGM4Yjg2Y2MzZjBiNGM1ZGE2YWIyYmIyMWMyZjM1ZTRfOS0zLTEtMS0w_7b225b4f-4d80-4e49-b402-90dcd65aab18"
      unitRef="usd">72300000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RleHRyZWdpb246YjAxZDQzN2VhNTBlNDMyNzkzNjA1M2FiODRkMTlmMDRfMTg0NA_c161c948-eee1-42fc-a4bb-f840b902fc43">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#x2019;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three months ended March&#160;31, 2021, and 2020, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$211.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$133.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$223.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$149.85&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMy0xLTEtMS0w_e3f03640-e971-43ab-b57a-cfc1c5c060ab"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMy0zLTEtMS0w_cc018001-a43d-442a-9bb4-cdb68e4b64f6"
      unitRef="number">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNC0xLTEtMS0w_4a8b2903-5c7f-4105-b1a7-88ddb854ead2">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNC0zLTEtMS0w_72adcec3-8e66-45e4-a5df-6ce901310228">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNS0xLTEtMS0w_6f7f1998-e1c0-4acf-bf2a-9a86935e8273"
      unitRef="number">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNS0zLTEtMS0w_eb6f9835-4374-45f9-8c4e-b7a223ee5278"
      unitRef="number">0.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i577e648a5a674003ad770f39fc13f19d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNi0xLTEtMS0w_fb149a3c-387b-4289-8139-0ed1cf120b20"
      unitRef="usdPerShare">211.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ieb9e4ca886e745369ad5611fa915d295_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfNi0zLTEtMS0w_cbf1cde6-16f6-420e-8db3-dfe2c799a5ef"
      unitRef="usdPerShare">133.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOC0xLTEtMS0w_f4364b3f-ec2b-4454-bfe2-8370d43a7cf9"
      unitRef="number">0.001</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOC0zLTEtMS0w_63972bd6-094d-49a7-8762-380bfd8c8074"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOS0xLTEtMS0w_03444556-7978-45fb-93c1-d190675c977f">P1Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfOS0zLTEtMS0w_9659e619-8e30-4a59-b3f1-486f6b9f99bd">P1Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTAtMS0xLTEtMA_cff53355-05be-450c-b4ee-f1591b242bed"
      unitRef="number">0.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTAtMy0xLTEtMA_7007caf0-ccdf-4daa-966e-87f9d620644a"
      unitRef="number">0.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i44a25c99be6b45f29c1ecec3b78de9c8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTEtMS0xLTEtMA_afbbc87d-b6ab-4ac1-a7fc-60a06b3c0c99"
      unitRef="usdPerShare">223.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i70442d9b27d14f88a0846bc1421ea810_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV81OC9mcmFnOmIwMWQ0MzdlYTUwZTQzMjc5MzYwNTNhYjg0ZDE5ZjA0L3RhYmxlOjE2ZTZkZDJhNTZjYTQwNzA4MmE1ODA5MDRlZGI4ZTU0L3RhYmxlcmFuZ2U6MTZlNmRkMmE1NmNhNDA3MDgyYTU4MDkwNGVkYjhlNTRfMTEtMy0xLTEtMA_bb171172-2912-4c4a-93d3-1d70772c33c8"
      unitRef="usdPerShare">149.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfMzk1Nw_18571426-48f5-42b9-b227-248ffab2b204">INCOME TAXES&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense (benefit) for the three months ended March&#160;31, 2021, was $13.6 million, or 3.0% of income before taxes, compared to $(8.1)&#160;million, or (2.6)% of income before taxes, for the three months ended March&#160;31, 2020. The higher income tax expense for the three months ended March&#160;31, 2021, was primarily due to higher pre-tax income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rates for the three months ended March&#160;31, 2021, and 2020, differed from the U.S. federal statutory rate of 21% mainly due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and the federal research and development (&#x201c;R&amp;amp;D&#x201d;) credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes for the three months ended March&#160;31, 2021, and 2020, included excess tax benefits associated with employee equity plans of $73.4&#160;million and $65.4&#160;million, which reduced our effective tax rate by 16.4 and 21.2 percentage points, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of the Company&#x2019;s unrecognized tax benefits could change due to activities of various tax authorities, including potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect the Company&#x2019;s effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, the Company cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The outcome of these audits cannot be predicted with certainty. The Company&#x2019;s management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#x2019;s provision for income taxes. If any issues addressed in the Company&#x2019;s tax audits are resolved in a manner not consistent with management&#x2019;s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNzg_86dc735f-690a-467c-a855-e6d57921ff9a"
      unitRef="usd">13600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfODU_34a31302-6c66-4e17-a190-dfbaaf0bb129"
      unitRef="number">0.030</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfMTA5OTUxMTYzMTc5OA_264fc47b-fa28-462b-a596-7711f611ae77"
      unitRef="usd">-8100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfMTA5OTUxMTYzMTgwNg_94d9871b-f60f-4ceb-aa51-2a63fde7f720"
      unitRef="number">-0.026</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODQ5NQ_2e2584d4-6fde-480c-add5-82d6f3c5a72d"
      unitRef="usd">73400000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODUwMw_1e425e1e-2530-4da8-9261-32e01df49306"
      unitRef="usd">65400000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODU0OA_7c9e5672-7a6b-47a0-9bc8-c059f8289507"
      unitRef="number">0.164</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82MS9mcmFnOjExOGMzZWUzZGE5YzQ5MWNhODAyMjEwNzUxOWQ1N2FmL3RleHRyZWdpb246MTE4YzNlZTNkYTljNDkxY2E4MDIyMTA3NTE5ZDU3YWZfNjA0NzMxMzk3ODU1Ng_16d77c57-1448-419d-aed9-8657275a3fce"
      unitRef="number">0.212</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfNjYy_d07a8b57-80f2-4d01-be18-4ab9e7ec9a86">NET INCOME PER SHARE&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in basic calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in diluted calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to Intuitive Surgical, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation awards of approximately 0.3&#160;million and 1.0&#160;million shares for the three months ended March&#160;31, 2021, and 2020, respectively, were outstanding but were not included in the computation of diluted net income per share attributable to Intuitive Surgical, Inc. common stockholders because the effect of including such shares would have been anti-dilutive in the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfNjY2_8c1a2d42-6f14-44d0-919d-7221c754683e">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Intuitive Surgical, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in basic calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: dilutive effect of potential common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding used in diluted calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income per share attributable to Intuitive Surgical, Inc.:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMy0xLTEtMS0w_6f95209d-a19f-4220-850f-7d02a84843fd"
      unitRef="usd">426300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMy0zLTEtMS0w_7a378e0b-9b07-4515-a0d5-7f203c914c05"
      unitRef="usd">313500000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfNy0xLTEtMS0w_7da1fc1f-1355-40d8-967a-1e323b998045"
      unitRef="shares">118100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfNy0zLTEtMS0w_2b2f74e8-2193-4383-9eee-af75b5311fd9"
      unitRef="shares">116400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOC0xLTEtMS0w_ac7e7a93-d153-4c84-9395-9365ffcb934f"
      unitRef="shares">3200000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOC0zLTEtMS0w_b2f4111f-1fac-490b-baa7-fa438f012c20"
      unitRef="shares">3400000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOS0xLTEtMS0w_16785f74-cb44-4d02-b1d0-96d8979fc5c1"
      unitRef="shares">121300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfOS0zLTEtMS0w_c0f87020-799a-49ee-83d3-d75627cdaa66"
      unitRef="shares">119800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTEtMS0xLTEtMA_f9717467-7aec-428d-ac43-478872d0f293"
      unitRef="usdPerShare">3.61</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTEtMy0xLTEtMA_db4ef791-0e9f-48a5-bf95-56f47ab68f67"
      unitRef="usdPerShare">2.69</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTItMS0xLTEtMA_3c230895-6a71-42f0-88cf-f694eddfc566"
      unitRef="usdPerShare">3.51</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RhYmxlOmVjNDdhMzZkNWY1MDQ4ODk4NzVkMTNiODY0ZGI3YjRhL3RhYmxlcmFuZ2U6ZWM0N2EzNmQ1ZjUwNDg4OTg3NWQxM2I4NjRkYjdiNGFfMTItMy0xLTEtMA_08690a6b-d3f3-40c1-a75c-cdca3e5a1134"
      unitRef="usdPerShare">2.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfMjU1_41d64d8e-577b-4d53-94f1-e1dcf544b74c"
      unitRef="shares">300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmEyZDZjNTRkMzRjNzQxYWM4M2EzNzdhNGFkMzQxY2I5L3NlYzphMmQ2YzU0ZDM0Yzc0MWFjODNhMzc3YTRhZDM0MWNiOV82NC9mcmFnOjgyM2IzMjM2NzU4MjRiY2JhMDE3ZDZlMGUxNzgyZTg0L3RleHRyZWdpb246ODIzYjMyMzY3NTgyNGJjYmEwMTdkNmUwZTE3ODJlODRfMjYy_ed565bc4-48a3-4395-bd56-0246906ac32f"
      unitRef="shares">1000000.0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272843219528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Intuitive Surgical, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">State or Other Jurisdiction of Incorporation or Organization</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">I.R.S. Employer Identification No.</a></td>
<td class="text">77-0416458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1020 Kifer Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sunnyvale<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">523-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol(s)</a></td>
<td class="text">ISRG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,412,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001035267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272843088408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,401.8<span></span>
</td>
<td class="nump">$ 1,622.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">3,155.7<span></span>
</td>
<td class="nump">3,488.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">654.3<span></span>
</td>
<td class="nump">645.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">576.8<span></span>
</td>
<td class="nump">601.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="nump">277.8<span></span>
</td>
<td class="nump">267.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">6,066.4<span></span>
</td>
<td class="nump">6,625.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">1,592.9<span></span>
</td>
<td class="nump">1,577.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">2,673.0<span></span>
</td>
<td class="nump">1,757.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">336.6<span></span>
</td>
<td class="nump">367.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_IntangibleAndOtherAssets', window );">Intangible and other assets, net</a></td>
<td class="nump">527.0<span></span>
</td>
<td class="nump">503.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">344.5<span></span>
</td>
<td class="nump">336.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">11,540.4<span></span>
</td>
<td class="nump">11,168.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">103.1<span></span>
</td>
<td class="nump">81.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and employee benefits</a></td>
<td class="nump">194.8<span></span>
</td>
<td class="nump">235.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">358.1<span></span>
</td>
<td class="nump">350.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">248.6<span></span>
</td>
<td class="nump">298.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">904.6<span></span>
</td>
<td class="nump">965.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">445.6<span></span>
</td>
<td class="nump">444.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,350.2<span></span>
</td>
<td class="nump">1,409.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 8)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of March 31, 2021, and December 31, 2020</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of March 31, 2021, and December 31, 2020, respectively</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">6,627.3<span></span>
</td>
<td class="nump">6,445.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">3,514.7<span></span>
</td>
<td class="nump">3,261.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="nump">11.4<span></span>
</td>
<td class="nump">24.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Intuitive Surgical, Inc. stockholders&#8217; equity</a></td>
<td class="nump">10,153.5<span></span>
</td>
<td class="nump">9,731.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest in joint venture</a></td>
<td class="nump">36.7<span></span>
</td>
<td class="nump">27.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">10,190.2<span></span>
</td>
<td class="nump">9,759.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 11,540.4<span></span>
</td>
<td class="nump">$ 11,168.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_IntangibleAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_IntangibleAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272843142584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000.0<span></span>
</td>
<td class="nump">300,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">118,400,000<span></span>
</td>
<td class="nump">117,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">118,400,000<span></span>
</td>
<td class="nump">117,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912686520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,292.1<span></span>
</td>
<td class="nump">$ 1,099.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">389.5<span></span>
</td>
<td class="nump">361.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">902.6<span></span>
</td>
<td class="nump">738.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">326.0<span></span>
</td>
<td class="nump">308.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">159.8<span></span>
</td>
<td class="nump">147.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">485.8<span></span>
</td>
<td class="nump">455.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">416.8<span></span>
</td>
<td class="nump">283.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Interest and other income, net</a></td>
<td class="nump">32.0<span></span>
</td>
<td class="nump">25.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before taxes</a></td>
<td class="nump">448.8<span></span>
</td>
<td class="nump">308.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">435.2<span></span>
</td>
<td class="nump">316.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net loss attributable to noncontrolling interest in joint venture</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">$ 426.3<span></span>
</td>
<td class="nump">$ 313.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to Intuitive Surgical, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 3.61<span></span>
</td>
<td class="nump">$ 2.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 3.51<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">118.1<span></span>
</td>
<td class="nump">116.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">121.3<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">$ 421.9<span></span>
</td>
<td class="nump">$ 312.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: comprehensive income attributable to noncontrolling interest</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">412.8<span></span>
</td>
<td class="nump">310.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,074.6<span></span>
</td>
<td class="nump">900.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">319.3<span></span>
</td>
<td class="nump">296.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">217.5<span></span>
</td>
<td class="nump">198.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of revenue</a></td>
<td class="nump">$ 70.2<span></span>
</td>
<td class="nump">$ 64.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272843197016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfCashFlowsAbstract', window );"><strong>Statement of Cash Flows [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 435.2<span></span>
</td>
<td class="nump">$ 316.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and loss on disposal of property, plant, and equipment</a></td>
<td class="nump">64.8<span></span>
</td>
<td class="nump">51.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Loss (gain) on investments, accretion, and amortization, net</a></td>
<td class="num">(12.6)<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">44.7<span></span>
</td>
<td class="nump">64.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">103.2<span></span>
</td>
<td class="nump">90.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of contract acquisition assets</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effects of acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(14.3)<span></span>
</td>
<td class="nump">118.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(41.2)<span></span>
</td>
<td class="num">(65.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaids and other assets</a></td>
<td class="num">(73.2)<span></span>
</td>
<td class="num">(131.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">23.7<span></span>
</td>
<td class="nump">21.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and employee benefits</a></td>
<td class="num">(40.2)<span></span>
</td>
<td class="num">(95.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">6.8<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(31.1)<span></span>
</td>
<td class="num">(34.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">477.6<span></span>
</td>
<td class="nump">352.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of investments</a></td>
<td class="num">(1,833.1)<span></span>
</td>
<td class="num">(690.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from Sale of Investments</a></td>
<td class="nump">72.0<span></span>
</td>
<td class="nump">98.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from maturities of investments</a></td>
<td class="nump">1,231.4<span></span>
</td>
<td class="nump">617.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Purchase of property, plant, and equipment and intellectual property</a></td>
<td class="num">(58.6)<span></span>
</td>
<td class="num">(105.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash</a></td>
<td class="num">(8.7)<span></span>
</td>
<td class="num">(37.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="num">(597.0)<span></span>
</td>
<td class="num">(117.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock relating to employee stock plans</a></td>
<td class="nump">84.0<span></span>
</td>
<td class="nump">91.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(178.3)<span></span>
</td>
<td class="num">(148.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Payment of deferred purchase consideration</a></td>
<td class="num">(7.9)<span></span>
</td>
<td class="num">(21.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(102.2)<span></span>
</td>
<td class="num">(178.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(220.8)<span></span>
</td>
<td class="nump">56.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">1,638.5<span></span>
</td>
<td class="nump">1,182.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">$ 1,417.7<span></span>
</td>
<td class="nump">$ 1,238.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68051541&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfCashFlowsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfCashFlowsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835984488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF THE BUSINESS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF THE BUSINESS</a></td>
<td class="text">DESCRIPTION OF THE BUSINESS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intuitive Surgical, Inc. (&#8220;Intuitive&#8221; or the &#8220;Company&#8221;) develops, manufactures, and markets the da Vinci</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgical System and the Ion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> endoluminal system.&#160;The Company&#8217;s products and related services enable physicians and healthcare providers to improve the quality of and access to minimally invasive care. The da Vinci Surgical System consists of a surgeon console or consoles, a patient-side cart, a high-performance vision system, and proprietary instruments and accessories. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform that utilizes instruments and accessories for lung biopsies.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837973000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#8220;Financial Statements&#8221;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first three months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Financial Statements include the results and the balances of the Company&#8217;s majority-owned joint venture (referred to herein as the &#8220;Joint Venture&#8221;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#8220;Fosun Pharma&#8221;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#8217; equity. The noncontrolling interest&#8217;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to additional risks and uncertainties due to the COVID-19 pandemic. The extent of the impact on the Company's business is highly uncertain and difficult to predict. The Company's customers continue to divert certain resources to treat COVID-19 patients and defer certain elective surgical procedures, both of which may impact the Company's customers' ability to meet their obligations, including to the Company. Furthermore, capital markets and economies worldwide have been negatively impacted by the COVID-19 pandemic, and it is possible that the impact could cause an extended local and/or global economic recession. Such economic disruption could have a material adverse effect on our business as hospitals curtail and reduce capital and overall spending. Policymakers around the globe have responded with fiscal policy actions to support the healthcare industry and economy as a whole. However, the magnitude and overall effectiveness of these actions remains uncertain.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on the Company's customers, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be materially adversely affected by delays in payments of outstanding receivables, supply chain disruptions, uncertain or reduced demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers. For example, we have experienced, and could continue to experience, increased difficulties in obtaining a sufficient amount of materials in the semiconductor and other markets. We are engaged in activities to seek to mitigate such supply disruptions by, for example, increasing our communications with our suppliers and modifying our purchase order coverage and inventory levels. As of the date of issuance of these Financial Statements, the extent to which the COVID-19 pandemic may materially adversely affect the Company's financial condition, liquidity, or results of operations is uncertain.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to monitor new accounting pronouncements issued by the FASB and does not believe any accounting pronouncements issued through the date of this report will have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, that are of significance, or potential significance, to the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837790760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s cash and available-for-sale marketable securities&#8217; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):  </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,694.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,495.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,511.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,649.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of March&#160;31, 2021 (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,822.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,848.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities, because certain borrowers have the right to call or prepay certain obligations. Realized gains and losses recognized on the sale of investments were not material for any of the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investment portfolio at any point in time contains available-for-sale debt securities including investments in U.S. treasury and U.S. government agency securities, taxable and tax-exempt municipal notes, corporate notes and bonds, commercial paper, non-U.S. government agency securities, cash deposits, and money market funds. The Company segments its portfolio based on the underlying risk profiles of the securities and have a zero loss expectation for U.S. treasury and U.S. government agency securities. The Company regularly reviews the securities in an unrealized loss position and evaluates the current expected credit loss by considering factors such as historical experience, market data, issuer-specific factors, and current economic conditions. For the three months ended March&#160;31, 2021, the credit losses related to available-for-sales debt securities were not significant.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values. The Company generally recognizes equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to equity investments (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.229%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020<br/>Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Changes in Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sales/Purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible and other assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments with readily determinable value (Level 1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments without readily determinable value (Level 2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in Interest and other income, net.</span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a $14.3&#160;million increase in fair value, which was reflected in Interest and other income, net, due to changes in observable prices for certain equity investments that had been held at cost, because they lacked readily determinable market values. Additionally, in January 2021, the Company sold all of its shares of Teladoc Health, Inc. ("Teladoc"), a publicly traded company, for $71.5&#160;million and recognized a gain of $11.4&#160;million, which was reflected in Interest and other income, net. This gain was offset by a $7.5&#160;million loss recognized upon the settlement of a corresponding derivative collar contract. There were no decreases in fair value reflected in net income due to impairments.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Derivatives</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The objective of the Company&#8217;s hedging program is to mitigate the impact of changes in currency exchange rates on net cash flow from foreign currency-denominated sales, expenses, intercompany balances, and other monetary assets or liabilities denominated in currencies other than the U.S. dollar (&#8220;USD&#8221;). The terms of the Company&#8217;s derivative contracts are generally twelve months or shorter. The derivative assets and liabilities are measured using Level 2 fair value inputs.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into currency forward contracts as cash flow hedges to hedge certain forecasted revenue transactions denominated in currencies other than the USD, primarily the Euro (&#8220;EUR&#8221;), the British Pound (&#8220;GBP&#8221;), the Japanese Yen (&#8220;JPY&#8221;),&#160;and the Korean Won (&#8220;KRW&#8221;). The Company also enters into currency forward contracts as cash flow hedges to hedge certain forecasted expense transactions denominated in EUR and the Swiss Franc (&#8220;CHF&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these derivatives, the Company reports the unrealized after-tax gain or loss from the hedge as a component of accumulated other comprehensive income/(loss) in stockholders&#8217; equity and reclassifies the amount into earnings in the same </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period in which the hedged transaction affects earnings. The amounts reclassified to revenue and expenses related to the hedged transactions and the ineffective portions of cash flow hedges were not material for the periods presented.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Derivatives Not Designated as Hedging Instruments</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of forward contracts that the Company uses to hedge intercompany balances and other monetary assets or liabilities denominated in currencies other than the USD, primarily the EUR, GBP, JPY, KRW, CHF, Indian Rupee ("INR"), Mexican Peso ("MXN"), Chinese Yuan ("CNY"), and New Taiwan Dollar ("TWD").</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.364%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized gains/(losses) in Interest and other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains/(losses) related to balance sheet re-measurement</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in January 2021, the Company settled a collar contract previously entered into to hedge its equity investment in Teladoc Health, Inc. For the three months ended March&#160;31, 2021, a loss of $7.5&#160;million was recognized in Interest and other income, net.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:47.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.257%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional amounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Forward contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross fair value recorded in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272918533960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</a></td>
<td class="text">BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Details</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide details of selected balance sheet line items (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Inventory</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:69.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases &#8211; short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaids and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other accrued liabilities&#8211;short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred purchase consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities&#8211;short-term</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other long-term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes&#8211;long-term</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue&#8211;long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Cash Flow Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental non-cash investing and financing activities (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payments and contingent consideration related to business combinations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835969096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE AND CONTRACT ACQUISITION COSTS</a></td>
<td class="text">REVENUE AND CONTRACT ACQUISITION COSTS<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by types and geography (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Outside of U.S. (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total OUS revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price allocated to remaining performance obligations relates to amounts allocated to products and services for which revenue has not yet been recognized. A significant portion of this amount relates to performance obligations in the Company&#8217;s service contracts that will be satisfied and recognized as revenue in future periods. In addition, non-lease elements associated with the Company's lease arrangements are primarily comprised of service contracts that will be satisfied and recognized as revenue in future periods. The transaction price allocated to the remaining performance obligations and the non-lease elements associated with lease arrangements was $1,673 million as of March&#160;31, 2021. The remaining performance obligations are expected to be satisfied over the term of the individual sales arrangements, which generally are 5 years. Service revenue associated with the lease arrangements will generally be recognized over the service period, which generally coincides with the lease term.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s contract assets and liabilities (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company invoices its customers based on the billing schedules in its sales arrangements. Payments are generally due 30 days from date of invoice. Contract assets for the periods presented primarily represent the difference between the revenue that was recognized based on the relative standalone selling price of the related performance obligations satisfied and the contractual billing terms in the arrangements. Deferred revenue for the periods presented primarily relates to service contracts where the service fees are billed up-front, generally quarterly or annually, prior to those services having been performed. The associated deferred revenue is generally recognized over the term of the service period. The Company did not have any significant impairment losses on its contract assets for the periods presented.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company recognized $153.9&#160;million of revenue that was included in the deferred revenue balance as of December&#160;31, 2020. During the three months ended March&#160;31, 2020, the Company recognized $137.0&#160;million, of revenue that was included in the deferred revenue balance as of December&#160;31, 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intuitive System Leasing</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, and 2020, variable lease revenue relating to usage-based arrangements was not material.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Accounts Receivable</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for doubtful accounts is based on the Company&#8217;s assessment of the collectibility of customer accounts. The Company regularly reviews the allowance by considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer&#8217;s ability to pay. For the three months ended March&#160;31, 2021, and 2020, bad debt expense was not significant.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage, and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. Although the Company has historically not experienced significant credit losses, it is possible that there could be a material adverse impact from potential adjustments of the carrying amount of lease and trade receivables as hospital cash flows are impacted by their response to the COVID-19 pandemic and deferral of elective surgical procedures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272929695064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-type Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of gross lease receivables at March&#160;31, 2021, are as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of lessor's sales-type leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888252<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835965912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2021</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material acquisitions for the three months ended March&#160;31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions in 2020</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orpheus Medical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company acquired Orpheus Medical Ltd. and its wholly-owned subsidiaries (&#8220;Orpheus Medical&#8221;) to deepen and expand our integrated informatics platform (the &#8220;Orpheus Medical Acquisition&#8221;). Orpheus Medical provides hospitals with information technology connectivity, as well as expertise in capturing, processing, and archiving clinical videos across the hospital. The Orpheus Medical Acquisition did not have a material impact on the financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition activity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.5&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution rights and others</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense related to intangible assets was $6.9 million and $12.3 million for the three months ended March&#160;31, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to intangible assets as of March&#160;31, 2021, is as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preceding expected amortization expense is an estimate. Actual amounts of amortization expense may differ from estimated amounts due to additional intangible asset acquisitions, measurement-period adjustments to intangible assets, changes in foreign currency exchange rates, impairments of intangible assets, accelerated amortization of intangible assets, and other events.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837990776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">CONTINGENCIES</a></td>
<td class="text">CONTINGENCIES<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is involved in a variety of claims, lawsuits, investigations, and proceedings relating to securities laws, product liability, intellectual property, insurance, contract disputes, employment, and other matters. Certain of these lawsuits and claims are described in further detail below. It is not possible to predict what the outcome of these matters will be, and the Company cannot guarantee that any resolution will be reached on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A liability and related charge to earnings are recorded in the Financial Statements for legal contingencies when the loss is considered probable and the amount can be reasonably estimated. The assessment is re-evaluated each accounting period and is based on all available information, including the impact of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to each case. Nevertheless, it is possible that additional future legal costs (including settlements, judgments, legal fees, and other related defense costs) could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Liability Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently named as a defendant in a number of individual product liability lawsuits filed in various state and federal courts. The plaintiffs generally allege that they or a family member underwent surgical procedures that utilized the da Vinci Surgical System and sustained a variety of personal injuries and, in some cases, death as a result of such surgery. Several of the filed cases have trial dates in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cases raise a variety of allegations including, to varying degrees, that plaintiffs&#8217; injuries resulted from purported defects in the da Vinci Surgical System and/or failure on the Company&#8217;s part to provide adequate training resources to the healthcare professionals who performed plaintiffs&#8217; surgeries. The cases further allege that the Company failed to adequately disclose and/or misrepresented the potential risks and/or benefits of the da Vinci Surgical System. Plaintiffs also assert a variety of causes of action, including, for example, strict liability based on purported design defects, negligence, fraud, breach of express and implied warranties, unjust enrichment, and loss of consortium. Plaintiffs seek recovery for alleged personal injuries and, in many cases, punitive damages. The Company disputes these allegations and is defending against these claims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimate of the anticipated cost of resolving the pending cases is based on negotiations with attorneys for the claimants. The final outcome of the pending lawsuits and claims, and others that might arise, is dependent on many variables that are difficult to predict, and the ultimate cost associated with these product liability lawsuits and claims may be materially different than the amount of the current estimate and accruals and could have a material adverse effect on the Company&#8217;s business, financial position, and future results of operations. Although there is a reasonable possibility that a loss in excess of the amount recognized exists, the Company is unable to estimate the possible loss or range of loss in excess of the amount recognized at this time.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Patent Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 30, 2017, Ethicon LLC, Ethicon Endo-Surgery, Inc., and Ethicon US LLC (collectively, &#8220;Ethicon&#8221;) filed a complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint, which was served on the Company on July 12, 2017, alleges that the Company&#8217;s EndoWrist</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stapler instruments infringe several of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,585,658, 8,479,969, 9,113,874, 8,998,058, 8,991,677, 9,084,601, and 8,616,431. A claim construction hearing occurred on October 1, 2018, and the court issued a scheduling order on December 28, 2018. On March 20, 2019, the court granted the Company&#8217;s Motion to Stay pending an Inter Partes Review to be held at the Patent Trademark and Appeals Board to review patentability of six of the seven patents noted above and vacated the trial date. On August 1, 2019, the court granted the parties' joint stipulation to modify the stay in light of Ethicon's U.S. International Trade Commission (&#8220;USITC&#8221;) complaint against Intuitive involving U.S. Patent Nos. 8,479,969 and 9,113,874, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2018, Ethicon filed a second complaint for patent infringement against the Company in the U.S. District Court for the District of Delaware. The complaint alleges that the Company&#8217;s SureForm 60 Staplers infringe five of Ethicon&#8217;s patents. Ethicon asserts infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 8,602,288, 8,602,287, and 9,326,770. The Company filed an answer denying all claims. On March 19, 2019, Ethicon filed a Motion for Leave to File a First Amended Complaint, removing allegations related to U.S. Patent No. 9,326,770 and adding allegations related to U.S. Patent Nos. 9,844,379 and 8,479,969. On July 17, 2019, the court entered an order denying the amendment, without prejudice, and granting the parties&#8217; joint stipulation to stay the case in its entirety in light of the USITC investigation involving U.S. Patent Nos. 9,844,369 and 7,490,749, discussed below.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 30, 2019, Ethicon filed a complaint with the USITC, asserting infringement of U.S. Patent Nos. 9,884,369, 7,490,749, 9,844,379, 9,113,874, and 8,479,969. On June 28, 2019, the USITC voted to institute an investigation (No. 337-TA-1167) with respect to the claims in this complaint. The accused products include the Company's EndoWrist 30, EndoWrist 45, SureForm 45, and SureForm 60 Staplers, as well as the stapler reload cartridges. The evidentiary hearing took place in February 2021. A Final Initial Determination by the USITC was scheduled for October 2021. An unfavorable ruling by the USITC could have an adverse effect on our results of operations, including a prohibition on importing the accused products into the U.S. or necessitating workarounds that may limit certain features of our products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Litigation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, Restore Robotics LLC and Restore Repair LLC (&#8220;Restore&#8221;) filed a complaint alleging anti-trust claims against the Company. On May 13, 2019, Restore filed an amended complaint alleging anti-trust claims relating to the da Vinci Surgical System and EndoWrist service, maintenance, and repair processes. On September 16, 2019, the Court partially granted and partially denied the Company's Motion to Dismiss the amended complaint.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company filed an answer denying the anti-trust allegations and filed a counterclaim against Restore. The Company filed amended counterclaims after the Court partially granted and partially denied Restore's Motion to Dismiss the counterclaim. The amended counterclaims allege that Restore violated the Federal Lanham Act, the Federal Computer Fraud and Abuse Act, and Florida's Deceptive and Unfair Trade Practices Act and that Restore is also liable to the Company for Unfair Competition and Tortious Interference with Contract. On January 7, 2020, the Court denied Restore's Motion to Dismiss the amended counterclaims.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or before February 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from these matters.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, Rebotix Repair Inc. (&#8220;Rebotix&#8221;) filed a complaint alleging anti-trust claims against the Company relating to EndoWrist service, maintenance, and repair processes. The complaint was formally served on the Company on October 6, 2020. On March 8, 2021, the Court partially granted and partially denied the Company's Motion to Dismiss the complaint. The Company filed an answer denying the anti-trust allegations and filed counterclaims against Rebotix. The counterclaims allege that Rebotix violated the Federal Lanham Act and Florida's Deceptive and Unfair Trade Practices Act and that Rebotix is also liable to the Company for Tortious Interference with Contract.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its initial scheduling order, the Court stated that it anticipated trial in this case to occur in or around March 2022. Based on currently available information, the Company is unable to make a reasonable estimate of loss or range of losses, if any, arising from this matter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837318424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholders&#8217; Equity</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in stockholders&#8217; equity (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,445.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,261.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,731.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,759.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,153.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,190.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,756.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,263.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,284.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,926.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,530.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors (the &#8220;Board&#8221;) has authorized an aggregate of&#160;$7.5 billion of funding for the Company&#8217;s common stock repurchase program (the &#8220;Repurchase Program&#8221;) since its establishment in March 2009. The most recent authorization occurred in January 2019 when the Board increased the authorized amount available under the Repurchase Program to&#160;$2.0 billion. As of March&#160;31, 2021, the remaining amount of share repurchases authorized by the Board was $1.6 billion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides share repurchase activities (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss), Net of Tax, Attributable to Intuitive</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837179064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATIONIn April 2020, the Company's shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from 28,450,000 to 32,450,000. As of&#160;March&#160;31, 2021, approximately&#160;6.6 million&#160;shares were reserved for future issuance under the Company's stock plans. A maximum of approximately&#160;2.9 million&#160;of these shares can be awarded as restricted stock units (&#8220;RSUs&#8221;).<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Option Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise&#160;Price Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, options to purchase an aggregate of 3.5 million shares of common stock were exercisable at a weighted average price of $252.72 per share.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units Information</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSUs activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at March&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Employee Stock Purchase Plan (&#8220;ESPP&#8221;), employees purchased approximately 0.1 million shares for $41.4 million and approximately 0.1 million shares for $36.6 million during the three months ended March&#160;31, 2021, and 2020, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-based Compensation Expense</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense for the three months ended March&#160;31, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense after income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#8217;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three months ended March&#160;31, 2021, and 2020, were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$211.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$133.25</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$223.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$149.85</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837990776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit) for the three months ended March&#160;31, 2021, was $13.6 million, or 3.0% of income before taxes, compared to $(8.1)&#160;million, or (2.6)% of income before taxes, for the three months ended March&#160;31, 2020. The higher income tax expense for the three months ended March&#160;31, 2021, was primarily due to higher pre-tax income.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the three months ended March&#160;31, 2021, and 2020, differed from the U.S. federal statutory rate of 21% mainly due to excess tax benefits associated with employee equity plans, the effect of income earned by certain overseas entities being taxed at rates lower than the federal statutory rate, and the federal research and development (&#8220;R&amp;D&#8221;) credit benefit, partially offset by U.S. tax on foreign earnings and state income taxes (net of federal benefit). </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the three months ended March&#160;31, 2021, and 2020, included excess tax benefits associated with employee equity plans of $73.4&#160;million and $65.4&#160;million, which reduced our effective tax rate by 16.4 and 21.2 percentage points, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files federal, state, and foreign income tax returns in many U.S. and OUS jurisdictions. Years before 2016 are closed for the significant jurisdictions. Certain of the Company&#8217;s unrecognized tax benefits could change due to activities of various tax authorities, including potential assessment of additional tax, possible settlement of audits, or through normal expiration of various statutes of limitations, which could affect the Company&#8217;s effective tax rate in the period in which they change. Due to the uncertainty related to the timing and potential outcome of audits, the Company cannot estimate the range of reasonably possible change in unrecognized tax benefits that may occur in the next 12 months.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. The outcome of these audits cannot be predicted with certainty. The Company&#8217;s management regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of the Company&#8217;s provision for income taxes. If any issues addressed in the Company&#8217;s tax audits are resolved in a manner not consistent with management&#8217;s expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837385304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME PER SHARE</a></td>
<td class="text">NET INCOME PER SHARE<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in basic calculation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in diluted calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation awards of approximately 0.3&#160;million and 1.0&#160;million shares for the three months ended March&#160;31, 2021, and 2020, respectively, were outstanding but were not included in the computation of diluted net income per share attributable to Intuitive Surgical, Inc. common stockholders because the effect of including such shares would have been anti-dilutive in the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272917369768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements (&#8220;Financial Statements&#8221;) of Intuitive Surgical, Inc. and its wholly and majority-owned subsidiaries have been prepared on a consistent basis with the audited Consolidated Financial Statements for the fiscal year ended December&#160;31, 2020, and include all adjustments, consisting of only normal, recurring adjustments, necessary to fairly state the information set forth herein. The Financial Statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) and, therefore, omit certain information and footnote disclosure necessary to present the Financial Statements in accordance with United States (&#8220;U.S.&#8221;) generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). These Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, which was filed with the SEC on February&#160;10, 2021. The results of operations for the first three months of fiscal year 2021 are not necessarily indicative of the results to be expected for the entire fiscal year or any future periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Consolidation and Joint Ventures</a></td>
<td class="text">The Financial Statements include the results and the balances of the Company&#8217;s majority-owned joint venture (referred to herein as the &#8220;Joint Venture&#8221;) with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (&#8220;Fosun Pharma&#8221;). The Company holds a controlling financial interest in the Joint Venture, and the noncontrolling interest is reflected as a separate component of consolidated stockholders&#8217; equity. The noncontrolling interest&#8217;s share of the earnings in the Joint Venture is presented separately in the condensed consolidated statements of comprehensive income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to monitor new accounting pronouncements issued by the FASB and does not believe any accounting pronouncements issued through the date of this report will have a material impact on the Company's consolidated financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no new or material changes to the significant accounting policies discussed in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2020, that are of significance, or potential significance, to the Company.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355100-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.3A-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355119-122828<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272838017848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Summary of Cash and Available-For-Sale Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company&#8217;s cash and available-for-sale marketable securities&#8217; amortized cost, gross unrealized gains, gross unrealized losses, and fair value by significant investment category reported as cash and cash equivalents, short-term investments, or long-term investments as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):  </span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,678.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,694.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,495.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,511.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,444.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,640.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,144.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,228.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,155.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Allowance for Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and<br/>Cash<br/>Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-<br/>term<br/>Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-<br/>term<br/>Investments</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,626.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,649.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,252.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">671.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,036.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29.8pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,920.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,829.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,869.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,488.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the contractual maturities of the Company&#8217;s cash equivalents and available-for-sale investments (excluding cash and money market funds), as of March&#160;31, 2021 (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in less than one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,166.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature in one to five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,673.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,822.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,848.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Summary of Equity Investment Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the activity related to equity investments (in millions):</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:24.229%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020<br/>Carrying Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Changes in Fair Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Sales/Purchases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March&#160;31, 2021</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intangible and other assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments with readily determinable value (Level 1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity investments without readily determinable value (Level 2)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Recorded in Interest and other income, net.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These derivative instruments are used to hedge against balance sheet foreign currency exposures. The related gains and losses were as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.364%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized gains/(losses) in Interest and other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains/(losses) related to balance sheet re-measurement</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notional amounts for derivative instruments provide one measure of the transaction volume. Total gross notional amounts (in USD) for outstanding derivatives and the aggregate gross fair value at the end of each period were as follows (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:47.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.252%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.257%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notional amounts:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Forward contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross fair value recorded in:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272913317864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory Details</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide details of selected balance sheet line items (in millions):</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Inventory</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Prepaids and Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.538%"><tr><td style="width:1.0%"/><td style="width:69.968%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.997%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Prepaids and other current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases &#8211; short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaids and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Accrued Liabilities - Short-term</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other accrued liabilities&#8211;short-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of deferred purchase consideration payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other accrued liabilities&#8211;short-term</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Long-term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other long-term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes&#8211;long-term</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue&#8211;long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides supplemental non-cash investing and financing activities (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred payments and contingent consideration related to business combinations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272913044728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Revenue Disaggregated by Types and Geography</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by types and geography (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Outside of U.S. (&#8220;OUS&#8221;)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total OUS revenue</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Total </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments and accessories</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Systems</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,292.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Summary of Contract Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s contract assets and liabilities (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock', window );">Sales-type Lease Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Operating Lease Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue from Intuitive System Leasing arrangements (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease revenue </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contract balances and changes in contract balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=118952077&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=118952077&amp;loc=SL77927221-108306<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912426296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock', window );">Schedule of Lease Receivables</a></td>
<td class="text">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock', window );">Schedule of Lease Receivables</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-type Leases. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease receivables relating to sales-type lease arrangements are presented on the Condensed Consolidated Balance Sheets as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Prepaids and other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Intangible and other assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock', window );">Schedule of Contractual Maturities of Gross Lease Receivables</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of gross lease receivables at March&#160;31, 2021, are as follows (in millions):</span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock', window );">Amortized Cost Basis by Year of Origination and Credit Quality Indicator</a></td>
<td class="text">The following table summarizes the amortized cost basis by year of origination and credit quality indicator as of March&#160;31, 2021 (in millions):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.311%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Investment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Credit Rating:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">High</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moderate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Low</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessor, Sales-type Lease, Lease Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's leasing arrangements, which includes direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209026<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919230-210447<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=SL6953659-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837987944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Summary of Changes in Goodwill</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in the carrying amount of goodwill (in millions):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition activity</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344.5&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of March&#160;31, 2021, and December&#160;31, 2020 (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:29.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.703%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution rights and others</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(271.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule Of Estimated Future Amortization Expense Of Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expense related to intangible assets as of March&#160;31, 2021, is as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Fiscal Year</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837286136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stockholders Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the changes in stockholders&#8217; equity (in millions):</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.478%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,445.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,261.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,731.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,759.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,627.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,153.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,190.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:25.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.170%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest in Joint Venture</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,756.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,494.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,263.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,284.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adoption of new accounting standard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock through employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares withheld related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense related to employee stock plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest in joint venture</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,926.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,530.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchase Activities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides share repurchase activities (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income, Net of Tax</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of accumulated other comprehensive income (loss), net of tax, attributable to Intuitive are as follows (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.886%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains&#160;(Losses)<br/>on&#160;Hedge<br/>Instruments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gains<br/>(Losses)&#160;on Available-for-Sale Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign<br/>Currency<br/>Translation<br/>Gains&#160;(Losses)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Benefit Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272838878776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity Under All Stock Plans</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of stock option activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>Outstanding</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise&#160;Price Per<br/>Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited/expired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of RSU Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSUs activity under all stock plans for the three months ended March&#160;31, 2021, is presented as follows (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested balance at March&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Share-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes share-based compensation expense for the three months ended March&#160;31, 2021, and 2020 (in millions):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales &#8211; services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of sales</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense after income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company&#8217;s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three months ended March&#160;31, 2021, and 2020, were as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$211.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$133.25</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value at grant date</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$223.17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$149.85</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835850536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of basic and diluted net income per share attributable to Intuitive Surgical, Inc. (in millions, except per share amounts):</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Intuitive Surgical, Inc.</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in basic calculation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: dilutive effect of potential common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding used in diluted calculation</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share attributable to Intuitive Surgical, Inc.:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.51&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.62&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272842556424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,401.8<span></span>
</td>
<td class="nump">$ 1,622.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">5,822.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost', window );">Total assets measured at fair value, Amortized Cost</a></td>
<td class="nump">7,204.7<span></span>
</td>
<td class="nump">6,829.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">29.9<span></span>
</td>
<td class="nump">39.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue', window );">Total assets measured at fair value, Fair Value</a></td>
<td class="nump">7,230.5<span></span>
</td>
<td class="nump">6,869.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">3,155.7<span></span>
</td>
<td class="nump">3,488.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">2,673.0<span></span>
</td>
<td class="nump">1,757.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">565.1<span></span>
</td>
<td class="nump">644.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">565.1<span></span>
</td>
<td class="nump">644.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">821.2<span></span>
</td>
<td class="nump">838.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">3,495.4<span></span>
</td>
<td class="nump">3,252.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,511.3<span></span>
</td>
<td class="nump">3,275.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">1,245.8<span></span>
</td>
<td class="nump">1,567.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">1,444.3<span></span>
</td>
<td class="nump">869.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">817.2<span></span>
</td>
<td class="nump">625.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">817.2<span></span>
</td>
<td class="nump">625.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | U.S. treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">212.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">2,678.2<span></span>
</td>
<td class="nump">2,626.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">23.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,694.1<span></span>
</td>
<td class="nump">2,649.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">1,245.8<span></span>
</td>
<td class="nump">1,567.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">1,444.3<span></span>
</td>
<td class="nump">869.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">140.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">3,144.2<span></span>
</td>
<td class="nump">2,933.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">16.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,154.1<span></span>
</td>
<td class="nump">2,949.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">1,909.9<span></span>
</td>
<td class="nump">1,920.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">1,228.7<span></span>
</td>
<td class="nump">888.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">64.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">643.0<span></span>
</td>
<td class="nump">671.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">643.0<span></span>
</td>
<td class="nump">671.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">627.5<span></span>
</td>
<td class="nump">607.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">1,640.2<span></span>
</td>
<td class="nump">1,425.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,647.3<span></span>
</td>
<td class="nump">1,437.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">966.7<span></span>
</td>
<td class="nump">1,036.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">680.6<span></span>
</td>
<td class="nump">397.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">72.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">676.5<span></span>
</td>
<td class="nump">716.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">677.8<span></span>
</td>
<td class="nump">719.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">254.6<span></span>
</td>
<td class="nump">233.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">423.2<span></span>
</td>
<td class="nump">412.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">184.5<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for Credit Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">186.0<span></span>
</td>
<td class="nump">121.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short- term Investments</a></td>
<td class="nump">61.1<span></span>
</td>
<td class="nump">43.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long- term Investments</a></td>
<td class="nump">$ 124.9<span></span>
</td>
<td class="nump">$ 78.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118955579&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272839724184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Mature in less than one year</a></td>
<td class="nump">$ 3,166.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Mature in one to five years</a></td>
<td class="nump">2,655.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Total</a></td>
<td class="nump">5,822.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Mature in less than one year</a></td>
<td class="nump">3,175.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Mature in one to five years</a></td>
<td class="nump">2,673.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal', window );">Total</a></td>
<td class="nump">$ 5,848.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Available For Sale Securities Debt Maturities Fair Value Total</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272932138264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="nump">$ 60.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="nump">60.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Changes in Fair Value</a></td>
<td class="nump">11.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments', window );">Sales/Purchases/Others</a></td>
<td class="num">(71.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable value, Carrying Value</a></td>
<td class="nump">30.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss', window );">Changes in Fair Value</a></td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments', window );">Sales/Purchases/Others</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable value, Carrying Value</a></td>
<td class="nump">45.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaids and other current assets | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaids and other current assets | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable value, Carrying Value</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember', window );">Intangible and other assets, net | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments with readily determinable value beginning balance, Carrying Value</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember', window );">Intangible and other assets, net | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity investments without readily determinable value, Carrying Value</a></td>
<td class="nump">$ 45.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Sales, Purchases and Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=isrg_IntangibleAndOtherAssetsNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837517896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange gains/(losses) related to balance sheet re-measurement</a></td>
<td class="num">$ (7.1)<span></span>
</td>
<td class="num">$ (8.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward contracts | Other income | Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Recognized gains/(losses) in Interest and other income, net</a></td>
<td class="nump">7.4<span></span>
</td>
<td class="nump">$ 3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=isrg_CollarContractMember', window );">Collar Contract | Other income | Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Recognized gains/(losses) in Interest and other income, net</a></td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30700-110894<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=isrg_CollarContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=isrg_CollarContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272914485240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details) - Forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">$ 165.0<span></span>
</td>
<td class="nump">$ 154.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Designated as Hedging Instruments | Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Designated as Hedging Instruments | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Not Designated as Hedging Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">384.4<span></span>
</td>
<td class="nump">309.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Not Designated as Hedging Instruments | Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Derivatives Not Designated as Hedging Instruments | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amounts of outstanding currency forward contracts</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912731240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 167.9<span></span>
</td>
<td class="nump">$ 184.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">67.9<span></span>
</td>
<td class="nump">75.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">341.0<span></span>
</td>
<td class="nump">341.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 576.8<span></span>
</td>
<td class="nump">$ 601.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835666728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">$ 72.4<span></span>
</td>
<td class="nump">$ 28.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity investments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent', window );">Net investment in sales-type leases &#8211; short-term</a></td>
<td class="nump">79.0<span></span>
</td>
<td class="nump">81.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other prepaids and other current assets</a></td>
<td class="nump">126.4<span></span>
</td>
<td class="nump">97.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="nump">$ 277.8<span></span>
</td>
<td class="nump">$ 267.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type Lease, Net Investment in Lease, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6787-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5865-108316<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835718552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">$ 50.7<span></span>
</td>
<td class="nump">$ 47.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_DeferredPurchaseConsiderationPaymentsCurrent', window );">Current portion of deferred purchase consideration payments</a></td>
<td class="nump">12.7<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent', window );">Business Combination, Contingent Consideration, Liability, Current</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">183.4<span></span>
</td>
<td class="nump">225.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total other accrued liabilities&#8212;short-term</a></td>
<td class="nump">$ 248.6<span></span>
</td>
<td class="nump">$ 298.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_DeferredPurchaseConsiderationPaymentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Purchase Consideration Payments, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_DeferredPurchaseConsiderationPaymentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912731960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes&#8212;long-term</a></td>
<td class="nump">$ 319.5<span></span>
</td>
<td class="nump">$ 305.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue&#8212;long-term</a></td>
<td class="nump">31.1<span></span>
</td>
<td class="nump">32.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">95.0<span></span>
</td>
<td class="nump">106.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 445.6<span></span>
</td>
<td class="nump">$ 444.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912706584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental non-cash investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges', window );">Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment</a></td>
<td class="nump">$ 73.5<span></span>
</td>
<td class="nump">$ 45.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquisition of property, plant, and equipment in accounts payable and accrued liabilities</a></td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">50.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments', window );">Deferred payments and contingent consideration related to business combinations</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Present Value of Future Cash Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTransfersAndChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTransfersAndChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272838039288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,292.1<span></span>
</td>
<td class="nump">$ 1,099.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=isrg_InstrumentsandAccessoriesMember', window );">Instruments and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">705.9<span></span>
</td>
<td class="nump">617.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=isrg_SystemsMember', window );">Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">368.7<span></span>
</td>
<td class="nump">283.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=isrg_ServicesMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">217.5<span></span>
</td>
<td class="nump">198.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">847.5<span></span>
</td>
<td class="nump">781.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S. | Instruments and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">500.8<span></span>
</td>
<td class="nump">444.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S. | Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">202.7<span></span>
</td>
<td class="nump">198.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember', window );">U.S. | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">144.0<span></span>
</td>
<td class="nump">138.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">444.6<span></span>
</td>
<td class="nump">317.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;) | Instruments and accessories</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">205.1<span></span>
</td>
<td class="nump">173.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;) | Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">166.0<span></span>
</td>
<td class="nump">84.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember', window );">Outside of U.S. (&#8220;OUS&#8221;) | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 73.5<span></span>
</td>
<td class="nump">$ 60.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=isrg_InstrumentsandAccessoriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=isrg_InstrumentsandAccessoriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=isrg_SystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=isrg_SystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=isrg_ServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=isrg_ServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionDomesticMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicDistributionAxis=us-gaap_GeographicDistributionForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272843144632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Price allocated to remaining performance obligations</a></td>
<td class="nump">$ 1,673.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">$ 153.9<span></span>
</td>
<td class="nump">$ 137.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligations</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837376168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract assets</a></td>
<td class="nump">$ 39.1<span></span>
</td>
<td class="nump">$ 34.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 389.2<span></span>
</td>
<td class="nump">$ 382.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118944033&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837793816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseIncome', window );">Sales-type lease revenue</a></td>
<td class="nump">$ 17.3<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Operating lease revenue</a></td>
<td class="nump">$ 59.0<span></span>
</td>
<td class="nump">$ 39.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919372-209981<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=77888421&amp;loc=SL77919311-209978<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=118952077&amp;loc=SL77927221-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=77888421&amp;loc=SL77919311-209978<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6A<br> -URI http://asc.fasb.org/extlink&amp;oid=118952077&amp;loc=SL77927221-108306<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919372-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912750504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Lease Receivables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsLineItems', window );"><strong>Capital Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalesTypeLeaseGrossInvestmentInLease', window );">Gross lease receivables</a></td>
<td class="nump">$ 281.0<span></span>
</td>
<td class="nump">$ 286.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalestypeLeaseDeferredSellingProfit', window );">Unearned income</a></td>
<td class="num">(10.6)<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">270.4<span></span>
</td>
<td class="nump">275.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="num">(4.0)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Gross lease receivables</a></td>
<td class="nump">266.4<span></span>
</td>
<td class="nump">270.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsLineItems', window );"><strong>Capital Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Gross lease receivables</a></td>
<td class="nump">79.0<span></span>
</td>
<td class="nump">81.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Intangible and other assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeasedAssetsLineItems', window );"><strong>Capital Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseLeaseReceivable', window );">Gross lease receivables</a></td>
<td class="nump">$ 187.4<span></span>
</td>
<td class="nump">$ 189.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalesTypeLeaseGrossInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type Lease, Gross Investment in Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalesTypeLeaseGrossInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalestypeLeaseDeferredSellingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type Lease, Deferred Selling Profit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalestypeLeaseDeferredSellingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912911912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 66.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths', window );">2022</a></td>
<td class="nump">74.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears', window );">2023</a></td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears', window );">2024</a></td>
<td class="nump">49.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears', window );">2025</a></td>
<td class="nump">27.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">5.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived', window );">Total</a></td>
<td class="nump">$ 281.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in the next fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of the fiscal year following latest fiscal year. Excludes interim and annual period when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919391-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272839337656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Credit Quality Indicator (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">149.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">58.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">270.4<span></span>
</td>
<td class="nump">$ 275.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalCreditAssessmentAxis=isrg_HighMember', window );">High</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">14.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">70.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">28.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">129.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalCreditAssessmentAxis=isrg_ModerateMember', window );">Moderate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">77.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">30.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">17.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">136.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalCreditAssessmentAxis=isrg_LowMember', window );">Low</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems', window );"><strong>Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear', window );">2021</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear', window );">2020</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear', window );">2019</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear', window );">2018</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear', window );">2017</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear', window );">Prior</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseNetInvestmentInLease', window );">Net Investment</a></td>
<td class="nump">$ 4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919379-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated five or more years prior to latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated four years prior to latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated in current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated in fiscal year prior to latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated three years prior to latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net investment in sales-type lease originated two years prior to latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919232-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=isrg_HighMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=isrg_HighMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=isrg_ModerateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=isrg_ModerateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=isrg_LowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=isrg_LowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272839102520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeaseTermOfContract1', window );">Sales-type leases terms</a></td>
<td class="text">24 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorSalesTypeLeaseTermOfContract1', window );">Sales-type leases terms</a></td>
<td class="text">84 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorSalesTypeLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's sales-type lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=119202524&amp;loc=SL77919359-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorSalesTypeLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912708760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Goodwill and Other (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments', window );">Deferred payments and contingent consideration related to business combinations</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">344.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 6.9<span></span>
</td>
<td class="nump">$ 12.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Present Value of Future Cash Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272838150728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning Balance</a></td>
<td class="nump">$ 336.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisition activity</a></td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Translation and other</a></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending Balance</a></td>
<td class="nump">$ 344.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=116868678&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272838432392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 319.3<span></span>
</td>
<td class="nump">$ 349.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(232.1)<span></span>
</td>
<td class="num">(271.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">87.2<span></span>
</td>
<td class="nump">77.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology-Based Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">215.3<span></span>
</td>
<td class="nump">198.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(161.7)<span></span>
</td>
<td class="num">(158.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">53.6<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution rights and others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">44.1<span></span>
</td>
<td class="nump">91.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(31.8)<span></span>
</td>
<td class="num">(77.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">12.3<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">59.9<span></span>
</td>
<td class="nump">59.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(38.6)<span></span>
</td>
<td class="num">(35.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 21.3<span></span>
</td>
<td class="nump">$ 23.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272918113080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 18.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">23.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">18.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">2026 and thereafter</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 87.2<span></span>
</td>
<td class="nump">$ 77.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Amortization Expense, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272841813176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details) - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">117,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 9,759.1<span></span>
</td>
<td class="nump">$ 8,284.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock through employee stock plans</a></td>
<td class="nump">84.0<span></span>
</td>
<td class="nump">91.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(178.0)<span></span>
</td>
<td class="num">(148.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense related to employee stock plans</a></td>
<td class="nump">103.2<span></span>
</td>
<td class="nump">90.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">426.3<span></span>
</td>
<td class="nump">313.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(13.3)<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest in joint venture</a></td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">118,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 10,190.2<span></span>
</td>
<td class="nump">8,530.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_CumulativeEffectPeriodOfAdoptionAxis=isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares)</a></td>
<td class="nump">117,700<span></span>
</td>
<td class="nump">116,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock through employee stock plans (in shares)</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares)</a></td>
<td class="nump">118,400<span></span>
</td>
<td class="nump">116,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-In Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">6,445.2<span></span>
</td>
<td class="nump">5,756.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock through employee stock plans</a></td>
<td class="nump">84.0<span></span>
</td>
<td class="nump">91.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense related to employee stock plans</a></td>
<td class="nump">103.2<span></span>
</td>
<td class="nump">90.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">6,627.3<span></span>
</td>
<td class="nump">5,926.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">3,261.3<span></span>
</td>
<td class="nump">2,494.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(172.9)<span></span>
</td>
<td class="num">(142.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(94.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">426.3<span></span>
</td>
<td class="nump">313.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">3,514.7<span></span>
</td>
<td class="nump">2,570.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings | Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(13.5)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">11.4<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember', window );">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">9,731.5<span></span>
</td>
<td class="nump">8,263.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock through employee stock plans</a></td>
<td class="nump">84.0<span></span>
</td>
<td class="nump">91.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld related to net share settlement of equity awards</a></td>
<td class="num">(178.0)<span></span>
</td>
<td class="num">(148.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense related to employee stock plans</a></td>
<td class="nump">103.2<span></span>
</td>
<td class="nump">90.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">426.3<span></span>
</td>
<td class="nump">313.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(13.5)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">10,153.5<span></span>
</td>
<td class="nump">8,506.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember', window );">Total Intuitive Surgical, Inc. Stockholders&#8217; Equity | Adoption of new accounting standard</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest in Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">27.6<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest in joint venture</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">$ 36.7<span></span>
</td>
<td class="nump">$ 23.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118258462&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116855982&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_CumulativeEffectPeriodOfAdoptionAxis=isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_CumulativeEffectPeriodOfAdoptionAxis=isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_ParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272914529896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 521.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Value of shares repurchased</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912733944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember', window );">Repurchase Program | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Amount of share repurchases authorized</a></td>
<td class="nump">7,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_StockRepurchaseProgramincreasedtoauthorizedamount', window );">Stock repurchase program, increased to authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining amount of share repurchases authorized</a></td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_StockRepurchaseProgramincreasedtoauthorizedamount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increased to authorized shares repurchase amount for Stock Repurchase Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_StockRepurchaseProgramincreasedtoauthorizedamount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=isrg_CommonStockRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272839576424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract', window );"><strong>Gains&#160;(Losses) on&#160;Hedge Instruments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Beginning balance</a></td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Ending balance</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract', window );"><strong>Unrealized Gains (Losses)&#160;on Available-for-Sale Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Beginning balance</a></td>
<td class="nump">29.5<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Ending balance</a></td>
<td class="nump">19.5<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward', window );"><strong>Foreign Currency Translation Gains&#160;(Losses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Beginning balance</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(9.7)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Ending balance</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(20.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Employee Benefit Plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Beginning balance</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(8.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Ending balance</a></td>
<td class="num">(6.3)<span></span>
</td>
<td class="num">(8.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(15.1)<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive income (loss)</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Net current-period other comprehensive income (loss)</a></td>
<td class="num">(13.5)<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=116690757&amp;loc=SL116692626-108610<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeTranslationAdjustmentSummaryRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeTranslationAdjustmentSummaryRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32157-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b,c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e709-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109978405&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724394-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272912783256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable, number of shares</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable, weighted-average exercise price (usd per share)</a></td>
<td class="nump">$ 252.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee Stock Purchase Plan, number of shares purchased by employees</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=isrg_A2010IncentiveAwardPlanMember', window );">2010 Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,450,000<span></span>
</td>
<td class="nump">32,450,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance</a></td>
<td class="nump">6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | 2010 Incentive Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee Stock Purchase Plan, value of shares purchased by employees</a></td>
<td class="nump">$ 41.4<span></span>
</td>
<td class="nump">$ 36.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=isrg_A2010IncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=isrg_A2010IncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272935028072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance, Number Outstanding | shares</a></td>
<td class="nump">4.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted, Number Outstanding | shares</a></td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised, Number Outstanding | shares</a></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options forfeited/expired, Number Outstanding | shares</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance, Number Outstanding | shares</a></td>
<td class="nump">4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract', window );"><strong>Weighted&#160;Average Exercise&#160;Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">$ 305.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">740.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">194.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Options forfeited/expired, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">572.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance, Weighted Average Exercise Price Per Share | $ / shares</a></td>
<td class="nump">$ 328.52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>isrg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272839099944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested beginning balance (in shares) | shares</a></td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested ending balance (in shares) | shares</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested beginning balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 489.91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (usd per share) | $ / shares</a></td>
<td class="nump">738.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (usd per share) | $ / shares</a></td>
<td class="nump">427.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (usd per share) | $ / shares</a></td>
<td class="nump">555.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested ending balance (usd per share) | $ / shares</a></td>
<td class="nump">$ 593.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272914417192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">$ 104.2<span></span>
</td>
<td class="nump">$ 91.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Income tax benefit</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">18.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense after income taxes</a></td>
<td class="nump">83.6<span></span>
</td>
<td class="nump">72.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Total cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">18.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Total cost of sales | Cost of sales - products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Total cost of sales | Cost of sales - services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=isrg_SellingGeneralAndAdministrativeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">53.1<span></span>
</td>
<td class="nump">45.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=isrg_ResearchAndDevelopmentMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense before income taxes</a></td>
<td class="nump">$ 30.1<span></span>
</td>
<td class="nump">$ 27.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ConsolidatingReportingAxis=isrg_CostOfSalesProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ConsolidatingReportingAxis=isrg_CostOfSalesProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_isrg_ConsolidatingReportingAxis=isrg_CostOfSalesServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">isrg_ConsolidatingReportingAxis=isrg_CostOfSalesServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=isrg_SellingGeneralAndAdministrativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=isrg_SellingGeneralAndAdministrativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=isrg_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=isrg_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272914528344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility (percent)</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value at grant date (usd per share)</a></td>
<td class="nump">$ 211.00<span></span>
</td>
<td class="nump">$ 133.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility (percent)</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value at grant date (usd per share)</a></td>
<td class="nump">$ 223.17<span></span>
</td>
<td class="nump">$ 149.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272835663816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit)</a></td>
<td class="nump">$ 13.6<span></span>
</td>
<td class="num">$ (8.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax expense, percentage of pre-tax income</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 13.6<span></span>
</td>
<td class="num">$ (8.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Excess tax benefits associated with employee equity plans</a></td>
<td class="nump">$ 73.4<span></span>
</td>
<td class="nump">$ 65.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">excess tax benefits associated with employee equity plans (in percent)</a></td>
<td class="nump">16.40%<span></span>
</td>
<td class="nump">21.20%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117330312&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117330312&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837201080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Intuitive Surgical, Inc.</a></td>
<td class="nump">$ 426.3<span></span>
</td>
<td class="nump">$ 313.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding used in basic calculation</a></td>
<td class="nump">118.1<span></span>
</td>
<td class="nump">116.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Add: dilutive effect of potential common shares</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares outstanding used in diluted calculation</a></td>
<td class="nump">121.3<span></span>
</td>
<td class="nump">119.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income per share attributable to Intuitive Surgical, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 3.61<span></span>
</td>
<td class="nump">$ 2.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 3.51<span></span>
</td>
<td class="nump">$ 2.62<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140272837458968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME PER SHARE - Additional Information (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Employee stock options excluded from computation of diluted net income per share</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>73
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MZD;I72,?'.<SUQ #LR" TRA4"2(L(3&.M?JSD]1_E? X)I>Y@=?-N[4%IZW
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M-P#>KY6RAX;[0'79.OT/4$L#!!0    ( "^#E5)^4-9&>08  '$9   8
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M6O!XH!".G[53*#B]YP77G'FW"WC@!O:#H^?;GCX9N#G[;Z,!PY3 Q[VWS98
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M ]U#/]T_"HAVI:4H"K-P>06,A_K69,2_!=PA<S132^>&+W25A]8\<EC!FI@
M?3B /GP.Z'\PW Z>!WAE@]]AN$KCU51""4<GG'[P6]N3)BG^8"\<9YK.BLYI
MZ*KH%J/S<///"$C<6UXI5+ -M SF*:!(MN?[[8T6^^:(_%YH+<KF<L<HR#<&
M\'XC8$?3W9A3]_Z_+.M_ 5!+ P04    "  O@Y52YLAE<-<"  #)"0  &
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M6A3-Y9:SE,O: -ZOA="'F_H#Q[\YS/\%4$L#!!0    ( "^#E5(%J]U1( <
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M;!.OY6[ ;,-%FE<Q$VH+3B%Z/O%Y]X+$4\ L0N1_Y=@G<ER?J*]JL<29:U"
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MDTHB9@Z^*PRW$]KKS+W8%,CK@7]:ZEGM.@&>:PI).B97XXB[AYP?@:;DP3)
MT(ME]+BB;!:\/ZFM<Q2E)0+2(\Q4CM/,%_*0^5I5'K9X.P\O=#)NO";>34TR
M2=Q^\>G^BJ\Z+XX]5E#R'!S3-MSM_0RDAH/7M=@]JFQ5]RY0E1_$5O4I8% >
MAB>+X#3$K1Y@"TO.*G$RC)HT7Q84$?Q@YAT9_@,\JS:;%1HK#+F/D*AR('SS
M*,TDU-\&_IM[-MC!5S5 D4M!Y1AH5BJGZ Q+]_<[X?XJ(@2D69G,A5MO"S3/
ME4/>?KJK'.(!Z0WU:U#O5J,UK\G>O[G=)/M)XLP8I<1O0,N*ZJ?;W]94/*2
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M0W":=BA2 _.V\&O)#UT9@NMP:2@#Y$'5K4TF%LI<.'Z#+J/<;WP[[L91\"R
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M8#SLU,VB>7&Z])?MN7;4#?PPHV\E-"Q ZPNM7?/"#MJOK]-_ 5!+ P04
M"  O@Y52V+<>*Z@-  #7)@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6S-6MMR&[D1_1644A5[J\8425U([=JNDF4K4<KVNBQ[]R&5!W &)&'/#+@
MAI+R]3G=C;E0EF3OEI/-B\2Y .@^W7WZ .33*^<_A[4Q45U791V>[:UCW/RX
MOQ_RM:ET&+F-J?%DZ7RE(R[]:C]LO-$%#ZK*_>EX?+Q?:5OO/7_*]][YYT]=
M$TM;FW=>A::JM+]Y84IW]6QOLM?>>&]7ZT@W]I\_W>B5N33QX^:=Q]5^-TMA
M*U,'ZVKES?+9WNGDQQ>']#Z_\(LU5V'P69$G"^<^T\5%\6QO3 :9TN219M#X
MMS5GIBQI(ICQ6YISKUN2!@X_M[.?L^_P9:&#.7/EK[:(ZV=[\SU5F*5NROC>
M7?W=)'^.:+[<E8'_JBMY]VBZI_(F1%>EP;"@LK7\U]<)A\& ^?B> =,T8,IV
MRT)LY4L=]?.GWETI3V]C-OK KO)H&&=K"LIE]'AJ,2X^/_OY[8>+MW][]?;L
MXM7ET_V(*>G!?IZ&OY#ATWN&'Z@WKH[KH%[5A2EVQ^_#E,Z>:6O/B^F#$[[1
M?J0.)IF:CJ>3!^8[Z/P[X/D.[O//596-R*(8E*X+=09S;;TR=6Y-4"]MR$L7
M&F_4/T\7(7HDR;\>6/6P6_605SW\HZC^CN'JW+M*152"BH[_9RJN#3RI-KJ^
M438H6V]=N34%/BBMMMI;$V^46ZJ\U+8*F2KU56ALQ">\:D*T*TTU@6O"9.-=
M;DP!6 +JK-0$$*T53-YX&PDHFB"C%XLFCZJT>F%+&V]HOHB*0HDUNJ3G&^/E
M-D#5=0Y;<R!.N*K"ADT3#>8QU:9T-Q04,<#!'X^LCM'X,%)GF -T0@[@03"=
M^?RR^*0T8E:8D'N[$,>7C>=I"H/!I5H0WXS4122 :A?5QH5@%R6C"/XJ+$RZ
M6NO(8(*N<@>$NR63,:C&DN82.X>PY[JF65>-AI_18%J:BYYX$US9,.>DT;BE
MP:9PM 8<565\;G59TJLZN%JS5<93I.Q2T31E.5*G/<Z\.H<&D^1K[5?LAM&^
MYJ@1&-[DSA>"!1EZ;FL$ .NHRXAQ4@)@<56:%6[F.X5PM38R"M40"#$\#K8P
MP(FBNF 36PATY9HZ$@+)-_'A1E%F563C2'V@]T(P(=#"-*,W3\Q6EPW[0'B
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MN0!%48GMI$GZH1]$4GC<YSD7ESS>*/W6Y$)8]KXL*G/2RZU=/Q\.39J+DIM
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M$-"U63SRD_KA[PZ3PK:I:K(-E75QJ2\K=T=C _<+A(1JHL)1TS"5!=0+@%B
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M!TO;ZX8;84F:PK\Z>G$$CB@(H?A^5>99OH2'3:OZD163DIB@85,_:;B?^,B
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M01H!W-\(H0\3 ] ^B"=_ U!+ P04    "  O@Y52@J9>590$  #F#   &0
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MJ[N[\^_7-S>0W)[#]>TBN;VZGMU<0#*?7RSFT%ZP9<%-9^Q;=$8F?KH#GM7
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MC=/U2%,OK-JX,6*I+!:S$W.< KDF!3Q?*67W"W+0S)73?P%02P,$%     @
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MN*C9/$V;JBFYP>!K>*A(%SS.B=-7@IW4J:P$NY D?E(;^$?#YXU:%BDO1[3
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M(=K4MRRRJOT?O'3:: *6VZHNUEUAY6"=YKN_R=]=1_0*0.(H@+H":&P!W!7
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M[4M8!7FUJ&H?E5HK;.(S;'EA1]7*7KO5"C\_]%J[V3H3W^LSJA;H?]%KW2,
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MK[.4QL@D>XQMBE2Y!?;WM93F>> "E#=]PW\ 4$L#!!0    ( "^#E5*\R@Q
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M-W3Q+B@,JU;^:ITK2Q>U'Z;TED+M%M#WA5+VR7 )JM=9_Q=02P,$%     @
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M+9("C P2EN9?\EK$H0((ZGL 80$(/PNH%8":%9HSL[+Z1)-N6XHU2&.-WLS
MQL:B40U+S2E.M,1=ACC=O8BOXU%O ).KP> >^H/[>'@]@7C4A_']U> .+H<C
MW!_&US <78[O;N+[X7@$IW K:4;83 %)9S#62RJAMY*2IAIBI:A6<-RGFC"N
MOJ'UPZ0/QT??X A8"C>,<SQ!U?8T"C TO&E!]B(G&^XA>T.D"[7@!$(_#';
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M$N]7*HT![L^%T.\3T\++&[O[%U!+ P04    "  P@Y52VUY?IR(#  #6!P
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MU&Y1F"HF3;$Q,G<_ZUP:[+Q;ICB<J;()^'TII=EM;(%JW'?^ %!+ P04
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MG]3#/V&^@?N]FFP:Y9HT+%]C#]_T/J/ZZ0B-$ZP4$DMT#0=:9?*I6)8?%P!
MYYHP];-&KEG*-:U<<X]<995!*Q2,P7E41FG7RN9<OF?)S*7R,(22/52+O2/$
M]XI/&?K":JNTVGJKU<V&_(W&N>/%:\<O--JE1OM_5+]3RG5J4SIE(N/:Z*@8
M2P)7Z29%A7"F8R'IK^TSDJ]$SMNJ5+G3JB]SM_34K?64)_KL!*5YL8\0Y:&I
M!HF0%A5["-LL=AV=[NO-$'CU-GNES=Y?=H/I:Y2O"OE_*6)OQUYM[['G5JY9
M1N3*MBL%)P:T\[NJG"T[XJEM!%OS(_]DG#>V9YJ\S<)-M*)<H80L@=([[L#R
MRKQUY0,M4GN9WPH-K<$^QM#MB30!\'XIA-X,C$#Y_V'X!U!+ P04    "  P
M@Y527R3/R$ %  "6&   &0   'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6S%
M66U3XS80_BN:]*:%F8MMR8F3T) 9$FAA>A1*H)U^%(Z2>$ZV<K)"H+^^\@N6
M;=E*Y@J4#^"7W=6STN[SR&*\8_QKO"9$@.>01O%I9RW$YL2V8W]-0AQ;;$,B
M^6;)>(B%O.4K.]YP@A>I4TAMY#B>'>(@ZDS&Z;-;/AFSK:!!1&XYB+=AB/G+
ME%"V.^W SNN#NV"U%LD#>S+>X!69$_&PN>7RSBZB+(*01'' (L#)\K1S!D]F
M+DH<4HL_ [*+2]<@2>61L:_)S=7BM.,DB @EODA"8/GGB<P(I4DDB>-;'K13
MC)DXEJ]?H_^2)B^3><0QF3'Z5[ 0Z]/.L ,69(FW5-RQW27)$^HG\7Q&X_0W
MV.6V3@?XVUBP,'>6",(@RO[BYWPB2@XR3K,#RAU0W:'7XN#F#FZ::(8L3>L<
M"SP9<[8#/+&6T9*+=&Y2;YE-$"7+.!=<O@VDGYC,[V]FOUW>?#F_N)O_!"[^
M>+BZ_QMTP8R%&Q:12,2 +<&9[V_#+<6"+,"-6!.>ON=DG2SG$P%7D<]"\AG\
M+LM.FM_C9W!T3@0.:'PL@SW,S\'1IV/P"001N XHE>L7CVTAX2<@;#^'.LV@
MHA:H+KAFD5C'X"):D$75WY9I%[FCU]RGR!CP&G,+N/ S0 Z"#7AFA[L[!CAN
ML11N&L]MB?>K;+KXQQ^@Y_Q\](7%,9&3QZ+LP259K))YC@7?ALFR&,;K%>/U
MTO%Z+>--R2J(HB!:R3Z@./))TY)D(;PT1$()3Y,NLD9C^ZD\3[J18PT*FPJX
M?@&N;P27E9E?*;,@+3-P1.7D'(-'(DF,2"KQ*8[C8!GX6+055C;6H 2P9WFU
M)'0;9 V;D_"*)#QC$F<AVR8MI##*!EIR%DKV4AW%]J7:E)&GH856OY:1;M.%
M;>LR*%(:&%-*6MS?<BYKL+LA/&#?B7^@8?,L6,.OV\"2307^L( _-,*7U+&G
MX(?:H*Z%:L!T&]A6*J,"V,C8_ ^1%&$:_"/K(>4!\$H!6?]+P3M[DGR*'RGI
MRKKOSC$E8$[D4@0B("8Z@(Z2 N>_$T(>H](G(ZWTFJP<J]<\1[ D5O #62$?
MK%]I$*>>"=07VVM;;8A4)NC_HH9\Y'):6E*Z2;>ELZ"2+^A^"#7DP^Q9%E=?
MEG[KLBA)A&9-W,\/>8#*P WUKUNY7HE'JO"4*,*^D27DSE7N2R,P2Z?9?P'W
M'$<Q34L<-.P?3+2@1 R:5>PP6M#%IE?2FGQ6/$-E5M$I/8)F07IC2M UISNR
MO%'EIYY5@X\D.Z\E,R55T*Q5[TD1P_T483*I9J0T#HX^AB%&W[%*#3[MJX24
M:"*S:.YGC#Q A<_J?(%TO32A4X*)H)$P+L(-92^$@"F)R#(0X%;"-.T6D%(P
M9%:P@V@ACU')RROM _+L&ZR&K>M9Q:OD"9GEZ6V) NDB5>\@HTDU":5/R*Q/
M[\@)2)<L1]N2-QJUR!I2LH;,'WMOQ0M(_X9K2*')J"T%)9+(+)('T$##YYAG
MN75T#5;#TO:B"D^I)!H8>>">"4Q-;:]4"9E5Z;"VU[^04$\[-FBP@JCM(P$I
ME4%FE7GC1F_0#;G3U*IJ=/".VE7:XIJUY1V[W=4%!VI'(@U&7=16C*X2)=?\
M%?=6[>[JGV9=Z&I[\28SMS4+I7^N6?_V=WP>H'PN!J$F?@U60ZNN=G;IA#<D
M?)4>?,=RPF1]9 >>Q=/B</TL/5*N/9_"DUEV1*["9"?VUYBODH,'2I8RI&,-
M9"WS[! \NQ%LDYXC/S(A6)A>K@E>$)X8R/=+QL3K33) \:^(R;]02P,$%
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MV93F/I%5#58UM%BYNN=!:%-%N<^EJ5M1V@EF?"Z$WC;L DTE//P?4$L#!!0
M   ( #"#E5)K(P^<,P,  "T*   9    >&PO=V]R:W-H965T<R]S:&5E=#4U
M+GAM;)V666_:0!" _\K(K:I4:GQBCA:0($F/A[01-.GSQAY@%7N7[B[02OWQ
MW<,QM!@*?;'WFIEOQCOCZ6^X>)(+1 4_RH+)@;=0:ODV"&2VP))(GR^1Z9T9
M%R51>BKF@5P*)+D5*HL@#L-V4!+*O&'?KMV)89^O5$$9W@F0J[(DXN<8"[X9
M>)'WO#"A\X4R"\&POR1SG**Z7]X)/0MJ+3DMD4G*&0B<#;Q1]'8<M8R /?%
M<2-WQF!<>>3\R4P^Y0,O-$188*:,"J)?:[S"HC":-,?W2JE7VS2"N^-G[>^M
M\]J91R+QBA??:*X6 Z_K08XSLBK4A&\^8N50:O1EO)#V"9OJ;.A!MI**EY6P
M)B@I<V_RHPK$CD!R2""N!&++[0Q9RFNBR+ O^ :$.:VUF8%UU4IK.,K,5YDJ
MH7>IEE/#Z<?1Y.9R/)K>7,/5E]N[F\_3T==/7S[#)4S=AP(^@\GT'D8F?E3]
MA(MK5(06\K4^,T&I!,T4YC!5/'N">T:5A LMH/?E@@B40!G<TJ+0'T'V Z6A
MC>D@JP#'#C ^ )C +6=J(>&&Y9C_*1]H9VN/XV>/Q_%1A;=$^)!$;R .X^@E
M!!6E>Q[1G]013:S^Y%!$_Z6H52MJ646M XKNV5I'5T?V$>>4,<KF^OX5A&4(
M%SJD#O@U_((F=!<)9Z!C#9C\7 \CO]L/U@U4:4V5'J7Z( @S4*<BI'L(H9\V
M([1KA/91A <7EE,)VGL$EZ'?;D;HU B=HPBZ(LR0GD/A]*6[<6A&Z-8(W=.N
M![+\?^Y&M^%N=)J1>C52[^C5_V9K(.:O7D3M\-UHC4(7=K W!G1U0GA/J( '
M4JSP2'Y$X;9VA?^=(2N9PQ*%"X")Q#;5&XN0L]3;"4>KV_-[47-$HIWZ&IV6
M+^<"574[VB'J)%T_:AT@BK=$\4GI<RY0O _4BCN'DCG:ULLH.367SD5*]I'2
M-/7#Y #3MO1&)];>OY/K7,+6WK5*>XG?^3O1@IT_>(EB;OL4"1E?,>5^YO5J
MW0N-7 >P/>X:*?U_T\D@H<"9%@W]CJXYPO4F;J+XTO8#CUSI[L(.%[J?0V$.
MZ/T9Y^IY8@S4'>+P-U!+ P04    "  P@Y52O\1V%]4#  #W#P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970U-BYX;6S-5VV/VC@0_BL6ZH=66I(XX;4")& Y
M=:5NBZ#M?3C=!Y,,8&T2<[:![>E^?"=.-@D0TCM=M8(/Q';FY9EY'(]G<!3R
M26T!-'F.PE@-&UNM=^]M6_E;B)BRQ YB?+,6,F(:IW)CJYT$%ABE*+1=Q^G8
M$>-Q8S0P:W,Y&HB]#GD,<TG4/HJ8_#Z!4!R'#=IX65CPS58G"_9HL&,;6(+^
MNIM+G-FYE8!'$"LN8B)A/6R,Z?NI:Q2,Q#<.1U4:DR24E1!/R>0A&#:<!!&$
MX.O$!,/' :80AHDEQ/%79K21^TP4R^,7Z[^9X#&8%5,P%>'O/-#;8:/7( &L
MV3[4"W'\ %E [<2>+T)E_LDQDW4:Q-\K+:),&1%$/$Z?[#E+1$D![50KN)F"
M>Z[0NJ+@90J>"31%9L*Z9YJ-!E(<B4RDT5HR,+DQVA@-CQ,:EUKB6XYZ>K3\
M,%[,FI/Q<G9/II\?Y[-/R_&7A\^?2),LM?"?FA/,44"F(L*-HYA)_>PY&0-Y
M>P^:\5"]0^&ORWOR]LT[\H;PF#SR,$1!-; U0DP<V7X&9Y+"<:_ \<BCB/56
MD5D<0'"J;V-H>7SN2WP3M];@(Y,6\>@=<1V75N"9_GMUIP:.EZ?;,_:\*_9F
MT2X4WP'($N2!^_C<,@G-U462[\@X#(6?)ERLR0)\L8GYWR@V!\E%(JVT(G]\
M1 _D04.D_JS!U\KQM0R^UK7M4(+CESF'C/,5X-$!2#*^!:+9,U2RG'KI&"_)
M27(84:=EN0/[4,[]I52?EH1.(FCG$;1K(WC(D2'6&-9<5^%+;71+GEW'ZIS!
MNQ2B/:M?#:^3P^O\OP2SM0;YT_QV+J#U/*O=+__.@KG4Z+J65QU,-P^F6QO,
M%Z%9B&$HG6Q1Q<)SL"=6>[G5WDU^(_T<7_]5OI'42[N\!^D9:?VJ'7B%-.H4
M1[[S7VDC_YA<%?,FV4D1['U=QR@M51EZDYQ2MT#HO@JKF9L3SMHESE)BJZ1<
MJW>%V:*Z4.\7,*M2#FJ9+0H&;=TFLT5!H/45X9<Q>UD/VE;WG-@JH?857HNB
M07]2-?":R^/-'=E@29-(,8L#P@*\#W*E)4MNPG6I*LYSVKU-,HO:0'NO0V;O
MDB?/.C]_*Z1:9<Y/@R@*"*VO( M0P*2_-30&<,!F:H>MD:Z[[Q:GN^O<)(=N
M40Q<^BH<9F[*]T?/N>"P0LKM7MPR[5(+%8'<F,Y2(;Q]K--N(U_-N]>QZ=G.
MUB?8U:8]:&$F;8FQE]CP6)$0UFC2L;IX5,BTRTPG6NQ,H[82&ML^,]QB9PXR
M$<#W:R'TRR1QD/?ZHQ]02P,$%     @ ,(.54CU_+/N^ P  W P  !D   !X
M;"]W;W)K<VAE971S+W-H965T-3<N>&ULS5?1;N(X%/V5JVA7ZDA#$B=08 1(
M0!E-I>T4E9V9A]4^N(D!BR1F;0/E[_?:"0$Z(72D:K4O$#L^QS[7U\<WO9V0
M*[5D3,-+FF2J[RRU7G_R/!4M64J5*]8LPS=S(5.JL2D7GEI+1F,+2A,O\/U;
M+Z4\<P8]VS>5@Y[8Z(1G;"I!;=*4ROV()6+7=XASZ'CBBZ4V'=Z@MZ8+-F/Z
MVWHJL>65+#%/6::XR$"R>=\9DD]CTC0 .^([9SMU\@Q&RK,0*].XC_N.;U;$
M$A9I0T'Q;\O&+$D,$Z[CGX+4*><TP-/G _MG*Q[%/%/%QB+YP6.][#L=!V(V
MIYM$/XG=%U8(:AF^2"3*_L*N&.L[$&V4%FD!QA6D/,O_Z4L1B!- T+H " I
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M>-'*O)3.&UJL;37Z+#36MO9QB9\?3)H!^'XNA#XTS 3E!\W@7U!+ P04
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MNIP?KND[!+4SH/=+I>SCQ#EHOFRF_P%02P,$%     @ ,(.54O WFBEN P
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M-_]*<O6KLB_8J['>/T]=9/<<1,;G(/(L:K)W^B*CY"0UAO7^O75(V#DB--8
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M(-\#D.]Q(=/X/D[6\1XK6B9Y&D9=$W]:TXR:1],>OD?0^#W"Q5S$81;;[>J
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M(E.V;!:2E<==;<<=>1__!5!+ P04    "  P@Y52F!M:GOL!  #+(P  &@
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MHM[M3^I=IL]#+M>>KS5>_R>IGL[GYNOE+\NOG7B_:"\X)_AWY_$O4$L#!!0
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ +X.54E>ZS"95!0  >!4  !@              ("!#0@  'AL+W=O<FMS
M:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( "^#E5)^4-9&>08  '$9   8
M              " @9@-  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"
M% ,4    "  O@Y52YLAE<-<"  #)"0  &               @(%'%   >&PO
M=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ +X.54F_AH'>\!0
M?Q@  !@              ("!5!<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM
M;%!+ 0(4 Q0    ( "^#E5(%J]U1( <  $\<   8              " @48=
M  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  O@Y52N!^)
M^TD#   &!P  &               @(&<)   >&PO=V]R:W-H965T<R]S:&5E
M=#8N>&UL4$L! A0#%     @ +X.54IQ<&@-,"0  <1<  !@
M ("!&R@  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( "^#
ME5*NI0:CH0T  /TE   8              " @9TQ  !X;"]W;W)K<VAE971S
M+W-H965T."YX;6Q02P$"% ,4    "  O@Y521L&]T-4$  !."P  &
M        @(%T/P  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%
M  @ +X.54KU'H3MZ"   3A8  !D              ("!?T0  'AL+W=O<FMS
M:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  O@Y52"4= [F4#   I!P
M&0              @($P30  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+
M 0(4 Q0    ( "^#E5*^N&%XG@4  (D-   9              " @<Q0  !X
M;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ +X.54MBW'BNH
M#0  UR8  !D              ("!H58  'AL+W=O<FMS:&5E=',O<VAE970Q
M,RYX;6Q02P$"% ,4    "  O@Y52*9NTK D'   7%   &0
M@(& 9   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( "^#
ME5(Q@B&=@08  -\0   9              " @<!K  !X;"]W;W)K<VAE971S
M+W-H965T,34N>&UL4$L! A0#%     @ +X.54M5R)4/ !0  ^0T  !D
M         ("!>'(  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
M    "  O@Y522IDUE8D#  !/"   &0              @(%O>   >&PO=V]R
M:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( "^#E5)-> XR"P8  'T/
M   9              " @2]\  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL
M4$L! A0#%     @ +X.54FC&DD1$"   )1<  !D              ("!<8(
M 'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  O@Y52V";0
MA2P%  !P#0  &0              @('LB@  >&PO=V]R:W-H965T<R]S:&5E
M=#(P+GAM;%!+ 0(4 Q0    ( "^#E5( N!LQ$P0  !P+   9
M  " @4^0  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @
M+X.54H*F7E64!   Y@P  !D              ("!F90  'AL+W=O<FMS:&5E
M=',O<VAE970R,BYX;6Q02P$"% ,4    "  O@Y52\;%U[S4$  !C"@  &0
M            @(%DF0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4
M Q0    ( "^#E5)__F( 708  /P2   9              " @="=  !X;"]W
M;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ +X.54E0!L+JL!0
M4 \  !D              ("!9*0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX
M;6Q02P$"% ,4    "  O@Y52DMA=51<#  #H!@  &0              @(%'
MJ@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( "^#E5)&
M._]TL@@  .PX   9              " @96M  !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&UL4$L! A0#%     @ +X.54E'1]7>? @  W 8  !D
M     ("!?K8  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( #"#E5+0=.@."0,  +T'   9              "
M@=K'  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ ,(.5
M4MM>7Z<B P  U@<  !D              ("!&LL  'AL+W=O<FMS:&5E=',O
M<VAE970S-"YX;6Q02P$"% ,4    "  P@Y52B: /DLL"  #C!@  &0
M        @(%SS@  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0
M   ( #"#E5)7[=KS)0,  &T'   9              " @771  !X;"]W;W)K
M<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ ,(.54F\#-!UJ!   V10
M !D              ("!T=0  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q0
M2P$"% ,4    "  P@Y52,:I*PPL#  !="   &0              @(%RV0
M>&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( #"#E5+R,PL^
M6@(  $X%   9              " @;3<  !X;"]W;W)K<VAE971S+W-H965T
M,SDN>&UL4$L! A0#%     @ ,(.54@?PSMZ* @  ^@4  !D
M ("!1=\  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  P
M@Y52-12:<1 #  #I"0  &0              @($&X@  >&PO=V]R:W-H965T
M<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( #"#E5(_"R%%>0(  (,&   9
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M970T-BYX;6Q02P$"% ,4    "  P@Y52(L6X#+ #  !C#@  &0
M    @($[]   >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (
M #"#E5+(U?WIS0(  'P'   9              " @2+X  !X;"]W;W)K<VAE
M971S+W-H965T-#@N>&UL4$L! A0#%     @ ,(.54I[_,IL="   >BT  !D
M             ("!)OL  'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"
M% ,4    "  P@Y52SX'$(Q<#  !V"0  &0              @(%Z P$ >&PO
M=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( #"#E5*W$WTFZP(
M $L(   9              " @<@& 0!X;"]W;W)K<VAE971S+W-H965T-3$N
M>&UL4$L! A0#%     @ ,(.54E\DS\A !0  EA@  !D              ("!
MZ@D! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  P@Y52
MLO[B>0X$  #-#@  &0              @(%A#P$ >&PO=V]R:W-H965T<R]S
M:&5E=#4S+GAM;%!+ 0(4 Q0    ( #"#E5*K:\]T00,  !4+   9
M      " @:83 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%
M  @ ,(.54FLC#YPS P  +0H  !D              ("!'A<! 'AL+W=O<FMS
M:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    "  P@Y52O\1V%]4#  #W#P
M&0              @(&(&@$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+
M 0(4 Q0    ( #"#E5(]?RS[O@,  -P,   9              " @90> 0!X
M;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ ,(.54O0$_382
M P  Y0@  !D              ("!B2(! 'AL+W=O<FMS:&5E=',O<VAE970U
M."YX;6Q02P$"% ,4    "  P@Y52\#>:*6X#  #X"0  &0
M@('2)0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( #"#
ME5)F\T7X:@(  %T%   9              " @7<I 0!X;"]W;W)K<VAE971S
M+W-H965T-C N>&UL4$L! A0#%     @ ,(.54D,/D(@G P  #!,   T
M         ( !&"P! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  P@Y52EXJ[
M',     3 @  "P              @ %J+P$ 7W)E;',O+G)E;'-02P$"% ,4
M    "  P@Y52C9)II/ $   5*   #P              @ %3, $ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ ,(.54I@;6I[[ 0  RR,  !H
M     ( !<#4! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ ,(.54G32QF+> 0  6B,  !,              ( !HS<! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     $0 1 "3$@  LCD!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>152</ContextCount>
  <ElementCount>364</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>51</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF THE BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS</Role>
      <ShortName>DESCRIPTION OF THE BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2124106 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2130107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2136108 - Disclosure - CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/CONTINGENCIES</Role>
      <ShortName>CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2143110 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2150111 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2152112 - Disclosure - NET INCOME PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE</Role>
      <ShortName>NET INCOME PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2325304 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/LEASES</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2331305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2338306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2344307 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2353308 - Disclosure - NET INCOME PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables</Role>
      <ShortName>NET INCOME PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2417410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails</Role>
      <ShortName>BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2422413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails</Role>
      <ShortName>REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - LEASES - Lease Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails</Role>
      <ShortName>LEASES - Lease Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2427416 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails</Role>
      <ShortName>LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2428417 - Disclosure - LEASES - Credit Quality Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails</Role>
      <ShortName>LEASES - Credit Quality Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2429418 - Disclosure - LEASES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails</Role>
      <ShortName>LEASES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - Intangible Assets, Goodwill and Other (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails</Role>
      <ShortName>Intangible Assets, Goodwill and Other (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2435422 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2441425 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2442426 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2447429 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2448430 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2449431 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2451432 - Disclosure - INCOME TAXES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails</Role>
      <ShortName>INCOME TAXES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails</Role>
      <ShortName>NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="isrg-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails</Role>
      <ShortName>NET INCOME PER SHARE - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="isrg-20210331.htm">isrg-20210331.htm</File>
    <File>ex-311q121.htm</File>
    <File>ex-312q121.htm</File>
    <File>ex-31xamendedandrestatedce.htm</File>
    <File>ex-321q121.htm</File>
    <File>ex-322q121.htm</File>
    <File>isrg-20210331.xsd</File>
    <File>isrg-20210331_cal.xml</File>
    <File>isrg-20210331_def.xml</File>
    <File>isrg-20210331_lab.xml</File>
    <File>isrg-20210331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "isrg-20210331.htm": {
   "axisCustom": 2,
   "axisStandard": 16,
   "contextCount": 152,
   "dts": {
    "calculationLink": {
     "local": [
      "isrg-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "isrg-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "isrg-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "isrg-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "isrg-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "isrg-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 500,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 5
   },
   "keyCustom": 17,
   "keyStandard": 347,
   "memberCustom": 15,
   "memberStandard": 36,
   "nsprefix": "isrg",
   "nsuri": "http://www.intuitivesurgical.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.intuitivesurgical.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124106 - Disclosure - LEASES",
     "role": "http://www.intuitivesurgical.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130107 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136108 - Disclosure - CONTINGENCIES",
     "role": "http://www.intuitivesurgical.com/role/CONTINGENCIES",
     "shortName": "CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143110 - Disclosure - SHARE-BASED COMPENSATION",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150111 - Disclosure - INCOME TAXES",
     "role": "http://www.intuitivesurgical.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152112 - Disclosure - NET INCOME PER SHARE",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE",
     "shortName": "NET INCOME PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
     "shortName": "Condensed Consolidated Balance Sheets (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS (Tables)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325304 - Disclosure - LEASES (Tables)",
     "role": "http://www.intuitivesurgical.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331305 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338306 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344307 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353308 - Disclosure - NET INCOME PER SHARE (Tables)",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables",
     "shortName": "NET INCOME PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Summary of Cash and Available-For-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "isrg:CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407402 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Summary of Equity Investment Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i222e4ab4f50046478fb8626cd2050931_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Derivative Instruments Used to Hedge against Balance Sheet Foreign Currency Exposures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i3a170e992d9b457f9595e8e31c382067_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
     "shortName": "FINANCIAL INSTRUMENTS - Gross Notional Amounts for Outstanding Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i3a170e992d9b457f9595e8e31c382067_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Prepaids and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxesPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Accrued Liabilities - Short-term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TaxesPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Other Long-term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417410 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Revenue Disaggregated by Types and Geography (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ic20d6d2cffa74ad38d0883a8f21b0bb6_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422413 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Summary of Contract Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)",
     "role": "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails",
     "shortName": "REVENUE AND CONTRACT ACQUISITION COSTS - Sales-type and Operating Lease Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseLeaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "isrg:SalesTypeLeaseGrossInvestmentInLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - LEASES - Lease Receivables (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails",
     "shortName": "LEASES - Lease Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "isrg:LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "isrg:SalesTypeLeaseGrossInvestmentInLease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427416 - Disclosure - LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails",
     "shortName": "LEASES - Schedule of Contractual Maturities of Gross Lease Receivables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428417 - Disclosure - LEASES - Credit Quality Indicator (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails",
     "shortName": "LEASES - Credit Quality Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i3c76c59d0038424ab43ff393ceb37cad_I20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeaseTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429418 - Disclosure - LEASES - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails",
     "shortName": "LEASES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i3c76c59d0038424ab43ff393ceb37cad_I20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LessorSalesTypeLeaseTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "isrg:BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - Intangible Assets, Goodwill and Other (Details)",
     "role": "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails",
     "shortName": "Intangible Assets, Goodwill and Other (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Summary of Changes in Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434421 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435422 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)",
     "role": "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS - Schedule Of Estimated Future Amortization Expense Of Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Stockholders Equity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i545d4914e37e4c5497107f4880ab0f98_I20191231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i7ad02e4b971a44478eba65b1f3e5b707_D20200101-20200331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Share Repurchase Activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "icf9ca3e5cf134c18815b3626f97849e0_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441425 - Disclosure - STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Stock Repurchase Program (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i498b236f9cf74fd3aec70a88fa0cf0fb_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442426 - Disclosure - STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)",
     "role": "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Components of Accumulated Other Comprehensive Income, Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - SHARE-BASED COMPENSATION - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
     "shortName": "SHARE-BASED COMPENSATION - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i19647b4382894b77b728740dfcec06ae_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of Stock Option Activity Under All Stock Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "if1e8abbc9f904cd8a70381d22f05a4c7_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ic700f68e41144f91bd35e317ae4e9f00_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447429 - Disclosure - SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of RSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ic700f68e41144f91bd35e317ae4e9f00_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448430 - Disclosure - SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails",
     "shortName": "SHARE-BASED COMPENSATION - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i577e648a5a674003ad770f39fc13f19d_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449431 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)",
     "role": "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
     "shortName": "SHARE-BASED COMPENSATION - Schedule of Estimated Fair Value of Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "i577e648a5a674003ad770f39fc13f19d_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451432 - Disclosure - INCOME TAXES - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails",
     "shortName": "INCOME TAXES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails",
     "shortName": "NET INCOME PER SHARE - Computation of Basic and Diluted Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF THE BUSINESS",
     "role": "http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS",
     "shortName": "DESCRIPTION OF THE BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - NET INCOME PER SHARE - Additional Information (Details)",
     "role": "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails",
     "shortName": "NET INCOME PER SHARE - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION",
     "role": "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION",
     "shortName": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "isrg-20210331.htm",
      "contextRef": "ib71ef30fb24943e4ab2002bf990d318d_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 51,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "State or Other Jurisdiction of Incorporation or Organization"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "I.R.S. Employer Identification No."
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol(s)"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "isrg_A2010IncentiveAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2010 Incentive Award Plan",
        "label": "2010 Incentive Award Plan [Member]",
        "terseLabel": "2010 Incentive Award Plan"
       }
      }
     },
     "localname": "A2010IncentiveAwardPlanMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_AccelerateShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerate Share Repurchase Program [Member]",
        "label": "Accelerate Share Repurchase Program [Member]",
        "terseLabel": "ASR Program"
       }
      }
     },
     "localname": "AccelerateShareRepurchaseProgramMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Available-For-Sale Securities Adjustment, Net of Tax [Abstract]",
        "label": "Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax [Abstract]",
        "terseLabel": "Unrealized Gains (Losses)\u00a0on Available-for-Sale Securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTaxAbstract",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax [Abstract]",
        "label": "Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax [Abstract]",
        "terseLabel": "Gains\u00a0(Losses) on\u00a0Hedge Instruments"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTaxAbstract",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_AccumulatedOtherComprehensiveIncomeRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Roll Forward]",
        "label": "Accumulated Other Comprehensive Income [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeRollForward",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available For Sale Securities Debt Maturities Fair Value Total",
        "label": "Available For Sale Securities Debt Maturities Fair Value Total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Present Value of Future Cash Payments",
        "label": "Business Combination, Consideration Transferred, Present Value of Future Cash Payments",
        "terseLabel": "Deferred payments and contingent consideration related to business combinations"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPresentValueofFutureCashPayments",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails",
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Expense",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Expense",
        "terseLabel": "Net additional expense"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationExpense",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Change in Undiscounted Expected Outcome",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Undiscounted Expected Outcome",
        "terseLabel": "Decrease in undiscounted expected contingent liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInUndiscountedExpectedOutcome",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration Arrangements, Undiscounted Expected Outcome",
        "label": "Business Combination, Contingent Consideration Arrangements, Undiscounted Expected Outcome",
        "terseLabel": "Estimated total undiscounted contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsUndiscountedExpectedOutcome",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets",
        "terseLabel": "Net tangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedNetTangibleAssets",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost",
        "label": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Total assets measured at fair value, Amortized Cost"
       }
      }
     },
     "localname": "CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": 3.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value",
        "label": "Cash and Cash Equivalents and Debt Securities, Available-for-sale, Fair Value",
        "totalLabel": "Total assets measured at fair value, Fair Value"
       }
      }
     },
     "localname": "CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_ChindexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chindex [Member]",
        "label": "Chindex [Member]",
        "terseLabel": "Chindex"
       }
      }
     },
     "localname": "ChindexMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CollarContractMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collar Contract",
        "label": "Collar Contract [Member]",
        "terseLabel": "Collar Contract"
       }
      }
     },
     "localname": "CollarContractMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CommonStockRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Repurchase Program [Member]",
        "label": "Common Stock Repurchase Program [Member]",
        "terseLabel": "Repurchase Program"
       }
      }
     },
     "localname": "CommonStockRepurchaseProgramMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ConsolidatingReportingAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidating Reporting [Axis]",
        "label": "Consolidating Reporting [Axis]",
        "terseLabel": "Consolidating Reporting [Axis]"
       }
      }
     },
     "localname": "ConsolidatingReportingAxis",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_ConsolidatingReportingDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consolidating Reporting [Domain]",
        "label": "Consolidating Reporting [Domain]",
        "terseLabel": "Consolidating Reporting [Domain]"
       }
      }
     },
     "localname": "ConsolidatingReportingDomain",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CostOfSalesProductMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Sales Product [Member]",
        "label": "Cost Of Sales Product [Member]",
        "terseLabel": "Cost of sales - products"
       }
      }
     },
     "localname": "CostOfSalesProductMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CostOfSalesServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Sales Service [Member]",
        "label": "Cost Of Sales Service [Member]",
        "terseLabel": "Cost of sales - services"
       }
      }
     },
     "localname": "CostOfSalesServiceMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption, Adjustment",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative Effect, Period of Adoption",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_DeferredPurchaseConsiderationPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Purchase Consideration Payments",
        "label": "Deferred Purchase Consideration Payments",
        "terseLabel": "Deferred cash payments"
       }
      }
     },
     "localname": "DeferredPurchaseConsiderationPayments",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_DeferredPurchaseConsiderationPaymentsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Purchase Consideration Payments, Current",
        "label": "Deferred Purchase Consideration Payments, Current",
        "terseLabel": "Current portion of deferred purchase consideration payments"
       }
      }
     },
     "localname": "DeferredPurchaseConsiderationPaymentsCurrent",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Sales, Purchases and Other Adjustments",
        "label": "Equity Securities, FV-NI, Sales, Purchases and Other Adjustments",
        "terseLabel": "Sales/Purchases/Others"
       }
      }
     },
     "localname": "EquitySecuritiesFVNISalesPurchasesAndOtherAdjustments",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments",
        "label": "Equity Securities without Readily Determinable Fair Value, Sales, Purchases and Other Adjustments",
        "terseLabel": "Sales/Purchases/Others"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueSalesPurchasesAndOtherAdjustments",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)",
        "label": "Equity Securities without Readily Determinable Fair Value, Unrealized Gain (Loss)",
        "terseLabel": "Changes in Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUnrealizedGainLoss",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Amortization Expense, after Year Four",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Four",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_GoldmanSachsCo.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goldman, Sachs &amp; Co. [Member]",
        "label": "Goldman, Sachs &amp; Co. [Member]",
        "terseLabel": "Goldman"
       }
      }
     },
     "localname": "GoldmanSachsCo.Member",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_HighMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "High",
        "label": "High [Member]",
        "terseLabel": "High"
       }
      }
     },
     "localname": "HighMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_InstrumentsandAccessoriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments and Accessories [Member]",
        "label": "Instruments and Accessories [Member]",
        "terseLabel": "Instruments and accessories"
       }
      }
     },
     "localname": "InstrumentsandAccessoriesMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_IntangibleAndOtherAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges and other non-current assets.",
        "label": "Intangible And Other Assets",
        "terseLabel": "Intangible and other assets, net"
       }
      }
     },
     "localname": "IntangibleAndOtherAssets",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_IntangibleAndOtherAssetsNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible and Other Assets, Net",
        "label": "Intangible and Other Assets, Net [Member]",
        "terseLabel": "Intangible and other assets, net"
       }
      }
     },
     "localname": "IntangibleAndOtherAssetsNetMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_LessorSalesTypeLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessor, Sales-type Lease, Lease Income",
        "label": "Lessor, Sales-type Lease, Lease Income [Table Text Block]",
        "terseLabel": "Schedule of Lease Receivables"
       }
      }
     },
     "localname": "LessorSalesTypeLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "isrg_LowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Low",
        "label": "Low [Member]",
        "terseLabel": "Low"
       }
      }
     },
     "localname": "LowMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ManufacturingProcessTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Manufacturing Process Technology",
        "label": "Manufacturing Process Technology [Member]",
        "terseLabel": "Manufacturing process technology"
       }
      }
     },
     "localname": "ManufacturingProcessTechnologyMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ModerateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Moderate",
        "label": "Moderate [Member]",
        "terseLabel": "Moderate"
       }
      }
     },
     "localname": "ModerateMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Before Reclassification Adjustments, Net of Tax",
        "label": "Other Comprehensive Income Loss Before Reclassification Adjustments Net Of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development [Member]",
        "label": "Research And Development [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Year Five and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedYearFiveAndThereafter",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SalesTypeLeaseGrossInvestmentInLease": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type Lease, Gross Investment in Lease",
        "label": "Sales-type Lease, Gross Investment in Lease",
        "terseLabel": "Gross lease receivables"
       }
      }
     },
     "localname": "SalesTypeLeaseGrossInvestmentInLease",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SalesTypeLeaseNetInvestmentInLeaseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type Lease, Net Investment in Lease, Current",
        "label": "Sales-type Lease, Net Investment in Lease, Current",
        "verboseLabel": "Net investment in sales-type leases \u2013 short-term"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseCurrent",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SalestypeLeaseDeferredSellingProfit": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-type Lease, Deferred Selling Profit",
        "label": "Sales-type Lease, Deferred Selling Profit",
        "negatedLabel": "Unearned income"
       }
      }
     },
     "localname": "SalestypeLeaseDeferredSellingProfit",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SchllyFiberopticGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sch\u00f6lly Fiberoptic GmbH [Member]",
        "label": "Sch\u00f6lly Fiberoptic GmbH [Member]",
        "terseLabel": "Sch\u00f6lly"
       }
      }
     },
     "localname": "SchllyFiberopticGmbHMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_SellingGeneralAndAdministrativeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs related to selling, general and administrative activities.",
        "label": "Selling General And Administrative [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Services [Member]",
        "label": "Services [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServicesMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "isrg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted\u00a0Average Exercise\u00a0Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "isrg_StockRepurchaseProgramincreasedtoauthorizedamount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increased to authorized shares repurchase amount for Stock Repurchase Program",
        "label": "Stock Repurchase Program, increased to authorized amount",
        "terseLabel": "Stock repurchase program, increased to authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramincreasedtoauthorizedamount",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "isrg_SystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Systems [Member]",
        "label": "Systems [Member]",
        "terseLabel": "Systems"
       }
      }
     },
     "localname": "SystemsMember",
     "nsuri": "http://www.intuitivesurgical.com/20210331",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r52",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r128",
      "r233",
      "r236",
      "r398",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "auth_ref": [
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.",
        "label": "Accelerated Share Repurchases, Final Price Paid Per Share",
        "terseLabel": "Final average price per share paid (in dollars per share)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r2",
      "r20",
      "r129",
      "r130",
      "r234"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Loss (gain) on investments, accretion, and amortization, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r17",
      "r377",
      "r389"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes\u2014long-term"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r55",
      "r60",
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r58",
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53",
      "r60",
      "r61",
      "r62",
      "r351",
      "r356",
      "r361"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r60",
      "r61",
      "r62"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r59",
      "r62",
      "r66",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "BALANCE SHEET DETAILS AND OTHER FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld related to net share settlement of equity awards"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r242",
      "r244",
      "r271",
      "r272"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense related to employee stock plans"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r244",
      "r267",
      "r270"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense before income taxes"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Share-based compensation expense after income taxes"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r94",
      "r187",
      "r194"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Employee stock options excluded from computation of diluted net income per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r126",
      "r376",
      "r388"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r51"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r138"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": 1.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails_1": {
       "order": 2.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r135",
      "r166"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost",
        "terseLabel": "Mature in one to five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r140",
      "r143",
      "r386"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value",
        "terseLabel": "Mature in one to five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost",
        "terseLabel": "Mature in less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r140",
      "r142",
      "r385"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "isrg_AvailableForSaleSecuritiesDebtMaturitiesFairValueTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value",
        "terseLabel": "Mature in less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r133",
      "r136",
      "r166"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Available-for-sale Securities [Table Text Block]",
        "terseLabel": "Summary of Cash and Available-For-Sale Securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r246",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]",
        "verboseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r329",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r301",
      "r302",
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": {
     "auth_ref": [
      "r300",
      "r303"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Current",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Current"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r295",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r97",
      "r98",
      "r99"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Acquisition of property, plant, and equipment in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Capital Leased Assets [Line Items]",
        "terseLabel": "Capital Leased Assets [Line Items]"
       }
      }
     },
     "localname": "CapitalLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for lessor's leasing arrangements, which includes direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
        "label": "Capital Leases in Financial Statements of Lessor Disclosure [Text Block]",
        "terseLabel": "Schedule of Lease Receivables"
       }
      }
     },
     "localname": "CapitalLeasesInFinancialStatementsOfLessorDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r179"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of contract acquisition assets"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNet": {
     "auth_ref": [
      "r178"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Net",
        "terseLabel": "Costs capitalized as contract acquisition costs"
       }
      }
     },
     "localname": "CapitalizedContractCostNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r0",
      "r35",
      "r96"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "isrg_CashandCashEquivalentsandDebtSecuritiesAvailableforsaleFairValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r91",
      "r96",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r91",
      "r355"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r45",
      "r203",
      "r381",
      "r394"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Contingencies (Note 8)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r202",
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, 300.0 shares authorized, $0.001 par value, 117.0 shares and 116.0 shares issued and outstanding as of March 31, 2021, and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r69",
      "r71",
      "r72"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive income attributable to Intuitive Surgical, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r71",
      "r308",
      "r318"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r101",
      "r102",
      "r310",
      "r319",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Consolidation and Joint Ventures"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contract balances and changes in contract balances.",
        "label": "Contract with Customer, Asset and Liability [Table Text Block]",
        "terseLabel": "Summary of Contract Assets and Liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r225",
      "r227",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract assets"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r225",
      "r226",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSummaryofContractAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r235"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r238",
      "r241",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Cost of revenue:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Total cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CumulativeTranslationAdjustmentSummaryRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Cumulative Translation Adjustment Summary [Roll Forward]",
        "terseLabel": "Foreign Currency Translation Gains\u00a0(Losses)"
       }
      }
     },
     "localname": "CumulativeTranslationAdjustmentSummaryRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r137",
      "r166",
      "r169",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Allowance for Credit Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Prepaids and Other Current Assets"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r286"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r94",
      "r103",
      "r287",
      "r289"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue\u2014long-term"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r94",
      "r198"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and loss on disposal of property, plant, and equipment"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Recognized gains/(losses) in Interest and other income, net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r330",
      "r332",
      "r336",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r323",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amounts of outstanding currency forward contracts"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Designated as Hedging Instruments"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Revenue Disaggregated by Types and Geography"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution rights and others"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to Intuitive Surgical, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r75",
      "r111",
      "r114",
      "r115",
      "r116",
      "r117",
      "r120",
      "r383",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income per share attributable to Intuitive Surgical, Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r75",
      "r111",
      "r114",
      "r115",
      "r116",
      "r117",
      "r120",
      "r383",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r107",
      "r279",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Income tax expense, percentage of pre-tax income"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r273",
      "r279"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Excess tax benefits associated with employee equity plans"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "auth_ref": [
      "r273",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent",
        "terseLabel": "excess tax benefits associated with employee equity plans (in percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and employee benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r267"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "verboseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r350"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "periodEndLabel": "Equity investments with readily determinable value beginning balance, Carrying Value",
        "periodStartLabel": "Equity investments with readily determinable value beginning balance, Carrying Value",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Changes in Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "periodEndLabel": "Equity investments without readily determinable value, Carrying Value",
        "periodStartLabel": "Equity investments without readily determinable value, Carrying Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r238",
      "r239",
      "r241",
      "r347",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r238",
      "r239",
      "r241",
      "r347",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r238",
      "r239",
      "r241",
      "r347",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r153",
      "r156",
      "r157",
      "r158",
      "r159",
      "r167",
      "r168",
      "r171",
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.",
        "label": "Financial Instruments Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancingReceivableCreditQualityIndicatorsTableTextBlock": {
     "auth_ref": [
      "r131",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financing receivables by credit quality indicator. The credit quality indicator is a statistic about the credit quality of financing receivables. Examples include, but not limited to, consumer credit risk scores, credit-rating-agency ratings, an entity's internal credit risk grades, loan-to-value ratios, collateral, collection experience and other internal metrics.",
        "label": "Financing Receivable Credit Quality Indicators [Table Text Block]",
        "terseLabel": "Amortized Cost Basis by Year of Origination and Credit Quality Indicator"
       }
      }
     },
     "localname": "FinancingReceivableCreditQualityIndicatorsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r188",
      "r191",
      "r193",
      "r196",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r193",
      "r375"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Patents and developed technology"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails",
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleOfEstimatedFutureAmortizationExpenseOfIntangibleAssetsDetails",
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived Intangible Assets Acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Swiss"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r352",
      "r353",
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign exchange gains/(losses) related to balance sheet re-measurement"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r238",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Non-U.S. government securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionAxis": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographic distribution of business activity identified as either domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Axis]",
        "terseLabel": "Geographic Distribution [Axis]"
       }
      }
     },
     "localname": "GeographicDistributionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeographicDistributionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic or foreign. Excludes names of countries, states and provinces, and cities.",
        "label": "Geographic Distribution [Domain]",
        "terseLabel": "Geographic Distribution [Domain]"
       }
      }
     },
     "localname": "GeographicDistributionDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionDomesticMember": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as domestic.",
        "label": "Geographic Distribution, Domestic [Member]",
        "terseLabel": "U.S."
       }
      }
     },
     "localname": "GeographicDistributionDomesticMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicDistributionForeignMember": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocation of business activity identified as foreign.",
        "label": "Geographic Distribution, Foreign [Member]",
        "terseLabel": "Outside of U.S. (\u201cOUS\u201d)"
       }
      }
     },
     "localname": "GeographicDistributionForeignMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r180",
      "r181"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending Balance",
        "periodStartLabel": "Goodwill, Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails",
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r182"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisition activity"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r183",
      "r184",
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Translation and other"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofSummaryofChangesinGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r326",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r282",
      "r284",
      "r285",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r125",
      "r290"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense",
        "verboseLabel": "Income tax expense (benefit)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r278",
      "r279",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Re-measurement of deferred tax assets"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and employee benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effects of acquisition:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaids and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentAxis": {
     "auth_ref": [
      "r131",
      "r159",
      "r164",
      "r165",
      "r206",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by entity-defined rating.",
        "label": "Internal Credit Assessment [Axis]",
        "terseLabel": "Internal Credit Assessment [Axis]"
       }
      }
     },
     "localname": "InternalCreditAssessmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity defined credit risk rating.",
        "label": "Internal Credit Assessment [Domain]",
        "terseLabel": "Internal Credit Assessment [Domain]"
       }
      }
     },
     "localname": "InternalCreditAssessmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r27",
      "r175"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r1",
      "r50",
      "r174"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r175"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r28",
      "r175"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]",
        "terseLabel": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Summary of Contractual Maturities of Cash Equivalents and Available-For-Sale Investments"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LessorSalesTypeLeaseTermOfContract1": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessor's sales-type lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessor, Sales-type Lease, Term of Contract",
        "terseLabel": "Sales-type leases terms"
       }
      }
     },
     "localname": "LessorSalesTypeLeaseTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LessorSalesTypeLeasesTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of lessor's sales-type leases.",
        "label": "Lessor, Sales-type Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LessorSalesTypeLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r25",
      "r379",
      "r392"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated carrying amounts of obligations as of the balance sheet date, excluding long-term debt, incurred as part of the normal operations that are expected to be paid after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Credits and Other Liabilities.",
        "label": "Liabilities, Other than Long-term Debt, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesOtherThanLongtermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserveCurrent": {
     "auth_ref": [
      "r45",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.",
        "label": "Estimated Litigation Liability, Current",
        "terseLabel": "Litigation related accruals"
       }
      }
     },
     "localname": "LitigationReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r3",
      "r41"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short- term Investments",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long- term Investments",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r49",
      "r378",
      "r391"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest in joint venture"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Notes [Member]",
        "terseLabel": "Municipal securities"
       }
      }
     },
     "localname": "MunicipalNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r123",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF THE BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/DESCRIPTIONOFTHEBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r91",
      "r92",
      "r95"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r67",
      "r70",
      "r74",
      "r95",
      "r119",
      "r382",
      "r395"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Intuitive Surgical, Inc.",
        "totalLabel": "Net income attributable to Intuitive Surgical, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r67",
      "r70",
      "r312",
      "r317"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: net loss attributable to noncontrolling interest in joint venture",
        "verboseLabel": "Net income attributable to noncontrolling interest in joint venture"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete provisions"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest in Joint Venture"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "auth_ref": [
      "r122",
      "r365",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.",
        "label": "Operating Lease, Lease Income",
        "terseLabel": "Operating lease revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r122",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from operating lease.",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "terseLabel": "Operating Lease Revenue"
       }
      }
     },
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r42"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesOtherThanLongtermDebtNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherLongtermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r58",
      "r60",
      "r308",
      "r314"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r54",
      "r60",
      "r356",
      "r357",
      "r360",
      "r361"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r56",
      "r57"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities and unrealized holding gain (loss) related to transfers of securities into the available-for-sale classification and out of the held-to-maturity classification.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r56",
      "r57",
      "r60"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r53",
      "r358"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r64",
      "r65",
      "r359"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r68",
      "r71",
      "r73",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r68",
      "r71",
      "r308",
      "r309",
      "r314"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: comprehensive income attributable to noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r68",
      "r71",
      "r308",
      "r309",
      "r314"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Net current-period other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r58",
      "r60"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r65",
      "r149"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r65",
      "r327"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r65",
      "r240"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r55",
      "r60",
      "r345"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Accrued Liabilities - Short-term"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSDerivativeInstrumentsUsedtoHedgeagainstBalanceSheetForeignCurrencyExposuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r42"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Total other accrued liabilities\u2014short-term"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesMember": {
     "auth_ref": [
      "r329",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other liabilities.",
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental non-cash investing activities:"
       }
      }
     },
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Intangible and other assets, net"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Long-term Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r4",
      "r7"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other prepaids and other current assets"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Intuitive Surgical, Inc. Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "terseLabel": "Payment of contingent liability"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r83",
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisition of businesses, net of cash"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "negatedLabel": "Purchase of property, plant, and equipment and intellectual property"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r246",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; no shares issued and outstanding as of March 31, 2021, and December 31, 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r6",
      "r33",
      "r34"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaids and other current assets",
        "totalLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSGrossNotionalAmountsforOutstandingDerivativesDetails",
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r5",
      "r7",
      "r176",
      "r177"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONPrepaidsandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r80",
      "r81",
      "r134"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Capital contribution from noncontrolling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r86",
      "r89",
      "r109"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Payment of deferred purchase consideration"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r82",
      "r134"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities",
        "terseLabel": "Proceeds from Sale of Investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock relating to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r67",
      "r70",
      "r90",
      "r126",
      "r127",
      "r308",
      "r311",
      "r313",
      "r317",
      "r318"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r15",
      "r16",
      "r199",
      "r393"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": {
     "auth_ref": [
      "r200"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Transfers and Changes",
        "terseLabel": "Equipment transfers, including operating lease assets, from inventory to property, plant, and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTransfersAndChanges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net realized gains or losses on investments during the period, not including gains or losses on securities separately or otherwise categorized as trading, available-for-sale, or held-to-maturity.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Realized Investment Gains (Losses)"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofContractualMaturitiesofCashEquivalentsandAvailableForSaleInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r62",
      "r66",
      "r73"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Amounts reclassified from accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r275",
      "r401"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r22",
      "r218",
      "r390"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r232",
      "r233"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSRevenueDisaggregatedbyTypesandGeographyDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE AND CONTRACT ACQUISITION COSTS"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of when remaining performance obligation is expected to be recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Explanation",
        "terseLabel": "Timing of performance obligation"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligations"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Gross Lease Receivables"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Four Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in the next fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in remainder of the fiscal year following latest fiscal year. Excludes interim and annual period when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Three Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r366"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received, Two Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESScheduleofContractualMaturitiesofGrossLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseIncome": {
     "auth_ref": [
      "r122",
      "r365",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease income from variable lease payments, interest income from net investment on sales-type lease, and profit (loss) recognized at commencement.",
        "label": "Sales-type Lease, Lease Income",
        "terseLabel": "Sales-type lease revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSSalestypeandOperatingLeaseRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock": {
     "auth_ref": [
      "r122",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of income from sales-type lease.",
        "label": "Sales-type Lease, Lease Income [Table Text Block]",
        "terseLabel": "Sales-type Lease Revenue"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/REVENUEANDCONTRACTACQUISITIONCOSTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SalesTypeLeaseLeaseReceivable": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type lease.",
        "label": "Sales-type Lease, Lease Receivable",
        "terseLabel": "Gross lease receivables"
       }
      }
     },
     "localname": "SalesTypeLeaseLeaseReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLease": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease.",
        "label": "Sales-type Lease, Net Investment in Lease",
        "totalLabel": "Net Investment"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails",
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss": {
     "auth_ref": [
      "r152",
      "r154",
      "r155"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on net investment in sales-type lease.",
        "label": "Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]",
        "terseLabel": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Line Items]"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about credit quality indicator for net investment in sales-type lease.",
        "label": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]",
        "terseLabel": "Sales-type Lease, Net Investment in Lease, Credit Quality Indicator [Table]"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseCreditQualityIndicatorTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated five or more years prior to latest fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated Five or More Years before Latest Fiscal Year",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFiveOrMoreYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated four years prior to latest fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated Four Years before Latest Fiscal Year",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedFourYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated in current fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated in Current Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInCurrentFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated in fiscal year prior to latest fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated in Fiscal Year before Latest Fiscal Year",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedInFiscalYearBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated three years prior to latest fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated Three Years before Latest Fiscal Year",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedThreeYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SalesTypeLeaseNetInvestmentInLease",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net investment in sales-type lease originated two years prior to latest fiscal year.",
        "label": "Sales-type Lease, Net Investment in Lease, Originated Two Years before Latest Fiscal Year",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "SalesTypeLeaseNetInvestmentInLeaseOriginatedTwoYearsBeforeLatestFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESCreditQualityIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Income, Net of Tax"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r141",
      "r144",
      "r145",
      "r146",
      "r147",
      "r148",
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/IntangibleAssetsGoodwillandOtherDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalLeasedAsssetsTable": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Capital Leased Assets [Table]",
        "terseLabel": "Schedule of Capital Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfCapitalLeasedAsssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/LEASESLeaseReceivablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Share-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r108",
      "r322",
      "r324",
      "r325",
      "r326",
      "r328",
      "r334",
      "r336",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Gross Notional Amounts for Derivatives and Aggregate Gross Fair Value Outstanding"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Net Income Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r244",
      "r266",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Summary of Changes in Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r13",
      "r30",
      "r31",
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventory Details"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r335",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Derivatives Not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r246",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r248",
      "r260",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity Under All Stock Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r46",
      "r105",
      "r208",
      "r209",
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stockholders Equity"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "terseLabel": "Debt and Equity Securities, FV-NI [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table]"
       }
      }
     },
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofEquityInvestmentActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchase Activities"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule Of Estimated Future Amortization Expense Of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78",
      "r173"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)",
        "terseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested ending balance (in shares)",
        "periodStartLabel": "Unvested beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested ending balance (usd per share)",
        "periodStartLabel": "Unvested beginning balance (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Common stock reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable, number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable, weighted-average exercise price (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Options forfeited/expired, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value at grant date (usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "auth_ref": [
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Estimated Fair Value of the Option Using Black-Scholes Option Pricing Model, Weighted Average Assumptions"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r250",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance, Number Outstanding",
        "periodStartLabel": "Beginning balance, Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance, Weighted Average Exercise Price Per Share",
        "periodStartLabel": "Beginning balance, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r243",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails",
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited/expired, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted, Weighted Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r263",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld related to net share settlement of equity awards",
        "terseLabel": "Shares withheld related to net share settlement of equity awards"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYComponentsofAccumulatedOtherComprehensiveIncomeNetofTaxDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r48",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee Stock Purchase Plan, number of shares purchased by employees"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock through employee stock plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised, Number Outstanding"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONSummaryofStockOptionActivityUnderAllStockPlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee Stock Purchase Plan, value of shares purchased by employees"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r18",
      "r19",
      "r218",
      "r245",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock through employee stock plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/SHAREBASEDCOMPENSATIONScheduleofEstimatedFairValueofOptionUsingBlackScholesOptionPricingModelWeightedAverageAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Amount of share repurchases authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining amount of share repurchases authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase and retirement of common stock (in shares)",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase and retirement of common stock",
        "terseLabel": "Value of shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r18",
      "r19",
      "r211",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYStockRepurchaseProgramDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r23",
      "r24",
      "r132"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Intuitive Surgical, Inc. stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r306",
      "r307",
      "r316"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedBalanceSheetsUnaudited",
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofStockholdersEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": {
     "auth_ref": [
      "r276",
      "r277"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.",
        "label": "Tax Adjustments, Settlements, and Unusual Provisions",
        "terseLabel": "Increase in income tax expense"
       }
      }
     },
     "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/BALANCESHEETDETAILSANDOTHERFINANCIALINFORMATIONOtherAccruedLiabilitiesShorttermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology-Based Intangible Assets [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/GOODWILLANDINTANGIBLEASSETSScheduleofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Summary of Equity Investment Activity"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price per share (in dollars per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/STOCKHOLDERSEQUITYScheduleofShareRepurchaseActivitiesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r238",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government agencies"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r238",
      "r241",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/FINANCIALINSTRUMENTSSummaryofCashandAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities",
        "terseLabel": "Increase in unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/INCOMETAXESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Add: dilutive effect of potential common shares"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r113",
      "r117"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares outstanding used in diluted calculation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Shares used in computing net income per share attributable to Intuitive Surgical, Inc.:",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r112",
      "r117"
     ],
     "calculation": {
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding used in basic calculation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.intuitivesurgical.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeUnaudited",
      "http://www.intuitivesurgical.com/role/NETINCOMEPERSHAREComputationofBasicandDilutedNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(d),(e))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=118952077&loc=SL77927221-108306"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=SL6953659-111524"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27337-111563"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117546-209714"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919244-210447"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919253-210447"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919258-210447"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919230-210447"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919232-210447"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921835-210448"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82921842-210448"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955255&loc=SL82922352-210448"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922888-210455"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922895-210455"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955579&loc=SL82922900-210455"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942371&loc=SL82922954-210456"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5865-108316"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=116646759&loc=d3e15243-108350"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12069-110248"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130533-203044"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=117330312&loc=d3e23163-113944"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28511-109314"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28446-109314"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5227-128473"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-02)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-03)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3A-04)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355119-122828"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708775-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32157-110900"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b,c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=84164817&loc=d3e45280-112737"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/subtopic&trid=2209026"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=77888421&loc=SL77919311-209978"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919391-209981"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919359-209981"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919372-209981"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=119202524&loc=SL77919379-209981"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888252"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6)(a)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62557-112803"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r402": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r403": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r404": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r405": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r406": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r407": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e709-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6787-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0001035267-21-000067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001035267-21-000067-xbrl.zip
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M3(O/!#J#4RI?Z2O&BZ3!RHYF&79'3P08-DEDE#!;T(]%_PD8J :A %)I%4H
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MO.[63=X[[C!EF)QTRNXR,]%2C&2]G,-JYH2!"YE!0D8/7&6,9U-69-X6$B-
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M7, 50Z>$XE;1 %2I%D*RR*BEPE$&#VO5A70?J-0X"8<\J)LJY1"I*BHTIPR
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M#R^W&H"C\X_;# %<N%L.P.7TU='Y=$.-/O+L\DVIMAZLZ[H18+U&* M*<)9
MX]HW%GW5?W[5NK\;],T?N2^)7-G4E_A-)'4;SC+W^/YQY+_GX!G.7\S,0788
M>]3MQ!?2>78B>/CZY?9ETL.#R^U[JT)4MW:1I)P8*/?>9-5SCO]%A<R0N*6^
MJ_*5ZZ/ZM[J'LS>"A_\ 4$L#!!0    ( #"#E5*0BIK(T 0  (H4   .
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M^*.'AYV>M'.7#^NA8^$1/H>CXQSEH#]<>=?O^9$;[O3W0O]S[L+::0Z .\D
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MI(12)A"/J<'T)_,GST #9N]/HK<R8(IU6COFP9]09X4QREIP*S'^)/YD:F'
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M2T,]<%P60(U<%,A28K6C$+V4J23KG(ES)JB $.$8L(!215D,Q @L:#3:1 9
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MN3=FPF.CO*3#XX\3HCM]*^WDWK?#2TMZ=B48QX2BZ.H_1P-HV*"<B><7)11
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M\+^N/$J<MQEOJ9%E^N/6E2I/595%JG:1L@EI ,WUN@4E*:9K6=,&#0]IV".
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M'_+JJ#93MW[/5__O)[WB]5?KI[O.U;O]GI^N='O=-WWCBL*&HVX^W$W)AM'
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M!"6HZV5,*.AERB""Y&!D,. )#=FK3'4H+4&9VB1+'T&JP=[E4>D5N?>#W*F
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MTAF@45"7#)'9H;S!J5DJRZHZ2I9=WU2D+@:IT[HHE@>5G8Q A.(@2EU#JZB
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MM;_(GLDWFI+';JA\^YM\(#G[B >:AKUPC.;;J%GBI-?&$XN?/;!7+'=[IVZ
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M[J(*/J6 6V\@((P.8%V2X*V6S$6GM'8%Q4*(3;Y$*%[DF3HIESD,?C#T@^[
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M.1EI H]2 Y<L@>!2@654@PF!V*PMLW$IS=BGU*/D1;=WUNVY04+D^$&K/X%
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M(7DJJ$^)VM(%R!([?_RRHK^B?V'HK^D+<Q# -'U!.:6]HQXB3A&(D@MH,TV
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M-B!TLF@_*]*X]9PR*CKOBOUL%]:UKT)VC2%;@]SW8A_/!+EQGK)E2N N&]%
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M;]EA+ :G >__H]WSQ\]SU6C'_WPX/_@<3F#4Y$&C?;S?^0#O^/3M8&OS.ZP
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M@-[Y/,LG%B;V%5S217.\NZ#MA5@0N.&?UQ/XUFM3@PJW'X[Z"_^?#*JS@XE
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M'G%.*3(@ "@F#* ;500]!@46SRDD;J4V+6X\%:^V)!XE.FZS'/DI*E:%.7?
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M-AYM4O 0CPX^[XJ]=]M\M]$\SK_5.]O@)?[1O.(E;KUM[S?>MG8;?W9VMP[
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M,.E'F.2)\XGC9+577 MC+<ARDDGX0"VCU7G5$F+2Q,\6+F&-C4$F:?"S,6<
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M.P\?I0ZL[&3>!Z2=S.UD"HL9950@'JU!W!N#3/(&46*ETC@:S^3&-N=;Y*:
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M'<S[@<?9#B:F.HCD'!)>4L29\\AB@$<B@PW<6V)=/AW+BZE=\+'@X\I-[3L
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M4.=ERB?\B%Y9BII2AN*F+ I<12^4Q$\^B=_]H%(+WG_P-7:^Q+W::"V =!5
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M@-QX[\5G0/OWM/7BZ/,>_>?3_KM69__WM_QLD&WK^WMH]_7)A^[?W;WOG2-
M_*_[!X??6I_>X_W?7W__\ [:HV_YAX.CM ]29?_U1YZT4BD$1&WM"1 869UR
M>1,LC3":,2$;\0WT&\-.CH?'AB8!8.X%39P+X[226*;H= B!T70V*/?Y?NM@
M%R1;Z_GNRS?GCWF=B<D^?PCFY^];[)]1E.,4(]@5D0>-'694PV^862>8$P\W
M3/A5!EF V!I3\[^;=5@\$#ITYB2C>+OWI=\!A2A#H:V^V$$[CDXR</F.;7<!
MK3KVZW#<SK@%MV:\/K03Y,TX=CSH@TC. F,X*=D&H@/>-8R IP#1,)3<P&:^
M,8S]J.JTK6MWVJ.3W-XH=CJQD1QP'="[^1K8S/8\]#4O4]84JAP)/*[1.':/
M._V3S*/S0 HR! SMX5;U'-JP[1IYX0)(G&GWZYN;,55V$$%/'/I!VS4#3^-!
MW4R(\'"G<K'3_[I5[8[R!/7ZH^JX/QS6$ XC PD9VM"EKT=V5$]F?SSR_6Z<
MO7+2F>IKNY/;VIPZ:$ZGW=M>;O5P;&&<HYB/*4!;^<H@UD<+,R5/GH:O;#X9
M4,%7\!K@ =^VG4Z^U0Y!/M:]BH.\4FT0NM!,I[-UR?CL]:;=G1FMU#,X#60'
MZ3PXK)<BVD&OIKR\H(,<=!R:]<R3#<H^$!',5?5F!,\U\CN?"^G$0_C2SZ,[
M+&9LG@*,'^95A\O#-FB1L29Q5T_S=!D;526OXF1]FG4XF6DS6U76I;*\'P[S
MBW.+@XCB%]L9UV/(:YK5AMQ0YIBIX@)O@%N='38+#FM9V2] DO7[V[WFA!%0
M1^82WQG7BEKN4M91@":!!'OQL#]J3UD4%(Y1IQG[9C48=_)L 3V&+VU?$^QT
M+L:@G'7F&6KN7?6WC::2^YG9:\+D]2@\='8+UCPKS4>@!@TS)=8CGG%-3=XS
MC6YR7&'Z\N&H/E\P'<]"GS^-P^'D8W,[P/2""C6EBA!3K6'6S?TK#ZD3JB/[
M!98A,R3,;U9/ _02;@(;(N;IZLVSY?_W7YH2]2M,_W@(Q)C'D4YI:'KXMWGU
M9 # K>-.HQ5F\&HF_6;,=T]ZUU\3=/[SE./^;$^1_E& R<&BU&N4_1'P;-8
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M+<G=?ODXN37>-2R\NP*;L_#NW?'N7N.Z O[=^6B,C4%)@1QP*N*!)N2HD\B
M[DEE4BDF7)CWH3'O50(=D^%$&*^U==P1H;G(08]UD;T<%7=E,["P[*VP[-XI
MRS(5.1A_$G'J0>@ZCY%QBF=KT6E+C3,D+,\Y\'@B=1XGV][Q,9,B<^^2@=^>
M,G!0-@KO(@HI!L0-HTC3?- D1)H+^_E$7"USS[MW[D7FEE"7<N>#N/-IA[KT
M%LJ1P%U-/1+X4'WJPV_5E]@;C0>QA+Z4-AYT&X]SZZYDG7H0RW2?IO7"#FNI
M1;5R-7UWP<Y.7J=H#4:"IHBX5A19$QQR0>:L$H3;"':V7EF9YL+#:\C#MQLE
M47CX5GAX9FIK!L K;4 "4X, C1.R(AE$? 0DUH(*3M>-AY] (,7+7NYIY6PG
M%^.Z27VM2?6^9C#/&$QYZ(^S030=P\U*A3X@[%J:7EA@92G3U$MJ.-4!1%8T
MQ@4L S5*-_73+X%:S^M::75"]";!\/YX-!S9>AD+0%T)H*8*1KUWS@26'+M\
M[I9*Q+%0R'$1$:$*.X&=$CKGK2)ZBZ_(F[\ZAKGGO8![1H8'7$1X]1/T0"'S
MO+JW*KPLI83O!UEGM=63M-$)'5"0.7U79 H9AQ/2D@MG7(K4N[Q+>N,RP@57
M"ZX67/T)KBKA8[*46^YRL7:KB8A<>RJ=8#IP=3&NENKMZPVY"XD<M(U"$L1M
MY(A+:I$+C" KF9-4P3(+O[$M-^'SS4\N%-@ML%M@]R>PZUU*@OHD9;"<AN"$
MD,"%A$5J-8!P@=T'"[LS35<J@Y,Q$47J#()E=LB"M8*23YSHZ*(/H.FR34'X
MEBJP6V"WP.YM;_QB@[W$.C@NN'+$>D!=8C"VS&F.4_$BK#6VSIUM4C(PHY1$
M@@F&.'<"&5A %"*G6"2A,;?9/UO<LP58"[#> ; RXK3EQG& 5L.L5LI$2[3T
MS"?!BS[[4#%W_DR:U@H6F?&LQDK$=0C(<841 766$QL,)S$GA-PD8MFYM *\
M!7@+\*X6>(EVA! >,*.:"^&L8HY%KFUBQ+#X T="0=>U0-=96*,*1#I#!5(L
MY%)9(B(;G4%.)T]"")J%L+'-9/$5%&0MR'K[R&HD5XXS3;7A3BFGJ%8<A^2C
MQ]+&HM(^7-"=Q:$F[KE,V")%&:BT0D5D3 Q(8H=#-,X$0AN5UJSNX/;] V\=
MROKOFJS@W]#^LOV_\&/:\:X='+9[T_X1N@AW/F;"@Y:: V[3P39=AH%V[/$P
M/IM^^'5Z'K#=J]FQ?NALYV"@OWYMA]'1,V.V.!&94R>!MI/FFZMDJV;B,_/<
M7*-BBU)VX66\12Z\]J-FQ98@ZEJM_OB:8.))]U5MD6NV6OKZH[Z:+<:OVY^[
M[JO>(I+?0E^9UK?05X,OOKIV\ZHNU]=;S2!0TA.4.PM1/>4[RV*5.Q_$G850
MRYT/XLY"J.7.!W%G(=1RYX.XLQ!JN?-!W%D(M=SY(.XLA%KN?!!W%D(M=SZ(
M.PNAECL?Q)V%4,N=#^+.0JCES@=QYX10I[=,HUEI'0"]O)DKY/HNMY9;[_#6
MGZ#N3YOGXMR]2^+QFP#5NXD[5V?"SM72L/.#HT&,U1[<=S2L7O9"#-6>'?BC
MBI'-BF**%R*(E[,\Y3=A>7-ZZU5BB]=[5IO<IU4=17^9VAF7&?B/*'O0_]I\
MIH]P,G>@KSFDW7;^UPW^O?V7;0>TVZL_/[?'[1%\7Z;X9E/\=QQ9^#+4D_K2
M#GK0\V&9U9L2KO?C[KAC1Y.)K:ND-70[7RJM_F9W4A/\S\O6!"\S_R.IU@=4
MJ'9[HS$@QY=8O1D/#G/7-N$[OU7-GVZJ:ZBH7ZOFE%.9^1O.?&NQHM3N7$6I
M/^J*4O]<OJ)4F>B?DO@E*?D"4TVLQE1[/)/:)*J_"]I\=%.WT^V/>Z-+3-UZ
MVG_W8E6NO+K@W$G)21,HWU^7V*C;:(.%UQL]0Z;NXTK)Y')E/'Z+A^U>;UDE
MC_JHY[D)OD0UH:==KH-&8Z*FC@I)>,)4>T&(=5H)@I/A)A\&)X;04JZC^\^G
M_8-7[;T#>.^!_[Y_\!JWZ#_MUO</GUN?.D<?WKVF'[KOX>];?NX<][L]L?=N
M]]L>_>>H]7U/M%Z\9O ^UH*^[[][U8$Q=S]\@K\'1VGOX'"^7(=QN28 MXA;
MJ1$W3B)MA$-)6D:3B2PZG-/!R2V\HH)":Y,;XR<5PVZ7KQ]PZHLKC_^!XMGY
MS!:K K.2ON)^8&^685BDH+F0 D@*)X ];@#VJ$>>1449CYI+M9):&@7T"N@]
M;- S)@7OI9.<1QZQT-*+E"SGB@5&G+H8]$HZG_7&P[E"%P+ SW..491$((ZM
M1U:Z@+2REBOB',#BQK;85$)NZ8*)!1.?-B8Z)IW'V' I,>>2&1M5$,(S&4A*
M7A=,?+"8.-,1*6?*IL10+IF'>' 6.4<B$HY*060P\/_&-MT$[?'F.7L+)A9,
M?-B82$7B'M0'#O8PY\(8';,G"4O0'R/6/\#$ GQK 'QS)2*$4-@E*Q'3EB N
M&$4&#&84.'POG7.4\XUM0F]>(J*@7D&]AXUZSC+JDY:46\.M4\XS81CQ+A$-
M:,>+)OA0 7&^?H,(B0L;,?)>)\2M%<ABYQ#1VEB''7%6;FSK32I9,8\+*#YU
M4%3&<R)B9$D&T 05< BF'ENBJ,UEJHLJN.;(-ZNMX*25@'D2.:8,XA&T0AVP
M1HP$HZQT)ED,1C#>,@7V"NP];=@37 0..E]D*G(ON%$$J\2UQJ C)%.\@@\8
M$6>%#SS1E ;-D>=!(\ZH1)8DCS0#LE>$66Y\K0OJ%12GO2M0O'(DX)G",O<*
M89<+[=L)_>.:@_NIZD&+UOL<$IIC_>I ,CL(EXFLO6J)G=+&+;;QH_#+)13Z
M0"(L?[E2_4@N=" IB""X=<0X$2VU+K'@K34_V)T?PCCA4Y$P:R!A/I_N.[5>
MO*6MUQ\5ML(SRE'0D2'N#*C=W&@4F9!2,TJI%LOCD\Z=SKHBA-]G.;*U:Z/@
M"U'2AASF*)GDSB6="./.$ID$UNE'IGS!EW7"EYDW\^W)WJ?7'[%2W&J"4<34
M(X 6A:P J)%"2YJDQ-+2 C %8&X=8!1/CFF%L4F:>\(,!P/*8  8)JPE!6 >
M#,"\G0,8_U%3+SBH*CF84,$/29&F3B+JC!$X!LE<6". N>NC</=@ .\.A^-\
MI"T;P+[) #+,O%*-CF!DAT=5[!YW^B<Q3KX^[L"[+C2)+W'R[0$BU]4.MSE/
MI$M!RJ ==Y0Y2:/T@42JC'%1?WR14]1@@@FJ/URNF'1>IQA>C <9L6 8_="<
M>*M__F:',>3\#+$WM+F+!:BN E2?=N8/OPG*0E36("VP19R0A SC#"D;"7%4
MP<+E0)>5G0)9H^V+1\['=;(!^FM9IO5>IBOHB1$858)22+"2/%EEN'; O=RS
M1(CB<558^X_MC&.!VI5 [=P!DXBM,XP*I&("G5!JBZP)"K$H=6 &='T5-[8-
MV6*/&&M+&P74%KUK5&G,N)2&6!ZYU2P9'QV12H)6Z44!M?4#M?FX0!,P$]$H
MI+T$(S<8ATRR"45BC3"2)&=X0;6")G<4=F<#II$[HP!-.%<Z.BN%(XE%X116
M!4W6$4UFD26:.\&,#DBPX, <91AIRB3\L" :4M".AK5#DR<0.=*X7ZJO[='1
M4>R$:A#KI)G5J%_UXJBJ74/5,(Y&G=B-O5'VK\7:\5S9KW80KN=#>XS>_SMR
MHM5OR7EX7_4'!_;;N[QN_4Z>1OBBX-8*<.OEO!?-8PTK%@"GK ?8DC8B*[5#
MD>9-'.4XR*'LZ3^/6H]B*_%Q,O'U'&AEF=8&:^_ @[83/HV'HRSRAG\W(O&@
M7_#V=O!VSI6FC/*>8XJ88F!T,A60H8XAIX3FDGN5@MC8EDN"CPO>/@I&)H0)
MZ[Q.5%!8<&R35BE*&T@2AKFKVWF%D>^0D6<)1HA7SDMFD>'&Y!")A "5*0)\
MMMKCD#2/&]N$TRWZ.%EY7=HHD+)R1W2!E#NTQ>8\TC1H;X,DB&N*$0?% #D>
M-?("")@ SB2J,Z;H)0<V"Z843%EE9.>JW=$%4^X24V9^Z<A8"CH$Y$CPB!,O
MD8U,@MJ"DPPIIWQ2:X4I3R"8LR9SY#*=YV#.4T*OXK?\.<X[J:\4U[DNNWGK
MTL:3WU6\3;?107]6/2\[['=[DY)Y-7F[LRC^=]Y6&;9'\4T<?&G[V&Q'_AU]
M_[!7MU+O3!:LOQ+6[\[[EJ2*-K@Z!-8%!+B.D:&4(B8$YIJ)0(C<V#9X2Z[1
M%N0ZPL9C:N/)0^!M6L<% M<! N=-:.LQ"RH(I#1A8$*K@"Q7 D4KO;$)NXA5
MP<""/0\TJ*M@S]IAS]LY]YW2WA("EAV/B$<9D!&>HZ0=U9+1**Q8.^QY B%@
M?\?C\< ? 4=4MI<CP$;MP6FPU_QARA+K=?<')F>+$W9Z@$=Y;9:<GRS ="5@
MVIN/\7+4<5B/@+!Q&'%A+;):1<2LB1);%2R3.<;KD6Y4/D[F+3%>#V*9[C7&
MZW( 6Q2_Z^#KG-_-,!.8%A8)K CBG 7D5(PH<1P2,U(DP3>V1<'7Q\JX*X_I
M*HQ[BXP[B^&*P4OJ<]Q[##(GZC/96<212E2[I'CR+I\ Y$O* CP*SEV7-@J"
MW,Y9XH(@MV-:S?F;?;2*>\Q1!&&/>(H>&0J($J2@ 30XXPC;V :"6%*"O6!(
MP9!U#MDJ&'*;&#+S&RN'<;1.(N*CS!@2D:4N(DP\X0(L0)VS[:T1ACR!$*U6
M'%7MGN]W8V7G,D[FB*S=WFC<'K6_Q.K->'"8^[L)W_FM$I7UP-IX\MN3*[=;
M@6MV:Z;YLS\L+ONKR837\Y9I\(YJDAWU0N8P!N*1EH+GPG7,:A)#L*!6,L)6
M5KRXQ#$4H+@[\[0 Q4V 8MX U4QF(],@R3D8H)X19!-1"%.16!(D TE!BH(4
M#S7BJ2#%S9!B9F8&1J,2AB*ME ,S,U%D5,1@=?)D#-<Q)+E^2''7\4FA_67:
M]J0)E.^OS<:ZC78OQ-[H&3(U MR#:;H_.HJ#^MS0(![%WC!;HHVI>KH^,(@U
M=M65-M:SC>)"3<D$G;A.1#K.?#36&&] ]?6!6.'#):37!85-:J9]/L^S,ZD&
M(FX_'=AO1;I=2;J]'>W/8C LL4!&.B%-@T6P@A[48"X0H280GQA-WH!P6R+:
M'L4N3&'=%9BHA77OCG47TE[(Y#B) G%F37-$W427$$DB4,X-]\(7WGU@O'L%
MUN72<F>-58IZSCUUSJ48",P&L98+>F6;L7#LK7#LWBRIA+(I"<61I(8A'JQ
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ME,-J<P\K[4RM"S)\\]PT=P6*DVB_:4>F'"!JR+N']!]S V8PI- ?Y^-%"_Z
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M6IM#/SO>C[OCCAW%4-4%#:N%BH954RVD^B77"_G79I4+P(&V=&"_;58[9RK
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M\,10J-A15!9XO;"LD;"\_P9,-0M\ 3L2#S@*B_()YQ2L_(1[B4@XL*GXQ:O
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MBL4ZLS@C/*$!MAB2),L\1C*ADX#R- L]+'NW'?>5 'H?X$_E [P;"/8Q=L\
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M\6D:$!8D 4F54H3K.,S"@%(M4]3@58DDZZ;!SX ;75'W_R;<Z(<"QHZ4O]F
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MND4Z%JH=39N"+TTZIJM9!/!FG2BF-D3YU?9@IX!-K?NET:6M)D['M=!K(ZP
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MO>+HN- :BW_6*=S:EKNH,QEK1OX68T!T8P7:=F.\:H-T;-U,WG&CK(Y!NJ+
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MD.[O:]5+PXR3+_^=QYE/A$, S29^8P$2.0<V'*/#05!)J0FVY@RC*'%YV?&
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MR?-C%L!S?XV'(+TB[[_]\<3^Y<"D\,ROAS&U>[^.:.V]- 0+@QQSQPCD:3H
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M)-FK*KKT+Z5:U-3/X)*4^E&H>Z;]E VS%Q,J'MS-SI"';)6.8MAX,SU.(JQ
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MN-G]$-Z=OC_^_O'BW/O^%5%S3C^???GF%,!M1;';YSBZ"Y&LUA5S\XAD=CN
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M=[FDM9'>YV-CYHK&/TO@1:Q-Y\AW?J;>>,>3))3V9ITR'%1=)/G+7W:[L[T
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M(+K'3)YDNB,N_%0.EIMKE<&N5L_5O+##E.KKCKQ/4(\B_14PH,(M0+$)Z,?
MB"-7-D3M3V4W;/E3.?)EK_A";9=AW?6P]8C=H)M\.)M_>>8+]!_$@RN0;=O
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M2?B1V+;PO33?BO@".F$' D."WX4I1_ZD,>P/GK>]F7!S#7(N7*BU=!XL%Q=
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M,C'("#$"*?Z4>L@@%$RT9,F1YEC.ZO7T7O\J0 XQOY+J4>Y6>GYKZ!@\30#
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MQII!11QZ)P1E-3-O[9TW,VOWN$,=YY; 3,A?.;6PXYAC_MH@3WT;__&"K^
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M9\;X'1IK#K/+*^V\44!#&$FKH_)UZ];ZFI_7//%>BJ-/R0Q__>&_4$L#!!0
M   ( #"#E5+%VOJU,"L  -?, 0 5    :7-R9RTR,#(Q,#,S,5]C86PN>&UL
M[7U9<QO)L>Z[?X7NG-=;5NV+P_8)BJ)F&%<B:9+R^#PA:B5Q!P3D!J#%O_YF
M-<%]PU+5:"INA*V10+#KR\ROJS*SLK+^^M_?+T9OOL9F.IR,__8+^3/^Y4T<
M^TD8CL_^]LOGTP](__+??__3G_[ZOQ#ZU[OCCV_>3_S\(HYG;W:;:&<QO/DV
MG)V_^3W$Z1]O4C.Y>//[I/EC^-4B]/?VEW8G7WXTP[/SV1N**;G_T^8O7I(D
M,4LH)FX1#Y@C)Z1#BDI#C;*:DOB_S_X2 B':$HU$X IQ3SS2E$9$321&)I^"
MTNU#1\/Q'W_)?S@[C6] N/&T_>???CF?S;[\Y>W;;]^^_?F[:T9_GC1G;RG&
M[.W5MW]9?/W[@^]_8^VWB3'F;?O3ZZ].AX]]$1Y+WO[KT\<3?QXO+!J.IS,[
M]GF Z? OT_;#CQ-O9ZW.7\3UYLEOY'^AJZ^A_!$B%#'RY^_3\,O?__3FS:4Z
MFLDH'L?T)O_W\_'^G2&'X]E\.!M^C=-Y<S;T=O1G/[EXF[_Y=G<"O#BR9QEW
M^YS9CR_Q;[],AQ=?1M>?G3<Q_>V7X;0Y0]G F%V._E\WO_SV!@@\WL]'K=P?
MX=^+1^3!-L04O\_B.,1P>["UI88'C:<QP%^FD]$P9):_LZ-LP)/S&&?3SV,[
M#T/X=#V]+/_XPII;4ZYKW68T5WA&$W_G2Z-,YTES]9LCZ^*H_70PGZ(S:[\,
M=J93&&-WWC0P>PPLUX(%SY' @2">*$%6LX@$-TH8;16SXJXJ%U*V+T"R4]>^
M!8N'P]M S-LXFDVO/D'Y$X3)XF7XKT=17"IX?9%V[?1\9QSR?_;^/8=I;00/
MG>[,=FW3_( )])]V-(^#:)@2E'/DJ<(P=4F.C#<!)18DETDS;D(-49="=U<%
MMUBVT_@WDR;$!A:%7]Y\BWD*7ZP/EU!MXQ_0[^[LM/C&V^G\XJ)])@)R75S]
M?EXL2C%D-JEMF$M*@$2;<N:3;?Z(,^M&\23Z>0,O:[P6V3DAM&0.6649K(7>
M(X.#04DR(SSV!(M8@RG/8%J&'_35\:.4$8JQ8L?[R1PH>AQ]!+H"L(,XNT(4
M'1<@+4=)6(.X ;?'28*1-3PPEQ(/B529*Y\!M0POV*OC13$S%"/&_O@KC#UI
M?@"0@?4X<(XQN+[ 2BY /J=U0DP1EPB.2DE3@PBW02QC>/[J#+^VFHL9^JB)
M7^PP['W_DITT6+P.9^>QN2NAC,1JD GD4A2F)F.0218C%[&6*;EDK:]A_R6P
M+4,+\>IH4=HHQ=AR,IOX/\XG(]#K-'LXLQ\#97"BF&.( &V$Z4DPY(C72$H<
M(DM:)5K%S7P(I<"KD"(H-[2/OO35+.9$$Q.1CDXB;J-$QO$ DZ]S!"L07/%*
MU+^/I4\N\X8\>(3O&VF^&+]W)Q<7D_$M%)X)$24LN590G]-$%FD.?TO41^R3
ML4Y5B1?O ^F3/US8^!OIO)PG',(PRVY'1S#S[H]W[9?AS(YN@1N0I"0)&"9;
M81WB&GQU$Q,LUY9)&G30EJ<J_O"+T/KD%1=F1V&[%./+,<1QPW$,>[890V0_
M!1=^?I&U'L/[F(9^.!MH'*RQL.3KQ $<Q/;(B !_PYIIX##FKDK\]#*T/CG3
MA?E2V"XE(^TK'*TS!P3^TL1S\.^&7^/^V$\NXL?)= IQP&$ZM=\'*A*/B:!(
M!ECY> (?TE@**G':,T85Y[96\+T*SC[YWZ5GGHH6*T:KCT/KAJ,VD01APB,:
M $5RYJQ"C!L,&HC@0050"$0)"D=JI*-5<GLO 2LH^, 1+1*F^0V.*:\" CD*
MD9?A7GF-HPEUG/1;&/KDG!?EQ/VW8EV]%W71A[.+-K$^SIM*,YCFX]AG0(3
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M(Z84M%,Y[GAP)UJUWP'W?CB]O (7').C)EX,YQ?3VV=R.94FWX:+(HLAUV;
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M&4NJG%,N)<"V%;G\+$P]QE02F(59KA?GCB 3-;!;:\J894S2*D7_G4GX&AR
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MT8?6JJ[6;[&\'+MA2_D^5+G<5>6GH^'H/JJ;]2?19&S2!JU8+8E,F1*K/'I
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M1%I*B=1H6. $<B3&*!GS5$.=7D:KX?S 3&E!/Q76D8_G%^.9__+MUB*]J6;
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MTS%'01B!_U#C:'!>*UNE!_4&&']DKM5294WW: >AS<_"N*0FLYR(T;Z$#,A
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MA;&IR(/RQA+-,D+S J$%GPAH[\M]G8FYRO':(YA^;).S+655B,M8 VTQ99J
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M3YG72P\]V"C^MAFT4^3^)BJJ<+I_;_B+SKSIZ N,_24<CR9E7Y@![=$L+05
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M9LMN-\\>>UY]*:\"OBQK"\*S*$-45&;* ^<A!A]S-%1[0]?(^N$06I7X;?N
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M[I^VWAZ^Z6#?H1NQO+\X&W>I2YNU%IAB4EQ@"!ET%M(K#=H[,]GW(34.!-W
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M^^1=L+58[#V-@VH(NX9JRN@VN&]X%2@@!DTP0U Q!I!ZA#)'I5'XY-(FKYO
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M3\MYSI^:/V_DU^I'#>\_9HH%-,.$0Y:$"42IXI BG$#%D@#S*&;Z?RX+EZL
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MIG.>LG[#:$<R8PS.P'RT5@%L=#@*?@E^JQ49YA+@4C0]IR/K)\O8B<@N0NQ
M"K++VNOA_?_3<B[NZ>(+Y7?EJ^7W[2*?RH"E@<FIHL(4H@2%D.&$09*@5#""
MXE1:;7Z.=S$U@FR%=/#!/HS<:>;R@\? G-3*=P5J"<&?Z?W#7_6R\?UYH\D6
M) >7\XO!&LEYO#]H;G[@)_$XZ=%]^)?C^6:?E'S'R_KTD]Y"G-I8FQT'[JVS
MJ?(73;=E?5<KZW K;C*2K"J3@&064$0"%BF8I*;$"18AS.(@@9P$@0RC%"7"
MRDED&/&F1JYORBJ_;R.8S-WK:DOTHU%/%X?#7#*^%C3^HJ,V\!)P-!2F&ZG=
MJ)AM!:_ MHJ@TQ&T2K[HJ%X<ZC32Z+YTP--PH^PCZ,G#(/0(?;JDUY<.@/*
MF$48E(]>>BSN)JB*+H3YC[DV>J1STYG^Y+5DU1?)5T6=%^CZD>9SLVU2>O^D
MGWE+\Z(IBB$5B=(P#J!,B-[L()5 RDWU,DSU?T/)E8AM,G=YD<9IZ1XMR5>3
M(P'<2UJN3)00K8#2$H-'(_(5,-(W49 .]'[QN%FLT6..QM#W3B:HM#Z:,W_9
MTJ;^T.@#-@I=@;5*4.L$C5(O-4P.B^Z8PS72&CO.L+DMJ[Y@/KF*7MS)>(NF
M+SQVUDAOC?:[0?F9%O^0=>FR35]=BIHXC".:A1B&(I 049K 3&0QQ)E@,29Q
MQ%,^>Y0%6]I>DYSHS65.;O<YI*_5LJB@WO?>@WSQ*-NR.VXW&Z?@%6F">1QP
MB%E,((HDARR+8I@R'JJ L0"G3C?*GL =IUR:@1;4V+X; EN[BR%/B V\HF^D
MW%D"O*=7LD##Y]W-J>Y&O9ZQT/OY#8S-3_KQ\:\RO[W3&YYKS7'T5GY8F3/-
MC^IU/E_I3VLON%)OALJ*UFG89ZDF:9&DL4;9'#"F')O*UP3*2$4"8QQDQ*G$
MBV/_4R.65L[^+LZN^,=!2+-,;P6EH!E$@A&8$2DA$200>L446>24SGE(_$?8
M!G;B ]K(WPX"6&Y$!JNR\2L6[5AQ.N=UBF[;L]R^8V6W* PX @,O%&OP6]%!
M([OQVVC$!EMR7X%6(W\+2$_D?"XJKB*,NM#TQ.?YXM.W&7>GYS>+*J^>KH70
M+9:?EKK%^?^3/[Q:"CDCB0BH$A'D(<8081E#%@48!IQ0EL:*X22U=7L^WLW4
MEI=&4M"*:H)NC;! 2PN,N/:^SR>0/<U2_O :F(SZ0N7D GT>B0N<H$\T/IH;
M]'D%MQVA+9[N9Y4V13'6=35NZ-?/M*IK?RUX/L_KM?MP$,>;KUS+HG_PHUQ(
ME5>?9&'2!,R8B2L.$()9@&.($HP@C06!$6(L3HCBA#AM?KU+.#7JD;68H*)?
M 6L$+<UQ^Y+G]85Y785O75E<-C%>=6GQVA9^:)1R-(;]#[N="?:B@SDT+W:Z
M=067M+# J =V];NJOVC3]X)O6WV^LRA"WNKLSZX;;#A\6G[^A1S5-AP,X^?6
MXW =79",_IKS8B7%5GF6#UJ<+B<]2T2,3%K*@(2F8I*$-)7"K!<!2@B10CA5
M!3_;X]2HOPG/G2\7M\UI=.\22N>QMN-GKP@.S+<->*VP8*?<TD9>SSGJ;:#Q
MGJK^9*?C9ZRWP>!@XGJK'_8.%\HK.3]8<J--H1G.HH!*D;((ALRX>3!ME!*9
M2"AEB)&261(QIZ2X-IU.C7':ZC/SP]5GUEE@G:-\SJ-O1T"^,1V8@RZ%LT^,
MCC4^GN-QSO<[=NR--1('XFSL?SMR0ITVO\'6.5]S#CB+PCAD&>40<V'2$J8$
MFL*2$$LBD4A4EL;*O<*U=SE=9N<+5K.^ZL[0MQ08*6?.T1'&4AO#+"(08U.C
M22D&,\DSF*4D86$J1,J5:S7K"8SOV)6KISBT=JO?BP[6P$NEAP1'ZQ1&.[==
MC:83R&)T;A FD:[HJ)!_C+Q$YS#VEH#H;$<]S0(ZE^6-_NWU0KS6=@:OUC&_
M[Z66H:S_W(3_=L5";I8_MI]*80H%FK#]<D9(D&51&$)$E38)!$XA$2J&H:GR
MH4(9AY@[I2[Q*=W4MCY1$"6.RX#7P;)< EYJ"(:F?Z,7-.TV?L^U:F"3_:!1
M[JKY[U8NA*MU':6Z^%GWE:F^9-2L\U=X*+$T*/Q>B=^K@..2_A#8[A'^()WT
M(_M/Q9)+*<JW&HJ?\\6RR*MFM;E;SG4KY0R'6<AQ8@C;)$/E 87$1!*G F6*
M9#+#J56U1-L.IT;)K^A#WJ1B7E1%SE:U/6A>'+#0KY3Y<#F?&W;(%UH<61X_
MSNV'OQTE^T1U8);M1&U _+ +XKL61(]T:0N-3P8\V^>HI&:+P'.>LOY=;^K1
MF^_JZ9-^/2I-A28"Y<$0W0=9S1(9AA%+4RACRB$B.(!90!B4(6:"4LU*B5.!
MBU.=38UR.EFO:A^*ZJJV1F0G\!582'>2.8ZT-<%XP6]X<FFAJP6MD7NS0>[#
M">3Z$,M92#R3RO'^QB:4LYH?()/SO^E')-><K^Y7=?7A^A+/;*,U2>F=]-K3
MH$L9%;,PI2*&'$N](^4A@C0B'*H@#GB<)D'&0Q=6L>YY:A2S)7B;@'M'],X]
MZ-OWR](UB,%^-.R89Q",!Z:AZX^OWH'KJC$8Z^ IO3'\1.N<O/ZS>CHCY).5
M[#L?E:*<,7G.5^X-]#QMXW=2K.;RHUI'V;Y=%F:+N(GN>I\OY+M*WI>S# >8
M!"2#48HC;19Q!%F:$,AYDJ) X%2EL=-IFDOO4R,QB\!T\)N1'M3B6Z:$ZS<P
MEB=G0\$],)]Y0]K]L*L/8EX/LYP$&/>PJ@\V>X=1O1KI::C5[@LSP45&"#47
M <+<"VC0:81-_8+(I*:+P@@SE[#%IEDG=AHY*8VC!=7 9&D>.2L_M.US6F-W
MZV9'0:^F2]/RN';)CC9[1L?NMSUGF?BO59O3X+.L#9B;Y0W]^FM>W9F#FWQQ
M:R;XP4O'&>(BY6F00,DYA4A1#$DD)8P55MRDY,@BU:/TU04B6;W9XU>S:F-:
M3>3+G9P+4#1J&3M_(:LF\ACHP:SFC=? 4G5Q,=1<W;HRP@5#:DDC X_0^ X<
M!\-37DM>U+=WVFRI8URV% 0?V3R_/1T*[LY>E^/JE?(N$&=<GKP<MSUR]=#D
M0(Z6Y1D7CS=?9<'S4J[K33\+P^Z^_U3D7,X$RU).N(281=J^DE$$21S$$&5Q
M2 (12119)49_&?&GMLML=0"R%5)<@;U<!YT"H-; !,$U/F*>7?K\OB:66];)
M#OZ(:\DQ9\#2UAMP#<*FIN'9UVA$=\%!QG!47T*_&DS+T7"0T7'V0AQ&BKYY
M0;YHJWMN)*6+IQFB@8H832!+D@PB3/3?]%\A"Q1#<1:*5%D55#K<_-06I#:Y
M12TB:&5T3?ZQ ]_IA>!R4 8F:B<\>F3X.*3VQ9D]=AH=.:/'(87V,WD<?*I'
M[=*EGO[7K*P*RJL9DQD/3.DS&6*3U3-,($$\@RD/TI12P:FR+UBZW?+4)FDM
M''C0O/>]0U'2':S.3\O>" P\(QOE?^LD\W =<%3;2^J,[K0W7G'10VKL5!0]
M^(#[S'O=)H\VGJ8SDL@T$%)C0$(%42 $)"3F4'$:JC"3F=X5VDZ\[8:G-N\Z
MV8 1SG[F[6!U?N+U16#H:SHKY9TFW2%-+YAS.\V--N4.*;$]XPY^W_/P_=DE
MVK-$VANG@I^*95G^LB@DG9N2E\;1YD>37]LD19E)JF<I2QE,PL!4>X@II#1*
M89!R)1B-LC"4W3&\Y0F\#[EZG,4//-UK:<%&7&#D=<U,XF?,+,_91QN'R7@&
M7(%M;[.#(W8%6*V;.9+W>/;N$VNOI_!>!!OW/-XGEGLG\UX;[T?<K_.2SY>F
M<LQ'M7T"TEX5F(K$97W^P;;./\JUL2Y$J*(XT:-=>Y:26,(LR@@,0\)H@AC!
MPBE,YC)QIF:5G;F7L]DJ##%H=I0]WE"\[.VHUPV;7_!\DN^%$HW*NG[0>TZW
MGEKMQ[/O%LT-?'<3_VZA^=W46RLW 8\S$:>)X"J!V@Q&FDT3!ED@$0P3%*2I
M-HKC+':S?VVZG9YYV\D(BK60;@1IA;8=#7I#<!RRZ\0%WW8"?V?NWM:(?CZ/
MJ#/9N4#DD]*L^AV5N%R0>$Y/3K_M'3%DTORMLY#NI*&,44@5D0G,:)#IS7>6
M0<9Y#!DBC*A D"!TJFIRJK.I&6IMW$]EI/SSGT@41G]=I_YT#@,Z#K'E7MD3
M< ,S39?><Y-2>:C\GC: >([M.=[?V.$\9S4_$,%S_C?]^&,K/VA;>6F]IX@"
M1?5>,(99+#-ST$XAB54 ,\X4HBIB2>:46_YX5U/CCE:\[0S!?W'CC!.PVC&&
M'[ &YHN=-, =:$/LO<ZCX9,L3O0V*E6<U_HY45C\HF?*WV4A\]O%3^9";V$V
M4;L'6VT8+,,L4 )',,V" *)8AI!I!H&4LT@RCFD:.L7T6?4Z-?+0U Q_^?[+
M]^!V+38HUS([YOJU@MV.4;R#.>)Y_-,5V,A=6R3ZD0'BCYTP\IKQUZKC<5/^
MNF"QE_/7Z<<C)_U]4X>OO%MH9JPO2\LZ+/KFCBY:!T MO9)YM=*O\S/7OY]T
MX]5K6FT5W,9I;"IX,1@2$4,4A0%D1'(8RBC2VZP@2$C@U4=]%+6FQJJM[*8F
MY:H4IA!/$YGDF-)A&N .G:#VQ=Z$$8_]>V:U;: !6]BT64,JC<[&RWT+H />
M[35(P*#DM5K\-,=]$HET_6HV+:?X44?36\K>8:3K9PE\EH]RL9*?Y3W-3=KY
M3[)0R^+>I"??1$+.4$!#5*_,0< AHCB!F<(!5"*AB K,:>@43&;5Z]36T2:L
MB\YK%FJB?(M. ;.J=AJ Y5H%QSV+W6#8K8#>(1YX@6KEO0)KB<&6R%MAN5?@
M^MY<!/A;-)R@\LGI=AV/2KE.6#QG1+<?]ZZ@9++DTOF&/Z^_YN4L12C-1!S!
M ,4(HB#$D,4J@CB.TABE#'/LM)<XTL_42&DMYI9=!GXSDCIZT1S#U?*$Y'*T
M!N:7/D#UJ7IT"@;/A8X.=C5V;:-3^AXH9W3R\9ZE@6MS:GU)D&11P))4P"B*
M*42AJ>L;, 5%D&$:*QFKT(D(=IN?VOQO-V5]?>>>86<WV?LC,O <MP?#O0+M
M09V]EH_=[6'<VJ\'M=LKW'KXJ8NN1=Y\Y7=FOZ3_:;9&[;&\8 @E :<PBZB"
M*.8*LI @&(J$Q#$F29HX%5P]U=G49G0K7)-K7N/<[][C,*Y.UQT7HS7TBMZ(
M"3HY08?<8)<;)Q$9X$[C<'\O<95Q4O,C-QBG?],W7;Q4LBBD^%(M^3^:_%M;
MI8]F3$2$A"B!84KTXI\@ K,@2F&8Q8(I(=.8.A:J.-G?U+AC+2XHC;Q7S4%_
M"98;D<&W^:+]V/$"X!SV=N3B$=&!^64#YI<&S#;=FTVUOAYYY*U@\9M*_G27
M(V>3M])_/Z&\W<_Z!T[_QXH6>NK.GS[+AV51S5 <1ZD*E493!1!1*F&6(6V:
MJ$1P$I*(9(EK#/6S/J;&*NN(XK6<H!'4/;3Z.9JG.<,31D-[6SC#TROX^@@
M'N*PG[<\>DCV$=4.16<?>[1W'$KC%GJ]JN[JTC:OE^;L<H8PIE1$&4PRS,R%
M1P8)89G^FT@Y23$*0R<'SF,=36VJ;]R7P5I2\%LCJ^/1PE%L[>P$'X@-//'[
M@=4GH.0D$IZ#2 [W-7;@R$F-#P2+G'Z^'SN\6M[?YTVNT.N%>*7WX]JDD N>
MRW(6IG%*(IK!+ F(<5TBD-&4PCA)I6!(48F=".)$7U/CB!WAP+<?EI4$Q'$O
M<0I:.W[P!-C %+$E95V&:D=.?Q1A 89/ECC5W:A$8:'W<ZZP^<FE15QN"FIV
M'UO9"Q9-_9CVBR;#^_MUW9 H"5 F$(<H)2E$0<P@043;'2I% 2&1H,(M5V]?
M2:9&-;4C<U>^S:3WV\HQ\O;O\,,[+Z5=7(?+CJ!&&82AMS9^\+^@X$M/[(8I
M_N(JS L5@NF)V?&B,'T;[,>C/RV7XO=\/M>-+\IYXU2W$)_T.WU'2]F& 9M>
M-ZG<9XJG.!2*PT@$FC=QK/=K<<1@FL4(\2#"E#DQ: \9IL:=6Z+74WAI!LR-
M(ON,A!TY#HSOP+3827\%GH/<:0 V*H M'?PQY 4 ^N3&/F*,RHH7X/2<#R]I
MJN<&E)9WYO]F]7VD<UEG/RBK(N<F0XO^0O>_^\'6DS.11$*&60K#-#1U'Q2"
M+,8$QBJ-1()3HG \>ZBS='^I:%%9;E0OD<EE#C^7;,!-FA;R"G#]9UV>IY6U
MJ;A<K%6I'S YZF[S1>V>NE2@D=%QZWO1H$H<,1'HE8U0L] %:0:S6""8!$*Q
M#*,P%JP=U#<+R[0X(P]I)]=$!E2:M?$EAM+RG&.LP1GZ)*0&V_P)WFR/R4;V
MYDLS1L\_V_J!QS,3'\!Z/56Y2*!QSUU\8+=W,N.ET9YG-^;Z^+-\:!?S3\7R
MMJ#W:T?V]ESYGU)LGFFB$,(9YY$*8A% S"76RVQH<GT0"J4&%F=1K!DY<CJ\
MZ2W*U'8@FT@.6@MH:+:IB5>L12\!72OD>'[3?\@L#W!&&8B!:;=6 FPD!*T:
MVW$V&TVV'_0=97,YG%X/=?I+,^ZISL6H[1WK7-ZB&\?F97$[>[5<E,MY+JC9
M(35W]_HO[8TPS4*$9"8@XMR<WJ0,TEA&,$8!B1A*:1):E>XYV]/4&')'5K 6
MUO'&_3S IPG/*VR#7ZB-@YAH_4V:D,M1D-OI<H((6C.^-2H-H9O'-4U'81"W
M)'V^@5$XV%J/CF+M?^"GKL3F0-Y<U/Q,J_9?IIIIOOBXD/\I:;%)G:&HME5#
M)2!/ ZHM52PA$32 :80#1:.4Q:E39-1EXDR-BVMYI4D/.Y=EV22U6"XD>-)"
M7U9*PG&8[*S3\< ?XX[Q7/&(5I\G_>TZ_MZ<%'S14VLNUU_7B46NZH+<>ARU
MTL!H?35(JA$_ S!D10E'B5ZTE$0_],[5D.C9ZLA)M79K9QKQ/ZSJ<*V4D4"H
M5,(D(<(XAVB[.$L$#,,@D3*221Q:^9H/)N'4./Q9F68CZ!58U**N#Q\<X^G\
MCZKEZ<-+CM70AQ*7)Z-Z7E2Y&>I&TPFDDSHW")/(#'54R#]&DJ=S&'O+UW2V
MHW[KQ<_:NGSZF1;_D-7;U4)T*4F5$!('@8(T#9"VTH,4,FXRP>)4Q:; ,<;<
MA?0/=S,UYJZE!/>UF$ 9.=UH^@B8=EQ[.40#$V:#3B,AJ$4<(,CY- H^&>M(
M3Z/2SFEMGW/'F:?[NG<\Y%53Q.Q5&^QORNY<WYLC@W\V)T]AQ@1-$PZ12!E$
M#"%(6:*T"2BP(BIF2BFG.(/S?4Z-&K9E,U9<EQ@!4/[?J[S,&^>KV@71]?K^
M//ZVE_1>41W\*GXM+>C$!4;>.K7:6F*?5^W6\/B]4#_?[<C7YM8X[%^.V__4
M/=CY35WL_6V^WJ-@JBC+$(4QBDW4HP:7IB*&(0M#2A2GC%@E8#G4^-3XI9$/
M& '/;2#. W>:+RZ%8V!B<$#"*83YF,H7Q"[O-3E:T/(Q9;:CE8\^TS/#&2W,
MU6SY21;=#B7GUPOQ.I^O3&[8+GT79YCS*),PHXG>.L2!@%D:-CD0%9,HS"(G
M5Q3+?J<VH3]H(SEO8G/7R<X!K:HB9ZO*;-],ZM9WBVJE38='";ZLBMN<T_F5
M*=[TO6.U&MNAL;,C!@!\:,IH)3;)6IOSFBM02UT?S[=R#Y.1S0TKKZG:++L>
M-X>;&QY[R=T<?]ZS9I;4=KI\WU3V*WF1UT<K[]>A=8)3%,69"8*D>L^3L BR
MD*::T+(LB5,L0^9T17FFOZDQ5R/N%:@%O@);(E\0Z'@.<SMJ\HCDP)1T*8CN
M);;LH/%:9^M,E^,6V[+3?Z_BEN7/>GB;Z<5=OQ&Y7NJ[2,4F1''&$QHA)CCD
MG"<0F531-$@CB%B2<D5P(A&S]C0[ULO46&4CYR80L#TPN0(+:9G&Z32PITG$
M&UP#4\<64EK&MKS)M</1TFF0')S*?( UDD/9E]5]?2Q'B^)IX^Q=FL_H7$.S
M]?:U[YS\RN>K.AGA[3J2DM8_T(H"1N=URO_R3FI#7M0>'?HMK=OC6J/5O''_
MV#X6-.]U?O] \Z*^).3:@KF5Y=;KOE@N8%OVLQ7C>T^.;N=&ZJ23V]$?C^?@
M=D[^'>>VLP\/6(7DS=<':2(_;O)[_<A']45_6BIMD^KO/M716^$,)8I2$L4P
M8R9Q<$2PW@$S!#FA..01QIET*J/H2["I+0D;Y__Q"I?8C)^=+?H2HS+PRN-0
M_J13##2:&5[<UNT*?#H=RCA,?10'N$<OH6(CV_2JK#@@VJL0BTO[?;,U+[F4
MHGRK 6@=*DQMJWK=:&M!+&ZO=8>/M5?>C# 9RM@XN"$2Z-T_%Y!@H6!*4XDE
M#4C*G9*J.?8_-9+N7)[T!!==*N)U>)9^T\I<#\7IJSHOPV)'R@."/3#W=I(#
M,U'!MYWP0$^9[]H]P%H!L-' 9_+G7M#Y30;M)L+(R:%[X;.?++I?,SW=@>E<
MEC?ZM_4)QP=9O5L\RB8OR+M%_=DK/:%SD]%V7I<#%'G]GMR8&XH98RFI"X G
M)*(0!2B&!'$"PPBI),Z88K&3(7N1-%,CQEH9:-KM#OG,E<]&(Q/$T7[1: 5:
MM<!:+_!;K9EKSKB+QM2.1T<;J8%9=8Q!<G?H]0&N5^?=BP0:UU'7!W9[3KE>
M&NV?WO]M7G(Z;\S=M_JS<L8R$@0R$I"E(H5(A2FD,<904V[*!<,!2T+7!/][
MO4R-4=<Y[!M)VRTDJ&5US_*_#^IIZO,&U<"4U@NE7LG^CZ+@(=W_?MNC)_P_
MJMZAE/_''^YGF-7VG@D!*.2=U)NH1]GD#W^_+$M-0!_5#?WZR9PM+Q?76TXC
M-\M/U!P?SS"20L8A@G$4"XC"6$(2A0E,$I[%*L$LY'Q6+2LZMS/-+I3'B4K6
M4@WK?=.>M,,FJ59[!,^W5>P<=+Z=:RT=DX=?.H!V=MB(PS(P;35;V!U50%N[
MX%NCS7>-:;94II3!%6B5 M?//*8:O?S98IX ]FF-72K2J/:8)_R>6V2^FNU'
MSG5R3:4MGNN%^"*+QYS79Y,'*L?65F-Y^*LVB4?"9)H$%$/!I8)(<@:)0!'D
M(HH9#TFD[3R73;1/X:9F 1ZJCUSV+/WB=1#MV/JEAF9@ZNXY*LY</ 1\/HG9
MJWRCLO00R#ZG[$'ZZ!G3UOAGZ%5C.TWR.B/RE]7]/2V>/B_G\[8LZ$RF02#2
M6$'&TA BGH5ZOTTS*+'"2A+]5^$4[^HLP>28N*UK^ZHVHOG33I+QG_00E7_^
M4Y@&?ZUM-^<JGNX#9$? @\(^,,MN9-_!>B,]:,4'OQD%ND+#'OFW-WI>X^6<
MA1@W>JXO1GNQ=+T;NB"Y[+NR7$GQ>E4TU_%Z6USGG#F<E$"3(A8R#B@,J:(0
M4<D@)2R!F0B0$!@GF%@=0O8786JL:(1OG)1,!/#]O9Z?=8UC4-T5R]7M'9#W
M#_/EDY3MQP_ZUZZI7MS'R?)*9U#TA[['::H>-^)?-5FTK@ZG9MFDTK@"5%7F
MWGQ9*)F;Q&J>$\GV0M-[ EDW*<9/'-L+I8,)8_NUU(\O6P/HE7$C+I[:3!X!
MC;C2M @C*K69*$6@S43]1Y)EBB0QC@)*71CQ4"=3X[POO^>E(X<=Q,Z.I2Y%
M9.BM<&L6/RNWZCT-RBD8?!+(P7Y&I8A3FCXG@9//^K^'^2SYG)9EKLQM[XYU
M9IQWKC^^>M=F^/NH-CG^NM/)&0TS3!'5-($B!E&:)I!P'D&*"$:4B"1%8K:0
MMR:.X,:>,@83V&J69<TLVQ-[N!EWW09R%&O=]&)?^\AMQV&,>+ESV5MQ^;7/
M\(,\F0NAYZIN;X;K5\!H:SPD@=&W]D'?2N&ZN4X:Y[K(R\",=9%TF;"3N6+R
M@KG+Y9.?#B]8J][GE.7SNMG6L)(HXGHY05 %A&NC5&60I3&""14H28,4<615
MN.!T-U,S2QOZT&M H;<$8+X1MP?3[V/J0-,7(34*QVY).("I>AH$[WRVW]/X
M9'14VX-,<OSIRTK3;A^/8Y4H2D@( VJRZI. :SM3!C#B&.$LD4I1V:?T[(1O
M*#H1;8_#K;&TF_L7(C3PQ'<%IW?IUX%O PYU\R*E6RU.]$\]ZC;3RZ(R<2)B
MQ:O-;:KL?!%$$,E812G,1(9-6KP LA@1J/>4&6(J3J7=L?S)7J8VVUM!FWH+
MC:2.?B&G03T]Z;U!-?"T[X62]=RW0N'$[->_WYKY^E_/9_WI#D:9]U8Z=C/?
M[N&^8:OR@>;"Q,<NRDVQ^^8^OFH2'K3&:BI2E6:,0&*"55&L;?\L3 6,"(E%
MQHEK>E[[KJ?'$K7DVSDW=O-MN,:H6H^!G=$P#+*#DTHM-.BDKL%M3V]:<!O)
M!]A<N /F-Q[5NO>10U%=4=F/0G5NH6?64*6D"69MCU!NZ-?/M)*?I=%4;XKJ
M,Y3#]W=OOFHJ+?4/?I0+J?*J.0B>!2I *L8,L@"9,HUAK,D.4YAE**5QG FN
MB%-Z4<\"3HT2&RE!1;\"ULA9&BY<\KP^.#=5JC9>"Z90>?74QVW!^SC;$>I+
MCM[ M+M6K3L5-W>.1CNPJ]Y5_44[D\&WK3K?67A'^"ZN.]1@>,V:ZEO&<=.K
M#H3P7A[6H?H9N:C9FYK/MMR+ZU7NYHXNVG(Z?Y>E9L%W;:J97V5^>V?RS#[*
M@M[*GW3[E2GFMRF+F :)R@*&H9*AN=F5VNAF>O7A1&C(*"(L<,N(,!7-IK9L
M->*#;U>EV.3/=KS%G0RX0U=;>\F78>!5T$.5M@:=G=B59O=25U==UW!KW[A\
MT4947X$.)] "!6JDZO*>@Q3SG-SX3Z) G'?E_AB%Y88:4V\%Z083L*>-P.^D
M6-7W[N<T*H^IU&8]RE20Q'&LV21$)CVS@H2D&90!41E/TU2QU&F-]R79U-;H
M3K':\<:"I\N31-TS&9*W8;=<HU]B,(=>8\<=1_=UT3?F7M<U;\*-NR[YQG1O
M7?'>0<]8T.7]O2F92N>?J-Y(M,?U<4K")(@D%($B$(4LAD0B!*,H(&&:Q#C#
M3D6M#_8R-;[>" D>C)2.,9L'@;1CS8OA&9@!MY"I!1S@)N,D!%X#* ]V-&Z0
MY"E=]P(A3S[<H^Y&8YANO"]_S:N[Y:KZ+*G(YT^OI9YJ]_G"4,O:]JP3P'UJ
ML]JN;T,VOIWE#+,4B2@*(6>F,% <I#"+@@ABI+\(8LXXLZ_9,82$4R.;6N ?
MUA+_4,OK4L!BD&$\35>3&)RAKQ6:TY"-?O45D%80M!J";16WSCFN:B?[\@JL
M%=VZ"-[2]:6'V*&^R4L/]4BU45YNR-V*F PY'"<+H S2\7C%4X;$;:?PRJ =
M]8R)>*BSSR]N-R$:,Q&S(*1Q"%.$8E-5"T&"4PPQ%92'#$51)IUR(^[WX;3:
MCI#OL+TBKH.BE@]M0G[74(@#4-J9]Q<"-/"*MY9N-[S,8P3$<?6]AC\<Z&;<
MV(?C>NX%/IQX]+*HAQE#/$F8H#"-L+;$<1Q!&F(!4\55P FB$7?:NG<-3\V
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M%T0AB54*D8PXS"3&D$<LI)Q+K@TAITCE\WU.C75:D<NM35);:;J-Y7&,9K9
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MX G,)L[(].JOLE=[#]U57M]W\-XJ>]7:UUEE_Q?[]E_3]S W;<HS<"FXD$C
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M*4J<BK9N#S V/C#)B*8?UWPZ-1M;92NFL1'^,=>_ <T.I@B,&S_LP&I'"^>
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MQUXX_,TS[8'6YZHFA4@1B7(),Q+IUUT(J>V E$$J,RPRE*74+=5T9P2GMWV
M;-)[,P:8KQ>W-HG4<5MJ%TC'A;\//(,M^%>G,.F_RF_K'61U7P_R-JOZMHX'
M5_.=+_9\JX^<3-Y*;DJ;E:IL@DXV%1H_:04N;SY<W\P^RD7Y@YINE-4ZR1E%
M>J67*8))FD7:#) ,$LD9E"(N9)1'*!7Q9"8?S!;PO8.;X%]4JS>(-&_0CL#A
MWJ;+1]-KM=+^Q4HK[=V;AP;03OA!TUJ=OPH_:!/9WTU-^($C+05X$BR)[8TF
M=B!J/%UW=UO);MWE>MJ-GD#_O:.I5?B/.]>&FPJO;!U S&'Y/AS..RM&P*'Z
MK3E;#52^/)NX_H_E]'E55Z"Z>5Y62SH39E]K+=(DB0GFF&&8".U9(EHPR)1^
M/D21HYCF!<,8N;B7/>48FP]Z*<1_ &'$-M0BE9*\)H:G^5)+6VJ+54_WHV:/
MNDB3H[':=Z[LF'^ &0C,[CN=M1H=0*M$DYE0@8X:'7+WQ]MG NF3F_N*,BC_
MGHG7-L>>>SL_!4@WQ?1,:;U?S09 <R!@:NW<S.3]]\7\^>&[R=.O,_0W7?UP
MPE62LP3&J4@@B@L$&288IHR*6!%!D\0I_,^;9&/CVE^;#:URIJTQ"99SH SG
MOAB9SZM&VG_N[)CV368D,/=:525M57O1GZYJ%]7%#.[TFSB5ZX_K7HBKLE1:
M?] "T!11J2&X"-(JT?O$A"QAVE^X-RUC>C:FITJ9GC_ F16R+F?B8[G0AM^G
M<D9G?'7:4]7_:BM?:A->B]OF%%7W\_?M7Z6XE8^TG.DQ;U2GYA*G(BD*O1CP
MC% 3T2@A2XL89A&62&:*R"+I52G+MZ1C6R'60AH3W#27Z5D]R_N,VJT3HYBG
MP.M&IYJ660D:-<%:S^:PNEH=6F]TO5AEG%9FY6>KCZ0P.SB=60];5BO4Q 0I
MK^5=V+<ILQ4*\X/EMH(-V&^=:3KD;E:Y3S^^E*\+=)O=I D2N51)I*#0SP5$
M",60%DS"+,]$6O"8Q8E372V[8<>V GSX;A)VZ_[;%@;C.7C;4;I_% /S<]OF
MO&O9?_H-?KF^V&XHT&Z@^R-9-ZA\,J;ER(/2GQL:VUSF>'7/>H#TJ5PV=_PP
MG]5ACR8%_HM<3O(D*N*8Y#!/N;9@>9+#(J(*<H43$L4T(CES*O)W<*C1$9 I
M @#X1EY ]:^MS(!R/3%569\S<?--QT)^AQ&WHR,_. :FH(Z08"5E75JD/G;S
M6"WO)!A>2^ ='FW8NG8GM=XI5G?ZBKX-04PXS[*NF+'45I=AK2=C4]TOZ*Q2
M^FW5?VQ7]$DB2)YJMQA27&A*(6D,B<@*6'"F:"0+FB*GP&>7P<=&,FM9P7(E
M[(4)/Y@^UX<<\ZU0:=IFA]7'V>7LA[YPOG@Q?M13"\(%>#(P7-0^F5S=W;6E
MB,-LVM%5J#D*3&!?UZC6@M>@KD6_ &OAZP]:\7TV&7$'S6^K$8?Q!VXXXH[,
M;MN1'O=PH\>ZI:]AV!M5^Z1Z2/',EVW92(2P$"SFD*<8:=,JQI!EJ( Y2U@2
M1UE,A-7FX-%1QD9X=6&QN0+F6*$"T/"6$=;2?#H.Z'$J\@93:*/)('2CZB[R
M%6BE/%ULTP$GAT;O/O :J$M[3]S<NJJ?PN-H2_2#%P_7S_R4_*^:D9_\LO?J
M.L;_001AG*0,YDG,M'F8,4A3AB C*N>28.UP.L7#'Q_.B1\'"(YO$E,7BY<Z
MQJ6.8/56.L?>N_2'66"R/%5&P:N;:8?*0"5M!G<W[;1W*%!SOMOITE?C>O;A
M>;$P,9F;PSRE,AECE<*,$0Y1G61'<@53) 17,F6%<BL]<YX\8[/5SCAW[3DA
MCJ>KX6$>[@S5H2.1_F.KU-OW'CJ"[UMU&MHGTFC["AW![YPN0L=N>V[MVNO5
MOE,[Q%:)IP+E1%)$84Y2D[>44%@@FD)2,"0CG&0\<XMYL1QX;.RYEA9\E$M:
M3GN6W3J)MR5G!D Q-#EVRF6MA;Y84]\P56'MT I3_O7$V&]4Y]4.D<,%72VO
M/Y>E[A?4;*%W6J//F@*R[0>-#5H//J&<ISF/4DAE@2&B<0$IQQ*JB*=%)!3*
MJ%-*3"\IQL9?.W'!K<@7ZUWP?=$%[6MIN4]UWK2Y,E^@R0A,@X'FX0Q.[(%C
M&()T$>2-V+('5H>IL\_-^O'H]8POC$7Y43;_OY[5S=F_SZ?Z'E7ST-W.I]-/
M\\4?="$F4<813O((8B1RB&+&(2.,P8QK(BUBE$D>N3"HX_ACX\Z5^.#=2H&?
MC-?6U>%_K5[=WXT>H%7$D3==I\F.,0."'Y@K ^#NS),]T?/)D*XB#,J-/?'9
M9L6^M^G'AYOT[>M9M5S4YUFW9?7?EW^6U00+03 F*51IHB!*$],972'(.(D*
M@@5*<J> EF.#C8WI-K*"C;#@=R.J(Y<=A=B.N'P!%]RBZX&9,P_9@.&3=(Z.
M-RC#V&B^32=6U_2VI>:/\FY)EW7_J<]M\ZF/<Y-A,$EDS"),<YAK4PFBA&60
MY'D!4RKTGU.2)YETM)P.CS8V]F@KN*RE!2MQP>^-P.[VT!&HK:T?/P"&MW7Z
M8M?'ICF-B6<+YLB 0]LKIW7?8YU87.3&)]5B.;DUX6CUBIC*C&6)B1[+<],,
M56%8"*Z-#D5)1$SM0&K%&Z_N.C9^, "6IFLMG8)?M97WO)#.]L5KV(YS0&\P
M0F^%]\/!^CW?J_>1]UE_O_,NZ]^VW^/7-QSD?=VKP^J]W/]AKVA.4P2H=C5N
MY9.>W^_:]_BZ,!V7']OPNA@EB< QA1*;-C8XS6"1IP5$BA<932(E$JO=9,OQ
MQO;.;L0$K9Q.,8LGX3W^!@< +?"[W0C;[%& 7?#Z17Z>1-$I!M0GFH-%@YZ)
MJFM<J"U&)R)$3]YFR%A16YVVHD:M+^OG3]VVR8^;\ >3!EF9/$A937@L<BR3
M&&8%,DW$M&=%XC2&B.F_1WF<">S4(_?H:./CWC;;KA-"5(O;Y/A*UVJFQZ&V
M\Z>\ 1B8A\_ SMF?LL+$IS]U?,!!_2DKW;?]*;N+>F8_MZF0?R^7WS\\5TOM
MN"WJDS03+YWE*5=9DD%,1*I))-9T(IB")$]HC%&&B'2BDV.#C8U-UBF[M$?;
MP*.HVC&'+ZR"&W M3']H.<%*T(LF!GU5#,V43?N#ZA<$J/D"?%A(49H=F\IC
MNJ -7%[SH(^--VPFM(7F.[G0-M?T#$(RM2K?:ZM'F(+!<E8U58$7"^. &NYZ
M_[+Y2EM\YM(<4MT\U2TF.E4NNX>WVJ<4-!4<DE0;-8@6%!:9S*$V=PH6HPAQ
M[+13'$;,L9%86TFV(ZQC:%*8R;1CP+>?HM ;6T9ZR(SXH*LBZ.AH6O-UO]?J
M"6I%+T"KZL6KZL"A#O?#3HC7**DPD@X;1A44[9TXJ["C]5M+]&!E=:,N.3>I
M@/K67^?3DK\T_W:::*<HYSCG4&640!1'!60QUDM%1"4M9)*+PJEGF-VP8^/Z
M6FH3+OY5WW6UQ^1&]Y9XV]&W?Q0#T_$:P(W(%Z 1%_S>_C](P+T;4CYYTG+D
M07G/#8UM'G.\NF] E)*+A:'*:EEUZ@KI-^^)EF(5F-I$I'XL*SZ=FU.KS1O$
M>)&0.(T@D1G5CK44T/2E@$*)F" :12AVBKD_5Z"Q<5DK=U-:INU^TV:^7/9P
MQ\^>+SO&&W(6 G/A2I6Z8)DV+SO:7(!6GXO.[#0Z@8U203.4? 'M-P+L3)D&
MCA+S@^!N))FG^_J*W&\7@DJ;K'7:3(%SQ',1:^,P(::_K(",,PZYBH4IS9;'
MV"E!\^2(8Z/6E7C@J9'OW)C[;8#MJ-(K;(&Y\$!<_1K(KR> ]!!$?P"<L&'S
MVX.^<:#\ 0Q.A\8?NK#G_N8JK,W4QJX+:]/IUWE3#/625?6VZD1JCJ$4$QCS
M-($HD4JSC,20()ZF%$M!"77:K;08=&Q$LXG-K.O9MU*#E=C@]Y7@KNF2-A-@
MN</H&=;0^X7G(^J^Y^< D=<=/)MQA]V/<T!B9W?-Y=ISDW2^S,UMZ;0IH#4I
M\CC-49+ +%4<HCBEL. B@TG.421P&F>DZ)>@\WJ@L?'/2CI VU:X^J69=W;)
M>>U0\A=S)FGV*M?EK9V=RP/ VSJ-Y\,9W!E<B7@!UJB>*,]V1L;.?AS"9.ML
MC?5&F3K[-3Z<I7/@^WT-FE?!:N+C\\)LF^G!YFWCP4FA6(H+*2!5QFF*A=3N
M$^*0X"2).>(Q%TZ]_4X/.38R:7MP+C8RNQHM)T&V-5E\0A?<8'D=@"I (RYH
MY+UH6YOZM%9LT?%KJYP<=6!+Q1:%73O%^LI010O7L4*?YHLF4JCN4Q.;8M$%
MS:$D4GM4>4:T,R44% 2A/&>2XS2=S.2#J?]U[[-HX7YYK%XRTKQD.U(%W-QY
M%6C%FT"KZ;% *[^S9,EA(4$?7>W" 8+?S@5TV&*%!V09697"XXBYER<\<;]S
M*WX=*37;U(LJ.(X0E1$L),(0J2+3-EPA(2UR*1.9B4PXN8'V0X_.ENN4UCM>
M0OG<>EXG)\62+X- '9HA_:%\1K4N6\#"E.@Z.?H;U>6R1>5P,2[K._3-2EBG
M435FY^7S\OM\84X2)PE/)$(LAA(3 1&2"!*6(B@9922/,D[=.D0>&6MLS-7F
M]55&U@M0-3XI78L+WFFKH_FK8ZK3,;SM.,H3BH%)J9L8N?(^P492G^D()^'P
MFXUP>+B!DQ%.ZKV;BW#Z$N^]-BXY?WY\GAJ_[/)QOEB6_VQR@1DFFEWB%/(T
MIA!)*F"1FF@!)5.DW4_$6!\WTUV2L3J8&VE!5UQO;3H.38P="P7">1SM/)RQ
M]]GCXP1\ _7]."3%6'J!G$#)H3_(J3N=';SP@5;?/VF7M%J?F1<%%ISA".(X
ME1"Q/('Z)B:,ON!Y7,@XBIW"Z(\--C;+ZM71NI$6U.+Z"%+8!=HY..$L^(8,
M2G!#[IQ@A(.0! I"V!WOK8(/#FI^).C@\#5N/")D.;F:+<OERP=I#LNGUS,A
M__P_\F5"99&1F!%(<XHA$H)"0JA&5%$IDR03B%B1Q\$1QL88C9"@E1+48@(M
MIQU/' ;R.#EX@2<P(S@C8\T#)[7?O/S5ZNVO)/_Y8?[C+_K:YL77/VR_[X?O
M.\A+?E*MU9M]^HL]BGK=RDKJ*[Y?SL1'^4-.YW4?V+924B+22!0)@:G,!$19
MRK1-D*4P%5F*I,P%55;5?4^.-+;7>R5KG>,@-M(Z%*(Z"NSQU]PK7(%?]S52
M6D[0$;1/[:ZCD#E4[?(%W4#UNOI#Z%:HRP:6HR6ZCMY@N.)<-GJ\*LME=<'
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M.Q;QA%!@_C!2@EK,"] (:G)[:L "!.!:8.*UJMV1X88M7W=:[YTZ=1:7G!G
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M J(825@@)2'.%<Z36$AJBK.=#C\Z0P8G8ALJ-,GA4*\G\A8GG^'Q#+V;N%(
M: WJ;GG=.CAU?=Z-%MT:G@/-@<,I;/BY&.C(-M"<N)WVGH?FT:/AGK<>[ASY
M/-U?'3J?>2N_R8HFKZ63U?*?SW1:*E-9[++ZFQ0/LEJGJVE/1AO2,H-1@;5?
M@U4$"<D$9)CD68:87G2$<\SK.1*-;0DRR69M6CYLRL>UH;)'LA/])"':3Z+E
MSLZ04Q-ZS^=TBF$WD7"C$Z 5:+0:-H_0&>0AT@;MA1I%EJ SAK9)@>XW[AM2
M7'>]J^[G;?;(*N>D'>$#K;ZO\DHF)&>8Y8K#(D4<HA0+2'&JY[;(]"P3RHMB
MO?=DQ\TNP_?8=PI,Q+5D57WF:MY:MI;] LR:%YEK^5UCD!TFQ(YEO8,\5 QS
M([8I8=:*!]YW(&ZYTDB_SKOS&>CL#IK?0&B'\0<.E'9'9C>0NL<]W!A.R')R
M-5N6RY=+(?1S6;7_^ZS'B2>I*C"G"8,13B*(,E/\#$<)3+*(8HEB&2=6IWU'
M1QG;IFPC*&A%O%C] (RPX&9F><AW'-CCE.0-KL#<TQLI:YZQ0F)#*-6*42K)
M?WZ8__B+OKXA$_W#-H<<O_<@9&&EWHH5[+Y\7I&#SEK=$HML>[1HHR:7N8QA
MILPF9U00R&2J/4^9I@DC>8*QT\'_R1''1@OK3/>.Q!>K)57V[)-S&G<[X\4K
MFH%9XUP@>V?^GP0G1!;_X4'?)"/_) :'LNM/7^B]3>S[EU_I/^:+#Z90U.6?
M935)I1 B9@12@4WR!J&P8'$!\PB1",<()2+UU!MV>^RQL='Q!J: O8!:?E K
M 'XW*KBV\'*8&#N2"@1W8+KRBK3/_K"',!NH*>S.\&/I!'L(%X?VKP=OT8_C
M?EG,J^KK8J[*Y22.A.*2YC"C20H1*S D..-08AEC@1@N.'?9M^_<>VP[\+5H
MX*F6S8U[NH#9<4M/& )S1X/ U^,(.'/"'EU]OO/=VP_Z3N_1:_N=W?<5[UNZ
M]2"3C!2*Q@F",HH3B#+]CI)<$HAPE.><)!&63FE?IP8<FX51[Q@^M4)[VYUM
ML#U[1]89L3?>A:WE'63;]14R VVU-F..97OU%0(.6ZJOKSMS&_5N29?R9J&I
MZD>I%9JD!:=9K!+(*$%ZV:=2.S': " B5PF5DB4RZ[63NC70V%AD>XNP%E=#
M"E8"]]Q-W<;7<4/U#-0&WE.U!ZS_INH!-'SMJV[?_FVV5@\H>7!W]=#W^YD;
MS7EU?4_#/Y_G3=GKVGL6C(I8<@5Q(01$.8X@BQ-AJMDAFFHSQ+$FQ9&QQD8/
M;>C'6E:P$M;-X#B&KIVMX0FSP.1P$"[O^PX6>/@T+HX--ZA=8:'WMDEA<XF_
M4QGS2*L\R1$G&:1IK@DC3;C^J<!0$)JDA4HT;UAU S\QSMC(8M_!0:^MS4.X
M]C]K&1=-] '*RZE*('8X--2;GZ <88537^]K1JP;$W]H^V=(\?YEE1G^3*=M
MP/++1TU'6WG$L:1QCK3[$4><:3LCBF"1BAA&0A**.?]_W7UKD^.XE>7W^16,
M\(2W.T+P\@&2P#IB(K)>[=RHJJRMJAZ'PQ\4>&9R1BGED,IRIW_] B E42\*
MH$ FVQ_<KLPDB7L/I,,+X-YS,4^I6YS1WYBI<<N)UE#*_G86_R:)2DMF_B +
ML]K7Q67;_''P854"4PO0 L8UCKEB>FT#G7$F;?!(:->A>^>'/HTY,7TO@?9E
MT(IR'[#Z#:BNL&?DB.MZY(Y#,@_/[-FJ3X]W)[^7@E3/Y8NI7#0#S F*,BCU
M%A#4I]<XS=6_XA#$B60PI8Q(Z+2A?':DJ7%K?3*J$_8;4VLIXN;[Z!B[G<?7
MCO^\H#8PN?4%S+TQWB4PO+:_.SO8N$WN+OE\U,KNX@W]F.*S6.N PFPP<4U/
MOU;Z)+KF+EW#L&TV/8\S(3.),8B9UC_F&"GJB!" !,4933'CN5.QE_W04SM3
M-E5=YF2JL5V_\G]ZUI7^Q?)G];_&@U:K;C=^<9@5.\(9!NN!&4C#;*+=+VV8
M?]W O#4^N+D,LS,KN2/FDZ8<1A^5M]Q1.22R'D_HF=.W*95M.N[L==KY9&A4
M\#O=I>>YU/(-ZH+/JV6Y^?$-J8JZ?_(\80S& D8@C4,((&(,$!IF($E$FH0\
M9H(Y:<5XLVQJ,=:NQMQTWZK-->O3MOW]0BY_TVG'F*\R20,3JJ?Y<<\?](VE
MU^Q";\:-FWOH&].CS$3O WAK?:F6T)5Z>93FA^\E6592E,J::$X)XQ%D!%!"
M,(!A)@!*(YVK3:F,,XB0Z%4@8C/XU-BX[L2S55IC;;NO[EUY?@K<SB]\ SO6
MH<9>I\D]RX.6Z8,VCKR(U\#](,^/_]IM'B\B8]&]\?(S^M'91YWF5<M3OA,5
M*XLG,X")3!B7:1[2#- (*?9*:02H4,ML3I,,)I!%F90N[-4QUM3(JC9UMA%A
M;9G;+USL@MF.H3R!-S A78&;,P=9(.*3<KJ&&Y5A+/P^)!2;6ZX^?+U9+(PF
M2?M7FPXX"&64Y'$$9"J%WN?7$MF8 ,$$#V'"\IPZM?:V&W9JK-(R<18HNX-:
M^:=];M>W^Y#E/#B?AWI"=[R3SRN O>: TP*G@8XRNT9^K4-+"S0ZCB=M[KXF
MX_0[^>WF>?VPTF>==>X8(Y1&F>:D) )0,@IPDB8@(3"F"8(I1$ZY8Z>'F1X;
MF<1)96:PM;-7ZM@95&VYYEJL!N<6=YAZII:>0\%_5NG12*^04'K.V].YI&>O
M]I9&^E']XG8M'JLYS7(,XT@M=SBG*EK)($!4ARPQB@1-.$G<&B1W#38U5CB=
M)ZG-#8R]UZ>5[G!VVYNY%KVQ]F*<@?.19GJ$R,"YIKOQ7COA],ASBZS3XWNN
M:JI:?2$O>BW5]&J?PR0G+(9ZH2.)/J&3 +$\ 8B@A*IP@E#.>C14/1AF:LRQ
ML5(7R&HS>[5//832CB*N!VA@<MABTU@X"QH;O7=,/8/! -U2#T=ZC4ZI9[P]
MTR7UW-4]>^^P!\&?%^).[N16;Y=JG?)<5]-NDY##/$S2"",@8+V/*@'&:HV1
MAAASA7$:NLF$V0X\-8*HE1\^KYH^H#>/]5="KLH]?6.30'Y_7QHAUKI*O"T7
M?_>\KM;JFF)Y[]@/QG:^[#AGB%D8F(4V)NLTRIW10<OJ0?/!71'SV@G&=NQQ
MV\ X(G+4 \;U_IY,5]PO"UDPLEP?]YO>?6\H$2K D1RDA$$ (:& 0A4 Q7D8
M"4DS%KF5X-D-.S66^_;KIT\W7_\6W'T(OMW^\OGVP^W;F\^Z@>O;NU\_?[_]
M_$OPY>[C[=O;]XXM7"TGP9*\O$,[-'7M# Y.]J ?AK&<8/+*5W8CC\M63F@<
M<97;W3U:5;U=5>L[J:O-JF^B_%$PT;12CR5)0Y%' +,P!3!!,<"<<*!69SFE
M<2I4>&9#3)VC3(V'M)VFC9ZV- !!51MKF?K=#6@WR7B#:6!.,0C=2=.KJ H:
M*R^WHW? R:$/E ^\1NKTU!,WMTY.E_#H[-5T]N;QNC%=LG^OW]+%B_LJ+]TN
M%=68L@_QCJS)9E<ESB.&2(9!CB4#,&,,X(2JM2F-2<3S#'+BJ&%_>J"I<6(C
M)-0R5E?!DHN;,6[H=K.C3\P&)LB^</507>K&XFK5I3./'UEUJ=O)8]6E"]?[
M;[-VON_;#?^OY_HL?MNH2V8)"K-$@@1R!*",($ YXR!,)4X1RL.4Q;ZZK;D8
MYD0Z__)-UYRFU&[Q^!H3-3#36;1@VWDR:^E;R%4)=(2M&WUL_)L%1*HO[GB]
MV/J /E9+-B?;)M.9K0^B+@W:>CV_I_B":6!O*K2_F8[JMU7U+/B<J$5QK,7U
MDIAJZ06U/*9)' *>A9B(1'*1.65WGQEG:B%@;690:3MGFQ[SA3$U^*E8-K]Q
M).!S&-OQJ0?D!E\I&]"^U:#51LZ"VDR/R@O=.'C573@SU+BJ"]W^'FDN7+B\
M[QKQZ+FM$[9Y+,,H@C@!<:)0A"1F (F<@!QRF%(D$AYCMY5BUW!3(XMF 73J
MX^]^#FF)N.WJT1>.XZPA>T/88RUI@\S5*\K.049>5]HX?+RZM+KKZICC"RGO
M2B,$RLWY_1=1FM'F>1YA%!(,TI!2 !$4@$**  E1@DB:,\BLU+\=QIP:O>S'
M(D^D#'Z8% <=A_#58D'**E KQCHFZ1^2G)T"Y_#$!["CABK*8*T37IO<)) H
MHVL"&B1RN0310%',V6%?*Z*YA$-'='/QUIY9#/H9;T@EN%Z4J159+4E<ENKC
M8U2*W[SL+FEZ(MS\@Y1<JUOJS;AM7H59V7U_(,L[4T=7?5Z92A7!_RJ*^P?U
M_S<_1$GNQ2_JT6NMIK<5+Y@S3!*$$[76RO,8P)Q*M>K"' @8YK&(LE@0/J]W
MB10"Y=J.^Z;@F@L''#HX'!W\VI@?4'%?+)<Z9X 2=0436B&+]Z;7*2 ^CU+(
M29QFNF2) !A3#%"89(#&F0R3D!"*9?-A>K^T[*L^!<?</TH;]T;X( D3(/T+
M?8KLHH IF#JA,,/X"JAV-F@#$K00T?IP[>L:5 (#RRRH@=G+OJRWH=<*FZ !
M9Q9LX9D%&X""!J' 0%0+^>XR9#VF/TUHSKTF5TW!KW%3MZ;@\;G$L"G9=EWC
MO*]BH:/6[ZOOY+>_%NN'A]5"ORST)O]))^=IS',14@9HE H5#L(,("J9"@<C
M''$>QE@M@I<F$YY_=^^KYVJ/%<'BFF"/K!J.;)7U0I<5%3PH:X]T3[FE6-<O
MW: 2Z_6BIMR5#$3-JT1_1'HVZ7.>1[MWZ*#3,FI3OYFIAV[9/CO]IMM]B?TW
M^NN+XA - )UM>97&@'T1.]<PL/?S^FO-+-5GX^6S6,]I+,.<9P1@JAMW(!0"
M!&4"PC@2.8UQR&,GY?CVPZ>V3[BUS5T39H=7PF.1RA#D.*.Z82L!"*D?&9-"
M(L1$J/O$VV?K],9KA(R;6FJP\(":':_WQ6)@KMZ:I181PB,!GW+7M[C-]OFC
M2]@<>G9*J.;HFFLK2$_4J%=O7EH_U5)Q:1JE7""BXD,H 4SR%)!(?9/SE-(,
MQ5&68J>NB*X&3(T8VP6-I_07U/)9K<'W!!GZJ/<YSY/EELJ Z ^]_>$=^"NJ
M2=W0&Z:JU-*&5ZHN=4/H?)6IXW-ZU'"9&@A]8R-66*N<?A.+A:X6,TWNYR%+
MDRA-0Y!"]1\8<1T$AC%@E/ DD@E$$=HLFKMYT';('NOBP;>C!2F7IO6$SBET
M*%:R0;B;O[RB-A)?:6N!?NY.FK2V.&A,#FJ;/0/I4 #F&="1:L&N!]:M+,P!
MI<X*,9OGC%<LYN#57MV8RWW]2\C8JGQ:U<K3YE3^K2[>+5_>KKB8,XG5 CQ4
M<6B<"Q619AC0.)> )5G.>9@P2AWS SO'FUP NNE$7Y_<_-_GLJAXP4S$HT*C
M/5_,9>4]61;_=!"]MYV(;LH> -Z!&7M;>]8R=Q9L\6Z,#K35?NO0+.#Q4([6
M-<KH56D6+I\J3K.YK>?"6//:=W7OS9*_*TK!UA^*)5DRQ6J&Z2KSWZ^"B>*'
MCC@WG2L/NK]*C&(1Z;I6G/!&D"2$"9 9SJ@(6828D^JT'[,FQV&MM=SY/K^U
M#I-Q,-AYZ'B^XFE>+9?7H\_6>$&LULBJ?0JV3M634\V.)FFVZ_D[J+R35[R]
M+M/]6#;NXMTKFD=+>K]/[\?RGYZ7!2N>R.+S:JU[.!G)C(2P+!:*LZ,092J@
M9 P@1A* LS!%!,J$$:>&[*<&F1H#;VT,JFT=H!NQGH32CB:O!6A@TMMA8^SS
M*#-B X!/%CHYSJB<TN7I(4-T7MOO^_Z+6-V7Y.FA8.^*:ET6]-DD^FBM^ BF
M"2$2 9+P", ,,4!PE@(>IB+&D9!8.!6#G!]J:M_]G:5!V]1>0OP= -MQ@1_8
M!F:$GH@Y\\)E,'RR0\=HHW+$9:\/F<+BCAX' 9]6IMO93L(-9B(F$L0Y3M12
M+E9+.91!0'&6T$@D,.-62[D3SYX:(VRL<]B*/@#+8ON^/P1#O^\;P_KHL!W
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MJ_*1*'_NZ**X-S'1^]^>!%/AS/?B45UR)[^IWU92;YZMEA^W^M0)9E2J3QN
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MUYG8\0NH3^(_J2+J?0M_7X74)]'U7DQ]>I1^;Y,W9*$'_O8@Q/KCJFXK:/@
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M/R]4<Y[FY1_>Y:NKOH-W7['OWH//,+C/_H/!QN!=LK@C6UKZ#6@P,AA0I>&
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M@*4,O6'G2YN9J"!YG2GA46A=Y4QF$R(;&0[>=4:GFIX:L(N%_'LL?$DHLV%
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MR27I(',?$^&&!%7E7/>U#*?K&&';J*4!A&WJG'RXOGP7I BF=%WR(FOTD7,
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M$9)RKERFT"%7F>SQ#$U-E:KTY"UUI;)VT;=:F(Q8(DS0"!%'0 AFP CN@*N
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M+AH?2)4$P[8$]WM0TR,B.]#?KO;PM.8,W)NCC@%CP7I1RF=+%VC!/0%#A(7
MDK2&TIQ)%>_^6:KZO4J])^#MHHF7?2BXW0WIGSURCP>#%>\W+]][%6'>W-*]
M=*-5F<,PS29YX>5W?N:ZVVMK**!#0=0YO]6>,&DB!X_F'S>&P,!S8G%/(#Y*
M'H-/KH;][/C\=L.*F\_NQZ(,\73R9O73%)<=2M T'^?WPQGJ\A_)30<LH^V)
MI0<@%QJM&J6 P28#*756RA/)217Y5..HJ;/B3="W:Y55'9TWD/WL0A"?T+J<
M_I%&W])'M%/GLX&C5#)-(U"''J+(!J,;+1TXW,T)3RPC)ZWB_CXS317 ]@WY
MG33]2M!^^L>D+/390&2K5*8)0K2XTCU%M7B*O%M"/'JMT;(J?2JZ9**ILMF^
MT;V59E\+JA&A:<D]88YD&CQ85\X%28GRHHZXL%E@SK.<7=UKWIVPT52A;>_(
MWDZ[KP3;[R>7TQ7STMML,H'2E@V$\ :,U Z2XRJ;Q!BK5(;9)1?])H@:0_9V
MNFWBD&]'S@O7[_$+?,3I>9HFEY&X 1.)V!#)8N@@"&<<>*<HY.03D='A#WZ:
M#ZE+XEKP50W#MR$-OA(#/6"1<$(8 R*< Y&4!B=S J:BHI*H+!1MU2ZOA6?=
M,)Y[TV1GQYEU$_F/7VO:.=_\_&-KY),W8*2C?/%!")/+<>DT\WDR&H;A;:0J
MQ7RR'"3!=2ETJ:@.3D&FM$S*LI:**F=O3Y-4_VC\<04L:^9\IBZ9;"#P,J:@
M7-ATC'$@6@>C4XQ4UG5-MZ&ZWWQP1^C:_(B\*STVL'T?C?%98S=:LK0<\5DX
M7=YUL"H32R3X7)HI*(ZN2$H$,$CTDD7CN:C2".,YHGJ^:;0_;$PJ*:IAT*T*
MTPT7GEJB@0K*0$0FP3"E0*$C0:1+'%?Q/F'7PGVD[M2_)JZVT$7?4?7?AF?G
MJSL(C,;@#%)L2<H@) 91SD6S.*9@7*%+G,3/W+1[SVQ3_]NH:;*[S/I6]<=)
M+"T,TXITI;(5C.(F[Z0L-40)G%("N#%,,&1,2+66NN\^M]^SOUHJWT%V?:O]
MP^2/%=4D6$=2DI"CPCA3)P->: ZFM"0G6CFC\EH:OWYDOT=AM92]G<0:\!&V
M];0^W%0KFL YB1&RXK@K>H<,$TJ!)$*LT-39.L.'=Z:\YPM>O;FX^U7YB\#X
M\71X-AR7FNBC\>KJ[JU:(Z.B)L;$TIX,HUP>%3C#'# ;I.%&X)]U*Q"VH_ME
MAG!;HFQCC'>G\A>'\!L^WZ0\F2()<_SP+>Z#39'CA@<YE]Y1WF@P&1T6%9W'
ML"=[7^<Z;K=LO$S[W@?^.P7$"UL.5]5(3W NO5<VBPR!XO8JA,Q@$F&@=+DR
MX9,*OJ=\\;HL].MPOYQET"$07MH2N"Y;>H)WW/^\DR1 L!9W0R]1!<H[X$ZH
M4G\JA.CI0NOZ3/1;J/:"ED&78'AA"^&ZRND)UJU@FFEE0&6;D77+P##!(;M(
MO-9:95UE '>'//1;U?9RED&74'AIJV#X#;_[B%P_)P##.+?26J">H0"8D.5^
MJ@>6E4[4&R)(E?%<G7/2;Z'<"UH1G</B1:R+ 2=2<N0&--$)Y<M+]V;Y_[7W
MIDUN'KFZX/?Y+YC(??DR$259]E&,+.E*<O?<3XQ<D!+/J2)]29:[=7[](%FL
M1;6)RYM\D^73$6V7+(G$\@ )()%  NE]*DP:+AOWZ3])VK@M<;TC=R?%G4B/
MW',+L?=OD7OV4UMTR&W/1IL'U1@,<U%+<E+2@:H7<M[7_:I!UTN:R+1J$L<-
M^Z"Z;MO Z]E*R[28_EG%>'4_D*V13/($.CM%'*8 W@0!P;%4M*8<%AN-_'Z2
MIJX>->^"@,=6=@TA]Q&/O^5B-?D49E]QW=>2'8N%DPMF*M8)E>@A"":!>,G:
M1*&\V^8=,7WH':#0K^Z#Y(=O'1L. ^EP?JA >T#!YNJZL, QH  4SH!2@HQ"
MR "H,*)17KJ\3=E_>QR,V?%S@,;NZWP/\8VL]=^GL^G%Y<6&<"VT+D@JDJ)6
M='*R$!AF4A>%[D%$+M,VC8!;Z?V';QY9\_OH;3Z$$,?6?OCW'<+)GX5B! 7@
M*M-1J%*"&),AGQ<QY.(H^MIF</AVVK_[S>/<SPVF_;V%V$':^_CQ=YN9*>.T
M3U8 BRZ!8MZ"RX9#T(I[KU4.O-%FVV?I&GM(R+ Q0PME=(*M^TL O^#BXL/-
M>"T^,3XG9K@#712)2Z"N>QXRQ(*F]M@QI8ZV5/@>;3W&I7MB88M5PX<HIOL!
M@;]]^/#+/]^^>W?V_I>W[[^<O?_M[:M:?_C\YLM>V\J?^[AAJR1;$SY0>>2W
M^3S_:WI^?C;+;XGRV=<I^;2KJ92WRU]OUUTS'NF4B\!UK!AACDY,C,"TX=P&
MXX-J,G9J)RH/]6);?=GMMCUTG ()25&$HG^H6!?M&6Y!8K!DE9BS;W(;LAN9
MX_JV=BB[[^D:*N^4G=[^F]=__J%'<X -=[3O"% 4%@,CF#A6-^?5S<4F)$B"
M)^&-%C(VV0UW5#=XNX;D^FOO[&^.#%6R""Y9$D"V&J*(#$00EBGGT;DV8S>?
MINFD'-P.^'EZ!^-A:ND@7;AEY=?I;+K"=W6^Q7WQW=MM*UU*+!0)0A=3VU$5
M>,T%&&U]<MH$V6:+WAZTCINRCH'(-FKL"*GSYUC\]7)517HQ7ZRF_[W6\V8U
MW/WUS('5:?X:?%V8HUR2X%7V8)P*G--O\3;K^H9D8MS.XN-C^^B*[S[8O"^$
M:YV$S1K$ UH3MOWH80//O1@:)?STMLY(Y0YX-.0\F;$02W'UK9)508N8;9,;
M_I'"SU>7R^D,E\NS]'\NI\MU]\CRU?<[O[JJPR;I YTC=1*7IZQ1)P^1E0#2
M&+1"6LHIFQ2N=R7TE +579#V=%C00($=Q 2/<+6^3^8^^F"# 68C@BK*00PV
M@\Y>9 Q<ZM0$AT_0T\O>\!8@N+_\>0"-= JL^N,"<3.K0"F!C!<.V84,RGH.
MGI&!ELR"PLR(W28OTWY*V<A[GH?0_Q:8VE\98T_W>/VMKM/X]^;FF@ASUD0%
M7%[-JS 0@HJ 44>AF%4QVI_%:@\_MC\,'*"O^2#"&UOMY(7/S[__.B6ZYW^N
MINFWB_@?&S9LX2Z)^H:+!4W^-@N(*2<PB3%?-\^9J+?"P-/?,?)Z[G: &$BL
M'1PYSR2WK[[_'OYSOGA]'DB&ZWZYS)2))H(-=9&<474*.#')B%5"/8]HFES@
M[T!C+_N[CQ#SM-)<WZ"\9>Q]N+BV8^-=$5P$X.@3*&<%>,<"\>A=T+E$[XX-
MS,?H'/=\;(:7[7%YL/+&/DY_#[/+4G<%+JZ662<R\2^8OLWFY_.OWZ^'OB5=
M@B53-DFXJ]2Y1IK$GY!(/Q0NMQN?MLVW=8NIPW4];RGX#KS<^_DLS2_^Q!6>
M?:689#WO_;H_U5 P$D,-1^JD=\D41,T89.E8E%)S[V,+A_8T2>,>K,? V<!J
MZ0!@CP0A[VZ:"JM!> I_@3E>)SK4L5>A*+ :D[->A'BT2L*[G5I]VTVM&;EB
MM9]N.L+9Z_E%K,_&B9?7)+'I>A1JE=8BS)97E/%)CH)CK/F1CA:4(/_L-<K:
M;"JRY9J<>).Q,KL0V5TA8T]H/(&YP?4T=EBV V,?KY3YCW!^6:]VU_>WK\/R
MV_7"E4F1:'26 3P/M=DZ._+Q2D*22KC =7!\N]+8@$1U5T<Y#(^CZJP#?WF[
MW&=3C[J6!2[76\<GG#'C"G/ 8FV##1G!UR,&I766&:T$-FDL_AEAXY[/S?SB
MH/KHTQ?612[$X@\6=K98U"=Q:];_F.7I<KWQ!7-M84GT[P^7*PJ$*<Q13G'/
M#%B) A26#*X$ =%R$GBRCDEW@$<\@+1QQ[L=TR\>2W^GB=[7W^J/;V?/22$(
M#+(.?XA"L+IWF 2 =7>\9%8QI;SW+5&\!8GC3FGK"<U#Z[.?,__7^>()_M]-
M0YS6F4DWBP'/TFKZ%RD"EQ,?=;%%$G<%UR^-#3@5#9@B>;U6JDNW&@8$^U$]
M[HRUUM'"$31YVL[X[*(:[M4[TT?^RJ91=A*\\R4A GI+JE"6[)@9";X6U!"%
M9EP>P2]O1^VXP]=Z=-$-M#PV['_9?.?'RT7Z5B?:W67H)N=T6")CJEZ1U57"
MJK8618JOBE)T*B6KA-UN&?167[<5\-QI 6]X.8^-G$=,Z1.F^=?9]+\QO\W$
MS[1,P\W5Q2;;S&&6K\^,NF=SN;R\P/P>5U]^N.B8H,LJ.5= >VM!Y1"K)"3D
M$$0PI :3P[Z><C@RMT*J/RVD]J/7#B+9/85Q]I@PZOS.&7W=]TE).GB=$:2L
M!X2,I!LG"UE]+B8IBIGP6-<"AW.SW?T!.QDCZ$?U+PS_M8I-O_&&_LA?X7Q]
MWDFIHE1!0^1< Z6Q#EQ2]28;C32)T7'7)-5KR]9V%O$BKM3& L,+,XW[?1[K
MEWA?*.NX?L<T"4H&GM$ JL) 657 HV9@;"[6,ZX5-AE%<%0NMS.<T[G[ZQ\J
M'=C1#=V\)!:88Y R*E"\6,J8ZQIJSI7E).8<FT1%NZ'O]&[\]A)P!\"XZH,[
M?ZP/[MI"^ 05T[IX ]EX.C1"X>!-CN"\8C99IWAL,NA\&^*V ]3I7-DU4TP'
M8+LF_)GFRW_B].NW%;GEOW 1ON(?2RR7Y^^F!2=<!F(YD8NMNZ+(XR8(+#.P
MQ603E=?"--DF>0C1VX'S=&[@CJ[('D![9Q;'AW*?S8E623AG%2#/&53&!%'1
M3X$+G^HT<)>:3&!YGJSM@'=Z5V4#*J/[J2C/3*^['27S^?+B(BR^S\O5]0F)
M_3H2.6!HRD#??+1A?GN+8Y21*RYD(PCHP)*AU('Q -%9!$Q*HP]>FC9K,$<9
M?/II?G[^ZWSQK[#($\;)N3-;YWX@12M*2O!.R?K@N9C(6$;?=-;,'5I.:7#*
M+GAY*BW95PT=G+\WF14E5#(P+L"75$!IZ2!B"<!\,C;JDD@\XZ>NK3&SMR:?
M2EAW$>O></@3%]-Y_KP*B]6@H+@.1'^Y>L:W_I8)DVBUJ+, =2&.ZH-3;YT$
M;8O-=;NL+4TRA>>(ZF. X]#@.5C\'?F7]?. \RN5S&Y:",[2NENPMESE_[R\
MV@RXG$COA$J! M<22&+(#?VD"R3CF0^:IRB;O*;<@]8^IBL.#;Q6RNH(CQ,O
M11'K-P*VU@]C1 @H.3BAA63(@W!-AG_M=-XU*ZPU.^]V$>N!Y]V;6>XE3WP0
M9S;.#I_ZOA%RPJU8'R433#&2#\( 6M;+6*,C!.<9H#6\".6<T4WN&T<:OOFS
MD<X3H6.)+'E (4@>23"@SV.07)'H+?.Y]=C-GY'81PXP/+KVG\.]D](Z.%YW
M&5JC2HKD$P@RIA!K12 X[P,@*J-8*1Y-$SP./9[J"",YAX7) 8.I=M%9WW!\
M= Y)#,KF[!6P8G4M!@F()%D*@8()/+FD@STR)$][,-5.>#EP,-4NRNL F[?C
MD%Y1<O60Q:L1-MQS9[(T8+*G4#S51_,8Z]I2FV6TIEC9Y&GY5M1UB\/#\3%O
MK:P.$$A1S6HQC9?K9JYZGWS-1T87*9&79*8&04F7('CB RU/(6$0NLVBM*<(
M.JUA5H?@;!"5= "MUY?+U?P"%Y_PJHRT_#;]\\9*F(PAN$CR,8I8X1DBTPE$
MCL12\BYCDWZG9V@:MXQW3( -I9@.,/:,V-[=M$,P:67,TH&V/()RT4 4W(#B
M"DV@"*3D)M=:VQ#7R_#;L;*+_;34-_*N!M#D6+@N&2$G0?Q(C^"S<^"8##(0
M,\XTN<'X&6'=!FQ[0F%[K.VNE[YQ=I;2Y<4E^7#,=[NV)L(+Y0128)#JFM3B
M/7AK$QC+E4Z8$F=-%E[N3FJW05US+ ZAN]W1Z:_0.<.O]8N_' .D[W$U<3D:
MBY3W9U/J>W!9@PK'("HR.I8M'1U-WL<]3U:W 5]S\.VJD_W=X'P5SONXH/M0
MWBQ7TXN*^R<W #[L=VU[B7<834>_Z!M0A*-<!A*N;3(E 5?UNJ9@ <^L A-]
M4584']NVMQWE,O"Y,^>ANCYAS2;)T]4,8$F ^-\8%A/,W,:<)42?,KD=)2$X
M01FFU#Q[0V>4/WH L27MIW1]N L>=PDM6JBY\TCX(<OOR<5\^1>>_X6_SV>K
M;_7E@DI6R00R<8JL2+80>&2 3(<213+6'_M>9PNR^^AJ[ W/!RGWY*!<C?7+
MO^:39#PO61@PHK9]*FD@Y."@>)5"X":8<NPZUM/4]M$5V1MP]U'E:>*5 (@3
MYJ)7ND3P0M9EWCE0_F(C&"E1B.)R\ V?->],;Q_]F%UB=F=UGB1J?YU?+B96
M9YZ<(%%J%VM7EZ"P*/"*-2$H2O(Q=N)F*[GC3B#N&;,[*W/L482[L7A6Z&MO
M^.0HE(P$*N^RH5@^U#=&B?@L*O@D?#;W6]F?&#1X !'C#@]N#\6C*JEO_UDK
MB(DI47),8!PR.@V*@:@X@B\1D>3'?9NVI &JNLW&_7;A#W=53O?EW=<?WG]Y
M^_ZW-^]?OWWS>9]:[(\?,&SA]!GB!JIROIY?7$ROGEH1KFZF-J<I/@8J8S5R
M1^<<=XY )82%D.J+GJ@9:IM*HY;JG:@\N+=HFR_[0O)_17_KOR:U(,"$MI"R
MK$UYA4/DN4 *.C-C-!KF1I/)#9GCUB[;H>Q!_U$[Y74_<N3SEP^O_]__^/#N
MES>?/K_Y7W^\_?*_]_%GCWS*L$[M9V0.Y-GJW,S5]QM01=3%\I1 ,HF@=(@0
M5'0@5131.,_1-+EW^)&,@Y]CK0BUW^;G9*[+JT]^/U_A8\AV7%JA+ ?-ZSX4
M2J A1.D!K5(4 "070I/)1EM3.*Y'.@ =#UY;-=')"7J;=3/?7O?93WY6:\_S
M&,F-_(\,)F5*S0)/]FH9M8]TW"AA>)*RQ.*:C+48V/_<7-<_1/U:EK=@-Y%9
MG8P&(^N2/&<<>*$,Y,!#U!89XTWBHNU)[,L#[8"/I]][#JJ5#LH$MYQ]66 @
MB_Z^YO#5]W7/^BU;)<JZ_DL1,[7CB-<U2EE3\LN<4MD4)UR3NNJ6](U[T]H$
M:</IHRN8W>F=7(^-IGR"B/J&LR6=*&_K)GA\-U\N[UD5"RY+5CQHK.\D(@42
M7F8!5D:MA9%%MG[ZOA?=X]ZC-H%E>_V=8&!V9\+B@_/A@"[$_;ZH=4BW,[,#
MQ7L/O^UV!F#TV6".$.F8I>S">*@#32G%0.$RY]:*)KGGTR0-' =>^__U:QZ#
MJB 2C\8152I[#H%Q#<XYQ9B5VFMYA,#O+DTCSUD8!AD_B?KVUD$/YR\I8[U'
M\$H\U6G/9^L:7GWD'[WW6=%YD$2]9W4Y$Q_DHF.P+(04G-=-)H\^2U4OHSL.
MU/V#6L90BN@ 5?=XV+QN528)6]?GV%Q?.Q2;*<X(&3AR5,F+X'B3L4V/4C.V
M8QI,V_.A1=\!?NI=PGRV-K#-"V85$D6$H@Z_S^O59 I<\0RD=*FZ;"U$DZ+J
M TIZ*%T<I-U'KFWV%W4'6#G+>3TH/YQ_#-/\=O8Z_#E=A?,-,\X7)@(E%$;E
MNM)1,P@2$S!=BD.>8O%MME\\1U4/18DA,32<"CK TZ>:J<PPOPF+V73V]7J$
M0K*8@^8!0KT55=D$H !2 &+R7"63M&G2]/HX.3W4#X9$T !"[P Z6Y1 KH>^
MD$,MH2ZZBJ8NW*CK!*W3Q%@N4AOKI6TR1F!K"L=MFF[@HIJHI@/,?5P+=$,[
M9EXHS5# <J*CFZ0"+A<&5C$;N&6L8)/3[BX1X[8N#X^<O07< 3C>SPG9LQ5]
M*OV)KV]G],FXO.&%4E5#+$"Q1A,O,H)#P<%3SFIM<<1+DVK1<T2-VVP\/'@&
M4\#87>ROK[PG.<LWI6!:7>TL^%#.\OS/M7HV>6O0F?*%(GC=4,8H;[6"G*BR
MG&ED)HM[&WJ>:%??YMMZF;$T3!FHC9![1\VUA2G!$QH&7/EJ89$$IHT$(9R*
M.0N=Y$^O1';XOG%2^$8:W@4_>XB[=P3=+JS8.%69D0LO$41DE#)$6\#;H,$K
M:V/R5HK$AO%!][ZY8U3MH_>=_-(A2N@@3%K[[HTG?W<SIB<:)I0A-RY0D+A2
MB.!UEO6F6CKOF(^Z3<O]8]2,F_"WNO0X7/ =H(>RQ]J1@[_@U;_?SAY>.WZZ
MLXW%%VVBH]S2)59G+M:].N3P0:S7N%+0IWB3N5D[TCGRNX7#D3$_GIHZ0.&=
M.O[G;R3BY8?+U7(59IGRCDDV.?H<B1<= JB0#$0G&1BILO4L)9:;W.,^1]2X
M^&J*AJ>O6 Y333=K!!_*BN1Y?ED9^EA?RY(.5U?3KM?=7O/'T^")(-:EK=L3
MI1*4 !=/$8++H%T=>QVRD-BF47D0\L=-0(\)X!'4W1?4WRZ7ES]N:[PRY/4_
MUWL#:M$(9\NK<9]8K/,4YD+FNM1G= A1Y (F)U.$L$RR)F78/6@=-ZX\.H@;
M*K*#&. )%O\1SB_Q"0XC,>:R]/6=IZ3CAP7*"86%%+.W/D15<KL&R9U('?=&
MJ@.D#J7&'H"Z-KK:+$#R^A+^_<_IZEL5)?%*_^$)'I5-D<X)#::P!"I*13PF
M#]:A"0Y1E-BF&7$/8L>]!#LJ6%NKLI]YV'>6XZZ7;-!GS[?E.,<DLHP)2+CK
MECZLR^@-E*B\-('.&=<DZ3^ YG'OXHZ)X6,IMDLH?YD_T;ZU9CC>9_@3DNB7
MTQ5^QL5?TX179],G3/.OL_6GK(^IB2U.VR@)CTJ16#2W%.L7 5J7PF0)0<36
M>&_"V+B#B$8RBO$ATD/,4B7]"?_<[$S/9S-B:35=/)9.3)S/-B0ZT;))%(_5
M6Q#O:O=C*:B5%IKIW"RLWI+(K:#L7@*4FZFN'X>^'8M7AB=YI.15&3 FAJLW
ME[$D)#8M3YHQBK^:M++N0.-6V/1_'VSNKKA^H/D>5[?/?R=,^IQX-N \DGEI
MC76Z%$)QUME$\HL%6X#O!RJVNWM@+P%?^TN_@S/WN8?DQ-B'0E'Z)&5,Q4@+
M=NVPZ^5)8"B@&.$RTU(ZWZ2/<1OBM@/:B[CE&EQ7'>#OXV*>$//R5Y+L[]/9
M?$'R6H<)&PE.M$O%YF2A"%<')F#M!PX&6#9<*9><QB8](C\C;#O<O8C+J4%U
MU 'F?G#86]VK4>J$L?819^2U^.L91%.;KPR95JAK,DJ3=[4[4[H=*E_$;5-;
M+>X-T[]P$>?'Z#C!^N)/&@:ZL#JI. N(5I#?#SK+(!V7HLD5Z.$=)R_B"FDP
MW1QX#_]FEGMJ.%&\SALB0:)TBC)Z@Q""I$/!*\\I-'92-9IG<;2&$_XR;I6.
MK^]!D3[*A*EJZ+>5A+-$'T$?@X>LNSSH^XXX;VHGUMN,&14Z*%6B@_I$E.#.
M+*4V0@-3I?"H*/&134J^PXZ7VO3=_C!C\*K/.V2EI) 9<@FN]MXZB*&008GD
M%,_>,=>D</,D13U,XMA+^T]TP1\H\PY2E^>GVIAD4_'>0=8UP!5*@R\F 3=1
MQ.)(^ZS)9I&.ATD-I/F=1DGMHH8.,/7XFUQOC#11DU!X?8==B@"?2X)@#"O&
M($K>T-F>T"BIG;2]U2BI743? 7X>SC=B1BLI90%3> ;%?2;:$VE;6(5)AQS;
MK(P]B5%2.VGWIZ.D=A%U!UBY%T9^7,R_+L+%VHX2I<K1I+H9Q9 =^:# 61DA
MFLSK.Z3B8Q/0/$W2N,\/&IU<PRB@6RAMC(Q+RSBS%G1QAIQRL!"+46 E\4BQ
M(I.^27/4<T2-?(@-I/BM\+2'%D9_!G_K6A^PL_&UO&BF4C90NV=!1<V )*/!
M>(;.,2M2N%=Q?>KA^T^_JT>L[*/4>3L)=^""-@?\(X[ZW<V#6NM-B;7S&G-=
M^(7:@N-2 ;J<)>>H=&ER?[D%;>.^3&ISO@VMD@Y0ME-O7>VL<R4B1"U#?4^5
M*+I$1L&FRR[:D$O#<>Q#MD6VCLJ'0\@AK9"[J*L#*/X@KK-$DB0:SO["1?B*
MK^?+.K9DS=B$%>48H@:GF:O7 B1 I2@IMB*7J$R4ILF%^;8$=C$?MAD$FZBI
M _CMTLFI9-$:;>4EJ?H>VD!,AD%!([2/G/O4)@,8N 6W]8C9D?W@[LHZQ1TU
MC\:\PUX:/OL5S>\)MV>PS=5@25:1PTJ4.(0$BH< D7D$5]#[B!1,^B979\>Z
M&BQ,&6:Y!L]T38R*)@,ABK2O'0 \&/K7W_=J<!?M;W\UN(O,>S@<GR[P9&>4
MY3F 8QI!>4/Q9A81,@O%12F3->W>=>]?6AWA4G GG6]?6MU% =U":5/_"9JK
MJ.KK&%MJRE($1.261.0BQURL5FV6+Y]B:74GQ>]26MU%"R=06J4LV+)$=D>Z
M%Y2(D+""00,B8TK,D%GR+>?3GG)I=2>E[EA:W47"8P/F+"4\IVQUA8^+ZWJ-
MCN)&&,: ^3H74Q4%WDL+T5OC,%1^]5:@V>[[1AZ'W00X#23=P_GU;,.&%MRX
M[ 245'=0H#$0G,Y0B$>&+AG;9F'1X5U2(]PU'Q00#::&#C#U>#,'83\AAE+7
M^19B(@L(W!K0.MF25-+$XO]T2>VJ[:VZI'81?0?X>=BZXTJTC)PSY,36:W 8
M4 Z;($A9=!0L*-:D1GX275([:?>G75*[B'I$K"P7*R+^LKZM(-FMOK\/%[BV
M'I^(>E0>7&WU4G6&2XRVUF%EXJ1EP[=:C4:??P<F]*O[$'F*@%YOBO<YG081
M\L@@N?,0X^L"UU[W/DL;.[)")1')<"C$)[_KDR6_2PF ]0FU9"IO=Q&W%7*V
MIFH<AS.,XN>MM3!V\O7;_#Q?A-GGD+XM7\__[^M]$YPS9Q@EC2Q2^JB8 L<3
M5G^L-2K-MUWZ\>C'CP>(1CJ<#RK0#L*7K6X+L[&&*PG(4]T=8!!<$@QLTBP%
MGSU/38:-#]7JU.Q=<IOT:FB5=("RQRM89Y>K;_/%]+\QGUU4V^03KAG+7CC@
MI;X%"XI"N60R 2/&9))U632Y#MN2OBX"ZN%P\?S%_B!*&OO0>YRGZ>8]=E[-
MPPU[8<W>)/! _Z.$UL<Z;S^ZFJK0/T(TP;-@N"QEJP-QYZ\^@=ZE/=!U!#5T
MZ^ ^88TPIK.OMT9T)R[9F)--/IC" J1@''&:/7@=-;A2N/%1\:R.Z/.V(?D$
M^IL&=X.#J[(_T#[6QYHH?5**4S3K2JZ/LQF0[#PH+;WU46?;<.S'LZ1UL6;[
M6" \5#4=@.UC^+Z>B/SK?''+UX=RIZ8W,4)&88V%[+&^H/0, F<&N-,44I1B
M;)O5[C\GK8O-W,W -K!J.@#;[?5GOG?_N?QU6D=Q+^IP[3#-MQW3 9T-F0,S
MLKZ5R^2U91& TE#*[I5 V63$PLZ4=K'GNQD4VRKN!%N,;Z_;YH6$<[5.%O-3
M(T/?XVI>QX4.VH-\( VMFY2'%%&;+N:8HA(B"I LU^<83H$+20%CB<)"[:S.
M33H3ANEBOFXH^9E@[TXP*Q%CJ>NWK; (2C@&T0L%T66M,?"Z-7G;%IX=OK>'
M LU>6K_?O--*UF/78[9@K8[]O%V;_?I;F'W%Y=L9F>UOE('5WZWS:E^'Y;=?
MS^?_^@_,]-M7R[6O9R7?:$"%C,2! NUX!,7)2(+G"GA EB6E9L*XH5 X'-DC
MKD-OB;P=$3X2#/H(7ML+9Q*%#,H4#C[%NGTI6/#:)2@I61]8S-$WR>R/PEW?
M)C06M!_&VIWAK)O5M4_)XX\9I3SGM?AWS?^'V2_TW7^MY;,\6TR7T]G7N\6:
M&SGX)$IVP@)E*^0KC=(0 A8(1<?:S$NA09-WJ\.S,LX]Q8D9U\@(ZN 8>TY!
MGS#5$L*T4&ZW!L[-QK2JG+,/K]_^()4;$3B#3NN2P80L-UN%"]8]V-FB0Z=R
M:7)H->!EG$N4%V)%Q\)0/ZN@GI/$'2[_UR4YE_*]WE,MK[1RZSZ8SZ&6<+E1
MG YB(R%PP0!=LBI;F71H,D'F8,K'N>EY098R/#[V/U[FJW!^2EE2RKP^D8(4
MZXVN3^0L M.0A"K!2Y6D92\[2QK\5NO$#*L_G(V\6&07_9W]%:;GM2&R;H$.
MY_@9$T6V=;W [6G]0%NFA!2L8J!TI#BW\/JVNHX-%($D9#TZL=V;X89$]IT#
M';-&UUS%':0R#40Q83YRO5Y!FFQM<*. -'!K06)QW$;#DVBR>[$!+_U7V]J#
M=+]3HQEBNJ^D;<O]*RSSV@;P5*YW&[_&8G)]L@')U@69-E9'QQ)@#%X8C)GA
MT?.;03GL^\P9Q<SZ1%<')]9AA9.-Q#Z46YG="*+P@@:%!2.C!15<AJBB :><
M-8JE$%.3B6S-..J_$->561T//:=1?-OI"+<N,<:9@BQB7:B;-2DE%M#6N(#)
M1*F:[,(X:J0W:BFN*UMIAHW3J;_M) *N?31:!"A6DC)X=!"0:^"<19^<%X$U
M,8^Q<J)1:VLO(B?:!3&=+.2]K11^6839\OS>*?KY\N(B+'Y8!\N8U=)F!D(7
M0XD?"=U9E8$E8K(PC11\MC"+G2GM.Y0ZM"IV' 5VD#QL::C$'4Z_SEY?$HFS
M]/U18=P8:M9*Z\2(<9EJ@=MI<((+0&.Y24%@YDW6I33@9>09MVW1MY_/;@:%
M[NM8CW%.!V7E?);OR.'Z)NBY!A]+R8]/.H-0*M!A)@-X5WL4F"B92\<R'C4[
M&)"WD<<@'M5F>H-*!R?*KK[C,;'\O/#P:=-9]\>?\]FZ K%X-_T_E].\_N.W
M?0X^4U08'(BZW4R5D"%$A<"CU,H+[4)I,N>Z(QF,//:M"VOL'7JG4?W:5H*/
MA $I<X.Y=M_%(B@,L!*"<ARR4\5:*V6,34:LMF%GY$%4)V=2!P+B= I@NX7&
MW!I)V2>86.=]9^DA*A=!:^N2B(74U"33'RM+:C8RX05D23M H9/*UE.\_X)E
M.L/\"F?TP^KC.;']D.&/\\5:$JO58AHO5[4 ^&7^<:WLF^JC--ZA)_A2AI@H
MUO4!''<,LK)1<F6":K-*O#5C?5^K#%4WZPH>'21%6WJ->^*IO[T^3-=_Y^.<
M>%]OWZO"6LONQH-H7E2*-D$2PH.R:,!GS<#6P;=,DZI8DQ=GC?D:M_S6%XCW
M.X>.@JCN*W=5$L_R_K@N=V@92E%I2])RJ$N=@^/ N52@SH;UNGA,^N@-:2T9
M'K?&U[5AG@0&.S@2#VL\VEJ2-^(1'F-PP0$SBG2JR:$YETE:/&8N/7>R3;YU
M9#['K?>=K&6.C;C^2X"'JG"BZSY7;R)P;C5EN<F#*\K556>U^8G)1OOD6S$T
M;AGP)"WMJ!@ZG;KAWD$Z'?0V"9,AI+J:5',!41@#/"E?8D%NVLS0[R'M:U9/
M[-JR>D)4)Z7(+47RH+]11(MHM 94*8#"P"&@K&FNCS(IF\9]E;?7,]31NDR'
M*AP>0YD=)#\[LCEQ0I=05R^&$"PH[R4X6Q"2Y\+XK)2W8UX6]5&O.PIV#L/K
M3HH<O:RV-O[GV-J^..$I#U):.]!U28)**8++F9'(46<=>-3EWEC<)Q[Z#T+.
MN.6K8^)T)!5VX&+OL[3.XW\N^:L;V]7]>6R9*:&B!U]XW8.$GDXS32><"DIE
M:X.,34;&#\G$N)6A,9SS:! XM)K3O,"Z3:XMBO$I4H9"F0 'I21"\-E R<45
MG9..I4E\?"#=XY9EQH#Y,15].D65VY0V,,9Y=H#9U7=C3D.L!=E2K% YH,UV
MS.G'?10]3B%VWD61G=0FKO8WU24FE!P3#_^<KKY]FY_GZ>QK??)8?_=5W?E4
M62>^U^J>Q.2X%G2^),1$)PV+$ QGH(TU3*!)W#9Y/[4/L3TL,CQH"\/1--7_
M0IK_./OTYM79YS>_O/[P^\<W[S^??7G[X?V/Y&^Y5N;Q3QIX.<P6Y ZTXN67
MZ3*=SXF$JTU9-_K_A&OG]7J^7"W7"(D5(=<KMFY@R7E"H9&!5X42IX@97*DE
M5N%8"HG%))M<?!U&]J&N;^MO?W7WV[^0REZ=US5D7**WOA30*I-M)2G!*:4@
MF5R"](H5;!)^'DCWN"6P(R+UO@,]IKY/U)>N]X7OMZCKN<\[AE]]C/0^O"M2
M]D*0C2"TRZ R*^ TK^])0@H<,7NC7IYW_9R^8;Y<3UYZ-#19[^G[\&?]<7F6
M2-,4)ZUU>&MP7CO#G0F@LQ5D<!1.!VT]4"A#3L Q9*G)HZS#23]I'[L+7A\$
MJ<?5>@=5W)]Q_ E)K--4=TA6WO^834G4]1;R"?8-$1FE9I!#'4I&*2,$26>=
M9N@8UT'(V":W&I:/<=.NCBV@)1ZZ,H>[3%>!_Y"D;D1^MEC4^>17TC]??SK]
MZ:=$MU;;J^^U'^2>D#3*G(,/P$HHH 2)*RK27^222=1U8EF3[O91N!WWFJ0+
MT^H56ST8X*/LW1'&J^\/157]S^94_HW^X&KY=G9UN?1/G'[]1FH]^PL7X2NN
M?_,7TO.O8;KX1SB_Q'O"$E:@"3R"QGIX!UOOH P)RS"AA2']LB;]?J-R/>Z%
MSI@&>3)8.]%\_"SG:?V*</YV5N:+B_7W';).>_=O.4;NOCV;?63T41D6$F>4
MD]3M1,$A>%<B)'0R!N6B&;GR-TI&?_? ?<KPUR8\B6A4P2R(/TXQ;1*4X@EE
M@ >G9<B89*/[HZ$X..G\?A?T[IK=M,% !V'5%>7TA\_^/5U.$@I,/"8HO,:$
MG$3H>,H@O;7)L>2=;S- \BX5XX)P)"3<OZ'?6RU[8XJBDS@_5K#^I.AN&9_E
MFK2\#Q?XR_PB3&<3%IW&7#@X7Q0HZ0KE*IG".I:$RTDDW:B"U("9D?NU]T?7
MKI%R:T5WX$(?JWQ]^OS'[W@1<3$Q3#.+G@'/,H!BE(?XX"T4+:.V.F;AFXS3
M>9:JD5WLZ*!YT*XZE 8[@.,;2ICFWQ'7K&Q8T"PYJ8AF)72L5[P9R+@5,(&2
MF- ZR"9UQ$=H&;> WAWT#M56%\?]M3S6QTFT2F1C/$3F/"@O(H0DPCH6-]&3
M0'R3:^&[1(P,LBY"R+V5TH$/NV=@04HE)6K(/IJZ!D-!4-Q 45%&$PJ/RK6$
M5 \QV_[J? (7>\AV1&1</8<E/;&WLT3BFOZ%:SNIW&S<)D:D;TP,A$5);IB"
M65>'@'@9..?*26'O'7)/K;1][FOZ0,$^RILWD60'WF+O<OV[Z0S?KO!B.0G:
M^^B2!YMJ_YW6"GST 5*@Y"<8@RRUN6@]F/1Q;TW[..J.#(!3AOS[RVKA&W7]
ML 9J?2\UL89B6>29L!H3>91D(8J X'/.VJ+PQ3699]F*H<XSW8&!.91=#(F2
M#JR%N+_8].B]#G].5^'\BC'*^W'Q%]:')[]>KBX7^':YO QT*DX<5U$XSR$$
M2O>5S)3<99] RBRS",$IV^3EP,Z4=IY.M\5W6[UV -Q#&Q'>_!L7:;JLMGME
MTA.?7? BZ3JXBT([Y2QX@8$.7+)<3-8*UB25&IR3D>.>$W7L@^#B91G&O?:<
MS>_@Q\64_ 5*C")B@CID@X11"J7<08,@Y3EI%7+7Y!PX$G_C=GB]'",:#$.G
M;%I7;X+?SI:KQ>4ZX5N_+?_R+<PV J/CN."4Q'3=&3>I4VU*M C18YUU[@IX
M6SRI3R2N7%%&CG.E.QR/XTX7.%43:XRE'LRL1JTU+L5\=_G@50#[PZW0Q\M%
M^D8"6L^+G$@;9'&&U)$Y>1.M'&5=40(7A?.L,F>ES8FT'[U;P=^\5/@?0<?]
M0GG=V_PDEQ,M \,8.&A=(T[N$MDK:I",)1N#<:E1I6D?:K>"L?U[P7A _9YH
M&_MFP]F\W'G^>?W<[8\98>+L_/Q*,-6L!^]OW^_KC]'X/H!@^NB(%UHGZ9R
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MV?_G__K_ 5!+ 0(4 Q0    ( #"#E5(L"!#]. @  !PK   .
M  "  0    !E>"TS,3%Q,3(Q+FAT;5!+ 0(4 Q0    ( #"#E5*_"*N40 @
M "4K   .              "  60(  !E>"TS,3)Q,3(Q+FAT;5!+ 0(4 Q0
M   ( #"#E5+<?IF?9R$  'T- 0 >              "  = 0  !E>"TS,7AA
M;65N9&5D86YD<F5S=&%T961C92YH=&U02P$"% ,4    "  P@Y52ZM:[ ,\$
M  !L%   #@              @ %S,@  97@M,S(Q<3$R,2YH=&U02P$"% ,4
M    "  P@Y52D(J:R- $  "*%   #@              @ %N-P  97@M,S(R
M<3$R,2YH=&U02P$"% ,4    "  P@Y52XS55#J+\ 0#:11< $0
M    @ %J/   :7-R9RTR,#(Q,#,S,2YH=&U02P$"% ,4    "  P@Y52QA*0
MP@82  "]MP  $0              @ $[.0( :7-R9RTR,#(Q,#,S,2YX<V10
M2P$"% ,4    "  P@Y52Q=KZM3 K  #7S $ %0              @ %P2P(
M:7-R9RTR,#(Q,#,S,5]C86PN>&UL4$L! A0#%     @ ,(.54F35N,QZ4
M3GL# !4              ( !TW8" &ES<F<M,C R,3 S,S%?9&5F+GAM;%!+
M 0(4 Q0    ( #"#E5+6PVI->/(  .H4"@ 5              "  8#' @!I
M<W)G+3(P,C$P,S,Q7VQA8BYX;6Q02P$"% ,4    "  P@Y52<5@Z74.)  !&
M=08 %0              @ $KN@, :7-R9RTR,#(Q,#,S,5]P<F4N>&UL4$L%
3!@     +  L Q@(  *%#!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
